Citrus Sinensis ID: 038103
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 804 | 2.2.26 [Sep-21-2011] | |||||||
| P17801 | 817 | Putative receptor protein | N/A | no | 0.930 | 0.915 | 0.443 | 0.0 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | yes | no | 0.866 | 0.840 | 0.340 | 1e-108 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.915 | 0.844 | 0.341 | 1e-105 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.868 | 0.875 | 0.340 | 1e-100 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.881 | 0.813 | 0.314 | 6e-93 | |
| Q39202 | 832 | G-type lectin S-receptor- | no | no | 0.861 | 0.832 | 0.309 | 1e-88 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.349 | 0.339 | 0.484 | 3e-75 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.348 | 0.271 | 0.453 | 2e-64 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.369 | 0.412 | 0.417 | 9e-64 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.414 | 0.649 | 0.406 | 1e-63 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 647 bits (1669), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/802 (44%), Positives = 500/802 (62%), Gaps = 54/802 (6%)
Query: 29 LTRGNSLAVEK-ENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSV-----NRTVVWMAN 82
L G+SL VE E+ L S +GTFSSGFY+V T+A+ +S+W++ + N+T+VW AN
Sbjct: 32 LPLGSSLVVESYESSTLQSSDGTFSSGFYEVYTHAFTFSVWYSKTEAAAANNKTIVWSAN 91
Query: 83 RDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQ-AQLLETGNLVLVNEANT 141
DRPV+ +RS LTLQ++GN+ LTD D + VW + GVQ A+LL+TGNLV+ +
Sbjct: 92 PDRPVHARRSALTLQKDGNMVLTDYDGAAVWRADGNNFTGVQRARLLDTGNLVIEDSGGN 151
Query: 142 TIWKSFDSPTDTLLPSQLLTKNTTLVSM---RSPGTYLSGFYNLKFDDNNILDLIFNGPL 198
T+W+SFDSPTDT LP+QL+T T LV RSPG Y+ +F D ++L LI++ P
Sbjct: 152 TVWQSFDSPTDTFLPTQLITAATRLVPTTQSRSPGNYI-----FRFSDLSVLSLIYHVPQ 206
Query: 199 ISSIYWPNSAFTVFLNGRTPYNSSRRAYVNASGLFRSSDTF---KFNASDYGVGPKRRLT 255
+S IYWP+ ++ +GR YNS+R + SG+ SSD ASD G G KRRLT
Sbjct: 207 VSDIYWPDPDQNLYQDGRNQYNSTRLGMLTDSGVLASSDFADGQALVASDVGPGVKRRLT 266
Query: 256 LDYDGILRLYSFDESTRLWKISWLPAGLDYCTVHGLCGPNGICVNRPRQKTCICPNGFRR 315
LD DG LRLYS ++S W +S + A C +HGLCGPNGIC P TC CP G+
Sbjct: 267 LDPDGNLRLYSMNDSDGSWSVS-MVAMTQPCNIHGLCGPNGICHYSP-TPTCSCPPGYAT 324
Query: 316 NDPSDWIKGCSPLFNLSCDR---NELDFMELPNTDYYGYDLVTYGIGISLQECRNRCLSD 372
+P +W +GC + N +CDR + F+ LPNTD++G D + + +SL+ CR+ C+SD
Sbjct: 325 RNPGNWTEGCMAIVNTTCDRYDKRSMRFVRLPNTDFWGSDQ-QHLLSVSLRTCRDICISD 383
Query: 373 CKCKGFGYSTDGQGECFPKGNLLNGHNMPGKYV-SMHIKIPRGKINYSAELEKARVND-- 429
C CKGF Y +G G C+PK L +G P V ++++K+P G +A + ++ V D
Sbjct: 384 CTCKGFQYQ-EGTGSCYPKAYLFSGRTYPTSDVRTIYLKLPTGVSVSNALIPRSDVFDSV 442
Query: 430 ---LNCSAAAVVLGGDNANGEKPTKNRYMK--------YLISLAGSFAVIETVFISLGWW 478
L+C N + +P + + Y +F V+E FIS W+
Sbjct: 443 PRRLDCDRM-------NKSIREPFPDVHKTGGGESKWFYFYGFIAAFFVVEVSFISFAWF 495
Query: 479 YVFRRHVH-EEL--ANLGCIVLALGFKRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDD 535
+V +R + EL + G + F+R++Y EL +ATR FK E+G+G G+V++GVL+D
Sbjct: 496 FVLKRELRPSELWASEKGYKAMTSNFRRYSYRELVKATRKFKVELGRGESGTVYKGVLED 555
Query: 536 ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLD 595
+R VAVK+LE V QG F AE+S+IGRINH NLV++ GFC+E H+LLV EYVENGSL
Sbjct: 556 DRHVAVKKLENVRQGKEVFQAELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLA 615
Query: 596 KLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKV 655
+LF++ G +L W+ R+NIA+G AKGL+YLH ECLEWV+HCDVKP+NILLD FEPK+
Sbjct: 616 NILFSEGGNI-LLDWEGRFNIALGVAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKI 674
Query: 656 TDFGLSKLFKERHDTK-FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSA 714
TDFGL KL T+ S VRGT GY+APEW+ +L I AK DVYSYG+VLLELLTG
Sbjct: 675 TDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEWVSSLPITAKVDVYSYGVVLLELLTGTRV 734
Query: 715 SDYLSASASDSSYCNHLVQWVAKQM---EQEGLEKIIDPRLNDVYDREKLDRMVKVALLC 771
S+ + + S LV+ ++ ++ EQ ++ +D +LN + + ++K+A+ C
Sbjct: 735 SELVGGTDEVHSMLRKLVRMLSAKLEGEEQSWIDGYLDSKLNRPVNYVQARTLIKLAVSC 794
Query: 772 VAENRDTRPPMSKVVKLLTAHD 793
+ E+R RP M V+ L + D
Sbjct: 795 LEEDRSKRPTMEHAVQTLLSAD 816
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 394 bits (1012), Expect = e-108, Method: Compositional matrix adjust.
Identities = 268/788 (34%), Positives = 400/788 (50%), Gaps = 91/788 (11%)
Query: 32 GNSLAVEKENDFLVSPNGTFSSGFYKVGT-NAYCYSIWFTNSVNRTVVWMANRDRPVNGK 90
G+ + N SPN TFS F + N++ ++ F SV +W A
Sbjct: 30 GSVIYASGSNQNWPSPNSTFSVSFVPSPSPNSFLAAVSFAGSVP---IWSAG----TVDS 82
Query: 91 RSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNEANTTIWKSFDSP 150
R L L +G+L LT+ + VW + T + +TG +L+N + +W SFD+P
Sbjct: 83 RGSLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFDNP 142
Query: 151 TDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNSA-- 208
TDT++ SQ T L SG Y+ + + + L L +N S+IYW +
Sbjct: 143 TDTIVQSQNFTAGKIL---------RSGLYSFQLERSGNLTLRWN---TSAIYWNHGLNS 190
Query: 209 ----------FTVFLNGRTPYNSSRR---AYVNASGLFRSSDTFKFNASDYGVGPKRRLT 255
++ NG S A + SG + S+TF+F L
Sbjct: 191 SFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIVYSGDYGDSNTFRF------------LK 238
Query: 256 LDYDGILRLYSFDESTRLWKISWLPAGLDYCTVHGLCGPNGICVNRPRQKTCICPN-GFR 314
LD DG LR+YS S ++ + +D C V+G CG GIC C CP+ F
Sbjct: 239 LDDDGNLRIYS-SASRNSGPVNAHWSAVDQCLVYGYCGNFGICSYNDTNPICSCPSRNFD 297
Query: 315 RNDPSDWIKGCSPLFNLSCDRNELDFMELPNTDYYGY--DLVTYGIGISLQECRNRCLSD 372
D +D KGC LS ++L +T + Y D + CR CLS
Sbjct: 298 FVDVNDRRKGCKRKVELSDCSGNTTMLDLVHTRLFTYEDDPNSESFFAGSSPCRANCLSS 357
Query: 373 CKCKGFGYSTDGQGECFPK--GNLLNGHNMPGKYVSMHIKIPRGKINYSAELEKARVNDL 430
C +DG G C+ K G+ G+ P + ++K+ + + LE+A D
Sbjct: 358 VLCLASVSMSDGSGNCWQKHPGSFFTGYQWPSVPSTSYVKVCGPVV--ANTLERATKGDD 415
Query: 431 NCSAAAVVLGGDNANGEKPTKNRYMKYLISLAGSFAVIETVFISLG-WWYVFRRHVHEEL 489
N S + +++++A ++ V + +G WW R++
Sbjct: 416 NNSKVHL-------------------WIVAVAVIAGLLGLVAVEIGLWWCCCRKN--PRF 454
Query: 490 ANLGCIVLALGFK-----RFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRL 544
L L + +FTY EL+R T++FK+++G GGFG+V+RGVL + VVAVK+L
Sbjct: 455 GTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQL 514
Query: 545 EGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGT 604
EG+ QG+ +F EV+ I +H NLV+L GFC++ H+LLVYE++ NGSLD LF +
Sbjct: 515 EGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTT-DS 573
Query: 605 ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664
A L W+ R+NIA+GTAKG++YLHEEC + ++HCD+KP+NIL+DD+F KV+DFGL+KL
Sbjct: 574 AKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLL 633
Query: 665 KERHDT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASAS 723
+ + S VRGTRGYLAPEW+ NL I +K+DVYSYG+VLLEL++GK D S
Sbjct: 634 NPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFD-----VS 688
Query: 724 DSSYCNHLVQWVAKQMEQEGLEKIIDPRLND--VYDREKLDRMVKVALLCVAENRDTRPP 781
+ + W ++ E+ + I+D RL++ D E++ RMVK + C+ E RP
Sbjct: 689 EKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPT 748
Query: 782 MSKVVKLL 789
M KVV++L
Sbjct: 749 MGKVVQML 756
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 383 bits (983), Expect = e-105, Method: Compositional matrix adjust.
Identities = 278/813 (34%), Positives = 421/813 (51%), Gaps = 77/813 (9%)
Query: 27 PRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVG-TNAYCYSIWFTN-SVNRTVVWMANRD 84
P + G+ L + N VS NGTF+ GF + T+ + SIWF + T+VW NR+
Sbjct: 28 PHIGLGSKLKASEPNRAWVSANGTFAIGFTRFKPTDRFLLSIWFAQLPGDPTIVWSPNRN 87
Query: 85 RPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLL-ETGNLVLVNE---AN 140
PV K + L L+ GNL L+D+++ VVW++NT ++ GV++ ++ E+GN +L+ A
Sbjct: 88 SPVT-KEAVLELEATGNLVLSDQNT-VVWTSNT-SNHGVESAVMSESGNFLLLGTEVTAG 144
Query: 141 TTIWKSFDSPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNI---LDLIFN-- 195
TIW+SF P+DTLLP+Q LT + L S SP + G Y+LK + L L +N
Sbjct: 145 PTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSRH--GHYSLKMLQQHTSLSLGLTYNIN 202
Query: 196 -GPLISSIYWPNSAFTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKF-----------NA 243
P + YW + T ++ G + + N+
Sbjct: 203 LDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKIVYGESSIGAVYVYKNPVDDNRNYNNS 262
Query: 244 SDYGVGPK---RRLTLDYDGILRLYSFDE---STRLWKISWLPAGLDYCTVHGLCGPNGI 297
S+ G+ RRL L+ +G LRLY +D + W W A + C + G+CG NG+
Sbjct: 263 SNLGLTKNPVLRRLVLENNGNLRLYRWDNDMNGSSQWVPEW-AAVSNPCDIAGICG-NGV 320
Query: 298 C-VNRPRQKT-CICPNGFRRNDPSDWIKGCSPLFNL--SCDRN-----ELDFMELPNTDY 348
C ++R ++ C+C G + + K CS +L C+ N + T+Y
Sbjct: 321 CNLDRTKKNADCLCLPGSVKLPDQENAKLCSDNSSLVQECESNINRNGSFKISTVQETNY 380
Query: 349 YGYD--LVTYGIGIS-LQECRNRCLSDCKCKGFGYSTDGQGE-CFPKGNL-LNGHNMPGK 403
Y + ++ IS +++C CLSDCKC Y D + C+ +L G PG
Sbjct: 381 YFSERSVIENISDISNVRKCGEMCLSDCKCVASVYGLDDEKPYCWILKSLNFGGFRDPG- 439
Query: 404 YVSMHIKIPRGKINYSAELEKARVNDLNCSAAAVVLGGDNANGEKPTKNRYMKYLISLAG 463
S K R N + +++ K R +I +
Sbjct: 440 ---------------STLFVKTRAN----ESYPSNSNNNDSKSRKSHGLRQKVLVIPIVV 480
Query: 464 SFAVIETVFISLGWWYVFRRHVHEELANLGCIVLALGFKRFTYAELKRATRNFKQEVGKG 523
V+ + L ++ + R+ + A ++L FTY +L+ T NF Q +G G
Sbjct: 481 GMLVLVALLGMLLYYNLDRKRTLKRAAK-NSLILCDSPVSFTYRDLQNCTNNFSQLLGSG 539
Query: 524 GFGSVFRGVLDDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582
GFG+V++G + E +VAVKRL+ L G+ EF EV+ IG ++H NLV+L G+C+E+ H+
Sbjct: 540 GFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHR 599
Query: 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKP 642
LLVYEY+ NGSLDK +F+ TA++L W R+ IAV TA+G++Y HE+C ++HCD+KP
Sbjct: 600 LLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKP 659
Query: 643 QNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYG 702
+NILLDD+F PKV+DFGL+K+ H + +RGTRGYLAPEW+ N I KADVYSYG
Sbjct: 660 ENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRPITVKADVYSYG 719
Query: 703 IVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLD 762
++LLE++ G+ D +S A D Y W K++ K +D RL V + E++
Sbjct: 720 MLLLEIVGGRRNLD-MSYDAEDFFYPG----WAYKELTNGTSLKAVDKRLQGVAEEEEVV 774
Query: 763 RMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795
+ +KVA C+ + RP M +VVKLL E
Sbjct: 775 KALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDE 807
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 367 bits (943), Expect = e-100, Method: Compositional matrix adjust.
Identities = 264/776 (34%), Positives = 388/776 (50%), Gaps = 78/776 (10%)
Query: 33 NSLAVEKENDFLVSPNGTFSSGFYKV--GTNAYCYSIWFTNSVNRTVVWMANRDRPV-NG 89
S + K N ++S F GF+ G++ + I + + T VW+ANR RPV +
Sbjct: 22 QSKVIIKGNQTILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDP 81
Query: 90 KRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNEANTTIWKSFDS 149
S L L G L +++ VVW T+ G + ETGNL+L+N+ + +W+SFD+
Sbjct: 82 DSSTLELTSTGYLIVSNLRDGVVWQTDN-KQPGTDFRFSETGNLILINDDGSPVWQSFDN 140
Query: 150 PTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDN-NILDLIFNG--PLISSIYWPN 206
PTDT LP +T T + S RS GFY+L+ + N L++ G P S+ W
Sbjct: 141 PTDTWLPGMNVTGLTAMTSWRSLFDPSPGFYSLRLSPSFNEFQLVYKGTTPYWSTGNWTG 200
Query: 207 SAFTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKFNASDYGVGPKRRLT---LDYDGILR 263
AF PY R +VN + + +F + + RLT + +G L+
Sbjct: 201 EAFVGVPEMTIPY-IYRFHFVNP---YTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLK 256
Query: 264 LYSFDESTRLWKISWLPAGLDYCTVHGLCGPNGICVNRPRQKTCICPNGFR-RNDPS--- 319
Y++D T+ W + WL D C V+ LCG G C + K C C GFR RND +
Sbjct: 257 QYTWDPQTQSWNMFWLQPE-DPCRVYNLCGQLGFCSSE-LLKPCACIRGFRPRNDAAWRS 314
Query: 320 -DWIKGCSPLFNLSCDRNELDFMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCKGF 378
D+ GC S +++ D E Y D+ + +S C CL + C GF
Sbjct: 315 DDYSDGCRRENGDSGEKS--DTFEAVGDLRYDGDVKMSRLQVSKSSCAKTCLGNSSCVGF 372
Query: 379 GYSTDGQGECFPKGNLLNGHNMPGKYVSMHIKIPRGKINYSAELEKARVNDLNCSAAAVV 438
+ K NL + ++ P N + K+ + + CS V
Sbjct: 373 YHKE--------KSNL----------CKILLESPNNLKNSKGNISKSII--ILCS----V 408
Query: 439 LGGDNANGEKPTKNRYMKYLISLAGSFAVIETVFISLGWWYVFRRHVHEELANLGCIVLA 498
+G IS+ G ++ + + R E+ G VL
Sbjct: 409 VGS-----------------ISVLGFTLLVPLILLKRSRKRKKTRKQDED----GFAVLN 447
Query: 499 LGFKRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERV-VAVKRLEGVLQGDAEFWAE 557
L K F++ EL+ AT F +VG GGFG+VF+G L VAVKRLE G++EF AE
Sbjct: 448 L--KVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAE 505
Query: 558 VSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIA 617
V IG I H NLV+L+GFC+EN H+LLVY+Y+ GSL L + +L W+ R+ IA
Sbjct: 506 VCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRT--SPKLLSWETRFRIA 563
Query: 618 VGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG 677
+GTAKG++YLHE C + ++HCD+KP+NILLD + KV+DFGL+KL + +RG
Sbjct: 564 LGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRG 623
Query: 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKS----ASDYLSASASDSSYCNHLVQ 733
T GY+APEW+ L I KADVYS+G+ LLEL+ G+ SD L ++
Sbjct: 624 TWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKW-FFPP 682
Query: 734 WVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
W A+++ Q ++ ++D RLN Y+ E++ RM VA+ C+ +N + RP M VVK+L
Sbjct: 683 WAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKML 738
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 342 bits (878), Expect = 6e-93, Method: Compositional matrix adjust.
Identities = 260/826 (31%), Positives = 389/826 (47%), Gaps = 117/826 (14%)
Query: 27 PRLTRGNSLAVEK-ENDFLVSPNGTFSSGFYKVGTNAYCYSIWFT--NSVNRTVVWMANR 83
P T N V+ + FL+S N F +G + G + +F+ + + + +W +NR
Sbjct: 32 PNFTASNLRFVDSSKGAFLLSRNSIFKAGLFSPGGDDSSTGFYFSVVHVDSGSTIWSSNR 91
Query: 84 DRPVNGKRSKLTLQRNGNLALTDKDSSV-VWSTNTFTDEGVQAQLLETGNLVLVNEANTT 142
D PV+ + L G + D S + VWST +L + GNL+L++ N +
Sbjct: 92 DSPVSSS-GTMNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLRLTDAGNLLLLDHLNVS 150
Query: 143 IWKSFDSPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYN---------LKFDDNNILDLI 193
+W+SFD PTD+++ Q L L S + +G Y +++ N L
Sbjct: 151 LWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGESDGLMQWRGQNYWKLR 210
Query: 194 FNGPLISSIYWPNSAFTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKFNASDYGVGPKRR 253
+ +P TV +G + V L SSD R
Sbjct: 211 MHIRANVDSNFPVEYLTVTTSGLALMARNGTVVVVRVALPPSSDF-------------RV 257
Query: 254 LTLDYDGILRLYSFDESTRLWKISWLPAGLDYCTVHGLCGPNGICV--NRPRQKTCICPN 311
+D G + F + + S +D C + +CG G+C N ++C CP+
Sbjct: 258 AKMDSSGKFIVSRFSGKNLVTEFS---GPMDSCQIPFVCGKLGLCNLDNASENQSCSCPD 314
Query: 312 GFRRNDPSDWIKG-CSPL-----FNLSCDRNELDFMELP-NTDYYGY---DLVTYGIGIS 361
R D KG C P+ +SC+ + ++EL Y+ D V +G+
Sbjct: 315 EMRM----DAGKGVCVPVSQSLSLPVSCEARNISYLELGLGVSYFSTHFTDPVEHGL--P 368
Query: 362 LQECRNRCLSDCKCKGFGYST---------DGQGECFPKGNLLNGHNMPGKYVSMHIKIP 412
L C + C +C C G Y D G N H++ G YV + I+
Sbjct: 369 LLACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLIG-YVKLSIR-- 425
Query: 413 RGKINYSAELEKARVNDLNCSAAAVVLGGDNANGEK-PTKNRYMKYLISLAGSFAVIETV 471
K N A G +N G P L+ +G F +I
Sbjct: 426 --KTN------------------AQPPGNNNRGGSSFPV---IALVLLPCSGFFLLIA-- 460
Query: 472 FISLGWW---YVFR----------RHVHEELANLGCIVLALGFKRFTYAELKRATRNFKQ 518
+ L WW V R R E +LG + ++F + EL++AT NFK
Sbjct: 461 -LGLLWWRRCAVMRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKM 519
Query: 519 EVGKGGFGSVFRGVLDDERVVAVKRLEGV-LQGDAEFWAEVSIIGRINHRNLVKLQGFCA 577
++G GGFGSV++G L DE ++AVK++ L G EF E++IIG I H NLVKL+GFCA
Sbjct: 520 QIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCA 579
Query: 578 ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLH 637
LLVYEY+ +GSL+K LF+ G +L+W +R++IA+GTA+GL+YLH C + ++H
Sbjct: 580 RGRQLLLVYEYMNHGSLEKTLFS--GNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIH 637
Query: 638 CDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKAD 697
CDVKP+NILL DHF+PK++DFGLSKL + + F+ +RGTRGYLAPEW+ N I KAD
Sbjct: 638 CDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKAD 697
Query: 698 VYSYGIVLLELLTGKSASDYLSASAS--DSSYCNHLVQ------------WVAKQMEQEG 743
VYSYG+VLLEL++G+ + S S S + + NH + EQ
Sbjct: 698 VYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGR 757
Query: 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
++ DPRL ++ +++V++AL CV E RP M+ VV +
Sbjct: 758 YMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPTMAAVVGMF 803
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 328 bits (841), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 247/799 (30%), Positives = 381/799 (47%), Gaps = 106/799 (13%)
Query: 46 SPNGTFSSGFYKVGTN-AYCYSIWFTNSVNRTVVWMANRDRPVNG---KRSKLTLQRNGN 101
SP+G F+ GF K+ N + SIWF ++T+VW A G SK+TL +G
Sbjct: 52 SPSGDFAFGFRKIQPNDGFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGG 111
Query: 102 LALTDKDSSVVW--------STNTFTDEGVQAQLLETGNLVLV----NEANTTIWKSFDS 149
L + D +W S FTD+G N VL +++ +W SF++
Sbjct: 112 LVIADPRGQELWRALSGGSVSRGRFTDDG---------NFVLFRDGSEDSDEVLWSSFEN 162
Query: 150 PTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNSAF 209
PTDTLLP+Q + L S R+ ++ G ++L+ +D+ L L L + + +
Sbjct: 163 PTDTLLPNQNIEVGRNLSSRRTETSFKKGRFSLRLEDDGNLQL---HSLNAETASESDIY 219
Query: 210 TVFLNGRT--PYNSSRRAYVNASG----LFRSSDTFKFNASDYGVGPKRRLTLDYDGILR 263
+ + T P N + N SG L R++ F D + +L
Sbjct: 220 SQYYESNTNDPNNPGIQLVFNQSGEIYVLQRNNSRFVVKDRDPDFSIAAPFYISTGFLLS 279
Query: 264 LYSFDESTRLWKISWLPAGLD-YCTV-----HGLCGPNGIC-VNRPRQKTCICPNGFRRN 316
E+ R+ L D C+ + CG N IC + ++ C CP F
Sbjct: 280 TIIPKEARRIVGGCLLGLCRDNMCSPDDALGNMACGYNNICSLGNNKRPKCECPERFVLK 339
Query: 317 DPSDWIKGCSPLFNL-SC---------DRNELDFMELPNTDYYGYDLVTYGIGISLQECR 366
DPS+ C P F + +C D N +F+ L T++ D +Y + C+
Sbjct: 340 DPSNEYGDCLPDFEMQTCRPENQTANSDVNLYEFITLEKTNWPFGDYESYA-NYDEERCK 398
Query: 367 NRCLSDCKCKGFGYSTDGQGECFPKGNLLNGHNMPGKYVSMHIKIPRGKINYSAELEKAR 426
CLSDC C + T+ +C+ K P +S + PRG S K R
Sbjct: 399 ASCLSDCLCAAVIFGTNRDLKCWKK-------KFP---LSHGERSPRGD---SDTFIKVR 445
Query: 427 VNDLNCSAAAVVLGGDNANGEKPTKNRYMKYLISLAGSFAVIETVFISLGWWYVFRR--- 483
N S A V + G+ A + + +LI +A S + + F+ +R+
Sbjct: 446 ----NRSIADVPVTGNRA--------KKLDWLI-IACSVLLGTSAFVIFDTSCSYRKTKK 492
Query: 484 ---HVHEELANLGCIVLA-----LGFKRFTYAELKRATRNFKQEVGKGGFGSVFRGVLD- 534
+ + ++G L + FTY EL ATR+F +E+G+G FG V++G L+
Sbjct: 493 SKNMMKNQARDIGRTTATTTANELNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYLEV 552
Query: 535 ---DERVVAVKRLEGV-LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590
E VAVK+L+ + L + EF EV +IG+I+H+NLV+L GFC E + +++VYE++
Sbjct: 553 AGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLP 612
Query: 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH 650
G+L LF P + W+ R NIAV A+G+ YLHEEC E ++HCD+KPQNILLD++
Sbjct: 613 QGTLANFLFRRPRPS----WEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEY 668
Query: 651 FEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
+ P+++DFGL+KL + +RGT+GY+APEW N I +K DVYSYG++LLE++
Sbjct: 669 YTPRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVC 728
Query: 711 GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALL 770
K A D L+ W Q LE + + + D E ++R VK+A+
Sbjct: 729 CKKAVDLEDNVI--------LINWAYDCFRQGRLEDLTEDDSEAMNDMETVERYVKIAIW 780
Query: 771 CVAENRDTRPPMSKVVKLL 789
C+ E RP M V ++L
Sbjct: 781 CIQEEHGMRPNMRNVTQML 799
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 283 bits (724), Expect = 3e-75, Method: Compositional matrix adjust.
Identities = 140/289 (48%), Positives = 193/289 (66%), Gaps = 8/289 (2%)
Query: 504 FTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGR 563
F+Y EL+ AT+NF ++G GGFGSVF+G L D +AVKRLEG+ QG+ +F EV IG
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGT 542
Query: 564 INHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLF-NDPGTASILQWDQRYNIAVGTAK 622
I H NLV+L+GFC+E KLLVY+Y+ NGSLD LF N +L W R+ IA+GTA+
Sbjct: 543 IQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTAR 602
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
GL+YLH+EC + ++HCD+KP+NILLD F PKV DFGL+KL + +RGTRGYL
Sbjct: 603 GLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYL 662
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742
APEW+ + I AKADVYSYG++L EL++G+ ++ S++ W A + ++
Sbjct: 663 APEWISGVAITAKADVYSYGMMLFELVSGRRNTE-----QSENEKVRFFPSWAATILTKD 717
Query: 743 G-LEKIIDPRLN-DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
G + ++DPRL D D E++ R KVA C+ + RP MS+VV++L
Sbjct: 718 GDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQIL 766
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 247 bits (631), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 132/291 (45%), Positives = 185/291 (63%), Gaps = 11/291 (3%)
Query: 504 FTYAELKRATRNF--KQEVGKGGFGSVFRGVLDDERVVAVKRLE-GVLQGDAEFWAEVSI 560
FTY+ELK AT++F ++G+GGFG V++G L+D RVVAVK L G QG +F AE+
Sbjct: 682 FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVA 741
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT 620
I + HRNLVKL G C E EH++LVYEY+ NGSLD+ LF D L W RY I +G
Sbjct: 742 ISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLH--LDWSTRYEICLGV 799
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG 680
A+GL YLHEE ++H DVK NILLD P+++DFGL+KL+ ++ +RV GT G
Sbjct: 800 ARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIG 859
Query: 681 YLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740
YLAPE+ M + K DVY++G+V LEL++G+ SD + +L++W E
Sbjct: 860 YLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSD-----ENLEEEKKYLLEWAWNLHE 914
Query: 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791
+ ++ID +L D ++ E+ RM+ +ALLC + RPPMS+VV +L+
Sbjct: 915 KSRDIELIDDKLTD-FNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSG 964
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 245 bits (626), Expect = 9e-64, Method: Compositional matrix adjust.
Identities = 131/314 (41%), Positives = 194/314 (61%), Gaps = 17/314 (5%)
Query: 486 HEELANLGC---IVLALGFKRFTYAELKRATRNFKQE--VGKGGFGSVFRGVLDDERVVA 540
H ++ + G +L G F+Y EL T+ F ++ +G+GGFG V++G L D +VVA
Sbjct: 338 HHQMQSSGTPDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVA 397
Query: 541 VKRLE-GVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLF 599
VK+L+ G QGD EF AEV II R++HR+LV L G+C ++H+LL+YEYV N +L+ L
Sbjct: 398 VKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLH 457
Query: 600 NDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659
+L+W +R IA+G+AKGL+YLHE+C ++H D+K NILLDD +E +V DFG
Sbjct: 458 GK--GLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFG 515
Query: 660 LSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLS 719
L++L +RV GT GYLAPE+ + K+ ++DV+S+G+VLLEL+TG+ D
Sbjct: 516 LARLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQ 575
Query: 720 ASASDSSYCNHLVQW----VAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAEN 775
+S LV+W + K +E L ++ID RL Y ++ RM++ A CV +
Sbjct: 576 PLGEES-----LVEWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHS 630
Query: 776 RDTRPPMSKVVKLL 789
RP M +VV+ L
Sbjct: 631 GPKRPRMVQVVRAL 644
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 245 bits (625), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 144/354 (40%), Positives = 210/354 (59%), Gaps = 21/354 (5%)
Query: 459 ISLAGSFAVIETVFISLGWWYVFRRHVHEELANLGCIVLALGFKR--FTYAELKRATRNF 516
IS+ G V+ +F + ++ ++ A I L LG + FTY EL RAT F
Sbjct: 129 ISIGGGVFVLTLIF-----FLCKKKRPRDDKALPAPIGLVLGIHQSTFTYGELARATNKF 183
Query: 517 KQE--VGKGGFGSVFRGVLDDERVVAVKRLE-GVLQGDAEFWAEVSIIGRINHRNLVKLQ 573
+ +G+GGFG V++G+L++ VAVK+L+ G QG+ EF AEV+II +I+HRNLV L
Sbjct: 184 SEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLV 243
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
G+C +LLVYE+V N +L+ L ++W R IAV ++KGLSYLHE C
Sbjct: 244 GYCIAGAQRLLVYEFVPNNTLEFHLHGK--GRPTMEWSLRLKIAVSSSKGLSYLHENCNP 301
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKID 693
++H D+K NIL+D FE KV DFGL+K+ + + +RV GT GYLAPE+ + K+
Sbjct: 302 KIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTFGYLAPEYAASGKLT 361
Query: 694 AKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW----VAKQMEQEGLEKIID 749
K+DVYS+G+VLLEL+TG+ D + A DS LV W + + +E+ E + D
Sbjct: 362 EKSDVYSFGVVLLELITGRRPVDANNVYADDS-----LVDWARPLLVQALEESNFEGLAD 416
Query: 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQDESIS 803
+LN+ YDRE++ RMV A CV RP M +VV++L + S ++ I+
Sbjct: 417 IKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGNISPSDLNQGIT 470
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 804 | ||||||
| 225435226 | 797 | PREDICTED: putative receptor protein kin | 0.973 | 0.982 | 0.662 | 0.0 | |
| 449440305 | 791 | PREDICTED: putative receptor protein kin | 0.957 | 0.973 | 0.622 | 0.0 | |
| 449440309 | 806 | PREDICTED: putative receptor protein kin | 0.983 | 0.981 | 0.592 | 0.0 | |
| 449440307 | 811 | PREDICTED: putative receptor protein kin | 0.963 | 0.955 | 0.596 | 0.0 | |
| 359482077 | 803 | PREDICTED: putative receptor protein kin | 0.936 | 0.937 | 0.492 | 0.0 | |
| 147791818 | 809 | hypothetical protein VITISV_042870 [Viti | 0.936 | 0.930 | 0.494 | 0.0 | |
| 359482081 | 803 | PREDICTED: putative receptor protein kin | 0.940 | 0.941 | 0.490 | 0.0 | |
| 359482079 | 801 | PREDICTED: LOW QUALITY PROTEIN: putative | 0.935 | 0.938 | 0.485 | 0.0 | |
| 359482073 | 809 | PREDICTED: putative receptor protein kin | 0.940 | 0.934 | 0.484 | 0.0 | |
| 225440502 | 809 | PREDICTED: putative receptor protein kin | 0.972 | 0.966 | 0.463 | 0.0 |
| >gi|225435226|ref|XP_002282125.1| PREDICTED: putative receptor protein kinase ZmPK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1088 bits (2814), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 526/794 (66%), Positives = 638/794 (80%), Gaps = 11/794 (1%)
Query: 13 APTVAWSQAWSQGIPRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNS 72
PTVA A + +P L G SL+VEKE LVSP G+FSSGFY+VGTN YCY+IWFTNS
Sbjct: 13 GPTVA--LALTHKLPSLKPGLSLSVEKEGQLLVSPEGSFSSGFYRVGTNVYCYAIWFTNS 70
Query: 73 VNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLLETGN 132
+TVVWMANRDRPVNGK S+LTL RNGNL LTD D S+VWST+TF+D V+ QLLETGN
Sbjct: 71 AEKTVVWMANRDRPVNGKGSRLTLHRNGNLVLTDADGSIVWSTDTFSDGEVEVQLLETGN 130
Query: 133 LVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNILDL 192
LVL+N+A IW+SFD PTDTLLP+Q LT+NT+LVSMRS T+ SGFY +FDDNN+L+L
Sbjct: 131 LVLINQAKEVIWESFDFPTDTLLPTQPLTRNTSLVSMRSRDTFSSGFYRFQFDDNNLLNL 190
Query: 193 IFNGPLISSIYWPNSAFTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKFNASDYGVGPKR 252
+++GP++SS+YWP TVF + RTPYNS++ A +N G FRSSD KFNASDYGVGPKR
Sbjct: 191 VYDGPVVSSVYWP---LTVFFSRRTPYNSTKIAALNNMGRFRSSDNLKFNASDYGVGPKR 247
Query: 253 RLTLDYDGILRLYSFDESTRLWKISWLPAGLDYCTVHGLCGPNGICVNRPRQKTCICPNG 312
RLTLDYDGILRLYS DE T +W+I+WLP+G+D C VHGLCG G+C P +C CP+G
Sbjct: 248 RLTLDYDGILRLYSLDELTGIWEIAWLPSGVDACLVHGLCGEYGVCRYNP-LPSCACPDG 306
Query: 313 FRRNDPSDWIKGCSPLFNLSCDRNELDFMELPNTDYYGYDLVTYGIGISLQECRNRCLSD 372
F RNDPSDW KGCSP FN+SC EL FMEL +TDY+GYDL +Y IGISL+ C+N CL+D
Sbjct: 307 FDRNDPSDWTKGCSPSFNMSCAPAELGFMELLHTDYFGYDLNSYNIGISLEACKNACLND 366
Query: 373 CKCKGFGYSTDGQGECFPKGNLLNGHNMPGKYVSMHIKIPRGKINYSAELEKARVND-LN 431
C CKGFGY+ DGQG+C+PK LLNG++MP + MHIK+P+G + A EK R D LN
Sbjct: 367 CTCKGFGYALDGQGQCYPKRYLLNGYHMPDTAMIMHIKVPKGIMASQAGGEKLRTYDQLN 426
Query: 432 CSAAAVVLGGDNANGEKPTKNRYMKYLISLAGSFAVIETVFISLGWWYVFRRHVHEELAN 491
CS +VL NA E P KN YMKYLIS AGS AVIE VFI LGWW+VFR+ + EEL N
Sbjct: 427 CSTPEIVLRNINAGAENPNKNWYMKYLISFAGSVAVIEIVFIGLGWWFVFRKRIREELVN 486
Query: 492 LGCIVLALGFKRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEG-VLQG 550
+G IVLA+GFK FT+ ELKRATRNF++E+G+GGFG+V++GVLDD+R+VAVKRLEG +LQG
Sbjct: 487 MGYIVLAMGFKHFTFGELKRATRNFREEIGRGGFGTVYKGVLDDKRIVAVKRLEGIILQG 546
Query: 551 DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQW 610
D+EFWAEVSIIG+INHRNLVK+ GFCAEN+ KLLVYEY+ENGSLDK+LF+ +A L W
Sbjct: 547 DSEFWAEVSIIGKINHRNLVKMWGFCAENDDKLLVYEYLENGSLDKILFS-ADSAMRLGW 605
Query: 611 DQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670
+QRYNIA+GTAKGLSYLHEECLEWVLHCDVKPQNILLDDH EPKVTDFGLSKLFK+ +D
Sbjct: 606 EQRYNIAIGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHLEPKVTDFGLSKLFKDTNDM 665
Query: 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNH 730
FSRVRGTRGYLAPEWM+NL+I+AKADVYSYG+VLLELLTGK AS + A+A S + N
Sbjct: 666 GFSRVRGTRGYLAPEWMINLRINAKADVYSYGVVLLELLTGKRASGFNLATAEGSGH-NQ 724
Query: 731 LVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790
+VQW +++++ LE++IDPRL ++++ RMV+VALLCV ++RDTRP MSKVV+LL
Sbjct: 725 MVQWFRLKIQEQELEEVIDPRLEKRCHKKEVQRMVRVALLCVEDDRDTRPAMSKVVELLV 784
Query: 791 AHDHESSQDESISD 804
+ E +E ++D
Sbjct: 785 G-EEELVPNEEMTD 797
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440305|ref|XP_004137925.1| PREDICTED: putative receptor protein kinase ZmPK1-like [Cucumis sativus] gi|449483675|ref|XP_004156656.1| PREDICTED: putative receptor protein kinase ZmPK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 983 bits (2541), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 484/777 (62%), Positives = 586/777 (75%), Gaps = 7/777 (0%)
Query: 22 WSQGIPRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMA 81
W +G LT+GNS+ VE EN FL S NG FSSGFYKVG N++ +SIWF S ++TVVWMA
Sbjct: 18 WPEGTTTLTQGNSIDVEDENQFLTSTNGIFSSGFYKVGNNSFSFSIWFARSADKTVVWMA 77
Query: 82 NRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNEANT 141
NRD PVNGK+SKL L NGNL LTD D S WSTNT T + V+ +LL+ GNLVLVN+
Sbjct: 78 NRDNPVNGKQSKLRLNFNGNLVLTDADGSFTWSTNTITTQQVELKLLDNGNLVLVNQIGV 137
Query: 142 TIWKSFDSPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNILDLIFNGPLISS 201
+W+SFD PTDTLLP Q KN+TLVS+++PGTY SGFY KF+D+N+L++I+N P +SS
Sbjct: 138 FLWQSFDFPTDTLLPQQQFLKNSTLVSIKTPGTYSSGFYFFKFNDDNVLNIIYNSPSLSS 197
Query: 202 IYWPNSAFTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKFNASDYGVGPKRRLTLDYDGI 261
IYWP+ VF NGR+ YNSSR A +N G F S+D FNA DYG GPKRRLT+D+DG+
Sbjct: 198 IYWPDPGKNVFDNGRSRYNSSRVAILNDMGRFESTDNLNFNAIDYGFGPKRRLTMDFDGV 257
Query: 262 LRLYSFDESTRLWKISWLPAG-LDYCTVHGLCGPNGICVNRPRQKTCICPNGFRRNDPSD 320
LRLYS EST W+I+WLP G LD C VHGLCG GIC P TCICP GF RN PSD
Sbjct: 258 LRLYSLVESTGSWEITWLPDGPLDACLVHGLCGEFGICSYTP-LPTCICPPGFIRNHPSD 316
Query: 321 WIKGCSPLFNLSCDRNELDFMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCKGFGY 380
W KGC P FNLSCD +LDF++LP TDYYGYDLV + G+S++ CRN CL+ C+C GFGY
Sbjct: 317 WSKGCKPSFNLSCDSKDLDFIQLPRTDYYGYDLVGFARGVSVETCRNSCLNSCQCLGFGY 376
Query: 381 STDGQGECFPKGNLLNGHNMPGKYVSMHIKIPRGKINYSAELEKARVNDLNCSAAAVVLG 440
STDG G CFPKG L NG+ P MHIKIP+G+ EL++ NDL CSA+ +V
Sbjct: 377 STDGLGLCFPKGVLRNGNRKPDTMRLMHIKIPKGRP--KTELKEEFSNDLKCSASEIVRN 434
Query: 441 GDNANGEKPTKNRYMKYLISLAGSFAVIETVFISLGWWYVFRRHVHEELANLGCIVLALG 500
+ E K RYM LI+ IE +F GWW VFR+ V+EEL N+G IVLA+G
Sbjct: 435 TE-IFPENKIKFRYMGLLIAFVAIAGFIELIFFGFGWWNVFRKRVNEELVNMGYIVLAMG 493
Query: 501 FKRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSI 560
FKRFTYAE+KRATRNFKQ +GKGGFG+V+RG LDD R+VAVKRLEG+LQGDAEFWAEVSI
Sbjct: 494 FKRFTYAEMKRATRNFKQVIGKGGFGTVYRGELDDGRIVAVKRLEGILQGDAEFWAEVSI 553
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT 620
IG+INH+NLVKL GFCAE +HK+LVYE+V+NGSLDKLLF++ ++ L +QRY IAVGT
Sbjct: 554 IGKINHKNLVKLWGFCAEEKHKILVYEFVKNGSLDKLLFSN-NSSQPLGLEQRYEIAVGT 612
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG 680
AKGL+YLHEECLEWVLHCDVKPQNILLD+ EPKV DFG+SKLFKE + FSRVRGTRG
Sbjct: 613 AKGLAYLHEECLEWVLHCDVKPQNILLDEELEPKVADFGMSKLFKEIDENGFSRVRGTRG 672
Query: 681 YLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740
YLAPEWMM+ KIDAKADVYSYGIVLLEL++GKSAS++ S+S S ++LV W+ +E
Sbjct: 673 YLAPEWMMDQKIDAKADVYSYGIVLLELVSGKSASNFQSSSNSMDFRYSNLVSWMIDNVE 732
Query: 741 QEGLEKIIDPRLNDV-YDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796
+ +E IDPRL + D K++ +V+V LLCV E+R+ RP MS+VV+LLT+ S
Sbjct: 733 KGKMEDAIDPRLEESEKDVRKIEMLVRVGLLCVKEDRNLRPAMSRVVELLTSFQGTS 789
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440309|ref|XP_004137927.1| PREDICTED: putative receptor protein kinase ZmPK1-like [Cucumis sativus] gi|449483667|ref|XP_004156654.1| PREDICTED: putative receptor protein kinase ZmPK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 979 bits (2532), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/807 (59%), Positives = 612/807 (75%), Gaps = 16/807 (1%)
Query: 3 FPCLFVLLILAPTVAWSQAWSQGIPRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNA 62
FP L LL LA T W+ A S G+ LT GNS+AVE EN FL+SPNGTFSSGFY VG N+
Sbjct: 5 FPFLSSLL-LASTAVWAAA-SAGLQSLTPGNSIAVEDENQFLISPNGTFSSGFYPVGNNS 62
Query: 63 YCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEG 122
YCYSIW+T S +TVVWMANRD+PVNG +S+LTL + NL LTD D ++VWST+T ++
Sbjct: 63 YCYSIWYTKSFEKTVVWMANRDKPVNGAKSRLTLNIDSNLVLTDADGTIVWSTDTVSNGE 122
Query: 123 VQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNL 182
+Q +LLETGNLV++N++ IW+SFD PTDTLLP Q K +TLVSM++ G YLSGFY
Sbjct: 123 IQLRLLETGNLVVMNQSQNFIWQSFDFPTDTLLPQQRFLKTSTLVSMQNRGVYLSGFYFF 182
Query: 183 KFDDNNILDLIFNGPLISSIYWPNSAFTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKFN 242
KF+D N+L+L++N P +S IYWP++ TVF+NGR+PYNSSR A ++ G F SSD KFN
Sbjct: 183 KFNDYNVLNLLYNSPSLSGIYWPDTMVTVFVNGRSPYNSSRIAILDEMGGFESSDKLKFN 242
Query: 243 ASDYGVGPKRRLTLDYDGILRLYSFDESTRLWKISWLPAG--LDYCTVHGLCGPNGICVN 300
A+DYG+GPKRRLT+D+DG+LRLYS EST W ++W+P+G +D C VHGLCG GIC
Sbjct: 243 ATDYGLGPKRRLTVDFDGVLRLYSLVESTGNWTVTWIPSGARIDPCLVHGLCGDYGICEY 302
Query: 301 RPRQKTCICPNGFRRNDPSDWIKGCSPLFNLSCD----RNELDFMELPNTDYYGYDLVTY 356
P TC CP GF RNDPSDW KGC PL NL+C+ E+DF+ LPNTDY+G+D Y
Sbjct: 303 DPL-PTCSCPPGFIRNDPSDWTKGCKPLVNLTCNSINPSKEMDFIALPNTDYFGHDW-GY 360
Query: 357 GIGISLQECRNRCLSDCKCKGFGYSTDGQGECFPKGNLLNGHNMPGKYVSMHIKIPRGKI 416
S++ C++ CLS C+C GFGY+ DG G+C+PK L NG+ P V M IK+ + +
Sbjct: 361 VDKFSIEMCKDWCLSSCECTGFGYALDGTGQCYPKMALRNGYRKPSTAVRMFIKVTKDEY 420
Query: 417 NYSAELEKARVNDLNCSAAAVVLGGDNANGEKPTKNRYMKYLISLAGSFAVIETVFISLG 476
+ S L + N+LNCS + +VLG ++ EK K R M L+ + + + E +F+ G
Sbjct: 421 SLSLALRHS-TNELNCSVSQIVLGTEHVYAEKSNKFRSMGLLVGVVVAIGISELIFVGFG 479
Query: 477 WWYVFRRHVHEELANLGCIVLALGFKRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDE 536
WW VFR+ V+EEL N+G IVLA+GFKRF+Y ELKRAT+NFKQE+GKGGFG+V++G LDD
Sbjct: 480 WWNVFRKRVNEELVNMGYIVLAMGFKRFSYDELKRATKNFKQEIGKGGFGTVYKGELDDG 539
Query: 537 RVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDK 596
RVVAVKRL+GVLQG+AEFWAEVSIIG+INH+NLVKL GFCA+ HK+LVYEYV+NGSLDK
Sbjct: 540 RVVAVKRLDGVLQGEAEFWAEVSIIGKINHKNLVKLWGFCADKHHKMLVYEYVKNGSLDK 599
Query: 597 LLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVT 656
LF+D ++ +L +QRY IAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD+ EPKV
Sbjct: 600 FLFSD--SSQVLGLEQRYEIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDESMEPKVA 657
Query: 657 DFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASD 716
DFG+SKLF+E +++ FS+VRGTRGYLAPEWMMNLKIDAKADVYSYGIV+LELL+GK+A
Sbjct: 658 DFGMSKLFREINESGFSKVRGTRGYLAPEWMMNLKIDAKADVYSYGIVVLELLSGKTAYG 717
Query: 717 YLSASA-SDSSYCNHLVQWVAKQMEQEGLEKIIDPRL--NDVYDREKLDRMVKVALLCVA 773
+ S++ D +V+WV + E+ +EK++DPRL D +++K+D ++KVALLCV
Sbjct: 718 FESSTVCKDGGRNIDMVKWVMEVAEKGEVEKVMDPRLKVEDKQNKKKIDILLKVALLCVK 777
Query: 774 ENRDTRPPMSKVVKLLTAHDHESSQDE 800
E+R+ RP MS+VV+LLT ++ SS +
Sbjct: 778 EDRNMRPAMSRVVELLTGYEEPSSHGD 804
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440307|ref|XP_004137926.1| PREDICTED: putative receptor protein kinase ZmPK1-like [Cucumis sativus] gi|449483671|ref|XP_004156655.1| PREDICTED: putative receptor protein kinase ZmPK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 979 bits (2532), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/791 (59%), Positives = 605/791 (76%), Gaps = 16/791 (2%)
Query: 25 GIPRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRD 84
G+ RLT G+S+AV+KEN FL+SPNGTFSSGFY+VG N+YC+SIWFTNS ++TVVWMANRD
Sbjct: 26 GMQRLTSGSSIAVDKENQFLISPNGTFSSGFYRVGNNSYCFSIWFTNSFHKTVVWMANRD 85
Query: 85 RPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNEANTTIW 144
+PVNG++S+LTL + NL LTD D +VVWST+T + ++ +LLETGNLV++N++ IW
Sbjct: 86 KPVNGEQSRLTLNFDSNLILTDADDTVVWSTDTTSVGEIELRLLETGNLVVMNQSQHFIW 145
Query: 145 KSFDSPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYW 204
+SFD PTDTLLP+Q K +TL+SMRS GTYLSGFY KF+D+NIL+LIFNGP +SSIYW
Sbjct: 146 QSFDFPTDTLLPTQRFLKTSTLISMRSLGTYLSGFYYFKFNDDNILNLIFNGPSLSSIYW 205
Query: 205 PNSAFTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKFNASDYGVGPKRRLTLDYDGILRL 264
P + F+NGR PYNSSR A ++ +G F SSD F+FNA+D GVGPKRRLT+DYDG+LRL
Sbjct: 206 PYTLVLSFVNGRNPYNSSRIAILDETGSFESSDGFQFNATDDGVGPKRRLTMDYDGVLRL 265
Query: 265 YSFDESTRLWKISWLPAG-LDYCTVHGLCGPNGICVNRPRQKTCICPNGFRRNDPSDWIK 323
YS DEST WKI+WLP G +D C VHGLCG GIC P TC CP GF RNDPSDW K
Sbjct: 266 YSLDESTGNWKITWLPGGRIDACMVHGLCGDYGICEYNPL-PTCTCPPGFSRNDPSDWTK 324
Query: 324 GCSPLFNLSCD-------RNELDFMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCK 376
GC P FN +CD E DF+ LPNTDY+GYD Y G+ ++ C+N CL++CKC
Sbjct: 325 GCKPPFNFTCDSSYNSSSSKEFDFLPLPNTDYFGYDW-GYAAGVPIEICKNICLTNCKCA 383
Query: 377 GFGYSTDGQGECFPKGNLLNGHNMPGKYVSMHIKIPRGKINYSAELEKARVNDLNCSAAA 436
GFGY+ DG +C+PK L NG+ P V M +K+P+ EL+ + ++LNCS +
Sbjct: 384 GFGYAMDGSAQCYPKTALRNGYRKPDTAVQMFMKVPKSLRRSWLELKSS--SELNCSDSE 441
Query: 437 VVLGGDNANGEKPTKNRYMKYLISLAGSFAVIETVFISLGWWYVFRRHVHEELANLGCIV 496
+VL + GEK K RY+ LI L + E +FI GWW++FR+ V+EEL N+G IV
Sbjct: 442 LVL-NTHVYGEKGEKFRYIGLLIGLVVTIGASELIFIGFGWWFIFRKRVNEELVNMGYIV 500
Query: 497 LALGFKRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWA 556
LA+GFKRF+Y E+KRAT+NFKQE+GKGGFG+V++G L+D RVVAVKRLEGVLQGDAEFWA
Sbjct: 501 LAMGFKRFSYNEMKRATKNFKQEIGKGGFGTVYKGELEDGRVVAVKRLEGVLQGDAEFWA 560
Query: 557 EVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASI-LQWDQRYN 615
EVSIIG+INH+NLVKL GFCAE HK+LVYEYV+NGSLDK LF+D + L +QRY
Sbjct: 561 EVSIIGKINHKNLVKLWGFCAEKHHKMLVYEYVKNGSLDKHLFSDDSNEELTLGLEQRYV 620
Query: 616 IAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRV 675
IAVGTAKGLSYLHEECLEWVLHCD+KPQNILLD+ E KV DFG+SKLF+E +++ FS+V
Sbjct: 621 IAVGTAKGLSYLHEECLEWVLHCDIKPQNILLDEGLEAKVADFGMSKLFREINESGFSKV 680
Query: 676 RGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV 735
RGTRGYLAPEWMMNLKIDAKADVYSYGIV+LEL++GK+AS++ + C LV+W+
Sbjct: 681 RGTRGYLAPEWMMNLKIDAKADVYSYGIVVLELISGKNASNFRWFGIEEEGECTDLVKWI 740
Query: 736 AKQMEQEGLEKIIDPRL--NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793
K +E+ ++K++DPRL + +K++ ++KVA+ CV E+R++RP MS++V+LLT ++
Sbjct: 741 MKSIEKGEVKKVVDPRLKVENEEQNKKMEMLLKVAVECVREDRNSRPAMSQIVELLTCYE 800
Query: 794 HESSQDESISD 804
+ ++ + D
Sbjct: 801 QSNLHEDIVRD 811
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482077|ref|XP_003632708.1| PREDICTED: putative receptor protein kinase ZmPK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 758 bits (1956), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/782 (49%), Positives = 522/782 (66%), Gaps = 29/782 (3%)
Query: 29 LTRGNSLAVEKE-NDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPV 87
L RG+SL+VE + +D++ SP+ +F+ GFY +G NAY +SIWFTNS RTVVWMANR+RPV
Sbjct: 29 LQRGSSLSVEDDSDDYITSPDKSFTCGFYGMGENAYWFSIWFTNSKERTVVWMANRNRPV 88
Query: 88 NGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNEANTTIWKSF 147
NG+ S+++LQR+G + L D D S VW TNT + + +A+LL+TGNLVL + +W+SF
Sbjct: 89 NGRGSRISLQRDGTMMLRDADGSTVWETNTTSTDVDRAELLDTGNLVLKDPRGKILWQSF 148
Query: 148 DSPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNS 207
D PTDTLLP+Q+ T +T L+S+ G + SG++N FD++N+L ++++GP ISS+YWPN
Sbjct: 149 DFPTDTLLPNQIFTTSTKLISILRKGDFSSGYFNFLFDNDNVLRMMYDGPEISSLYWPNP 208
Query: 208 AFTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKFNASDYGVGPKRRLTLDYDGILRLYSF 267
+ VF NGRT YNSSR A ++ G F SSD F ASD G G KRRLT+DYDG LRLYS
Sbjct: 209 DWDVFQNGRTNYNSSRIAVLDEMGRFLSSDRMSFKASDMGFGVKRRLTMDYDGNLRLYSL 268
Query: 268 DESTRLWKISWLPAGLDYCTVHGLCGPNGICVNRPRQKTCICPNGFRRNDPSDWIKGCSP 327
+ ST LW ISW A C VHGLCG NGIC+ P K C CP G+ DPSDW KGC
Sbjct: 269 NHSTGLWNISW-EALRQQCKVHGLCGRNGICIYTPEPK-CSCPPGYEVTDPSDWSKGCKS 326
Query: 328 LFNLSCDR-NELDFMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCKGFGYSTDGQG 386
FN SC + ++ F+ELP TDYYG+DL Y +S++ CR CL DC C+GF Y G+G
Sbjct: 327 KFNQSCSQTQQVKFVELPQTDYYGFDL-NYSQSVSMEACRKICLDDCLCQGFVYRLTGEG 385
Query: 387 ECFPKGNLLNG---HNMPGKYVSMHIKIPRGKINYSAELEKARV---NDLNCSAAAVVLG 440
CF K L NG N PG S+++K+P E V +DL C + V +
Sbjct: 386 NCFAKSTLFNGFKSSNFPG---SLYLKLP-----VDVETSAPTVLNGSDLICESKEVEVV 437
Query: 441 GDNANGEKPTKNRYMKYLISLAGSFAVIETVFISLGWWYVFRRHVHEELANLGCIVLALG 500
++ + +K YL S A + IE +FI GWW++FR H A G ++
Sbjct: 438 HSSSVYDTASKKMRWVYLYSFASAIGAIEVLFIVSGWWFLFRVHNVPSSAEDGYGPISSP 497
Query: 501 FKRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSI 560
F+RF+Y ELK+AT NFK E+G+GGFG+V++GVL+DER VAVK+L QG+ EFWAEVS
Sbjct: 498 FRRFSYTELKKATNNFKVELGRGGFGAVYKGVLEDERAVAVKKLGDATQGEGEFWAEVST 557
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT 620
IG+I H NLV++ GFC+E H+L+VYE+VEN SLDK LF + S L W +R+N+AVGT
Sbjct: 558 IGKIYHMNLVRMWGFCSEGRHRLVVYEHVENLSLDKHLF----STSCLGWKERFNVAVGT 613
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE--RHDTKFSRVRGT 678
A+GL+YLH ECLEWV+HCDVKP+NILLD+ FEPK+ DFGL+KL + +FSR+RGT
Sbjct: 614 ARGLAYLHHECLEWVIHCDVKPENILLDNGFEPKIADFGLAKLSQRGGPGSGEFSRIRGT 673
Query: 679 RGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDS-SYCNHLVQWVAK 737
+GY+APEW MNL I AK DVYSYG+V+LE++ G S ++ + + V+ V +
Sbjct: 674 KGYMAPEWAMNLPITAKVDVYSYGVVVLEMVRGIRLSKWVGEDGEEQEAELTRFVRAVKR 733
Query: 738 QM---EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794
++ E +E +DPRL + R++ +V++ + CV E+R RP M+ VV++L +
Sbjct: 734 KIQYGEDNWVEDTVDPRLKGKFSRQQAAMLVEIGISCVEEDRSKRPTMATVVQVLLECED 793
Query: 795 ES 796
E+
Sbjct: 794 EA 795
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147791818|emb|CAN61835.1| hypothetical protein VITISV_042870 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 755 bits (1950), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/781 (49%), Positives = 519/781 (66%), Gaps = 28/781 (3%)
Query: 29 LTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVN 88
L RG+SL+VE ++D++ SP+ +F+ GFY +G NAY +SIWFTNS RTVVW ANR+ PVN
Sbjct: 36 LRRGSSLSVEDDSDYITSPDKSFTCGFYGMGKNAYWFSIWFTNSKERTVVWTANRNTPVN 95
Query: 89 GKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNEANTTIWKSFD 148
G+ S+++LQR+G + L D D S VW TNT + + +A+LL TGNLVL + +W+SFD
Sbjct: 96 GRGSRISLQRDGTMILRDADGSTVWETNTTSTDVDRAELLYTGNLVLKDPRGKILWQSFD 155
Query: 149 SPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNSA 208
PTDTLLP+Q+LT +T L+S+ G + SG + FD++N+L +I++GP ISS+YWPN
Sbjct: 156 FPTDTLLPNQILTTSTKLISIIRRGDFSSGHFYFFFDNDNVLRMIYDGPDISSLYWPNPD 215
Query: 209 FTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKFNASDYGVGPKRRLTLDYDGILRLYSFD 268
+ VF NGRT YNSSR A ++ G F SSD F ASD G G KRRLT+DYDG LRLYS +
Sbjct: 216 WDVFQNGRTNYNSSRIAVLDEMGRFLSSDRMSFKASDMGFGVKRRLTMDYDGNLRLYSLN 275
Query: 269 ESTRLWKISWLPAGLDYCTVHGLCGPNGICVNRPRQKTCICPNGFRRNDPSDWIKGCSPL 328
STRLW ISW A C VHGLCG NGIC+ P K C CP G+ +DPSDW KGC
Sbjct: 276 HSTRLWNISW-EALSQQCKVHGLCGRNGICIYTPEPK-CSCPPGYEVSDPSDWSKGCKSK 333
Query: 329 FNLSCDR-NELDFMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCKGFGYSTDGQGE 387
FN SC + ++ F+ELP TDYYG+DL Y +SL+ CR CL DC C+GF Y G+G
Sbjct: 334 FNHSCSQPQQVKFVELPQTDYYGFDL-NYSPSVSLEACRKICLEDCLCQGFAYRLTGEGN 392
Query: 388 CFPKGNLLNGH---NMPGKYVSMHIKIPRGKINYSAELEKARV---NDLNCSAAAVVLGG 441
CF K L NG+ N PG S+++K+P E V +DL C + V +
Sbjct: 393 CFAKSTLFNGYKSSNFPG---SLYLKLP-----VDVETSAPTVLNGSDLICESKEVEVVH 444
Query: 442 DNANGEKPTKNRYMKYLISLAGSFAVIETVFISLGWWYVFRRHVHEELANLGCIVLALGF 501
++ + +K YL S A + IE + I GWW++FR H A G ++ F
Sbjct: 445 SSSVYDTASKQMRGVYLYSFASAIGAIEVLLIVSGWWFLFRVHNVPSSAEDGYGPISSQF 504
Query: 502 KRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSII 561
+RF+Y ELK+AT NFK E+G+GGFG+V++GVL+DER VAVK+L QG+ EFWAEVS I
Sbjct: 505 RRFSYTELKKATNNFKVELGRGGFGAVYKGVLEDERAVAVKKLGDATQGEGEFWAEVSTI 564
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTA 621
G+I H NLV++ GFC+E H+L+VYE+VEN SLDK LF + S L W +R+N+AVGTA
Sbjct: 565 GKIYHMNLVRMWGFCSEGRHRLVVYEHVENLSLDKHLF----STSCLGWKERFNVAVGTA 620
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE--RHDTKFSRVRGTR 679
+GL+YLH ECLEWV+HCDVKP+NILLD+ FEPK+ DFGL+KL + +FSR+RGT+
Sbjct: 621 RGLAYLHHECLEWVIHCDVKPENILLDNGFEPKIADFGLAKLSQRGGPGSGEFSRIRGTK 680
Query: 680 GYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDS-SYCNHLVQWVAKQ 738
GY+APEW MNL I AK DVYSYG+V+LE++ G S ++ + + V+ V ++
Sbjct: 681 GYMAPEWAMNLPITAKVDVYSYGVVVLEMVRGIRLSKWVGEDGEEQEAELTRFVRAVKRK 740
Query: 739 M---EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795
+ E +E +DP L + R++ MVK+ + CV E+R RP M+ VV++L + E
Sbjct: 741 IQYGEDNWIEDTVDPXLKGKFSRQQAAMMVKIGISCVEEDRIKRPTMATVVQVLLECEDE 800
Query: 796 S 796
+
Sbjct: 801 A 801
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482081|ref|XP_003632709.1| PREDICTED: putative receptor protein kinase ZmPK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1948), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/779 (49%), Positives = 525/779 (67%), Gaps = 23/779 (2%)
Query: 29 LTRGNSLAVEKE-NDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPV 87
L RG+SL+VE + +D++ SP+ +F+ GFY +G NAY +SIWFTNS RTVVWMANR+RPV
Sbjct: 29 LQRGSSLSVEDDSDDYITSPDKSFTCGFYGMGENAYWFSIWFTNSKERTVVWMANRNRPV 88
Query: 88 NGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNEANTTIWKSF 147
NG+ S+++LQR+G + L D D S VW TNT + + +A+LL+TGNLVL + +W+SF
Sbjct: 89 NGRGSRISLQRDGTMMLRDADGSTVWETNTTSTDVDRAELLDTGNLVLKDPRGKILWQSF 148
Query: 148 DSPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNS 207
PTDTLLP+Q+ T +T L+S+ G + SG++N FD++N+L ++++GP IS +YWPN
Sbjct: 149 GFPTDTLLPNQIFTTSTKLISILRRGDFSSGYFNFLFDNDNVLRMMYDGPEISRLYWPNP 208
Query: 208 AFTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKFNASDYGVGPKRRLTLDYDGILRLYSF 267
+ VF NGRT +NSSR A ++ G F SSD FNASD G G KRRLT+DYDG LRLYS
Sbjct: 209 DWDVFGNGRTNFNSSRTAVLDEMGRFLSSDKMSFNASDMGFGVKRRLTMDYDGNLRLYSL 268
Query: 268 DESTRLWKISWLPAGLDYCTVHGLCGPNGICVNRPRQKTCICPNGFRRNDPSDWIKGCSP 327
+ ST LW ISW A + C VHGLCG NGIC+ P K C CP G+ +DPSDW KGC
Sbjct: 269 NHSTGLWVISW-KALSEQCKVHGLCGRNGICIYTPEPK-CSCPPGYEVSDPSDWSKGCKS 326
Query: 328 LFNLSCDR-NELDFMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCKGFGYSTDGQG 386
FN SC + ++ F+ELP TDYYG+DL Y +S++ CR CL DC C+GF Y G+G
Sbjct: 327 KFNQSCSQTQQVKFLELPQTDYYGFDL-NYSQSVSMEACRKICLDDCLCQGFAYRLTGEG 385
Query: 387 ECFPKGNLLNGH---NMPGKYVSMHIKIPRGKINYSAELEKARVNDLNCSAAAVVLGGDN 443
C+ K L NG+ N PG S+++K+P I SA +DL C + V + +
Sbjct: 386 NCYAKSTLFNGYKSSNFPG---SLYLKLPV-DIETSAPT-VLNGSDLICESKEVEVVHSS 440
Query: 444 ANGEKPTKNRYMKYLISLAGSFAVIETVFISLGWWYVFRRHVHEELANLGCIVLALGFKR 503
+ + +K YL S A + IE +FI GWW++F+ H A G ++ F+R
Sbjct: 441 SVYDTASKKMRWVYLYSFASAIGAIEVLFIVSGWWFLFKVHNVPSSAEDGYGSISSPFRR 500
Query: 504 FTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGR 563
F+Y ELK+AT NFK E+G+GGFG+V++GVL+DER VAVK+L QG+ EFWAEVS IG+
Sbjct: 501 FSYTELKKATNNFKVELGRGGFGAVYKGVLEDERAVAVKKLGDATQGEGEFWAEVSTIGK 560
Query: 564 INHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKG 623
I H NLV++ GFC+E H+L+VYE+VEN SLDK LF + S L W +R+N+AVGTA+G
Sbjct: 561 IYHMNLVRMWGFCSEGRHRLVVYEHVENLSLDKHLF----STSCLGWKERFNVAVGTARG 616
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE--RHDTKFSRVRGTRGY 681
L+YLH ECLEWV+HCDVKP+NILLD+ FEPK+ DFGL+KL + +FSR+RGT+GY
Sbjct: 617 LAYLHHECLEWVIHCDVKPENILLDNGFEPKIADFGLAKLSQRGGPGSGEFSRIRGTKGY 676
Query: 682 LAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDS-SYCNHLVQWVAKQM- 739
+APEW MNL I AK DVYSYG+V+LE++ G S ++ + + V+ V +++
Sbjct: 677 MAPEWAMNLPITAKVDVYSYGVVVLEMVRGIRLSKWVGEDGEEQEAELTRFVRAVKRKIQ 736
Query: 740 --EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796
E +E +DPRL + R++ +V++ + CV E+R RP M+ VV++L + E+
Sbjct: 737 YGEDNWVEDTVDPRLKGKFSRQQATMLVEIGISCVEEDRSKRPTMATVVQVLLECEGEA 795
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482079|ref|XP_002272157.2| PREDICTED: LOW QUALITY PROTEIN: putative receptor protein kinase ZmPK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 740 bits (1910), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/781 (48%), Positives = 517/781 (66%), Gaps = 29/781 (3%)
Query: 29 LTRGNSLAVEKE-NDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPV 87
L RG+SL+VE + +D++ SP+ +F+ GFY +G NAY +SIWFTNS RTVVWMANR+RPV
Sbjct: 29 LQRGSSLSVEDDSDDYITSPDKSFTCGFYGMGENAYWFSIWFTNSKERTVVWMANRNRPV 88
Query: 88 NGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNEANTTIWKSF 147
NG+ S+++LQR+G + L D D S VW TNT + + +A+LL+TGNLVL + +W+SF
Sbjct: 89 NGRGSRISLQRDGTMMLRDADGSTVWETNTTSTDVDRAELLDTGNLVLKDPRGKILWQSF 148
Query: 148 DSPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNS 207
D PTDTLLP+Q+ T +T L+S+ G + SG++N FD++N+L ++++GP ISS+YWPN
Sbjct: 149 DFPTDTLLPNQIFTTSTKLISILRRGDFSSGYFNFLFDNDNVLRMMYDGPEISSLYWPNP 208
Query: 208 AFTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKFNASDYGVGPKRRLTLDYDGILRLYSF 267
+ VF NGRT YNSSR A ++ G F SSD F ASD G G KRRLT+DYDG LRLYS
Sbjct: 209 DWDVFQNGRTNYNSSRIAVLDEMGRFLSSDQMSFKASDMGFGVKRRLTMDYDGNLRLYSL 268
Query: 268 DESTRLWKISWLPAGLDYCTVHGLCGPNGICVNRPRQKTCICPNGFRRNDPSDWIKGCSP 327
+ ST LW IS A C VHGLCG NGIC+ P K CP G+ +DPSDW KGC
Sbjct: 269 NHSTGLWNIS-XEALRQQCKVHGLCGRNGICIYTPEPKGS-CPPGYEVSDPSDWSKGCKS 326
Query: 328 LFNLSCDR-NELDFMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCKGFGYSTDGQG 386
FN SC + ++ F+ELP TDYYG+DL Y +S++ CR CL DC C+GF Y G+G
Sbjct: 327 KFNQSCSQTQQVKFVELPQTDYYGFDL-NYSQSVSMEACRKICLDDCLCQGFAYRLTGEG 385
Query: 387 ECFPKGNLLNGH---NMPGKYVSMHIKIPRGKINYSAELEKARV---NDLNCSAAAVVLG 440
C+ K L NG+ N PG S+++K+P E V +DL C + V +
Sbjct: 386 NCYAKSTLFNGYKSSNFPG---SLYLKLP-----VDVETSAPTVLNGSDLICESKEVEVV 437
Query: 441 GDNANGEKPTKNRYMKYLISLAGSFAVIETVFISLGWWYVFRRHVHEELANLGCIVLALG 500
++ + +K YL S A + I +FI GWW++FR H A G ++
Sbjct: 438 HSSSVYDTASKKMRWVYLYSFASAIGAIVVLFIVSGWWFLFRVHNVPSSAEDGYGPISSP 497
Query: 501 FKRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSI 560
F+RF+Y ELK+AT NFK E+G+GGFG+V++GVL DER VAVK+L QG+ EFWAEVS
Sbjct: 498 FRRFSYTELKKATNNFKVELGRGGFGAVYKGVLVDERAVAVKKLGDSTQGEGEFWAEVST 557
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT 620
IG+I H NLV++ GFC+E H+L+VYE+VEN SLDK LF + S L W +R+N+AVGT
Sbjct: 558 IGKIYHMNLVRMWGFCSEGRHRLVVYEHVENLSLDKHLF----STSCLGWKERFNVAVGT 613
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE--RHDTKFSRVRGT 678
A+GL+YLH ECLEWV+HCDVKP+NILLD+ FEPK+ DF L+KL + +FSR+RGT
Sbjct: 614 ARGLAYLHHECLEWVIHCDVKPENILLDNGFEPKIADFVLAKLSQRGGPGSGEFSRIRGT 673
Query: 679 RGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDS-SYCNHLVQWVAK 737
+GY+APEW MNL I AK DVY YG+V+LE++ G S ++ + + V+ V +
Sbjct: 674 KGYMAPEWAMNLPITAKVDVYCYGVVVLEMVRGIRLSKWVGEDGEEQEAELTRFVRVVKR 733
Query: 738 QM---EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794
++ E +E +DPRL + R++ +V++ + CV E+R RP M+ VV++L D
Sbjct: 734 KIQYGEDNWVEDTVDPRLKGKFSRQQAAMLVEIGISCVEEDRSKRPTMATVVQVLLECDA 793
Query: 795 E 795
+
Sbjct: 794 Q 794
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482073|ref|XP_002272276.2| PREDICTED: putative receptor protein kinase ZmPK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/778 (48%), Positives = 515/778 (66%), Gaps = 22/778 (2%)
Query: 29 LTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVN 88
L RG+SL+VE ++D++ SP+ +F+ GFY +G NAY +SIWFTNS +TVVW ANR+ PVN
Sbjct: 36 LRRGSSLSVEDDSDYITSPDKSFTCGFYGMGKNAYWFSIWFTNSKEKTVVWTANRNTPVN 95
Query: 89 GKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNEANTTIWKSFD 148
G+ S++ LQR+G + L D S VW TNT + + +A+LL+TGNLVL + +W+SFD
Sbjct: 96 GRGSRIWLQRDGTMILRAADGSTVWETNTTSTDVDRAELLDTGNLVLKDPRGKVLWQSFD 155
Query: 149 SPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNSA 208
PTDTLLP+Q+LT +T L+S+ + SG + F ++N+L +I++GP ISS+YWPN
Sbjct: 156 FPTDTLLPNQILTTSTKLISIIRREDFSSGHFYFFFYNDNVLRMIYDGPDISSLYWPNPD 215
Query: 209 FTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKFNASDYGVGPKRRLTLDYDGILRLYSFD 268
+ VF N RT YNSSR A ++ G F SSD F ASD G G KRRLT+DYDG LRLYS +
Sbjct: 216 WDVFQNRRTNYNSSRIAVLDEMGRFLSSDRMSFKASDMGFGVKRRLTMDYDGNLRLYSLN 275
Query: 269 ESTRLWKISWLPAGLDYCTVHGLCGPNGICVNRPRQKTCICPNGFRRNDPSDWIKGCSPL 328
S+ LW ISW A C VHGLCG NGIC+ P K C CP G+ +DPSDW KGC
Sbjct: 276 HSSGLWNISW-EALSQQCKVHGLCGRNGICIYTPEPK-CSCPPGYEVSDPSDWSKGCKSK 333
Query: 329 FNLSCDR-NELDFMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCKGFGYSTDGQGE 387
FN SC + ++ F+ELP TDYYG+DL Y +SL+ CR CL DC C+GF Y G+G
Sbjct: 334 FNHSCSQPQQVKFVELPQTDYYGFDL-DYSPSVSLEACRKICLEDCLCQGFAYRLTGEGN 392
Query: 388 CFPKGNLLNGH---NMPGKYVSMHIKIPRGKINYSAELEKARVNDLNCSAAAVVLGGDNA 444
CF K L NG+ N PG S+++K+P + + +DL C + V + ++
Sbjct: 393 CFAKSTLFNGYKSSNFPG---SLYLKLPVDVQTSAPTVLNG--SDLICESKEVEVVHSSS 447
Query: 445 NGEKPTKNRYMKYLISLAGSFAVIETVFISLGWWYVFRRHVHEELANLGCIVLALGFKRF 504
+ +K YL S A + IE + I GWW++FR H A G ++ F+RF
Sbjct: 448 VYDTASKQMRWVYLYSFASAIGAIEVLLIVSGWWFLFRVHNVPSSAENGYGPISSQFRRF 507
Query: 505 TYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI 564
+Y ELK+AT NFK E+G+GGFG+V++GVL+DER VAVK+L QG+ EFWAEVS IG+I
Sbjct: 508 SYTELKKATNNFKVELGRGGFGAVYKGVLEDERAVAVKKLGDATQGEGEFWAEVSTIGKI 567
Query: 565 NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGL 624
H NLV++ GFC+E H+L+VYE+VEN SLDK LF + S L W +R+N+AVGTA+GL
Sbjct: 568 YHMNLVRMWGFCSEGRHRLVVYEHVENLSLDKHLF----STSCLGWKERFNVAVGTARGL 623
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE--RHDTKFSRVRGTRGYL 682
+YLH ECLEWV+HCDVKP+NILLD+ FEPK+ DFGL+KL + +FSR+RGT+GY+
Sbjct: 624 AYLHHECLEWVIHCDVKPENILLDNGFEPKIADFGLAKLSQRGGPGSGEFSRIRGTKGYM 683
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDS-SYCNHLVQWVAKQM-- 739
APEW MNL I AK DVYSYG+V+LE++ G ++ + + V+ V +++
Sbjct: 684 APEWAMNLPITAKVDVYSYGVVVLEMVRGIRLLKWVGEDGEEQEAELTRFVRAVKRKIQY 743
Query: 740 -EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796
E +E +DPRL + + R++ MVK+ + CV E+R RP M+ VV++L + E+
Sbjct: 744 GEDNWIEDTVDPRLKEKFSRQQAAMMVKIGISCVEEDRIKRPTMATVVQVLLECEDEA 801
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225440502|ref|XP_002272467.1| PREDICTED: putative receptor protein kinase ZmPK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1882), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/803 (46%), Positives = 526/803 (65%), Gaps = 21/803 (2%)
Query: 3 FPCLFVLLILAPTVAWSQAWSQGIPRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNA 62
FPC+ + L+++ +++ + L RG+SL+VE ++D++ SP+ +F+ GFY G NA
Sbjct: 11 FPCILLTLLISYLFSFATCKTHNF--LQRGSSLSVEDDSDYITSPDRSFTCGFYGAGENA 68
Query: 63 YCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEG 122
Y +SIWFTNS RTVVWMANRDRPVNG+ S+++L+R+G + L D D S VW TNT + +
Sbjct: 69 YWFSIWFTNSKERTVVWMANRDRPVNGRGSRISLRRDGIMNLRDADGSTVWETNTTSTDV 128
Query: 123 VQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNL 182
+A+LL+TGNLVL N +W+SFD PTDTLLP+Q+LT+ T L+S+ G + SG+Y L
Sbjct: 129 DRAELLDTGNLVLKNPHGKILWQSFDFPTDTLLPNQILTRRTKLISIIRGGDFSSGYYIL 188
Query: 183 KFDDNNILDLIFNGPLISSIYWPNSAFTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKFN 242
FD++NIL ++++GP ISS+YWPN + N R NSSR A ++ G F SSD F
Sbjct: 189 YFDNDNILRMMYDGPSISSLYWPNPDLGILPNKRRNSNSSRIAVLDEMGRFLSSDNASFR 248
Query: 243 ASDYGVGPKRRLTLDYDGILRLYSFDESTRLWKISWLPAGLDYCTVHGLCGPNGICVNRP 302
ASD G+G KRRLT+ YDG LRLYS + ST LW ISW+ G + VHGLCG NGICV P
Sbjct: 249 ASDMGLGVKRRLTIGYDGNLRLYSLNHSTGLWMISWMAFG-ERNRVHGLCGRNGICVYTP 307
Query: 303 RQKTCICPNGFRRNDPSDWIKGCSPLFNLSCDR-NELDFMELPNTDYYGYDLVTYGIGIS 361
K C CP G+ +DPSDW KGC F+ SC R ++ F+ELP+TD+YG D V + +S
Sbjct: 308 EPK-CSCPPGYEVSDPSDWSKGCKSKFHRSCSRPQQVKFVELPHTDFYGSD-VNHLTSVS 365
Query: 362 LQECRNRCLSDCKCKGFGYSTDGQGECFPKGNLLNGHNMPGKYVSMHIKIPRGKINYSAE 421
L+ CR CL DC C+ F Y G G CF K L NG P ++++K+P ++
Sbjct: 366 LETCRKTCLEDCLCEAFAYRLTGNGLCFNKIALFNGFRSPNFPGTIYLKLPVDVETSAST 425
Query: 422 LEKARVNDLNCSAAAVVLGGDNANGEKPTKNRYMK--YLISLAGSFAVIETVFISLGWWY 479
L +VL + T N+ M+ YL S A + +E +FI GWW+
Sbjct: 426 LVNVSNPICESKEVEIVLSSPSM---YDTANKGMRWVYLYSFASALGALEVLFIVSGWWF 482
Query: 480 VFRRHVHEELANLGCIVLALGFKRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVV 539
+FR G ++ F++F+Y ELK+AT NFK E+G+GGFG+V++G+L+DERVV
Sbjct: 483 LFRVPKVTSPVEDGYGPISSQFRKFSYTELKKATNNFKVELGRGGFGAVYKGILEDERVV 542
Query: 540 AVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLF 599
AVK+L V+QG+ EFWAE+S I +I H NLV++ GFC+E H+LLVYE+VEN SLDK LF
Sbjct: 543 AVKKLRDVIQGEGEFWAEISTIRKIYHMNLVRMWGFCSEGRHRLLVYEHVENLSLDKHLF 602
Query: 600 NDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659
+ + L W +R+N+AVGTA+GL+YLH ECLEWV+HCDVKP+NILLD+ FEPK+ DFG
Sbjct: 603 ----STTFLGWKERFNVAVGTARGLAYLHHECLEWVIHCDVKPENILLDNGFEPKIADFG 658
Query: 660 LSKLFKE--RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717
L+KL + +FSR+RGT+GY+APEW MNL I AK DVYS+G+V+LE++ G S++
Sbjct: 659 LAKLSQRGGPGSREFSRIRGTKGYMAPEWAMNLPITAKVDVYSFGVVVLEMVRGIRLSNW 718
Query: 718 LSASASDS-SYCNHLVQWVAKQMEQEG---LEKIIDPRLNDVYDREKLDRMVKVALLCVA 773
+ + + V+ V ++++ E ++ +D RL + R + ++++ + CV
Sbjct: 719 VMEDGKEQEAELTRFVKLVKEKIQCEEDNWIDDTVDRRLKGRFSRHQAATLIEIGISCVE 778
Query: 774 ENRDTRPPMSKVVKLLTAHDHES 796
E+R RP M+ VV++L + E+
Sbjct: 779 EDRSKRPTMATVVQVLLECEDEA 801
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 804 | ||||||
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.349 | 0.339 | 0.480 | 4.9e-110 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.349 | 0.342 | 0.505 | 2.3e-95 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.351 | 0.324 | 0.466 | 2.6e-95 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.817 | 0.792 | 0.354 | 1e-91 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.369 | 0.349 | 0.374 | 5.2e-80 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.347 | 0.328 | 0.375 | 1.2e-79 | |
| TAIR|locus:2197704 | 831 | AT1G61390 [Arabidopsis thalian | 0.351 | 0.340 | 0.362 | 6.8e-79 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.337 | 0.332 | 0.363 | 6.8e-79 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.898 | 0.879 | 0.303 | 1.6e-77 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.355 | 0.355 | 0.364 | 5e-77 |
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 702 (252.2 bits), Expect = 4.9e-110, Sum P(2) = 4.9e-110
Identities = 139/289 (48%), Positives = 188/289 (65%)
Query: 504 FTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGR 563
F+Y EL+ AT+NF ++G GGFGSVF+G L D +AVKRLEG+ QG+ +F EV IG
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGT 542
Query: 564 INHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLF-NDPGTASILQWDQRYNIAVGTAK 622
I H NLV+L+GFC+E KLLVY+Y+ NGSLD LF N +L W R+ IA+GTA+
Sbjct: 543 IQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTAR 602
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
GL+YLH+EC + ++HCD+KP+NILLD F PKV DFGL+KL + +RGTRGYL
Sbjct: 603 GLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYL 662
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGKXXXXXXXXXXXXXXXCNHLVQWVAKQMEQE 742
APEW+ + I AKADVYSYG++L EL++G+ W A + ++
Sbjct: 663 APEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKV-----RFFPSWAATILTKD 717
Query: 743 G-LEKIIDPRLN-DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
G + ++DPRL D D E++ R KVA C+ + RP MS+VV++L
Sbjct: 718 GDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQIL 766
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 736 (264.1 bits), Expect = 2.3e-95, Sum P(2) = 2.3e-95
Identities = 146/289 (50%), Positives = 197/289 (68%)
Query: 503 RFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIG 562
RF Y +L+ AT NF ++G+GGFGSV+ G L D +AVK+LEG+ QG EF AEVSIIG
Sbjct: 482 RFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIG 541
Query: 563 RINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK 622
I+H +LV+L+GFCAE H+LL YE++ GSL++ +F +L WD R+NIA+GTAK
Sbjct: 542 SIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAK 601
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
GL+YLHE+C ++HCD+KP+NILLDD+F KV+DFGL+KL F+ +RGTRGYL
Sbjct: 602 GLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYL 661
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGKXXXXXXXXXXXXXXXCNHLVQWVAKQMEQE 742
APEW+ N I K+DVYSYG+VLLEL+ G+ C H + K+ME+
Sbjct: 662 APEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEK----C-HFPSFAFKKMEEG 716
Query: 743 GLEKIIDPRLN--DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
L I+D ++ DV D E++ R +K AL C+ E+ TRP MSKVV++L
Sbjct: 717 KLMDIVDGKMKNVDVTD-ERVQRAMKTALWCIQEDMQTRPSMSKVVQML 764
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 699 (251.1 bits), Expect = 2.6e-95, Sum P(3) = 2.6e-95
Identities = 140/300 (46%), Positives = 197/300 (65%)
Query: 502 KRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGV-LQGDAEFWAEVSI 560
++F + EL++AT NFK ++G GGFGSV++G L DE ++AVK++ L G EF E++I
Sbjct: 503 QKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEIAI 562
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT 620
IG I H NLVKL+GFCA LLVYEY+ +GSL+K LF+ G +L+W +R++IA+GT
Sbjct: 563 IGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFS--GNGPVLEWQERFDIALGT 620
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG 680
A+GL+YLH C + ++HCDVKP+NILL DHF+PK++DFGLSKL + + F+ +RGTRG
Sbjct: 621 ARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRG 680
Query: 681 YLAPEWMMNLKIDAKADVYSYGIVLLELLTGKX--XXXXXXXXXXXXXXCNH-------- 730
YLAPEW+ N I KADVYSYG+VLLEL++G+ NH
Sbjct: 681 YLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNHSSTTTTST 740
Query: 731 -LVQW--VAKQMEQEG-LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVV 786
LV + A M ++G ++ DPRL ++ +++V++AL CV E RP M+ VV
Sbjct: 741 GLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPTMAAVV 800
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 914 (326.8 bits), Expect = 1.0e-91, P = 1.0e-91
Identities = 259/731 (35%), Positives = 378/731 (51%)
Query: 99 NGNLALTDKDSSV-VWSTNTFTDEGVQAQLLETGNLVLVNEANTTIWKS-FD-------S 149
N LA SV +WS T G +L +G+L L N + TT+W S D S
Sbjct: 60 NSFLAAVSFAGSVPIWSAGTVDSRG-SLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGS 118
Query: 150 PTDT----LL-----P--SQLLTKNTTLVSMRS--PGTYL-SGFYNLKFDDNNILDLIFN 195
DT LL P S T+V ++ G L SG Y+ + + + L L +N
Sbjct: 119 IEDTGEFILLNNRSVPVWSSFDNPTDTIVQSQNFTAGKILRSGLYSFQLERSGNLTLRWN 178
Query: 196 GPLISSIYWP---NSAFTVFLNG-RTPYNSSRRAYVNASGLFRSSDTFKFNASDYGVGPK 251
S+IYW NS+F+ L+ R ++ + S L ++ + DYG
Sbjct: 179 ---TSAIYWNHGLNSSFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIVY--SGDYGDSNT 233
Query: 252 RR-LTLDYDGILRLYSFDESTRLWKISWLPAGLDYCTVHGLCGPNGICVNRPRQKTCICP 310
R L LD DG LR+YS S ++ + +D C V+G CG GIC C CP
Sbjct: 234 FRFLKLDDDGNLRIYS-SASRNSGPVNAHWSAVDQCLVYGYCGNFGICSYNDTNPICSCP 292
Query: 311 N-GFRRNDPSDWIKGCSPLFNLS-CDRNELDFMELPNTDYYGY--DLVTYGIGISLQECR 366
+ F D +D KGC LS C N ++L +T + Y D + CR
Sbjct: 293 SRNFDFVDVNDRRKGCKRKVELSDCSGNTT-MLDLVHTRLFTYEDDPNSESFFAGSSPCR 351
Query: 367 NRCLSDCKCKGFGYSTDGQGECFPKGNLLNGHNMPGKYVSMHIKIPRGKINYSAELEKAR 426
CLS C +DG G C+ K H PG + + + +Y
Sbjct: 352 ANCLSSVLCLASVSMSDGSGNCWQK------H--PGSFFTGYQWPSVPSTSYVKVCGPVV 403
Query: 427 VNDLNCSAAAVVLGGDNANGEKPTKNRYMKYLISLAGSFAVIETVFISLG-WWYVFRRHV 485
N L + GD+ N ++ +++++A ++ V + +G WW R++
Sbjct: 404 ANTLERATK-----GDDNN------SKVHLWIVAVAVIAGLLGLVAVEIGLWWCCCRKNP 452
Query: 486 HEELANLGCIVL--ALGFK-RFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVK 542
+ +L A G +FTY EL+R T++FK+++G GGFG+V+RGVL + VVAVK
Sbjct: 453 RFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVK 512
Query: 543 RLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDP 602
+LEG+ QG+ +F EV+ I +H NLV+L GFC++ H+LLVYE++ NGSLD LF
Sbjct: 513 QLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTD 572
Query: 603 GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662
+A L W+ R+NIA+GTAKG++YLHEEC + ++HCD+KP+NIL+DD+F KV+DFGL+K
Sbjct: 573 -SAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAK 631
Query: 663 LFKERHDTKF--SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKXXXXXXXX 720
L + D ++ S VRGTRGYLAPEW+ NL I +K+DVYSYG+VLLEL++GK
Sbjct: 632 LLNPK-DNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEK 690
Query: 721 XXXXXXXCNHLVQWVAKQMEQEGLEKIIDPRLND--VYDREKLDRMVKVALLCVAENRDT 778
W ++ E+ + I+D RL++ D E++ RMVK + C+ E
Sbjct: 691 TNHKKFSI-----WAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQ 745
Query: 779 RPPMSKVVKLL 789
RP M KVV++L
Sbjct: 746 RPTMGKVVQML 756
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 497 (180.0 bits), Expect = 5.2e-80, Sum P(2) = 5.2e-80
Identities = 118/315 (37%), Positives = 180/315 (57%)
Query: 482 RRHVHEELANLGCIVLALGFKRFTYAELKRATRNFKQ--EVGKGGFGSVFRGVLDDERVV 539
RRH+ E N + L L + E+ AT NF ++G+GGFG V++G L D + +
Sbjct: 497 RRHISRE-NNTDDLELPL----MEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEM 551
Query: 540 AVKRLEGV-LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL 598
AVKRL +QG EF EV +I R+ H NLV+L C + K+L+YEY+EN SLD L
Sbjct: 552 AVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHL 611
Query: 599 FNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDF 658
F D S L W R++I G A+GL YLH++ ++H D+K NILLD + PK++DF
Sbjct: 612 F-DKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDF 670
Query: 659 GLSKLF-KERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKXXXXX 717
G++++F ++ + +V GT GY++PE+ M+ K+DV+S+G++LLE+++ K
Sbjct: 671 GMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGF 730
Query: 718 XXXXXXXXXXCNHLVQWVAKQMEQEGLEKIIDPRLND---VYDREKLDRMVKVALLCVAE 774
W E +GLE IIDP + D + + ++ R +++ LLCV E
Sbjct: 731 YNSDRDLNLLGCVWRNW----KEGKGLE-IIDPIITDSSSTFRQHEILRCIQIGLLCVQE 785
Query: 775 NRDTRPPMSKVVKLL 789
+ RP MS V+ +L
Sbjct: 786 RAEDRPTMSLVILML 800
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 511 (184.9 bits), Expect = 1.2e-79, Sum P(2) = 1.2e-79
Identities = 109/290 (37%), Positives = 173/290 (59%)
Query: 504 FTYAELKRATRNF--KQEVGKGGFGSVFRGVLDDERVVAVKRLEGVL-QGDAEFWAEVSI 560
F+ + AT +F + E+G+GGFG V++GVL+D R +AVKRL G QG EF E+ +
Sbjct: 517 FSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIIL 576
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT 620
I ++ HRNLV+L G C E E K+LVYEY+ N SLD LF++ A ++ W R++I G
Sbjct: 577 IAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQA-LIDWKLRFSIIEGI 635
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK-ERHDTKFSRVRGTR 679
A+GL YLH + ++H D+K N+LLD PK++DFG++++F +++ RV GT
Sbjct: 636 ARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTY 695
Query: 680 GYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKXXXXXXXXXXXXXXXCNHLVQWVAKQM 739
GY++PE+ M K+DVYS+G++LLE+++GK L+ +
Sbjct: 696 GYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGS------LIGYAWYLY 749
Query: 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
E+++DP++ + + R + VA+LCV ++ RP M+ V+ +L
Sbjct: 750 THGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLML 799
|
|
| TAIR|locus:2197704 AT1G61390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 473 (171.6 bits), Expect = 6.8e-79, Sum P(2) = 6.8e-79
Identities = 107/295 (36%), Positives = 165/295 (55%)
Query: 500 GFKRFTYAELKRATRNFKQ--EVGKGGFGSVFRGVLDDERVVAVKRLEGVL-QGDAEFWA 556
G F ++ AT NF ++G+GGFG V++G L D + +AVKRL QG EF
Sbjct: 504 GVNLFDMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKRLSSSSGQGTDEFMN 563
Query: 557 EVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNI 616
E+ +I ++ H+NLV+L G C + E KLL+YEY+ N SLD LF D + W +R+NI
Sbjct: 564 EIRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVFLF-DSTLKFEIDWQKRFNI 622
Query: 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK-ERHDTKFSRV 675
G A+GL YLH + V+H D+K NILLD+ PK++DFGL+++ + ++ RV
Sbjct: 623 IQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARMSQGTQYQDNTRRV 682
Query: 676 RGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKXXXXXXXXXXXXXXXCNHLVQWV 735
GT GY+APE+ K+D+YS+G++LLE++ G+ W
Sbjct: 683 VGTLGYMAPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSEEGKTLLAYA-----WE 737
Query: 736 AKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790
+ E +G++ ++D L D ++ R V++ LLCV RP +++ +LT
Sbjct: 738 S-WCETKGVD-LLDQALADSSHPAEVGRCVQIGLLCVQHQPADRPNTLELMSMLT 790
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 488 (176.8 bits), Expect = 6.8e-79, Sum P(2) = 6.8e-79
Identities = 103/283 (36%), Positives = 164/283 (57%)
Query: 513 TRNFKQE--VGKGGFGSVFRGVLDDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNL 569
T NF E +G+GGFG V++G L D + +A+KRL QG EF E+ +I ++ HRNL
Sbjct: 498 TNNFSMENKLGQGGFGPVYKGNLQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNL 557
Query: 570 VKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
V+L G C E E KLL+YE++ N SL+ +F+ L W +R+ I G A GL YLH
Sbjct: 558 VRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLE-LDWPKRFEIIQGIACGLLYLHR 616
Query: 630 E-CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK-ERHDTKFSRVRGTRGYLAPEWM 687
+ CL V+H D+K NILLD+ PK++DFGL+++F+ +H RV GT GY++PE+
Sbjct: 617 DSCLR-VVHRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYA 675
Query: 688 MNLKIDAKADVYSYGIVLLELLTGKXXXXXXXXXXXXXXXCNHLVQWVAKQMEQEGLEKI 747
K+D+Y++G++LLE++TGK L+++ + G +
Sbjct: 676 WTGMFSEKSDIYAFGVLLLEIITGKRISSFTIGEEGKT-----LLEFAWDSWCESGGSDL 730
Query: 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790
+D ++ ++ R V++ LLC+ + RP +++V+ +LT
Sbjct: 731 LDQDISSSGSESEVARCVQIGLLCIQQQAGDRPNIAQVMSMLT 773
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 780 (279.6 bits), Expect = 1.6e-77, P = 1.6e-77
Identities = 244/805 (30%), Positives = 382/805 (47%)
Query: 23 SQGIPRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCY-SIWFTNSVNRTVVWMA 81
S G +T + L++ L SP G++ GF+ + Y IWF R +VW+A
Sbjct: 16 SYGYAAITTSSPLSIGVT---LSSPGGSYELGFFSSNNSGNQYVGIWFKKVTPRVIVWVA 72
Query: 82 NRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTF-TDEGVQAQLLETGNLVLV-NEA 139
NR++PV+ + LT+ NG+L L D +VWS+ T +A+LL+TGNLV+V N
Sbjct: 73 NREKPVSSTMANLTISSNGSLILLDSKKDLVWSSGGDPTSNKCRAELLDTGNLVVVDNVT 132
Query: 140 NTTIWKSFDSPTDTLLP-SQLL-----TKNTTLVSMRSPGTYLSGFYNLKFDDN-NILDL 192
+W+SF+ DT+LP + L+ K L S +S G + + L
Sbjct: 133 GNYLWQSFEHLGDTMLPLTSLMYDIPNNKKRVLTSWKSETDPSPGEFVAEITPQVPSQGL 192
Query: 193 IFNGPLISSIYWPNS--AFTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKFNASD-YGVG 249
I G SS YW + A T F G ++S YVN G+ + + N + +
Sbjct: 193 IRKG---SSPYWRSGPWAGTRF-TGIPEMDAS---YVNPLGMVQD----EVNGTGVFAFC 241
Query: 250 PKRRLTLDY-----DGILRLYSFDESTRLWKISWLPAGLDYCTVHGLCGPNGICVNRPRQ 304
R L Y +G LR+ + + T W I L C ++G CGP G+CV R
Sbjct: 242 VLRNFNLSYIKLTPEGSLRI-TRNNGTD-W-IKHFEGPLTSCDLYGRCGPFGLCV-RSGT 297
Query: 305 KTCICPNGFR-RNDPS----DWIKGCSPLFNLSCDRNELDFMELPNTD-YYGYDLV---- 354
C C GF ++D +W +GC NLSC N + + D +Y +
Sbjct: 298 PMCQCLKGFEPKSDEEWRSGNWSRGCVRRTNLSCQGNSSVETQGKDRDVFYHVSNIKPPD 357
Query: 355 TYGIG-ISLQE-CRNRCLSDCKCKGFGYSTDGQGECFPKGNLLNGHNMPGKYVSMHIKIP 412
+Y + S +E C CL +C C F Y G G LL+ G ++ +++
Sbjct: 358 SYELASFSNEEQCHQGCLRNCSCTAFSY-VSGIGCLVWNQELLDTVKFIGGGETLSLRLA 416
Query: 413 RGKINYSAELEKARVNDLNCSAAAVVLGGDNANGEKPTKNRYMKYLISLAGSFAVIETVF 472
++ ++ V L+ S +++ A G +Y + GS +++
Sbjct: 417 HSELTGRKRIKIITVATLSLSVCLILVLV--ACG-------CWRYRVKQNGS-SLVSKDN 466
Query: 473 ISLGWWYVFRRHVHEELANLGCIVLALGFKRFTYAELKRATRNFK--QEVGKGGFGSVFR 530
+ W +L + V L F F +L+ AT NF ++G+GGFG+V++
Sbjct: 467 VEGAW--------KSDLQSQD--VSGLNF--FEIHDLQTATNNFSVLNKLGQGGFGTVYK 514
Query: 531 GVLDDERVVAVKRL-EGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589
G L D + +AVKRL +QG EF E+ +I ++ HRNL++L G C + E KLLVYEY+
Sbjct: 515 GKLQDGKEIAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYM 574
Query: 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD 649
N SLD +F+ I W R+NI G A+GL YLH + V+H D+K NILLD+
Sbjct: 575 VNKSLDIFIFDLKKKLEI-DWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDE 633
Query: 650 HFEPKVTDFGLSKLFK-ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLEL 708
PK++DFGL++LF +H V GT GY++PE+ K+D+YS+G+++LE+
Sbjct: 634 KMNPKISDFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEI 693
Query: 709 LTGKXXXXXXXXXXXXXXXCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLD--RMVK 766
+TGK +L+ + + G ++D L+D ++ R V
Sbjct: 694 ITGKEISSFSYGKDN-----KNLLSYAWDSWSENGGVNLLDQDLDDSDSVNSVEAGRCVH 748
Query: 767 VALLCVAENRDTRPPMSKVVKLLTA 791
+ LLCV RP + +V+ +LT+
Sbjct: 749 IGLLCVQHQAIDRPNIKQVMSMLTS 773
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 5.0e-77, Sum P(2) = 5.0e-77
Identities = 108/296 (36%), Positives = 166/296 (56%)
Query: 500 GFKRFTYAELKRATRNFK--QEVGKGGFGSVFRGVLDDERVVAVKRLEGVL-QGDAEFWA 556
G F ++ AT NF ++G+GGFG V++G L D + + VKRL QG EF
Sbjct: 472 GVNFFEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQGTEEFMN 531
Query: 557 EVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNI 616
E+++I ++ HRNLV+L G+C + E KLL+YE++ N SLD +F DP L W +R+NI
Sbjct: 532 EITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIF-DPCLKFELDWPKRFNI 590
Query: 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK-ERHDTKFSRV 675
G A+GL YLH + V+H D+K NILLDD PK++DFGL+++F+ ++ RV
Sbjct: 591 IQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRV 650
Query: 676 RGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKXXXXXXXXXXXXXXXCNHLVQWV 735
GT GY++PE+ K+D+YS+G+++LE+++GK W
Sbjct: 651 VGTLGYMSPEYAWAGLFSEKSDIYSFGVLMLEIISGKRISRFIYGDESKGLLAYTWDSWC 710
Query: 736 AKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791
+ G ++D L D ++ R V++ LLCV RP +V+ +LT+
Sbjct: 711 -----ETGGSNLLDRDLTDTCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTS 761
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9XID3 | Y1343_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3401 | 0.8669 | 0.8407 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 804 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-34 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-30 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-29 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 8e-29 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 5e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-27 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-25 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-07 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 1e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-06 | |
| cd01100 | 73 | cd01100, APPLE_Factor_XI_like, Subfamily of PAN/AP | 4e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-05 | |
| cd00053 | 36 | cd00053, EGF, Epidermal growth factor domain, foun | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-05 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| pfam14295 | 48 | pfam14295, PAN_4, PAN domain | 3e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-05 | |
| cd00054 | 38 | cd00054, EGF_CA, Calcium-binding EGF-like domain, | 6e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-04 | |
| smart00179 | 39 | smart00179, EGF_CA, Calcium-binding EGF-like domai | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| smart00181 | 35 | smart00181, EGF, Epidermal growth factor-like doma | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 4e-51
Identities = 68/202 (33%), Positives = 106/202 (52%), Gaps = 13/202 (6%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEF---WAEVSIIGRINHRNLVK 571
+++G G FG+V++ ++VAVK L+ + + E+ I+ R++H N+V+
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
L + +H LV EY E G L L L D+ IA+ +GL YLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN- 117
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW-MMNL 690
++H D+KP+NILLD++ K+ DFGL+K + + + GT Y+APE +
Sbjct: 118 --GIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGN 174
Query: 691 KIDAKADVYSYGIVLLELLTGK 712
K DV+S G++L ELLTGK
Sbjct: 175 GYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 8e-48
Identities = 70/194 (36%), Positives = 104/194 (53%), Gaps = 12/194 (6%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDA--EFWAEVSIIGRINHRNLVKLQGFC 576
+G+GGFG+V+ + VA+K ++ E E+ I+ ++NH N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 577 AENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVL 636
+ H LV EY E GSL LL + G L D+ I + +GL YLH ++
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSNG---II 114
Query: 637 HCDVKPQNILLD-DHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPE-WMMNLKIDA 694
H D+KP+NILLD D+ + K+ DFGLSKL + + GT Y+APE +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTS-DKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 695 KADVYSYGIVLLEL 708
K+D++S G++L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 3e-45
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQGDAEFWAEVSIIGRINHRNLVKL 572
+++G+G FG V+ ++VA+K + + + + E+ I+ ++ H N+V+L
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGTAKGLSYL 627
+ + LV EY E G L LL ++ L+ Q L YL
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR--Q-------ILSALEYL 113
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
H + ++H D+KP+NILLD+ K+ DFGL++ K + GT Y+APE +
Sbjct: 114 HSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLD--PGEKLTTFVGTPEYMAPEVL 168
Query: 688 MNLKIDAKADVYSYGIVLLELLTGKS 713
+ D++S G++L ELLTGK
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 77/286 (26%), Positives = 137/286 (47%), Gaps = 43/286 (15%)
Query: 516 FKQEVGKGGFGSVFRGVLDD-----ERVVAVKRL--EGVLQGDAEFWAEVSIIGRINHRN 568
+++G+G FG V++G L + VAVK L + Q EF E I+ +++H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
+VKL G C E E +V EY+E G L L + L + A+ A+G+ YL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQIARGMEYLE 119
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG---YLAPE 685
+ +H D+ +N L+ ++ K++DFGLS ++ +D + R RG + ++APE
Sbjct: 120 SKN---FIHRDLAARNCLVGENLVVKISDFGLS---RDLYDDDYYRKRGGKLPIRWMAPE 173
Query: 686 WMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAK--QMEQEG 743
+ K +K+DV+S+G++L E+ T Y S + +++++ ++ Q
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTL-GEQPYPGMSNEE------VLEYLKNGYRLPQP- 225
Query: 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
+ + L C AE+ + RP S++V++L
Sbjct: 226 --------------PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 77/286 (26%), Positives = 138/286 (48%), Gaps = 42/286 (14%)
Query: 516 FKQEVGKGGFGSVFRGVLDD-----ERVVAVKRL--EGVLQGDAEFWAEVSIIGRINHRN 568
+++G+G FG V++G L E VAVK L + Q EF E I+ +++H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
+VKL G C E E ++V EY+ G L L + L + A+ A+G+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGMEYLE 120
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG---YLAPE 685
+ +H D+ +N L+ ++ K++DFGLS+ D +V+G + ++APE
Sbjct: 121 SKN---FIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYY--KVKGGKLPIRWMAPE 174
Query: 686 WMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAK--QMEQEG 743
+ K +K+DV+S+G++L E+ T Y S ++ +++++ K ++ +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTL-GEEPYPGMSNAE------VLEYLKKGYRLPKP- 226
Query: 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
+ K+ L C AE+ + RP S++V++L
Sbjct: 227 --------------PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 9e-38
Identities = 77/290 (26%), Positives = 134/290 (46%), Gaps = 50/290 (17%)
Query: 516 FKQEVGKGGFGSVFRGVLDD-----ERVVAVKRL--EGVLQGDAEFWAEVSIIGRINHRN 568
+++G+G FG V++G L E VAVK L + EF E SI+ +++H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
+V+L G C + E +V EY+ G L L L +A+ AKG+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK---LTLKDLLQMALQIAKGMEYLE 119
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE------RHDTKFSRVRGTRGYL 682
+ +H D+ +N L+ ++ K++DFGLS+ E R K ++ ++
Sbjct: 120 SKNF---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIK----WM 171
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742
APE + + K +K+DV+S+G++L E+ T + Y + V + +E
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTL-----------GEQPYPGMSNEEVLELLEDG 220
Query: 743 G-LEKIIDPRL--NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
L + P +++Y+ + L C A + + RP S++V+ L
Sbjct: 221 YRLPR---PENCPDELYE---------LMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 32/209 (15%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA---EVSIIGRINHRNLVKLQGF 575
+G+G FGSV+ + D ++AVK +E + E A E+ I+ + H N+V+ G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 576 CAENEHK-LLVY-EYVENGSLDKLL-----FNDPG----TASILQWDQRYNIAVGTAKGL 624
+ E L ++ EYV GSL LL +P T IL+ GL
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-------------GL 114
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR-VRGTRGYLA 683
+YLH ++H D+K NIL+D K+ DFG +K + + + VRGT ++A
Sbjct: 115 AYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLTGK 712
PE + + AD++S G ++E+ TGK
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 1e-33
Identities = 76/296 (25%), Positives = 134/296 (45%), Gaps = 59/296 (19%)
Query: 519 EVGKGGFGSVFRGVLDD----ERVVAVKRLEGVLQGDA------EFWAEVSIIGRINHRN 568
++G+G FG V++G L VAVK L+ DA +F E ++ ++ H N
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVK----TLKEDASEEERKDFLKEARVMKKLGHPN 57
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGTAKG 623
+V+L G C E E LV EY+E G L L S L + A+ AKG
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG--- 680
+ YL + +H D+ +N L+ + K++DFGLS+ + T G
Sbjct: 118 MEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSR----DVYDDDYYRKKTGGKLP 170
Query: 681 --YLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAK- 737
++APE + + +K+DV+S+G++L E+ T A+ Y S + +++++ K
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT-LGATPYPGLSNEE------VLEYLRKG 223
Query: 738 -QMEQEGLEKIIDPRL--NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790
++ + P +++Y+ + L C + + RP S++V+ L
Sbjct: 224 YRLPK--------PEYCPDELYE---------LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 4e-33
Identities = 71/213 (33%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 515 NFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWA----EVSIIGRINH-RNL 569
+++G+G FG V+ D ++VA+K L L+ ++ E+ I+ +NH N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 570 VKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
VKL F + LV EYV+ GSL+ L G L + I L YLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 630 ECLEWVLHCDVKPQNILLDDH-FEPKVTDFGLSKLFKER-----HDTKFSRVRGTRGYLA 683
+ ++H D+KP+NILLD K+ DFGL+KL + S GT GY+A
Sbjct: 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 684 PEWMMNL---KIDAKADVYSYGIVLLELLTGKS 713
PE ++ L + +D++S GI L ELLTG
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 30/210 (14%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKR--LEGVLQGD-AEFWAEVSIIGRINHRNLVK 571
+G+G FG V++G+ L+ VA+K+ LE + + E+ ++ + H N+VK
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLL-----FNDPGTAS----ILQWDQRYNIAVGTAK 622
G ++ ++ EY ENGSL +++ F + A +LQ
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ------------- 110
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
GL+YLHE+ V+H D+K NIL K+ DFG++ + S V GT ++
Sbjct: 111 GLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWM 166
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGK 712
APE + +D++S G ++ELLTG
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 517 KQEVGKGGFGSVFRG-VLDDERVVAVKRLEGVLQGDAEFW-AEVSIIGRINHRNLVKLQG 574
+++GKGGFG V++ + VA+K ++ + E E+ I+ + H N+VK G
Sbjct: 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 575 FCAENEHKLLVYEYVENGSLDKLL------FNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
+ + +V E+ GSL LL + A + + KGL YLH
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCK---------ELLKGLEYLH 115
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM 688
++H D+K NILL E K+ DFGLS + + V GT ++APE +
Sbjct: 116 SN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-TMV-GTPYWMAPEVIN 170
Query: 689 NLKIDAKADVYSYGIVLLELLTGK 712
D KAD++S GI +EL GK
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-29
Identities = 46/105 (43%), Positives = 59/105 (56%), Gaps = 6/105 (5%)
Query: 74 NRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTD-EGVQAQLLETGN 132
N+TVVW+ANR P+ L LQ +GNL L D + VVWS+NT G A L + GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 133 LVLVNEANTTIWKSFDSPTDTLLPSQLLTK-----NTTLVSMRSP 172
LVL + + +W+SFD PTDTLLP Q + L S +S
Sbjct: 61 LVLYDNSGKVLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSN 105
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 15/208 (7%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
E+ R + +++G G FG V+ G+ ++ VAVK L+ +F AE I+ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
L++L C E +V E ++ GSL + L G A L+ Q ++A A G++YL
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYL 119
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE-----RHDTKFSRVRGTRGYL 682
+ +H D+ +N+L+ ++ KV DFGL+++ KE R KF ++ T
Sbjct: 120 EAQNY---IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP-IKWT---- 171
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLT 710
APE + + K+DV+S+GI+L E++T
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 73/228 (32%), Positives = 115/228 (50%), Gaps = 29/228 (12%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVLQGDAE--FWAEVS 559
++R T K+E+G+G FG VF G +D+ +VAVK L+ DA F E
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 560 IIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL-FNDPGTASILQWDQR----- 613
++ H N+VK G C E + ++V+EY+E+G L+K L + P A + D
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 614 ----YNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669
IAV A G+ YL + +H D+ +N L+ K+ DFG+S ++ +
Sbjct: 121 LSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS---RDVYT 174
Query: 670 TKFSRVRGTR----GYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GK 712
T + RV G ++ PE +M K ++DV+S+G+VL E+ T GK
Sbjct: 175 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 8e-29
Identities = 47/112 (41%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 41 NDFLVSPNGTFSSGFYK-VGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRN 99
LVS F GF+K + + I + S +RTVVW+ANRD P G LTLQ +
Sbjct: 7 GQTLVSSGSLFELGFFKLIMQSRDYNLILYKGS-SRTVVWVANRDNPS-GSSCTLTLQSD 64
Query: 100 GNLALTDKDSSVVWSTNTFTDEGVQ-AQLLETGNLVLVNEANTTIWKSFDSP 150
GNL + D +VVWS+NT G LL+ GNLVL + +W+SFD P
Sbjct: 65 GNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-28
Identities = 47/111 (42%), Positives = 61/111 (54%), Gaps = 3/111 (2%)
Query: 39 KENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQR 98
LVS N F GF+ + I + +S +RTVVW+ANRD PV+ LTLQ
Sbjct: 5 SSGQTLVSGNSLFELGFFTLIMQNDYNLILYKSS-SRTVVWVANRDNPVSD-SCTLTLQS 62
Query: 99 NGNLALTDKDSSVVWSTNTFTDEGVQ-AQLLETGNLVLVNEANTTIWKSFD 148
+GNL L D D VVWS+NT G LL+ GNLV+ + +W+SFD
Sbjct: 63 DGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFD 113
|
Length = 114 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 518 QEVGKGGFGSVFRGVL----DDERVVAVKRLEGVLQGDA--EFWAEVSIIGRINHRNLVK 571
+ +G G FG V RG L E VA+K L+ +F E SI+G+ +H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
L+G ++ +++ EY+ENGSLDK L + G Q + G A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLSEMN 126
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG------YLAPE 685
+H D+ +NIL++ + KV+DFGLS R T+G + APE
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLS-----RRLEDSEATYTTKGGKIPIRWTAPE 178
Query: 686 WMMNLKIDAKADVYSYGIVLLELLT 710
+ K + +DV+S+GIV+ E+++
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 69/203 (33%), Positives = 118/203 (58%), Gaps = 15/203 (7%)
Query: 517 KQEV-GKGGFGSVFRGVLD----DERVVAVKRLEG--VLQGDAEFWAEVSIIGRINHRNL 569
KQ+V G G FG VFRG+L E VA+K L+ + +F +E SI+G+ +H N+
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 570 VKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
++L+G + + +++ EY+ENG+LDK L + G S Q G A G+ YL +
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSD 125
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG--YLAPEWM 687
+ +V H D+ +NIL++ + E KV+DFGLS++ ++ + ++ G + APE +
Sbjct: 126 --MNYV-HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 688 MNLKIDAKADVYSYGIVLLELLT 710
K + +DV+S+GIV+ E+++
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 69/207 (33%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 520 VGKGGFGSVFRGV--LDDERVVAVKRLE--GVLQGDAE--FWAEVSIIGRINHRNLVKLQ 573
+GKG FG V V D ++ A+K L+ +++ E +I+ RINH +VKL
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL- 58
Query: 574 GFCA-ENEHKL-LVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGTAKGLSY 626
A + E KL LV EY G L L F++ + Y A L Y
Sbjct: 59 -HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE-------RARFY--AAEIVLALEY 108
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
LH +++ D+KP+NILLD K+TDFGL+K + GT YLAPE
Sbjct: 109 LHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEV 164
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGKS 713
++ D +S G++L E+LTGK
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 10/203 (4%)
Query: 517 KQEVGKGGFGSVFRGV-LDDERVVAVKR--LEGVLQGDAEF-WAEVSIIGRINHRNLVKL 572
+++GKG FG V+ D ++ +K L + + + E EV I+ ++NH N++K
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
E +V EY + G L + + +Q + V L YLH
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-- 122
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR-VRGTRGYLAPEWMMNLK 691
+LH D+KPQNI L + K+ DFG+SK+ ++ V GT YL+PE N
Sbjct: 123 -KILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVVGTPYYLSPELCQNKP 179
Query: 692 IDAKADVYSYGIVLLELLTGKSA 714
+ K+D++S G VL EL T K
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 63/193 (32%), Positives = 98/193 (50%), Gaps = 10/193 (5%)
Query: 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGF 575
+GKG FG V G ++V AVK L+ F AE S++ + H NLV+L G
Sbjct: 10 LGATIGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWV 635
+ +V EY+ GSL L G A ++ Q+ A+ +G+ YL E+
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYL-RSRGRA-VITLAQQLGFALDVCEGMEYLEEKN---F 123
Query: 636 LHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAK 695
+H D+ +N+L+ + KV+DFGL+K + D+ V+ T APE + K K
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTK 179
Query: 696 ADVYSYGIVLLEL 708
+DV+S+GI+L E+
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 516 FKQEVGKGGFGSVFRGVLDDER-----VVAVKRL--EGVLQGDAEFWAEVSIIGRINHRN 568
F +++G+G FG V D VAVK L G Q ++F E+ I+ ++H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 569 LVKLQGFC---AENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
+VK +G C +L + EY+ +GSL L + + + KG+
Sbjct: 68 IVKYKGVCEKPGGRSLRL-IMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMD 123
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG---TRGYL 682
YL + +H D+ +NIL++ K++DFGL+K+ E D + + G Y
Sbjct: 124 YLGSQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLT 710
APE + K + +DV+S+G+ L EL T
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 67/209 (32%), Positives = 111/209 (53%), Gaps = 17/209 (8%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRL-EGVLQGDAEFWAEVSIIGRINH 566
E+ R + ++++G G FG V+ G + VAVK L G + +A F E I+ ++ H
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-FLQEAQIMKKLRH 60
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
LV+L C+E E +V EY+ GSL L + G L+ Q ++A A+G++Y
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK--LRLPQLVDMAAQIAEGMAY 118
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE-----RHDTKFSRVRGTRGY 681
L +H D+ +NIL+ ++ K+ DFGL++L ++ R KF ++ T
Sbjct: 119 LESRNY---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP-IKWT--- 171
Query: 682 LAPEWMMNLKIDAKADVYSYGIVLLELLT 710
APE + K+DV+S+GI+L E++T
Sbjct: 172 -APEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-25
Identities = 75/244 (30%), Positives = 120/244 (49%), Gaps = 23/244 (9%)
Query: 557 EVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNI 616
E++ +G++ H N+VKL G C + L++EY+E +L ++L N L W++R I
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKI 785
Query: 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR 676
A+G AK L +LH C V+ ++ P+ I++D EP + L L S
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-- 842
Query: 677 GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVA 736
Y+APE I K+D+Y +G++L+ELLTGKS +D ++ +V+W
Sbjct: 843 ---AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD------AEFGVHGSIVEWAR 893
Query: 737 KQMEQEGLEKIIDPRLN---DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793
L+ IDP + V E ++ M +AL C A + RP + V+K L +
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM-NLALHCTATDPTARPCANDVLKTLESAS 952
Query: 794 HESS 797
SS
Sbjct: 953 RSSS 956
|
Length = 968 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRL---EGVLQGDAEFWAEVSIIGRINHRNLVKLQGF 575
+G G FG V+ V LD ++AVK + + + E E+ ++ + H NLVK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWV 635
E + EY G+L++LL + G + Y + + +GL+YLH +
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQL--LEGLAYLHSH---GI 120
Query: 636 LHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG---YLAPEWMMNLKI 692
+H D+KP NI LD + K+ DFG + K T V+ G Y+APE + K
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 693 DAK---ADVYSYGIVLLELLTGK 712
AD++S G V+LE+ TGK
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 64/204 (31%), Positives = 115/204 (56%), Gaps = 16/204 (7%)
Query: 517 KQEVGKGGFGSVFRGVLD----DERVVAVKRLEG--VLQGDAEFWAEVSIIGRINHRNLV 570
++ +G G FG V RG L E VA+K L+ + +F +E SI+G+ +H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
L+G ++ +++ E++ENG+LD L + G +++Q + G A G+ YL E
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLSE- 124
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE-RHDTKFSRVRGTR---GYLAPEW 686
+ +V H D+ +NIL++ + KV+DFGLS+ ++ D ++ G + + APE
Sbjct: 125 -MNYV-HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 687 MMNLKIDAKADVYSYGIVLLELLT 710
+ K + +DV+SYGIV+ E+++
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRL-EGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
F +E+G G FG V G + VA+K + EG + D +F E ++ +++H NLV+L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQLYG 66
Query: 575 FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
C + +V EY+ NG L L G L + ++ + + YL
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNG--- 120
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR---GYLAPEWMMNLK 691
+H D+ +N L+ + KV+DFGL++ D +++ +GT+ + PE +
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVL---DDQYTSSQGTKFPVKWAPPEVFDYSR 177
Query: 692 IDAKADVYSYGIVLLELLTG 711
+K+DV+S+G+++ E+ +
Sbjct: 178 FSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 23/212 (10%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGD-----AEFWAEVSIIG 562
E R ++++G G FG V+ G+ + VA+K +L+ D +F EV +
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIK----ILKSDDLLKQQDFQKEVQALK 57
Query: 563 RINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK 622
R+ H++L+ L C+ E ++ E +E GSL L + G L ++A A+
Sbjct: 58 RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV--LPVASLIDMACQVAE 115
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE----RHDTKFSRVRGT 678
G++YL E+ +H D+ +NIL+ + KV DFGL++L KE D K + T
Sbjct: 116 GMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP-YKWT 171
Query: 679 RGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
APE + K+DV+S+GI+L E+ T
Sbjct: 172 ----APEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 27/203 (13%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAE 578
+G+G +GSV++ + + +VVA+K + V + E E+SI+ + + +VK G +
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 579 NEHKLLVYEYVENGSLDKLL------FNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
N +V EY GS+ ++ + A+IL T KGL YLH
Sbjct: 70 NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILY---------QTLKGLEYLH---S 117
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLS-KLFKERHDTKFSR--VRGTRGYLAPEWMMN 689
+H D+K NILL++ + K+ DFG+S +L DT R V GT ++APE +
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT----DTMAKRNTVIGTPFWMAPEVIQE 173
Query: 690 LKIDAKADVYSYGIVLLELLTGK 712
+ + KAD++S GI +E+ GK
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 6e-23
Identities = 66/203 (32%), Positives = 114/203 (56%), Gaps = 22/203 (10%)
Query: 520 VGKGGFGSVFRGVLD----DERVVAVKRLEG--VLQGDAEFWAEVSIIGRINHRNLVKLQ 573
+G G FG V G L E VA+K L+ + +F +E SI+G+ +H N++ L+
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
G +++ ++V EY+ENGSLD L G +++Q + G A G+ YL + +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYLSD--MG 126
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG------YLAPEWM 687
+V H D+ +NIL++ + KV+DFGLS++ ++ + ++ TRG + APE +
Sbjct: 127 YV-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT----TRGGKIPIRWTAPEAI 181
Query: 688 MNLKIDAKADVYSYGIVLLELLT 710
K + +DV+SYGIV+ E+++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 518 QEVGKGGFGSVFRGVLDDERVVAVK--RLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGF 575
+++GKG FG V++GVL VAVK R +F E I+ + +H N+VKL G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWV 635
C + + +V E V GSL L + L + +++ A G+ YL +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 636 LHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR----GYLAPEWMMNLK 691
+H D+ +N L+ ++ K++DFG+S +E ++ G + + APE + +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 692 IDAKADVYSYGIVLLELLTGKS 713
+++DV+SYGI+L E +
Sbjct: 172 YTSESDVWSYGILLWETFSLGD 193
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEF---WAEVSIIGRINHRNLV 570
+ +G G V+ + L + VA+KR++ + + EV + + NH N+V
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLL--------FNDPGTASILQWDQRYNIAVGTAK 622
K + LV Y+ GSL ++ ++ A++L+ K
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK---------EVLK 113
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK-LFKERHDTKFSR--VRGTR 679
GL YLH +H D+K NILL + K+ DFG+S L T+ R GT
Sbjct: 114 GLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 680 GYLAPEWMMNLK-IDAKADVYSYGIVLLELLTGK 712
++APE M + D KAD++S+GI +EL TG
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVLQGDA--EFWAEVS 559
E+ + F +E+G+G FG V++G L VA+K L+ + EF E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 560 IIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLF------------NDPGTASI 607
++ + H N+V L G C + + +++EY+ +G L + L D S
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 608 LQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667
L +IA+ A G+ YL +H D+ +N L+ + K++DFGLS ++
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLS---RDI 174
Query: 668 HDTKFSRVRGTR----GYLAPEWMMNLKIDAKADVYSYGIVLLEL 708
+ + RV+ ++ PE ++ K ++D++S+G+VL E+
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 521 GKGGFGSVFRGVLDDE-RVVAVKRLEGVLQGDAEF----WAEVSIIGRINHRNLVKLQG- 574
G+G G V++ ++ A+K++ GD EF E+ + +VK G
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVD--GDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 575 FCAENEHKLLVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
F E E + V EY++ GSL LL +P A I I KGL YLH
Sbjct: 68 FYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIA-----RQIL----KGLDYLHT 117
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
+ ++H D+KP N+L++ E K+ DFG+SK+ + D + V GT Y++PE
Sbjct: 118 K--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE---- 170
Query: 690 LKIDAK-----ADVYSYGIVLLELLTGK 712
+I + AD++S G+ LLE GK
Sbjct: 171 -RIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 38/228 (16%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDD------ERVVAVKRLEGVLQGDA------EFW 555
EL R +E+G+G FG V+ G+ E VA+K + +A EF
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIK----TVNENASMRERIEFL 57
Query: 556 AEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL--------FNDPGTASI 607
E S++ N ++V+L G + + L+V E + G L L N
Sbjct: 58 NEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGL--GP 115
Query: 608 LQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667
+ +A A G++YL ++V H D+ +N ++ + K+ DFG+++ E
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAA--KKFV-HRDLAARNCMVAEDLTVKIGDFGMTRDIYE- 171
Query: 668 HDTKFSRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
T + R +G +G L APE + + K+DV+S+G+VL E+ T
Sbjct: 172 --TDYYR-KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 519 EVGKGGFGSVFRGVL---DDERV-VAVKRL--EGVLQGDAEFWAEVSIIGRINHRNLVKL 572
E+G G FGSV +GV + V VAVK L E + G EF E S++ +++H +V+L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGT--ASILQWDQRYNIAVGTAKGLSYLHEE 630
G C + E +LV E G L K L + + + A A G++YL E
Sbjct: 62 IGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYL-ES 113
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG---TRGYLAPEWM 687
+V H D+ +N+LL + + K++DFG+S+ D + G + Y APE +
Sbjct: 114 K-HFV-HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY-APECI 170
Query: 688 MNLKIDAKADVYSYGIVLLELLT 710
K +K+DV+SYG+ L E +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 6/203 (2%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
E+ R + +++G G FG V+ G + VAVK L+ F E I+ ++ H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHD 61
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LV+L +E E +V EY+ GSL L F G L+ ++A A G++Y+
Sbjct: 62 KLVQLYAVVSE-EPIYIVTEYMSKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
E + ++ H D++ NIL+ D K+ DFGL++L ++ T + + APE
Sbjct: 119 --ERMNYI-HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 688 MNLKIDAKADVYSYGIVLLELLT 710
+ + K+DV+S+GI+L EL+T
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 519 EVGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGF 575
E+G G G V + + +++AVK RLE + E+ I+ + N +V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 576 CAENEHKLLVYEYVENGSLDKLL--FNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
N + EY++ GSLDK+L IL IAV KGL+YLHE+
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEK--H 120
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKID 693
++H DVKP NIL++ + K+ DFG+S + ++ GT Y+APE +
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPERIQGNDYS 177
Query: 694 AKADVYSYGIVLLELLTGK 712
K+D++S G+ L+EL TG+
Sbjct: 178 VKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKR--LEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
+ +GKG FG V++ + +VVA+K LE + E+ + + + K G
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66
Query: 575 FCAENEHKLLVYEYVENGSLDKLL----FNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+ ++ EY GS LL ++ A IL R GL YLHEE
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFIL----RE-----VLLGLEYLHEE 117
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
+H D+K NILL + + K+ DFG+S + + V GT ++APE +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQS 173
Query: 691 KIDAKADVYSYGIVLLELLTGK 712
D KAD++S GI +EL G+
Sbjct: 174 GYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-21
Identities = 62/203 (30%), Positives = 106/203 (52%), Gaps = 6/203 (2%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
E+ R + + ++G+G FG V+ G + VA+K L+ F E ++ ++ H
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 61
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LV+L +E E +V EY+ GSL L + G L+ Q ++A A G++Y+
Sbjct: 62 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYV 118
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
E + +V H D++ NIL+ ++ KV DFGL++L ++ T + + APE
Sbjct: 119 --ERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 688 MNLKIDAKADVYSYGIVLLELLT 710
+ + K+DV+S+GI+L EL T
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 29/218 (13%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL--DDERV---VAVKRL--EGVLQGDAEFWAEVSI 560
LK + +G G FG+V++GV + E+V VA+K L E + + E E +
Sbjct: 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV 62
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDP---GTASILQWDQRYNIA 617
+ ++H ++V+L G C ++ L+ + + G L + N G+ +L W
Sbjct: 63 MASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------C 115
Query: 618 VGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG 677
V AKG+SYL E+ L +H D+ +N+L+ K+TDFGL+KL D
Sbjct: 116 VQIAKGMSYLEEKRL---VHRDLAARNVLVKTPQHVKITDFGLAKLL----DVDEKEYHA 168
Query: 678 TRG-----YLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
G ++A E +++ K+DV+SYG+ + EL+T
Sbjct: 169 EGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 59/212 (27%), Positives = 108/212 (50%), Gaps = 17/212 (8%)
Query: 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGF 575
QE+G G FG V+ G ++R VA+K + + +F E ++ +++H LV+L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWV 635
C E LV+E++E+G L L G + + + +G++YL V
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESSN---V 121
Query: 636 LHCDVKPQNILLDDHFEPKVTDFGLSKL-----FKERHDTKFSRVRGTRGYLAPEWMMNL 690
+H D+ +N L+ ++ KV+DFG+++ + TKF V+ + +PE
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP-VK----WSSPEVFSFS 176
Query: 691 KIDAKADVYSYGIVLLELLT-GKSASDYLSAS 721
K +K+DV+S+G+++ E+ + GK+ + S S
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 3e-20
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 35/212 (16%)
Query: 517 KQEVGKGGFGSVFRGV-LDDERVVAVKRL------EGV----LQGDAEFWAEVSIIGRIN 565
+++G+G +G V++ +VA+K++ EG+ L+ E+S++ +
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLKELK 56
Query: 566 HRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPG--TASILQWDQRYNIAVGTAKG 623
H N+VKL LV+EY + L K L PG + ++++ +I +G
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIK-----SIMYQLLRG 110
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF--KERHDTKFSRVRGTRGY 681
L+Y H +LH D+KPQNIL++ K+ DFGL++ F R T V T Y
Sbjct: 111 LAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH--EVV-TLWY 164
Query: 682 LAPEWMMNLKI-DAKADVYSYGIVLLELLTGK 712
APE ++ K D++S G + E++TGK
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 64/203 (31%), Positives = 105/203 (51%), Gaps = 16/203 (7%)
Query: 517 KQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG-----DAEFWAEVSIIGRINHRNLV 570
++GKG FG VF+ V D+RV A+K+++ L E E ++ +++ ++
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQID--LSKMNRREREEAIDEARVLAKLDSSYII 62
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+ + +V EY ENG L KLL G L DQ + + GL++LH +
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR-VRGTRGYLAPEWMMN 689
+LH D+K N+ LD + K+ D G++KL + +T F+ + GT YL+PE +
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCED 175
Query: 690 LKIDAKADVYSYGIVLLELLTGK 712
+ K+DV++ G+VL E TGK
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 60/204 (29%), Positives = 109/204 (53%), Gaps = 8/204 (3%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRL-EGVLQGDAEFWAEVSIIGRINH 566
E+ R T +++G G FG V+ G + VA+K L +G + +A F AE +++ ++ H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQH 60
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
LV+L + E ++ EY+ENGSL L G L ++ ++A A+G+++
Sbjct: 61 PRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAF 117
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
+ + +H D++ NIL+ + K+ DFGL++L ++ T + + APE
Sbjct: 118 IERKNY---IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 174
Query: 687 MMNLKIDAKADVYSYGIVLLELLT 710
+ K+DV+S+GI+L E++T
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 7e-20
Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 519 EVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-----EVSIIGRINHRNLVKL 572
++G+G +G V++ +VA+K++ ++ + E + E+ ++ ++ H N+V+L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 573 QGFCAENEHK--LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+ +V+EY+++ L LL + + Q +GL YLH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTE---SQIKCYMKQLLEGLQYLHSN 119
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF-SRVRGTRGYLAPEWMMN 689
+LH D+K NIL+++ K+ DFGL++ + +R+ + +RV T Y PE ++
Sbjct: 120 G---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLG 175
Query: 690 LKI-DAKADVYSYGIVLLELLTGK 712
+ D++S G +L EL GK
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 509 LKRATRNFKQEVGKGGFGSVFRG------VLDDERVVAVKRLEG-VLQGDAEFWAEVSII 561
+KR K+E+G+G FG VF D+ +VAVK L+ L +F E ++
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 61
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASI------------LQ 609
+ H ++VK G C + + ++V+EY+++G L+K L A I L
Sbjct: 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 610 WDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669
Q +IA A G+ YL + +H D+ +N L+ + K+ DFG+S ++ +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMS---RDVYS 175
Query: 670 TKFSRVRGTR----GYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
T + RV G ++ PE +M K ++DV+S+G++L E+ T
Sbjct: 176 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 520 VGKGGFGSVFR-GVLDDERVVAVKRLEG--VLQGDAEFWA-EVSIIGRINHRNLVKLQGF 575
+G+G G VF+ + VA+K++ + G E+ + H +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWV 635
+LV EY+ L ++L ++ Q + Y + KG++Y+H +
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQ-VKSYMRML--LKGVAYMHANG---I 120
Query: 636 LHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL-KIDA 694
+H D+KP N+L+ K+ DFGL++LF E +S TR Y APE + K D
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 695 KADVYSYGIVLLELLTG 711
D+++ G + ELL G
Sbjct: 181 GVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA------EVSIIGRINHRNLVKL 572
+G+G +G V++ +VA+K+ + E+ ++ +NH N++KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKK---IKLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
LV+E+++ L KL+ L + +GL++ H
Sbjct: 64 LDVFRHKGDLYLVFEFMDT-DLYKLI---KDRQRGLPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI 692
+LH D+KP+N+L++ K+ DFGL++ F V TR Y APE ++ K
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKG 175
Query: 693 -DAKADVYSYGIVLLELLTGK 712
D++S G + ELL+ +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 30/225 (13%)
Query: 509 LKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVLQGD-AEFWAEVSII 561
+KR K E+G+G FG VF D+ +VAVK L+ + +F E ++
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 61
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQ-----------W 610
+ H+++V+ G C E L+V+EY+ +G L++ L + A IL
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 611 DQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670
Q IA A G+ YL L +V H D+ +N L+ K+ DFG+S ++ + T
Sbjct: 122 GQMLAIASQIASGMVYL--ASLHFV-HRDLATRNCLVGQGLVVKIGDFGMS---RDIYST 175
Query: 671 KFSRVRGTRGYLAPEWM-----MNLKIDAKADVYSYGIVLLELLT 710
+ RV G R L WM + K ++D++S+G+VL E+ T
Sbjct: 176 DYYRV-GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 34/211 (16%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVK-------RLEGVLQGDAEFWAEVSIIGRINH 566
+++G+G G V++ + VA+K E ++ E+ I+ H
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-------EILIMKDCKH 74
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGSLDKLL------FNDPGTASILQWDQRYNIAVGT 620
N+V + +V EY++ GSL ++ N+P A + +
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR---------EV 125
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG 680
+GL YLH + V+H D+K NILL K+ DFG + + + S V GT
Sbjct: 126 LQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPY 181
Query: 681 YLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
++APE + K D++S GI+ +E+ G
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 26/222 (11%)
Query: 509 LKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVL-QGDAEFWAEVSII 561
+KR K+E+G+G FG VF D+ +VAVK L+ +F E ++
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDK---------LLFNDPGTASILQWDQ 612
+ H ++VK G C E + ++V+EY+++G L+K +L + + L Q
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 613 RYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672
+IA A G+ YL + +H D+ +N L+ ++ K+ DFG+S ++ + T +
Sbjct: 122 MLHIAQQIAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMS---RDVYSTDY 175
Query: 673 SRVRGTR----GYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
RV G ++ PE +M K ++DV+S G+VL E+ T
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 64/204 (31%), Positives = 109/204 (53%), Gaps = 8/204 (3%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLE-GVLQGDAEFWAEVSIIGRINH 566
E+ R + ++G+G FG V+ G + VA+K L+ G + +A F E I+ ++ H
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRH 60
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
LV L +E E +V E++ GSL L F G L+ Q ++A A G++Y
Sbjct: 61 DKLVPLYAVVSE-EPIYIVTEFMGKGSL--LDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
+ E + ++ H D++ NIL+ D+ K+ DFGL++L ++ T + + APE
Sbjct: 118 I--ERMNYI-HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 687 MMNLKIDAKADVYSYGIVLLELLT 710
+ + K+DV+S+GI+L EL+T
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 518 QEVGKGGFGSVFRGVLD-DERVVAVK--RLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
+++GKG FG VF+G+ + ++VVA+K LE + E++++ + + + K G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 575 FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
++ ++ EY+ GS LL +PG L Q I KGL YLH E
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL--EPGP---LDETQIATILREILKGLDYLHSE---K 121
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR--VRGTRGYLAPEWMMNLKI 692
+H D+K N+LL +H E K+ DFG++ + DT+ R GT ++APE +
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 693 DAKADVYSYGIVLLELLTGK 712
D+KAD++S GI +EL G+
Sbjct: 179 DSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGDAEFWAEVSIIGRINH 566
E++R K ++G G +G V+ GV VAVK L+ EF E +++ I H
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 61
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGS-LDKLLFNDPGT--ASILQWDQRYNIAVGTAKG 623
NLV+L G C ++ E++ G+ LD L + A +L + +A +
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSA 116
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLA 683
+ YL ++ +H D+ +N L+ ++ KV DFGLS+L T + + + A
Sbjct: 117 MEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 173
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLT 710
PE + K K+DV+++G++L E+ T
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 513 TRNFKQE--VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA----EVSIIGRIN 565
NFK E +GKG F V++ + L D RVVA+K+++ DA+ E+ ++ +++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 566 HRNLVK-LQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGL 624
H N++K L F NE +V E + G L +++ + ++ + V L
Sbjct: 61 HPNVIKYLASFIENNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
++H + ++H D+KP N+ + K+ D GL + F + S V GT Y++P
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGKS 713
E + + K+D++S G +L E+ +S
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 518 QEVGKGGFGSVFRGVLDDE-----RVVAVKRLE-GVLQGDAEFW-AEVSIIGRINHRNLV 570
+ +G+G FG V D +VAVK L+ Q + W E++I+ + H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 571 KLQGFCAENEHK--LLVYEYVENGSL-DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
K +G C+E K L+ EYV GSL D L + A +L + Q+ +G++YL
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAYL 123
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG----YLA 683
H + +H D+ +N+LLD+ K+ DFGL+K E H+ + RVR + A
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE--YYRVREDGDSPVFWYA 178
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLT 710
E + K +DV+S+G+ L ELLT
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
E+ R + +++G G FG V+ G ++ VAVK L+ F E +++ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 61
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LV+L + E ++ EY+ GSL L +D G +L + + + A+G++Y+
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYI 119
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
+ +H D++ N+L+ + K+ DFGL+++ ++ T + + APE +
Sbjct: 120 ERKNY---IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176
Query: 688 MNLKIDAKADVYSYGIVLLELLT-------GKSASDYLSA 720
K+DV+S+GI+L E++T G S SD +SA
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA 216
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 509 LKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN 568
L Q +GKG FG V G +V AVK ++ A F AE S++ ++ H N
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQA-FLAEASVMTQLRHSN 60
Query: 569 LVKLQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LV+L G E + L +V EY+ GSL L + S+L D ++ + + YL
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
+H D+ +N+L+ + KV+DFGL+K DT V+ T APE +
Sbjct: 119 EANNF---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEAL 171
Query: 688 MNLKIDAKADVYSYGIVLLEL 708
K K+DV+S+GI+L E+
Sbjct: 172 REKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 517 KQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQG 574
+ +G+G +G V++ ++VA+K ++ + + E E +I+ + NH N+ G
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 575 -FCAEN----EHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
F +N + +L LV E GS+ L+ L+ + I T +GL+YLH
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK---ERHDTKFSRVRGTRGYLAPE 685
E V+H D+K QNILL + E K+ DFG+S R +T GT ++APE
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT----FIGTPYWMAPE 183
Query: 686 WMM-----NLKIDAKADVYSYGIVLLELLTGK 712
+ + DA++DV+S GI +EL GK
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 37/213 (17%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGD------AEFWAEVSIIGRINHRNLV 570
+ +G G FGSV+ G+ LDD AVK + G + E++++ ++ H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 571 KLQGFCAENEHKLLVY-EYVENGSLDKLL-----FNDPG----TASILQWDQRYNIAVGT 620
+ G E L ++ E V GSL KLL F +P T IL
Sbjct: 66 QYLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL------------ 112
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG 680
GL YLH+ +H D+K NIL+D + K+ DFG++K E K +G+
Sbjct: 113 -LGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK--SFKGSPY 166
Query: 681 YLAPEWMMNL-KIDAKADVYSYGIVLLELLTGK 712
++APE + AD++S G +LE+ TGK
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 30/222 (13%)
Query: 502 KRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDE-----RVVAVKRLEGVLQGD--AEF 554
KRF LKR +++G+G FG V D E VAVK L+ G+ A+
Sbjct: 3 KRF----LKRI-----RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL 53
Query: 555 WAEVSIIGRINHRNLVKLQGFCAENEHK--LLVYEYVENGSLDKLLFNDPGTASILQWDQ 612
E+ I+ + H N+VK +G C E+ L+ E++ +GSL + L P + + Q
Sbjct: 54 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQ 110
Query: 613 RYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672
+ AV KG+ YL ++V H D+ +N+L++ + K+ DFGL+K + D ++
Sbjct: 111 QLKYAVQICKGMDYLGSR--QYV-HRDLAARNVLVESEHQVKIGDFGLTKAIET--DKEY 165
Query: 673 SRVRGTRG----YLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
V+ + APE ++ K +DV+S+G+ L ELLT
Sbjct: 166 YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 520 VGKGGFGSVFRGVLDD-------ERVVAVKRLE--GVLQGDAEFWAEVSIIGRINHRNLV 570
+G G FG V+ G D VAVK L Q EF E ++ NH N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLL-------FNDPGTASILQWDQRYNIAVGTAKG 623
KL G C NE + ++ E +E G L L F P L + +I + AKG
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL----LTLKELLDICLDVAKG 118
Query: 624 LSYLHEECLEWVLHCDVKPQNILLD--DHFEP---KVTDFGLSKLFKERHDTKFSRVRGT 678
YL + +H D+ +N L+ + K+ DFGL+ ++ + + + R G
Sbjct: 119 CVYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLA---RDIYKSDYYRKEGE 172
Query: 679 R----GYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
++APE +++ K ++DV+S+G+++ E+LT
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 66/201 (32%), Positives = 99/201 (49%), Gaps = 24/201 (11%)
Query: 518 QEVGKGGFGSVF--RGVLDDERVVAVKRLEGVLQGDAEFW----AEVSIIGRINHRNLVK 571
+E+G G FG+V+ R V +E VVA+K++ + E W EV + ++ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRTNE-VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 572 LQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+G C EH LV EY + D L + LQ + I G +GL+YLH
Sbjct: 80 YKG-CYLREHTAWLVMEYCLGSASDILEVHKKP----LQEVEIAAICHGALQGLAYLHSH 134
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
+H D+K NILL + K+ DFG + L S V GT ++APE ++ +
Sbjct: 135 ER---IHRDIKAGNILLTEPGTVKLADFGSASLV----SPANSFV-GTPYWMAPEVILAM 186
Query: 691 ---KIDAKADVYSYGIVLLEL 708
+ D K DV+S GI +EL
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGD--AEFWAEVSIIGRINHRNLVKLQG 574
+ +G+G FG VF G L D VAVK L D A+F E I+ + +H N+V+L G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 575 FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
C + + +V E V+ G L + L+ + + A G+ YL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH--- 114
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR----GYLAPEWMMNL 690
+H D+ +N L+ + K++DFG+S +E D ++ G + + APE +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMS---REEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 691 KIDAKADVYSYGIVLLE 707
+ +++DV+S+GI+L E
Sbjct: 172 RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 62/227 (27%), Positives = 114/227 (50%), Gaps = 30/227 (13%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL-----DDERVVAVKRLEGV--LQGDAEFWAEVSI 560
EL + F +E+G+ FG +++G L D ++VA+K L+ + Q EF E S+
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLF------------NDPGTA-SI 607
+ ++H N+V L G + + +++EY+ G L + L ++ GT S
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 608 LQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667
L +IA+ A G+ YL + +H D+ +NIL+ + K++D GLS +E
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLS---REI 174
Query: 668 HDTKFSRVRGTR----GYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
+ + RV+ ++ PE +M K + +D++S+G+VL E+ +
Sbjct: 175 YSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 59/193 (30%), Positives = 105/193 (54%), Gaps = 12/193 (6%)
Query: 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCA 577
+ +G+G FG+V +G ++V AVK ++ + A F E +++ +++H+NLV+L G
Sbjct: 12 EIIGEGEFGAVLQGEYTGQKV-AVKNIKCDVTAQA-FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 578 ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLH 637
N +V E + G+L L G A + Q ++ A+G+ YL + L +H
Sbjct: 70 HN-GLYIVMELMSKGNLVNFL-RTRGRALV-SVIQLLQFSLDVAEGMEYLESKKL---VH 123
Query: 638 CDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKAD 697
D+ +NIL+ + KV+DFGL+++ D V+ T APE + + K +K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 698 VYSYGIVLLELLT 710
V+SYG++L E+ +
Sbjct: 180 VWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 15/218 (6%)
Query: 509 LKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRL-EGVLQGDAEFWAEVSIIGRINHR 567
+ F +E+G G FG V G + VA+K + EG + D EF E ++ +++H
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHE 59
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LV+L G C + +V EY+ NG L L Q Q + +G++YL
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYL 116
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR---GYLAP 684
+ +H D+ +N L+DD KV+DFGLS+ D +++ G++ + P
Sbjct: 117 ESKQF---IHRDLAARNCLVDDQGCVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWSPP 170
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSAS 721
E ++ K +K+DV+++G+++ E+ + GK + + S
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS 208
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 58/223 (26%), Positives = 87/223 (39%), Gaps = 32/223 (14%)
Query: 516 FKQEVGKGGFGSVFRGVLDD------------ERVVAVKRLEGVLQGDAEFWAEVSIIGR 563
+ +GKG FG V D ++ V + VL E I+
Sbjct: 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN-------ERRILQE 56
Query: 564 INHRNLVKL-QGFCAENEHKLLVYEYVENGSLD-KLLFNDPGTASILQWDQRYNIAVGTA 621
+NH LV L F + E+ LV + + G L L + +++
Sbjct: 57 LNHPFLVNLWYSFQ-DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-----WICEIV 110
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
L YLH + ++H D+KP NILLD+ +TDF ++ DT + GT GY
Sbjct: 111 LALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP--DTLTTSTSGTPGY 165
Query: 682 LAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASD 724
+APE + D +S G+ E L GK S + D
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD 208
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 9e-18
Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 56/242 (23%)
Query: 516 FKQEVGKGGFGSVFRGVL-DDERVVAVKRLEG--VLQGDAEFWA--EVSIIGRIN-HRNL 569
F + +G+G F +V + + A+K L+ +++ + E ++ R+N H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 570 VKLQGFCAENEHKL-LVYEYVENGSLDKLL-----FNDPGT----ASILQWDQRYNIAVG 619
+KL + ++E L V EY NG L + + ++ T A IL
Sbjct: 65 IKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL----------- 112
Query: 620 TAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD---------- 669
L YLH + ++H D+KP+NILLD K+TDFG +K+
Sbjct: 113 --LALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 670 ---------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK----SASD 716
+F+ GT Y++PE + +D+++ G ++ ++LTGK +++
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227
Query: 717 YL 718
YL
Sbjct: 228 YL 229
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 508 ELKRATRNFKQEVGKGGFGSV----------FRGVLDDER-----VVAVKRLEGVLQGDA 552
E R K+++G+G FG V F G E +VAVK L + A
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 553 --EFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL--------FNDP 602
+F E+ I+ R+ + N+++L G C ++ ++ EY+ENG L++ L F
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 603 GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662
+ +AV A G+ YL L +V H D+ +N L+ +H+ K+ DFG+S
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYL--ASLNFV-HRDLATRNCLVGNHYTIKIADFGMS- 176
Query: 663 LFKERHDTKFSRVRGTRGYLAPEWM-----MNLKIDAKADVYSYGIVLLELLT 710
+ + + R++G R L WM + K +DV+++G+ L E+ T
Sbjct: 177 --RNLYSGDYYRIQG-RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 34/216 (15%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLE---------GVLQGD--AEFWAEVSIIGRIN 565
+ +GKG +G V+ + + ++AVK++E Q D +E+ + ++
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 566 HRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGT 620
H N+V+ GF E+ + EYV GS+ L F + +
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE---------QV 117
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFS-RVRGTR 679
+GL+YLH + +LH D+K N+L+D K++DFG+SK + +D + ++G+
Sbjct: 118 LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 680 GYLAPEWMMNLK---IDAKADVYSYGIVLLELLTGK 712
++APE +++ AK D++S G V+LE+ G+
Sbjct: 175 FWMAPE-VIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 70/283 (24%), Positives = 123/283 (43%), Gaps = 45/283 (15%)
Query: 515 NFK--QEVGKGGFGSVFR-GVLDDERVVAVKRLEGVLQGDAEFWA---EVSIIGRINHRN 568
+FK +++GKG +GSV++ L D + A+K ++ E E+ I+ +NH N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 569 LVKL-QGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
++ + F N KL +V EY G L K + ++ + + I + +GL
Sbjct: 61 IISYKEAFLDGN--KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR-GTRGYLAPE 685
LHE+ +LH D+K NILL + K+ D G+SK+ K+ ++ + GT Y+APE
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPE 171
Query: 686 WMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745
K+D++S G +L E+ T + A+ M Q+
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFA-------------------PPFEARSM-QDLRY 211
Query: 746 KIID---PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKV 785
K+ P + +Y ++ + + RP K+
Sbjct: 212 KVQRGKYPPIPPIYSQD----LQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 63/233 (27%), Positives = 109/233 (46%), Gaps = 36/233 (15%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFR----GVLDDER--VVAVKRL--EGVLQGDAEFWAEVS 559
E R + +++G+G FG VF+ G+L E +VAVK L E A+F E +
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 560 IIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL-FNDP--------GTASILQW 610
++ +H N+VKL G CA + L++EY+ G L++ L P T+S +
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 611 DQRY---------NIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661
IA A G++YL E +H D+ +N L+ ++ K+ DFGLS
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLS 177
Query: 662 KLFKERHDTKFSRVRGTRG----YLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
+ + + + ++ PE + + ++DV++YG+VL E+ +
Sbjct: 178 ---RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 71/292 (24%), Positives = 129/292 (44%), Gaps = 62/292 (21%)
Query: 520 VGKGGFGSVFRGVLDDERVVAVKRLE----GVLQGDAEF---WAEVSIIGRINHRNLVKL 572
+GKG +G+V+ G+ + +++AVK++E VL + E+ EV ++ + H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLL-----FNDP----GTASILQWDQRYNIAVGTAKG 623
G C ++ + E+V GS+ +L +P T IL G
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-------------G 114
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF-----KERHDTKFSRVRGT 678
++YLH C V+H D+K N++L + K+ DFG ++ H + GT
Sbjct: 115 VAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171
Query: 679 RGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK---SASDYLSASASDSSYCNHLVQWV 735
++APE + K+D++S G + E+ TGK ++ D L+A
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--------------- 216
Query: 736 AKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787
M G + + PRL D + +D C+ ++ RP ++++
Sbjct: 217 ---MFYIGAHRGLMPRLPDSFSAAAID----FVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 82/289 (28%), Positives = 129/289 (44%), Gaps = 37/289 (12%)
Query: 518 QEVGKGGFGSVFRG----VLDDERVVAVKRLEGVLQGDAE--FWAEVSIIGRINHRNLVK 571
E+G G FG V G + RVV VK L D + F EV +NH N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASIL-QWDQRYNIAVGTAKGLSYLHEE 630
G C E+ LLV E+ G L L ++ G + + Q D +A A GL +LH+
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGL--SKLFKERHDTKFSRVRGTRGYLAPEWM- 687
+H D+ +N L K+ D+GL + ++ + TK R +LAPE +
Sbjct: 120 DF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR-WLAPELVE 175
Query: 688 ------MNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741
+ K++++S G+ + EL T A+D Y + + V KQ+ +
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT-----------AADQPYPDLSDEQVLKQVVR 224
Query: 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790
E K+ P+L+ Y DR +V C + +TRP +V +LLT
Sbjct: 225 EQDIKLPKPQLDLKYS----DRWYEVMQFCWLDP-ETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 520 VGKGGFGSVFRGV--LDDERVVAVKRLE---GVLQGDAEFWA-------EVSIIGRINHR 567
+G G FGSV+ G+ E ++AVK++E + E++++ + H
Sbjct: 8 IGSGSFGSVYLGMNASSGE-LMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
N+V+ G + +H + EYV GS+ LL N L N KGL+YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV----RNFVRQILKGLNYL 122
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK-----LFKERHDTKFSRVRGTRGYL 682
H ++H D+K NIL+D+ K++DFG+SK + + ++G+ ++
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGK 712
APE + KAD++S G +++E+LTGK
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 33/228 (14%)
Query: 506 YAELKRATRNFKQEVGKGGFGSVFRGVLDDERV---VAVKRLEGVLQGD--AEFWAEVSI 560
Y L+ F+ +G+G FG V + + + + A+KR++ D +F E+ +
Sbjct: 1 YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 561 IGRIN-HRNLVKLQGFCAENEHKLLVYEYVENGSL------DKLLFNDPG------TASI 607
+ ++ H N++ L G C + L EY +G+L ++L DP TAS
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 608 LQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667
L Q + A A+G+ YL ++ +H D+ +NIL+ +++ K+ DFGLS+
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR----- 172
Query: 668 HDTKFSRVRGTRGYLAPEWM----MNLKI-DAKADVYSYGIVLLELLT 710
+ V+ T G L WM +N + +DV+SYG++L E+++
Sbjct: 173 --GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEF-WAEVSIIGRINHRNLVKLQ 573
Q +G G +G V++ + +VA+K ++ D E E+S++ H N+V
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
G KL +V EY GSL + G L Q + T KGL+YLHE
Sbjct: 67 G-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLAYLHET-- 120
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM---MN 689
+H D+K NILL + + K+ DFG+S + S + GT ++APE
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERK 178
Query: 690 LKIDAKADVYSYGIVLLEL 708
D K D+++ GI +EL
Sbjct: 179 GGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 24/204 (11%)
Query: 518 QEVGKGGFGSVFRGVLD-DERVVAVK--RLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
+ +GKG FG VF+G+ + ++VVA+K LE + E++++ + + + K G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 575 FCAENEHKLLVYEYVENGSLDKLL----FNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+ ++ EY+ GS LL F++ A++L+ KGL YLH E
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---------EILKGLDYLHSE 120
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR--VRGTRGYLAPEWMM 688
+H D+K N+LL + + K+ DFG++ + DT+ R GT ++APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQ 174
Query: 689 NLKIDAKADVYSYGIVLLELLTGK 712
D+KAD++S GI +EL G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 28/204 (13%)
Query: 519 EVGKGGFGSVFRGVLDDE-RVVAVKRLEGVLQGDAE---FWAEVSIIGRINHRNLVKL-Q 573
E+G G FG V++ + A K ++ ++ + E F E+ I+ H N+V L +
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 574 GFCAENEHKLLVY-EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
+ EN KL + E+ + G+LD ++ L Q + + L++LH
Sbjct: 70 AYFYEN--KLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH-- 122
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK---ERHDTKFSRVRGTRGYLAPEWMM- 688
V+H D+K NILL + K+ DFG+S K ++ DT GT ++APE +
Sbjct: 123 -KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI----GTPYWMAPEVVAC 177
Query: 689 -NLK---IDAKADVYSYGIVLLEL 708
K D KAD++S GI L+EL
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 61/215 (28%), Positives = 90/215 (41%), Gaps = 41/215 (19%)
Query: 520 VGKGGFGSVF---RGVLDDERVVAVK-------RLEGVLQGDAEFWAEVSIIGRINHRNL 569
+ KG +G VF + D + A+K + + + E I+ + +
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVD---QVLTERDILSQAQSPYV 55
Query: 570 VKLQGFCA-ENEHKL-LVYEYVENGSLDKLLFN----DPGTASILQWDQRYNIAVGTAKG 623
VKL + + + + L LV EY+ G L LL N D A I
Sbjct: 56 VKL--YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLA 105
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL-FKERHDTKF------SRVR 676
L YLH ++H D+KP NIL+D + K+TDFGLSK+ R R+
Sbjct: 106 LEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 677 GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
GT Y+APE ++ D +S G +L E L G
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLD----DERVVAVKRLEGVLQGDAE--FWAEVSII 561
EL + ++ +G G FG + RG L E VA+ L F AE +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTA 621
G+ +H N+V+L+G ++V EY+ NG+LD L G Q + G A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL---MGMLPGLA 117
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
G+ YL E +H + +L++ K++ F +L +++ + ++ + G
Sbjct: 118 SGMKYLSEMGY---VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPV 172
Query: 682 L--APEWMMNLKIDAKADVYSYGIVLLELLT 710
L APE + + +DV+S+GIV+ E+++
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 18/198 (9%)
Query: 520 VGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAE--FWAEVSIIGRINHRNLVKLQGFCA 577
+GKG FG VF+G L D+ VAVK + L + + F +E I+ + +H N+VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 578 ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH-EECLEWVL 636
+ + +V E V G L L+ Q A+ A G++YL + C +
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLESKNC----I 115
Query: 637 HCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR----GYLAPEWMMNLKI 692
H D+ +N L+ ++ K++DFG+S+ + D G + + APE + +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 693 DAKADVYSYGIVLLELLT 710
+++DV+SYGI+L E +
Sbjct: 172 SSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 42/215 (19%)
Query: 515 NFKQEVGKGGFGSVFRG------------VLDDERVVAVKRLEGVLQGDAEFWAEVSIIG 562
F + +G G FG V +L ++V +K++E VL E I+
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVL-------NEKRILQ 56
Query: 563 RINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT-- 620
I H LV L G ++ + LV EYV G L F S L+ R+ V
Sbjct: 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL----F------SHLRKSGRFPEPVARFY 106
Query: 621 ----AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR 676
L YLH + ++ D+KP+N+LLD K+TDFG +K K R T +
Sbjct: 107 AAQVVLALEYLHSLDI---VYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT----LC 159
Query: 677 GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
GT YLAPE +++ D ++ GI++ E+L G
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 519 EVGKGGFGSVFRGVLD--DERVVAVKRLEGVLQGDAE---FWAEVSIIGRINHRNLVKLQ 573
+GKG FG+V + V D +++ K ++ + E +EV+I+ + H N+V+
Sbjct: 7 TIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 574 G--FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH--E 629
N+ +V EY E G L +L+ ++ + + I L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
+ VLH D+KP NI LD + K+ DFGL+K+ + V GT Y++PE + +
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNH 184
Query: 690 LKIDAKADVYSYGIVLLELLTGK 712
+ D K+D++S G ++ EL
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 520 VGKGGFGSVFRGVL------DDERVVAVKRLEGVLQGDA--EFWAEVSIIGRINHRNLVK 571
+G+G FG VF E +V VK L+ + EF E+ + +++H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLLF-----NDPGTASILQWDQRYNIAVGTAKGLSY 626
L G C E E ++ EY + G L + L ++ L Q+ + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
L +H D+ +N L+ E KV+ LSK K +LAPE
Sbjct: 133 LSNARF---VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 687 MMNLKIDAKADVYSYGIVLLELLT 710
+ K+DV+S+G+++ E+ T
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 519 EVGKGGFGSVFRG-VLDDERVVAVKRLEGVLQGDAEF----WAEVSIIGRINHRNLVKLQ 573
VG+G +G V + +VA+K+ + + D + EV ++ ++ H N+V L+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKES-EDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFN----DPGTASILQWDQRYNIAVGTAKGLSYLHE 629
LV+EYVE L+ L + P W + ++Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHS 118
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM- 688
++H D+KP+NIL+ + K+ DFG ++ + R + + TR Y APE ++
Sbjct: 119 HN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175
Query: 689 NLKIDAKADVYSYGIVLLELLTG 711
+ DV++ G ++ ELL G
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 520 VGKGGFGSVF--RGVLDDERVVAVKRL--EGVLQGDAEFWA--EVSIIGRINHRNLVKLQ 573
VG+G FG V R D+++V +K++ E + + D A E ++ ++H N+++
Sbjct: 8 VGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYY 65
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
E++ ++V EY G+L + + S+L D + V L ++H +
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYI-QKRCN-SLLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 634 WVLHCDVKPQNILLDDH-FEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI 692
+LH D+K QNILLD H K+ DFG+SK+ + +K V GT Y++PE
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK--SKAYTVVGTPCYISPELCEGKPY 178
Query: 693 DAKADVYSYGIVLLELLTGKSASD 716
+ K+D+++ G VL EL + K A +
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 520 VGKGGFGSVFR-GVLDDERVVAVKRLEG----VLQGDAEFWAEVSIIGRINHRNLVKLQG 574
+GKGGFG V V ++ A K+L+ +G+ E I+ +++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 575 FCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
+ E + L LV + G L ++N G + + A GL +LH+
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFPEARAIF-YAAQIICGLEHLHQR--- 114
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKID 693
+++ D+KP+N+LLDDH +++D GL+ K K R GT GY+APE + D
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK-GRA-GTPGYMAPEVLQGEVYD 172
Query: 694 AKADVYSYGIVLLELLTGKS 713
D ++ G L E++ G+S
Sbjct: 173 FSVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 27/220 (12%)
Query: 520 VGKGGFGSVFRGVLDD----ERVVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQ 573
+GKG FG V+ G L D + AVK L + L+ +F E I+ +H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 574 GFCAENE-HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVG--TAKGLSYLHEE 630
G C +E L+V Y+++G L + ++ ++ + I G AKG+ YL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV-----KDLIGFGLQVAKGMEYLASK 117
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP-EWM-- 687
+H D+ +N +LD+ F KV DFGL++ + +D ++ V G P +WM
Sbjct: 118 KF---VHRDLAARNCMLDESFTVKVADFGLAR---DIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 688 ---MNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASD 724
K K+DV+S+G++L EL+T + A Y + D
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFD 210
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 22/202 (10%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGD--AEFWAEVSIIGRINH---RNLVKLQ 573
+G+G +G+V+RG + RVVA+K + D ++ EV+++ ++ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV---GTAKGLSYLHEE 630
G + ++ EY E GS+ L+ P ++Y I+V L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGP-------IAEKY-ISVIIREVLVALKYIHKV 120
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
V+H D+K NIL+ + K+ DFG++ L + + +K S GT ++APE +
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ-NSSKRSTFVGTPYWMAPEVITEG 176
Query: 691 KI-DAKADVYSYGIVLLELLTG 711
K D KAD++S GI + E+ TG
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 70/213 (32%), Positives = 106/213 (49%), Gaps = 32/213 (15%)
Query: 516 FKQEVGKGGFGSV----FRGVLDDE-RVVAVKRLEGVLQGDAE----FWAEVSIIGRINH 566
F Q++GKG FGSV + + D+ VVAVK+L+ AE F E+ I+ + H
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ---HSTAEHLRDFEREIEILKSLQH 64
Query: 567 RNLVKLQGFC--AENEHKLLVYEYVENGSLDKLLFNDPG---TASILQWDQRYNIAVGTA 621
N+VK +G C A + LV EY+ GSL L +L + A
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY------ASQIC 118
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR--GTR 679
KG+ YL + +H D+ +NIL++ K+ DFGL+K+ + D ++ +VR G
Sbjct: 119 KGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ--DKEYYKVREPGES 173
Query: 680 G--YLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
+ APE + K +DV+S+G+VL EL T
Sbjct: 174 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 56/205 (27%), Positives = 102/205 (49%), Gaps = 26/205 (12%)
Query: 519 EVGKGGFGSVFRGV-LDDERVVAVKRL------EGVLQGDAEFWAEVSIIGRI---NHRN 568
E+G+G +G+V++ L+ R VA+K++ EG+ E++++ ++ H N
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR---EIALLKQLESFEHPN 62
Query: 569 LVKLQGFCA----ENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKG 623
+V+L C + E KL LV+E+V+ L L P L + ++ +G
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRG 119
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLA 683
+ +LH ++H D+KPQNIL+ + K+ DFGL++++ + + V T Y A
Sbjct: 120 VDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF--EMALTSVVVTLWYRA 174
Query: 684 PEWMMNLKIDAKADVYSYGIVLLEL 708
PE ++ D++S G + EL
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 52/203 (25%), Positives = 102/203 (50%), Gaps = 6/203 (2%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
E+ R + ++++G G FG V+ + VAVK ++ F AE +++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LVKL + E ++ E++ GSL L +D G+ + + + A+G++++
Sbjct: 62 KLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFI 118
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
+ +H D++ NIL+ K+ DFGL+++ ++ T + + APE +
Sbjct: 119 EQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 688 MNLKIDAKADVYSYGIVLLELLT 710
K+DV+S+GI+L+E++T
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 518 QEVGKGGFGSVFRGVLDD---ERV-VAVK-----RLEGVLQGDAEFWAEVSIIGRINHRN 568
+++G G FG V RG + + VAVK +L ++ +F E +I+ ++H N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD---DFLKEAAIMHSLDHEN 57
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSL-DKLLFNDPGTASI-LQWDQRYNIAVGTAKGLSY 626
L++L G + +V E GSL D+L + G I D AV A G+ Y
Sbjct: 58 LIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCD----YAVQIANGMRY 112
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD---TKFSRVRGTRGYLA 683
L + +H D+ +NILL + K+ DFGL + + D + + + A
Sbjct: 113 LESKRF---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL-KVPFAWCA 168
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLT 710
PE + +DV+ +G+ L E+ T
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 28/225 (12%)
Query: 520 VGKGGFGS--VFRGVLDDERVV----AVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQ 573
+GKG FG ++R DD VV + RL + DA E+ I+ + H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL--NEIVILSLLQHPNIIAYY 65
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV--GTAKGLSYLHEEC 631
++ L+ EY G+L + G +++ + +SY+H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ----LFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFS---RVRGTRGYLAPEWMM 688
+LH D+K NI L K+ DFG+SK+ +++S V GT Y++PE
Sbjct: 122 ---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL----GSEYSMAETVVGTPYYMSPELCQ 174
Query: 689 NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQ 733
+K + K+D+++ G VL ELLT K D + + + +VQ
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFD----ATNPLNLVVKIVQ 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 575 FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
F EN + + E+++ GSLD++ + + IAV +GL+YL+
Sbjct: 72 FLNEN-NICMCMEFMDCGSLDRIY----KKGGPIPVEILGKIAVAVVEGLTYLYNV--HR 124
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLS-KLFKERHDTKFSRVRGTRGYLAPEWMMNLKID 693
++H D+KP NIL++ + K+ DFG+S +L DT GT Y++PE + K
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT----FVGTSTYMSPERIQGGKYT 180
Query: 694 AKADVYSYGIVLLELLTGK---SASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750
K+DV+S GI ++EL GK + S+ D L+Q Q+ QE P
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ----QIVQEP-----PP 231
Query: 751 RLNDVYDREKLDRMVKVALLCVAENRDTRP 780
RL E L V C+ ++ RP
Sbjct: 232 RLPSSDFPEDLRDFVD---ACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 57/220 (25%), Positives = 109/220 (49%), Gaps = 32/220 (14%)
Query: 520 VGKGGFGSVFRGV------LDDERVVAVKRL-EGVLQGD-AEFWAEVSIIGRINHRNLVK 571
+G+G FG V + VAVK L E + + +E +++ ++NH +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLL------------FNDPGTASILQWDQRYNIAVG 619
L G C+++ LL+ EY + GSL L + +S L + +G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 620 --------TAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK-LFKERHDT 670
++G+ YL E L +H D+ +N+L+ + + K++DFGLS+ +++E
Sbjct: 128 DLISFAWQISRGMQYLAEMKL---VHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
K S+ R ++A E + + ++DV+S+G++L E++T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 51/164 (31%), Positives = 73/164 (44%), Gaps = 20/164 (12%)
Query: 557 EVSIIGRINHRNLVKLQG-FCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRY 614
E+ I +VK G F E+ + + EY E GSLD + + + R
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK------VKKRGGRI 102
Query: 615 N------IAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668
IA KGLSYLH ++H D+KP NILL + K+ DFG+S
Sbjct: 103 GEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159
Query: 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
F+ GT Y+APE + +DV+S G+ LLE+ +
Sbjct: 160 AGTFT---GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-FWAEVSIIGRINHRNLVKLQGFCA 577
+GKG +G V+ L + +A+K + + E+++ + HRN+V+ G +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 578 ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK---GLSYLHEECLEW 634
EN + E V GSL LL + G D I T + GL YLH+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLK----DNEQTIIFYTKQILEGLKYLHD---NQ 128
Query: 635 VLHCDVKPQNILLDDHFEP-KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKID 693
++H D+K N+L++ + K++DFG SK + GT Y+APE ID
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPE-----VID 182
Query: 694 -------AKADVYSYGIVLLELLTGK 712
A AD++S G ++E+ TGK
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 62/218 (28%), Positives = 108/218 (49%), Gaps = 33/218 (15%)
Query: 516 FKQEVGKGGFGSVFRGVLDDERV---VAVKRL-EGVLQGD-AEFWAEVSIIGRI-NHRNL 569
F+ +G+G FG V R ++ + + A+K L E + D +F E+ ++ ++ +H N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 570 VKLQGFCAENEHKLLVYEYVENGSL------DKLLFNDP------GTASILQWDQRYNIA 617
+ L G C + + EY G+L ++L DP GTAS L Q A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 618 VGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG 677
A G+ YL E+ +H D+ +N+L+ ++ K+ DFGLS+ + V+
Sbjct: 126 SDVATGMQYLSEKQF---IHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKK 175
Query: 678 TRGYLAPEWM----MNLKI-DAKADVYSYGIVLLELLT 710
T G L WM +N + K+DV+S+G++L E+++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 58/227 (25%), Positives = 107/227 (47%), Gaps = 30/227 (13%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVLQGD--AEFWAEVS 559
E+ +T F +E+G+ FG V++G L + + VA+K L+ +G EF E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 560 IIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLF------------NDPGTASI 607
+ R+ H N+V L G + + +++ Y + L + L +D S
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 608 LQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667
L+ +I A G+ +L V+H D+ +N+L+ D K++D GL F+E
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL---FREV 174
Query: 668 HDTKFSRVRGTR----GYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
+ + ++ G +++PE +M K +D++SYG+VL E+ +
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 38/227 (16%)
Query: 515 NFKQEVGKGGFGSV-----------------FRGVLDDERVVAVKRL--EGVLQGDAEFW 555
NF +++G+G FG V D +VAVK L + +F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 556 AEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL----FNDPGTA---SIL 608
EV I+ R++ N+ +L G C + ++ EY+ENG L++ L G A L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 609 QWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668
+ +A A G+ YL E L +V H D+ +N L+ ++ K+ DFG+S + +
Sbjct: 128 SFSTLLYMATQIASGMRYL--ESLNFV-HRDLATRNCLVGKNYTIKIADFGMS---RNLY 181
Query: 669 DTKFSRVRGTRGYLAPEWM-----MNLKIDAKADVYSYGIVLLELLT 710
+ + RV+G R L WM + K K+DV+++G+ L E+LT
Sbjct: 182 SSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQG-DAEFWAEVSIIGRINHRNLVKLQGF 575
+G+G +G V+R +VA+K R++ G E++++ + H N+V+L+
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 576 CAEN--EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
+ LV EY E L LL N P S Q + + +GL YLHE
Sbjct: 75 VVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSE---SQVKCLMLQLLRGLQYLHEN--- 127
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKID 693
+++H D+K N+LL D K+ DFGL++ + + T Y APE ++
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 694 AKA-DVYSYGIVLLELLTGK 712
A D+++ G +L ELL K
Sbjct: 187 TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 60/214 (28%), Positives = 107/214 (50%), Gaps = 33/214 (15%)
Query: 520 VGKGGFGSVFRGVLDDERV---VAVKRL-EGVLQGD-AEFWAEVSIIGRINHR-NLVKLQ 573
+G+G FG V + + + + A+KR+ E + D +F E+ ++ ++ H N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 574 GFCAENEHKLLVYEYVENGSL------DKLLFNDP------GTASILQWDQRYNIAVGTA 621
G C + L EY +G+L ++L DP TAS L Q + A A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
+G+ YL ++ +H D+ +NIL+ +++ K+ DFGLS+ + V+ T G
Sbjct: 123 RGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 172
Query: 682 LAPEWM----MNLKI-DAKADVYSYGIVLLELLT 710
L WM +N + +DV+SYG++L E+++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 20/199 (10%)
Query: 519 EVGKGGFGSVFRGVLD---DERVVAVKRLEGVLQGDA---EFWAEVSIIGRINHRNLVKL 572
E+G G FG+V +G+ E+ VAVK L+ A E E +++ ++++ +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
G C E E +LV E E G L+K L + + + +++G + YL E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLEETNF 116
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGT----RGYLAPEWMM 688
+H D+ +N+LL K++DFGLSK D + + + + APE M
Sbjct: 117 ---VHRDLAARNVLLVTQHYAKISDFGLSKALGA--DENYYKAKTHGKWPVKWYAPECMN 171
Query: 689 NLKIDAKADVYSYGIVLLE 707
K +K+DV+S+G+++ E
Sbjct: 172 YYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 8e-15
Identities = 64/234 (27%), Positives = 98/234 (41%), Gaps = 58/234 (24%)
Query: 520 VGKGGFGSVFRGVL----DDERVVAVKRL--EGVLQGD--AEFWAEVSIIGRINHRNLVK 571
+G+G FG V+ L D +V A+K L +++ + A AE I+ + +VK
Sbjct: 9 IGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 572 LQGFCA--ENEHKLLVYEYVENGSLDKLLFN----DPGTASILQWDQRYNIAVGTAKGLS 625
L + + + EH LV EY+ G L LL TA R+ IA L
Sbjct: 66 L--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-------RFYIAELVL-ALD 115
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR--------- 676
+H+ L ++ H D+KP NIL+D K+ DFGL K + D ++
Sbjct: 116 SVHK--LGFI-HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 677 -------------------GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
GT Y+APE + + D +S G++L E+L G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 518 QEVGKGGFGSVF--RGVLDDERVVAVKRL--------EGVLQGDAEF---WAEVSIIG-R 563
+ +G G FG V+ R + + ++A+K + + + D +EV+II +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 564 INHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKG 623
+ H N+V+ EN+ +V + +E L + + ++ +NI V
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLA 683
L YLH+E + ++H D+ P NI+L + + +TDFGL+K +++ ++K + V GT Y
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSC 181
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLT 710
PE + N KADV+++G +L ++ T
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 55/196 (28%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRL-EGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
F +E+G G FG V G + VA+K + EG + + +F E ++ +++H LV+L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYG 66
Query: 575 FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
C + + +V E++ENG L L G L D ++ +G+ YL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGK---LSKDMLLSMCQDVCEGMEYLERNSF-- 121
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDA 694
+H D+ +N L+ KV+DFG+++ + T S + + PE K +
Sbjct: 122 -IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 695 KADVYSYGIVLLELLT 710
K+DV+S+G+++ E+ T
Sbjct: 181 KSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 28/211 (13%)
Query: 520 VGKGGFGSVFRGV---LDDERV---VAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVK 571
+G G FG V+ G+ D + V VAVK L Q +++F E I+ + NH+N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLL---FNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
L G E + ++ E + G L L P S L A AKG YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 629 EECLEWVLHCDVKPQNILLDDHFEP----KVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
E +H D+ +N LL P K+ DFG++ ++ + + R +G R L
Sbjct: 134 ENHF---IHRDIAARNCLLTCK-GPGRVAKIADFGMA---RDIYRASYYR-KGGRAMLPI 185
Query: 685 EWM-----MNLKIDAKADVYSYGIVLLELLT 710
+WM ++ +K DV+S+G++L E+ +
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-14
Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 19/174 (10%)
Query: 552 AEFWAEVSIIGRINHRNLVKL--QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQ 609
A F E ++ R+ H N+V L G V+EYV +L ++L D +
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAADGALPAG-- 79
Query: 610 WDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFKE 666
+ + + L+ H + ++H D+KPQNI++ KV DFG+ L
Sbjct: 80 --ETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPG 134
Query: 667 RHD------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSA 714
D T+ + V GT Y APE + + +D+Y++G++ LE LTG+
Sbjct: 135 VRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRV 188
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 30/216 (13%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL--DDERV---VAVKRLEGVL--QGDAEFWAEVSI 560
ELKR + +G G FG+V++G+ + E V VA+K L + + EF E I
Sbjct: 8 ELKRV-----KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 62
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLF---NDPGTASILQWDQRYNIA 617
+ ++H +LV+L G C +L V + + +G L + ++ G+ +L W
Sbjct: 63 MASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------C 115
Query: 618 VGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG 677
V AKG+ YL E L +H D+ +N+L+ K+TDFGL++L + D K G
Sbjct: 116 VQIAKGMMYLEERRL---VHRDLAARNVLVKSPNHVKITDFGLARLLE--GDEKEYNADG 170
Query: 678 TR---GYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
+ ++A E + K ++DV+SYG+ + EL+T
Sbjct: 171 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 39/213 (18%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA------EVSIIGRIN-HRNL 569
+++G G FGSV+ + +VA+K+++ W EV + ++N H N+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNI 60
Query: 570 VKLQGFCAENEHKLLVYEYVENGSLDKL-------LFNDPGTASILQWDQRYNIAVGTAK 622
VKL+ EN+ V+EY+E G+L +L F++ SI+ Q +
Sbjct: 61 VKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIY--Q-------ILQ 110
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
GL+++H+ H D+KP+N+L+ K+ DFGL++ + R ++ TR Y
Sbjct: 111 GLAHIHKHGF---FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YTDYVSTRWYR 165
Query: 683 APEWMMNLK---IDAKADVYSYGIVLLELLTGK 712
APE + L+ + D+++ G ++ EL T +
Sbjct: 166 APE--ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 59/234 (25%), Positives = 105/234 (44%), Gaps = 38/234 (16%)
Query: 508 ELKRATRNFKQEVGKGGFGSV-----------------FRGVLDDERVVAVKRLEGVLQG 550
E R FK+++G+G FG V + +VAVK L
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 551 DA--EFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL----FNDPGT 604
+A +F E+ I+ R+ N+++L C ++ ++ EY+ENG L++ L +
Sbjct: 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120
Query: 605 ---ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661
+ + +A A G+ YL L +V H D+ +N L+ ++ K+ DFG+S
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYL--SSLNFV-HRDLATRNCLVGKNYTIKIADFGMS 177
Query: 662 KLFKERHDTKFSRVRGTRGYLAPEWM-----MNLKIDAKADVYSYGIVLLELLT 710
+ + + R++G R L WM + K +DV+++G+ L E+LT
Sbjct: 178 ---RNLYSGDYYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 37/217 (17%)
Query: 519 EVGKGGFGSVFRGVL---DDERVVAVKRLEGVLQGDAEFWA----EVSIIGRINHRNLVK 571
+G+G +G V++ D + A+K+ +G + E++++ + H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 572 LQGFCAENEHKL--LVYEYVENGSL---------DKLLFNDPGTASILQWDQRYNIAVGT 620
L E+ K L+++Y E+ ++ S+L W Q N
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL-W-QILN----- 119
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILL----DDHFEPKVTDFGLSKLFKERHDTKFS--R 674
G+ YLH WVLH D+KP NIL+ + K+ D GL++LF
Sbjct: 120 --GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 675 VRGTRGYLAPEWMMNLKIDAKA-DVYSYGIVLLELLT 710
V T Y APE ++ + KA D+++ G + ELLT
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRL-EGVLQGDAE---FWA--EVSIIGRINHRNLVKL 572
+G+G + V++ + R+VA+K++ G + + F A E+ ++ + H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 573 QG-FCAE-NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
F + N + LV+E++E L+K++ + + +L + + T +GL YLH
Sbjct: 68 LDVFGHKSNIN--LVFEFME-TDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHSN 121
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
W+LH D+KP N+L+ K+ DFGL++ F + K + TR Y APE +
Sbjct: 122 ---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP-NRKMTHQVVTRWYRAPELLFGA 177
Query: 691 KIDAKA-DVYSYGIVLLELLTGK 712
+ D++S G + ELL
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 83/322 (25%), Positives = 140/322 (43%), Gaps = 64/322 (19%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDD------ERVVAVKRL--EGVLQGDAEFWAEVS 559
E+ R +E+G+G FG V+ G D E VAVK + L+ EF E S
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 560 IIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLF-------NDPGT-ASILQWD 611
++ ++V+L G ++ + L+V E + +G L L N+PG LQ
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ-- 119
Query: 612 QRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671
+ +A A G++YL+ + +H D+ +N ++ F K+ DFG++ ++ ++T
Sbjct: 120 EMIQMAAEIADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMT---RDIYETD 173
Query: 672 FSRVRGTRGYLAPEWMM--NLK---IDAKADVYSYGIVLLELLTGKSASDYLSASASDSS 726
+ R +G +G L WM +LK +D++S+G+VL E+ +
Sbjct: 174 YYR-KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------- 216
Query: 727 YCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLD-------RMVKVALLCVAENRDTR 779
+A+Q Q GL + L V D LD R+ + +C N R
Sbjct: 217 --------LAEQPYQ-GLSN--EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMR 265
Query: 780 PPMSKVVKLLTAHDHESSQDES 801
P ++V LL H S + S
Sbjct: 266 PTFLEIVNLLKDDLHPSFPEVS 287
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 26/202 (12%)
Query: 518 QEVGKGGFGSVF--RGVLDDERVVAVKRLEGVLQGDAEFW----AEVSIIGRINHRNLVK 571
+E+G G FG+V+ R V +E VVA+K++ + E W EV + RI H N ++
Sbjct: 31 REIGHGSFGAVYFARDVRTNE-VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 572 LQGFCAENEHKL-LVYEYVENGSLDKL-LFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
+G C EH LV EY + D L + P LQ + I G +GL+YLH
Sbjct: 90 YKG-CYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAITHGALQGLAYLHS 143
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
+ +H D+K NILL + + K+ DFG + + + + GT ++APE ++
Sbjct: 144 HNM---IHRDIKAGNILLTEPGQVKLADFGSASIA-----SPANSFVGTPYWMAPEVILA 195
Query: 690 L---KIDAKADVYSYGIVLLEL 708
+ + D K DV+S GI +EL
Sbjct: 196 MDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 518 QEVGKGGFGSVFRGVLDDER-VVAVK--RLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
+ +GKG FG V++G+ + + VVA+K LE + E++++ + + + + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 575 FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
+ ++ EY+ GS LL PG L+ I KGL YLH E
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--KPGP---LEETYIATILREILKGLDYLHSE---R 121
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR--VRGTRGYLAPEWMMNLKI 692
+H D+K N+LL + + K+ DFG++ + DT+ R GT ++APE +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 693 DAKADVYSYGIVLLELLTGK 712
D KAD++S GI +EL G+
Sbjct: 179 DFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 35/270 (12%)
Query: 518 QEVGKGGFGSVF--RGVLDDERVVAVKRLEGVLQGDAEFW----AEVSIIGRINHRNLVK 571
+E+G G FG+V+ R V + E VVA+K++ + E W EV + ++ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSE-VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 572 LQGFCAENEHKL-LVYEYVENGSLDKL-LFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
+G C EH LV EY + D L + P LQ + + G +GL+YLH
Sbjct: 80 YRG-CYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYLHS 133
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
+ +H DVK NILL + K+ DFG + + + GT ++APE ++
Sbjct: 134 HNM---IHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILA 185
Query: 690 L---KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME----QE 742
+ + D K DV+S GI +EL + + +A + Y H+ Q + ++ E
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALY--HIAQNESPALQSGHWSE 241
Query: 743 GLEKIIDPRLNDV-YDREKLDRMVKVALLC 771
+D L + DR + ++K +
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 518 QEVGKGGFGSVF--RGVLDDERVVAVKRLEGVLQGDAEFWA---EVSIIGRINHRNLVKL 572
+++G+G FG ++ + D E V +K ++ E A EV ++ ++ H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
EN +V EY + G L K + G + DQ + V + GL ++H+
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGV--LFSEDQILSWFVQISLGLKHIHDR-- 120
Query: 633 EWVLHCDVKPQNILLDDH-FEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK 691
+LH D+K QNI L + K+ DFG+++ + + ++ V GT YL+PE N
Sbjct: 121 -KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQNRP 178
Query: 692 IDAKADVYSYGIVLLELLTGK 712
+ K D++S G VL EL T K
Sbjct: 179 YNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 69/284 (24%), Positives = 128/284 (45%), Gaps = 31/284 (10%)
Query: 515 NFKQE--VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDA----EFWAEVSIIGRINHR 567
NF+ E +G+G F V+R L D + VA+K+++ DA + E+ ++ ++NH
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 568 NLVK-LQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
N++K L F +NE + V E + G L +++ ++ + V + +
Sbjct: 63 NVIKYLDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
+H V+H D+KP N+ + K+ D GL + F + S V GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746
+ + K+D++S G +L E+ +S + + S C + +E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLFSLC-------------QKIEQ 222
Query: 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790
P L + EKL +V +C+ + D RP + V ++
Sbjct: 223 CDYPPLPTEHYSEKLRELVS---MCIYPDPDQRPDIGYVHQIAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVS-------IIGRINHRNLVK 571
+G+G FG V+ +D R +AVK++ E EV+ ++ + H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVP-FDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 572 LQGFCAENEHKLLVYEYVENGSL-DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
G ++E + EY+ GS+ D+L T ++ ++Y + +G+ YLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TRKYTRQI--LEGVEYLHSN 123
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE--RHDTKFSRVRGTRGYLAPEWMM 688
++H D+K NIL D K+ DFG SK + T V GT +++PE +
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 689 NLKIDAKADVYSYGIVLLELLTGK 712
KADV+S G ++E+LT K
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 520 VGKGGFGSVFR-GVLDDERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQG 574
+GKGGFG V V ++ A K+LE +G++ E I+ ++N R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 575 FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
+ E + L + + NG K G A + + A GL LH+E
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLHQE---R 122
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDA 694
+++ D+KP+NILLDDH +++D GL+ E K RV GT GY+APE + N +
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-GRV-GTVGYMAPEVVKNERYTF 180
Query: 695 KADVYSYGIVLLELLTGKS 713
D ++ G +L E++ G+S
Sbjct: 181 SPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 83/307 (27%), Positives = 128/307 (41%), Gaps = 78/307 (25%)
Query: 504 FTYAELKRATRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGDAE--FWAEVSI 560
FT +LK E+G+G FG+V + + ++AVKR+ + + ++ +
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV 55
Query: 561 IGRINH-RNLVKLQG---------FCAE-------NEHKLLVYEYVENGSLDKLLFNDPG 603
+ R + +VK G C E +K VYE V + +
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKY-VYE-VLKSVIPE------- 106
Query: 604 TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663
IL IAV T K L+YL EE ++H DVKP NILLD + K+ DFG+S
Sbjct: 107 --EILG-----KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQ 157
Query: 664 FKERHDTKFSRVR--GTRGYLAPEWM---MNLKIDAKADVYSYGIVLLELLTGKSASDYL 718
+ ++ R G R Y+APE + D ++DV+S GI L E+ TGK
Sbjct: 158 LVD----SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-- 211
Query: 719 SASASDSSYCNHLVQW--VAKQMEQEGLEKIID---PRLNDVYDREKLDRMVKVALLCVA 773
+W V Q+ Q ++ P L++ +RE V LC+
Sbjct: 212 --------------KWNSVFDQLTQ-----VVKGDPPILSNSEEREFSPSFVNFINLCLI 252
Query: 774 ENRDTRP 780
++ RP
Sbjct: 253 KDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 515 NFKQEVGKGGFGSV-FRGVLDDERVVAVKRLEGVLQGDAEF-WAEVSIIGRINHRNLVKL 572
NF + +G+G G V R VAVK+++ Q E + EV I+ H N+V++
Sbjct: 23 NFVK-IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
+ +V E++E G+L D T + + +Q + + K LS+LH +
Sbjct: 82 YSSYLVGDELWVVMEFLEGGAL-----TDIVTHTRMNEEQIATVCLAVLKALSFLHAQ-- 134
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI 692
V+H D+K +ILL K++DFG + + S V GT ++APE + L
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPY 192
Query: 693 DAKADVYSYGIVLLELLTGK 712
+ D++S GI+++E++ G+
Sbjct: 193 GTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 517 KQEVGKGGFGSVFRGVLDDERVVAVKRLE-------GVLQGDAEFWA--EVSIIGRINHR 567
+Q +GKG FG+V+ ++ D++ VA +RL+ G L + A E ++ +++H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
+VK E + ++ EY E LD L T L +Q + G+ Y+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD--TKFSRVRGTRGYLAPE 685
H+ +LH D+K +NI L ++ K+ DFG+S+L D T F+ GT Y++PE
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT---GTPYYMSPE 175
Query: 686 WMMNLKIDAKADVYSYGIVLLEL 708
+ + D+K+D++S G +L E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 27/205 (13%)
Query: 520 VGKGGFGSVF--RGVL--DDERVVAVKRLEGV---LQGDAEFWAEVSIIGRINHRNLVKL 572
+G+G FG VF R + D ++ A+K L+ ++ E I+ +NH +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 573 QGFCAENEHKL-LVYEYVENGSL-----DKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
+ + E KL L+ +++ G L +++F + D ++ +A A L +
Sbjct: 64 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE--------DVKFYLA-ELALALDH 113
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
LH +++ D+KP+NILLD+ K+TDFGLSK H+ K GT Y+APE
Sbjct: 114 LHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEV 169
Query: 687 MMNLKIDAKADVYSYGIVLLELLTG 711
+ AD +S+G+++ E+LTG
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-14
Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 6/158 (3%)
Query: 557 EVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNI 616
EV+++ + H N+V+ Q EN + +V +Y E G L K + G + DQ +
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRG--VLFPEDQILDW 106
Query: 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR 676
V L ++H+ +LH D+K QNI L K+ DFG++++ + + +
Sbjct: 107 FVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI- 162
Query: 677 GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSA 714
GT YL+PE N + K+D+++ G VL E+ T K A
Sbjct: 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 40/126 (31%), Positives = 72/126 (57%), Gaps = 9/126 (7%)
Query: 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNIL 646
E+++ GSLD++L A + + I++ +GL+YL E+ ++H DVKP NIL
Sbjct: 79 EHMDGGSLDQVL----KKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNIL 132
Query: 647 LDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLL 706
++ E K+ DFG+S + D+ + GTR Y++PE + ++D++S G+ L+
Sbjct: 133 VNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189
Query: 707 ELLTGK 712
E+ G+
Sbjct: 190 EMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 24/203 (11%)
Query: 520 VGKGGFGSVFR-GVLDDERVVAVKRL--EGVLQGDAE--FWAEVSIIGRINHRNLVKLQG 574
+G GGFG V V R A+K + +++ + ++E I+ NH +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 575 FCAENEHKLLVYEYVENGSL-----DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
+ ++ ++ EY G L D+ LF++ + R+ IA YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE--------YTARFYIA-CVVLAFEYLHN 111
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
+++ D+KP+N+LLD + K+ DFG +K K T ++ GT Y+APE ++N
Sbjct: 112 RG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT-WTFC-GTPEYVAPEIILN 166
Query: 690 LKIDAKADVYSYGIVLLELLTGK 712
D D +S GI+L ELLTG+
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 518 QEVGKGGFGSVFRG------------VLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN 565
+ + KG FGSV+ VL ++A ++ V AE +I+ +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVK-------AERAIM--MI 52
Query: 566 HR---NLVKLQGFCAENEHKLLVYEYVENG---SLDKLLFNDPGTASILQWDQRYNIAVG 619
+ KL ++ LV EY+ G SL K L P W ++Y
Sbjct: 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP-----EDWAKQY--IAE 105
Query: 620 TAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR 679
G+ LH+ ++H D+KP+N+L+D K+TDFGLS+ E + GT
Sbjct: 106 VVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----KKFVGTP 157
Query: 680 GYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
YLAPE ++ + D +D +S G V+ E L G
Sbjct: 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 518 QEVGKGGFGSV-FRGVLDDERVVAVKRLEGVLQGDAEFW----AEVSIIGRINHRNLVKL 572
E+G G FG+V F VVAVK++ + E W EV + ++ H N ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 573 QGFCAENEHKL-LVYEYVENGSLDKL-LFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+G C EH LV EY + D L + P LQ + I G +GL+YLH
Sbjct: 87 KG-CYLKEHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAITHGALQGLAYLHSH 140
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
+ +H D+K NILL + + K+ DFG + + + GT ++APE ++ +
Sbjct: 141 NM---IHRDIKAGNILLTEPGQVKLADFGSASK-----SSPANSFVGTPYWMAPEVILAM 192
Query: 691 ---KIDAKADVYSYGIVLLELLTGKSA 714
+ D K DV+S GI +EL K
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 62/221 (28%), Positives = 110/221 (49%), Gaps = 37/221 (16%)
Query: 506 YAELKRATRNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE------FWAEV 558
+EL+R R +G G G+V++ + R+ A+K V+ G+ E E+
Sbjct: 73 LSELERVNR-----IGSGAGGTVYKVIHRPTGRLYALK----VIYGNHEDTVRRQICREI 123
Query: 559 SIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRY--NI 616
I+ +NH N+VK N ++ E+++ GSL+ GT D+++ ++
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-------GTHI---ADEQFLADV 173
Query: 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR 676
A G++YLH ++H D+KP N+L++ K+ DFG+S++ + D S V
Sbjct: 174 ARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV- 229
Query: 677 GTRGYLAPEWM---MNL-KIDAKA-DVYSYGIVLLELLTGK 712
GT Y++PE + +N D A D++S G+ +LE G+
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 44/102 (43%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 616 IAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS-KLFKERHDTKFSR 674
+ V K L YL E+ V+H DVKP NILLD K+ DFG+S +L + T R
Sbjct: 119 MTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT---R 173
Query: 675 VRGTRGYLAPEWM----MNLKIDAKADVYSYGIVLLELLTGK 712
G Y+APE + N K D +ADV+S GI L+EL TG+
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-13
Identities = 22/87 (25%), Positives = 37/87 (42%), Gaps = 6/87 (6%)
Query: 329 FNLSCDRNELD--FMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCKGFGYSTDGQG 386
L+C + F++LP+ ISL+ECR CLS+C C + Y+ G
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNNGS-G 57
Query: 387 ECFPKGNLLNGHNMP-GKYVSMHIKIP 412
C LLN ++++++
Sbjct: 58 GCLLWNGLLNNLRSLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDA---EFWAEVSIIGRINHRNLVKLQ 573
Q VG G FG V + VA+K++ + E+ ++ + H N++ L
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 574 G-FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
F + E V E + L +LL + P +Q+ Y I +GL Y+H
Sbjct: 76 DIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFL-YQIL----RGLKYVHSA-- 127
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL-K 691
V+H D+KP NIL++++ + K+ DFGL+++ D + + TR Y APE M+ K
Sbjct: 128 -GVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 692 IDAKADVYSYGIVLLELLTGK 712
D + D++S G + E+L GK
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 38/217 (17%)
Query: 515 NFKQ--EVGKGGFGSVFRGV--LDDERVVAVKRLEGVLQGDAEFWA------EVSIIGRI 564
NFKQ ++G+G + +V++G E +VA+K + DAE E+S++ +
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGE-IVALK----EIHLDAEEGTPSTAIREISLMKEL 55
Query: 565 NHRNLVKLQGFCAENEHKL-LVYEYVENGSLDKLLFN-------DPGTASILQWDQRYNI 616
H N+V+L E+KL LV+EY++ L K + DP T +
Sbjct: 56 KHENIVRLHD-VIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQ----- 108
Query: 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR 676
KG+++ HE VLH D+KPQN+L++ E K+ DFGL++ F +T FS
Sbjct: 109 ---LLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEV 161
Query: 677 GTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGK 712
T Y AP+ ++ + D++S G ++ E++TG+
Sbjct: 162 VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 9/156 (5%)
Query: 557 EVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNI 616
E+ ++ N +V G + + E+++ GSLD++L A + + +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKV 108
Query: 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR 676
++ +GL+YL E+ ++H DVKP NIL++ E K+ DFG+S + F
Sbjct: 109 SIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 163
Query: 677 GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
GTR Y++PE + ++D++S G+ L+EL G+
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINH-RNLVKLQG-FC 576
VG G +G V++G + ++ A+K ++ + E E++++ + +H RN+ G F
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 577 AEN-----EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
+N + LV E+ GS+ L+ N G +W I +GLS+LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH- 130
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM--- 688
V+H D+K QN+LL ++ E K+ DFG+S +R + + GT ++APE +
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 689 --NLKIDAKADVYSYGIVLLELLTG 711
+ D K+D++S GI +E+ G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGF 575
+ +GKG +G V++ D + AVK L+ + D E AE +I+ + NH N+VK G
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 576 CAENEHKL-----LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV------GTAKGL 624
+ + + LV E GS+ +L+ +L QR + A+ G GL
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELV------KGLLICGQRLDEAMISYILYGALLGL 141
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
+LH ++H DVK NILL K+ DFG+S + + V GT ++AP
Sbjct: 142 QHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAP 197
Query: 685 EWMM-----NLKIDAKADVYSYGIVLLELLTG 711
E + + DA+ DV+S GI +EL G
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 61/223 (27%), Positives = 111/223 (49%), Gaps = 28/223 (12%)
Query: 508 ELKRATRNFKQEVGKGGFGSVF----RGVLDDE--RVVAVKRLE--GVLQGDAEFWAEVS 559
E+ R +E+G+G FG V+ +GV+ DE VA+K + ++ EF E S
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 560 IIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLF-------NDPGTASILQWDQ 612
++ N ++V+L G ++ + L++ E + G L L N+P A +
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA-PPSLKK 120
Query: 613 RYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672
+A A G++YL+ +H D+ +N ++ + F K+ DFG++ ++ ++T +
Sbjct: 121 MIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMT---RDIYETDY 174
Query: 673 SRVRGTRGYLAPEWMM--NLK---IDAKADVYSYGIVLLELLT 710
R +G +G L WM +LK +DV+S+G+VL E+ T
Sbjct: 175 YR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 64/210 (30%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 515 NFK--QEVGKGGFGSVFRGV-LDDERVVAVKRL------EGVLQGDAEFWAEVSIIGRIN 565
NF+ +++G+G +G V++ VVA+K++ EGV + E+S++ +N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV---PSTAIREISLLKELN 57
Query: 566 HRNLVKLQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGL 624
H N+VKL E+KL LV+E++ + L K + P + L + Y + +GL
Sbjct: 58 HPNIVKLLD-VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGL 113
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
++ H VLH D+KPQN+L++ K+ DFGL++ F T V T Y AP
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 169
Query: 685 EWMMNLKIDAKA-DVYSYGIVLLELLTGKS 713
E ++ K + A D++S G + E++T ++
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 5e-13
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEF----WAEVSIIGRINHRNL 569
+ +G G +G V V R VA+K++ V D E+ ++ + H N+
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENI 61
Query: 570 VKL----QGFCAENEHKL-LVYEYVENGSLDKLLF-NDPGTASILQWDQRYNIAVGTAKG 623
+ L + E+ + + +V E +E L K++ P T +Q+ Y I +G
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQIL----RG 115
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG--TRGY 681
L YLH V+H D+KP NIL++ + + K+ DFGL++ D K TR Y
Sbjct: 116 LKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172
Query: 682 LAPEWMMNLKIDAKA-DVYSYGIVLLELLTGK---SASDYL 718
APE +++ KA D++S G + ELLT K DY+
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 42/102 (41%), Positives = 61/102 (59%), Gaps = 10/102 (9%)
Query: 616 IAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS-KLFKERHDTKFSR 674
IAV K L YLH + L V+H DVKP N+L++ + + K+ DFG+S L T +
Sbjct: 108 IAVSIVKALEYLHSK-LS-VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA- 164
Query: 675 VRGTRGYLAPEWM---MNLK-IDAKADVYSYGIVLLELLTGK 712
G + Y+APE + +N K D K+DV+S GI ++EL TG+
Sbjct: 165 --GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-----FWAEVSIIGRINHRNLVK 571
+++G+G +G+VF+ + +VA+KR+ L D E E+ ++ + H+N+V+
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 572 LQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGT--ASILQWDQRYNIAVGTAKGLSYLH 628
L ++ KL LV+EY + L K + G I++ + KGL++ H
Sbjct: 64 LYDVL-HSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVK-----SFMFQLLKGLAFCH 116
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF--KERHDTKFSRVRGTRGYLAPEW 686
VLH D+KPQN+L++ + E K+ DFGL++ F R +S T Y P+
Sbjct: 117 SHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR---CYSAEVVTLWYRPPDV 170
Query: 687 MMNLKI-DAKADVYSYGIVLLE-------LLTGKSASDYL 718
+ K+ D++S G + E L G D L
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 61/245 (24%), Positives = 114/245 (46%), Gaps = 54/245 (22%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDER-----------------VVAVKRLEGVLQG 550
+ R FK+++G+G FG V + + + +VAVK +L+
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVK----ILRP 56
Query: 551 DA------EFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFN---- 600
DA +F EV I+ R+ N+++L G C + + ++ EY+ENG L++ L +
Sbjct: 57 DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLD 116
Query: 601 ---DPGTASILQ--------WDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD 649
+ G ++ + ++A+ A G+ YL L +V H D+ +N L+ +
Sbjct: 117 DKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--SSLNFV-HRDLATRNCLVGE 173
Query: 650 HFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM-----MNLKIDAKADVYSYGIV 704
+ K+ DFG+S + + + R++G R L WM + K +DV+++G+
Sbjct: 174 NLTIKIADFGMS---RNLYAGDYYRIQG-RAVLPIRWMAWECILMGKFTTASDVWAFGVT 229
Query: 705 LLELL 709
L E+L
Sbjct: 230 LWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 25/204 (12%)
Query: 516 FKQEVGKGGFGSVFRG-VLDDERVVAVK--RLEGVLQGDAEFWAEVSIIGRINHRNLVKL 572
+++ +G G G+V++ L R++AVK L+ ++ + +E+ I+ + + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 573 QG-FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
G F EN + E+++ GSLD + P +L IAV KGL+YL
Sbjct: 65 YGAFFVENRISICT-EFMDGGSLD-VYRKIP--EHVLG-----RIAVAVVKGLTYL---- 111
Query: 632 LEW---VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM 688
W +LH DVKP N+L++ + K+ DFG+S + GT Y+APE +
Sbjct: 112 --WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERIS 166
Query: 689 NLKIDAKADVYSYGIVLLELLTGK 712
+ +DV+S GI +EL G+
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 31/212 (14%)
Query: 519 EVGKGGFGSVF--RGVLDDERVVAVKRLEGVLQGDAEFWA-----EVSIIGRIN---HRN 568
E+G+G +G VF R + + R VA+KR+ +Q E EV+++ + H N
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 569 LVKLQGFCA----ENEHKL-LVYEYVENG---SLDKLLFNDPGTASILQWDQRYNIAVGT 620
+V+L C + E KL LV+E+V+ LDK+ +PG + D + +
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLL--- 120
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG 680
+GL +LH V+H D+KPQNIL+ + K+ DFGL++++ + + V T
Sbjct: 121 -RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLW 174
Query: 681 YLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
Y APE ++ D++S G + E+ K
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 32/206 (15%)
Query: 519 EVGKGGFGSVFR------GVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKL 572
E+G G FG V++ G L +V+ K E + ++ E+ I+ NH +VKL
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL----EDYMVEIEILATCNHPYIVKL 74
Query: 573 QG-FCAENEHKLLVYEYVENGSLDKLLFN-DPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
G F + + +++ E+ G++D ++ D G L Q I + L YLH
Sbjct: 75 LGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSM 129
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLS-KLFK--ERHDTKFSRVRGTRGYLAPEWM 687
++H D+K N+LL + K+ DFG+S K K +R D+ GT ++APE +
Sbjct: 130 ---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVV 182
Query: 688 M-----NLKIDAKADVYSYGIVLLEL 708
M + D KAD++S GI L+E+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 62/242 (25%), Positives = 109/242 (45%), Gaps = 42/242 (17%)
Query: 557 EVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFN-DPGTASILQWDQRYN 615
E+ ++ R+NH +++++ G E+ H L E++ GS+ LL +++ Y
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI---INYT 109
Query: 616 IAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP-KVTDFGLSKLFKERHDTKFSR 674
+ +GLSYLHE ++H DVK N+L+D + ++ DFG + R K +
Sbjct: 110 EQL--LRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA----RLAAKGTG 160
Query: 675 -------VRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSY 727
+ GT ++APE + + DV+S G V++E+ T K +A S
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK-----PPWNAEKHS- 214
Query: 728 CNH--LVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKV 785
NH L+ +A + + + P L D V L C+ + RPP ++
Sbjct: 215 -NHLALIFKIASATTAPSIPEHLSPGLRD------------VTLRCLELQPEDRPPSREL 261
Query: 786 VK 787
+K
Sbjct: 262 LK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 520 VGKGGFGSVFR-GVLDDERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQG 574
+GKGGFG V V ++ A KRLE +G++ E I+ ++N + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 575 FCAENEHKL-LVYEYVENGSLDKLLFN--DPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
+ E + L LV + G L ++N +PG + ++ A GL LH E
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG----FEEERALFYAAEILCGLEDLHREN 122
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK 691
++ D+KP+NILLDD+ +++D GL+ E ++ RV GT GY+APE + N +
Sbjct: 123 ---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE-GESIRGRV-GTVGYMAPEVLNNQR 177
Query: 692 IDAKADVYSYGIVLLELLTGKS 713
D + G ++ E++ G+S
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 28/204 (13%)
Query: 519 EVGKGGFGSVFR------GVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKL 572
E+G G FG V++ GVL +V+ K E + ++ E+ I+ +H N+VKL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL----EDYMVEIDILASCDHPNIVKL 67
Query: 573 -QGFCAENEHKLLVYEYVENGSLDKLLFN--DPGTASILQWDQRYNIAVGTAKGLSYLHE 629
F EN +L+ E+ G++D ++ P T ++ + T + L+YLHE
Sbjct: 68 LDAFYYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRV-----VCKQTLEALNYLHE 121
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM- 688
++H D+K NIL + K+ DFG+S R + GT ++APE +M
Sbjct: 122 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 689 ----NLKIDAKADVYSYGIVLLEL 708
+ D KADV+S GI L+E+
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 519 EVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDA---EFWAEVSIIGRINHRNLVKLQGF 575
E+G G G VF+ ++ ++L + A + E+ ++ N +V G
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWV 635
+ + E+++ GSLD++L A + +++ KGL+YL E+ +
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREK--HKI 125
Query: 636 LHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAK 695
+H DVKP NIL++ E K+ DFG+S + F GTR Y++PE + +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQ 182
Query: 696 ADVYSYGIVLLELLTGK 712
+D++S G+ L+E+ G+
Sbjct: 183 SDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERV--VAVKRLEG---VLQGDAE-FWAEVSII 561
++K NF + +G G FG V +E VA+KR E + Q + ++E I+
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL 85
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTA 621
INH V L G + + LV E+V G + L+ ++R+ VG
Sbjct: 86 NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF----------FTFLRRNKRFPNDVGCF 135
Query: 622 KG----LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG 677
L + + + L +++ D+KP+N+LLD K+TDFG +K+ DT+ + G
Sbjct: 136 YAAQIVLIFEYLQSLN-IVYRDLKPENLLLDKDGFIKMTDFGFAKVV----DTRTYTLCG 190
Query: 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
T Y+APE ++N+ AD ++ GI + E+L G
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 520 VGKGGFGSVFR-GVLDDERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQG 574
+GKGGFG V V ++ A K+LE +G+A E I+ ++N R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 575 FCAENEHKL-LVYEYVENGSLDKLLFN--DPGTASILQWDQRYNI--AVGTAKGLSYLHE 629
+ E + L LV + G L ++N +PG +D+ + A GL LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FDEERAVFYAAEITCGLEDLHR 120
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
E +++ D+KP+NILLDD+ +++D GL+ E + RV GT GY+APE + N
Sbjct: 121 E---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR-GRV-GTVGYMAPEVVKN 175
Query: 690 LKIDAKADVYSYGIVLLELLTGKS 713
+ D + G ++ E++ GKS
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 69/279 (24%), Positives = 128/279 (45%), Gaps = 31/279 (11%)
Query: 515 NFKQE--VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA----EVSIIGRINHR 567
NF+ E +G+G F V+R L D VA+K+++ DA+ A E+ ++ ++NH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 568 NLVKLQG-FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
N++K F +NE + V E + G L +++ + ++ + V L +
Sbjct: 63 NVIKYYASFIEDNELNI-VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
+H V+H D+KP N+ + K+ D GL + F + S V GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746
+ + K+D++S G +L E+ +S + + S C K++EQ
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLC--------KKIEQCDYP- 226
Query: 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKV 785
P +D Y E + ++ +C+ + + RP ++ V
Sbjct: 227 ---PLPSDHYSEE----LRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 68/203 (33%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDA--------EFWAEVSI-IGRINHRNL 569
+GKG FG V D + AVK VLQ A AE ++ + + H L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVK----VLQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 570 VKLQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
V L + + KL V +YV G +L F+ S + R+ A A L YLH
Sbjct: 59 VGLH-YSFQTADKLYFVLDYVNGG---ELFFHLQRERSFPEPRARF-YAAEIASALGYLH 113
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM 688
+++ D+KP+NILLD +TDFGL K E T S GT YLAPE +
Sbjct: 114 SLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT-STFCGTPEYLAPEVLR 169
Query: 689 NLKIDAKADVYSYGIVLLELLTG 711
D D + G VL E+L G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 66/203 (32%), Positives = 94/203 (46%), Gaps = 26/203 (12%)
Query: 519 EVGKGGFGSVFRG-VLDDERVVAVKRLEGVLQGDAEFWA--------EVSIIGRINHRNL 569
+VG+GG+G VF D +VA+KR++ L F E I+ L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL----FKLNEVRHVLTERDILTTTKSEWL 63
Query: 570 VKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQ-RYNIAVGTAKGLSYLH 628
VKL ++E+ L EYV G LL N +L D R+ +A + LH
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFE-AVDALH 118
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM 688
E L ++ H D+KP+N L+D K+TDFGLSK ++ V G+ Y+APE +
Sbjct: 119 E--LGYI-HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS----VVGSPDYMAPEVLR 171
Query: 689 NLKIDAKADVYSYGIVLLELLTG 711
D D +S G +L E L G
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-12
Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 25/210 (11%)
Query: 517 KQEVGKGGFGSVFRGVLDDER---VVAVKRLEGVLQG--DAE-FWAEVSIIGRI-NHRNL 569
Q++GKG +G V++ + D R VVA+K++ + DA+ + E+ + + +H N+
Sbjct: 12 LQKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNI 69
Query: 570 VKLQG-FCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
VKL AEN+ + LV+EY+E L ++ A+IL+ + I K L Y+
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYMET-DLHAVI-----RANILEDVHKRYIMYQLLKALKYI 123
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR----GTRGYLA 683
H V+H D+KP NILL+ K+ DFGL++ E + + V TR Y A
Sbjct: 124 HSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 684 PEWMMNLKIDAKA-DVYSYGIVLLELLTGK 712
PE ++ K D++S G +L E+L GK
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 45/221 (20%)
Query: 518 QEVGKGGFGSV----FRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQ 573
+E+G+G +G V ++E V A+K++ V I+ + R L L+
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETV-AIKKITNVFSK--------KILAKRALRELKLLR 56
Query: 574 GFCAENEHKLLVYEY----VENGSLDKL-LFNDP---GTASILQWDQR----------YN 615
F HK + Y V G+ ++L L+ + I++ Q Y
Sbjct: 57 HF---RGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQ 113
Query: 616 IAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH---DTKF 672
I G L Y+H VLH D+KP N+L++ E K+ DFGL++ F E
Sbjct: 114 ILCG----LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166
Query: 673 SRVRGTRGYLAPEWMMNLKIDAKA-DVYSYGIVLLELLTGK 712
+ TR Y APE M++ + KA DV+S G +L ELL K
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINH-RNLVKLQGF 575
+ VG G +G V++G + ++ A+K ++ + E E++++ + +H RN+ G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 576 ------CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
++ LV E+ GS+ L+ N G A L+ D I +GL++LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA--LKEDWIAYICREILRGLAHLH- 138
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM- 688
V+H D+K QN+LL ++ E K+ DFG+S +R + + GT ++APE +
Sbjct: 139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 689 ----NLKIDAKADVYSYGIVLLELLTG 711
+ D ++D++S GI +E+ G
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 52/235 (22%), Positives = 99/235 (42%), Gaps = 50/235 (21%)
Query: 512 ATRNFK--QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA------EVSIIG 562
R+++ ++G+G FG V++ + RVVA+K++ L + + E+ I+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFPITALREIKILK 62
Query: 563 RINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLF------NDPGTASILQWDQRYNI 616
++ H N+V L + E + + D + +L+ + +
Sbjct: 63 KLKHPNVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKL 112
Query: 617 AVGTAK--------GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE-- 666
K G++YLHE +LH D+K NIL+D+ K+ DFGL++ +
Sbjct: 113 TESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169
Query: 667 --------RHDTKFSRVRGTRGYLAPEWMMNLKIDAKA-DVYSYGIVLLELLTGK 712
K++ + TR Y PE ++ + A D++ G V E+ T +
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 31/214 (14%)
Query: 516 FKQEVGKGGFGSVFRGVLDDERVV-AVK--RLEGVLQGDAEF---WAEVSIIGRINHRNL 569
E+GKG +GSV++ + V A+K RLE +++F E+ I+ + +
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYI 61
Query: 570 VKLQG-FCAENEHKLLVY---EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
V G F E VY EY++ GSLDKL T I + D I KGL
Sbjct: 62 VDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPE-DVLRRITYAVVKGLK 116
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS-KLFKERHDTKFSRVRGTRGYLAP 684
+L EE ++H DVKP N+L++ + + K+ DFG+S L T G + Y+AP
Sbjct: 117 FLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAP 170
Query: 685 EWMM------NLKIDAKADVYSYGIVLLELLTGK 712
E + N ++DV+S G+ +LE+ G+
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRL-----EGVLQGDAEFWAEVSIIGRINHRNLVKLQ 573
+G+G +G VF+ + ++VA+K+ + V++ A E+ ++ ++ H NLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKHPNLVNLI 66
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE-CL 632
LV+EY ++ L++L N G + I T + +++ H+ C+
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEHLIKKIIWQTLQAVNFCHKHNCI 122
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM-NLK 691
H DVKP+NIL+ + K+ DFG +++ ++ TR Y APE ++ + +
Sbjct: 123 ----HRDVKPENILITKQGQIKLCDFGFARILT-GPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 692 IDAKADVYSYGIVLLELLTG 711
DV++ G V ELLTG
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWA--EVSIIGRINHRNLVKLQG 574
+++G+G + +V++G + ++VA+K + + F A E S++ + H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 575 FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
E LV+EYV L + + PG L + +GLSY+H+ +
Sbjct: 71 IIHTKETLTLVFEYVHT-DLCQYMDKHPGG---LHPENVKLFLFQLLRGLSYIHQR---Y 123
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM-NLKID 693
+LH D+KPQN+L+ D E K+ DFGL++ K +S T Y P+ ++ + +
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 694 AKADVYSYGIVLLELLTGKSA 714
D++ G + +E++ G +A
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 519 EVGKGGFGSV-FRGVLDDERVVAVKRLEGVLQGDAEF-WAEVSIIGRINHRNLVKLQGFC 576
++G+G G V V ++VAVK+++ Q E + EV I+ H N+V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 577 AENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVL 636
+ +V E++E G+L ++ T + + +Q + + K LS LH + V+
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQ---GVI 138
Query: 637 HCDVKPQNILLDDHFEPKVTDFGL-SKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAK 695
H D+K +ILL K++DFG +++ KE K + GT ++APE + L +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPELISRLPYGPE 196
Query: 696 ADVYSYGIVLLELLTGK 712
D++S GI+++E++ G+
Sbjct: 197 VDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 520 VGKGGFGSVFRG--VLDDERV---VAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKL 572
+G G FG+V++G + + E+V VA+K L + + E E ++ +++ ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDP--GTASILQWDQRYNIAVGTAKGLSYLHEE 630
G C + +L+ LD + + G+ +L W V AKG++YL E
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEER 128
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR---GYLAPEWM 687
L +H D+ +N+L+ K+TDFGL+KL D K G + ++A E +
Sbjct: 129 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKWMALESI 183
Query: 688 MNLKIDAKADVYSYGIVLLELLT-GKSASDYLSAS 721
++ ++DV+SYG+ + EL+T G D + AS
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 519 EVGKGGFGSVFRGVLD-DERVVAVK--RLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGF 575
++G+G + +VF+G E +VA+K RLE EVS++ + H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV---GTAKGLSYLHEECL 632
LV+EY+++ L + L N S+ +N+ + +GLSY H+
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSM------HNVKIFMFQLLRGLSYCHKR-- 122
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM-NLK 691
+LH D+KPQN+L+++ E K+ DFGL++ K +S T Y P+ ++ + +
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 692 IDAKADVYSYGIVLLELLTGK 712
D++ G +L E+ TG+
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 519 EVGKGGFGSVFRGVLDDERV---VAVKRLEGVLQGDA--EFWAEVSIIGRINHRNLVKLQ 573
E+G G FG V +GV + VA+K L+ + E E I+ ++++ +V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV---GTAKGLSYLHEE 630
G C E E +LV E G L+K L ++ N+ + G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITV------SNVVELMHQVSMGMKYLEGK 114
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGT--RGYLAPEWMM 688
+H D+ +N+LL + K++DFGLSK +R G + APE +
Sbjct: 115 NF---VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 689 NLKIDAKADVYSYGIVLLELLT 710
K +++DV+SYGI + E +
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 30/220 (13%)
Query: 519 EVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-----EVSIIGRI---NHRNL 569
E+G G +G+V++ VA+K + +Q + + EV+++ R+ +H N+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVR--VQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 570 VKLQGFCA----ENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGL 624
V+L CA + E K+ LV+E+V+ D + D L + ++ +GL
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
+LH C ++H D+KP+NIL+ + K+ DFGL++++ + V T Y AP
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALTPVVVTLWYRAP 176
Query: 685 EWMMNLKIDAKADVYSYGIVLLE------LLTGKSASDYL 718
E ++ D++S G + E L G S +D L
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 6e-12
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 40/217 (18%)
Query: 517 KQEVGKGGFGSVFRGV--LDDERVVAVKRLEGVLQGDAEFWA-----EVSIIGRINHRNL 569
+G+G +G V +V A+K++ + + + E+ I+ R H N+
Sbjct: 10 LSYIGEGAYGMVCSATHKPTGVKV-AIKKISPF---EHQTFCQRTLREIKILRRFKHENI 65
Query: 570 VKLQ------GFCAENEHKLLVYEYVENGSLDKL-----LFNDPGTASILQWDQRYNIAV 618
+ + F + N+ +V E +E L KL L ND + Q
Sbjct: 66 IGILDIIRPPSFESFND-VYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQ--------- 114
Query: 619 GTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD-TKF-SRVR 676
+GL Y+H VLH D+KP N+LL+ + + K+ DFGL+++ HD T F +
Sbjct: 115 -ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 677 GTRGYLAPEWMMNLKIDAKA-DVYSYGIVLLELLTGK 712
TR Y APE M+N K KA D++S G +L E+L+ +
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 36/213 (16%)
Query: 518 QEVGKGGFGSVFRGVL----DDERVVAVKRLEGVLQ-------GDAEFWAEVSIIGRINH 566
+ +G+G F ++++GVL D + V + + VL+ F+ S++ +++H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
++LVKL G C +E+ ++V EYV+ G LD L + S+ W + ++A A L Y
Sbjct: 61 KHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLH-W--KLDVAKQLASALHY 116
Query: 627 LHEECLEWVLHCDVKPQNILL--DDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY--- 681
L ++ L +H +V +NIL+ E V LS D +R
Sbjct: 117 LEDKKL---VHGNVCGKNILVARYGLNEGYVPFIKLS-------DPGIPITVLSREERVE 166
Query: 682 ----LAPEWMMNL--KIDAKADVYSYGIVLLEL 708
+APE + N + AD +S+G LLE+
Sbjct: 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 45/235 (19%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVLQGDA------EFW 555
EL R + +G+G FG V + ++ VAVK +L+ DA +
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK----MLKDDATEKDLSDLV 63
Query: 556 AEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSL-------------DKLLFND 601
+E+ ++ I H+N++ L G C + +V EY +G+L
Sbjct: 64 SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123
Query: 602 PGTASILQWDQRYNIAVGTAKGLSYL-HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGL 660
P ++ Q D + A A+G+ +L ++C+ H D+ +N+L+ + K+ DFGL
Sbjct: 124 PPEETLTQKDL-VSFAYQVARGMEFLASKKCI----HRDLAARNVLVTEDHVMKIADFGL 178
Query: 661 SKLFKERHDTKFSRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
+ ++ H + R T G L APE + + ++DV+S+G++L E+ T
Sbjct: 179 A---RDIHHIDYYRKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 520 VGKGGFGSVFR-GVLDDERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQG 574
+GKGGFG V V ++ A K+LE +G+A E I+ ++N R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 575 FCAENEHKL-LVYEYVENGSLDKLLFN--DPGTASILQWDQRYNI--AVGTAKGLSYLHE 629
+ E + L LV + G L ++N +PG +D++ I A GL L
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG------FDEQRAIFYAAELCCGLEDLQR 120
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
E +++ D+KP+NILLDD +++D GL+ E + RV GT GY+APE + N
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR-GRV-GTVGYMAPEVINN 175
Query: 690 LKIDAKADVYSYGIVLLELLTGKS 713
K D + G ++ E++ G+S
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 50/176 (28%), Positives = 93/176 (52%), Gaps = 12/176 (6%)
Query: 539 VAVKRLEGVLQGDAEF-WAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKL 597
VAVK+++ Q E + EV I+ +H N+V + + +V E++E G+L +
Sbjct: 50 VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI 109
Query: 598 LFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTD 657
+ T + + +Q + + + LSYLH + V+H D+K +ILL K++D
Sbjct: 110 V-----THTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSD 161
Query: 658 FGL-SKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
FG +++ KE K + GT ++APE + L + D++S GI+++E++ G+
Sbjct: 162 FGFCAQVSKEVPKRK--SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 36/211 (17%)
Query: 520 VGKGGFGSVFRGVLDDE-RVVAVKRL--EGVLQGDAEFWAEVSIIGR------INHRNLV 570
+GKG FG V L A+K L + VL+ D E +++ R H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD---VECTMVERRVLALAWEHPFLT 59
Query: 571 KLQGFCA--ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT------AK 622
L FC EH V EY+ G L +F+ +Q R++ A
Sbjct: 60 HL--FCTFQTKEHLFFVMEYLNGGDL---MFH-------IQSSGRFDEARARFYAAEIIC 107
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
GL +LH++ +++ D+K N+LLD K+ DFG+ K + K S GT Y+
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG-EGKASTFCGTPDYI 163
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGKS 713
APE + K + D +S+G++L E+L G+S
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 520 VGKGGFGSV-FRGVLDDERVVAVK---RLEGVLQGD-AEFWAEVSIIGRINHRNLVKLQG 574
+G+G FG V ++V A+K + E + + D A FW E I+ N +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL-- 108
Query: 575 FCA--ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
FCA ++++ +V EY+ G L L+ N +W + Y V A L +H L
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE---KWAKFYTAEVVLA--LDAIHSMGL 163
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI 692
+H DVKP N+LLD H K+ DFG E + GT Y++PE + +
Sbjct: 164 ---IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 693 DA----KADVYSYGIVLLELLTGKS 713
D + D +S G+ L E+L G +
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDT 245
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 520 VGKGGFGSVFRGVL--DDERV---VAVK--RLEGVLQGDAEFWAEVSIIGRINHRNLVKL 572
+G G FG+V++G+ D E V VA+K R + + E E ++ + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDP--GTASILQWDQRYNIAVGTAKGLSYLHEE 630
G C + +L+ LD + N G+ +L W V AKG+SYL E
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLEEV 128
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM--- 687
L +H D+ +N+L+ K+TDFGL++L D + G + +WM
Sbjct: 129 RL---VHRDLAARNVLVKSPNHVKITDFGLARLL----DIDETEYHADGGKVPIKWMALE 181
Query: 688 --MNLKIDAKADVYSYGIVLLELLT 710
++ + ++DV+SYG+ + EL+T
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 72/288 (25%), Positives = 134/288 (46%), Gaps = 34/288 (11%)
Query: 520 VGKGGFGSVFRGVLDDE-RVVAVKR-LEGVLQGDAEFWA--EVSIIGRINHRNLVKLQGF 575
VG+G +G V + + ++VA+K+ LE + A E+ ++ ++ H NLV L
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWV 635
+ LV+E+V++ LD L G ++Y + +G+ + H +
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRV--RKYLFQI--LRGIEFCH---SHNI 121
Query: 636 LHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM-NLKIDA 694
+H D+KP+NIL+ K+ DFG ++ + V TR Y APE ++ + K
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKYGR 180
Query: 695 KADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAK--QMEQEGLEKIIDP-- 750
D+++ G ++ E+LTG + L SD H+++ + QE +K +P
Sbjct: 181 AVDIWAVGCLVTEMLTG----EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK--NPLF 234
Query: 751 ---RLNDVYDREKLDR--------MVKVALLCVAENRDTRPPMSKVVK 787
RL +V + E L++ ++ +A C+ + D RP S+++
Sbjct: 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 27/203 (13%)
Query: 523 GGFGSVFRGV-LDDERVVAVKRL--EGVLQGDAEF----WAEVSIIGRINHRNLVKLQ-- 573
G +G V+R +VA+K+L E +G F E++I+ ++ H N+V ++
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTVKEV 72
Query: 574 --GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
G N K+ +V EYVE+ L L+ + + + G+++LH+
Sbjct: 73 VVG---SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQ---SEVKCLMLQLLSGVAHLHDN 125
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
W+LH D+K N+LL++ K+ DFGL++ + ++++ T Y APE ++
Sbjct: 126 ---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PYTQLVVTLWYRAPELLLGA 181
Query: 691 KI-DAKADVYSYGIVLLELLTGK 712
K D++S G + ELLT K
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 516 FKQEVGKGGFGSV--FRGVLDDERVVAVKRLEGVLQGDAEFWA---EVSIIGRINHRNLV 570
F + VGKG +G V R D ++ V +K+L E A E ++ ++ H N+V
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYV-IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 571 KL-QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
+ + E+ +V + E G L L G +L +Q V A L YLHE
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHE 120
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
+ +LH D+K QN+ L KV D G++++ + + D S + GT Y++PE N
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA-STLIGTPYYMSPELFSN 176
Query: 690 LKIDAKADVYSYGIVLLELLTGKSA 714
+ K+DV++ G + E+ T K A
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 51/219 (23%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 504 FTYAELKRATRNFKQEVGKGGFGSVFRGVL--DDERV---VAVKRLEGVLQGDAEFWA-- 556
EL++ + +G G FG+V +G+ + + + VA+K ++ G F
Sbjct: 4 LKETELRKL-----KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD-RSGRQTFQEIT 57
Query: 557 -EVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTAS---ILQWDQ 612
+ +G ++H +V+L G C +L V + GSL + + +L W
Sbjct: 58 DHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW-- 114
Query: 613 RYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL-FKERHDTK 671
V AKG+ YL E + +H ++ +NILL ++ DFG++ L + +
Sbjct: 115 ----CVQIAKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167
Query: 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
+S + ++A E ++ + ++DV+SYG+ + E+++
Sbjct: 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 38/218 (17%)
Query: 520 VGKGGFGSVFRGVLDDERV---VAVKRLEGVLQGDAEFWA-----EVSIIGRINHRNLVK 571
VG G +GSV + D+R VA+K+L Q +E +A E++++ + H N++
Sbjct: 23 VGSGAYGSVCSAI--DKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIG 78
Query: 572 L-QGFCAENEHK-----LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
L F + LV Y++ L K++ + L D+ + GL
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP------LSEDKVQYLVYQMLCGLK 131
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH-DTKFSRVRGTRGYLAP 684
Y+H ++H D+KP N+ +++ E K+ DFGL+ RH D + + TR Y AP
Sbjct: 132 YIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEMTGYVVTRWYRAP 183
Query: 685 EWMMN-LKIDAKADVYSYGIVLLELLTGKS---ASDYL 718
E ++N + + D++S G ++ E+LTGK+ DYL
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 221
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 30/208 (14%)
Query: 523 GGFGSVFRGVLDD-----ERVVAVKRLEGVLQGDAE-----FWAEVSIIGRINHRNLVKL 572
G FG +F G+L D E V VK V +E E ++ ++H+N++ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKT---VKDHASEIQVTLLLQESCLLYGLSHQNILPI 73
Query: 573 QGFCAENEHKLLV-YEYVENGSLDKLLFN----DPGTASILQWDQRYNIAVGTAKGLSYL 627
C E+ V Y Y+ G+L L + L Q ++A+ A G+SYL
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK-LFKERH----DTKFSRVRGTRGYL 682
H+ V+H D+ +N ++D+ + K+TD LS+ LF + D + V+ ++
Sbjct: 134 HKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK----WM 186
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLT 710
A E ++N + + +DV+S+G++L EL+T
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 518 QEVGKGGFGSVFRGVLD-DERVVAVK--RLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
+++G+G + +VF+G E +VA+K RLE EVS++ + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 575 FCAENEHKLLVYEYVENGSLDKLL---FNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
++ LV+EY LDK L +D G +I+ +GL+Y H
Sbjct: 72 IVHTDKSLTLVFEY-----LDKDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR- 123
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM-NL 690
VLH D+KPQN+L+++ E K+ DFGL++ K +S T Y P+ ++ +
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGSS 180
Query: 691 KIDAKADVYSYGIVLLELLTGK 712
+ + D++ G + E+ +G+
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 68/217 (31%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 518 QEVGKGGFGSVFRGVLD--DERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQG 574
+ +GKG +G VF+ VL+ + AVK L+ + D E AE +I+ + +H N+VK G
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 575 FCAENEHK-----LLVYEYVENGSLDKLL---------FNDPGTASILQWDQRYNIAVGT 620
+ + K LV E GS+ L+ +P A IL
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH---------EA 133
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS-KLFKERHDTKFSRVRGTR 679
GL +LH +H DVK NILL K+ DFG+S +L R S GT
Sbjct: 134 LMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTP 188
Query: 680 GYLAPEWM-----MNLKIDAKADVYSYGIVLLELLTG 711
++APE + ++ DA+ DV+S GI +EL G
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 39/213 (18%)
Query: 520 VGKGGFGSVF------RGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQ 573
+GKGGFG V G L + + KRL+ +G E I+ +++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK-RKGYEGAMVEKRILAKVHSRFIVSL- 58
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFN----DPG---------TASILQWDQRYNIAVG 619
+ + + L LV + G L ++N +PG TA I+
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIIS---------- 108
Query: 620 TAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR 679
GL +LH+ +++ D+KP+N+LLD+ +++D GL+ K+ +K GT
Sbjct: 109 ---GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGYAGTP 161
Query: 680 GYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
G++APE + + D D ++ G+ L E++ +
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGV---LDDERV---VAVKRLEGVLQGDAE--FWAEVS 559
E R +F + +G G FG V L VAVK L+ +E+
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 560 IIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV 618
I+ + NH N+V L G C L++ EY G L L F S L + + +
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL--LNFLRRKRESFLTLEDLLSFSY 148
Query: 619 GTAKGLSYL-HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG 677
AKG+++L + C+ H D+ +N+LL K+ DFGL++ +D+ + V+G
Sbjct: 149 QVAKGMAFLASKNCI----HRDLAARNVLLTHGKIVKICDFGLARDIM--NDSNYV-VKG 201
Query: 678 -TR---GYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
R ++APE + N ++DV+SYGI+L E+ +
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 519 EVGKGGFGSVFRGVLDD---ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG- 574
+VG+G +G V++ D E+ A+K++EG E++++ + H N++ LQ
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-GISMSACREIALLRELKHPNVIALQKV 66
Query: 575 FCAENEHKL-LVYEYVENGSLDKLLFNDPGTASI----LQWDQRYNIAVGTAKGLSYLHE 629
F + ++ K+ L+++Y E+ + F+ A+ L ++ G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 630 ECLEWVLHCDVKPQNILL----DDHFEPKVTDFGLSKLFKE--RHDTKFSRVRGTRGYLA 683
WVLH D+KP NIL+ + K+ D G ++LF + V T Y A
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 684 PEWMMNLKIDAKA-DVYSYGIVLLELLTGK 712
PE ++ + KA D+++ G + ELLT +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 38/103 (36%), Positives = 60/103 (58%), Gaps = 13/103 (12%)
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH-DTKFSRVRGTRG 680
+GL Y+H ++H D+KP NI +++ E K+ DFGL+ RH D + + TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA-----RHTDDEMTGYVATRW 180
Query: 681 YLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKS---ASDYLS 719
Y APE M+N + + D++S G ++ ELLTGK+ SD++
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID 223
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 66/242 (27%), Positives = 109/242 (45%), Gaps = 39/242 (16%)
Query: 580 EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT------AKGLSYLHEECLE 633
EH V E++ G L +F+ +Q R+++ T GL +LH +
Sbjct: 69 EHLFFVMEFLNGGDL---MFH-------IQDKGRFDLYRATFYAAEIVCGLQFLHSK--- 115
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSK--LFKERHDTKFSRVRGTRGYLAPEWMMNLK 691
+++ D+K N++LD K+ DFG+ K +F + + F GT Y+APE + LK
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC---GTPDYIAPEILQGLK 172
Query: 692 IDAKADVYSYGIVLLELLTGKSA-----SDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746
D +S+G++L E+L G+S D L S + H +W+ K+ ++ LEK
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PHYPRWITKE-SKDILEK 229
Query: 747 II--DP--RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQDESI 802
+ DP RL V + K E R+ PP VK + D+ + E +
Sbjct: 230 LFERDPTRRLG-VVGNIRGHPFFKTINWTALEKRELDPPFKPKVK--SPSDYSNFDREFL 286
Query: 803 SD 804
S+
Sbjct: 287 SE 288
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 36/216 (16%)
Query: 519 EVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-----EVSIIGRINHRNLVKL 572
++G+G +G V++ D +VA+K++ L + E + E+ I+ ++NHRN+V L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 573 Q----------GFCAENEHKLLVYEYVEN---GSLDKLL--FNDPGTASILQWDQRYNIA 617
+ F + LV+EY+++ G L+ L F++ S ++
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK-------- 123
Query: 618 VGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG 677
+GL+Y H++ LH D+K NILL++ + K+ DFGL++L+ ++
Sbjct: 124 -QLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 678 TRGYLAPEWMMNLKIDAKA-DVYSYGIVLLELLTGK 712
T Y PE ++ + A DV+S G +L EL T K
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 518 QEVGKGGFGSVFRGV------LDDERVVAVKRLEGVLQGDAEFWA--EVSIIGRINHRNL 569
+++G+G + +V++G+ L +V+++K EGV F A E S++ + H N+
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-----PFTAIREASLLKGLKHANI 65
Query: 570 VKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV---GTAKGLSY 626
V L E V+EY+ L + + PG YN+ + +GL+Y
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGL------HPYNVRLFMFQLLRGLAY 118
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
+H + +LH D+KPQN+L+ E K+ DFGL++ T S V T Y P+
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDV 174
Query: 687 MMN-LKIDAKADVYSYGIVLLELLTGKSA 714
++ + D++ G + +E+L G+ A
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 520 VGKGGFGSVFRGVLDDERV----VAVK--RLEGVLQGDAE-FWAEVSIIGRINHRNLVKL 572
+G+G FGSV G L + VAVK +L+ + E F +E + + +H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 573 QGFCAENEHK------LLVYEYVENGSLDK-LLFNDPGTASI---LQWDQRYNIAVGTAK 622
G C E +++ ++++G L LL++ G LQ ++ V A
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF--MVDIAL 124
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK------LFKERHDTKFSRVR 676
G+ YL +H D+ +N +L + V DFGLSK +++ K V+
Sbjct: 125 GMEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP-VK 180
Query: 677 GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
++A E + + +K+DV+++G+ + E+ T
Sbjct: 181 ----WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 65/199 (32%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLE--GVLQGDAE--FWAEVSIIGR-INHRNLVKLQ 573
+GKG FG V +E+ AVK L+ +L+ E +E +++ + + H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
F + KL V +Y+ G +L ++ L+ R+ A A L YLH
Sbjct: 63 -FSFQTADKLYFVLDYINGG---ELFYHLQRERCFLEPRARF-YAAEIASALGYLHSLN- 116
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI 692
+++ D+KP+NILLD +TDFGL K E H+ S GT YLAPE +
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 693 DAKADVYSYGIVLLELLTG 711
D D + G VL E+L G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 64/198 (32%), Positives = 90/198 (45%), Gaps = 14/198 (7%)
Query: 520 VGKGGFGSVFRGVLD-DERVVAVKRLE--GVLQGDAE--FWAEVSIIGR-INHRNLVKLQ 573
+GKG FG V D AVK L+ +L+ + AE +++ + + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
E V +YV G +L F+ L+ R+ A A + YLH
Sbjct: 63 YSFQTAEKLYFVLDYVNGG---ELFFHLQRERCFLEPRARF-YAAEVASAIGYLHSLN-- 116
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKID 693
+++ D+KP+NILLD +TDFGL K E +T S GT YLAPE + D
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT-STFCGTPEYLAPEVLRKEPYD 174
Query: 694 AKADVYSYGIVLLELLTG 711
D + G VL E+L G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 518 QEVGKGGFGSVFRGVLDDERV----VAVK--RLEGVLQG-DAEFWAEVSIIGRINHRNLV 570
+++G+G +G V++ +RV +A+K RLE +G + E+S++ + H N+V
Sbjct: 8 EKIGEGTYGVVYKA---RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+LQ + LV+EY++ L K + + P A + + Y + +G++Y H
Sbjct: 65 RLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI--LRGIAYCHS- 120
Query: 631 CLEWVLHCDVKPQNILLDDHFEP-KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
VLH D+KPQN+L+D K+ DFGL++ F T F+ T Y APE ++
Sbjct: 121 --HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT-FTHEVVTLWYRAPEILLG 177
Query: 690 LK-IDAKADVYSYGIVLLELLTGK 712
+ D++S G + E++ K
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 36/210 (17%)
Query: 517 KQEVGKGGFGSV----FRG--------VLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI 564
+ +G G FG V +G L ++ +K+++ V Q E SI+ +
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQ-------EKSILMEL 75
Query: 565 NHRNLVK-LQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWD--QRYNIAVGTA 621
+H +V + F EN L+ E+V G L F A D + Y+ + A
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLL-EFVVGGEL----FTHLRKAGRFPNDVAKFYHAELVLA 130
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
YLH + +++ D+KP+N+LLD+ KVTDFG +K +R T + GT Y
Sbjct: 131 --FEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT----LCGTPEY 181
Query: 682 LAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
LAPE + + D ++ G++L E + G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 520 VGKGGFGSVF--RGVLDDERVVAVK-RLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFC 576
VG+G FG + V D++ + RL + E ++ ++ H N+V +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 577 AENEHKLLVYEYVENGSLDKLLFNDPGT----ASILQWDQRYNIAVGTAKGLSYLHEECL 632
+ H +V EY + G L + + G +ILQW V G+ ++HE+
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHEK-- 119
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI 692
VLH D+K +NI L + + K+ DFG ++L + V GT Y+ PE N+
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPY 177
Query: 693 DAKADVYSYGIVLLELLTGK 712
+ K+D++S G +L EL T K
Sbjct: 178 NNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 34/210 (16%)
Query: 520 VGKGGFGSVFRGVLDD-ERVVAVKRL--EGVLQGDAEFWAEVSIIGRI-----NHRNLVK 571
+GKG FG V L + + AVK L + +LQ D R+ H L +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE--KRVLALAGKHPFLTQ 60
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYN------IAVGTAKGLS 625
L + V EYV G L +F+ +Q R++ A GL
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDL---MFH-------IQRSGRFDEPRARFYAAEIVLGLQ 110
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE--RHDTKFSRVRGTRGYLA 683
+LHE +++ D+K N+LLD K+ DFG+ K E S GT Y+A
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIA 164
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLTGKS 713
PE + D ++ G++L E+L G+S
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 55/216 (25%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGV---LDDERV-VAVKRLEGVLQGD--AEFWAEVSII 561
E++R + +G+G FG V++GV ++E++ VAVK + +F E I+
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT- 620
+ +H ++VKL G EN +V E G L S LQ +Y++ + +
Sbjct: 62 RQFDHPHIVKLIGVITENP-VWIVMELAPLGEL----------RSYLQ-VNKYSLDLASL 109
Query: 621 -------AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFS 673
+ L+YL + +H D+ +N+L+ K+ DFGLS+ ++ K S
Sbjct: 110 ILYSYQLSTALAYLESKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS 166
Query: 674 RVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELL 709
+ + ++APE + + + +DV+ +G+ + E+L
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 520 VGKGGFGSV--FRGVLDDERVVAVKRL---EGVLQGD-AEFWAEVSIIGRINHRNLVKLQ 573
+G+G FG V R ++V A+K L E + + D A FW E I+ N +V+L
Sbjct: 51 IGRGAFGEVQLVRHK-SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
++++ +V EY+ G L L+ N +W + Y V A L +H
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE---KWARFYTAEVVLA--LDAIHSMGF- 163
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKID 693
+H DVKP N+LLD K+ DFG + GT Y++PE + + D
Sbjct: 164 --IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 694 A----KADVYSYGIVLLELLTG 711
+ D +S G+ L E+L G
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 17/227 (7%)
Query: 520 VGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGDAEFWAEVSIIGRI-----NHRNLVKLQ 573
+G+G + V L ER+ A+K ++ L D E V + NH LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 574 GFCAENEHKLL-VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
C + E +L V EYV G L +F+ + + R+ + + L+YLHE
Sbjct: 63 S-CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARF-YSAEISLALNYLHER-- 115
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI 692
+++ D+K N+LLD K+TD+G+ K DT S GT Y+APE +
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIAPEILRGEDY 173
Query: 693 DAKADVYSYGIVLLELLTGKSASDYLSASAS-DSSYCNHLVQWVAKQ 738
D ++ G+++ E++ G+S D + +S + D + ++L Q + ++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 520 VGKGGFGSVFRGVLD-DERVVAVKRLEG--VLQGDAEFWAEVSIIGR------INHRNLV 570
+GKG FG VF L + A+K L+ VL D E +++ + H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD---VECTMVEKRVLSLAWEHPFLT 59
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT------AKGL 624
L E+ V EY+ G L +F+ +Q ++++ T GL
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDL---MFH-------IQSCHKFDLPRATFYAAEIICGL 109
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
+LH + +++ D+K NILLD K+ DFG+ K D K GT Y+AP
Sbjct: 110 QFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKE-NMLGDAKTCTFCGTPDYIAP 165
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGKS 713
E ++ K + D +S+G++L E+L G+S
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 24/204 (11%)
Query: 519 EVGKGGFGSVFRGVLD-DERVVAVK--RLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGF 575
++G+G + +V++G + +VA+K RLE EVS++ + H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 576 CAENEHKLLVYEYVENGSLDKLL---FNDPGTASILQWDQRYNIAV---GTAKGLSYLHE 629
+ LV+EY LDK L +D G + + +N+ + +GL+Y H
Sbjct: 73 IHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINM-----HNVKLFLFQLLRGLNYCHR 122
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM- 688
VLH D+KPQN+L+++ E K+ DFGL++ K +S T Y P+ ++
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVVTLWYRPPDILLG 178
Query: 689 NLKIDAKADVYSYGIVLLELLTGK 712
+ + D++ G + E+ TG+
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 520 VGKGGFGSVFRGVLDDERV---VAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKL- 572
VG G +GSV D R+ VAVK+L Q + E+ ++ + H N++ L
Sbjct: 23 VGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 573 ----QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
EN +++ + + L+ ++ + +Q+ + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-----LIYQLLRGLKYIH 135
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM 688
+ +H D+KP N+ +++ E ++ DFGL++ + D + + TR Y APE M+
Sbjct: 136 SAGI---IHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRWYRAPEIML 188
Query: 689 N-LKIDAKADVYSYGIVLLELLTGKS---ASDYL 718
N + + D++S G ++ ELL GK+ +DY+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI 222
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 519 EVGKGGFGSVFRGVLDD---ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG- 574
+VG+G +G V++ D +R A+K++EG E++++ + H N++ LQ
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-GISMSACREIALLRELKHPNVISLQKV 66
Query: 575 FCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK--------GLS 625
F + + K+ L+++Y E+ + F+ A+ + + G K G+
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPVQLPRGMVKSLLYQILDGIH 122
Query: 626 YLHEECLEWVLHCDVKPQNILL----DDHFEPKVTDFGLSKLFKE--RHDTKFSRVRGTR 679
YLH WVLH D+KP NIL+ + K+ D G ++LF + V T
Sbjct: 123 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 680 GYLAPEWMMNLKIDAKA-DVYSYGIVLLELLTGK 712
Y APE ++ + KA D+++ G + ELLT +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 25/203 (12%)
Query: 520 VGKGGFGSVFR-GVLDDERVVAVKRL-EGVLQGDAEF---WAEVSIIGRINHRNLVKLQG 574
+GKG FG V + D +R+ A+K + + + +E AE +++ ++N +V L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 575 FCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVG---TAKGLSYLHEE 630
F ++ KL LV ++ G L F+ LQ + R++++ TA+ L L E
Sbjct: 60 FSFQSPEKLYLVLAFINGGEL----FHH------LQREGRFDLSRARFYTAELLCAL--E 107
Query: 631 CLEW--VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM 688
L V++ D+KP+NILLD + DFGL KL + D + GT YLAPE ++
Sbjct: 108 NLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT-NTFCGTPEYLAPELLL 166
Query: 689 NLKIDAKADVYSYGIVLLELLTG 711
D ++ G++L E+LTG
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 10/143 (6%)
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
GL ++H +V++ D+KP NILLD+H +++D GL+ F ++ K GT GY+
Sbjct: 109 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYM 162
Query: 683 APEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741
APE + + D+ AD +S G +L +LL G S D + + +A ++
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH--KTKDKHEIDRMTLTMAVELPD 220
Query: 742 EGLEKIIDPRLNDVYDREKLDRM 764
++ L + R+ R+
Sbjct: 221 SFSPELRSL-LEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 46/213 (21%)
Query: 520 VGKGGFGSVFRG------------VLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
VG G FG V V+ V+ +K+ + V E ++ ++H
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN-------EKRVLKEVSHP 61
Query: 568 NLVKLQGFCAENEHKLL--VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKG-- 623
+++L F E++ + L + EYV G L S L+ R++ + G
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGEL----------FSYLRNSGRFSNSTGLFYASE 109
Query: 624 ----LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR 679
L YLH + +++ D+KP+NILLD K+TDFG +K ++R T + GT
Sbjct: 110 IVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT----LCGTP 162
Query: 680 GYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
YLAPE + + + D ++ GI++ E+L G
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 10/94 (10%)
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH-DTKFSRVRGTRG 680
+GL Y+H ++H D+KP N+ +++ E K+ DFGL+ RH D + + TR
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRW 182
Query: 681 YLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKS 713
Y APE M+N + + D++S G ++ ELLTG++
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 57/232 (24%), Positives = 111/232 (47%), Gaps = 37/232 (15%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGV---LDDER-----VVAVKRL--EGVLQGDAEFWAE 557
EL R + +G+G FG V +D ++ VAVK L + + ++ +E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 558 VSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLF--NDPGT---------- 604
+ ++ I H+N++ L G C ++ ++ EY G+L + L PG
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 605 ASILQWDQRYNIAVGTAKGLSYL-HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663
L + + A A+G+ YL ++C+ H D+ +N+L+ + K+ DFGL++
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKCI----HRDLAARNVLVTEDNVMKIADFGLAR- 182
Query: 664 FKERHDTKFSRVRGTRG-----YLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
+ H+ + + + T G ++APE + + ++DV+S+G++L E+ T
Sbjct: 183 --DVHNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 510 KRATRNFKQEVGKGGFGSVFRGV---LDDERVVAVKRLEGVLQGDAEFWA-EVSIIGRIN 565
K+ TR +++G+G G+VF + E VA+K++ Q E E+ ++ +
Sbjct: 19 KKYTR--YEKIGQGASGTVFTAIDVATGQE--VAIKQINLQKQPKKELIINEILVMKELK 74
Query: 566 HRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
+ N+V + +V EY+ GSL D T + + Q + + L
Sbjct: 75 NPNIVNFLDSFLVGDELFVVMEYLAGGSL-----TDVVTETCMDEAQIAAVCRECLQALE 129
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGL-SKLFKERHDTKFSRVRGTRGYLAP 684
+LH V+H D+K N+LL K+TDFG +++ E+ +K S + GT ++AP
Sbjct: 130 FLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAP 184
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGK 712
E + K D++S GI+ +E++ G+
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 7/92 (7%)
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
GL ++H +V++ D+KP NILLD+H +++D GL+ F ++ K GT GY+
Sbjct: 109 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYM 162
Query: 683 APEWMMN-LKIDAKADVYSYGIVLLELLTGKS 713
APE + D+ AD +S G +L +LL G S
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE----------FWAEVSIIGRINHRN 568
+G+G FG V+ +D R +A K++ Q D E E+ ++ + H
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQV----QFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 569 LVKLQGFCAENEHKLLV--YEYVENGSL-DKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
+V+ G + K L EY+ GS+ D+L T S+ ++Y + +G+S
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV---TRKYTRQI--LEGMS 120
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE--RHDTKFSRVRGTRGYLA 683
YLH ++H D+K NIL D K+ DFG SK + T V GT +++
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLTGK 712
PE + KADV+S G ++E+LT K
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 520 VGKGGFGSVFRGVLDD-ERVVAVKRL---EGVLQGDAEFWAEVSIIGRINHRNLVKLQGF 575
VG+G +G V + + + +VA+K+ E + E+ ++ + N+V+L+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWV 635
LV+EYVE L+ LL P ++ + K + + H+ +
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPP---EKVRSYIYQLIKAIHWCHKN---DI 121
Query: 636 LHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAK 695
+H D+KP+N+L+ + K+ DFG ++ E + ++ TR Y +PE ++
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 696 ADVYSYGIVLLELLTGK 712
D++S G +L EL G+
Sbjct: 182 VDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 65/238 (27%), Positives = 111/238 (46%), Gaps = 48/238 (20%)
Query: 505 TYAELKRATRNFKQEVGKGGFGSVFRGVLDDERV---VAVKRLEGVLQGD---AEFWAEV 558
T E+ R+ KQ VG G +G+V + D R VA+K+L Q + + E+
Sbjct: 9 TIWEVPDRYRDLKQ-VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYREL 65
Query: 559 SIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFND-----P--GT------- 604
++ + H N++ L + + + SLD+ F+D P GT
Sbjct: 66 RLLKHMKHENVIGL------------LDVFTPDLSLDR--FHDFYLVMPFMGTDLGKLMK 111
Query: 605 ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664
L D+ + KGL Y+H ++H D+KP N+ +++ E K+ DFGL++
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-- 166
Query: 665 KERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKS---ASDYL 718
+ D++ + TR Y APE ++N + D++S G ++ E+LTGK D+L
Sbjct: 167 --QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 510 KRATRNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-EVSIIGRINHR 567
K+ F +++G+G G+V+ + + + VA+K++ Q E E+ ++ H
Sbjct: 18 KKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHP 76
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
N+V + +V EY+ GSL D T + + Q + + L +L
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFL 131
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGL-SKLFKERHDTKFSRVRGTRGYLAPEW 686
H V+H D+K NILL K+TDFG +++ E+ +K S + GT ++APE
Sbjct: 132 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEV 186
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGK 712
+ K D++S GI+ +E++ G+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-09
Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 42/225 (18%)
Query: 520 VGKGGFGSVFRGVLDD---ERVVAVKRLEGVLQGDA----EFWAEVSIIGRINHRNLVKL 572
+GKGG G V+ D R VA+K++ L + F E I + H +V +
Sbjct: 10 IGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQ-RYNIAVGTAKG--LSYLHE 629
C++ + Y+E +L LL S+ Q + +A T+ G LS H+
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLL------KSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 630 EC--LEW-----VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD------------- 669
C +E+ VLH D+KP NILL E + D+G + K +
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 670 ----TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
T ++ GT Y+APE ++ + D+Y+ G++L ++LT
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 26/207 (12%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQG-DAEFWAEVSIIGRINHRNLVKLQ 573
+++G+G +G V++ +VA+K RLE +G + E+S++ +NH N+V+L
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
E+KL LV+E++ + L K + + P T + Y + +G++Y H
Sbjct: 65 DVVHS-ENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQL--LQGIAYCHSH-- 118
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG------TRGYLAPEW 686
VLH D+KPQN+L+D K+ DFGL++ F VR T Y APE
Sbjct: 119 -RVLHRDLKPQNLLIDREGALKLADFGLARAFG-------VPVRTYTHEVVTLWYRAPEI 170
Query: 687 MMNLKIDAKA-DVYSYGIVLLELLTGK 712
++ + + D++S G + E++ +
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 51/153 (33%), Positives = 67/153 (43%), Gaps = 23/153 (15%)
Query: 575 FCA--ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
FC+ H +V EYVE G LL N L D T L YLH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY-- 120
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKL--------FKERHDTKFSR------VRGT 678
++H D+KP N+L+ K+TDFGLSK+ E H K +R V GT
Sbjct: 121 -GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 679 RGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
Y+APE ++ D ++ GI+L E L G
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 557 EVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNI 616
E ++ +NH ++++++ +V + + L L I DQ I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPI---DQALII 162
Query: 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR 676
+GL YLH + ++H DVK +NI ++D + + D G ++ F +
Sbjct: 163 EKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLA 217
Query: 677 GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELL 709
GT APE + K ++KAD++S GIVL E+L
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 20/150 (13%)
Query: 521 GKGGFGSVFRGVLD-DERVVAVK--RLEGVLQGDAEFWA--EVSIIGRINHRNLVKLQGF 575
G+G + +V++G ++VA+K RLE + A F A E S++ + H N+V L
Sbjct: 14 GEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT---AKGLSYLHEECL 632
+ LV+EY++ L + + + G S+ +N+ + +GL+Y H+
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSM------HNVRLFLFQLLRGLAYCHQR-- 122
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662
VLH D+KPQN+L+ + E K+ DFGL++
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQG-DAEFWAEVSIIGRINHRNLVKLQ 573
+++G+G +G V++G ++VA+K RLE +G + E+S++ + H N+V LQ
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASI---LQWDQRYNIAVGTAKGLSYLHEE 630
+ L++E++ L K L + P + L Y I +G+ + H
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCHSR 120
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK-----ERHDTKFSRVRGTRGYLAPE 685
VLH D+KPQN+L+D+ K+ DFGL++ F H+ T Y APE
Sbjct: 121 ---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV------TLWYRAPE 171
Query: 686 WMM-NLKIDAKADVYSYGIVLLELLTGK 712
++ + + D++S G + E+ T K
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 52/208 (25%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 518 QEVGKGGFGSVFRGVLD-DERV--VAVKRLEGVLQGDAE---FWAEVSIIGRINHRNLVK 571
+ +G+G FGSV G L+ D+ + VAVK ++ + +E F +E + +H N+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 572 LQGFCAENEHK------LLVYEYVENGSLDK-LLFNDPG-TASILQWDQRYNIAVGTAKG 623
L G C + +++ ++++G L LL++ G L A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRV-RGTRGYL 682
+ YL + +H D+ +N +L+++ V DFGLSK + R+ + ++
Sbjct: 125 MEYLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLT 710
A E + + K+DV+S+G+ + E+ T
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLE---GVLQGDAEFWA---EVSIIGRINHRNLVKL 572
+G+G FG V+ D R +AVK++ + E A E+ ++ + H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 573 QGFCAENEHKLL--VYEYVENGSL-DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
G + E K L EY+ GS+ D+L T ++ +RY + +G+SYLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV---TRRYTRQI--LQGVSYLHS 124
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE--RHDTKFSRVRGTRGYLAPEWM 687
++H D+K NIL D K+ DFG SK + T V GT +++PE +
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 688 MNLKIDAKADVYSYGIVLLELLTGK 712
KADV+S ++E+LT K
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 19/163 (11%)
Query: 554 FWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQR 613
F+ S++ +++H +L + G C ++V E+VE+G LD L + G + W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPV-AW--K 119
Query: 614 YNIAVGTAKGLSYLHEECLEWVLHCDVKPQNIL-----LDDHFEP--KVTDFGLSKLFKE 666
+A A LSYL ++ L +H +V +NIL L + P K++D G+S
Sbjct: 120 ITVAQQLASALSYLEDKNL---VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 667 RHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLEL 708
R + + R+ ++APE + + AD +S+G LLE+
Sbjct: 177 REE-RVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 515 NFKQEVGKGGFGSVFRGVLDDER---VVAVKRLEGVLQGDAE----FWAEVSIIGRINHR 567
+ K VG+G FG V V+ ++ + A+K ++ + E F E I+ N
Sbjct: 4 DVKSLVGRGHFGEV--QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLL--FNDPGTASILQ-WDQRYNIAVGTAKGL 624
+ +LQ + ++ LV EY G L LL + D + Q + +A+ + +
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS-KLFKERHDTKFSRVRGTRGYLA 683
Y+H D+KP+N+L+D K+ DFG + +L + V GT Y+A
Sbjct: 122 GYVHR---------DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIA 171
Query: 684 PEWMMNLKIDAKA------DVYSYGIVLLELLTGKS 713
PE + + D K D +S G++ E++ G+S
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 62/198 (31%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 520 VGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGR-INHRNLVKLQ 573
+GKG FG V D + AVK L+ + + AE +++ + + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
E V ++V G +L F+ S + R+ A A L YLH
Sbjct: 63 YSFQTTEKLYFVLDFVNGG---ELFFHLQRERSFPEPRARFYAA-EIASALGYLHSIN-- 116
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKID 693
+++ D+KP+NILLD +TDFGL K + DT + GT YLAPE + D
Sbjct: 117 -IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT-TTFCGTPEYLAPEVIRKQPYD 174
Query: 694 AKADVYSYGIVLLELLTG 711
D + G VL E+L G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE----------FWAEVSIIGRINHRN 568
+G+G FG V+ D R +AVK++ Q D E E+ ++ + H
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQV----QFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 569 LVKLQGFCAENEHKLL--VYEYVENGSL-DKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
+V+ G + + L E++ GS+ D+L T ++ ++Y + +G+S
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV---TRKYTRQI--LEGVS 120
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE--RHDTKFSRVRGTRGYLA 683
YLH ++H D+K NIL D K+ DFG SK + T V GT +++
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLTGK 712
PE + KAD++S G ++E+LT K
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
+GL Y+H VLH D+KP N+LL+ + + K+ DFGL++ E+ D V TR Y
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 682 LAPEWMMNL-KIDAKADVYSYGIVLLELLTGK 712
APE ++N + DV+S G + ELL K
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 47/177 (26%), Positives = 88/177 (49%), Gaps = 10/177 (5%)
Query: 537 RVVAVKRLEGVLQGDAEF-WAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLD 595
R VAVK ++ Q E + EV I+ H+N+V++ E ++ E+++ G+L
Sbjct: 47 RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106
Query: 596 KLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKV 655
++ + + L +Q + + L YLH + V+H D+K +ILL K+
Sbjct: 107 DIV-----SQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKL 158
Query: 656 TDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
+DFG + + S V GT ++APE + + D++S GI+++E++ G+
Sbjct: 159 SDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 520 VGKGGFGSVFR-GVLDDERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQG 574
+GKGGFG V V + ++ A K+L+ G+ E I+ ++N +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 575 FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
H LV + G L ++N G L+ ++ + + G+ +LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYN-VGERG-LEMERVIHYSAQITCGILHLHSMD--- 115
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDA 694
+++ D+KP+N+LLDD +++D GL+ K+ ++ GT GY+APE +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI--TQRAGTNGYMAPEILKEEPYSY 173
Query: 695 KADVYSYGIVLLELLTGKS 713
D ++ G + E++ G++
Sbjct: 174 PVDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQGD--AEFWAEVSIIGRINHRNLVKL 572
Q VG G +G V++ L + AVK +LE GD + E+ ++ H N+V
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLE---PGDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
G E + EY GSL + ++ G S LQ + T +GL+YLH +
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQDI-YHVTGPLSELQIAY---VCRETLQGLAYLHSKG- 126
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM---N 689
+H D+K NILL D+ + K+ DFG++ + S + GT ++APE N
Sbjct: 127 --KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKN 183
Query: 690 LKIDAKADVYSYGIVLLEL 708
+ D+++ GI +EL
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 33/80 (41%), Positives = 45/80 (56%), Gaps = 1/80 (1%)
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDA 694
+++ D+K +NILLD +TDFGLSK F + GT Y+APE +
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185
Query: 695 KA-DVYSYGIVLLELLTGKS 713
KA D +S GI++ ELLTG S
Sbjct: 186 KAVDWWSLGILIFELLTGAS 205
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 39/217 (17%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-----EVSIIGRINHRNLVK 571
++G+G FG VF+ +++VA+K++ +++ + E + E+ I+ + H N+V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 572 LQGFC-----AENEHK---LLVYEYVENGSLDKLL------FNDPGTASILQWDQRYNIA 617
L C N +K LV+E+ E+ L LL F +++ N
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMK--MLLN-- 130
Query: 618 VGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG 677
GL Y+H +LH D+K NIL+ K+ DFGL++ F ++K +R
Sbjct: 131 -----GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 678 ---TRGYLAPEWMMNLKIDAKA-DVYSYGIVLLELLT 710
T Y PE ++ + D++ G ++ E+ T
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 35/231 (15%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGV---LDDER-----VVAVKRLE--GVLQGDAEFWAE 557
E R + +G+G FG V R +D R VAVK L+ + A+ +E
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE 67
Query: 558 VSIIGRIN-HRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL-----------FNDPGTA 605
+ ++ I H+N++ L G C + ++ EY G+L + L F+
Sbjct: 68 MELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 606 S-ILQWDQRYNIAVGTAKGLSYLH-EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663
L + + A A+G+ YL C+ H D+ +N+L+ + K+ DFGL++
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRCI----HRDLAARNVLVTEDNVMKIADFGLAR- 182
Query: 664 FKERHD----TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
HD K S R ++APE + + ++DV+S+GI++ E+ T
Sbjct: 183 --GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 518 QEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQ 573
+ +G G G VF V D ++ VAVK++ VL Q E+ II R++H N+VK+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVY 68
Query: 574 GFCAENEHKL--------------LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVG 619
+ L +V EY+E L +L P L +
Sbjct: 69 EVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGP-----LSEEHARLFMYQ 122
Query: 620 TAKGLSYLHEECLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFKERHDTK--FSRVR 676
+GL Y+H VLH D+KP N+ ++ + K+ DFGL+++ + K S
Sbjct: 123 LLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 677 GTRGYLAPEWMMNLKIDAKA-DVYSYGIVLLELLTGK 712
T+ Y +P +++ KA D+++ G + E+LTGK
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 510 KRATRNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR- 567
K+ TR +++G+G G+V+ + + + VA+K++ Q E ++ R N
Sbjct: 19 KKYTRF--EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNP 76
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
N+V + +V EY+ GSL D T + + Q + + L +L
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALDFL 131
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGL-SKLFKERHDTKFSRVRGTRGYLAPEW 686
H V+H D+K NILL K+TDFG +++ E+ +K S + GT ++APE
Sbjct: 132 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEV 186
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGK 712
+ K D++S GI+ +E++ G+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 72/308 (23%), Positives = 124/308 (40%), Gaps = 83/308 (26%)
Query: 520 VGKGGFGSVFRGVL--DDERVVAVKRL---EGVLQGD-AEFWAEVSIIGRINHRNLVKLQ 573
+G+G FG V R V D + A+K+L E + + A AE I+ ++ +VKL
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL- 66
Query: 574 GFCA--ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQ-RYNI-----AVGTAKGLS 625
+ + + + L+ EY+ G + LL ++ R+ I A+ + L
Sbjct: 67 -YYSFQDENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKLG 121
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR--------- 676
Y+H D+KP N+LLD K++DFGL K+ H T+F R+
Sbjct: 122 YIHR---------DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 677 ----------------------------GTRGYLAPEWMMNLKIDAKADVYSYGIVLLEL 708
GT Y+APE + + + D +S G+++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 709 LTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVA 768
L G + S + ++ ++ W +E L+ + L+ E D + +
Sbjct: 233 LVGYPP--FCSDNPQET--YRKIINW------KETLQFPDEVPLSP----EAKDLIKR-- 276
Query: 769 LLCVAENR 776
L C AE R
Sbjct: 277 LCCEAERR 284
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 21/222 (9%)
Query: 520 VGKGGFGSV-FRGVLDDERVVAVK---RLEGVLQGD-AEFWAEVSIIGRINHRNLVKLQG 574
+G+G FG V +V A+K + E + + D A FW E I+ N +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 575 FCAENEHKLLVYEYVENGSLDKLL--FNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
++ + +V EY+ G L L+ ++ P +W + Y V A L +H
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-----KWARFYTAEVVLA--LDAIHSMGF 163
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI 692
+H DVKP N+LLD K+ DFG + + GT Y++PE + +
Sbjct: 164 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 693 DA----KADVYSYGIVLLELLTGKSASDYLSASASDSSYCNH 730
D + D +S G+ L E+L G + S + S NH
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 262
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 510 KRATRNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR- 567
K+ TR +++G+G G+V+ + + + VA++++ Q E ++ R N
Sbjct: 20 KKYTRF--EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
N+V + +V EY+ GSL D T + + Q + + L +L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGL-SKLFKERHDTKFSRVRGTRGYLAPEW 686
H V+H D+K NILL K+TDFG +++ E+ +K S + GT ++APE
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEV 187
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGK 712
+ K D++S GI+ +E++ G+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 29/212 (13%)
Query: 518 QEVGKGGFGSVFRG----VLDDERV----VAVKRLEGVLQGDAE-FWAEVSIIGRINHRN 568
+ +G+G F +F+G V D + V +K L+ + +E F+ S++ +++H++
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
LV G C + ++V EYV+ GSLD L + +I W + +A A L +L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS-W--KLEVAKQLAWALHFLE 117
Query: 629 EECLEWVLHCDVKPQNILL-----DDHFEP---KVTDFGLSKLFKERHDTKFSRVRGTRG 680
++ L H +V +N+LL P K++D G+S + + R+
Sbjct: 118 DKGL---THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-EILLERIP---- 169
Query: 681 YLAPEWMMNLK-IDAKADVYSYGIVLLELLTG 711
++ PE + N + + AD +S+G L E+ +G
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 74/289 (25%), Positives = 124/289 (42%), Gaps = 38/289 (13%)
Query: 518 QEVGKGGFGSVFRGVLDDERVVA---VKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKL 572
QE+G G FG V + + VA VK L+ + EF + + H N+++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDP---GTASILQWDQRYNIAVGTAKGLSYLHE 629
G C E LLV+EY E G L L + + +L QR +A A G++++H+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL-QR--MACEIAAGVTHMHK 117
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS-KLFKERHDTKFSRVRGTRGYLAPEW-- 686
LH D+ +N L KV D+G+ +KE + +LAPE
Sbjct: 118 HNF---LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 687 -----MMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741
++ + ++V++ G+ L EL +A Y + SD NH+++ +Q
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFE-NAAQPY--SHLSDREVLNHVIK------DQ 225
Query: 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790
+ K+ P+L Y +R +V C + + R +V +LLT
Sbjct: 226 Q--VKLFKPQLELPYS----ERWYEVLQFCWL-SPEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 59/236 (25%), Positives = 111/236 (47%), Gaps = 45/236 (19%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGV---LDDER-----VVAVKRLEGVLQGDA------E 553
E+ R + +G+G FG V LD E+ VAVK +L+ DA +
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK----MLKSDATEKDLSD 69
Query: 554 FWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL-----------FN- 600
+E+ ++ I H+N++ L G C ++ ++ EY G+L + L +N
Sbjct: 70 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNP 129
Query: 601 DPGTASILQWDQRYNIAVGTAKGLSYL-HEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659
L + + A A+G+ YL ++C+ H D+ +N+L+ + K+ DFG
Sbjct: 130 TQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFG 185
Query: 660 LSKLFKERHDTKFSRVRGTRG-----YLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
L++ + H + + + T G ++APE + + ++DV+S+G++L E+ T
Sbjct: 186 LAR---DIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 45/225 (20%)
Query: 515 NFK--QEVGKGGFGSVF----RGVLDDERVVAVKRLE--GVLQ--GDAEF-WAEVSIIGR 563
NF+ + +G G +G VF G D ++ A+K L+ ++Q AE E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 564 INHRN--LVKLQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT 620
+ R LV L + + + KL L+ +YV G L L+ QR +
Sbjct: 61 V-RRCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLY------------QREHFTESE 106
Query: 621 AK--------GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF-KERHDTK 671
+ L +LH+ +++ D+K +NILLD +TDFGLSK F E +
Sbjct: 107 VRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163
Query: 672 FSRVRGTRGYLAPEWMMNLKI---DAKADVYSYGIVLLELLTGKS 713
+S GT Y+APE ++ D D +S G++ ELLTG S
Sbjct: 164 YSFC-GTIEYMAPE-VIRGGSGGHDKAVDWWSLGVLTFELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 520 VGKGGFGSVF--RGVL--DDERVVAVKRLEGVL----QGD-AEFWAEVSIIGRINHRNLV 570
+GKGG+G VF R V D ++ A+K L+ Q D A AE +I+ + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 571 KLQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
L + + KL L+ EY+ G L F I D + L +LH+
Sbjct: 64 DLI-YAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLALEHLHQ 118
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR-GTRGYLAPEWMM 688
+ +++ D+KP+NILLD K+TDFGL K + H+ + GT Y+APE +M
Sbjct: 119 Q---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 689 NLKIDAKADVYSYGIVLLELLTG 711
D +S G ++ ++LTG
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 28/92 (30%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL---FKERHDTKFSRVRGT 678
+GL Y+H V+H D+KP N+L+++ E ++ DFG+++ H + T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 679 RGYLAPEWMMNL-KIDAKADVYSYGIVLLELL 709
R Y APE +++L + D++S G + E+L
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 65/242 (26%), Positives = 99/242 (40%), Gaps = 58/242 (23%)
Query: 520 VGKGGFGSV--FRGVLDDERVVAVKRLE--GVLQGD--AEFWAEVSIIGRINHRNLVKLQ 573
+G G FG V R V D + A+K L VL + A AE I+ ++ +VKL
Sbjct: 9 IGIGAFGEVCLVRKV-DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWD-QRYNIAVGTAKGLSYLHEECL 632
+ ++ V +Y+ G + LL I + D R+ IA T + +H+
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTC-AIESVHKMGF 122
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF-------------------- 672
+H D+KP NIL+D K+TDFGL F+ HD+K+
Sbjct: 123 ---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 673 -----------SRVR-----------GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
R R GT Y+APE ++ D +S G++L E+L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239
Query: 711 GK 712
G+
Sbjct: 240 GQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 8e-08
Identities = 42/145 (28%), Positives = 72/145 (49%), Gaps = 9/145 (6%)
Query: 576 CAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
C + +L LV EYV G L +F+ + + R+ A L++LHE
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARF-YAAEICIALNFLHER---G 116
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDA 694
+++ D+K N+LLD K+TD+G+ K DT S GT Y+APE + +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT-STFCGTPNYIAPEILRGEEYGF 175
Query: 695 KADVYSYGIVLLELLTGKSASDYLS 719
D ++ G+++ E++ G+S D ++
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 55/190 (28%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 565 NHRNLVKLQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKG 623
NH LV L C + E +L V E+V G L +F+ + + R+ + +
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARF-YSAEISLA 108
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLA 683
L++LHE +++ D+K N+LLD K+TD+G+ K DT S GT Y+A
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT-STFCGTPNYIA 164
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSAS-ASDSSYCNHLVQWVAKQMEQE 742
PE + D ++ G+++ E++ G+S D + S D + ++L Q +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI------- 217
Query: 743 GLEKIID-PR 751
LEK I PR
Sbjct: 218 -LEKQIRIPR 226
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 518 QEVGKGGFGSVFRGVLD---DERVVAVKRLE--GVLQGDAEFWAEVSIIGRINHRNLVKL 572
+E+G G FG V G ++ V VK L +Q +F E + H NL++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQR--YNIAVGTAKGLSYLHEE 630
G C E LLV E+ G L L A ++ D +A A GL +LH+
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL-FKERH----DTKFSRVRGTRGYLAPE 685
+H D+ +N LL K+ D+GLS +KE + D + +R L E
Sbjct: 120 NF---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 686 WMMNLKI---DAKADVYSYGIVLLELL 709
NL + +++V+S G+ + EL
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 48/225 (21%)
Query: 515 NFKQEVGKGGFGSVF----RGVLDDERVVAVKRLEG--VLQGDAEFWAEVSIIGRINHRN 568
NF +GKG FG V +G + + A+K L+ ++Q D E +++ +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVIIQDDD---VECTMV----EKR 52
Query: 569 LVKLQG---------FCAENEHKL-LVYEYVENGSLDKLL-----FNDPGTASILQWDQR 613
++ L G C + +L V EYV G L + F +P
Sbjct: 53 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY------ 106
Query: 614 YNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK--LFKERHDTK 671
A A GL +LH + +++ D+K N++LD K+ DFG+ K +F +
Sbjct: 107 ---AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160
Query: 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASD 716
F GT Y+APE + D +++G++L E+L G+ D
Sbjct: 161 FC---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 520 VGKGGFGSVFRGVLD--DERVVAVKRL--EGVLQGDAEFWAEVSII-GRI-----NHRNL 569
+GKG FG V L DE V A+K L + +LQ D + ++ RI H L
Sbjct: 3 LGKGSFGKVMLAELKGTDE-VYAIKVLKKDVILQDDD---VDCTMTEKRILALAAKHPFL 58
Query: 570 VKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
L + V EYV G L +F + + R+ A T L +LH
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTL-ALMFLHR 114
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK--LFKERHDTKFSRVRGTRGYLAPEWM 687
V++ D+K NILLD K+ DFG+ K + T F GT Y+APE +
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC---GTPDYIAPEIL 168
Query: 688 MNLKIDAKADVYSYGIVLLELLTGK 712
L+ D ++ G+++ E++ G+
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 44/175 (25%), Positives = 70/175 (40%), Gaps = 32/175 (18%)
Query: 557 EVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL-----DKLLFNDPGTASILQWD 611
E+ I+ I H N++ L E + LV + + L K+ + IL
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCIL--- 125
Query: 612 QRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK------LFK 665
+ GL+ LH+ + +H D+ P NI ++ K+ DFGL++
Sbjct: 126 ------LQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 666 ERHDTKFSRVRG-------TRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGK 712
+ + R T Y APE +M K D++S G + ELLTGK
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 518 QEVGKGGFGSVFRGVL-DDERVVAVKRLEG--VLQGDAEFWAEVSII-GRI-----NHRN 568
+ +GKG FG V L + R+ AVK L+ +LQ D E ++ RI NH
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDD---VECTMTEKRILSLARNHPF 57
Query: 569 LVKLQGFCAENEHKLL-VYEYVENGSLDKLLFNDPGTASILQWDQRYN------IAVGTA 621
L +L C + +L V E+V G L +F+ +Q +R++ A
Sbjct: 58 LTQLY-CCFQTPDRLFFVMEFVNGGDL---MFH-------IQKSRRFDEARARFYAAEIT 106
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF-SRVRGTRG 680
L +LH++ +++ D+K N+LLD K+ DFG+ K + + K S GT
Sbjct: 107 SALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPD 161
Query: 681 YLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
Y+APE + + D ++ G++L E+L G
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-07
Identities = 22/63 (34%), Positives = 32/63 (50%), Gaps = 4/63 (6%)
Query: 253 RLTLDYDGILRLYSFDESTRLWKISW-LPAGLDYCTVHGLCGPNGICVNRPRQKTCICPN 311
RLTL +G L +++ +++ W + W P D C V+G CGP G C + C C
Sbjct: 48 RLTLSSEGSLERFTWIPNSQDWNLFWSAPK--DQCDVYGRCGPYGYC-DVNTSPKCNCIK 104
Query: 312 GFR 314
GF
Sbjct: 105 GFV 107
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 53/228 (23%), Positives = 108/228 (47%), Gaps = 29/228 (12%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGV---LDDER-----VVAVKRL-EGVLQGD-AEFWAE 557
E R + +G+G FG V +D ++ VAVK L + + D ++ +E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 558 VSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLF--NDPG----------T 604
+ ++ I H+N++ L G C ++ ++ EY G+L + L PG
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 605 ASILQWDQRYNIAVGTAKGLSYL-HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK- 662
+ + + A+G+ YL ++C+ H D+ +N+L+ ++ K+ DFGL++
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARD 186
Query: 663 LFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
+ + K + R ++APE + + ++DV+S+G+++ E+ T
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 31/81 (38%), Positives = 46/81 (56%), Gaps = 2/81 (2%)
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI-- 692
+++ D+K +NILLD + +TDFGLSK F E + GT Y+AP+ +
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH 185
Query: 693 DAKADVYSYGIVLLELLTGKS 713
D D +S G+++ ELLTG S
Sbjct: 186 DKAVDWWSMGVLMYELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 19/163 (11%)
Query: 554 FWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQR 613
F+ S++ +++H+++V L G C + ++V E+VE G LD L + W +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD-LFMHRKSDVLTTPW--K 107
Query: 614 YNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL-----DDHFEP--KVTDFGLSKLFKE 666
+ +A A LSYL ++ L +H +V +NILL D P K++D G+
Sbjct: 108 FKVAKQLASALSYLEDKDL---VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS 164
Query: 667 RHDTKFSRVRGTRGYLAPEWMMNLK-IDAKADVYSYGIVLLEL 708
R + R+ ++APE + + K + AD +S+G L E+
Sbjct: 165 RQE-CVERIP----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 37/210 (17%)
Query: 520 VGKGGFGSVFRGVLDDE----RVVAVKRL--EGVLQGD--AEFWAEVSIIGRINHRNLVK 571
+GKG FG V +L E + A+K L E ++ D A E ++ H L
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 572 LQGFCAENEHKLLVYEYVENGSL-----DKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
L+ ++ V EY G L + +F++ + Y + +A L Y
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RFYGAEIVSA--LGY 110
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR----GTRGYL 682
LH V++ D+K +N++LD K+TDFGL K GT YL
Sbjct: 111 LHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYL 162
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGK 712
APE + + D + G+V+ E++ G+
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
+GL YLH +LH D+KP N+L++ + K+ DFGL+++ + ++ T+ Y
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 682 LAPEWMMNLK-IDAKADVYSYGIVLLELLTGK 712
APE +M + + D++S G + ELL +
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 53/189 (28%), Positives = 79/189 (41%), Gaps = 34/189 (17%)
Query: 532 VLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591
+L+DER A R +E+ + +H +VK ++ LL+ EY
Sbjct: 102 MLNDERQAAYAR------------SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149
Query: 592 GSLDK---------LLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKP 642
G L+K L F + + Y I + L +H + +H D+K
Sbjct: 150 GDLNKQIKQRLKEHLPFQEYEVGLLF-----YQIVLA----LDEVHSRKM---MHRDLKS 197
Query: 643 QNILLDDHFEPKVTDFGLSKLFKERHDTKF-SRVRGTRGYLAPEWMMNLKIDAKADVYSY 701
NI L K+ DFG SK + + S GT YLAPE + KAD++S
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSL 257
Query: 702 GIVLLELLT 710
G++L ELLT
Sbjct: 258 GVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 63/234 (26%), Positives = 93/234 (39%), Gaps = 58/234 (24%)
Query: 521 GKGGFGSVF----RG--------VLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN 568
GKG G VF +G VLD + ++ +++ VL E I+ ++H
Sbjct: 10 GKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL-------TEQEILATLDHPF 62
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQ-RYNIAVGTAKGLSYL 627
L L + LV +Y G L +LL PG L + R+ A L YL
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLL-ALEYL 119
Query: 628 HEECLEWVLHCDVKPQNILL--DDHFEPKVTDFGLSKL------FKERHDTKFSRVR--- 676
H L +++ D+KP+NILL H ++DF LSK + K SR
Sbjct: 120 H---LLGIVYRDLKPENILLHESGHI--MLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 677 -------------------GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
GT Y+APE + + D ++ GI+L E+L G
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL-FKERHDTKF-SRVRGTR 679
+ L Y+H V H D+KP+NIL + + K+ DFGL+++ F + F + TR
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 680 GYLAPEWMMNL--KIDAKADVYSYGIVLLELLTGK 712
Y APE + K D++S G + E+LTGK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 30/208 (14%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGF--- 575
+G G FG V+ + +D VA+K+ VLQ E+ I+ +NH N++ L+ +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKK---VLQDPQYKNRELLIMKNLNHINIIFLKDYYYT 130
Query: 576 --CAENEHKL---LVYEYVENGSLDKLLF---NDPGTASILQWDQRYNIAVGTAKGLSYL 627
+NE + +V E++ + N+ L Y + + L+Y+
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC----RALAYI 186
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEP-KVTDFGLSK--LFKERHDTKFSRVRGTRGYLAP 684
H + ++ H D+KPQN+L+D + K+ DFG +K L +R + +R Y AP
Sbjct: 187 HSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC----SRFYRAP 239
Query: 685 EWMM-NLKIDAKADVYSYGIVLLELLTG 711
E M+ D++S G ++ E++ G
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 520 VGKGGFGSVFRGVLDDE----RVVAVKRLEGVLQGDA---EFWAEVSIIGRINHRNLVKL 572
+GKG FGSV L E + VAVK L+ + + EF E + + +H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 573 QGFCAENEHK------LLVYEYVENGSLDKLLF-----NDPGTASILQWDQRYNIAVGTA 621
G + K +++ ++++G L L +P T LQ R+ I + A
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLP-LQTLVRFMIDI--A 123
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS-KLFKERHDTKFSRVRGTRG 680
G+ YL + +H D+ +N +L+++ V DFGLS K++ + + +
Sbjct: 124 SGMEYLSSKNF---IHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 681 YLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
+LA E + + +DV+++G+ + E++T
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 32/83 (38%), Positives = 44/83 (53%), Gaps = 1/83 (1%)
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR-GTRGYLAPEWMMNLKID 693
++H D+K NILL + K+ DFG SK++ R GT Y+APE
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 694 AKADVYSYGIVLLELLTGKSASD 716
KAD++S G++L ELLT K D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-06
Identities = 48/206 (23%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQ 573
+ ++ + G S +G ER++A KR++ + + E+ +GR+NH N++K++
Sbjct: 171 ASTEEAEARRGVNSTNQGKPKCERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIE 229
Query: 574 --------GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
+ ++ +Y ++ + + D + D L R I +
Sbjct: 230 EILRSEANTYMITQKYDFDLYSFMYDEAFD---WKD----RPLLKQTR-AIMKQLLCAVE 281
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF-KERHDTKFSRVRGTRGYLAP 684
Y+H++ L +H D+K +NI L+ + + DFG + F KER + V GT +P
Sbjct: 282 YIHDKKL---IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV-GTVATNSP 337
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLT 710
E + D++S G++LL++L+
Sbjct: 338 EILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 48/232 (20%)
Query: 520 VGKGGFGSVFRGVL--DDERVVAVK--RLEGVLQGD--AEFWAEVSIIGRINHRNLVKLQ 573
+G+G FG V R V D + A+K R +L+ + A AE I+ + +VK+
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
+ + L+ E++ G + LL ++ + ++ IA T + +H+
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKD---TLSEEATQFYIA-ETVLAIDAIHQLGF- 122
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR------------------- 674
+H D+KP N+LLD K++DFGL K+ H T+F R
Sbjct: 123 --IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 675 ---------------VRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
GT Y+APE M + D +S G+++ E+L G
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 505 TYAELKRATRNFKQEVGKGGFGSV---FRGVLDDERVVAVKRLEGVLQGDAEF---WAEV 558
T+ LKR +N K +G G G V + +L ER VA+K+L Q + E+
Sbjct: 19 TFTVLKR-YQNLK-PIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYREL 74
Query: 559 SIIGRINHRNLVKL------QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQ 612
++ +NH+N++ L Q E + +V E + D ++Q +
Sbjct: 75 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----------DANLCQVIQMEL 123
Query: 613 RYN----IAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668
+ + G+ +LH ++H D+KP NI++ K+ DFGL++
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
V TR Y APE ++ + D++S G ++ E++ G
Sbjct: 181 MMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 73/303 (24%), Positives = 117/303 (38%), Gaps = 55/303 (18%)
Query: 515 NFKQEVGKGGFGSVF---RGVLDDERVVAVKRLEGVLQGDAE--FWAEVSIIGRINHRNL 569
NF +GKG FG V R D+ + + + + V+Q D E ++ +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62
Query: 570 VKLQGFCAENEHKL-LVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGTAKG 623
+ C + +L V EYV G L + F +P Q A + G
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP---------QAVFYAAEISVG 113
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR-GTRGYL 682
L +LH +++ D+K N++LD K+ DFG+ K + D +R GT Y+
Sbjct: 114 LFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYI 168
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742
APE + D ++YG++L E+L G+ D S H V + K + +E
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY-PKSLSKE 227
Query: 743 -------------------GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMS 783
G E D R + + R D++ ENR+ +PP
Sbjct: 228 AVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKL---------ENREIQPPFK 278
Query: 784 KVV 786
V
Sbjct: 279 PKV 281
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|238533 cd01100, APPLE_Factor_XI_like, Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-06
Identities = 18/53 (33%), Positives = 26/53 (49%), Gaps = 2/53 (3%)
Query: 340 FMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCKGFGYSTDGQGECFPKG 392
F + N D+ G DL T S ++C+ C +D C F Y+T +CF K
Sbjct: 6 FRQGSNVDFRGGDLST-VFASSAEQCQAACTADPGCLAFTYNTK-SKKCFLKS 56
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 73 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 40/226 (17%)
Query: 505 TYAELKRATRNFKQEVGKGGFGSV---FRGVLDDERVVAVKRLEGVLQGDA---EFWAEV 558
T+ LKR +N K +G G G V + VLD R VA+K+L Q + E+
Sbjct: 12 TFTVLKR-YQNLK-PIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 559 SIIGRINHRNLVKL------QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQ 612
++ +NH+N++ L Q E + LV E + D ++Q +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----------DANLCQVIQMEL 116
Query: 613 RYN----IAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668
+ + G+ +LH ++H D+KP NI++ K+ DFGL++
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR----TA 169
Query: 669 DTKF--SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
T F + TR Y APE ++ + D++S G ++ E++ K
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 48/232 (20%)
Query: 520 VGKGGFGSVFRGVL--DDERVVAVK--RLEGVLQGD--AEFWAEVSIIGRINHRNLVKLQ 573
+G+G FG V R V D V A+K R +L+ + AE I+ + +VK+
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
+ + L+ E++ G + LL ++ + + ++ IA T + +H+
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKD---TLTEEETQFYIA-ETVLAIDSIHQLGF- 122
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR------------------- 674
+H D+KP N+LLD K++DFGL K+ H T+F R
Sbjct: 123 --IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 675 ---------------VRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
GT Y+APE M + D +S G+++ E+L G
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 55/211 (26%), Positives = 82/211 (38%), Gaps = 37/211 (17%)
Query: 521 GKGGFGSV----FRG--------VLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN 568
G+G FG V ++ L ++A +E ++ F H
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIF----ETANSERHPF 63
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSL----DKLLFNDPGTASILQWDQRYNIAVGTAKGL 624
LV L +H V EY G L +F++P Y V GL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA-------VFYAACV--VLGL 114
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER--HDTKFSRVRGTRGYL 682
YLHE +++ D+K N+LLD K+ DFGL KE + S GT +L
Sbjct: 115 QYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFL 168
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGKS 713
APE + D + G+++ E+L G+S
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 40/150 (26%), Positives = 62/150 (41%), Gaps = 15/150 (10%)
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLL--FNDPGTASILQWDQRYNIAVGTAKGLS 625
N+V L + + LV ++ E G L + F + + +W +A L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------LD 99
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPE 685
LH E ++ D+ P NILLDD ++T F ++ D + Y APE
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV----ENMYCAPE 152
Query: 686 WMMNLKIDAKADVYSYGIVLLELLTGKSAS 715
+ D +S G +L ELLTGK+
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK--LFKERHDTKFSRVRGTRGY 681
L +LH+ +++ D+KP+NILLD + DFGLSK L + F GT Y
Sbjct: 109 LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEY 162
Query: 682 LAPEWMMNLKIDAK-ADVYSYGIVLLELLTGKS 713
LAPE +++ K K D +S G+++ E+ G S
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWS 195
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 18/201 (8%)
Query: 520 VGKGGFGSVFRGVLDDERVV----AVKRL--EGVLQGD--AEFWAEVSIIGRINHRNLVK 571
+GKG FG V +L E+ A+K L E ++ D A E ++ H L
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
L+ ++ V EY G L F + D+ L YLH E
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSALDYLHSE- 114
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK 691
+ V++ D+K +N++LD K+TDFGL K + T GT YLAPE + +
Sbjct: 115 -KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKTFCGTPEYLAPEVLEDND 172
Query: 692 IDAKADVYSYGIVLLELLTGK 712
D + G+V+ E++ G+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQG-DAEFWAEVSIIGRINHRN-LVKL 572
+++G+G +G V++ + ++VA+K RLE +G E+S++ ++ +V+L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 573 QGFCAEN-EHKL------LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
E+ E K LV+EY+++ + N G L + KG++
Sbjct: 67 --LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEP-KVTDFGLSKLF-----KERHDTKFSRVRGTR 679
+ H+ V+H D+KPQN+L+D K+ D GL + F H+ T
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV------TL 175
Query: 680 GYLAPEWMMNLK-IDAKADVYSYGIVLLELLTG 711
Y APE ++ D++S G + E+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 7e-06
Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 25/155 (16%)
Query: 565 NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGL 624
++ N +KL + +L+ +Y+++G L LL + L + I + L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEAL 122
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVT--DFGLSKLFKERHDTKFSRVRGTRGYL 682
+ LH+ ++H D+K +N+L D + ++ D+GL K T S GT Y
Sbjct: 123 NDLHK---HNIIHNDIKLENVLYDR-AKDRIYLCDYGLCK----IIGTP-SCYDGTLDYF 173
Query: 683 APEWMMNLKI-----DAKADVYSYGIVLLELLTGK 712
+PE KI D D ++ G++ ELLTGK
Sbjct: 174 SPE-----KIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 23/203 (11%)
Query: 520 VGKGGFGSVFRGVLDDERV------VAVKRLEGVLQGD--AEFWAEVSIIGRINHRNLVK 571
+GKG FG V +L E+ + + R E ++ D A E ++ H L
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
L+ ++ V EY G L F + ++ L YLH
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSK--LFKERHDTKFSRVRGTRGYLAPEWMMN 689
V++ D+K +N++LD K+TDFGL K + F GT YLAPE + +
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEVLED 169
Query: 690 LKIDAKADVYSYGIVLLELLTGK 712
D + G+V+ E++ G+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 61/246 (24%), Positives = 100/246 (40%), Gaps = 58/246 (23%)
Query: 518 QEVGKGGFGSV-FRGVLDDERVVAVK--RLEGVLQGD--AEFWAEVSIIGRINHRNLVKL 572
+ +G G FG V +D + A+K R + VL + A AE I+ ++ +VKL
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
+ ++ V +Y+ G + LL +L R+ IA T + +H+
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA---RFYIAELTL-AIESVHKMGF 122
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF----SRVR------------ 676
+H D+KP NIL+D K+TDFGL F+ H++K+ S +R
Sbjct: 123 ---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 677 ------------------------------GTRGYLAPEWMMNLKIDAKADVYSYGIVLL 706
GT Y+APE ++ D +S G++L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 707 ELLTGK 712
E+L G+
Sbjct: 240 EMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 32/221 (14%)
Query: 505 TYAELKRATRNFKQEVGKGGFG---SVFRGVLDDERVVAVKRLEGVLQGDA---EFWAEV 558
T+ LKR + + +G G G + F VL VAVK+L Q + E+
Sbjct: 16 TFTVLKRYQQ--LKPIGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYREL 71
Query: 559 SIIGRINHRNLVKL------QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQ 612
++ +NH+N++ L Q E + LV E ++ +L +++ + L ++
Sbjct: 72 VLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHME------LDHER 124
Query: 613 RYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672
+ G+ +LH ++H D+KP NI++ K+ DFGL++ T F
Sbjct: 125 MSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR----TACTNF 177
Query: 673 --SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
+ TR Y APE ++ + D++S G ++ EL+ G
Sbjct: 178 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 52/201 (25%), Positives = 82/201 (40%), Gaps = 19/201 (9%)
Query: 520 VGKGGFGSVFRGVLDDERV------VAVKRLEGVLQGD--AEFWAEVSIIGRINHRNLVK 571
+GKG FG V +L E+ + + + E ++ D A E ++ H L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
L+ + V EYV G L F + D+ L YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL----FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG- 114
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK 691
+++ D+K +N++LD K+TDFGL K T GT YLAPE + +
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT-MKTFCGTPEYLAPEVLEDND 171
Query: 692 IDAKADVYSYGIVLLELLTGK 712
D + G+V+ E++ G+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|238010 cd00053, EGF, Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-05
Identities = 11/31 (35%), Positives = 14/31 (45%)
Query: 286 CTVHGLCGPNGICVNRPRQKTCICPNGFRRN 316
C C G CVN P C+CP G+ +
Sbjct: 2 CAASNPCSNGGTCVNTPGSYRCVCPPGYTGD 32
|
Length = 36 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 44/205 (21%), Positives = 86/205 (41%), Gaps = 33/205 (16%)
Query: 521 GKGGFGSVFRG-VLDDERVVAVKRLEGVLQGDAEF--WAEVSIIGRIN-HRNLVKLQGFC 576
G+G F V + + A+K ++ + + E+ + R++ H N+++L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVL 67
Query: 577 AENEHKLL----------VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
+ + L +YE ++ K + S + Y + K L +
Sbjct: 68 FDRKTGRLALVFELMDMNLYELIKG---RKRPLPEKRVKSYM-----YQLL----KSLDH 115
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
+H + H D+KP+NIL+ D K+ DFG + + ++ TR Y APE
Sbjct: 116 MHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP--PYTEYISTRWYRAPEC 169
Query: 687 MM-NLKIDAKADVYSYGIVLLELLT 710
++ + K D+++ G V E+L+
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEF---WAEVSIIGRINHRNLVKLQ 573
Q +G G +G V++ ++ + A+K ++ L+ +F E+ ++ H N+V
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
G + + E+ GSL + ++ G S Q ++ T +GL YLH +
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDI-YHVTGPLSESQIAY---VSRETLQGLYYLHSK--- 125
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK-- 691
+H D+K NILL D+ K+ DFG+S + S + GT ++APE +
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKG 184
Query: 692 -IDAKADVYSYGIVLLEL 708
+ D+++ GI +EL
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-05
Identities = 21/62 (33%), Positives = 29/62 (46%), Gaps = 7/62 (11%)
Query: 338 LDFMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCKGFGYS-TDGQGECFPK-GNLL 395
L M+LP+T D I L+EC RCLS+C C + Y+ G C G L+
Sbjct: 10 LPNMKLPDTTAAIVDR-----SIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWTGELV 64
Query: 396 NG 397
+
Sbjct: 65 DM 66
|
Length = 66 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 557 EVSIIGRINHRNLVKL-QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYN 615
E+ I+ I+HR ++ L + ++ +++ +Y + LF + L +Q
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD------LFTYVDRSGPLPLEQAIT 189
Query: 616 IAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT-KFSR 674
I + L+YLH ++H DVK +NI LD+ + DFG + DT +
Sbjct: 190 IQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 675 VRGTRGYLAPEWMMNLKID---AKADVYSYGIVLLELL 709
GT +PE L +D AK D++S G+VL E+
Sbjct: 247 WSGTLETNSPEL---LALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 32/113 (28%), Positives = 61/113 (53%), Gaps = 8/113 (7%)
Query: 621 AKGLSYL-HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK-LFKERHDTKFSRVRGT 678
A+G+ +L +C+ H D+ +NILL ++ K+ DFGL++ ++K+ + R
Sbjct: 183 ARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 679 RGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHL 731
++APE + + ++DV+S+G++L E+ + AS Y D +C L
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-LGASPYPGVQI-DEEFCRRL 289
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 61/247 (24%), Positives = 101/247 (40%), Gaps = 60/247 (24%)
Query: 518 QEVGKGGFGSV-FRGVLDDERVVAVK--RLEGVLQGD--AEFWAEVSIIGRINHRNLVKL 572
+ +G G FG V +D + + A+K R + VL + A AE I+ ++ +V+L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWD-QRYNIAVGTAKGLSYLHEEC 631
+ ++ V +Y+ G + LL I D R+ IA T + +H+
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTC-AVESVHKMG 121
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF------------------- 672
+H D+KP NIL+D K+TDFGL F+ HD+K+
Sbjct: 122 F---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 673 --------SRVR-------------------GTRGYLAPEWMMNLKIDAKADVYSYGIVL 705
R++ GT Y+APE ++ D +S G++L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 706 LELLTGK 712
E+L G+
Sbjct: 239 YEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|222657 pfam14295, PAN_4, PAN domain | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 3e-05
Identities = 15/48 (31%), Positives = 22/48 (45%), Gaps = 2/48 (4%)
Query: 346 TDYYGYDLVTYGI-GISLQECRNRCLSDCKCKGFGYSTDGQ-GECFPK 391
TDY G DL + + S + C C +D C+ + Y G C+ K
Sbjct: 1 TDYPGGDLRSGPVSVDSPEACCAACAADSGCRAWTYVDPASGGTCWLK 48
|
Length = 48 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 61/250 (24%), Positives = 104/250 (41%), Gaps = 43/250 (17%)
Query: 515 NFKQEVGKGGFGSVF---RGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVK 571
NF +GKG FG V R D+ + + + + V+Q D E +++ + ++
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD---VECTMV----EKRVLA 55
Query: 572 LQG---------FCAENEHKL-LVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNI 616
L G C + +L V EYV G L + F +P
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY--------- 106
Query: 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK--LFKERHDTKFSR 674
A A GL +LH + +++ D+K N++LD K+ DFG+ K ++ F
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC- 162
Query: 675 VRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW 734
GT Y+APE + D +++G++L E+L G++ + S H V +
Sbjct: 163 --GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 220
Query: 735 VAKQMEQEGL 744
K M +E +
Sbjct: 221 -PKSMSKEAV 229
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 520 VGKGGFGSVFRGVLDD-ERVVAVKRL---EGVLQGD-AEFWAEVSIIGRINHRNLVKLQG 574
+G+G FG V L + ++V A+K L E + + + A F E ++ +++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 575 FCAENEHKLLVYEYVENGSLDKLL--FNDPGTASILQ-WDQRYNIAVGTAKGLSYLHEEC 631
+ + LV +Y G L LL F D + + + IA+ + L Y+H
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR-- 126
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK 691
D+KP NIL+D + ++ DFG E + S GT Y++PE + ++
Sbjct: 127 -------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 692 IDAKA------DVYSYGIVLLELLTGKS 713
D K D +S G+ + E+L G++
Sbjct: 180 -DGKGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 33/113 (29%), Positives = 61/113 (53%), Gaps = 8/113 (7%)
Query: 621 AKGLSYL-HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK-LFKERHDTKFSRVRGT 678
AKG+ +L +C+ H D+ +NILL ++ K+ DFGL++ ++K+ + R
Sbjct: 189 AKGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 679 RGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHL 731
++APE + + ++DV+S+G++L E+ + AS Y D +C L
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKI-DEEFCRRL 295
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|238011 cd00054, EGF_CA, Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 6e-05
Identities = 11/31 (35%), Positives = 12/31 (38%)
Query: 284 DYCTVHGLCGPNGICVNRPRQKTCICPNGFR 314
D C C G CVN C CP G+
Sbjct: 3 DECASGNPCQNGGTCVNTVGSYRCSCPPGYT 33
|
Many of these proteins require calcium for their biological function and calcium-binding sites have been found to be located at the N-terminus of particular EGF-like domains; calcium-binding may be crucial for numerous protein-protein interactions. Six conserved core cysteines form three disulfide bridges as in non calcium-binding EGF domains, whose structures are very similar. EGF_CA can be found in tandem repeat arrangements. Length = 38 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 26/165 (15%)
Query: 520 VGKGGFGSVFRGV--LDDERVVAVKRL--EGVLQGD--AEFWAEVSIIGRINHRNLVKLQ 573
+GKG FG V R V D ++ A+K L + + D A AE ++ + +V L
Sbjct: 9 IGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFN-DPGTASILQWDQRYNIA-----VGTAKGLSYL 627
+ ++ L+ E++ G L +L D + + R+ +A + L ++
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAVHKLGFI 123
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672
H D+KP NIL+D K++DFGLS F ++HD+ +
Sbjct: 124 HR---------DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 41/165 (24%), Positives = 68/165 (41%), Gaps = 22/165 (13%)
Query: 557 EVSIIGRINHRNLVKLQGFCAENEHKL----LVYEYVENGSLDKLLFNDPGTASILQWDQ 612
E+ + RI+ N++K+ GF + L L+ EY G L ++L + L +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LSFKT 123
Query: 613 RYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF---EPKVTDFGLSKLFKERHD 669
+ ++A+ KGL L++ KP L F E L K
Sbjct: 124 KLDMAIDCCKGLYNLYKY--------TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175
Query: 670 TKFSRVRGTRGYLAPEWMMNL--KIDAKADVYSYGIVLLELLTGK 712
F V Y + + + ++ + K D+YS G+VL E+ TGK
Sbjct: 176 PPFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
G+ +LH ++H D+KP NI++ K+ DFGL++ + TR Y
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 184
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGK 712
APE ++ + D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|214542 smart00179, EGF_CA, Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 2e-04
Identities = 11/31 (35%), Positives = 12/31 (38%)
Query: 284 DYCTVHGLCGPNGICVNRPRQKTCICPNGFR 314
D C C G CVN C CP G+
Sbjct: 3 DECASGNPCQNGGTCVNTVGSYRCECPPGYT 33
|
Length = 39 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 24/111 (21%)
Query: 618 VGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-----------HFEP-----KVTDFGLS 661
G A L Y H E ++H D+KP+NIL++ P ++ D G
Sbjct: 240 TGVA--LDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-- 293
Query: 662 KLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
ERH + + TR Y +PE ++ L D++S G ++ EL TGK
Sbjct: 294 GCCDERHSR--TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 33/95 (34%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 621 AKGLSYL-HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR 679
AKG+S+L + C+ H D+ +NILL K+ DFGL++ R+D+ + V+G
Sbjct: 224 AKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDI--RNDSNYV-VKGNA 276
Query: 680 ----GYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
++APE + N ++DV+SYGI+L E+ +
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 39/271 (14%)
Query: 520 VGKGGFGSV-FRGVLDDERVVAVKRL---EGVLQGD-AEFWAEVSIIGRINHRNLVKLQG 574
+G+G FG V + ER+ A+K L E + + + A F E +++ + + + L
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 575 FCAENEHKLLVYEYVENGSLDKLL--FNDPGTASILQ-WDQRYNIAVGTAKGLSYLHEEC 631
+ + LV +Y G L LL F D + + + +A+ + L Y+H
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHR-- 126
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL- 690
D+KP N+LLD + ++ DFG + + S GT Y++PE + +
Sbjct: 127 -------DIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 691 ----KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746
K + D +S G+ + E+L G++ Y LV+ K M E E+
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGET-----------PFYAESLVETYGKIMNHE--ER 226
Query: 747 IIDP-RLNDVYDREKLDRMVKVALLCVAENR 776
P + DV + K D + + L+C E R
Sbjct: 227 FQFPSHITDVSEEAK-DLIQR--LICSRERR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 33/99 (33%), Positives = 57/99 (57%), Gaps = 13/99 (13%)
Query: 621 AKGLSYL-HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR 679
A+G+ +L + C+ H DV +N+LL D K+ DFGL++ +D+ + V+G
Sbjct: 222 AQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIM--NDSNYV-VKGNA 274
Query: 680 ----GYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKS 713
++APE + + ++DV+SYGI+L E+ + GKS
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 26/92 (28%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 621 AKGLSYL-HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK-LFKERHDTKFSRVRGT 678
A+G+ +L +C+ H D+ +NILL ++ K+ DFGL++ ++K+ + R
Sbjct: 184 ARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 679 RGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
++APE + + ++DV+S+G++L E+ +
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 3e-04
Identities = 18/52 (34%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 336 NELDFMELPNTDYYGYDLVTYGIGISLQECRNRCL-SDCKCKGFGYSTDGQG 386
++ F+ LPNT G+ + SL+EC ++CL S+C C+ F Y+ +G
Sbjct: 2 SDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNNGTKG 52
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 3e-04
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVL------------QGDAEFWAEVSIIGRIN 565
+++G G FG VF +V KR + + ++ EV+++ +
Sbjct: 19 KKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 566 HRNLVK-LQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKG 623
H+N+V+ + F + KL ++ E+ + G L + + ++ +I
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 624 LSYLHE----ECLEWVLHCDVKPQNILLDDHFE-----------------PKVTDFGLSK 662
L+Y H E VLH D+KPQNI L K+ DFGLSK
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 663 LFKERHDTKFSRVRGTRGYLAPEWMMN--LKIDAKADVYSYGIVLLELLTGKS 713
++ GT Y +PE +++ D K+D+++ G ++ EL +GK+
Sbjct: 191 NIGI--ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
|
Length = 1021 |
| >gnl|CDD|214544 smart00181, EGF, Epidermal growth factor-like domain | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 4e-04
Identities = 13/29 (44%), Positives = 15/29 (51%), Gaps = 1/29 (3%)
Query: 286 CTVHGLCGPNGICVNRPRQKTCICPNGFR 314
C G C NG C+N P TC CP G+
Sbjct: 2 CASGGPCS-NGTCINTPGSYTCSCPPGYT 29
|
Length = 35 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 26/93 (27%), Positives = 45/93 (48%), Gaps = 3/93 (3%)
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
+ + YLHE ++H D+K +NI ++ + + DFG + + + K+ GT
Sbjct: 193 RAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 682 LAPEWMMNLKIDAKADVYSYGIVLLELLTGKSA 714
APE + D++S GIVL E+ T +
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282
|
Length = 391 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 520 VGKGGFGSV-FRGVLDDERVVAVKRL---EGVLQGD-AEFWAEVSIIGRINHRNLVKLQG 574
+G+G FG V + + +V A+K L E + + + A F E ++ + R + L
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68
Query: 575 FCAENEHKLLVYEYVENGSLDKLL--FNDPGTASILQ-WDQRYNIAVGTAKGLSYLHEEC 631
+ + LV +Y G L LL F D + + + +A+ + L Y+H
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHR-- 126
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR-GTRGYLAPEWMMNL 690
D+KP N+LLD + ++ DFG S L T S V GT Y++PE + +
Sbjct: 127 -------DIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 691 KIDAKA------DVYSYGIVLLELLTGKS 713
+ D K D +S G+ + E+L G++
Sbjct: 179 E-DGKGRYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 30/88 (34%), Positives = 42/88 (47%), Gaps = 15/88 (17%)
Query: 584 LVYEYVENGSLDKLL----FNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCD 639
LV EY+ G + LL + D A I+ A L YLH ++H D
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMA-------VKYIS-EVALALDYLHRHG---IIHRD 129
Query: 640 VKPQNILLDDHFEPKVTDFGLSKLFKER 667
+KP N+L+ + K+TDFGLSK+ R
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKVTLNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 32/130 (24%), Positives = 58/130 (44%), Gaps = 14/130 (10%)
Query: 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL-HEECLEWVLHCDVKPQ 643
+ E D L+ P L + + A G+ +L + C+ H D+ +
Sbjct: 217 LPSAPERTRRDTLINESP----ALSYMDLVGFSYQVANGMEFLASKNCV----HRDLAAR 268
Query: 644 NILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGT---RGYLAPEWMMNLKIDAKADVYS 700
N+L+ + K+ DFGL++ D+ + T ++APE + N +DV+S
Sbjct: 269 NVLICEGKLVKICDFGLARDIM--RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWS 326
Query: 701 YGIVLLELLT 710
+GI+L E+ T
Sbjct: 327 FGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 804 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.62 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.62 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.51 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.49 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.44 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.44 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.27 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.98 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.91 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.89 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.82 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.82 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.61 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.58 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.57 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.39 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.38 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.35 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.34 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.27 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.27 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.17 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.08 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.01 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.94 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.79 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.75 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.74 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.7 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.64 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.58 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.53 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.48 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.44 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.41 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.38 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.34 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.32 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.29 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.2 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.94 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.75 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.74 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.44 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.16 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.07 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.06 | |
| PLN02236 | 344 | choline kinase | 95.84 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.55 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.23 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.18 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.17 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.02 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.78 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.56 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.52 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-55 Score=470.19 Aligned_cols=288 Identities=46% Similarity=0.793 Sum_probs=254.1
Q ss_pred CccccchHHHHHHHhccc--ccccccCcceEEEEEecCCcEEEEEEecCcCCC-hHHHHHHHHHHhcCCCCcccceeeeE
Q 038103 500 GFKRFTYAELKRATRNFK--QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQG-DAEFWAEVSIIGRINHRNLVKLQGFC 576 (804)
Q Consensus 500 ~~~~~~~~~l~~~t~~~~--~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~ 576 (804)
..+.|++.+|.+||.+|+ +.||+|+||.||+|.+++++.||||++...... ..+|.+|++++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 467799999999999998 579999999999999999999999998855444 67799999999999999999999999
Q ss_pred EeCC-eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEE
Q 038103 577 AENE-HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKV 655 (804)
Q Consensus 577 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 655 (804)
.+.+ +++||||||++|+|+++|+..... .++|.+|++||.++|+||+|||+.+.++|+||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9999 599999999999999999874332 8899999999999999999999999889999999999999999999999
Q ss_pred eecCCcccccccCCcccccc-ccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH
Q 038103 656 TDFGLSKLFKERHDTKFSRV-RGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 656 ~Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
+|||+|+..... ....... .||.+|+|||++..+..++|+|||||||+|+||+||+.+.+... ......+.+|
T Consensus 219 sDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-----~~~~~~l~~w 292 (361)
T KOG1187|consen 219 SDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-----PRGELSLVEW 292 (361)
T ss_pred cCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-----CcccccHHHH
Confidence 999999765441 1111222 79999999999999999999999999999999999998887533 1122348999
Q ss_pred HHHHhhhcCcccccCCcCC-CccCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 735 VAKQMEQEGLEKIIDPRLN-DVYDR-EKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
++..+.++.+.+++|+++. ..++. +++.++.++|++|++.+|.+||+|.+|+++|+.+...
T Consensus 293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 9999999999999999997 55554 7899999999999999999999999999999665544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=395.98 Aligned_cols=264 Identities=28% Similarity=0.433 Sum_probs=229.5
Q ss_pred HHHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 508 ~l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
++.+....+.++||+|-||.||.|.+++...||+|.++......++|.+|+++|.+|+|+|||+++|+|..+..++||||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 55666677789999999999999999998899999999777777889999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
||+.|+|.++|+. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+...++
T Consensus 282 ~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 282 YMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred ecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 9999999999976 25677999999999999999999999999 999999999999999999999999999976666
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.........-+..|.|||.+..+.|+.|+|||||||+||||+| |+.|+.... ...+.+.
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------------n~ev~~~-------- 416 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------------NEEVLEL-------- 416 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------------HHHHHHH--------
Confidence 5555555666889999999999999999999999999999999 888876543 1112223
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
++...+-..+..++..+.+|+..||+.+|++|||++.+...|+.+.....
T Consensus 417 -le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 417 -LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred -HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 33334444566677899999999999999999999999999988766443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=391.77 Aligned_cols=253 Identities=32% Similarity=0.477 Sum_probs=211.9
Q ss_pred cccccccCcceEEEEEecCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCC-eeEEEEeeccCC
Q 038103 517 KQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENE-HKLLVYEYVENG 592 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~g 592 (804)
.+.||+|+||+||+|.+++...||||++...... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4559999999999999988777999999854433 458999999999999999999999999988 799999999999
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC-CeEEeecCCcccccccCCcc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF-EPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~~ 671 (804)
+|.++++.. ....+++..+++++.|||+||.|||++++ ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 126 sL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TS 200 (362)
T ss_pred cHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-cc
Confidence 999999763 35679999999999999999999999885 99999999999999997 99999999999765432 33
Q ss_pred ccccccCCCccchhhhc--cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 672 FSRVRGTRGYLAPEWMM--NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~--~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
.+...||+.|||||.++ ..+|+.|+|||||||+||||+||+.||.... ..+.+......
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~-----------~~~~~~~v~~~-------- 261 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA-----------PVQVASAVVVG-------- 261 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC-----------HHHHHHHHHhc--------
Confidence 34478999999999999 5699999999999999999999999998643 11112222111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
..+...+......+..|+.+||+.||..||++.+++.+|+.+..
T Consensus 262 -~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 262 -GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred -CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 12222233355689999999999999999999999999986644
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=395.13 Aligned_cols=272 Identities=29% Similarity=0.441 Sum_probs=225.7
Q ss_pred chHHHHHHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeE
Q 038103 505 TYAELKRATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFC 576 (804)
Q Consensus 505 ~~~~l~~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~ 576 (804)
...++.+....+.++||+|+||+||+|+.. +.+.||||.++... +...+|++|+++++.++|||||+|+|+|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 344666777788899999999999999953 35679999998543 3567899999999999999999999999
Q ss_pred EeCCeeEEEEeeccCCChhhhhccCCC------C----CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEE
Q 038103 577 AENEHKLLVYEYVENGSLDKLLFNDPG------T----ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNIL 646 (804)
Q Consensus 577 ~~~~~~~lV~E~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIL 646 (804)
.+++.+++|+|||..|+|.+||..... . ...|+..+.+.||.|||.||+||.++. +|||||.++|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhce
Confidence 999999999999999999999965321 1 233889999999999999999999988 999999999999
Q ss_pred EcCCCCeEEeecCCcccccc-cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCC
Q 038103 647 LDDHFEPKVTDFGLSKLFKE-RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASD 724 (804)
Q Consensus 647 l~~~~~~kl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~ 724 (804)
|.++..+||+||||++..-. +.........-.++|||||.+..++||+++|||||||+||||++ |+.|+....
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS----- 710 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS----- 710 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-----
Confidence 99999999999999996533 32222223345789999999999999999999999999999999 999986543
Q ss_pred ccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCCCC
Q 038103 725 SSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQDE 800 (804)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~~~ 800 (804)
-+.+.+.++++++. ..+.+++.++..|+..||+.+|++||+++||-..|+...+....--
T Consensus 711 -------n~EVIe~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~ 770 (774)
T KOG1026|consen 711 -------NQEVIECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYS 770 (774)
T ss_pred -------hHHHHHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcccc
Confidence 12344555555542 3456677799999999999999999999999999988766655433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=348.96 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=206.2
Q ss_pred cchHHHHHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCC
Q 038103 504 FTYAELKRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENE 580 (804)
Q Consensus 504 ~~~~~l~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 580 (804)
.+..||.+ ...||+|..|+|||++++ +++.+|+|.+.... .-.+++.+|++++++.+||+||+++|.|..+.
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 44555544 567999999999999976 57889999995332 33578999999999999999999999999988
Q ss_pred -eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHh-hCCCcEEecccccCeEEEcCCCCeEEeec
Q 038103 581 -HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE-ECLEWVLHCDVKPQNILLDDHFEPKVTDF 658 (804)
Q Consensus 581 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 658 (804)
...++||||++|+|+.++.. .+.+++..+-+|+.++++||.|||+ +. ||||||||+|||++..|++||+||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccc
Confidence 59999999999999999964 3568999999999999999999997 55 999999999999999999999999
Q ss_pred CCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH
Q 038103 659 GLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 659 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
|.++.+... ......||..|||||.+.+..|+.++||||||+.++|+++|+.|+....+.. ....+.+...
T Consensus 224 GVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~------~~~~~Ll~~I 294 (364)
T KOG0581|consen 224 GVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY------LDIFELLCAI 294 (364)
T ss_pred cccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC------CCHHHHHHHH
Confidence 999977654 4456789999999999999999999999999999999999999986531111 1122222111
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..+. .|++... ....++..++..|++.||.+||++.|+++
T Consensus 295 -v~~p-----pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 295 -VDEP-----PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -hcCC-----CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 1222221 24457899999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=336.80 Aligned_cols=259 Identities=23% Similarity=0.365 Sum_probs=214.4
Q ss_pred HHHHhcccccccccCcceEEEEE-ecCCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceee-eEEeCCe-eE
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQG-FCAENEH-KL 583 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~-~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~ 583 (804)
..+.+.+.++||+|.||.|||+. +.+|..+|.|.++-.. +...+..+|+.+|++|+|||||++++ -+.++.+ ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 34566778899999999999999 6789999999998322 23456889999999999999999999 4555555 89
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCC-CcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL-EWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
||||++..|+|...++.-+..++.+++..+++++.|++.||..+|+.-+ ..|+||||||.||+|+++|.+||+||||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999998877788889999999999999999999999431 349999999999999999999999999999
Q ss_pred cccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
.+..... .....+|||.||+||.+...+|+.|+||||+||++|||+.-+.||.... +. ...+++.++
T Consensus 177 ~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----------~~-~L~~KI~qg 243 (375)
T KOG0591|consen 177 FLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----------LL-SLCKKIEQG 243 (375)
T ss_pred HhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----------HH-HHHHHHHcC
Confidence 8876433 3345789999999999999999999999999999999999999997532 22 234566666
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L 789 (804)
++..+.+. -..+.+.+|+..|+..||+.||+.-.+++.+
T Consensus 244 d~~~~p~~--------~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 244 DYPPLPDE--------HYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred CCCCCcHH--------HhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 55444332 3345788899999999999999855555444
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=379.15 Aligned_cols=266 Identities=29% Similarity=0.506 Sum_probs=223.5
Q ss_pred ccchHHHHHHHhcc-----------cccccccCcceEEEEEecC----CcEEEEEEecCcC--CChHHHHHHHHHHhcCC
Q 038103 503 RFTYAELKRATRNF-----------KQEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVL--QGDAEFWAEVSIIGRIN 565 (804)
Q Consensus 503 ~~~~~~l~~~t~~~-----------~~~LG~G~fg~Vykg~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~ 565 (804)
.++|++--+|-.+| .+.||.|.||.|++|+++. ...||||.++... +...+|+.|+.||++++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 46677655554444 4569999999999999753 3569999999543 44578999999999999
Q ss_pred CCcccceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeE
Q 038103 566 HRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNI 645 (804)
Q Consensus 566 H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 645 (804)
||||++|.|+.......++|.|||+||+|+.||+.+ ...+++.++..++++||.||.||.+.+ +|||||.++||
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNI 762 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNI 762 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhhe
Confidence 999999999999999999999999999999999874 345889999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeecCCcccccccCCcccccccc--CCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCccccccc
Q 038103 646 LLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG--TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASA 722 (804)
Q Consensus 646 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~ 722 (804)
|++.+...||+||||++.+.++.....+...| ..+|.|||.+...+++.++|||||||+|||.++ |.+|+-....
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-- 840 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-- 840 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--
Confidence 99999999999999999887766544444333 578999999999999999999999999999988 9999854320
Q ss_pred CCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 723 SDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
++ +-..++..++...+++++..|.+|+++|||.|..+||.+.+||.+|.++...
T Consensus 841 ------Qd-------------VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 841 ------QD-------------VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ------HH-------------HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 11 1122333445556778888999999999999999999999999999887664
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.88 Aligned_cols=195 Identities=30% Similarity=0.496 Sum_probs=174.3
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
|.+.++||+|+|++||+|+++ ++.+||||.+.... ...+-+..|+.+|+.++|||||++++++..++..+||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 455677999999999999975 47899999997442 23455788999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC------CCeEEeecCCccc
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH------FEPKVTDFGLSKL 663 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~------~~~kl~Dfgla~~ 663 (804)
.+|+|..||+. ...++......++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|+.
T Consensus 92 ~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 92 NGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999975 346999999999999999999999999 9999999999999765 4689999999998
Q ss_pred ccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
+.. .......+|++-|||||+++.++|+.|+|+||.|++|||+++|+.||+.
T Consensus 165 L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 165 LQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 764 3334567899999999999999999999999999999999999999974
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.70 Aligned_cols=246 Identities=23% Similarity=0.358 Sum_probs=207.6
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecC----cCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEG----VLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
.+|...+.||+|||..||+++. ..|..||+|++.+ .....+...+|+++.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4456667899999999999996 8899999999974 2233466889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
|+|++++|.++++ .++.+++..+..++.||+.||.|||+++ |+|||||..|++|+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999996 4677999999999999999999999999 99999999999999999999999999998876
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
+.. .....+||+.|+|||++....++..+||||+||+||-|+.|++||+... +.+ ....++.....
T Consensus 171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----------vke-ty~~Ik~~~Y~- 236 (592)
T KOG0575|consen 171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----------VKE-TYNKIKLNEYS- 236 (592)
T ss_pred ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----------HHH-HHHHHHhcCcc-
Confidence 533 3345789999999999999999999999999999999999999998532 111 12222222111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
- +........+|+.++|+.+|.+|||+++|+.
T Consensus 237 --~-------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 --M-------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --c-------ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 1122235778899999999999999999983
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=345.42 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=203.6
Q ss_pred HHHHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcC---C-----ChHHHHHHHHHHhcCCCCcccceeeeEEeCC
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL---Q-----GDAEFWAEVSIIGRINHRNLVKLQGFCAENE 580 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~---~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 580 (804)
.+..|-+.+.||+|+||.|-+|.- .+|+.||||++.+.. . .....++|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 445566788999999999999995 569999999997321 1 2234579999999999999999999999999
Q ss_pred eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC---CCeEEee
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH---FEPKVTD 657 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~D 657 (804)
..|||+|||++|.|.+++-. .+.+....-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999964 345677777889999999999999999 9999999999999655 7899999
Q ss_pred cCCcccccccCCccccccccCCCccchhhhccCCC---CcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH
Q 038103 658 FGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI---DAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 658 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
||+|+.... ...+...+||+.|.|||++..... ..|.|+||+||+||-+++|..||.....+ ..
T Consensus 323 FGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-------~s---- 389 (475)
T KOG0615|consen 323 FGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-------PS---- 389 (475)
T ss_pred cchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-------cc----
Confidence 999998763 445667899999999999986543 34789999999999999999999642211 11
Q ss_pred HHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 735 VAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+.+++..|.+.. ......+..++..+|+.++|..||++|||+.|+++
T Consensus 390 l~eQI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 390 LKEQILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHHHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 233334443321 11223445678899999999999999999999874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=382.14 Aligned_cols=268 Identities=26% Similarity=0.415 Sum_probs=218.6
Q ss_pred HHHHHHhcccccccccCcceEEEEEecC--Cc----EEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEeC
Q 038103 508 ELKRATRNFKQEVGKGGFGSVFRGVLDD--ER----VVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAEN 579 (804)
Q Consensus 508 ~l~~~t~~~~~~LG~G~fg~Vykg~~~~--~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 579 (804)
++......+...||+|+||.||+|.+.+ +. .||||.++.. .+...+|.+|..+|++++|||||+++|+|.+.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 3445555667789999999999999654 32 4999999854 45668899999999999999999999999999
Q ss_pred CeeEEEEeeccCCChhhhhccCC---CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEe
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDP---GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVT 656 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 656 (804)
...++++|||++|+|..||+... .....|+...++.++.|||+|+.|||++. +|||||.++|+||++...+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEc
Confidence 99999999999999999998641 12567899999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccc-cccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHH
Q 038103 657 DFGLSKLF-KERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 657 Dfgla~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
|||||+.+ +.+.........-...|||||.+..+.|+.|+|||||||+||||+| |..||.... -.+.
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~-----------n~~v 913 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS-----------NFEV 913 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc-----------hHHH
Confidence 99999943 3333333223344678999999999999999999999999999999 889987533 1111
Q ss_pred HHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCCC
Q 038103 735 VAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQD 799 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~~ 799 (804)
.....+.+ +-..+..+++.+++|+.+||+.+|++||++..+++.++.+.....+.
T Consensus 914 ~~~~~~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 914 LLDVLEGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred HHHHHhCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 11122222 22335667789999999999999999999999999998877654443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=341.80 Aligned_cols=268 Identities=24% Similarity=0.404 Sum_probs=216.2
Q ss_pred hHHHHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 506 YAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 506 ~~~l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
..|+.+....|.++||+|-||.|..+...++..||||+++.... ...+|.+|+++|.+++|||||+++|+|..++.++
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 44667777788999999999999999999999999999985433 3478999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+|+|||++|+|.+||..+. ...+.-....+|+.|||.||+||.+.+ ++||||.++|+|++.++++||+|||+++.
T Consensus 612 mI~EYmEnGDLnqFl~ahe--apt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHE--LPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHHHhcCcHHHHHHhcc--CcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence 9999999999999997652 223455667789999999999999998 99999999999999999999999999996
Q ss_pred ccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh--CCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 664 FKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT--GKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 664 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
+-.... .......-.++|||||.+..++++.++|||+||+++||+++ ..+||+... .....+-+.....
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt--------~e~vven~~~~~~ 758 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT--------DEQVVENAGEFFR 758 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh--------HHHHHHhhhhhcC
Confidence 544332 33334455789999999999999999999999999999876 667776432 1122222222222
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
.+..... ...+..++..+.++++.||+.|-++||+++++...|...
T Consensus 759 ~~~~~~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 759 DQGRQVV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCccee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2211111 122455667899999999999999999999999888654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.22 Aligned_cols=263 Identities=25% Similarity=0.399 Sum_probs=209.6
Q ss_pred hHHHHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 506 YAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 506 ~~~l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
+-||......+.+.||+|.||+||+|++.+. ||||.++.... ..+.|++|+..+++.+|.||+-+.|+|.....
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd--VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHGD--VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccccc--eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 3345555556678999999999999998653 99999984432 34679999999999999999999999999887
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
.||+.+|++.+|..+|+. ....++..+..+||.|||+||.|||.++ |||||||..||++.+++.|||+||||+.
T Consensus 463 AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 999999999999999986 3466888899999999999999999999 9999999999999999999999999998
Q ss_pred cccc-cCCccccccccCCCccchhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH
Q 038103 663 LFKE-RHDTKFSRVRGTRGYLAPEWMMN---LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 663 ~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
.... ..........|...|||||+++. .+|+..+||||||+++|||+||..||.... .+ .+.-+
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~d-----------qIifm 604 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RD-----------QIIFM 604 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hh-----------heEEE
Confidence 6543 22233334557889999999974 579999999999999999999999997211 00 00001
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
+..|.+. +++ -....+....+.+|+..||..++++||.+.+|+.+|+.+..
T Consensus 605 VGrG~l~----pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 605 VGRGYLM----PDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ecccccC----ccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1111111 111 01123455689999999999999999999999998887766
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.10 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=203.5
Q ss_pred hcccccccccCcceEEEEE-ecCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEEEEe
Q 038103 514 RNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EHKLLVYE 587 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~-~~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 587 (804)
++-.++||+|.||.|||++ ..+|+.||+|++..... ......+||.+|++|+||||++|.+...+. ...|||+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 3334679999999999999 56799999999984332 234567899999999999999999999877 68999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
||+. +|.-++.. .+..++..++..++.|++.||+|+|.++ |+|||||.+|||||.+|.+||+|||||+++...
T Consensus 199 YMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 199 YMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred cccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9988 88888864 4557899999999999999999999999 999999999999999999999999999998887
Q ss_pred CCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH--------
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ-------- 738 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 738 (804)
.....+..+-|..|+|||++.+. .|+.+.|+||.||||.||+.|+..+......+ -.+.+.+.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve--------Ql~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE--------QLHKIFKLCGSPTEDY 343 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH--------HHHHHHHHhCCCChhc
Confidence 77767777889999999999875 69999999999999999999999886543111 11111111
Q ss_pred hhhcCcc--cccCC------cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 739 MEQEGLE--KIIDP------RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 739 ~~~~~~~--~~~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
|....+. ..+.+ .+.+. -.......++|+..+|..||.+|.|+.++++
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1111111 11111 11111 1112356778888999999999999999884
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.49 Aligned_cols=262 Identities=24% Similarity=0.400 Sum_probs=203.6
Q ss_pred HHHHhcccccccccCcceEEEEEe------cCCcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEEeCC
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCAENE 580 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 580 (804)
.+..+.+.++||+|+||.||+|.. .+++.||||+++.... ..+.+.+|+.++.++ +||||++++++|....
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 345677888999999999999974 2356799999974322 235688999999999 8999999999987654
Q ss_pred -eeEEEEeeccCCChhhhhccCCCC-------------------------------------------------------
Q 038103 581 -HKLLVYEYVENGSLDKLLFNDPGT------------------------------------------------------- 604 (804)
Q Consensus 581 -~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------------------------- 604 (804)
..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 678999999999999998642110
Q ss_pred ---CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC-ccccccccCCC
Q 038103 605 ---ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRG 680 (804)
Q Consensus 605 ---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~ 680 (804)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134788889999999999999999998 99999999999999999999999999986543222 11223445678
Q ss_pred ccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHH
Q 038103 681 YLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDRE 759 (804)
Q Consensus 681 y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 759 (804)
|+|||++.+..++.++||||||+++|||++ |+.||...... .. .......+... .. +..
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~----~~~~~~~~~~~-----~~----~~~ 301 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EE----FCQRLKDGTRM-----RA----PEN 301 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HH----HHHHHhcCCCC-----CC----CCC
Confidence 999999999999999999999999999997 99998642210 01 11112222111 11 112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 760 KLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 760 ~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
....+.+|+.+|++.+|++||++.+|+++|+.+..
T Consensus 302 ~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 23468899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=349.41 Aligned_cols=263 Identities=28% Similarity=0.414 Sum_probs=209.5
Q ss_pred HHHHHhcccccccccCcceEEEEEecC--C--cE-EEEEEecC-c---CCChHHHHHHHHHHhcCCCCcccceeeeEEeC
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDD--E--RV-VAVKRLEG-V---LQGDAEFWAEVSIIGRINHRNLVKLQGFCAEN 579 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~--~--~~-vavK~l~~-~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 579 (804)
|......+.++||+|+||.||+|++.. + .. ||||..+. . .....+|.+|+++|++++|||||+++|++...
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 334444556899999999999999653 2 23 89999884 2 22347899999999999999999999999999
Q ss_pred CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
..+++|||+|++|+|.++|... ...++..++..++.+.|.||+|||+.+ ++||||.++|+|++.+..+||+|||
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence 9999999999999999999864 336999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHH
Q 038103 660 LSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 660 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
|++.-.. .........-..+|+|||.+..+.|+.++|||||||++||+++ |..|+.... ...+...
T Consensus 308 Ls~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~------------~~~v~~k 374 (474)
T KOG0194|consen 308 LSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK------------NYEVKAK 374 (474)
T ss_pred cccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC------------HHHHHHH
Confidence 9886431 1111112235688999999999999999999999999999999 888886533 1122333
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCC
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQ 798 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~ 798 (804)
+...... ...+...+..+..++.+|+..+|++||+|.+|.+.|+.+.....+
T Consensus 375 I~~~~~r--------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 375 IVKNGYR--------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHhcCcc--------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 3121111 111223445677888899999999999999999999887666554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=333.68 Aligned_cols=264 Identities=22% Similarity=0.350 Sum_probs=207.0
Q ss_pred HHHhcccccccccCcceEEEEE-ecCCcEEEEEEecCcCCChHH--HHHHHHHHhcCC-CCcccceeeeEEeCC-eeEEE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE--FWAEVSIIGRIN-HRNLVKLQGFCAENE-HKLLV 585 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~-~~~~~~vavK~l~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lV 585 (804)
..+|...++||.|.||.||+|+ ...+..||||+++.....-++ -.+|++.|++|+ |||||++..++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 3567778999999999999999 567889999999865544444 467999999998 999999999999988 99999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
||||+. +|.++++. ++..+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+...
T Consensus 89 fE~Md~-NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999977 99999976 5778999999999999999999999999 9999999999999999999999999999776
Q ss_pred ccCCccccccccCCCccchhhhc-cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHH----HHHhh
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMM-NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV----AKQME 740 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 740 (804)
.. ...+..+.|..|+|||++. .+-|+.+.|+|++|||++||.+-+..|......+. ...+.+.+ .+.+.
T Consensus 162 Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq----i~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 162 SK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ----IYKICEVLGTPDKDSWP 235 (538)
T ss_pred cC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH----HHHHHHHhCCCccccch
Confidence 53 4455677899999999874 66799999999999999999999988854321110 00000000 00000
Q ss_pred h---------cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 741 Q---------EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 741 ~---------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+ -.+.....-.+....+ ......++|+..|++.||.+|||+.+.+++
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0 0111111111111122 256788999999999999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=341.12 Aligned_cols=266 Identities=24% Similarity=0.349 Sum_probs=229.0
Q ss_pred chHHHHHHHhcccccccccCcceEEEEEecC-CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 505 TYAELKRATRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 505 ~~~~l~~~t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
.--|+.+......++||.|.||.||.|.++. .-.||||.++......++|++|+.+|+.++|||+|+|+|+|..+...|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 3445666666678899999999999999876 456999999987788899999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
||+|||..|+|.+||+.- .+..++--.++.++.||+.||+||..++ +|||||.++|+|+.++..+||+||||+++
T Consensus 340 IiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999763 4556777788999999999999999998 99999999999999999999999999999
Q ss_pred ccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
+..+..+........+.|.|||-+....|+.|+|||+|||+||||.| |..|+.... ...+.
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------------lSqVY------ 476 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------------LSQVY------ 476 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------------HHHHH------
Confidence 98877666666667889999999999999999999999999999999 888875432 11122
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
.++....+.+.+..++..+++|+..||+.+|.+||++.|+-+.+|.+..+.
T Consensus 477 ---~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 477 ---GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred ---HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 233344444456667779999999999999999999999999999887653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.71 Aligned_cols=263 Identities=21% Similarity=0.304 Sum_probs=199.1
Q ss_pred cccccccCcceEEEEEecC-CcEEEEEEecCcCCCh---HHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 517 KQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGD---AEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
..++|+|+||.|||++.++ |+.||||++..+..+. +-.++|+++|++++|+|||.++.+|.....++||+||++.
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh- 85 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH- 85 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-
Confidence 4579999999999999764 8999999998554432 4478899999999999999999999999999999999988
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 672 (804)
++.+-|...+ .-++.....+++.|+++|+.|+|+++ ++||||||+||||+.++.+||+|||+|+.+.. .....
T Consensus 86 TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 86 TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 5555555433 23778889999999999999999999 99999999999999999999999999998875 33445
Q ss_pred cccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhh---HHHHHHHHhhh-cCcccc
Q 038103 673 SRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNH---LVQWVAKQMEQ-EGLEKI 747 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~ 747 (804)
+....|..|+|||.+.+ .+|....|||++||++.||++|...|......+.-...... ++..-...+.. ..+..+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 66778999999999887 78999999999999999999999887543211100000000 00001111111 112222
Q ss_pred cCCcCCCc-----cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 748 IDPRLNDV-----YDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 748 ~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.-|..... .-+....-+++++..|++.||.+|++-+++++
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 22222111 11223457889999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=320.33 Aligned_cols=240 Identities=27% Similarity=0.316 Sum_probs=196.3
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
..+.+.+.||+|+||+||+++.. +++.+|+|.+++.. .+.+...+|..+|.+++||.||+++-.|.+.+++|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 44566788999999999999955 58899999997532 23466889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+.||.|..+|++ ...+++....-++..|+.||.|||+.+ ||||||||+|||||++|+++|+||||++..-.
T Consensus 105 d~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 105 DYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred eccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999964 456888888888999999999999999 99999999999999999999999999996443
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
. ......++||+.|||||++....|+..+|.||+|+++|||++|..||.... ... +.+.+..+.+.
T Consensus 178 ~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----------~~~-~~~~I~~~k~~- 243 (357)
T KOG0598|consen 178 D-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----------VKK-MYDKILKGKLP- 243 (357)
T ss_pred C-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----------HHH-HHHHHhcCcCC-
Confidence 2 233445899999999999999999999999999999999999999997532 111 12222222211
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRP 780 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 780 (804)
. .+.-......+++...++.||++|.
T Consensus 244 ----~----~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 ----L----PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ----C----CCccCCHHHHHHHHHHhccCHHHhc
Confidence 0 0111223567888888999999996
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=336.05 Aligned_cols=240 Identities=25% Similarity=0.414 Sum_probs=203.0
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCChhhh
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKL 597 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~ 597 (804)
+=||+|+.|.||+|++.+ +.||||+++... ..+++-|++|+|+||+.|.|+|.....++||||||+.|-|.+.
T Consensus 130 eWlGSGaQGAVF~Grl~n-etVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLHN-ETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeeccC-ceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 459999999999999976 459999876321 2578899999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcccccccc
Q 038103 598 LFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG 677 (804)
Q Consensus 598 l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 677 (804)
|+. +..+.-....+|..+||.||.|||.+. |||||||.-||||..+..+||+|||-++...+. .+...+.|
T Consensus 203 Lka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaG 273 (904)
T KOG4721|consen 203 LKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAG 273 (904)
T ss_pred Hhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhh
Confidence 964 556888888999999999999999998 999999999999999999999999999976653 34455889
Q ss_pred CCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccC
Q 038103 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYD 757 (804)
Q Consensus 678 t~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (804)
|..|||||+++..+.++|.|||||||+||||+||..||....... .+-.+-...|....+
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--------------------IIwGVGsNsL~LpvP 333 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--------------------IIWGVGSNSLHLPVP 333 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--------------------eEEeccCCcccccCc
Confidence 999999999999999999999999999999999999997543111 011111223333445
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 758 REKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
..+++-+.-|+++||+-.|.+||++++++..|+-..
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 566778889999999999999999999999996543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.64 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=208.0
Q ss_pred HHhcccccccccCcceEEEEE-ecCCcEEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~-~~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
..|++.++||.|..++||+|+ .+.+..||||++... ....+++++|++.|+.++||||++++..|..+..+++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 456778899999999999999 567899999999732 23358899999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
|..||+.+.++..- ..-+++..+..|.+++++||.|||.+| -||||||+.||||+.+|.+||+|||.+..+-+..
T Consensus 106 Ma~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999997642 233889999999999999999999999 8999999999999999999999999887654422
Q ss_pred C---ccccccccCCCccchhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 669 D---TKFSRVRGTRGYLAPEWMMN--LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 669 ~---~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
. .......||+.|||||+++. ..|+.|+|||||||+..||.+|+.||....+ .......+. +.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-----------mkvLl~tLq-n~ 248 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-----------MKVLLLTLQ-ND 248 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-----------HHHHHHHhc-CC
Confidence 2 12245789999999999654 3589999999999999999999999975431 112222222 22
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.....-..+..+........+.+++-.|++.||.+|||++++++
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 22222222222333444568889999999999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=299.64 Aligned_cols=258 Identities=21% Similarity=0.340 Sum_probs=202.1
Q ss_pred hcccccccccCcceEEEEE-ecCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~-~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
|.-.++||+|.||.||+|+ ...|+.||||+++..... .....+|++.|+.++|+||+.+++++.+...+.||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 3445789999999999999 457899999999844322 356789999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
+. +|+..|+. ....++-.++..++.++.+|++|+|++. |+||||||.|+|+++++.+||+|||+|+.+.....
T Consensus 84 ~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 84 PT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 88 99999976 5667899999999999999999999999 99999999999999999999999999999876544
Q ss_pred ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC-----
Q 038103 670 TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG----- 743 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 743 (804)
..... .-|..|+|||.+.+. .|+...|+||.||++.||+-|..-|.....- +-...+.+.+....
T Consensus 157 ~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi--------dQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 157 IQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI--------DQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred ccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH--------HHHHHHHHHcCCCCcccCc
Confidence 33333 668999999998865 5999999999999999999988766432210 00111111111110
Q ss_pred ----------cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 744 ----------LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 744 ----------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+.....+.+.. .-.......++|+..++..||.+|++++|++++
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111111111 222334456899999999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=379.02 Aligned_cols=270 Identities=28% Similarity=0.510 Sum_probs=217.8
Q ss_pred ccchHHHHHHHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 038103 503 RFTYAELKRATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEH 581 (804)
Q Consensus 503 ~~~~~~l~~~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 581 (804)
.++++++..+ ....+.||+|+||.||+|+. .++..||||+++..... ..+|++++++++|||||+++|+|.+...
T Consensus 682 ~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 682 SITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 3455555543 34456799999999999996 57889999998743332 2356889999999999999999999999
Q ss_pred eEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCc
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 661 (804)
.++||||+++|+|.++++. ++|..+.+++.|+|+||+|||..+.+.|+||||||+||+++.++.+++. |+.+
T Consensus 758 ~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred CEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 9999999999999999942 8899999999999999999997655569999999999999999988875 6665
Q ss_pred ccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 662 KLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
...... ....++..|+|||++.+..++.|+|||||||++|||+||+.|++... .....+.+|+......
T Consensus 830 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~------~~~~~~~~~~~~~~~~ 898 (968)
T PLN00113 830 GLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF------GVHGSIVEWARYCYSD 898 (968)
T ss_pred cccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc------CCCCcHHHHHHHhcCc
Confidence 433221 12357889999999999999999999999999999999999985321 1223456666655555
Q ss_pred cCcccccCCcCCC--ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 742 EGLEKIIDPRLND--VYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 742 ~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
.....++|+.+.. ..+.++..++.+++.+|++.+|++||+|++|+++|+.+...
T Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 5566677777644 34566778899999999999999999999999999987653
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.28 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=210.3
Q ss_pred HHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.++.+.+.||+|++|.||+|...+++.||+|.++......+++.+|++++++++|+||+++++++...+..+++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 45567788899999999999999988888899999986555667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999996532 356899999999999999999999998 9999999999999999999999999998765322
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.........+..|+|||.+....++.++||||||++++||++ |+.||.... ... +...+.... .
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~----~~~~~~~~~-~-- 222 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--------NAE----VLQQVDQGY-R-- 222 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--------HHH----HHHHHHcCC-C--
Confidence 222222223467999999998899999999999999999999 998885421 011 111111111 0
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
...+......+.+++.+|++.+|++||++.++++.|+.+
T Consensus 223 ------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 ------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 011122345789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=326.15 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=198.8
Q ss_pred hcccccccccCcceEEEEEecC-CcEEEEEEecCcCC-ChHHHHHHHHHHhcCCCCcccceeeeEEeCC--eeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQ-GDAEFWAEVSIIGRINHRNLVKLQGFCAENE--HKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~~ 589 (804)
+...+.||+|+||.||++...+ |...|||.+..... ..+.+.+|+.+|.+++|||||+++|...... .++++|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 4446789999999999999654 88999999874321 2456899999999999999999999854444 689999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-CCCeEEeecCCcccccc--
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-HFEPKVTDFGLSKLFKE-- 666 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~-- 666 (804)
++|+|.+++... +..++...+..+..||++||+|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 99 ~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 99 PGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred CCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999764 226999999999999999999999999 999999999999999 79999999999997763
Q ss_pred cCCccccccccCCCccchhhhccCC-CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLK-IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
..........||+.|||||++..+. ...++||||+||+++||+||+.|+... ....+++.......
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----------~~~~~~~~~ig~~~--- 239 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----------FEEAEALLLIGRED--- 239 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----------cchHHHHHHHhccC---
Confidence 2223344578999999999999643 345999999999999999999998641 00111111111111
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L 789 (804)
.-|.+ +........+++..|++.+|++|||++++++.-
T Consensus 240 --~~P~i----p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 240 --SLPEI----PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred --CCCCC----CcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11222 222344688999999999999999999999764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.91 Aligned_cols=243 Identities=23% Similarity=0.364 Sum_probs=204.3
Q ss_pred cccccccCcceEEEEE-ecCCcEEEEEEecCcCCCh-HHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCCh
Q 038103 517 KQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGD-AEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~-~~~~~~vavK~l~~~~~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
.++||+|+.|.||.+. ..+++.||||++....+.. +-+.+|+.+|+..+|+|||+++..+...+++++|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 4679999999999998 4568899999998666654 4578999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccccc
Q 038103 595 DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR 674 (804)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 674 (804)
.+.+. ...+++.++..|..++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+..... ....
T Consensus 358 TDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~T 428 (550)
T KOG0578|consen 358 TDVVT-----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRST 428 (550)
T ss_pred hhhhh-----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccc
Confidence 99994 445999999999999999999999999 99999999999999999999999999998766543 3455
Q ss_pred cccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCC
Q 038103 675 VRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLND 754 (804)
Q Consensus 675 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 754 (804)
..||+.|||||.+....|.+|.||||||++++||+.|..||-... .-.+...+......++-
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~------------PlrAlyLIa~ng~P~lk------ 490 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN------------PLRALYLIATNGTPKLK------ 490 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC------------hHHHHHHHhhcCCCCcC------
Confidence 789999999999999999999999999999999999999985321 11122222222222111
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 755 VYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
........+.+++.+||+.|+++||++.|+++
T Consensus 491 -~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 -NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 12233447889999999999999999999985
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.41 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=204.6
Q ss_pred HHHHHhcccccccccCcceEEEEEec----CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLD----DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~----~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
|....+.+.+.||+|+||.||+|.+. .+..||+|.++.... ..+.+.+|+.++.+++||||+++++++..+...
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 34566778899999999999999853 356899999885432 235688999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccc
Confidence 9999999999999999652 346899999999999999999999998 9999999999999999999999999877
Q ss_pred cccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
..............++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ..+ .+...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~----~~~~~~ 223 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDV----IKAVED 223 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHH----HHHHHC
Confidence 543222111122334678999999999999999999999999999775 9999864320 111 111222
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
+... ..+......+.+++..||+.+|++||++.+|.+.|+.+
T Consensus 224 ~~~~---------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 224 GFRL---------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCC---------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1110 11222345788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.96 Aligned_cols=244 Identities=18% Similarity=0.318 Sum_probs=197.0
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCCh----HHHHHHHHHHhcCCCCcccceeeeEEe----CCeeEEEEeec
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGD----AEFWAEVSIIGRINHRNLVKLQGFCAE----NEHKLLVYEYV 589 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~----~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~ 589 (804)
..||+|+++.||+|.. +++.||||+++...... +.+.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 3599999999999998 67889999998554433 567799999999999999999999877 34688999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
++|+|.+++.. ...+++....+++.+++.||+|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999999964 34688999999999999999999985 5 7899999999999999999999999998654321
Q ss_pred CccccccccCCCccchhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMN--LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||+... ...+. ..+......
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--------~~~~~----~~i~~~~~~- 240 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--------TKEIY----DLIINKNNS- 240 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--------HHHHH----HHHHhcCCC-
Confidence 22457889999999976 689999999999999999999999997432 01111 111111111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
.. .+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 241 ---~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 241 ---LK----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---CC----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11 11123456889999999999999999999999998764
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=302.13 Aligned_cols=263 Identities=21% Similarity=0.272 Sum_probs=214.2
Q ss_pred HHHhcccccccccCcceEEEEE-ecCCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCC-----eeE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENE-----HKL 583 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~-~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 583 (804)
..+|.+.+.||+|||+-||.++ +.+++.+|+|++.... ++.+..++|++.-++++|||+++++.++..+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3567788999999999999999 6788899999998554 56678899999999999999999999976443 489
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
|+++|...|+|.+.+......+..+++.+.+.|+.+|++||++||+.. ++.+||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999999887777889999999999999999999999988 4699999999999999999999999999987
Q ss_pred ccccCCc--------cccccccCCCccchhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHH
Q 038103 664 FKERHDT--------KFSRVRGTRGYLAPEWMM---NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLV 732 (804)
Q Consensus 664 ~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~ 732 (804)
..-.... .......|..|+|||.+. +..+++++|||||||+||+|+.|..||+..-...
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G---------- 248 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG---------- 248 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC----------
Confidence 6432211 112244789999999985 4567899999999999999999999997532111
Q ss_pred HHHHHHhhhcCc-ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 733 QWVAKQMEQEGL-EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 733 ~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
+.+ ..+..+.+.-.-+....+.+.+|+++|++.||.+||++.+++..++.+.
T Consensus 249 ---------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 ---------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111 1122223321112224568999999999999999999999999987654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=329.52 Aligned_cols=264 Identities=23% Similarity=0.406 Sum_probs=202.1
Q ss_pred HHHhcccccccccCcceEEEEEecC-----------------CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccc
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDD-----------------ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVK 571 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~-----------------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~ 571 (804)
+..+.+.++||+|+||.||++..++ +..||+|.+..... ...++.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4556778899999999999998532 34699999874322 2457899999999999999999
Q ss_pred eeeeEEeCCeeEEEEeeccCCChhhhhccCCC---------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEE
Q 038103 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPG---------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVL 636 (804)
Q Consensus 572 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iv 636 (804)
+++++.+....++||||+++++|.+++..... ....+++..+++++.||+.||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999999854211 1235788899999999999999999998 99
Q ss_pred ecccccCeEEEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhC--CC
Q 038103 637 HCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG--KS 713 (804)
Q Consensus 637 H~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg--~~ 713 (804)
||||||+|||++.++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986543222 122234457889999999988999999999999999999974 45
Q ss_pred CCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 714 ASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 714 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
|+.... .......+............. ..+......+.+|+.+|++.+|++||||.+|++.|+.
T Consensus 241 p~~~~~--------~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELT--------DEQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCC--------HHHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 554321 112222222222211111000 0111233578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.53 Aligned_cols=256 Identities=24% Similarity=0.412 Sum_probs=208.4
Q ss_pred HHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
...+.+.++||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++.+......++++||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 45567788999999999999998888889999987555556789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 85 KGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 99999999653 3456889999999999999999999988 999999999999999999999999999876543322
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......++..|+|||.+....++.++||||||+++|||++ |+.||.... .... ...+..+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--------~~~~----~~~~~~~~~~---- 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--------NSDV----MSALQRGYRM---- 223 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--------HHHH----HHHHHcCCCC----
Confidence 2233345678999999998889999999999999999998 999985321 0111 1111111100
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
+ ... .....+.+++.+|++.+|++||++++++++|+..
T Consensus 224 ~-~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 P-RME----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred C-CCC----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1 011 1234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=341.10 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=203.6
Q ss_pred HHHHHhcccccccccCcceEEEEEe------cCCcEEEEEEecCcC--CChHHHHHHHHHHhcC-CCCcccceeeeEEeC
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVL--QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAEN 579 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 579 (804)
+....+.+.+.||+|+||.||+++. .++..||||+++... ...+.+.+|+.++..+ +||||++++++|..+
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3345677789999999999999973 235689999997432 2345688999999999 899999999999999
Q ss_pred CeeEEEEeeccCCChhhhhccCCC--------------------------------------------------------
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPG-------------------------------------------------------- 603 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 603 (804)
...++||||+++|+|.+++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999864211
Q ss_pred ---------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 604 ---------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 604 ---------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
....+++..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 1125788999999999999999999988 9999999999999999999999999998664432
Q ss_pred Ccc-ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 669 DTK-FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 669 ~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
... .....++..|+|||.+....++.++||||||+++|||++ |..||..... ...+. ..+..+...
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-------~~~~~----~~~~~~~~~- 336 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-------DSKFY----KMIKEGYRM- 336 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-------hHHHH----HHHHhCccC-
Confidence 211 122335678999999999999999999999999999998 8888754220 01111 111211100
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
..+ ......+.+|+.+|++.||++||+|.+|+++|+..
T Consensus 337 -~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 -LSP-------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CCC-------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 001 11134688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=322.35 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=207.2
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
...+.+.++||+|+||.||+|... .++.||+|.+.......+++.+|++++++++|+||+++++++......+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 345667789999999999999965 4788999998865555678999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999998653 2345899999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
........+..|+|||.+.+..++.++||||||+++|||++ |..|+.... ..+ .......+ .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----------~~~-~~~~~~~~-~---- 222 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------LSQ-VYELLEKG-Y---- 222 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----------HHH-HHHHHHCC-C----
Confidence 22222334668999999999999999999999999999998 888875421 001 11111111 0
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
.. ..+......+.+++.+|++.+|++||++.+++++|+.+
T Consensus 223 ~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 RM----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11 11112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=319.77 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=204.7
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
..+.+.++||+|+||.||++...++..+|+|.++......+++.+|+.++++++||||+++++++......++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 34566788999999999999988888899999876555667899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.........
T Consensus 84 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 84 GCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999998652 235889999999999999999999998 9999999999999999999999999998654332222
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
.....++..|+|||.+....++.++||||||+++|||++ |+.||.... ..... ....++. ....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--------~~~~~----~~i~~~~--~~~~~ 223 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--------NYEVV----EMISRGF--RLYRP 223 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHH----HHHHCCC--CCCCC
Confidence 222335668999999998889999999999999999999 888886422 01111 1112111 11111
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
. .....+.+++.+|++.+|++||+|.+++++|.
T Consensus 224 ~-------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 K-------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred C-------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1 12246899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.32 Aligned_cols=252 Identities=24% Similarity=0.405 Sum_probs=205.0
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
..+.+.+.||+|+||.||++...++..+|||.++......+++.+|+.++.+++||||+++++++.+....++||||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 45677889999999999999987777899999886555667899999999999999999999999998899999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 84 ~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 84 GCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999652 236899999999999999999999998 9999999999999999999999999998654432222
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+..... ... ......+....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~----~~~~~~~~~~~---- 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SET----VEKVSQGLRLY---- 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHH----HHHHhcCCCCC----
Confidence 222345678999999998889999999999999999999 9999864220 011 11111111110
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
. +......+.+++.+||+.+|++||++.++++.|+
T Consensus 222 -~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 -R----PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -C----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 1112357899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.60 Aligned_cols=266 Identities=25% Similarity=0.391 Sum_probs=200.4
Q ss_pred cccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhc--CCCCcccceeeeEEeCC----eeEEEEee
Q 038103 515 NFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGR--INHRNLVKLQGFCAENE----HKLLVYEY 588 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~E~ 588 (804)
.+.+.+|+|.||.||||.+.+ +.||||++. .+..+.|++|-.|.+. ++|+||+++++.=..+. ++.||+||
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp--~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFP--EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hhHHHhhcCccceeehhhccC-ceeEEEecC--HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 345779999999999999966 889999986 3455667787777664 58999999999866555 88999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhC------CCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC------LEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
.+.|+|.+||. ...++|....+|+..+++||+|||+.. +++|+|||||++||||.++++..|+|||+|.
T Consensus 290 h~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 290 HPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred ccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999995 457999999999999999999999864 3469999999999999999999999999999
Q ss_pred cccccCC-ccccccccCCCccchhhhccCC-CC-----cccchHHHHHHHHHHHhCCCCCccccccc---------CCcc
Q 038103 663 LFKERHD-TKFSRVRGTRGYLAPEWMMNLK-ID-----AKADVYSYGIVLLELLTGKSASDYLSASA---------SDSS 726 (804)
Q Consensus 663 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~s-----~k~DV~S~Gvll~el~tg~~p~~~~~~~~---------~~~~ 726 (804)
.+..... .......||.+|||||++.+.- +. .+.||||+|.+||||++.....+.....+ +.++
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 8875433 3334478999999999997532 22 36899999999999999776553210001 1111
Q ss_pred chhhHHHHHHHHhhhcCcccccCCcCCCc-cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 727 YCNHLVQWVAKQMEQEGLEKIIDPRLNDV-YDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
......+.+.++ . ..|.+... ....-+..+.+.+..||..||+-|.|+.=|-+++.++....
T Consensus 445 t~e~mq~~VV~k----K----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 445 TLEEMQELVVRK----K----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CHHHHHHHHHhh----c----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 111222222211 1 11222111 11234567889999999999999999999988887766554
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=319.74 Aligned_cols=248 Identities=34% Similarity=0.551 Sum_probs=193.3
Q ss_pred ccccccccCcceEEEEEec-----CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 516 FKQEVGKGGFGSVFRGVLD-----DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 516 ~~~~LG~G~fg~Vykg~~~-----~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.||.|.||.||+|.+. .+..|+||.++.... ..+++.+|++.+.+++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999976 256899999964332 357899999999999999999999999988889999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.++|... ....+++..+.+|+.||++||+|||+.+ ++|++|+++|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999864 2456899999999999999999999988 9999999999999999999999999998763221
Q ss_pred C-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 669 D-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 669 ~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
. ...........|+|||.+....++.++||||||+++|||++ |+.|+.... ..+ +...+.++....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-----------~~~-~~~~~~~~~~~~ 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-----------NEE-IIEKLKQGQRLP 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-----------HHH-HHHHHHTTEETT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------ccc-ccccccccccce
Confidence 1 22223446778999999999899999999999999999999 678875422 111 122222222111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L 789 (804)
. +......+.+++..||+.+|++||+|.++++.|
T Consensus 226 ~---------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 I---------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp S---------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred e---------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1 111234688999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=337.59 Aligned_cols=262 Identities=25% Similarity=0.412 Sum_probs=202.9
Q ss_pred HHHHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEEeC
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCAEN 579 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 579 (804)
+....+.+.+.||+|+||.||+++.. ++..||||+++.... ..+.+.+|+++++++ +|+||+++++.|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 33456777899999999999998842 235799999974332 235688999999999 899999999999999
Q ss_pred CeeEEEEeeccCCChhhhhccCCC--------------------------------------------------------
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPG-------------------------------------------------------- 603 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 603 (804)
...++||||+++|+|.++++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999999854210
Q ss_pred ----------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc-cc
Q 038103 604 ----------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT-KF 672 (804)
Q Consensus 604 ----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~ 672 (804)
....+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........ ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 1124788889999999999999999998 999999999999999999999999999865433221 11
Q ss_pred cccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 673 SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
....++..|+|||++....++.++||||||+++|||++ |+.||...... ..+ ......+ .. ..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-------~~~----~~~~~~~-~~----~~ 335 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-------SKF----YKMVKRG-YQ----MS 335 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-------HHH----HHHHHcc-cC----cc
Confidence 22335678999999998899999999999999999997 99998642210 011 1111111 10 00
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
.... ....+.+++.+|++.+|++||++.+|+++|+.+.
T Consensus 336 ~~~~----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDF----APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1111 1246889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.16 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=203.2
Q ss_pred HhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
.+.+.+.||+|+||.||++..+++..+|+|.+........++.+|++++++++|+||+++++++......++|+||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 45677889999999999999887778999998755555678899999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 672 (804)
+|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++..........
T Consensus 85 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 85 CLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999653 336899999999999999999999998 99999999999999999999999999986543222222
Q ss_pred cccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 673 SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
....++..|+|||.+....++.++||||||+++||+++ |+.||..... ... ......+ ....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~----~~~~~~~-----~~~~ 221 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--------SEV----VESVSAG-----YRLY 221 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--------HHH----HHHHHcC-----CcCC
Confidence 22233467999999998899999999999999999999 7888864220 011 1111111 0011
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
.+......+.+++.+|++.+|++||+|.+|++.|.
T Consensus 222 ----~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 ----RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred ----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 11123457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.96 Aligned_cols=248 Identities=22% Similarity=0.316 Sum_probs=202.1
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcC----CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL----QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 585 (804)
+.+.|.+.||+|+|++|++++. ..++++|||++.+.. ...+-...|-.+|.+| .||.|++|+-.|.+...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 3456789999999999999994 568999999997432 2234466788899999 899999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
+||+++|.|.++|.. -..++..-...++.+|+.||+|||+.| ||||||||+|||||+++++||+|||.|+.+.
T Consensus 153 Le~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999975 345888888999999999999999999 9999999999999999999999999999885
Q ss_pred ccCCc---------c---ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHH
Q 038103 666 ERHDT---------K---FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQ 733 (804)
Q Consensus 666 ~~~~~---------~---~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~ 733 (804)
..... . ...++||..|.+||++..+..++.+|+|+||||||+|+.|+.||.... .....+
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--------eyliFq 297 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--------EYLIFQ 297 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--------HHHHHH
Confidence 42211 1 144889999999999999999999999999999999999999996432 111111
Q ss_pred HHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 734 WVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
-+.. ++-.+...+ .+.+.+|+.+.|..||.+|++..+|-+.
T Consensus 298 kI~~----------l~y~fp~~f----p~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 KIQA----------LDYEFPEGF----PEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHH----------hcccCCCCC----CHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111 111122222 3467888889999999999999888654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=324.84 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=203.5
Q ss_pred HHHhcccccccccCcceEEEEEe-cCCcEEEEEEecCc-----C-CChHHHHHHHHHHhcCC-CCcccceeeeEEeCCee
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV-----L-QGDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHK 582 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~-----~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 582 (804)
...+.+.+.||+|.||+|+.|.. ..++.||+|.+... . ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 44667788999999999999985 46799999976542 1 23456778999999999 99999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC-CCeEEeecCCc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH-FEPKVTDFGLS 661 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla 661 (804)
++||||+.+|.|.+++.. ...+.+.....++.|++.|++|+|+++ |+||||||+|||++.+ +++||+|||++
T Consensus 96 ~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999964 456888999999999999999999999 9999999999999999 99999999999
Q ss_pred ccccccCCccccccccCCCccchhhhccCC-CC-cccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 662 KLFKERHDTKFSRVRGTRGYLAPEWMMNLK-ID-AKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
.... ..........||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+... ... +..++
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-----------~~~-l~~ki 235 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-----------VPN-LYRKI 235 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-----------HHH-HHHHH
Confidence 9875 2344556788999999999999877 86 68999999999999999999998522 111 12222
Q ss_pred hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038103 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVV 786 (804)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv 786 (804)
..+.+. +..... ...+..|+.+|++.+|.+|+++.+|+
T Consensus 236 ~~~~~~------~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 236 RKGEFK------IPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred hcCCcc------CCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 222211 111110 34688999999999999999999998
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=315.26 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=209.3
Q ss_pred HHHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 508 ~l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
++...++.+.++||+|+||.||++...+++.||+|.+.......+++.+|+.++++++|+|++++++++. ....++++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 3456788889999999999999999888999999999866666778999999999999999999999874 457899999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++... .+..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999998653 2346899999999999999999999988 999999999999999999999999999876533
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.........++..|+|||.+....++.++||||||++++|+++ |+.||.... .... ...+..+...
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~----~~~~~~~~~~- 222 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--------NPEV----IQNLERGYRM- 222 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--------hHHH----HHHHHcCCCC-
Confidence 2222223345678999999998889999999999999999999 999986422 0111 1111111100
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
.. +......+.+++.+|++.+|++||+++++++.|+.
T Consensus 223 ----~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ----PR----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01 11123469999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=314.99 Aligned_cols=255 Identities=26% Similarity=0.413 Sum_probs=206.4
Q ss_pred HHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
...+.+.++||+|+||.||+|+..+...||+|+++......+++.+|++++++++|+||+++++.+.+ ...++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 45678889999999999999998777789999998655566789999999999999999999998754 56799999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99999999653 2345789999999999999999999988 999999999999999999999999999876543332
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......++..|+|||......++.++||||||+++|||++ |+.||..... .. .......+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~----~~~~~~~~~------ 220 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------RE----VLDQVERGY------ 220 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HH----HHHHHhcCC------
Confidence 2223446678999999988899999999999999999999 7878754220 01 111111110
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
......+....+.+|+.+|++.+|++||++.+++++|+..
T Consensus 221 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0011223445788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=315.01 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=208.4
Q ss_pred HHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCC-ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ-GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+..+.+.++||.|+||.||+|...+++.+|+|.+..... ...++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 345677889999999999999988899999999985443 4567899999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999753 3456899999999999999999999998 99999999999999999999999999987644322
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
. .....++..|+|||.+....++.++||||||+++++|++ |+.|+.... ...... ....+ .
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--------~~~~~~----~~~~~-~---- 221 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYD----QITAG-Y---- 221 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHH----HHHhC-C----
Confidence 2 123345678999999998899999999999999999998 888886422 011111 11111 0
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
....+......+.+++.+|++.+|++|||+.++++.|+++
T Consensus 222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 ----RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0111122335688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=325.75 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=220.1
Q ss_pred HHHHHHhcccccccccCcceEEEEEecC---C--cEEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEeCC
Q 038103 508 ELKRATRNFKQEVGKGGFGSVFRGVLDD---E--RVVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENE 580 (804)
Q Consensus 508 ~l~~~t~~~~~~LG~G~fg~Vykg~~~~---~--~~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 580 (804)
+|.++...+.+.||+|-||.||+|++-+ | -.||||..+.. ....+.|..|..+|++++|||||+++|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 4666677778889999999999999532 2 35999998853 3345779999999999999999999999987 4
Q ss_pred eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCC
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGL 660 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 660 (804)
..++|||.++-|.|++||+. +...|+......++.||+.||+|||+.. .|||||..+|||+....-+||+|||+
T Consensus 464 P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 67899999999999999987 4456888899999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 661 SKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 661 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
++.+.++.....+...-...|||||.+....|+.++|||.|||.+|||++ |..||....
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk-------------------- 597 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK-------------------- 597 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc--------------------
Confidence 99998876666666666888999999999999999999999999999998 999997543
Q ss_pred hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
+.++-..+...-+...++.++..+..|+.+||..+|.+||++.++...|+.+.++
T Consensus 598 -NsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 598 -NSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred -ccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 1222222333334455667778999999999999999999999999998776653
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=314.25 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=205.5
Q ss_pred HHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
...+.+.++||+|+||.||++..+++..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4457778899999999999999888888999999865556678999999999999999999999885 456889999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++... ....+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 84 KGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999999653 2345889999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......++..|+|||.+....++.++||||||+++|||++ |+.||.... .... ...+..+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~----~~~~~~~~------ 220 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--------NREV----LEQVERGY------ 220 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--------HHHH----HHHHHcCC------
Confidence 2223345678999999988889999999999999999999 888885321 0111 11111110
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
....+......+.+|+.+|++.+|++|||+.++++.|+.
T Consensus 221 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 ---RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011122234568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.94 Aligned_cols=243 Identities=27% Similarity=0.414 Sum_probs=202.7
Q ss_pred ccccccccCcceEEEEEe-cCCcEEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 516 FKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 516 ~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
-.+.||+|.||.||||.. ..++.||+|.+... ....+++++|+.++.+++|+||.+++|.+..+..++++||||.+|
T Consensus 17 ~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gG 96 (467)
T KOG0201|consen 17 KLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGG 96 (467)
T ss_pred cchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCc
Confidence 347899999999999995 46889999999743 334578999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 672 (804)
++.+.|.. +..+.+....-|+.++..||.|||.++ .+|||||+.|||+..++.+||+|||.+..+.......
T Consensus 97 sv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 97 SVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred chhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 99999964 334477777778999999999999999 9999999999999999999999999999877655444
Q ss_pred cccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcC
Q 038103 673 SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRL 752 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 752 (804)
..+.||+.|||||++....|+.|+||||||++.+||++|..|+....+.. .--.+.+-..|.+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-----------------vlflIpk~~PP~L 231 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-----------------VLFLIPKSAPPRL 231 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-----------------EEEeccCCCCCcc
Confidence 67889999999999998899999999999999999999999986432100 0001122223344
Q ss_pred CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 753 NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+.+ ...+.+++..|++.+|+.||++.++++
T Consensus 232 ~~~~----S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 DGDF----SPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccc----CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 4433 346889999999999999999999874
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=319.08 Aligned_cols=256 Identities=25% Similarity=0.452 Sum_probs=204.2
Q ss_pred HhcccccccccCcceEEEEEecC------CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDD------ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
.+.+.+.||+|+||.||+|...+ ...||+|.++.... ...++.+|++++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 45677899999999999998643 25799999874322 23568899999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC
Q 038103 585 VYEYVENGSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE 652 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 652 (804)
++||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999999965311 1145888999999999999999999998 999999999999999999
Q ss_pred eEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhh
Q 038103 653 PKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNH 730 (804)
Q Consensus 653 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~ 730 (804)
+||+|||++........ .......+++.|+|||.+....++.++||||||+++|||++ |..||..... ..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--------~~ 234 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--------QE 234 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--------HH
Confidence 99999999986543221 22233446788999999998899999999999999999998 9999864220 11
Q ss_pred HHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 731 LVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
+...+..+.... .+......+.+|+.+|++.+|.+||++.+|+++|+++
T Consensus 235 ----~~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 ----VIEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ----HHHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 122222222111 1223345789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=315.40 Aligned_cols=254 Identities=30% Similarity=0.470 Sum_probs=203.4
Q ss_pred HHhcccccccccCcceEEEEEecC----CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
..+.+.+.||+|+||.||+|+... ...||||.++.... ...++.+|+.++.+++|+||+++++++.+....+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 456678899999999999999642 45799999874433 235788999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999652 346899999999999999999999988 9999999999999999999999999999775
Q ss_pred ccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 666 ERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 666 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ...+ ......+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--------~~~~----~~~~~~~~ 225 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--------NQDV----IKAVEDGY 225 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--------HHHH----HHHHHcCC
Confidence 2221 11122334678999999998899999999999999999998 998885321 0111 11111111
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
.. + .+......+.+|+.+|++.+|++||++.+|+++|+.+
T Consensus 226 ~~----~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 RL----P-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC----C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0 1112345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.75 Aligned_cols=243 Identities=26% Similarity=0.399 Sum_probs=203.5
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCCCh---HHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGD---AEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
|.+.+.||+|.||.||||+-+ +.+.||+|.+.+..+.+ +.+.+|++++++++|||||.++.+++...++++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 445678999999999999965 47889999998655544 44788999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
.+ +|..+|... ..+.+..+..++.+++.||.|||+.+ |+|||+||+|||++.++.+|++|||+|+.+... .
T Consensus 84 ~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t 154 (808)
T KOG0597|consen 84 VG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-T 154 (808)
T ss_pred hh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-c
Confidence 87 999999753 45899999999999999999999998 999999999999999999999999999987653 3
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
...+.+.||+-|||||.+.+++|+..+|.||+||++||+++|+.||-.. .+.+.+.....+ ...
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----------si~~Lv~~I~~d-~v~---- 218 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----------SITQLVKSILKD-PVK---- 218 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----------HHHHHHHHHhcC-CCC----
Confidence 4456688999999999999999999999999999999999999998531 122322222221 111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+.........++...++.||.+|.+..+++.
T Consensus 219 ------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 ------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 12234456788888999999999999988863
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=318.97 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=198.0
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+...+.||+|+||.||++.. .+++.||||.+.... .....+.+|+.++.+++|+||+++.+.+.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 44567899999999999995 568999999986322 2234578899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999888642 2335889999999999999999999998 9999999999999999999999999998654322
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+........
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~----- 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--------VKREEVDRRVKEDQ----- 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc--------hhHHHHHHHhhccc-----
Confidence 223456899999999999999999999999999999999999999753210 00111111111110
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPP-----MSKVVK 787 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~~Vv~ 787 (804)
..++......+.+|+..||+.||++||+ ++++++
T Consensus 222 -----~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 -----EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -----ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111122346789999999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=332.44 Aligned_cols=261 Identities=21% Similarity=0.327 Sum_probs=203.6
Q ss_pred HHHhcccccccccCcceEEEEEecC------CcEEEEEEecCcCC--ChHHHHHHHHHHhcCC-CCcccceeeeEEeCCe
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDD------ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEH 581 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 581 (804)
+..+.+.+.||+|+||.||+|+... +..||||+++.... ..+.+.+|++++.++. ||||++++++|.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4456677899999999999998532 34699999974332 2356899999999996 9999999999999999
Q ss_pred eEEEEeeccCCChhhhhccCCC----------------------------------------------------------
Q 038103 582 KLLVYEYVENGSLDKLLFNDPG---------------------------------------------------------- 603 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 603 (804)
.+|||||+++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864210
Q ss_pred ----------------------------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC
Q 038103 604 ----------------------------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD 649 (804)
Q Consensus 604 ----------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~ 649 (804)
....+++..+..++.|+++||+|||+.+ |+|+||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0124778888999999999999999988 999999999999999
Q ss_pred CCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccc
Q 038103 650 HFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSY 727 (804)
Q Consensus 650 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~ 727 (804)
++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~------ 346 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD------ 346 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh------
Confidence 99999999999986543222 12223346778999999998899999999999999999997 88888642100
Q ss_pred hhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 728 CNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
..+ ......+.. ...+......+.+++.+||+.+|++||++.+|+++|+.+.+
T Consensus 347 -~~~----~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 -STF----YNKIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -HHH----HHHHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 011 111111110 01112234578899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=316.41 Aligned_cols=258 Identities=29% Similarity=0.447 Sum_probs=206.0
Q ss_pred HHHHhcccccccccCcceEEEEEecC------CcEEEEEEecCcCCC--hHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLDD------ERVVAVKRLEGVLQG--DAEFWAEVSIIGRINHRNLVKLQGFCAENEH 581 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~~------~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 581 (804)
...++.+.+.||+|+||.||+|...+ ++.||||.++..... .+++.+|++++.+++|+||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 34567788899999999999998643 478999999754333 4679999999999999999999999999999
Q ss_pred eEEEEeeccCCChhhhhccCC----------CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC
Q 038103 582 KLLVYEYVENGSLDKLLFNDP----------GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF 651 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~ 651 (804)
.++||||+++++|.+++.... .....+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCC
Confidence 999999999999999996531 12345789999999999999999999998 99999999999999999
Q ss_pred CeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchh
Q 038103 652 EPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCN 729 (804)
Q Consensus 652 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~ 729 (804)
.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--------~ 231 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--------E 231 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--------H
Confidence 999999999986533221 11223345678999999999999999999999999999999 9999854220 1
Q ss_pred hHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 730 HLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
.. ......+..... +......+.+++.+||+.+|++||++.||+++|+.
T Consensus 232 ~~----~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 232 EV----IECITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HH----HHHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11 111222221111 11233568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.91 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=204.4
Q ss_pred HHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
...+.+.++||+|+||.||++...++..+|+|++.......+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3557788899999999999999887778999998755555677899999999999999999999875 456889999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999653 2345889999999999999999999988 999999999999999999999999999876443222
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......++..|+|||......++.++||||||+++|||++ |+.|+.... .... ......+ ..
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~----~~~~~~~-~~---- 221 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--------NREV----LEQVERG-YR---- 221 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHH----HHHHHcC-CC----
Confidence 2223345678999999998899999999999999999999 888885422 0111 1111111 00
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
. ..+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 222 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 M----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred C----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 1112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=325.66 Aligned_cols=261 Identities=24% Similarity=0.392 Sum_probs=203.0
Q ss_pred HHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEEeC-C
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCAEN-E 580 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 580 (804)
...+.+.+.||+|+||.||+|... .++.||+|+++.... ..+.+.+|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 456778899999999999999742 247899999874322 234677899999999 899999999988754 5
Q ss_pred eeEEEEeeccCCChhhhhccCCCC--------------------------------------------------------
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPGT-------------------------------------------------------- 604 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 604 (804)
..++++||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999998542110
Q ss_pred -CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC-ccccccccCCCcc
Q 038103 605 -ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYL 682 (804)
Q Consensus 605 -~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ 682 (804)
...++|..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+..... .......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136889999999999999999999988 99999999999999999999999999987643322 1222344567899
Q ss_pred chhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHH
Q 038103 683 APEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKL 761 (804)
Q Consensus 683 aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 761 (804)
|||++.+..++.++|||||||++|||++ |+.||...... .. .......+... ..+....
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-------~~----~~~~~~~~~~~---------~~~~~~~ 302 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-------EE----FCRRLKEGTRM---------RAPEYAT 302 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-------HH----HHHHHhccCCC---------CCCccCC
Confidence 9999999999999999999999999998 99998542110 01 11111111111 0111223
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 762 DRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 762 ~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
..+.+++.+|++.+|++||++.+|+++|+.+.+
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 468899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.61 Aligned_cols=257 Identities=26% Similarity=0.448 Sum_probs=209.3
Q ss_pred HHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+..+.+.+.||+|+||.||++..++++.+|||.+.......+++.+|+.++++++|+||+++++++......++|+||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 34556777889999999999999988888899999986666678899999999999999999999999998999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++... ....+++..+..++.+++.|++|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999753 2346899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.........+..|+|||.+.+..++.++||||||++++|+++ |+.||.... .... ......+ ...
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--------~~~~----~~~~~~~-~~~- 223 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--------NREV----LEQVERG-YRM- 223 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHH----HHHHHcC-CCC-
Confidence 222222334578999999998899999999999999999999 999885321 0111 1111111 000
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
..+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 224 -------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0111123578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=322.72 Aligned_cols=258 Identities=22% Similarity=0.375 Sum_probs=201.6
Q ss_pred HHHHhcccccccccCcceEEEEEec-CCc----EEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLD-DER----VVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~-~~~----~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
....+...+.||+|+||.||+|+.. ++. .||+|.++... ...+++.+|+.+++.++|+||++++|+|... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 3455667788999999999999853 333 48999987432 2346788999999999999999999999864 57
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 84 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence 7999999999999999752 345889999999999999999999998 9999999999999999999999999999
Q ss_pred cccccCCcc-ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 663 LFKERHDTK-FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 663 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
......... ......+..|+|||.+....++.++||||||+++|||++ |+.|++.... ..+ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~~----~~~~~ 225 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEI----SSILE 225 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHH----HHHHh
Confidence 765433221 122234678999999999999999999999999999998 9999864220 011 11111
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
.+.. ... +......+.+++.+|++.+|++||++.++++.|..+...
T Consensus 226 ~~~~--~~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 226 KGER--LPQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCC--CCC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 1110 000 111224678999999999999999999999998766543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.86 Aligned_cols=265 Identities=26% Similarity=0.358 Sum_probs=200.4
Q ss_pred cccccccccCcceEEEEEe-----cCCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEEE
Q 038103 515 NFKQEVGKGGFGSVFRGVL-----DDERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EHKLLV 585 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 585 (804)
.+.+.||+|+||+||++.. .+++.||+|.++... ...+.+.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5678899999999988653 357789999987433 2456788999999999999999999998764 357899
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999953 34899999999999999999999998 9999999999999999999999999998765
Q ss_pred ccCCc--cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 666 ERHDT--KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 666 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
..... ......++..|+|||.+....++.++||||||++++||++|+.|+........ ..............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~ 232 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE------EMIGPKQGQMTVVR 232 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh------hhhcccccccchhh
Confidence 42221 11122345679999999888899999999999999999999999754321100 00000000000001
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
+.+.++.......+......+.+++..|++.+|++||++++|+++|+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111111111122223457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.08 Aligned_cols=267 Identities=19% Similarity=0.260 Sum_probs=199.2
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
|.+.+.||+|+||.||+++.. +++.+|+|+++... ...+.+.+|++++++++|+||+++++++......++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 556788999999999999975 57889999987432 23456789999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
+++.+..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 83 EKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9877765543 2345889999999999999999999998 99999999999999999999999999987654333
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccc----hhhHHHHHHHHhhhcCcc
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSY----CNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 745 (804)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||............ ..................
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 3334456899999999999889999999999999999999999999642210000000 000000000000011111
Q ss_pred cccCCcCCC------ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 746 KIIDPRLND------VYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 746 ~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
....+.... .........+.+|+.+|++.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111100 001112346899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.90 Aligned_cols=256 Identities=23% Similarity=0.309 Sum_probs=201.0
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC---------------ChHHHHHHHHHHhcCCCCcccceeee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ---------------GDAEFWAEVSIIGRINHRNLVKLQGF 575 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~---------------~~~~~~~E~~~l~~l~H~niv~l~g~ 575 (804)
..|.+.++||+|.||.|-+|+. .+++.||||++.+... ..+..++|+.+|++++|+|||+|+.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 3566778999999999999995 4689999999963211 12468899999999999999999999
Q ss_pred EEeC--CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCe
Q 038103 576 CAEN--EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP 653 (804)
Q Consensus 576 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 653 (804)
..+. +.+|||+|||..|.+...=- ....++..+.++++.+++.||+|||.++ ||||||||+|+||++++++
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcE
Confidence 8765 57899999999887654321 2223899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccccc----CCccccccccCCCccchhhhccCC----CCcccchHHHHHHHHHHHhCCCCCcccccccCCc
Q 038103 654 KVTDFGLSKLFKER----HDTKFSRVRGTRGYLAPEWMMNLK----IDAKADVYSYGIVLLELLTGKSASDYLSASASDS 725 (804)
Q Consensus 654 kl~Dfgla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~ 725 (804)
||+|||.+..+... .........||+.|+|||...++. .+.+.||||+||+||-|+.|+.||....
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~------ 323 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF------ 323 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch------
Confidence 99999999976332 122334578999999999987633 3468899999999999999999996421
Q ss_pred cchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 726 SYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
..+ .. ..++...+.-...+++.+.+.+|++++|+.||++|.+..+|....--...
T Consensus 324 -----~~~-l~--------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 -----ELE-LF--------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred -----HHH-HH--------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 111 11 22333333322233556788999999999999999999999877644433
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=302.25 Aligned_cols=247 Identities=21% Similarity=0.334 Sum_probs=210.2
Q ss_pred HHHHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC----ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ----GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
.+.+|+|.+.||+|.||.|-++.. ..|+.||||.+++... ..-.+++|++||..|+||||+.++.+|...+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 456788889999999999999995 6799999999985432 33458899999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||..+|.|.+|+. .+..|+......++.||..|+.|+|.++ ++|||||.+|||+|.++++||+||||+.++
T Consensus 131 vMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999999995 4567999999999999999999999998 999999999999999999999999999987
Q ss_pred cccCCccccccccCCCccchhhhccCCCC-cccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMMNLKID-AKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
.+. .-.+.++|++-|.+||++.+.+|. +..|-|||||+||-|+.|..||+..+ .+. +.+++..|.
T Consensus 204 ~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~----lvrQIs~Ga 269 (668)
T KOG0611|consen 204 ADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKR----LVRQISRGA 269 (668)
T ss_pred ccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHH----HHHHhhccc
Confidence 653 345678999999999999999984 78999999999999999999998643 111 233444444
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+.+-- .+....-|+.|||..+|++|-|+.+|...
T Consensus 270 YrEP~-----------~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 270 YREPE-----------TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ccCCC-----------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 44322 22346678999999999999999999754
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.97 Aligned_cols=256 Identities=23% Similarity=0.401 Sum_probs=206.5
Q ss_pred HHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+..+++.+.++||+|+||.||++...++..+|+|.+.......+.+.+|++++++++|+|++++.+++.+ ...+++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 4456778889999999999999998888889999887544455678999999999999999999999887 778999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999653 2345789999999999999999999988 9999999999999999999999999998664432
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
........++..|+|||.+....++.++|+||||++++|+++ |+.||.... ...+ ......+....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--------~~~~----~~~~~~~~~~~- 223 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEV----IRALERGYRMP- 223 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--------HHHH----HHHHhCCCCCC-
Confidence 222223345677999999998889999999999999999999 888886422 0111 11111111100
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
........+.+++.+|++.+|++||++.++.++|+.
T Consensus 224 --------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 --------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=307.01 Aligned_cols=247 Identities=29% Similarity=0.422 Sum_probs=198.4
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCChh
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLD 595 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 595 (804)
+.||+|+||.||+|..++++.+|+|.+..... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999874332 2346889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcccccc
Q 038103 596 KLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRV 675 (804)
Q Consensus 596 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 675 (804)
+++... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 998642 345789999999999999999999998 99999999999999999999999999976443222222222
Q ss_pred ccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCC
Q 038103 676 RGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLND 754 (804)
Q Consensus 676 ~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 754 (804)
.++..|+|||++....++.++||||||+++||+++ |..||..... .. .......+...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----------~~-~~~~~~~~~~~--------- 213 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----------QQ-AREQVEKGYRM--------- 213 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----------HH-HHHHHHcCCCC---------
Confidence 34567999999998899999999999999999999 8888854220 01 11111111110
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 755 VYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
..+......+.+++.+|++.+|++||++.++++.|..
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 250 (250)
T cd05085 214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250 (250)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhcC
Confidence 1111234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.25 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=195.7
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCCh
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
+.||+|+||.||+|+.. +++.+|+|.+..... ....+.+|++++++++|+||++++++|......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999964 688999998764322 245689999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc-cc
Q 038103 595 DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK-FS 673 (804)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~ 673 (804)
.+++.. ....+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++.......... ..
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999864 2345889999999999999999999998 9999999999999999999999999998654321111 11
Q ss_pred ccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcC
Q 038103 674 RVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRL 752 (804)
Q Consensus 674 ~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 752 (804)
....+..|+|||.+....++.++||||||+++|||++ |..|+..... .. .........
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~----~~~~~~~~~--------- 213 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQ----TREAIEQGV--------- 213 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HH----HHHHHHcCC---------
Confidence 1123457999999998899999999999999999998 8888754220 00 111111110
Q ss_pred CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 753 NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
....+......+.+++.+|++.+|++||++.+|.++|.
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 214 RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 01111222457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.85 Aligned_cols=258 Identities=22% Similarity=0.390 Sum_probs=201.3
Q ss_pred HHHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEH 581 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 581 (804)
....+.+.++||+|+||.||+|... .+..||||.+.... ....++.+|+.++++++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3456778889999999999999853 24679999986432 234568899999999999999999999999999
Q ss_pred eEEEEeeccCCChhhhhccCCCC------CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEE
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGT------ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKV 655 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 655 (804)
.++|+||+++++|.+++...... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998643211 234678899999999999999999988 999999999999999999999
Q ss_pred eecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHH
Q 038103 656 TDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQ 733 (804)
Q Consensus 656 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 733 (804)
+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |..|+.... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--------~~~~-- 230 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--------NEQV-- 230 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHH--
Confidence 99999986543221 11112345678999999998899999999999999999999 688875322 0111
Q ss_pred HHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 734 WVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
............ +......+.+++.+|++.+|++||++.+++++|+.
T Consensus 231 --~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 231 --LRFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --HHHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111112111111 11223468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.78 Aligned_cols=198 Identities=25% Similarity=0.376 Sum_probs=171.7
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
...+.+.+.||+|+||.||+++.. ++..+|+|.+..... ..+++.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 345666788999999999999965 578899999874322 23578999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+. |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999964 3458899999999999999999998532 999999999999999999999999999865432
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22335689999999999998999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=312.09 Aligned_cols=262 Identities=27% Similarity=0.425 Sum_probs=207.1
Q ss_pred HHHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
++..+.+.+.||+|+||.||++... ++..+|+|.+.... .....+.+|++++.+++|+||+++++++......
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3455667789999999999999842 34568999987443 2345789999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhhccCC---------CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCe
Q 038103 583 LLVYEYVENGSLDKLLFNDP---------GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP 653 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 653 (804)
++|+||+++++|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 99999999999999986432 12235899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhH
Q 038103 654 KVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHL 731 (804)
Q Consensus 654 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~ 731 (804)
||+|||++........ .......++..|+|||.+.+..++.++||||||++++||++ |+.||..... ..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~- 230 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NE- 230 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HH-
Confidence 9999999986543221 12223345778999999998899999999999999999999 8888754220 11
Q ss_pred HHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 732 VQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 732 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
..+....+..... ... ....+.+|+.+|++.+|.+||++.+|.+.|+.+...
T Consensus 231 ---~~~~i~~~~~~~~-----~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 231 ---VIECITQGRVLQR-----PRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ---HHHHHHcCCcCCC-----CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1122222221111 111 223689999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=312.42 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=206.9
Q ss_pred HHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcCC-ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVLQ-GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
...+.+.+.||+|+||.||+++.. ++..+++|++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 344666788999999999999842 345689999874433 3457899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC
Q 038103 584 LVYEYVENGSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF 651 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~ 651 (804)
+||||+++++|.+++..... ....+++..++.++.||+.||+|||+++ |+|+||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 99999999999999965321 1235889999999999999999999998 99999999999999999
Q ss_pred CeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchh
Q 038103 652 EPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCN 729 (804)
Q Consensus 652 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~ 729 (804)
.+||+|||++........ .......++..|+|||.+....++.++||||||+++|||+| |+.||..... .
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~ 232 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------T 232 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 999999999986543221 12223446788999999999999999999999999999999 9999854220 0
Q ss_pred hHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 730 HLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
. +.+....+..... .......+.+++.+|++.+|++||++.+|+++|+.+..
T Consensus 233 ~----~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 233 E----VIECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred H----HHHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1 1122222222111 11223468899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.04 Aligned_cols=242 Identities=23% Similarity=0.270 Sum_probs=197.0
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 456788999999999999965 58899999986322 2345688899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++.. ...+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 83 VPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999964 345888999999999999999999998 999999999999999999999999999865432
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .. ....+..+..
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----------~~-~~~~i~~~~~---- 215 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----------FG-IYEKILAGKL---- 215 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HH-HHHHHHhCCc----
Confidence 1234689999999999998899999999999999999999999864220 01 1111111111
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPP-----MSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~~Vv~~ 788 (804)
.+.. .....+.+|+.+|++.||.+||+ ++++++.
T Consensus 216 --~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 --EFPR----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CCCc----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1111 12346889999999999999995 7887654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=307.50 Aligned_cols=244 Identities=27% Similarity=0.430 Sum_probs=194.7
Q ss_pred cccccCcceEEEEEe---cCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 519 EVGKGGFGSVFRGVL---DDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~---~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
+||+|+||.||+|.. .++..+|+|+++.... ..+++.+|+.++++++|+||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999975 3568899999874332 2457889999999999999999999885 45678999999999
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc--
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT-- 670 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-- 670 (804)
+|.+++.. ...+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999954 245889999999999999999999998 999999999999999999999999999876543221
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......++..|+|||.+....++.++||||||+++|||++ |+.||..... ..+ ...+..+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~----~~~i~~~~~~~--- 218 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEV----TQMIESGERME--- 218 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH----HHHHHCCCCCC---
Confidence 1122234578999999988889999999999999999998 9999864320 111 12222221111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
.+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 219 ------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 ------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111233468899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=317.25 Aligned_cols=238 Identities=24% Similarity=0.301 Sum_probs=190.8
Q ss_pred ccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCCh
Q 038103 520 VGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 520 LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
||+|+||.||+++.. +++.||+|.++.. ......+.+|+.++.+++||||+++++.+...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 5788999998632 22345678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccccc
Q 038103 595 DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR 674 (804)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 674 (804)
.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 999964 235889999999999999999999998 9999999999999999999999999998543222 22334
Q ss_pred cccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCC
Q 038103 675 VRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLND 754 (804)
Q Consensus 675 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 754 (804)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+... ....+.. .+
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----------~~~~~~-~~~~~~~------~~-- 212 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----------VNEMYR-KILQEPL------RF-- 212 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----------HHHHHH-HHHcCCC------CC--
Confidence 568999999999999999999999999999999999999986421 111111 1111111 11
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 755 VYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+......+.+++.+||+.||.+||++..+.+
T Consensus 213 --~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 213 --PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred --CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 1122346789999999999999986443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.97 Aligned_cols=256 Identities=26% Similarity=0.444 Sum_probs=202.0
Q ss_pred HHhcccccccccCcceEEEEEe-----cCCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-----DDERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-----~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
..+.+.+.||+|+||.||+|.. .++..+++|.++.... ...++.+|+.++++++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4566778999999999999984 2457899999974332 23578899999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCC-------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC
Q 038103 585 VYEYVENGSLDKLLFNDPG-------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF 651 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~ 651 (804)
||||+++++|.+++..... ....+++.....++.|++.||+|||+.+ ++|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 1235788999999999999999999998 99999999999999999
Q ss_pred CeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchh
Q 038103 652 EPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCN 729 (804)
Q Consensus 652 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~ 729 (804)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---------- 231 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---------- 231 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----------
Confidence 999999999986543221 22223345678999999988889999999999999999999 888875321
Q ss_pred hHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 730 HLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
...+.+......... .+......+.+++.+|++.+|++||++.+|.++|..
T Consensus 232 --~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 232 --NQEVIEMVRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 011122222211111 111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=323.87 Aligned_cols=262 Identities=19% Similarity=0.218 Sum_probs=196.0
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
..|.+.++||+|+||.||++.. ..++.||+|... ...+.+|++++++++||||+++++++......++|+|++.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 4467788999999999999996 457899999653 2346789999999999999999999999999999999995
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
++|..++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 167 -~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 167 -TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred -CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 588888854 345889999999999999999999998 999999999999999999999999999764433333
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc--------
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE-------- 742 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 742 (804)
......||+.|+|||++.+..++.++||||||+++|||++|+.|+-..............+.. +.......
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~-i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL-IIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH-HHHHhcCChhhcCcch
Confidence 334567999999999999999999999999999999999999886432111111000011110 00000000
Q ss_pred --Ccc---------cccCCcCCC--ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 743 --GLE---------KIIDPRLND--VYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 743 --~~~---------~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+. ....+.... .........+.+|+.+||+.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 000000000 001123456889999999999999999999984
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=332.44 Aligned_cols=261 Identities=20% Similarity=0.226 Sum_probs=212.4
Q ss_pred cccccccccCcceEEEEEecCC-cEEEEEEecC-cCCChHHHHHHHHHHhcCC-CCcccceeee-EEe------CCeeEE
Q 038103 515 NFKQEVGKGGFGSVFRGVLDDE-RVVAVKRLEG-VLQGDAEFWAEVSIIGRIN-HRNLVKLQGF-CAE------NEHKLL 584 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~~~-~~vavK~l~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~------~~~~~l 584 (804)
.+.+.|.+|||+.||.+....+ ..+|+||+-. .....+...+|+++|++|+ |+|||.+++. ... ..+.+|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 4567899999999999997765 9999999873 3345577899999999997 9999999993 221 236789
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
.||||.+|+|-+++..... ..|+...+++|+.|+++|+++||... +||||||||-+||||..+++.||+|||.+...
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred ehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 9999999999999975432 23999999999999999999999987 67999999999999999999999999999853
Q ss_pred cccCCccc--------cccccCCCccchhhh---ccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHH
Q 038103 665 KERHDTKF--------SRVRGTRGYLAPEWM---MNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQ 733 (804)
Q Consensus 665 ~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~ 733 (804)
-....... -...-|+.|+|||.+ ++.++++|+|||+|||+||-|+....||+...
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------------- 262 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------------- 262 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------------
Confidence 22211100 013358999999986 57789999999999999999999999997532
Q ss_pred HHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCC
Q 038103 734 WVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQDESI 802 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~~~~~ 802 (804)
-..+++....-.........+..||..||+++|++||++-+|++.+-.+.....+-+++
T Consensus 263 ----------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~ 321 (738)
T KOG1989|consen 263 ----------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDI 321 (738)
T ss_pred ----------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcccc
Confidence 23344555544334567789999999999999999999999999998888877776654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.82 Aligned_cols=240 Identities=23% Similarity=0.264 Sum_probs=193.9
Q ss_pred ccccccCcceEEEEEe-cCCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 518 QEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
+.||+|+||.||+++. .+++.||+|.++... ....++.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999996 468899999997432 22346788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 672 (804)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 99999864 345889999999999999999999998 999999999999999999999999999753221 1223
Q ss_pred cccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcC
Q 038103 673 SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRL 752 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 752 (804)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...+ ......+. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~----~~~~~~~~------~~~ 214 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKL----FELILMEE------IRF 214 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--------HHHH----HHHHHcCC------CCC
Confidence 34568999999999999999999999999999999999999985421 0011 11111111 111
Q ss_pred CCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 753 NDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
.. .....+.+++.+|++.||++|| ++.++++
T Consensus 215 p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 PR----TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CC----CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 11 2234688999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=306.35 Aligned_cols=251 Identities=25% Similarity=0.465 Sum_probs=203.6
Q ss_pred HhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
.+.+.+.||+|+||.||++....++.+|+|.+........++.+|++++++++|+|++++++++......++|+||++++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 45667889999999999999877788999998865556678999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 672 (804)
+|.+++... ...+++..+..++.+++.|++|||+.+ ++|+||||+||+++.++.+||+|||++...........
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 85 CLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999998652 345789999999999999999999998 99999999999999999999999999986543322222
Q ss_pred cccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 673 SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
....++.+|+|||.+.+..++.++||||||+++|||++ |+.||.... .... ......+ .....+.
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----------~~~~-~~~~~~~--~~~~~~~ 224 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----------NSEV-VETINAG--FRLYKPR 224 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----------HHHH-HHHHhCC--CCCCCCC
Confidence 22334678999999998899999999999999999998 899886422 0111 1111111 1111121
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
. ....+.+|+.+|++.+|++||++.+|+++|.
T Consensus 225 ~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 L-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred C-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1 2357899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=312.79 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=202.1
Q ss_pred HHhcccccccccCcceEEEEEecC------CcEEEEEEecCcCCC--hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDD------ERVVAVKRLEGVLQG--DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~------~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
..+.+.++||+|+||.||+|...+ ++.||+|+++..... .+++.+|+.++.+++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 456677899999999999998532 478999999744332 356889999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCC------------CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC
Q 038103 584 LVYEYVENGSLDKLLFNDP------------GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF 651 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~ 651 (804)
+++||+++++|.+++.... .....+++..+..++.|++.||+|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985211 11235788889999999999999999998 99999999999999999
Q ss_pred CeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchh
Q 038103 652 EPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCN 729 (804)
Q Consensus 652 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~ 729 (804)
.+||+|||+++....... .......+++.|+|||.+....++.++||||||+++|||++ |..|+.... ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~ 233 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQ 233 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------HH
Confidence 999999999886543222 11223345778999999988899999999999999999998 777875321 01
Q ss_pred hHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 730 HLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
. ..+....+.... .+......+.+|+..|++.+|++||++.+|++.|+.
T Consensus 234 ~----~~~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 D----VIEMIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H----HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 122222222111 112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.82 Aligned_cols=256 Identities=22% Similarity=0.353 Sum_probs=199.0
Q ss_pred HhcccccccccCcceEEEEEec-CCc----EEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DER----VVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~----~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
.+.+.+.||+|+||.||+|+.. +++ .+++|.+.... ....++..|+.++++++|+||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 4455688999999999999963 344 47788775322 223567888889999999999999998854 567889
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
+||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||+++...
T Consensus 87 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 87 TQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999965 3346899999999999999999999988 9999999999999999999999999998654
Q ss_pred ccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 666 ERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 666 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
.... .......++..|+|||.+....++.++||||||+++||+++ |+.|+..... ... ...+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~----~~~~~~~~ 228 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HEV----PDLLEKGE 228 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHH----HHHHHCCC
Confidence 3222 22234456788999999998899999999999999999998 9999864220 111 11122221
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
.. ..+. . ....+.+++.+|+..+|++||++.++++.|+.+.+..
T Consensus 229 ~~--~~~~---~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 229 RL--AQPQ---I----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred cC--CCCC---C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 11 1111 1 2235788999999999999999999999998866543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=335.30 Aligned_cols=250 Identities=23% Similarity=0.213 Sum_probs=200.1
Q ss_pred hcccccccccCcceEEEEEec-C-CcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-D-ERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
|.+.+.||+|+||.||++... + ++.||+|.+.... .....+.+|+.+++.++||||+++++++...+..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 667789999999999999853 3 5778888775333 233567889999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC-
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD- 669 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 669 (804)
+|+|.+++.........+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988653333456888999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..+. ......+....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----------~~~~-~~~~~~~~~~~--- 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----------QREI-MQQVLYGKYDP--- 290 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----------HHHH-HHHHHhCCCCC---
Confidence 22334568999999999999999999999999999999999999986422 0111 11111121111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
. +......+.+|+..|++.+|++||++.++++
T Consensus 291 --~----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 --F----PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --C----CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0 1112246889999999999999999999864
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=326.41 Aligned_cols=263 Identities=23% Similarity=0.367 Sum_probs=204.5
Q ss_pred HHHHHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcCCC--hHHHHHHHHHHhcCC-CCcccceeeeEEe
Q 038103 508 ELKRATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVLQG--DAEFWAEVSIIGRIN-HRNLVKLQGFCAE 578 (804)
Q Consensus 508 ~l~~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 578 (804)
++....+.+.++||+|+||.||+|+.. .++.||||+++..... .+.+.+|++++.++. |+||++++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 455556667789999999999999854 2467999999854322 346889999999997 9999999999999
Q ss_pred CCeeEEEEeeccCCChhhhhccCCC-------------------------------------------------------
Q 038103 579 NEHKLLVYEYVENGSLDKLLFNDPG------------------------------------------------------- 603 (804)
Q Consensus 579 ~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------- 603 (804)
....++|+||+++|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999965321
Q ss_pred ---------------------------------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCe
Q 038103 604 ---------------------------------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQN 644 (804)
Q Consensus 604 ---------------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 644 (804)
....+++..+..++.|++.||+|||+.+ ++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 1124678888999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCccccccc
Q 038103 645 ILLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASA 722 (804)
Q Consensus 645 ILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~ 722 (804)
||+++++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.|+.....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-- 347 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-- 347 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc--
Confidence 9999999999999999986543221 11223346788999999998889999999999999999998 8888754220
Q ss_pred CCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 723 SDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
.+.....+..+. . . ..+......+.+|+..|++.+|.+||++++|++.|+.+.
T Consensus 348 ---------~~~~~~~~~~~~-~----~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 ---------NEQFYNAIKRGY-R----M----AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---------hHHHHHHHHcCC-C----C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 011111111110 0 0 011112347889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=306.22 Aligned_cols=246 Identities=26% Similarity=0.388 Sum_probs=195.1
Q ss_pred cccccCcceEEEEEec---CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCC
Q 038103 519 EVGKGGFGSVFRGVLD---DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGS 593 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~---~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 593 (804)
+||+|+||.||+|+.. ++..||+|.+..... ..+++.+|+.++++++|+||+++++++. ....++|+||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 355799999874432 2356899999999999999999999885 457899999999999
Q ss_pred hhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc--
Q 038103 594 LDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK-- 671 (804)
Q Consensus 594 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~-- 671 (804)
|.+++.. ....+++..+++++.|++.||+|||+++ ++|+||||+|||++.++.+||+|||++..........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999864 2346899999999999999999999998 9999999999999999999999999998654432211
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
.....++..|+|||.+....++.++||||||+++||+++ |+.||..... .. +...+..+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~----~~~~~~~~~~------ 216 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PE----VMSFIEQGKR------ 216 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HH----HHHHHHCCCC------
Confidence 112223578999999988889999999999999999996 9999864320 01 1122222211
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
...+......+.+++..|++.+|++||++.+|.+.|+.+
T Consensus 217 ---~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 ---LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111222345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=319.54 Aligned_cols=250 Identities=27% Similarity=0.322 Sum_probs=199.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
|.+.+.||+|+||.||+|+.. +++.||||+++... .....+.+|++++.+++||||+++++++......++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 456788999999999999975 48899999997432 2345688899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 83 VPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999964 345888999999999999999999998 99999999999999999999999999986543
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+... . ..+.
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~-~-~~~~--- 218 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETWENLKYW-K-ETLQ--- 218 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHHHHHHhc-c-cccc---
Confidence 22345689999999999998999999999999999999999999964321 0111111100 0 0010
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+.. ..........+.+++.+|++.+|.+||++.++++.
T Consensus 219 ~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0100 00011234468899999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=317.38 Aligned_cols=244 Identities=25% Similarity=0.337 Sum_probs=206.9
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.||.|+-|.|-.|++ .+|+.+|||++.+. ......+.+|+-+|+.+.|||++++++++.+..++|||.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 45678899999999999995 57999999999743 12235678899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|.|.+++.. .+.+......+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||||.+-..
T Consensus 94 v~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-- 164 (786)
T KOG0588|consen 94 VPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP-- 164 (786)
T ss_pred cCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence 999999999964 456888999999999999999999999 99999999999999999999999999996433
Q ss_pred CccccccccCCCccchhhhccCCCC-cccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKID-AKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
......-+|++.|.|||++++.+|. .++||||.|||||.|+||+.||+... +..+..+++.|.++.-
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------------ir~LLlKV~~G~f~MP 232 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------------IRVLLLKVQRGVFEMP 232 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------------HHHHHHHHHcCcccCC
Confidence 2334556899999999999999985 68999999999999999999998422 3334556666655421
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
........+|+.+|+..||++|.|++||.+.
T Consensus 233 ----------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 233 ----------SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----------CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2223367789999999999999999999875
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=318.57 Aligned_cols=243 Identities=22% Similarity=0.272 Sum_probs=197.5
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
..+.+.+.||+|+||.||+++.. +++.||||.+.... ...+.+.+|+.++.+++||||+++++.+.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 44677789999999999999975 57899999987321 23456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999964 345788888999999999999999998 99999999999999999999999999986543
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.. ....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ....+.+..+.+.
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------------~~~~~~i~~~~~~- 233 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------------FRIYEKILAGRLK- 233 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------------HHHHHHHhcCCcC-
Confidence 22 235689999999999999999999999999999999999999864210 0111222222111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPP-----MSKVVK 787 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~~Vv~ 787 (804)
+... ....+.+|+..||+.||.+||+ +.++++
T Consensus 234 -----~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 -----FPNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -----CCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 2236789999999999999997 566653
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=307.85 Aligned_cols=259 Identities=20% Similarity=0.354 Sum_probs=206.3
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||+|+.. +++.||||.+.... ....++.+|++++++++||||+++++++...+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 3566788999999999999954 68899999876322 123468889999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.........++...+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999988654334456888999999999999999999998 999999999999999999999999999876543
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.. ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ...... .........
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---------~~~~~~-~~~~~~~~~-- 226 (267)
T cd08228 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------NLFSLC-QKIEQCDYP-- 226 (267)
T ss_pred hH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---------cHHHHH-HHHhcCCCC--
Confidence 22 12234578899999999988899999999999999999999999853210 111111 111111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
..........+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 227 ------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 ------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1111233457899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=313.96 Aligned_cols=259 Identities=22% Similarity=0.334 Sum_probs=196.1
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
.|.+.++||+|+||.||+|+.. +++.||+|.++... .....+.+|+.++++++|+||+++++++......++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 3666788999999999999965 57899999987432 23456789999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++ +|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 86 DS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred Cc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 75 89988864 2345788999999999999999999998 9999999999999999999999999998643322
Q ss_pred ccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh-------
Q 038103 670 TKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ------- 741 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 741 (804)
.......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...... .....+......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--------EELHLIFRLLGTPTEETWP 229 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCCCChHHhh
Confidence 12233467899999998865 56899999999999999999999998642210 011111111000
Q ss_pred -----cCcccccCCcCCCcc----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 742 -----EGLEKIIDPRLNDVY----DREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 742 -----~~~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
........+...... .........+|+.+|++.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 001111111110000 0112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=288.63 Aligned_cols=233 Identities=24% Similarity=0.291 Sum_probs=193.7
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+++...||.|+||.|.+++.+ +|..+|+|++++.. ...+...+|..+|+.+.||.++++.+.+.+...++|||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 344678999999999999965 58899999997432 2335577899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
.++|.|..+|+. ..+++.+...-+|.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||.|+.....
T Consensus 126 v~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 126 VPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred cCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999964 356889999999999999999999999 999999999999999999999999999976543
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
+...+||+.|+|||.+...++..++|.|+|||++|||+.|..||....+ -.+.+++.++.+.
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------------~~iY~KI~~~~v~--- 259 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------------IQIYEKILEGKVK--- 259 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------------HHHHHHHHhCccc---
Confidence 5668899999999999999999999999999999999999999965321 1122333333221
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCC
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTR 779 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R 779 (804)
++.-....+.+|+...++.|-.+|
T Consensus 260 -------fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 -------FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -------CCcccCHHHHHHHHHHHhhhhHhh
Confidence 122223356777888888888888
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=306.96 Aligned_cols=258 Identities=22% Similarity=0.359 Sum_probs=206.1
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||++.. .+++.+|||.+.... ....++.+|+.+++.++|+||+++++++.+++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 355678899999999999995 578899999886322 123578899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.........+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999998654334567899999999999999999999998 999999999999999999999999998866443
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.. ......++..|+|||.+....++.++||||||+++|||++|..|+..... ..... .......
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~-~~~~~~~----- 223 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------NLYSL-CKKIEQC----- 223 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---------hHHHH-hhhhhcC-----
Confidence 22 12234578899999999988999999999999999999999999853210 00111 1111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
..+.+ ........+.+++.+|++.+|++||||.+|+++++.+
T Consensus 224 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 DYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11111 1122345788999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.78 Aligned_cols=261 Identities=21% Similarity=0.300 Sum_probs=194.9
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
..|.+.++||+|+||.||+|+.. +++.||||.+.... .....+.+|+.++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 34667789999999999999975 68899999987432 2335678899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
++ ++|.+++.. ....++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 85 VH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 96 588887754 2345788899999999999999999998 9999999999999999999999999997543221
Q ss_pred CccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC----
Q 038103 669 DTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG---- 743 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 743 (804)
.......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||..... .......+........
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~ 229 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD-------IQDQLERIFLVLGTPNEDTW 229 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc-------HHHHHHHHHHHhCCCChhhc
Confidence 22233567899999999865 4588999999999999999999999964321 0111111111110000
Q ss_pred -----cccccCCcCCC--ccC-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 744 -----LEKIIDPRLND--VYD-------REKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 744 -----~~~~~d~~l~~--~~~-------~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
........... ... ......+.+|+..|++.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000000 000 001235778999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.49 Aligned_cols=200 Identities=27% Similarity=0.397 Sum_probs=172.8
Q ss_pred HHHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
|....|.+.++||+|+||.||++... ++..+|+|.+..... ..+++.+|++++.+++|+||+++++++.+.+..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34566778899999999999999975 578899998874322 235688999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++++|.+++.. ...+++.....++.+++.||.|||+.+. |+|+||||+|||++.++.+||+|||++....
T Consensus 82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 82 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999999964 3357889999999999999999998522 9999999999999999999999999998653
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
... .....++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 156 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred hhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 321 2234688999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=314.15 Aligned_cols=260 Identities=23% Similarity=0.366 Sum_probs=204.6
Q ss_pred HHHHhcccccccccCcceEEEEEecC------CcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEEeCC
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLDD------ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCAENE 580 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 580 (804)
....+.+.+.||+|+||.||++...+ ...+|+|++..... ...++.+|+.++.++ +|+||+++++++..+.
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34456677889999999999998642 36799999874322 235688999999999 8999999999999999
Q ss_pred eeEEEEeeccCCChhhhhccCC------------CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc
Q 038103 581 HKLLVYEYVENGSLDKLLFNDP------------GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD 648 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~ 648 (804)
..+++|||+++|+|..++.... .....+++..++.++.|++.||+|||+.+ |+|+||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 9999999999999999986421 23456899999999999999999999988 99999999999999
Q ss_pred CCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCcc
Q 038103 649 DHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSS 726 (804)
Q Consensus 649 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~ 726 (804)
.++.+||+|||+++.+..... .......++..|+|||.+....++.++||||||+++|||++ |..|+....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------- 239 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------- 239 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-------
Confidence 999999999999987654322 11222334678999999988899999999999999999998 888875322
Q ss_pred chhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 727 YCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
..+ +......+.. ...+......+.+|+.+|++.+|++||||.++++.|+.+.
T Consensus 240 ----~~~-~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 240 ----VEE-LFKLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----HHH-HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 001 1111111111 1112223457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.90 Aligned_cols=259 Identities=21% Similarity=0.367 Sum_probs=208.3
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||+|... +++.||+|.++... ...+.+.+|++++++++|+|++++++.+...+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 4567789999999999999976 78899999886311 224678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.........+++..+..++.++++||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999998654444566899999999999999999999998 999999999999999999999999998865443
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.. ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ...... ......+.....
T Consensus 160 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---------~~~~~~-~~~~~~~~~~~~ 228 (267)
T cd08224 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---------MNLYSL-CKKIEKCDYPPL 228 (267)
T ss_pred Cc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---------ccHHHH-HhhhhcCCCCCC
Confidence 22 1223457889999999998889999999999999999999999985321 011111 111111111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
........+.+++.+|++.+|++||++.+|+++|+.+.
T Consensus 229 --------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 --------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11133457889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=312.19 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=200.8
Q ss_pred cccccccccCcceEEEEEec------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 515 NFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
.+.+.||+|+||.||+|+.. +...+++|.+..... ...++.+|+.++++++||||+++++.+......++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45678999999999999853 235789998874332 2356889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCC--------------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEE
Q 038103 587 EYVENGSLDKLLFNDPG--------------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNIL 646 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIL 646 (804)
||+.+++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEE
Confidence 99999999999854211 1235789999999999999999999988 999999999999
Q ss_pred EcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCC
Q 038103 647 LDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASD 724 (804)
Q Consensus 647 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~ 724 (804)
+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||++++||++ |+.|+....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----- 234 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA----- 234 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-----
Confidence 99999999999999986543222 11222345678999999988889999999999999999999 998885321
Q ss_pred ccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 725 SSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.+.+......+. ....+......+.+++.+|++.+|++||++.++++.|+++..
T Consensus 235 -------~~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 -------PERLFNLLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -------HHHHHHHHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111112222111 011111223468899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=308.22 Aligned_cols=254 Identities=29% Similarity=0.503 Sum_probs=201.3
Q ss_pred HHhcccccccccCcceEEEEEecC-C---cEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDD-E---RVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~-~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
..+...+.||+|+||.||+|+... + ..+|+|.++... ...+++.+|++++.+++|+|++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 345567889999999999999642 3 379999987432 2345788999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999964 2346899999999999999999999998 9999999999999999999999999998664
Q ss_pred ccCCcccc--ccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 666 ERHDTKFS--RVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 666 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
........ ....+..|+|||.+....++.++||||||+++|||++ |+.||.... ... ....+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--------~~~----~~~~i~~~ 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--------NHE----VMKAINDG 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--------HHH----HHHHHhcC
Confidence 43221111 1223457999999998889999999999999999998 999985322 011 11111111
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
. . .+ ........+.+++.+|++.+|++||+|.+|++.|+++
T Consensus 227 ~--~--~~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 F--R--LP-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C--C--CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0 00 1112345689999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=309.07 Aligned_cols=246 Identities=21% Similarity=0.319 Sum_probs=194.5
Q ss_pred ccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCCh
Q 038103 520 VGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 520 LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
||+|+||+||++... +++.+|+|.+.... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999964 68899999986322 1235677899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccccc
Q 038103 595 DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR 674 (804)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 674 (804)
..++.........+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9888653334456899999999999999999999998 99999999999999999999999999986544322 2234
Q ss_pred cccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCC
Q 038103 675 VRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLND 754 (804)
Q Consensus 675 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 754 (804)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .. ........ ....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-------~~-~~~~~~~~--------~~~~-- 218 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-------EN-KELKQRIL--------NDSV-- 218 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-------hH-HHHHHhhc--------ccCC--
Confidence 568999999999999999999999999999999999999996422100 00 00111111 0100
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 755 VYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
..+......+.+++..|++.+|++|| +++++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11122344688999999999999999 6677774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=325.72 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=205.3
Q ss_pred cccccccCcceEEEEEe-cCC----cEEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 517 KQEVGKGGFGSVFRGVL-DDE----RVVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~-~~~----~~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
.+.||+|+||+||||.+ +.+ -+||||.+... .+...++.+|+.+|.+++||||+|++|+|.... +.||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 56799999999999994 443 46999988743 344688999999999999999999999998766 88999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
+.|+|.+|++. ++..+..+..+.|..|||+||.|||.+. ++||||.++|||+..-.++||.|||+++.+..+..
T Consensus 780 P~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 780 PLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred ccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999987 5667888999999999999999999988 99999999999999999999999999998876544
Q ss_pred c-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 670 T-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 670 ~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
. ......-.+.|||-|.++...|+.++|||||||++||++| |..|++..... .+...++.
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------------eI~dlle~------ 915 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------------EIPDLLEK------ 915 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------------HhhHHHhc------
Confidence 3 2222334677999999999999999999999999999999 99998765411 12222222
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
.-+...++.....+..++.+||..|+..||+++++...+...
T Consensus 916 ---geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 916 ---GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred ---cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 222233555666899999999999999999999998777543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=311.86 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=192.2
Q ss_pred HhcccccccccCcceEEEEEec--CCcEEEEEEecCcCC---ChHHHHHHHHHHhcC---CCCcccceeeeEE-----eC
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD--DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRI---NHRNLVKLQGFCA-----EN 579 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~--~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l---~H~niv~l~g~~~-----~~ 579 (804)
+|.+.++||+|+||.||+++.. +++.||||+++.... ....+.+|+.+++++ +||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 3567788999999999999863 468899999874322 234566777777665 6999999999985 23
Q ss_pred CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
...++|+||+. ++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 46899999996 5899998653 2345889999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 660 LSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 660 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
+++..... .......|++.|+|||.+....++.++||||||+++|||++|+.||...... .....+....
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--------~~~~~i~~~~ 225 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--------DQLGKILDVI 225 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--------HHHHHHHHHh
Confidence 99865432 2233456899999999999889999999999999999999999998643210 1111111110
Q ss_pred hh---cCc-------ccccCCcCC---CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 740 EQ---EGL-------EKIIDPRLN---DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 740 ~~---~~~-------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.. ... ...+.+... ..........+.+|+.+|++.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 000 000000000 0011122346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=310.79 Aligned_cols=265 Identities=23% Similarity=0.409 Sum_probs=200.9
Q ss_pred HHHHHhcccccccccCcceEEEEEecC---------------CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccc
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDD---------------ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVK 571 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~---------------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~ 571 (804)
+.+..+.+.++||+|+||.||++...+ ...||+|.++.... ....+.+|++++.+++|+|+++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 345567788999999999999987543 23589999874322 2356889999999999999999
Q ss_pred eeeeEEeCCeeEEEEeeccCCChhhhhccCCC--------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccC
Q 038103 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPG--------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQ 643 (804)
Q Consensus 572 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 643 (804)
+++++......++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChh
Confidence 99999999999999999999999999854211 1124688999999999999999999998 999999999
Q ss_pred eEEEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh--CCCCCccccc
Q 038103 644 NILLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT--GKSASDYLSA 720 (804)
Q Consensus 644 NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t--g~~p~~~~~~ 720 (804)
||++++++.+||+|||++........ .......++..|+|||.+....++.++||||||++++||++ +..||....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~- 237 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS- 237 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC-
Confidence 99999999999999999986543221 11122345678999999998899999999999999999998 555654321
Q ss_pred ccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 721 SASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
..................... ..+......+.+|+.+|++.+|++||+|.+|++.|+
T Consensus 238 -------~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 -------DEQVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -------hHHHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111222111111111110000 001112347999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=310.69 Aligned_cols=262 Identities=25% Similarity=0.387 Sum_probs=205.8
Q ss_pred HHHHHhcccccccccCcceEEEEEecC-----CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEe-CC
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDD-----ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAE-NE 580 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~-----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~ 580 (804)
+.+.++.+.+.||+|+||.||+|...+ +..|++|++..... ..+.+.+|+.++++++|+||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345667788899999999999999765 67899999874322 24568899999999999999999999876 46
Q ss_pred eeEEEEeeccCCChhhhhccCCCC----CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEe
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPGT----ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVT 656 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 656 (804)
..++++||+++++|.+++...... +..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998653221 256899999999999999999999988 9999999999999999999999
Q ss_pred ecCCcccccccCCc-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHH
Q 038103 657 DFGLSKLFKERHDT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 657 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
|||+++.+...... ......++..|+|||.+....++.++||||||+++||+++ |+.||....+ ..+
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~--- 228 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEM--- 228 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHH---
Confidence 99999865432221 1122345678999999998889999999999999999999 9999864220 111
Q ss_pred HHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 735 VAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
......+. . +. ........+.+++.+|++.+|++||++.+|+++|+.+..
T Consensus 229 -~~~~~~~~--~-----~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 229 -AAYLKDGY--R-----LA--QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -HHHHHcCC--C-----CC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111111 0 00 011123468899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.35 Aligned_cols=264 Identities=24% Similarity=0.417 Sum_probs=203.8
Q ss_pred HHHhcccccccccCcceEEEEEecC-----------------CcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccc
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDD-----------------ERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVK 571 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~-----------------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~ 571 (804)
...+.+.++||+|+||.||++...+ +..||+|.+.... ...+++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3456778999999999999998543 2468999987433 23467889999999999999999
Q ss_pred eeeeEEeCCeeEEEEeeccCCChhhhhccCCC-------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCe
Q 038103 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPG-------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQN 644 (804)
Q Consensus 572 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 644 (804)
+++++..+...++++|++++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999965431 1236899999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh--CCCCCcccccc
Q 038103 645 ILLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT--GKSASDYLSAS 721 (804)
Q Consensus 645 ILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t--g~~p~~~~~~~ 721 (804)
|+++.++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ +..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999986543221 22223446778999999988889999999999999999998 566664321
Q ss_pred cCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 722 ASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
.......+.............. .+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 239 ------~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 ------DQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ------hHHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1112222222111111111111 111223578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=304.17 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=204.0
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
..+.+.+.||.|+||.||++... ++.||+|.+.......+++.+|+.++++++|+||+++++++......++|+||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 45667789999999999999875 67899999986555567899999999999999999999999998999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 85 GSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999653 2236899999999999999999999998 99999999999999999999999999987633221
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
....+..|+|||.+....++.++||||||++++|+++ |+.|+.... ...+ ......+....
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~----~~~~~~~~~~~---- 219 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDV----VPHVEKGYRME---- 219 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--------HHHH----HHHHhcCCCCC----
Confidence 2234667999999998889999999999999999997 998885422 0111 11111111100
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
.+......+.+++.+|++.+|++||++++++++|+.+
T Consensus 220 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 -----APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -----CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1112235788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=314.08 Aligned_cols=267 Identities=21% Similarity=0.343 Sum_probs=209.1
Q ss_pred HHHHHhcccccccccCcceEEEEEec--------CCcEEEEEEecCcC--CChHHHHHHHHHHhcC-CCCcccceeeeEE
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLD--------DERVVAVKRLEGVL--QGDAEFWAEVSIIGRI-NHRNLVKLQGFCA 577 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 577 (804)
+....+.+.+.||+|+||.||+++.. ++..||+|.+.... ....++.+|+.++..+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 45566778889999999999999741 24579999887432 3346788999999999 8999999999999
Q ss_pred eCCeeEEEEeeccCCChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeE
Q 038103 578 ENEHKLLVYEYVENGSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNI 645 (804)
Q Consensus 578 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 645 (804)
.....+++|||+++++|.+++..... ....+++..+..++.||++||+|||+.+ ++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999965321 1245788999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeecCCcccccccCCc-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccC
Q 038103 646 LLDDHFEPKVTDFGLSKLFKERHDT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASAS 723 (804)
Q Consensus 646 Ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~ 723 (804)
|+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 9999999999999999876543221 1222345678999999988889999999999999999998 777775321
Q ss_pred CccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCCC
Q 038103 724 DSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQD 799 (804)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~~ 799 (804)
..+ ..+....+... ..+......+.+++.+|++.+|++||+|.+|++.|+.+......+
T Consensus 245 -------~~~-~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~~ 303 (304)
T cd05101 245 -------VEE-LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTNE 303 (304)
T ss_pred -------HHH-HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhcC
Confidence 111 11122211111 011123356889999999999999999999999999887665544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=311.79 Aligned_cols=265 Identities=27% Similarity=0.361 Sum_probs=198.8
Q ss_pred HhcccccccccCcceEEEEEec-----CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-----DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EHKLL 584 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-----~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 584 (804)
.+.+.+.||+|+||.||++... +++.||+|++.... ...+++.+|++++++++|+||+++++++... ...++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 3556788999999999999853 47789999987433 2346789999999999999999999987543 46889
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
|+||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++...
T Consensus 85 v~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 85 VMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999964 2345899999999999999999999998 999999999999999999999999999976
Q ss_pred cccCCcc--ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccC----CccchhhHHHHHHHH
Q 038103 665 KERHDTK--FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASAS----DSSYCNHLVQWVAKQ 738 (804)
Q Consensus 665 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~ 738 (804)
....... .....++..|+|||.+.+..++.++||||||++++||++|..++........ .............+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 5432211 1112234569999999988999999999999999999998876543211000 000000000111111
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
.... ............+.+|+.+|++.+|++||||.+|+++|+.+
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111 00011112234689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=315.04 Aligned_cols=240 Identities=23% Similarity=0.277 Sum_probs=192.9
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
+.||+|+||.||+++.. +++.||+|.++... .....+.+|++++++++||||+++++.+......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999964 68899999997421 23345778999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 672 (804)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcc
Confidence 99988854 345889999999999999999999998 999999999999999999999999998753221 1222
Q ss_pred cccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcC
Q 038103 673 SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRL 752 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 752 (804)
....|++.|+|||++.+..++.++||||||+++|||++|+.||..... ... ......... .+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~----~~~~~~~~~------~~ 214 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERL----FELILMEEI------RF 214 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHH----HHHHhcCCC------CC
Confidence 345689999999999999999999999999999999999999864220 011 111111111 11
Q ss_pred CCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 753 NDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
... ....+.+++.+|++.+|++|| ++.++++
T Consensus 215 p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 PRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCC----CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 112 234678999999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.30 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=196.7
Q ss_pred ccccccCcceEEEEEecC----CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
++||+|+||.||+|+... +..+|+|.+..... ..+++.+|+++++++.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 26899999875443 4567899999999999999999999876 4568999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999653 26899999999999999999999988 9999999999999999999999999998765433221
Q ss_pred c--cccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 672 F--SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 672 ~--~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
. ....++..|+|||.+....++.++||||||+++|||++ |+.||+... ...+... .......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--------~~~~~~~----~~~~~~~--- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--------GAEVIAM----LESGERL--- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--------HHHHHHH----HHcCCcC---
Confidence 1 11223567999999998899999999999999999998 999986422 1111111 1111110
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
..+......+.+++.+|++.+|++||++.+|++.|+++.
T Consensus 218 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 ------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011122346889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=308.78 Aligned_cols=264 Identities=22% Similarity=0.358 Sum_probs=205.3
Q ss_pred HHHhcccccccccCcceEEEEEe-cCCc----EEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVL-DDER----VVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~-~~~~----~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
...+.+.+.||+|+||.||+|+. .+++ .||+|.++.... ..+++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 34556678899999999999984 3443 489999874322 34678899999999999999999999975 4578
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999999652 346899999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCc-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 664 FKERHDT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 664 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.|++... ...+.. .+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~----~~~~ 226 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--------AREIPD----LLEK 226 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHH----HHHC
Confidence 6543221 1112234678999999998899999999999999999998 888886422 011111 1111
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCC
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQDESI 802 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~~~~~ 802 (804)
+.... .+......+.+++..|++.||++||++.++++.|+.+.....+-+.|
T Consensus 227 ~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~~~~ 278 (279)
T cd05109 227 GERLP---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRFVVI 278 (279)
T ss_pred CCcCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCeEee
Confidence 11110 11122346889999999999999999999999999887776554433
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.19 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=204.3
Q ss_pred HHHHHhcccccccccCcceEEEEEecC------CcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCC
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDD------ERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENE 580 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 580 (804)
|....+.+.+.||+|+||.||+|...+ +..||+|.+.... ....++.+|+.++..++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 344566777899999999999998643 3689999987433 22356889999999999999999999999999
Q ss_pred eeEEEEeeccCCChhhhhccCCC------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeE
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPG------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPK 654 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 654 (804)
..++|+||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence 99999999999999999965321 1234789999999999999999999988 99999999999999999999
Q ss_pred EeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHH
Q 038103 655 VTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLV 732 (804)
Q Consensus 655 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~ 732 (804)
|+|||+++....... .......++..|+|||.+....++.++||||||+++||+++ |+.||.... ...+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--------~~~~- 230 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--------NEEV- 230 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--------HHHH-
Confidence 999999986543221 12223346788999999998889999999999999999998 888885322 0111
Q ss_pred HHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 733 QWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
.+....+..... +......+.+++..|++.+|++|||+.++++.|+.
T Consensus 231 ---~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 231 ---LKFVIDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---HHHHhcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111122111111 11124578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=331.52 Aligned_cols=253 Identities=23% Similarity=0.258 Sum_probs=201.3
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCC-------
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENE------- 580 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 580 (804)
..|.+.+.||+|+||.||+++. .+++.||||++..... ....+.+|+.++..++|+|++++...+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 3567788999999999999985 5689999999874322 2356788999999999999999988765432
Q ss_pred -eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 581 -HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 581 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecc
Confidence 368999999999999999764444567899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH
Q 038103 660 LSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 660 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
+++.+..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+. ...
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----------~~~~-~~~ 256 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----------MEEV-MHK 256 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----------HHHH-HHH
Confidence 9987654222 22334678999999999999999999999999999999999999996422 1111 111
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...+.... .+......+.+|+..||+.+|.+||++.++++.
T Consensus 257 ~~~~~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111111 111223468899999999999999999999764
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.49 Aligned_cols=241 Identities=22% Similarity=0.272 Sum_probs=194.1
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
+.||+|+||.||++... +++.||+|.+.... ....++.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999964 68899999997432 23356788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 672 (804)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence 99988854 345889999999999999999999998 999999999999999999999999998854322 1222
Q ss_pred cccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcC
Q 038103 673 SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRL 752 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 752 (804)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ... ......+. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~----~~~~~~~~------~~~ 214 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKL----FELILMED------IKF 214 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------HHH----HHHhccCC------ccC
Confidence 345689999999999998999999999999999999999999964220 011 11111111 111
Q ss_pred CCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038103 753 NDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVKL 788 (804)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~~ 788 (804)
... ....+.+|+.+|++.+|++|| ++.++++.
T Consensus 215 p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRT----LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112 234678999999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.15 Aligned_cols=246 Identities=25% Similarity=0.311 Sum_probs=199.0
Q ss_pred HHHHhcccccccccCcceEEEEEecC--CcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLDD--ERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~~--~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
....+.+.+.||+|+||.||+|...+ +..||+|++... ....+.+.+|++++..++||||+++++++.++...+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34457778899999999999998543 368999998632 223456889999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 108 lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999964 345889999999999999999999998 99999999999999999999999999986
Q ss_pred ccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
.... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------------~~~~~~i~~~~ 244 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP------------LLIYQKILEGI 244 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH------------HHHHHHHhcCC
Confidence 5432 2345689999999999988899999999999999999999999964220 01111122211
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVKL 788 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~~ 788 (804)
.. +.... ...+.+++.+|++.+|++|+ +++++++.
T Consensus 245 ~~------~p~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 IY------FPKFL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC------CCCCC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 10 11112 23578999999999999995 88888654
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=300.15 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=191.4
Q ss_pred ccccccCcceEEEEEecCC---cEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 518 QEVGKGGFGSVFRGVLDDE---RVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
++||+|+||.||++...++ ..+++|.++... ...+++.+|+.+++.++||||+++++.|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999985433 346677766332 23467999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc-CCcc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER-HDTK 671 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~-~~~~ 671 (804)
+|.+++..........++.....++.||++||+|||+.+ ++|+||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999764333345677788899999999999999988 999999999999999999999999998643221 1122
Q ss_pred ccccccCCCccchhhhcc-------CCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 672 FSRVRGTRGYLAPEWMMN-------LKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~-------~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
.....++..|+|||++.. ..++.++||||||+++|||++ |..|+.... ..+...... .+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----------~~~~~~~~~-~~~ 225 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-----------DREVLNHVI-KDQ 225 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-----------HHHHHHHHH-hhc
Confidence 234557889999998743 245789999999999999997 466664321 011111111 222
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
...+.++.+...++ ..+.+++..|+ .+|++||++++|++.|.
T Consensus 226 ~~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 226 QVKLFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccccCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33344454443333 35677888899 57999999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=308.50 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=200.4
Q ss_pred HHhcccccccccCcceEEEEEec------CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
..+.+.++||+|+||.||++... ++..+|+|.+.... ...+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 44556789999999999999742 35679999887433 334679999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCC-----------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCe
Q 038103 585 VYEYVENGSLDKLLFNDPG-----------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP 653 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 653 (804)
++||+++++|.+++..... ....+++..++.++.|++.|++|||+.+ ++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 1135889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhH
Q 038103 654 KVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHL 731 (804)
Q Consensus 654 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~ 731 (804)
||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~ 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------TEA 233 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------HHH
Confidence 9999999986543221 11122334678999999999899999999999999999998 8888753220 011
Q ss_pred HHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 732 VQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 732 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
......+... . .+......+.+|+.+||+.+|.+||++.+|++.|+.
T Consensus 234 ----~~~~~~~~~~-----~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 ----IECITQGREL-----E----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----HHHHHcCccC-----C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111111110 0 011123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.85 Aligned_cols=258 Identities=24% Similarity=0.392 Sum_probs=203.0
Q ss_pred HHHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEEeCC
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCAENE 580 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 580 (804)
....+.+.+.||+|+||.||++... .+..||||+++.... ..+.+.+|+.+++++ +|+||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3445677889999999999999741 245799999875432 235688999999999 7999999999999999
Q ss_pred eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCC
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGL 660 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 660 (804)
..++++||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999652 2234899999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCc-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHH
Q 038103 661 SKLFKERHDT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 661 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
++........ ......++..|+|||.+....++.++||||||+++|||++ |+.|+..... ...+ ...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-------~~~~----~~~ 256 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-------DSKF----YKL 256 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-------hHHH----HHH
Confidence 9866443221 1122345678999999998899999999999999999998 9998854221 0111 111
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
...+. . ...+......+.+++.+|++.+|++||++.+|++.|+..
T Consensus 257 ~~~~~-~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEGY-R--------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcCC-c--------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111 0 001111234688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.91 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=194.6
Q ss_pred ccccccCcceEEEEEecC-Cc--EEEEEEecCcC--CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLDD-ER--VVAVKRLEGVL--QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~-~~--~vavK~l~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+|+..+ +. .+++|.++... ...+.+.+|++++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 33 47888887432 2345788999999999 899999999999999999999999999
Q ss_pred CChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 592 GSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 592 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999865321 1235789999999999999999999988 9999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHH
Q 038103 660 LSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 660 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
++...... ........+..|+|||++....++.++||||||++++||++ |+.||.... .... ...
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----------~~~~-~~~ 223 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----------CAEL-YEK 223 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----------HHHH-HHH
Confidence 98632211 11111223567999999988889999999999999999997 999985421 0111 111
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
...+... ..+......+.+|+.+|++.+|.+||++.++++.|+.+.
T Consensus 224 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 LPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HhCCCCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111000 011122346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=318.90 Aligned_cols=244 Identities=21% Similarity=0.357 Sum_probs=189.7
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
.+.++||+|+||.||+++.. +++.||||.+..... ...++.+|++++++++|+||+++++++......++|+||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 34678999999999999965 688999999864322 235688999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.... ...+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..... .
T Consensus 157 ~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 157 GSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred Ccccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 9986543 2456778899999999999999998 99999999999999999999999999987643221 1
Q ss_pred ccccccCCCccchhhhcc-----CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 672 FSRVRGTRGYLAPEWMMN-----LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.....|+..|+|||.+.. ...+.++|||||||++|||++|+.||..... . ......... ....
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~----~~~~~~~~~-~~~~--- 292 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ----G----DWASLMCAI-CMSQ--- 292 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----c----cHHHHHHHH-hccC---
Confidence 233568999999998743 2345689999999999999999999973210 0 011111110 0000
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+ .........+.+|+.+||+.+|++||++.||++.
T Consensus 293 --~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 --PP----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 1111233468899999999999999999999975
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=296.81 Aligned_cols=263 Identities=20% Similarity=0.295 Sum_probs=200.6
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCc-ccceeeeEEeCC------e
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRN-LVKLQGFCAENE------H 581 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~ 581 (804)
.+...++||+|+||+||+|+. .+|+.||+|+++.... -.....+|+.++.+++|+| ||++.+++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 344457799999999999994 5688999999984433 2345689999999999999 999999998877 7
Q ss_pred eEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCc
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 661 (804)
+++|+||++. +|..++...+....-++-..+..++.||++||+|||+++ |+||||||+||||++.+.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 8999999977 999999765432234666889999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 662 KLFKERHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
+.+.-.. ...+...+|..|+|||.+.+. .|++..||||+|||+.||++++..|..... ......+.+.+.
T Consensus 168 ra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--------~~ql~~If~~lG 238 (323)
T KOG0594|consen 168 RAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--------IDQLFRIFRLLG 238 (323)
T ss_pred HHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--------HHHHHHHHHHcC
Confidence 9655322 235566789999999999877 699999999999999999999888864321 111122222222
Q ss_pred hcC------cccccCCcC--CCc-----cCH---HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 741 QEG------LEKIIDPRL--NDV-----YDR---EKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 741 ~~~------~~~~~d~~l--~~~-----~~~---~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
... +..+.+-.. ... ... .......+++.+|++.+|.+|.++..++++
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 211 111111111 000 001 111367899999999999999999999986
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.53 Aligned_cols=254 Identities=22% Similarity=0.386 Sum_probs=197.0
Q ss_pred cccccccccCcceEEEEEecCC-c--EEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeC------Cee
Q 038103 515 NFKQEVGKGGFGSVFRGVLDDE-R--VVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN------EHK 582 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~~~-~--~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 582 (804)
.+.+.||+|+||.||+|+..+. . .+|+|.++... ...+++.+|++++.+++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 3567899999999999997543 2 58999887432 2345688899999999999999999988532 246
Q ss_pred EEEEeeccCCChhhhhccCC--CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCC
Q 038103 583 LLVYEYVENGSLDKLLFNDP--GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGL 660 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 660 (804)
++++||+++|+|.+++.... .....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999874321 12345899999999999999999999988 99999999999999999999999999
Q ss_pred cccccccCCc-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHH
Q 038103 661 SKLFKERHDT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 661 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
++.+...... ......+++.|+|||.+....++.++||||||+++|||++ |+.||.... ... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~----~~~~ 226 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--------NSE----IYDY 226 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHH----HHHH
Confidence 9876442221 1122345678999999999899999999999999999999 788875421 011 1122
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
...+..... +......+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 227 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 LRQGNRLKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 222221110 112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=306.77 Aligned_cols=264 Identities=24% Similarity=0.408 Sum_probs=200.8
Q ss_pred HHHhcccccccccCcceEEEEEec-----------------CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccc
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-----------------DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVK 571 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-----------------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~ 571 (804)
+..+.+.++||+|+||.||++... +...+|+|++.... ....++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 345677889999999999998532 23469999987432 23467899999999999999999
Q ss_pred eeeeEEeCCeeEEEEeeccCCChhhhhccCCC-------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCe
Q 038103 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPG-------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQN 644 (804)
Q Consensus 572 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 644 (804)
+++++......++|+||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999865321 1235788899999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh--CCCCCcccccc
Q 038103 645 ILLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT--GKSASDYLSAS 721 (804)
Q Consensus 645 ILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t--g~~p~~~~~~~ 721 (804)
||++.++.+||+|||+++.+..... .......++..|+|||....+.++.++||||||+++|||++ |..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 9999999999999999986543221 11122334678999999888899999999999999999998 6677753221
Q ss_pred cCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 722 ASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
........+......... ..+. +......+.+|+.+|++.+|++||+|.+|++.|+.
T Consensus 240 -------~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 -------EQVIENTGEFFRDQGRQV-YLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -------HHHHHHHHHHHhhccccc-cCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111111111 1110 11233578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.96 Aligned_cols=254 Identities=23% Similarity=0.393 Sum_probs=198.8
Q ss_pred cccccccccCcceEEEEEecC----CcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCe------
Q 038103 515 NFKQEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEH------ 581 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~~----~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 581 (804)
.+.+.||+|+||.||+|.... +..||+|+++.... ...++.+|++.+++++|+|++++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 456789999999999998642 36799999874332 23578899999999999999999999876554
Q ss_pred eEEEEeeccCCChhhhhccCCC--CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 582 KLLVYEYVENGSLDKLLFNDPG--TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
.++++||+++++|..++..... ....+++.....++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCcc
Confidence 7999999999999999855321 2346889999999999999999999988 9999999999999999999999999
Q ss_pred CcccccccCCc-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHH
Q 038103 660 LSKLFKERHDT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAK 737 (804)
Q Consensus 660 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (804)
+++........ ......++..|+|||.+....++.++||||||+++|||++ |..|+.... ...+. +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--------~~~~~----~ 226 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--------NHEIY----D 226 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--------HHHHH----H
Confidence 99866433221 1122334678999999988889999999999999999999 888875422 01111 1
Q ss_pred HhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 738 QMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 738 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
....+.... .+......+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 227 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 YLRHGNRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHcCCCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111111 1122345789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=322.05 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=197.9
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
...+.+.+.||+|+||.||+++.. +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 456677889999999999999965 58899999996321 2334578899999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++|+|.+++.. ..++......++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 122 MEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999854 24777888889999999999999998 9999999999999999999999999998765
Q ss_pred ccCCccccccccCCCccchhhhccC----CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNL----KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
...........||+.|+|||.+... .++.++|||||||++|||++|+.||.... .... ...+..
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----------~~~~-~~~i~~ 261 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----------LVGT-YSKIMD 261 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-----------HHHH-HHHHHc
Confidence 4333233446789999999998653 47889999999999999999999996422 1111 111111
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDT--RPPMSKVVKL 788 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPtm~~Vv~~ 788 (804)
.... + .... .......+.+|+..|++.+|.+ ||++.++++.
T Consensus 262 ~~~~-~---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 262 HKNS-L---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCc-C---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1100 0 0001 1112346788999999999987 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=317.41 Aligned_cols=262 Identities=24% Similarity=0.400 Sum_probs=201.3
Q ss_pred HHHHhcccccccccCcceEEEEEe------cCCcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEEeC-
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCAEN- 579 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~- 579 (804)
....+.+.+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+.++.++ +|+||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 345678889999999999999973 3467899999974332 235688899999999 689999999988654
Q ss_pred CeeEEEEeeccCCChhhhhccCCC--------------------------------------------------------
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPG-------------------------------------------------------- 603 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 603 (804)
...++++||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999999864211
Q ss_pred -------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC-cccccc
Q 038103 604 -------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD-TKFSRV 675 (804)
Q Consensus 604 -------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~ 675 (804)
....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........ ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 0124688888999999999999999998 99999999999999999999999999986533222 112223
Q ss_pred ccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCC
Q 038103 676 RGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLND 754 (804)
Q Consensus 676 ~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 754 (804)
.++..|+|||.+....++.++||||||+++|||++ |..|+..... ...+ ......+.... ...
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~----~~~~~~~~~~~-----~~~ 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------DEEF----CRRLKEGTRMR-----APD 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc-------cHHH----HHHHhccCCCC-----CCC
Confidence 45678999999988899999999999999999997 8888754210 0111 11111211111 011
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 755 VYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
. ....+.+++..|++.+|++||++.+|++.|+.+.+
T Consensus 306 ~----~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 Y----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred C----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 12358899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.58 Aligned_cols=255 Identities=23% Similarity=0.333 Sum_probs=191.6
Q ss_pred cccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCC-----eeEEEEeecc
Q 038103 517 KQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENE-----HKLLVYEYVE 590 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E~~~ 590 (804)
.+.+|.|+||.||+|++. .+..||||+.-.... .--+|+++|+++.|||||+++-++.... ...||+|||+
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 367999999999999965 468999999863322 2236999999999999999999886433 3458999998
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC-CCeEEeecCCcccccccCC
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH-FEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~~~~ 669 (804)
. +|..+++.....+..++.-.+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ +.+||+|||.|+.+.....
T Consensus 106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 8 999999753334556777778889999999999999988 9999999999999977 8999999999998877555
Q ss_pred ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHH-------HHhhh
Q 038103 670 TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVA-------KQMEQ 741 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~ 741 (804)
.. ....|..|+|||.+.+. .|+.+.||||.||++.||+-|+..|...... .++.+.+. +.+..
T Consensus 182 ni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-------dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 182 NI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-------DQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-------HHHHHHHHHhCCCCHHHHhh
Confidence 43 33458899999998865 6999999999999999999999988642211 11221111 11111
Q ss_pred cCcc--cccCCcCC-----CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 742 EGLE--KIIDPRLN-----DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 742 ~~~~--~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.... +.-.+.+. ...........++|+.++++.+|.+|.++.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111 11112221 1122334457889999999999999999999874
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=299.86 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=192.2
Q ss_pred ccccccCcceEEEEEecC---CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 518 QEVGKGGFGSVFRGVLDD---ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~---~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
+.||+|+||.||+|...+ +..+|+|+++.... ...++.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 45799998874432 3357888999999999999999999999999999999999999
Q ss_pred ChhhhhccCCC-CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC-c
Q 038103 593 SLDKLLFNDPG-TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD-T 670 (804)
Q Consensus 593 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~ 670 (804)
+|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965322 2235677888899999999999999998 99999999999999999999999999975433221 1
Q ss_pred cccccccCCCccchhhhccC-------CCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 671 KFSRVRGTRGYLAPEWMMNL-------KIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~-------~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
......++..|+|||++... .++.++||||||+++|||++ |+.||..... ..... ....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--------~~~~~----~~~~~ 225 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--------EQVLT----YTVRE 225 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--------HHHHH----HHhhc
Confidence 12234567889999988642 35789999999999999996 9999864220 01111 11111
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
....+.++.+.... .+.+.+++..|+ .+|++|||+++|++.|+
T Consensus 226 ~~~~~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 QQLKLPKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCCCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 12222333332222 235677888898 58999999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.44 Aligned_cols=240 Identities=26% Similarity=0.315 Sum_probs=192.2
Q ss_pred ccccccCcceEEEEEe----cCCcEEEEEEecCcC-----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 518 QEVGKGGFGSVFRGVL----DDERVVAVKRLEGVL-----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.||+|+||.||+++. ..++.||||.++... .....+.+|+.++++++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357889999987421 2234578899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++.. ...+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999864 345778888899999999999999998 9999999999999999999999999987543222
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||.... .... ......+..
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-----------~~~~-~~~~~~~~~---- 217 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-----------RKKT-IDKILKGKL---- 217 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-----------HHHH-HHHHHcCCC----
Confidence 12233568999999999998889999999999999999999999996422 0111 111111111
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
.+... ....+.+++.+|++.+|++|| ++.++++
T Consensus 218 --~~~~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 --NLPPY----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCC----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11111 234678999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=311.08 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=199.7
Q ss_pred hcccccccccCcceEEEEEecC-C--cEEEEEEecCcC--CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEe
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDD-E--RVVAVKRLEGVL--QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~-~--~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 587 (804)
+.+.+.||+|+||.||+|...+ + ..+++|.++... ...+.+.+|++++.++ +||||+++++++......++++|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4567889999999999999754 3 347888887422 2345788999999999 79999999999999999999999
Q ss_pred eccCCChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEE
Q 038103 588 YVENGSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKV 655 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 655 (804)
|+++++|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEE
Confidence 9999999999965321 1235889999999999999999999988 999999999999999999999
Q ss_pred eecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHH
Q 038103 656 TDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 656 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
+|||++........ ......+..|+|||.+....++.++||||||+++|||++ |+.||.... ...
T Consensus 161 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~-----------~~~- 226 (297)
T cd05089 161 ADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-----------CAE- 226 (297)
T ss_pred CCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----------HHH-
Confidence 99999874322111 111223557999999998889999999999999999998 999986422 011
Q ss_pred HHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 735 VAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
+......+. .. ..+......+.+|+..|++.+|.+||++.++++.|+.+.+...
T Consensus 227 ~~~~~~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 227 LYEKLPQGY-----RM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHHHHhcCC-----CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111111110 01 1111223468899999999999999999999999987765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.36 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=198.4
Q ss_pred HHhcccccccccCcceEEEEEecC------CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDD------ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
..+.+.+.||+|+||.||+|...+ +..||+|.+..... ...++.+|+.++++++|+||+++++++.+....+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 445667889999999999999753 56799998864332 3456899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCC---CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC---CeEEee
Q 038103 584 LVYEYVENGSLDKLLFNDPG---TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF---EPKVTD 657 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~D 657 (804)
+|+||+++++|.+++..... ....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEecc
Confidence 99999999999999865321 1235899999999999999999999998 99999999999998654 599999
Q ss_pred cCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHH
Q 038103 658 FGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWV 735 (804)
Q Consensus 658 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 735 (804)
||+++....... ........+..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~--- 231 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVM--- 231 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH---
Confidence 999987632211 11112233567999999998899999999999999999997 9988864220 1111
Q ss_pred HHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 736 AKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 736 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
........ ...+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 232 -~~~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 -EFVTGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -HHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111100 0111222357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=321.69 Aligned_cols=249 Identities=24% Similarity=0.306 Sum_probs=199.3
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
|.+.+.||+|+||.||+++.. +++.||||+++... .....+.+|++++..++|+||+++++.+.++...++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 556788999999999999965 68899999997422 3345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 83 MPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999642 46889999999999999999999988 9999999999999999999999999998765433
Q ss_pred ----------------------------CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCccccc
Q 038103 669 ----------------------------DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSA 720 (804)
Q Consensus 669 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~ 720 (804)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~- 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC-
Confidence 112234568999999999999999999999999999999999999996432
Q ss_pred ccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 038103 721 SASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPP-MSKVVKL 788 (804)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-m~~Vv~~ 788 (804)
..... ..+... ...+.-+ . .......+.+|+..|++ +|.+||+ +.++++.
T Consensus 235 ----------~~~~~-~~i~~~-~~~~~~p---~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 ----------LQETY-NKIINW-KESLRFP---P--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ----------HHHHH-HHHhcc-CCcccCC---C--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 00111 111110 0000000 0 00123467889999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.57 Aligned_cols=254 Identities=29% Similarity=0.507 Sum_probs=201.5
Q ss_pred HHhcccccccccCcceEEEEEec----CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD----DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~----~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
..+.+.+.||+|+||.||+|... .+..+|+|.++.... ..+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45667889999999999999853 234799999874332 245789999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999652 345899999999999999999999998 9999999999999999999999999998765
Q ss_pred ccCCccc--cccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 666 ERHDTKF--SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 666 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
....... ....++..|+|||.+.+..++.++||||||+++||+++ |+.||..... .... ....++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~~~----~~~~~~ 225 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QDVI----KAIEEG 225 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HHHH----HHHhCC
Confidence 4322211 12223567999999998899999999999999999887 9999864220 0111 111111
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
. .. + .....+..+.+++.+|++.+|.+||+|.++++.|+.+
T Consensus 226 ~--~~--~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 Y--RL--P-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C--cC--C-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 00 0 0112234678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.81 Aligned_cols=254 Identities=28% Similarity=0.493 Sum_probs=200.4
Q ss_pred HHhcccccccccCcceEEEEEecC-C---cEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDD-E---RVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~-~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
+.+++.+.||+|+||.||+|.... + ..||||.++... ....+|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 446778899999999999999653 2 369999987432 2345799999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
+||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999999652 346889999999999999999999998 9999999999999999999999999998654
Q ss_pred ccCCcc-cc-ccc--cCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 666 ERHDTK-FS-RVR--GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 666 ~~~~~~-~~-~~~--gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
...... .. ... .+..|+|||.+....++.++||||||+++||+++ |+.||.... ...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--------~~~~~~----~i~ 225 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--------NQDVIN----AIE 225 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--------HHHHHH----HHH
Confidence 422211 11 111 2357999999999899999999999999999887 999986422 011111 111
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
.. ... ..+.+.+..+.+++..|++.+|++||+|.+|+++|+.+
T Consensus 226 ~~--~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 QD--YRL-------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cC--CcC-------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 000 01112234678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=299.97 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=201.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCc---CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV---LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+.+.+.||+|++|.||++... +++.|++|.+... ....+++.+|++++++++|||++++++++.+....++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 356688999999999999965 5888999998632 233467889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 82 ENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 999999999753 2456889999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......+++.|+|||++....++.++||||||++++||++|+.||..... .. .......+....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~----~~~~~~~~~~~~--- 220 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GA----LILKIIRGVFPP--- 220 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HH----HHHHHHcCCCCC---
Confidence 22334578899999999998999999999999999999999999864320 01 111111111111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+......+.+++.+|++.+|++||+|.++++.
T Consensus 221 ------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 ------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ------CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111233578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=304.96 Aligned_cols=256 Identities=24% Similarity=0.407 Sum_probs=201.5
Q ss_pred HHhcccccccccCcceEEEEEec------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
..+.+.++||+|+||.||++... ++..||+|.+..... ...++.+|+.++++++|+||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 44566788999999999999864 467899999874332 3467889999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCC------------------CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeE
Q 038103 584 LVYEYVENGSLDKLLFNDP------------------GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNI 645 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 645 (804)
+++||+++++|.+++.... .....+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhhe
Confidence 9999999999999996421 11234788899999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccC
Q 038103 646 LLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASAS 723 (804)
Q Consensus 646 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~ 723 (804)
++++++.+||+|||++........ ........+..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~---- 237 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA---- 237 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----
Confidence 999999999999999986543221 11122234667999999998899999999999999999998 877875321
Q ss_pred CccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 724 DSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
..+ .......+.... .+......+.+++.+|++.+|++||++.|+++.|+.
T Consensus 238 -------~~~-~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 -------HEE-VIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHH-HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 011 112222222211 111223578999999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=313.14 Aligned_cols=249 Identities=23% Similarity=0.284 Sum_probs=195.8
Q ss_pred hcccccccccCcceEEEEEe----cCCcEEEEEEecCcC-----CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeE
Q 038103 514 RNFKQEVGKGGFGSVFRGVL----DDERVVAVKRLEGVL-----QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 583 (804)
+.+.+.||+|+||.||+++. .+++.||+|.+.... ...+.+.+|+.++.++ +|+||+++++++......+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 45678899999999999985 357899999986321 2234678899999999 5999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999864 345889999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
.............||+.|+|||.+.+. .++.++||||||+++|||++|+.||....... . ...+......
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~----~~~~~~~~~~- 225 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN----T----QSEVSRRILK- 225 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC----C----HHHHHHHHhc-
Confidence 544433334456789999999999865 47889999999999999999999996422110 0 0111111111
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
.++.+... ....+.+++.+|++.||++|| +++++++
T Consensus 226 -----~~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 -----CDPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -----CCCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11112122 233678899999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=311.65 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=190.6
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+++.. +++.+|+|.++... .....+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36899999999999965 57889999997432 2234577888888776 899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 999988854 345889999999999999999999998 9999999999999999999999999997532221 22
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....||..|+|||++.+..++.++||||||+++|||++|+.||.......... .....++......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~---~~~~~~~~~~i~~~~~------~ 223 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD---QNTEDYLFQVILEKQI------R 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc---cccHHHHHHHHhcCCC------C
Confidence 234568999999999999999999999999999999999999996432211111 1112222222222211 1
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPM 782 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 782 (804)
+ +......+.+++.+|++.||++||+.
T Consensus 224 ~----p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 I----PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred C----CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1 11223467899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.20 Aligned_cols=266 Identities=24% Similarity=0.376 Sum_probs=204.6
Q ss_pred HHhcccccccccCcceEEEEEec-----CCcEEEEEEecCcCCC--hHHHHHHHHHHhcCCCCcccceeeeEEe--CCee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-----DERVVAVKRLEGVLQG--DAEFWAEVSIIGRINHRNLVKLQGFCAE--NEHK 582 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-----~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 582 (804)
..+.+.+.||+|+||.||+++.. .+..+|||.++..... .+++.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34556788999999999999854 3678999999855543 6789999999999999999999999887 5578
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++++||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999653 335899999999999999999999998 9999999999999999999999999999
Q ss_pred cccccCCc--cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCC---ccchhhHHHHHHH
Q 038103 663 LFKERHDT--KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASD---SSYCNHLVQWVAK 737 (804)
Q Consensus 663 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~ 737 (804)
........ ......++..|+|||.+....++.++||||||++++||++|+.|+......... .............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532221 111223456799999998889999999999999999999999987542211100 0000000111111
Q ss_pred HhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 738 QMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 738 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
...... ....+......+.+|+.+|++.+|++||+|.+|+++|+.+
T Consensus 238 ~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111 1111122335789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.94 Aligned_cols=246 Identities=21% Similarity=0.320 Sum_probs=192.5
Q ss_pred ccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCCh
Q 038103 520 VGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 520 LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
||+|+||.||+++.. +++.+|+|.+.... .....+..|++++++++||||+++.+.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999964 58899999986321 1234456799999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccccc
Q 038103 595 DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR 674 (804)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 674 (804)
..++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9888643 2345889999999999999999999998 9999999999999999999999999998654322 2233
Q ss_pred cccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCC
Q 038103 675 VRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLND 754 (804)
Q Consensus 675 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 754 (804)
..++..|+|||++....++.++||||||+++|||++|+.||...... ......... ..... +... ..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-------~~~~~~~~~-~~~~~----~~~~-~~ 220 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-------VAKEELKRR-TLEDE----VKFE-HQ 220 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-------hhHHHHHHH-hhccc----cccc-cc
Confidence 46889999999999888999999999999999999999998642210 000111111 11111 1000 01
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 038103 755 VYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789 (804)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L 789 (804)
.....+.+|+..|++.+|++||++.|+++.+
T Consensus 221 ----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 221 ----NFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ----cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 1234678999999999999999997766444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.89 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=199.2
Q ss_pred HHhcccccccccCcceEEEEEec-CCc--EEEEEEecCcC--CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DER--VVAVKRLEGVL--QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~--~vavK~l~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 585 (804)
..+.+.+.||+|+||.||+|..+ ++. .+|+|+++... ....++.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 34567788999999999999964 343 46888776422 2345788999999999 899999999999999999999
Q ss_pred EeeccCCChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCe
Q 038103 586 YEYVENGSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP 653 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 653 (804)
+||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999964321 1236889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHH
Q 038103 654 KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLV 732 (804)
Q Consensus 654 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~ 732 (804)
||+|||++....... .......+..|+|||++....++.++||||||++++||+| |..||..... ...
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~- 232 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AEL- 232 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------HHH-
Confidence 999999987432111 1111223567999999988889999999999999999998 9999853220 011
Q ss_pred HHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 733 QWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
......+. ....+......+.+|+.+|++.+|++||++.+++++|+.+.+.
T Consensus 233 ---~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 233 ---YEKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred ---HHHHhcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111110 0001111234678999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=299.77 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=198.3
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEE-eCCeeEEEEeecc
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCA-ENEHKLLVYEYVE 590 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~ 590 (804)
..+.+.+.||+|+||.||++... +..+|+|.++.. ...+.+.+|+.++++++|+|++++++++. .+...++++||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 45667789999999999999875 567899988643 23567889999999999999999999765 4567899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++... ....+++..+..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 84 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999653 2345889999999999999999999998 9999999999999999999999999988543322
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
.....+..|+|||++....++.++||||||+++|||++ |+.|+.... .... ......+...
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----------~~~~-~~~~~~~~~~---- 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----------LKDV-VPRVEKGYKM---- 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----------HHHH-HHHHhcCCCC----
Confidence 12234568999999998899999999999999999998 888875321 1111 1111111111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
.. .......+.+++.+|++.+|++||++.++++.|+.+
T Consensus 219 -~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 -DA----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11 112234788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.73 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=195.7
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
...+.+.+.||+|+||.||+++.. +++.+|+|.+.... .....+.+|+.+++.++||||+++++.+..+...++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 356777889999999999999965 57889999986321 2334578899999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++|+|.+++.. ..++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 122 MEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999953 24788889999999999999999998 9999999999999999999999999998765
Q ss_pred ccCCccccccccCCCccchhhhccC----CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNL----KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
...........||+.|+|||.+... .++.++||||+|+++|||++|+.||.... ...........
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-----------~~~~~~~i~~~ 262 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-----------LVGTYSKIMDH 262 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-----------HHHHHHHHHhC
Confidence 4333233456799999999998754 37889999999999999999999996422 01111111111
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDT--RPPMSKVVKL 788 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPtm~~Vv~~ 788 (804)
..... +.. .......+.+++..|++.++.+ ||++.++++.
T Consensus 263 ~~~~~-----~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNSLN-----FPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CcccC-----CCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 10000 000 1112345678888888755543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.21 Aligned_cols=263 Identities=22% Similarity=0.334 Sum_probs=204.9
Q ss_pred HHHHHhcccccccccCcceEEEEEec--------CCcEEEEEEecCcC--CChHHHHHHHHHHhcC-CCCcccceeeeEE
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLD--------DERVVAVKRLEGVL--QGDAEFWAEVSIIGRI-NHRNLVKLQGFCA 577 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 577 (804)
+....+.+.++||+|+||.||+++.. ....+|+|.++... ....++.+|+.++.++ +|+||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 34466788899999999999999852 23469999987432 2335688899999999 7999999999999
Q ss_pred eCCeeEEEEeeccCCChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeE
Q 038103 578 ENEHKLLVYEYVENGSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNI 645 (804)
Q Consensus 578 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 645 (804)
.....++|+||+++++|.+++..... ....+++..+.+++.|++.||+|||+.+ ++|+||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence 99999999999999999999965321 1235889999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccC
Q 038103 646 LLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASAS 723 (804)
Q Consensus 646 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~ 723 (804)
+++.++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---- 247 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 247 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC----
Confidence 999999999999999986543211 11112234568999999998889999999999999999998 888875321
Q ss_pred CccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 724 DSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
. +.+......+... ..+......+.+|+.+|++.+|++||+|.+|++.|+.+...
T Consensus 248 -------~-~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 -------V-EELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -------H-HHHHHHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1 1111122221111 11112234788999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=298.59 Aligned_cols=253 Identities=29% Similarity=0.396 Sum_probs=189.5
Q ss_pred ccccccCcceEEEEEecC---CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 518 QEVGKGGFGSVFRGVLDD---ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~---~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
++||+|+||.||+|...+ ...+++|.+..... ...++.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999998543 34688888764322 2356889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCC-CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC-c
Q 038103 593 SLDKLLFNDPGT-ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD-T 670 (804)
Q Consensus 593 sL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~ 670 (804)
+|.+++...... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999764322 234567888999999999999999998 99999999999999999999999999875432211 1
Q ss_pred cccccccCCCccchhhhcc-------CCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 671 KFSRVRGTRGYLAPEWMMN-------LKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~-------~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
......++..|+|||++.. ..++.++||||||+++|||++ |+.|+..... .+....... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----------~~~~~~~~~-~ 225 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-----------EQVLKQVVR-E 225 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-----------HHHHHHHhh-c
Confidence 1122345678999998743 356889999999999999999 7777753210 011111111 2
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
....+.++.+...++ ..+.+++..|+ .+|++||++++|+++|.
T Consensus 226 ~~~~~~~~~~~~~~~----~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 226 QDIKLPKPQLDLKYS----DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCccCCCCcccccCC----HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222233333332223 35566777788 49999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=311.87 Aligned_cols=268 Identities=20% Similarity=0.322 Sum_probs=197.0
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeC-----CeeEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN-----EHKLL 584 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l 584 (804)
|.+.+.||+|+||.||+|+.. +++.||||++.... ....++.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 556788999999999999964 68899999987432 2345688999999999999999999988643 25799
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||+. ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 v~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 82 VFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999996 589888853 345899999999999999999999998 999999999999999999999999999865
Q ss_pred cccCC--ccccccccCCCccchhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHH----
Q 038103 665 KERHD--TKFSRVRGTRGYLAPEWMMN--LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVA---- 736 (804)
Q Consensus 665 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---- 736 (804)
..... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...... .....+.
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--------~~~~~~~~~~~ 225 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--------HQLDLITDLLG 225 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--------HHHHHHHHHhC
Confidence 33222 12234568999999999875 67899999999999999999999998542210 0000000
Q ss_pred -------HHhhhcCccccc---CCcCCCcc---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hccCCCCCC
Q 038103 737 -------KQMEQEGLEKII---DPRLNDVY---DREKLDRMVKVALLCVAENRDTRPPMSKVVKL--LTAHDHESS 797 (804)
Q Consensus 737 -------~~~~~~~~~~~~---d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~--L~~~~~~~~ 797 (804)
..+......+.+ .+...... -......+.+++.+|++.+|++||+++++++. ++++.....
T Consensus 226 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~ 301 (338)
T cd07859 226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVER 301 (338)
T ss_pred CCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcccc
Confidence 000000000000 00000000 00123457899999999999999999999854 555444433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=302.01 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=197.3
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEeC------CeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAEN------EHKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------~~~~ 583 (804)
..+.+.+.||+|+||.||+|... +++.||+|++........++.+|+.++.++ +|+||+++++++... ...+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 34566778999999999999965 578899999986666667889999999998 799999999998753 4679
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
++|||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++..
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999998653 2346889999999999999999999998 99999999999999999999999999986
Q ss_pred ccccCCccccccccCCCccchhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMM-----NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
..... .......|+..|+|||++. ...++.++||||||+++|||++|+.|+...... .. ...
T Consensus 161 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----------~~--~~~ 227 (272)
T cd06637 161 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----------RA--LFL 227 (272)
T ss_pred ccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----------HH--HHH
Confidence 54322 2233456889999999986 345888999999999999999999998632200 00 001
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..........+ ......+.+|+.+|++.+|.+||++.+|++
T Consensus 228 ~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 IPRNPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HhcCCCCCCCC--------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11111111111 112246889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.41 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=203.6
Q ss_pred HHHHhcccccccccCcceEEEEEecC----CcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
.+.++.+.+.||+|+||.||+|...+ ...|+||...... ...+.+.+|+.++++++|+||+++++++.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34566778899999999999998643 3468999887433 234578999999999999999999999875 5578
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+|+||+++++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 83 IVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeee
Confidence 999999999999999652 335899999999999999999999988 99999999999999999999999999987
Q ss_pred ccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
.............++..|+|||.+....++.++||||||++++|+++ |+.||..... ... . .....+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~---~-~~~~~~ 224 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--------NDV---I-GRIENG 224 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--------HHH---H-HHHHcC
Confidence 65432222222334568999999988889999999999999999996 9999864320 011 1 111111
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
... .. +......+.+++.+|+..+|++||++.++++.|+++..++
T Consensus 225 ~~~-----~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 225 ERL-----PM----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred CcC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 110 01 1122347889999999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=297.97 Aligned_cols=247 Identities=27% Similarity=0.428 Sum_probs=197.8
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCChh
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLD 595 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 595 (804)
++||+|+||.||++...+++.||+|.+..... ..+++.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987789999999875433 3467899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccc-cc
Q 038103 596 KLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF-SR 674 (804)
Q Consensus 596 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~-~~ 674 (804)
+++... ...+++..+..++.+++.+|+|||+++ ++|+||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999652 335789999999999999999999998 99999999999999999999999999986543221111 12
Q ss_pred cccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCC
Q 038103 675 VRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLN 753 (804)
Q Consensus 675 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 753 (804)
...+..|+|||.+.++.++.++||||||++++||++ |..|+..... .. .......+. .
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~----~~~~~~~~~---------~ 213 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQ----TRERIESGY---------R 213 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HH----HHHHHhcCC---------C
Confidence 233567999999998899999999999999999999 7888754220 00 111111110 0
Q ss_pred CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 754 DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
...+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 01112234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.42 Aligned_cols=242 Identities=24% Similarity=0.299 Sum_probs=190.5
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHH---hcCCCCcccceeeeEEeCCeeEEEE
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSII---GRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
.+.+.||+|+||.||++... +++.||||.++... ...+.+..|++++ +.++||||+++++++......++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45678999999999999964 58899999997432 2234566666654 5678999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 82 EYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred cCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988843 45899999999999999999999998 99999999999999999999999999875332
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ... ...+..+..
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~----~~~i~~~~~-- 218 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEV----FDSIVNDEV-- 218 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHH----HHHHHhCCC--
Confidence 21 223346689999999999999999999999999999999999999864220 011 111111111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
..... ....+.+++.+|++.||.+|| ++.++++
T Consensus 219 ----~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ----RYPRF----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----CCCCC----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11111 234678999999999999999 4556554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=303.88 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=198.3
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
|...+.||+|+||.||++... +++.||||.+.... .....+.+|+.++++++|+||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 456678999999999999964 68899999986422 2234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|..++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 82 MNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999888642 2345899999999999999999999998 9999999999999999999999999998654322
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||..... ....+.+...+....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~~----- 221 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE--------KVKREEVERRVKEDQ----- 221 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch--------hhHHHHHHHHhhhcc-----
Confidence 22234688999999999988999999999999999999999999964221 001111111111110
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~~ 788 (804)
..++......+.+|+..|++.||.+|| ++.++++.
T Consensus 222 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -----EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -----cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111222344688999999999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=316.16 Aligned_cols=249 Identities=21% Similarity=0.244 Sum_probs=197.3
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 556788999999999999964 68899999997432 2345688899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 83 QPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999652 346889999999999999999999998 9999999999999999999999999998765443
Q ss_pred CccccccccCCCccchhhhc------cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 669 DTKFSRVRGTRGYLAPEWMM------NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
........||+.|+|||++. ...++.++||||||+++|||++|+.||..... ...........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----------~~~~~~i~~~~ 225 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----------AKTYNNIMNFQ 225 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----------HHHHHHHHcCC
Confidence 33333456899999999986 45678999999999999999999999964220 11111111111
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
......+ .......+.+|+..|++ +|.+||++.++++
T Consensus 226 ~~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 226 RFLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1111100 11123457788889998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=310.34 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=207.3
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCe-eEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEH-KLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~E 587 (804)
.|...+.+|+|+||.++..+.+ +.+.+++|.+..... ......+|+.++++++|||||.+.+.+.+++. .+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 3556788999999999999864 467899999974443 23457889999999999999999999999988 999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|++||+|.+.|... .+..++..++.+++.|++.|+.|||+.. |+|||||+.||+++.+..+||+|||+|+.+...
T Consensus 85 Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred ecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999764 3567899999999999999999999877 999999999999999999999999999988765
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
. .....+.||+.|+.||.+.+.+|..|+|||||||++|||++-+++|.... ....+. ++.++.
T Consensus 160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-----------m~~Li~-ki~~~~---- 222 (426)
T KOG0589|consen 160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-----------MSELIL-KINRGL---- 222 (426)
T ss_pred h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-----------hHHHHH-HHhhcc----
Confidence 4 23455789999999999999999999999999999999999999997533 111111 111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
++ ..+......+..++..|++.+|+.||++.+++.+
T Consensus 223 ~~-----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YS-----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CC-----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11 1233344578899999999999999999999865
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=313.29 Aligned_cols=265 Identities=23% Similarity=0.353 Sum_probs=206.6
Q ss_pred HHHHHHhcccccccccCcceEEEEEec--------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeE
Q 038103 508 ELKRATRNFKQEVGKGGFGSVFRGVLD--------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFC 576 (804)
Q Consensus 508 ~l~~~t~~~~~~LG~G~fg~Vykg~~~--------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~ 576 (804)
++...++.+.+.||+|+||.||++... ....||+|.++.... ..+++.+|++++.++ +|+||++++++|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 455567888899999999999999742 123689998874322 346788999999999 899999999999
Q ss_pred EeCCeeEEEEeeccCCChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCe
Q 038103 577 AENEHKLLVYEYVENGSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQN 644 (804)
Q Consensus 577 ~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 644 (804)
.+....++++||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 999999999999999999999965321 2345889999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeecCCcccccccCCc-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCccccccc
Q 038103 645 ILLDDHFEPKVTDFGLSKLFKERHDT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASA 722 (804)
Q Consensus 645 ILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~ 722 (804)
||++.++.+||+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ |..|+....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--- 241 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--- 241 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---
Confidence 99999999999999999865432211 1122234567999999999899999999999999999998 888875321
Q ss_pred CCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 723 SDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
..+ ....+..+.... .+......+.+++.+|++.+|++||+|.++++.|+.+....
T Consensus 242 --------~~~-~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 242 --------VEE-LFKLLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred --------HHH-HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 111 111111111111 11122346889999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=293.09 Aligned_cols=266 Identities=26% Similarity=0.355 Sum_probs=201.7
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhc--CCCCcccceeeeEEeCC----eeEEEEe
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGR--INHRNLVKLQGFCAENE----HKLLVYE 587 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~E 587 (804)
..+.+.||+|.||.||+|.++++ .||||++.. .+++.+.+|.++.+. |+|+||+.+++.=..+. +++||.+
T Consensus 213 I~L~e~IGkGRyGEVwrG~wrGe-~VAVKiF~s--rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRWRGE-DVAVKIFSS--RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred eEEEEEecCccccceeeccccCC-ceEEEEecc--cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 45567799999999999999865 599999963 455667788888775 59999999998754432 6899999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHh-----hCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE-----ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-----~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
|.+.|||.+||. +..++-...++++..+|.||++||. ++.+.|.|||||+.|||+..++...|+|+|||.
T Consensus 290 YHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 290 YHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred cccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 999999999994 4678999999999999999999996 567779999999999999999999999999999
Q ss_pred cccccCC---ccccccccCCCccchhhhccC----CCC--cccchHHHHHHHHHHHhCC----------CCCcccccccC
Q 038103 663 LFKERHD---TKFSRVRGTRGYLAPEWMMNL----KID--AKADVYSYGIVLLELLTGK----------SASDYLSASAS 723 (804)
Q Consensus 663 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~----~~s--~k~DV~S~Gvll~el~tg~----------~p~~~~~~~~~ 723 (804)
....+.+ .......||.+|||||++... .|. ..+||||||+++||++... .||...-+.+
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D- 443 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD- 443 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC-
Confidence 7765533 233457799999999998542 222 3699999999999998632 3433222111
Q ss_pred CccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 724 DSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
.+. +.+.+.+-..++...++.+ -.+.+.+..+.+|+..||..+|.-|-|+--+-+.|..+.+++.
T Consensus 444 -Ps~-----eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 444 -PSF-----EEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred -CCH-----HHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 111 1111111112222222221 2345778899999999999999999999999999988876443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=279.64 Aligned_cols=247 Identities=25% Similarity=0.339 Sum_probs=203.3
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
..+++.+.||+|.||.||.|+.+ ++-.||+|++.+.. +-+.++.+|+++-..|+||||+++++++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 34566789999999999999965 56789999987533 33567899999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||..+|+|...|+.. .....+......++.|+|.||.|+|..+ |+||||||+|+|++.++.+||+|||.+....
T Consensus 102 Eya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999753 3445778888899999999999999998 9999999999999999999999999998644
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.......+||..|.|||...+..++...|+|++|++.||++.|..||+.... ... ...+..- +
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~et----YkrI~k~---~ 238 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SET----YKRIRKV---D 238 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHH----HHHHHHc---c
Confidence 3334567899999999999999999999999999999999999999975220 011 1111111 1
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+.+| ........+++..|+..+|.+|.+..||++.
T Consensus 239 ~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 LKFP-------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccCC-------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1111 2223367889999999999999999999863
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=298.39 Aligned_cols=249 Identities=29% Similarity=0.458 Sum_probs=202.8
Q ss_pred ccccccCcceEEEEEecC----CcEEEEEEecCcCCC--hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVLQG--DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~----~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||++.... +..+++|.+...... .+++.+|++++..++|+|++++++++......++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999654 778999999854433 57889999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCC-----CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 592 GSLDKLLFNDPGT-----ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 592 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
++|.+++...... ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999763211 467899999999999999999999988 99999999999999999999999999997655
Q ss_pred cCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 667 RHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 667 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
... .......++..|+|||.+....++.++||||+|++++||++ |..||.... ...+ .+....+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~----~~~~~~~~~ 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEV----LEYLRKGYR 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--------HHHH----HHHHHcCCC
Confidence 321 22233456889999999998899999999999999999999 688886432 0111 112221111
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
. ..+......+.+++.+|++.+|++||++.++++.|+
T Consensus 226 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 L---------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred C---------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 111222457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.84 Aligned_cols=266 Identities=23% Similarity=0.345 Sum_probs=201.5
Q ss_pred HHhcccccccccCcceEEEEEe-----cCCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeC--Cee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-----DDERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EHK 582 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 582 (804)
.++...++||+|+||.||+++. .++..||+|.++... ...+.+.+|++++++++|+|++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4456678899999999999984 347789999987432 2345789999999999999999999999875 568
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999998642 335899999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCC--ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCC---ccchhhHHHHHHH
Q 038103 663 LFKERHD--TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASD---SSYCNHLVQWVAK 737 (804)
Q Consensus 663 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~ 737 (804)
....... .......++..|+|||.+.+..++.++||||||+++|||++++.|.......... .............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 7644222 1122345677899999998888999999999999999999987764321100000 0000001111111
Q ss_pred HhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 738 QMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 738 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
....+.... ........+.+|+.+|++.+|++||++.++++.|+.+
T Consensus 238 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 112111110 1112345799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=307.33 Aligned_cols=239 Identities=24% Similarity=0.330 Sum_probs=188.2
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhc-CCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGR-INHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+|+.. +++.||+|.++... ...+.+..|..++.. .+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999965 47889999987432 223445667777765 4899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|..++.. ...++......++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999999864 235888899999999999999999998 9999999999999999999999999998643322 22
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+ ...+... .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~----~~~i~~~------~~~ 214 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DEL----FDSILND------RPH 214 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHH----HHHHHcC------CCC
Confidence 3345689999999999998999999999999999999999999964220 011 1111111 011
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMS-KVV 786 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~-~Vv 786 (804)
+ +......+.+++.+|++.+|++||++. ++.
T Consensus 215 ~----~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 215 F----PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred C----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 111233578899999999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=305.86 Aligned_cols=262 Identities=25% Similarity=0.377 Sum_probs=202.6
Q ss_pred HHHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEH 581 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 581 (804)
...++.+.+.||+|+||.||+|... .+..||+|.+..... ...++.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3456777889999999999999753 245799998864332 23467889999999999999999999999999
Q ss_pred eEEEEeeccCCChhhhhccCCC------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEE
Q 038103 582 KLLVYEYVENGSLDKLLFNDPG------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKV 655 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 655 (804)
.++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964211 1234567788999999999999999998 999999999999999999999
Q ss_pred eecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHH
Q 038103 656 TDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQ 733 (804)
Q Consensus 656 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 733 (804)
+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |..|+.... ..+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-----------~~~ 229 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-----------NEQ 229 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-----------HHH
Confidence 99999986533221 11122334678999999998899999999999999999999 777875321 011
Q ss_pred HHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 734 WVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
+......+.... .+......+.+++.+|++.+|++||+|.++++.|+.....
T Consensus 230 -~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 230 -VLKFVMDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred -HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 111111111111 0112235799999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.83 Aligned_cols=237 Identities=25% Similarity=0.296 Sum_probs=191.2
Q ss_pred ccccccCcceEEEEEe----cCCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 518 QEVGKGGFGSVFRGVL----DDERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~----~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
+.||+|+||.||+++. .+++.+|+|++.... .....+..|++++.+++||||+++++++..+...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999874 357899999997432 233457789999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 9999999854 345899999999999999999999998 9999999999999999999999999998654322 2
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
......|++.|+|||.+....++.++||||||+++|||++|+.||.... .... .........
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--------~~~~----~~~i~~~~~------ 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--------RKET----MTMILKAKL------ 215 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--------HHHH----HHHHHcCCC------
Confidence 2234568999999999998889999999999999999999999986422 0011 111111111
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSK 784 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~ 784 (804)
.+ +......+.+|+.+|++.||++||++.+
T Consensus 216 ~~----p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GM----PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC----CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 01 1112346789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=298.03 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=197.1
Q ss_pred ccccccCcceEEEEEecC--C--cEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLDD--E--RVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~--~--~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|++|.||+|.... + ..||||.+..... ..+++.+|+.++++++|+||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 3699999975433 34678999999999999999999999988 889999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc-
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT- 670 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~- 670 (804)
++|.+++..... ..+++...+.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976321 56899999999999999999999998 999999999999999999999999999876542221
Q ss_pred -cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 671 -KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 671 -~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
......++..|+|||.+....++.++||||||++++||++ |+.|+..... ..... ...... ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~---~~~~~~--~~~- 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILK---KIDKEG--ERL- 220 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH---HHHhcC--CcC-
Confidence 1123446788999999998899999999999999999999 9999854220 11111 111111 000
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
..+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 221 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123357889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=318.88 Aligned_cols=250 Identities=24% Similarity=0.298 Sum_probs=190.9
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++.+++|+||+++++++.+....++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 445678999999999999854 57899999997432 2235688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++..+....
T Consensus 83 ~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 83 IPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999864 235788888999999999999999998 9999999999999999999999999986432110
Q ss_pred C----------------------------------------------ccccccccCCCccchhhhccCCCCcccchHHHH
Q 038103 669 D----------------------------------------------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYG 702 (804)
Q Consensus 669 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~G 702 (804)
. .......||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001234689999999999988999999999999
Q ss_pred HHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHh--cccCCCCCCC
Q 038103 703 IVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALL--CVAENRDTRP 780 (804)
Q Consensus 703 vll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~~P~~RP 780 (804)
|++|||++|+.||...... ..............+ .+ ....+. .+.+|+.+ |+..+|..||
T Consensus 236 ~il~elltG~~Pf~~~~~~-----------~~~~~i~~~~~~~~~-~~--~~~~s~----~~~dli~~ll~~~~~~~~R~ 297 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPT-----------ETQLKVINWENTLHI-PP--QVKLSP----EAVDLITKLCCSAEERLGRN 297 (381)
T ss_pred hHHHHHHhCCCCCcCCCHH-----------HHHHHHHccccccCC-CC--CCCCCH----HHHHHHHHHccCcccccCCC
Confidence 9999999999999642210 000111100000000 00 011233 45556655 6677777899
Q ss_pred CHHHHHHH
Q 038103 781 PMSKVVKL 788 (804)
Q Consensus 781 tm~~Vv~~ 788 (804)
++.++++.
T Consensus 298 ~~~~~l~h 305 (381)
T cd05626 298 GADDIKAH 305 (381)
T ss_pred CHHHHhcC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=309.15 Aligned_cols=260 Identities=23% Similarity=0.371 Sum_probs=202.5
Q ss_pred HHHhcccccccccCcceEEEEEec--------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEEeC
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD--------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCAEN 579 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~--------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 579 (804)
...+.+.++||+|+||.||+++.. ....+|+|.++.... ...++.+|+.++.++ +|+||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 456677889999999999999742 245699999874332 245688999999999 699999999999999
Q ss_pred CeeEEEEeeccCCChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL 647 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl 647 (804)
...++++||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999965321 2245889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCc
Q 038103 648 DDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDS 725 (804)
Q Consensus 648 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~ 725 (804)
+.++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----- 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----- 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 9999999999999986643221 11112234467999999998899999999999999999999 8888754220
Q ss_pred cchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 726 SYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.. +......+.... .+......+.+++.+|++.+|++||++.++++.|+.+..
T Consensus 243 ---~~----~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 243 ---EE----LFKLLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ---HH----HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11 111112111111 111223468899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=299.16 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=198.7
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
..+.+.++||+|+||.||+|+. .+++.||+|++.... .....+.+|+.++.+++|+||+++++.+......++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4567778999999999999996 568889999987433 33456888999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999853 345789999999999999999999988 99999999999999999999999999986643221
Q ss_pred ccccccccCCCccchhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 670 TKFSRVRGTRGYLAPEWMM---NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
......++..|+|||.+. ...++.++||||||++++||++|+.|+....+... . ..+....
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-----------~-~~~~~~~--- 225 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-----------L-FLMSKSN--- 225 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-----------h-eeeecCC---
Confidence 122345788999999884 44578899999999999999999999853221100 0 0000000
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L 789 (804)
...+.... .......+.+++.+|++.+|++||+++++++.|
T Consensus 226 ~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 FQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11111111 112235788999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.38 Aligned_cols=197 Identities=25% Similarity=0.334 Sum_probs=170.4
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.||+|+||.||++... +++.||||++.... .....+.+|+.++.+++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 455678999999999999864 58899999997432 2234678899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 83 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 83 LPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999964 346889999999999999999999998 9999999999999999999999999998653211
Q ss_pred C----------------------------------ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 038103 669 D----------------------------------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSA 714 (804)
Q Consensus 669 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p 714 (804)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001235689999999999999999999999999999999999999
Q ss_pred Ccc
Q 038103 715 SDY 717 (804)
Q Consensus 715 ~~~ 717 (804)
|..
T Consensus 236 f~~ 238 (363)
T cd05628 236 FCS 238 (363)
T ss_pred CCC
Confidence 964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=311.79 Aligned_cols=241 Identities=23% Similarity=0.271 Sum_probs=192.8
Q ss_pred ccccccCcceEEEEEe-cCCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 518 QEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
+.||+|+||.||++.. .+++.||+|.++... ....++..|++++..++|+||+++.+.+......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999995 468899999997422 22356778999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHh-hCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE-ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 99988854 3458899999999999999999997 67 9999999999999999999999999987543221 12
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ... ........ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~----~~~i~~~~------~~ 214 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKL----FELILMEE------IR 214 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------HHH----HHHHhcCC------CC
Confidence 2345689999999999999999999999999999999999999964220 011 11111111 11
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVKL 788 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~~ 788 (804)
+.... ...+.+++.+|++.||++|+ ++.++++.
T Consensus 215 ~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTL----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCC----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11122 23678899999999999996 89888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=299.30 Aligned_cols=248 Identities=24% Similarity=0.321 Sum_probs=197.5
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC------ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ------GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
+...+.||+|++|.||++.. .+++.+|+|.+..... ..+.+.+|++++++++||||+++++++.+....++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 45568899999999999996 4588999998863321 2246888999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++++|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 84 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 84 EYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999864 235788899999999999999999998 99999999999999999999999999986543
Q ss_pred cCCccc--cccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 667 RHDTKF--SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 667 ~~~~~~--~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
...... ....++..|+|||++.+..++.++||||||+++|||++|+.||.... ............ .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----------~~~~~~~~~~~~-~ 224 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE-----------AMAAIFKIATQP-T 224 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc-----------hHHHHHHHhccC-C
Confidence 222111 23457789999999999889999999999999999999999985321 000011111110 0
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
... .+......+.+++.+|++.+|++||++.++++.
T Consensus 225 ----~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 ----NPQ----LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCC----CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111 122233468899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=312.59 Aligned_cols=239 Identities=25% Similarity=0.318 Sum_probs=195.6
Q ss_pred HhcccccccccCcceEEEEEecC-CcEEEEEEecCcC----CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVL----QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 586 (804)
.++|...||+|.||+|+++.+++ ++.+|||.+++.. ...+..+.|.+++... +||.|++++..+...++++.||
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 45667889999999999999764 7899999998543 2345677888888877 5999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||..+|++..++ +...++.....-++..|+.||.|||+++ ||+||||.+|||||.+|++||+||||++.-..
T Consensus 449 ey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 449 EYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC
Confidence 999999965555 3456899999999999999999999999 99999999999999999999999999996432
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
....+++++||+.|+|||++.+..|+.+.|.|||||+||||+.|+.||..... .++.+. +..
T Consensus 521 -~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE--------ee~Fds----I~~----- 582 (694)
T KOG0694|consen 521 -QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE--------EEVFDS----IVN----- 582 (694)
T ss_pred -CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHH----Hhc-----
Confidence 23356789999999999999999999999999999999999999999975331 111111 110
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPM 782 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 782 (804)
.|+ .++.-...+.+.|+.+.+..+|++|.-+
T Consensus 583 -d~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 -DEV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 011 2233334467788888999999999887
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=301.77 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=201.0
Q ss_pred HHhcccccccccCcceEEEEEec------CCcEEEEEEecCcCCC--hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVLQG--DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
..+...+.||+|+||.||+++.. +.+.|++|.+...... .+++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 34555678999999999999954 3467999988744332 367899999999999999999999999989999
Q ss_pred EEEeeccCCChhhhhccCCCC-----CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeec
Q 038103 584 LVYEYVENGSLDKLLFNDPGT-----ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDF 658 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 658 (804)
+|+||+++++|.+++...... ...+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+|++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754311 125899999999999999999999998 999999999999999999999999
Q ss_pred CCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHH
Q 038103 659 GLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAK 737 (804)
Q Consensus 659 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (804)
|++...............++..|+|||.+.+..++.++||||||++++||++ |..||..... .. ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~----~~~ 229 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EE----VLN 229 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HH----HHH
Confidence 9987543322222233445778999999988889999999999999999999 7778753210 01 111
Q ss_pred HhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 738 QMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 738 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
....+..... ........+.+++.+|++.+|++||++.+++++|+
T Consensus 230 ~~~~~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 RLQAGKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHcCCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1121111111 11122347889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=307.78 Aligned_cols=235 Identities=23% Similarity=0.292 Sum_probs=188.7
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+++.. +++.||||.++.. ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999965 5789999998742 12345677888888876 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999998864 245889999999999999999999998 9999999999999999999999999988543221 22
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+ .+.+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~----~~~i~~~~~~------ 214 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDL----FEAILNDEVV------ 214 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHH----HHHHhcCCCC------
Confidence 3345689999999999998999999999999999999999999964320 111 1111111110
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPM 782 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 782 (804)
+.. .....+.+++.+|++.||++||++
T Consensus 215 ~~~----~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YPT----WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCC----CCCHHHHHHHHHHcccCHHHCCCC
Confidence 111 123467899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=296.03 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=201.4
Q ss_pred HhcccccccccCcceEEEEEecC-CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
.+.+.+.||+|+||.||+++..+ ++.+++|.+..... .+++.+|++++++++|+||+++++++......++++||+++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 45667889999999999999765 78999999874433 67899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........ .
T Consensus 83 ~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 83 GSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 999999864 3456899999999999999999999998 99999999999999999999999999987654321 2
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+....... ........ ..+.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~------------~~~~~~~~-----~~~~ 218 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR------------AIFMIPNK-----PPPT 218 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh------------hhhhhccC-----CCCC
Confidence 233457889999999998899999999999999999999999986432100 00000000 0011
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+ ..+......+.+++.+|++.+|++||++.+|++
T Consensus 219 ~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 L--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred C--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1 111223356889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=308.04 Aligned_cols=241 Identities=22% Similarity=0.306 Sum_probs=191.7
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+|+.. +++.||+|.++... ...+.+..|.+++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 47899999987432 2334577888888866 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 999988864 345889999999999999999999998 9999999999999999999999999998543221 22
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....|++.|+|||++....++.++||||||+++|||++|+.||..... ... ...+..+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~----~~~i~~~~~---~--- 214 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDL----FESILHDDV---L--- 214 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHH----HHHHHcCCC---C---
Confidence 2345689999999999998999999999999999999999999964320 111 111111111 0
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCC-------CHHHHHHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRP-------PMSKVVKL 788 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-------tm~~Vv~~ 788 (804)
.... ....+.+++..|++.+|++|| ++.++++.
T Consensus 215 ~p~~----~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVW----LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCC----CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1111 123678899999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=308.67 Aligned_cols=249 Identities=21% Similarity=0.301 Sum_probs=194.8
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+++.. +++.||||.++... ...+.+..|..++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999965 57899999997432 2234578899999988 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 999988853 345899999999999999999999998 999999999999999999999999998753221 122
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||+......... .....+.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~------~ 223 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD---QNTEDYLFQVILEKQI------R 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc---ccchHHHHHHHHcCCC------C
Confidence 334578999999999999999999999999999999999999997533211111 1111222222222211 1
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCC------HHHHHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPP------MSKVVK 787 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt------m~~Vv~ 787 (804)
+.... ...+.+++.+|++.||.+||+ +.++++
T Consensus 224 ~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11112 236789999999999999997 567653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=300.36 Aligned_cols=251 Identities=29% Similarity=0.492 Sum_probs=197.9
Q ss_pred hcccccccccCcceEEEEEecC-CcEEEEEEecCcCCChH---HHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGDA---EFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
|.+.+.||+|+||+||+++... ++.+|+|.+........ ...+|+.++++++|+||+++++++......++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 3567889999999999999765 66899999986543332 2355999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++. ....+++..+..++.|+++||++||+.+ ++|+||||+||++++++.++|+|||.+... ....
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL-SENN 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES-TSTT
T ss_pred cccccccccc----cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc-cccc
Confidence 9999999996 2455899999999999999999999998 999999999999999999999999999864 2222
Q ss_pred ccccccccCCCccchhhhc-cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 670 TKFSRVRGTRGYLAPEWMM-NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......++..|+|||++. ...++.++||||+|+++++|++|+.|+.... . .............. ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-------~-~~~~~~~~~~~~~~-~~~-- 221 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-------S-DDQLEIIEKILKRP-LPS-- 221 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-------H-HHHHHHHHHHHHTH-HHH--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc-------c-hhhhhhhhhccccc-ccc--
Confidence 3344566789999999998 7889999999999999999999999987431 0 00111111111100 000
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.... .......+.+++..|++.+|++||++.++++
T Consensus 222 -~~~~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 -SSQQ---SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -HTTS---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -cccc---cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0001167999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=301.10 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=196.0
Q ss_pred cccccCcceEEEEEecC-------CcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 519 EVGKGGFGSVFRGVLDD-------ERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~~-------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
.||+|+||.||+|+..+ ++.+|||.+.... ....++.+|+.++++++||||+++++++......++|+||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998643 2579999886433 34567899999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCC---CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC-----CeEEeecCCc
Q 038103 590 ENGSLDKLLFNDPG---TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF-----EPKVTDFGLS 661 (804)
Q Consensus 590 ~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-----~~kl~Dfgla 661 (804)
++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999965321 1234789999999999999999999988 99999999999999877 8999999999
Q ss_pred ccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 662 KLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 662 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--------~~~~----~~~~ 226 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--------NQEV----LQHV 226 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--------HHHH----HHHH
Confidence 86543221 11122345678999999999999999999999999999998 999885321 0011 1111
Q ss_pred hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
..+.. ...+......+.+++.+|++.+|.+||++.+|+++|+.
T Consensus 227 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 TAGGR---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred hcCCc---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11110 01112234578899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=299.30 Aligned_cols=262 Identities=22% Similarity=0.327 Sum_probs=204.2
Q ss_pred HHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
....+.+.+.||+|+||+||++... +++.||+|.+.... ...+++.+|++++..++|+||+++++++......++|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 4456677889999999999999954 58889999876432 23467899999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
||+++++|..++.. ...+++.....++.+++.||.|||+. + ++|+||||+||+++.++.++|+|||++....
T Consensus 83 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 83 EFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred ecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999998854 34589999999999999999999974 5 9999999999999999999999999987543
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
... .....++..|+|||.+.+..++.++||||||+++||+++|+.||...............+.......... .
T Consensus 156 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-- 229 (284)
T cd06620 156 NSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-P-- 229 (284)
T ss_pred hhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-c--
Confidence 221 1234688999999999888999999999999999999999999975332111111111122222221111 0
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
.+.+. ..+....+.+|+.+|++.+|++||++.+|+++..
T Consensus 230 ---~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 230 ---PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred ---CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 11111 1123456889999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.96 Aligned_cols=264 Identities=18% Similarity=0.203 Sum_probs=195.0
Q ss_pred HhcccccccccCcceEEEEEecC-CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
.+.+.+.||+|+||.||+++... ++.||||... ...+.+|++++++++|+|||++++++..+...++|+|++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 45667889999999999999754 7889999643 2346789999999999999999999999999999999995
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc-
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT- 670 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~- 670 (804)
++|..++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 244 ~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 244 SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 688888854 2346899999999999999999999998 999999999999999999999999999876443221
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh-cCccccc-
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ-EGLEKII- 748 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~- 748 (804)
......||..|+|||++.+..++.++|||||||+||||++|..++-..............+...+...... ..+....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 22345689999999999999999999999999999999998876532221111111112222211110000 0000000
Q ss_pred ---------------CCcCCCcc---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 749 ---------------DPRLNDVY---DREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 749 ---------------d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+...... .......+.+|+.+||+.||.+|||+.|+++.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000 00112357789999999999999999999874
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=282.53 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=194.6
Q ss_pred cccccccCcceEEEEEe-cCCcEEEEEEecCcCC--C-hHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeEEEEeecc
Q 038103 517 KQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ--G-DAEFWAEVSIIGRINHRNLVKLQGFCAE--NEHKLLVYEYVE 590 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~--~-~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 590 (804)
.++|++|.||.||+|+. ++++.||+|+++-... + .-.-.+|+.+|.+.+|||||.+..+... -+..|+|||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 46799999999999996 4688999999983322 1 1346899999999999999999988753 457899999998
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
. +|..++... ...+......-+..|+++|++|||... |+|||||++|+|++..|.+||+|||+|+.++.. ..
T Consensus 161 h-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k 232 (419)
T KOG0663|consen 161 H-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LK 232 (419)
T ss_pred h-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC-cc
Confidence 8 999999764 356888899999999999999999998 999999999999999999999999999988764 23
Q ss_pred cccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 671 KFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
..+...-|..|+|||.+.+. .|++..|+||+|||+.||++++..|......+ -...+...+. ...+-+-
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--------Ql~~If~llG--tPte~iw 302 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--------QLDKIFKLLG--TPSEAIW 302 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--------HHHHHHHHhC--CCccccC
Confidence 45566779999999999875 59999999999999999999998886433111 0111111111 1111111
Q ss_pred C-------------------cCCCccCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 750 P-------------------RLNDVYDRE-KLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 750 ~-------------------~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
| .++..+... ..+.-.+|+...+..||.+|-|+++.++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1 111111111 2356678888899999999999999875
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.26 Aligned_cols=238 Identities=25% Similarity=0.432 Sum_probs=189.1
Q ss_pred ccccccCcceEEEEEecCCc-----------EEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 518 QEVGKGGFGSVFRGVLDDER-----------VVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~-----------~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
+.||+|+||.||+|...+.. .+++|.+.........+.+|+.++++++|+||+++++++.. ...++|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999999976432 57888776443336788999999999999999999999988 7789999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC-------CeEEeecC
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF-------EPKVTDFG 659 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-------~~kl~Dfg 659 (804)
||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999753 226889999999999999999999988 99999999999999887 79999999
Q ss_pred CcccccccCCccccccccCCCccchhhhccC--CCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHH
Q 038103 660 LSKLFKERHDTKFSRVRGTRGYLAPEWMMNL--KIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVA 736 (804)
Q Consensus 660 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (804)
++..... .....++..|+|||++... .++.++||||||+++|||++ |..|+...... .. .
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-----------~~-~ 216 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-----------EK-E 216 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-----------hH-H
Confidence 9986543 1223456789999999876 78999999999999999999 46666432200 00 0
Q ss_pred HHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 737 KQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 737 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
....... ....+ ....+.+++.+|++.+|++||++.+|++.|+
T Consensus 217 ~~~~~~~--~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 217 RFYQDQH--RLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHHhcCC--CCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111100 00000 0157889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=296.49 Aligned_cols=252 Identities=24% Similarity=0.397 Sum_probs=199.3
Q ss_pred hcccccccccCcceEEEEEecC--CcEEEEEEecCcC-----------CChHHHHHHHHHHhc-CCCCcccceeeeEEeC
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDD--ERVVAVKRLEGVL-----------QGDAEFWAEVSIIGR-INHRNLVKLQGFCAEN 579 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~--~~~vavK~l~~~~-----------~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~ 579 (804)
|.+.+.||+|+||.||+|.... ++.+|+|.+.... ....++.+|+.++.+ ++|+||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4456789999999999999765 6789999885221 112456778888865 7999999999999999
Q ss_pred CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHh-hCCCcEEecccccCeEEEcCCCCeEEeec
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE-ECLEWVLHCDVKPQNILLDDHFEPKVTDF 658 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 658 (804)
...+++|||+++++|.+++.........+++..+++++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999886533345568999999999999999999996 55 999999999999999999999999
Q ss_pred CCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH
Q 038103 659 GLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 659 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
|++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... .... ...
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----------~~~~-~~~ 224 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----------MLSL-ATK 224 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----------HHHH-HHH
Confidence 9998755432 3344567889999999998889999999999999999999999985321 1111 111
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
...+....... . .....+.+++.+|++.+|++||++.+|..+|+
T Consensus 225 ~~~~~~~~~~~----~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 IVEAVYEPLPE----G----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HhhccCCcCCc----c----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111111111 1 12246889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.50 Aligned_cols=248 Identities=20% Similarity=0.299 Sum_probs=198.8
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
++.+.++||+|+||.||+|+. .+++.||+|.+.... ...+.+.+|+.++++++|+|++++++.+..+...++|+||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 455667899999999999995 468899999987433 345678899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 101 ~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 9999999853 34788999999999999999999998 99999999999999999999999999886543221
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
......+++.|+|||.+....++.++||||||+++|||++|+.||..... ..........+ . +
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-----------~~~~~~~~~~~-~-----~ 234 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----------LRALYLIATNG-T-----P 234 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-----------HHhHHHHhcCC-C-----C
Confidence 12234578899999999988899999999999999999999999864220 00001111111 0 0
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+ ..+......+.+++.+|++.+|++||++.+|++.
T Consensus 235 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 235 EL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00 1112233468899999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=298.72 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=191.0
Q ss_pred ccccccCcceEEEEEec----CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEe-CCeeEEEEeecc
Q 038103 518 QEVGKGGFGSVFRGVLD----DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAE-NEHKLLVYEYVE 590 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~ 590 (804)
+.||+|+||.||+|... +...+|+|++.... ...+.+.+|+.+++.++|||++++++++.. +...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 24579999986322 234578889999999999999999998764 456789999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC-
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD- 669 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 669 (804)
+++|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999652 234677888999999999999999988 99999999999999999999999999986543211
Q ss_pred --ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCC-CCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 670 --TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK-SASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 670 --~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.......++..|+|||.+....++.++||||||+++|||++|. .|+.... ...+. . ....+...
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--------~~~~~---~-~~~~~~~~- 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--------SFDIT---V-YLLQGRRL- 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH---H-HHhcCCCC-
Confidence 1112334567899999998889999999999999999999954 4453211 01111 1 11111100
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
.. +......+.+++..|++.+|++||++.+|++.|+.+.
T Consensus 222 ----~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 ----LQ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ----CC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00 1112346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.74 Aligned_cols=238 Identities=25% Similarity=0.369 Sum_probs=185.1
Q ss_pred cccccCcceEEEEEecC-------------------------CcEEEEEEecCcCC-ChHHHHHHHHHHhcCCCCcccce
Q 038103 519 EVGKGGFGSVFRGVLDD-------------------------ERVVAVKRLEGVLQ-GDAEFWAEVSIIGRINHRNLVKL 572 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~~-------------------------~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~H~niv~l 572 (804)
+||+|+||.||+|.+.. ...|++|.+..... ...++.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 13589998864322 23568889999999999999999
Q ss_pred eeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC-
Q 038103 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF- 651 (804)
Q Consensus 573 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~- 651 (804)
+++|.+....++||||+++|+|..++.. ....+++..+..++.|+++||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999864 3446889999999999999999999988 99999999999997643
Q ss_pred ------CeEEeecCCcccccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHH-hCCCCCcccccccC
Q 038103 652 ------EPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELL-TGKSASDYLSASAS 723 (804)
Q Consensus 652 ------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~-tg~~p~~~~~~~~~ 723 (804)
.+|++|||++...... ....++..|+|||.+.. ..++.++||||||+++|||+ +|+.|+......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-- 228 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS-- 228 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH--
Confidence 3799999998643221 12346778999998875 56899999999999999995 688888643210
Q ss_pred CccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 724 DSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
.... ..... ..+.... ...+.+++.+|++.+|++||++.+|++.|+
T Consensus 229 ------~~~~----~~~~~-------~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 ------EKER----FYEKK-------HRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ------HHHH----HHHhc-------cCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0111 11100 0011111 135889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.23 Aligned_cols=265 Identities=21% Similarity=0.297 Sum_probs=195.1
Q ss_pred cccccccccCcceEEEEEe-cCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCC-----eeEEE
Q 038103 515 NFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENE-----HKLLV 585 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV 585 (804)
.+.+.||+|+||.||++.. .+++.||||++..... ..+++.+|+++++.++|+||+++++++.... ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 3467899999999999996 4688999999874322 3356889999999999999999999998776 78999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
+||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 83 TELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred eeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 99997 478887743 346899999999999999999999998 9999999999999999999999999998755
Q ss_pred ccCCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCc--------cchhhH---HH
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDS--------SYCNHL---VQ 733 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~--------~~~~~~---~~ 733 (804)
...........++..|+|||.+.+. .++.++|||||||++|||++|+.||........-. .....+ ..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 4333333445678899999998764 47899999999999999999999996432110000 000000 00
Q ss_pred HHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 734 WVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.....+............+ ........+.+.+|+.+|++.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000000000 00111124568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.68 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=205.2
Q ss_pred HHhcccccccccCcceEEEEEec--CCc--EEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD--DER--VVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~--~~~--~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
+...+.|+||+|.||.|++|.+. +|+ .||||.++.... ...+|.+|+.+|.+|+|+|++||+|+..+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 34455688999999999999964 343 599999985433 46789999999999999999999999987 788999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
+|+++.|+|.+.|+. ..+..+-...+.+++.|||.||.||.+++ +|||||.++|+|+-....+||+||||.+.++
T Consensus 189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccC
Confidence 999999999999976 24556778889999999999999999998 9999999999999999999999999999886
Q ss_pred ccCCc-ccc-ccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 666 ERHDT-KFS-RVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 666 ~~~~~-~~~-~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
..... .+. ...-...|+|||.++...|+.++|||+|||++|||+| |..|+-.... .
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------------~--------- 322 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------------I--------- 322 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------------H---------
Confidence 64332 222 2334678999999999999999999999999999999 7788754320 0
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+.+.+|.+-+...+..+.+.++++++.||..+|.+||++..+++.
T Consensus 323 qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 323 QILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 1122233333334456678899999999999999999999999743
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.64 Aligned_cols=239 Identities=24% Similarity=0.324 Sum_probs=189.6
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhc-CCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGR-INHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+|+.. +++.||||.++.. ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999965 4788999999743 2233456678888876 4899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|..++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 999999864 345889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....||..|+|||++.+..++.++||||||+++|||++|+.||.... ...+ ........ +.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~----~~~i~~~~------~~ 214 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--------EEEL----FQSIRMDN------PC 214 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--------HHHH----HHHHHhCC------CC
Confidence 234568999999999999899999999999999999999999986422 0111 11111111 11
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMS-KVV 786 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~-~Vv 786 (804)
+.. .....+.+++.+|++.+|++||++. ++.
T Consensus 215 ~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 YPR----WLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCc----cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111 1224578999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.10 Aligned_cols=240 Identities=24% Similarity=0.314 Sum_probs=192.2
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+++.. +++.||||.++... .....+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999975 47889999997432 2335577888888887 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 999988864 235899999999999999999999998 9999999999999999999999999987532211 22
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+ ......... .
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------~~~~----~~~i~~~~~------~ 214 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------EDEL----FQSILEDEV------R 214 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------HHHH----HHHHHcCCC------C
Confidence 233568999999999999999999999999999999999999996422 0111 111111111 1
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPM-----SKVVK 787 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm-----~~Vv~ 787 (804)
. +......+.+|+.+||+.||.+||++ .++++
T Consensus 215 ~----~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 Y----PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred C----CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1 11123468899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=295.61 Aligned_cols=239 Identities=22% Similarity=0.402 Sum_probs=186.7
Q ss_pred ccccccCcceEEEEEecC-------------CcEEEEEEecCcCC-ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 518 QEVGKGGFGSVFRGVLDD-------------ERVVAVKRLEGVLQ-GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~-------------~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
+.||+|+||.||+|+..+ ...|++|.+..... ....+.+|+.++++++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 23588898764332 3356888999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC-------eEEe
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE-------PKVT 656 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~-------~kl~ 656 (804)
+|+||+++++|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999998864 2345899999999999999999999998 999999999999987654 8999
Q ss_pred ecCCcccccccCCccccccccCCCccchhhhc-cCCCCcccchHHHHHHHHHHH-hCCCCCcccccccCCccchhhHHHH
Q 038103 657 DFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM-NLKIDAKADVYSYGIVLLELL-TGKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 657 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~S~Gvll~el~-tg~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
|||++...... ....++..|+|||.+. ...++.++||||||+++|||+ +|+.|+.... ..+.
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----------~~~~ 218 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-----------LAEK 218 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-----------hhHH
Confidence 99998754322 2234678899999887 466899999999999999998 5777765321 0000
Q ss_pred HHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 735 VAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
.....+.. .... .....+.+|+.+||+.+|++||++.+|++.|+
T Consensus 219 --~~~~~~~~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 219 --ERFYEGQC-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred --HHHHhcCc-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 01111111 1111 11246789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=300.44 Aligned_cols=247 Identities=25% Similarity=0.394 Sum_probs=198.3
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+...+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++|+||+++++.+..+...++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34555678999999999999864 57889999887332 2335688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++.. ..+++..+..++.|+++|+.|||+++ ++|+||+|+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 999999998843 45889999999999999999999988 9999999999999999999999999998654322
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......++..|+|||++.+..++.++||||||++++||++|+.|+...... .. ....... .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~----~~~~~~~-----~ 217 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--------RV----LFLIPKN-----S 217 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--------hH----HhhhhcC-----C
Confidence 1222345788999999999888999999999999999999999998632200 00 0011111 1
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+.+ .......+.+++.+|++.+|++||+|.+|++.
T Consensus 218 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 PPTL----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCC----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1111 12234568899999999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=319.34 Aligned_cols=258 Identities=20% Similarity=0.294 Sum_probs=189.8
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeC--------CeeE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAEN--------EHKL 583 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~ 583 (804)
.|.+.+.||+|+||.||+|+.. .++.||||++.... ....+|+.++++++|+||+++++++... ...+
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 4667788999999999999964 57899999886432 2345799999999999999999876432 2467
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC-CeEEeecCCcc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF-EPKVTDFGLSK 662 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~ 662 (804)
+||||+++ +|.+++.........+++.....++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccch
Confidence 99999985 777776543334566899999999999999999999998 99999999999998665 69999999998
Q ss_pred cccccCCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|..||...... ..+.. +......
T Consensus 220 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-------~~~~~-i~~~~~~ 289 (440)
T PTZ00036 220 NLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-------DQLVR-IIQVLGT 289 (440)
T ss_pred hccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHH-HHHHhCC
Confidence 6643222 2234678999999998754 6899999999999999999999998642210 01111 1110000
Q ss_pred ----------cCccc-----ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 742 ----------EGLEK-----IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 742 ----------~~~~~-----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..... +....+...++......+.+|+.+||+.+|.+|||+.++++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000 00011111112223357889999999999999999999973
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=312.98 Aligned_cols=240 Identities=23% Similarity=0.404 Sum_probs=193.7
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEec---CcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCe--eEEEE
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLE---GVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEH--KLLVY 586 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~---~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~ 586 (804)
+|.++||+|+|-+||||... +|.+||--.++ ... ...+.|..|+.+|+.|+|+|||+++..+.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999965 46667644332 122 233679999999999999999999999987665 77999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC-CCeEEeecCCccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH-FEPKVTDFGLSKLFK 665 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~ 665 (804)
|.|..|+|+.|+.+. +.++...+..|++||++||.|||++. +||+|||||-+||+|+.+ |.+||+|+|||..++
T Consensus 123 EL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999999753 45788899999999999999999987 679999999999999865 899999999999876
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC--
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG-- 743 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 743 (804)
..... .+.|||.|||||... ..|++..||||||+.|+||+|+..|+.--. + ...+.+++-.|.
T Consensus 198 ~s~ak---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~----------n-~AQIYKKV~SGiKP 262 (632)
T KOG0584|consen 198 KSHAK---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT----------N-PAQIYKKVTSGIKP 262 (632)
T ss_pred ccccc---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC----------C-HHHHHHHHHcCCCH
Confidence 64332 378999999999887 789999999999999999999999985211 1 122233333332
Q ss_pred --cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 744 --LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 744 --~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+..+-|| .+.+++..|+.. ..+||++.|+++
T Consensus 263 ~sl~kV~dP------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 263 AALSKVKDP------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHhhccCCH------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 3333333 688999999998 999999999984
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=313.41 Aligned_cols=248 Identities=22% Similarity=0.270 Sum_probs=193.1
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.||+|+||.||+++.. +++.||||++.... .....+.+|+.++..++|+||+++++++.++...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 455688999999999999965 58899999997432 2234578899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 83 LPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999964 345899999999999999999999998 9999999999999999999999999997643211
Q ss_pred Cc-------------------------------------cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhC
Q 038103 669 DT-------------------------------------KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711 (804)
Q Consensus 669 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg 711 (804)
.. ......||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124589999999999999999999999999999999999
Q ss_pred CCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 038103 712 KSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPP---MSKVVK 787 (804)
Q Consensus 712 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt---m~~Vv~ 787 (804)
+.||..... .+..... ..... .+.-+ .. ......+.+++..|+. +|.+|++ +.++++
T Consensus 236 ~~Pf~~~~~-----------~~~~~~i-~~~~~-~~~~~---~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNP-----------QETYRKI-INWKE-TLQFP---DE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCH-----------HHHHHHH-HcCCC-ccCCC---CC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999964220 0111111 11000 00000 00 0112356778888886 9999998 888865
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=302.90 Aligned_cols=239 Identities=23% Similarity=0.306 Sum_probs=189.6
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+++.. +++.||+|.++.. ....+.+..|..++..+ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 5789999999743 22334567788887754 899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|..++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence 999999854 345888999999999999999999998 999999999999999999999999998743221 122
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ...+ .+..... .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--------~~~~----~~~~~~~------~~~ 214 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--------EDEL----FESIRVD------TPH 214 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHH----HHHHHhC------CCC
Confidence 334668999999999999999999999999999999999999996422 0111 1111111 111
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMS-KVV 786 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~-~Vv 786 (804)
+.... ...+.+++.+|++.||++||++. ++.
T Consensus 215 ~~~~~----~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YPRWI----TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCC----CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11112 23578899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=330.61 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=200.1
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC----ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ----GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.++||+|+||.||+|+.. +++.||+|++..... ..+++.+|++++++++||||+++++++.+++..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 3566788999999999999965 588999999974322 23568899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCC-------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCC
Q 038103 588 YVENGSLDKLLFNDPG-------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGL 660 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 660 (804)
|+++++|.+++..... ....+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999999864211 1234667888999999999999999998 99999999999999999999999999
Q ss_pred cccccccCC-----------------ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccC
Q 038103 661 SKLFKERHD-----------------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASAS 723 (804)
Q Consensus 661 a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~ 723 (804)
++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-- 237 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-- 237 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh--
Confidence 987621110 1112346899999999999999999999999999999999999998642100
Q ss_pred CccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhccCCC
Q 038103 724 DSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-PMSKVVKLLTAHDH 794 (804)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-tm~~Vv~~L~~~~~ 794 (804)
.. .. .... .++.-. ....+.+..+.+++.+|++.||++|| +++++++.|+....
T Consensus 238 ------ki---~~----~~~i---~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 ------KI---SY----RDVI---LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ------hh---hh----hhhc---cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 00 0000 000000 00012234678899999999999995 67777787766543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.05 Aligned_cols=254 Identities=24% Similarity=0.301 Sum_probs=196.4
Q ss_pred HHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
....+.+.+.||+|+||.||+++.. +++.+|+|.+.... .....+.+|+.+++.++||||+++++.+..+...++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3466777889999999999999965 57889999986321 223457889999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 121 VMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 9999999999999853 24778888899999999999999998 999999999999999999999999999876
Q ss_pred cccCCccccccccCCCccchhhhccC----CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMMNL----KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
............||+.|+|||.+... .++.++|||||||++|||++|+.||.... ..........
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----------~~~~~~~i~~ 261 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----------LVGTYSKIMN 261 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-----------HHHHHHHHHc
Confidence 54333333456799999999998754 37899999999999999999999996422 1111111111
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHh
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDT--RPPMSKVVKLL 789 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPtm~~Vv~~L 789 (804)
......+.+ .......+.+++..|++.++.+ ||++.++++..
T Consensus 262 ~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111111 1122345778889999844443 78898888753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=309.04 Aligned_cols=236 Identities=28% Similarity=0.316 Sum_probs=187.1
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHH-HHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVS-IIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+++.. +++.||+|++.... ....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999965 68899999986321 12234555554 56789999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 999999864 345888899999999999999999998 999999999999999999999999998753222 222
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..+. ......+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----------~~~~-~~~i~~~~~------~ 214 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----------TAEM-YDNILNKPL------R 214 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----------HHHH-HHHHHcCCC------C
Confidence 334568999999999999999999999999999999999999986422 1111 111111111 1
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMS 783 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~ 783 (804)
+.... ...+.+++.+|++.+|.+||++.
T Consensus 215 ~~~~~----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 LKPNI----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCC----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 11112 34688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.98 Aligned_cols=245 Identities=24% Similarity=0.310 Sum_probs=191.6
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCChh
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLD 595 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 595 (804)
..||+|+||.||+|+.. +++.|++|.+.... ...+.+.+|++++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 46999999999999954 57789999887433 34567899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCC--CHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-CCCeEEeecCCcccccccCCccc
Q 038103 596 KLLFNDPGTASIL--QWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-HFEPKVTDFGLSKLFKERHDTKF 672 (804)
Q Consensus 596 ~~l~~~~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~ 672 (804)
+++... ...+ ++..+..++.|++.||+|||+.+ |+|+||||+||+++. ++.+||+|||++........ ..
T Consensus 94 ~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~ 166 (268)
T cd06624 94 ALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CT 166 (268)
T ss_pred HHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cc
Confidence 999752 2234 78888899999999999999988 999999999999976 67999999999986543221 22
Q ss_pred cccccCCCccchhhhccCC--CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 673 SRVRGTRGYLAPEWMMNLK--IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~~~~--~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
....++..|+|||++.... ++.++||||||+++|||++|+.|+...... ....+ .. ....
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~--------~~~~~--~~-~~~~------- 228 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP--------QAAMF--KV-GMFK------- 228 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh--------hhhHh--hh-hhhc-------
Confidence 2345788999999986543 788999999999999999999998532100 00000 00 0000
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.....+....+.+.+++.+|++.+|++||++.++++.
T Consensus 229 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 -IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0111122334568899999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.97 Aligned_cols=239 Identities=22% Similarity=0.286 Sum_probs=189.7
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCC-cccceeeeEEeCCeeEEEEe
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHR-NLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E 587 (804)
+.+.+.||+|+||.||+|+.. +++.||||++.... ...+.+..|.+++..++|+ +|+++++++...+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456788999999999999965 46789999987421 2345678899999999764 58889999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 82 YVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999864 345789999999999999999999998 999999999999999999999999998753221
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+. ..+....
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~----~~i~~~~---- 217 (324)
T cd05587 155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELF----QSIMEHN---- 217 (324)
T ss_pred -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHH----HHHHcCC----
Confidence 1222345689999999999999999999999999999999999999964220 1111 1111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPM 782 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 782 (804)
..+... ....+.+++.+|++.+|.+||+.
T Consensus 218 --~~~~~~----~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 --VSYPKS----LSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCC----CCHHHHHHHHHHhhcCHHHcCCC
Confidence 111111 23467899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=294.69 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=196.1
Q ss_pred hcccccccccCcceEEEEEecC-CcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.+.++||+|+||.||++.... +..+++|.+.... ...+.+.+|+++++.++|+|++++++++..+...++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4566789999999999999754 7788999886432 3346788999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|..++.. ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 999988754 2346899999999999999999999998 9999999999999999999999999997653321 22
Q ss_pred ccccccCCCccchhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 672 FSRVRGTRGYLAPEWMM-----NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.....++..|+|||.+. ...++.++||||||+++|||++|+.||..... .+.+.... ......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----------~~~~~~~~-~~~~~~ 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-----------MRVLLKIA-KSEPPT 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-----------HHHHHHHh-hcCCCC
Confidence 23456889999999984 44578899999999999999999999864220 11111111 111111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+.. +......+.+++.+|++.+|++||++.++++.
T Consensus 228 ~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 228 LAQ-------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCC-------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 11123468899999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=304.72 Aligned_cols=256 Identities=24% Similarity=0.396 Sum_probs=198.3
Q ss_pred HhcccccccccCcceEEEEEec-CCc----EEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DER----VVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~----~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
.+...+.||+|+||.||+|... ++. .+|+|.+..... ...++.+|+.++++++|+||++++++|... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence 3445678999999999999853 343 578898874332 234688999999999999999999998754 56799
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
+||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||+++...
T Consensus 87 ~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 87 TQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred ehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 999999999999865 2345889999999999999999999998 9999999999999999999999999998765
Q ss_pred ccCCc-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 666 ERHDT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 666 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ...... ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--------~~~~~~----~~~~~~ 228 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--------TREIPD----LLEKGE 228 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHH----HHHCCC
Confidence 43221 1222335678999999998899999999999999999998 888885421 011111 111111
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
. ... +......+.+++..|+..+|++||+|.++++.|+.+...+
T Consensus 229 ~--~~~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 229 R--LPQ-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred C--CCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 1 000 1112346889999999999999999999999998875543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.99 Aligned_cols=239 Identities=22% Similarity=0.305 Sum_probs=190.0
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEe
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 587 (804)
+.+.+.||+|+||.||+++.. +++.||+|.+.... ...+.+..|..++..+ +|++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 456788999999999999965 47789999987432 2234566788888777 58999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 82 YVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999854 245889999999999999999999998 999999999999999999999999999754322
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
. .......||+.|+|||++....++.++|||||||++|||++|+.||..... ..+. ..+.....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~----~~i~~~~~--- 218 (323)
T cd05616 155 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELF----QSIMEHNV--- 218 (323)
T ss_pred C-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHH----HHHHhCCC---
Confidence 1 222345689999999999999999999999999999999999999964220 1111 11111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPM 782 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 782 (804)
. ++......+.+++.+|++.+|++|++.
T Consensus 219 ---~----~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ---A----YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---C----CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1 111223467899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=292.14 Aligned_cols=248 Identities=23% Similarity=0.304 Sum_probs=199.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
+.+.++||+|+||.||++... +++.+|+|.++.. ....+++.+|+.++++++|+||+++++.+......++++||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 456788999999999999954 5788999988632 2344678889999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++... ....++......++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 82 GGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 99999988642 3345788999999999999999999998 99999999999999999999999999986644222
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... .... ......+....+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----------~~~~-~~~~~~~~~~~~--- 220 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----------WKNL-ILKVCQGSYKPL--- 220 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----------HHHH-HHHHhcCCCCCC---
Confidence 1223567889999999998889999999999999999999999986421 1111 111122222111
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+......+.+|+.+||+.+|++||++.+|+..
T Consensus 221 ------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11123457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.42 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=193.9
Q ss_pred cccccccccCcceEEEEEe-cCCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 515 NFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
.+.+.||+|+||.||+++. .+++.||+|.+.... ....++.+|++++.+++||||+++++++...+..++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 4567899999999999995 467889999986432 2245688999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++...... .
T Consensus 84 ~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 84 GSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred CChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 9987553 2678888899999999999999998 999999999999999999999999999865432 2
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....++..|+|||.+....++.++||||||+++|||++|+.||.......... ..... ........ .+.
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~-~~~~~~~~-----~~~ 219 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL----MPLQL-LQCIVDED-----PPV 219 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc----chHHH-HHHHhccC-----CCC
Confidence 233568899999999998899999999999999999999999986432111110 00011 11111111 111
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+. .......+.+++.+|++.+|++||+++++++.
T Consensus 220 ~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11 11122367899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.43 Aligned_cols=240 Identities=23% Similarity=0.317 Sum_probs=191.4
Q ss_pred ccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 516 FKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 516 ~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
+...||+|+||.||.++-+ +|..+|+|+++++. ...+..++|-.+|....++.||+|+-.|.+.+.+||||||++
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 3467999999999999955 58999999998543 233567889999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc---
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER--- 667 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~--- 667 (804)
||++..+|.. ...|+.......+.+++-|++-||+.| +|||||||+|+|||..|++||+||||+.-+...
T Consensus 225 GGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 225 GGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred CccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 9999999964 467888888999999999999999999 999999999999999999999999999643210
Q ss_pred --------------------CCc----c-------------------ccccccCCCccchhhhccCCCCcccchHHHHHH
Q 038103 668 --------------------HDT----K-------------------FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIV 704 (804)
Q Consensus 668 --------------------~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvl 704 (804)
... . .....|||.|+|||++.+..|+..+|.||+|||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 000 0 012459999999999999999999999999999
Q ss_pred HHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC
Q 038103 705 LLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPP 781 (804)
Q Consensus 705 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt 781 (804)
+|||+.|-+||....+ ......+..|.... ....+. ....+..+||.+|+. ||++|.-
T Consensus 378 myEmLvGyPPF~s~tp----~~T~rkI~nwr~~l------~fP~~~--------~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETP----QETYRKIVNWRETL------KFPEEV--------DLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHhCCCCCCCCCH----HHHHHHHHHHhhhc------cCCCcC--------cccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999975331 11222333332211 111111 112567889999998 9999976
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=298.99 Aligned_cols=255 Identities=21% Similarity=0.309 Sum_probs=201.9
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
..|.+.+.||+|+||.||+++. .+++.||+|.+.... ...+.+.+|+.+++.++|+|++++++++..+...++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 4566778899999999999995 568899999987433 34466888999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999853 34788899999999999999999988 99999999999999999999999999986543322
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......+++.|+|||.+.+..++.++||||||+++|++++|+.||....... . ...... .. .
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-------~----~~~~~~-~~-----~ 232 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------A----LYLIAT-NG-----T 232 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-------h----eeeecc-CC-----C
Confidence 1223457889999999999889999999999999999999999985422100 0 000000 00 0
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HhccCCC
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK--LLTAHDH 794 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~--~L~~~~~ 794 (804)
+.+ ..+......+.+++.+|++.+|++||++.+|++ .++...+
T Consensus 233 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 233 PEL--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 000 011223346788999999999999999999987 4444333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=300.31 Aligned_cols=259 Identities=20% Similarity=0.333 Sum_probs=194.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+|.+.++||+|+||.||+|+.. +++.||+|.++... .....+.+|++++++++|+||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 4566788999999999999965 57889999987332 23456788999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++ +|.+++.. .+..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 87 DK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 76 88888754 2345788999999999999999999998 99999999999999999999999999986433221
Q ss_pred ccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh--------
Q 038103 670 TKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME-------- 740 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 740 (804)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ....+.....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED--------ELHLIFRLLGTPTEETWP 230 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHHhCCCCHHHHh
Confidence 2223457889999998865 468899999999999999999999986432110 0000110000
Q ss_pred ---hc-CcccccCCcCCC----ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 741 ---QE-GLEKIIDPRLND----VYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 741 ---~~-~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.. .....-.+.... .........+.+|+.+|++.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 000000000000 000112345789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=315.79 Aligned_cols=197 Identities=26% Similarity=0.350 Sum_probs=169.0
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
|.+.++||+|+||.||+++.. +++.||||.+.... .....+.+|++++.+++|+||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 556788999999999999964 58899999986321 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.+++.. ...++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 83 IPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999964 345788888899999999999999998 9999999999999999999999999985332100
Q ss_pred ------------------------------------------CccccccccCCCccchhhhccCCCCcccchHHHHHHHH
Q 038103 669 ------------------------------------------DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLL 706 (804)
Q Consensus 669 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~ 706 (804)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00011346899999999999999999999999999999
Q ss_pred HHHhCCCCCcc
Q 038103 707 ELLTGKSASDY 717 (804)
Q Consensus 707 el~tg~~p~~~ 717 (804)
||++|+.||..
T Consensus 236 ell~G~~Pf~~ 246 (376)
T cd05598 236 EMLVGQPPFLA 246 (376)
T ss_pred ehhhCCCCCCC
Confidence 99999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=296.04 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=196.5
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEE-----eCCeeEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCA-----ENEHKLLV 585 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~-----~~~~~~lV 585 (804)
++.+.+.||+|+||.||+++.. .++.+|+|.+........++.+|+.++.++ +|+||+++++++. .+...++|
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 4556678999999999999964 578899998875444456788999999999 6999999999884 34578999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++++|.+++.........+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 9999999999988643334456889999999999999999999988 9999999999999999999999999998654
Q ss_pred ccCCccccccccCCCccchhhhcc-----CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMN-----LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.|+...... ..... ..
T Consensus 176 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-----------~~~~~-~~ 242 (286)
T cd06638 176 STR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-----------RALFK-IP 242 (286)
T ss_pred cCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-----------HHHhh-cc
Confidence 322 12233468899999998753 45788999999999999999999998642210 00000 01
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L 789 (804)
........++ ......+.+|+.+|++.+|++||++.+|++.+
T Consensus 243 ~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 243 RNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1111111111 11224688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=303.19 Aligned_cols=198 Identities=23% Similarity=0.306 Sum_probs=170.4
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
|.+.+.||+|+||.||+++.. +++.||+|.+... ....+.+.+|+.++..++|+||+++++++.++...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 566788999999999999965 5889999998632 12335588899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 83 YVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999964 2345888999999999999999999998 9999999999999999999999999997655433
Q ss_pred CccccccccCCCccchhhhcc-----CCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMN-----LKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 333333568999999999863 4578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.60 Aligned_cols=257 Identities=24% Similarity=0.376 Sum_probs=201.8
Q ss_pred HHHhcccccccccCcceEEEEEecC-C----cEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDD-E----RVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~-~----~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
...+.+.+.||+|+||.||+|...+ + ..+|+|.+..... ...++.+|+.++++++|+||++++++|.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3456677899999999999999643 3 2589998874432 34578899999999999999999999987 7889
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+|+||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999999752 345899999999999999999999988 99999999999999999999999999987
Q ss_pred ccccCCcc-ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 664 FKERHDTK-FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 664 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
........ .....++..|+|||.+....++.++||||||++++|+++ |+.|++.... ..+ ...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~----~~~~~~ 226 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEI----PDLLEK 226 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHH----HHHHhC
Confidence 65432211 112223568999999988899999999999999999999 9999864320 111 112221
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
+.. ... +......+.+++..|+..+|.+||++.++++.|+.+...
T Consensus 227 ~~~--~~~-------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 227 GER--LPQ-------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCC--CCC-------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 111 001 111223578999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=298.78 Aligned_cols=196 Identities=26% Similarity=0.439 Sum_probs=160.7
Q ss_pred cccccccCcceEEEEEec---CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeEEEEeeccC
Q 038103 517 KQEVGKGGFGSVFRGVLD---DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAE--NEHKLLVYEYVEN 591 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~ 591 (804)
..+||+|+||.||+|+.. +++.+|+|.++... ....+.+|++++++++||||+++++++.. +...++++||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 357999999999999964 45789999987432 23457889999999999999999998854 4567899999865
Q ss_pred CChhhhhccCC-----CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE----cCCCCeEEeecCCcc
Q 038103 592 GSLDKLLFNDP-----GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL----DDHFEPKVTDFGLSK 662 (804)
Q Consensus 592 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfgla~ 662 (804)
+|.+++.... .....+++..+..++.||+.||+|||+++ |+||||||+|||+ +..+.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 8877764321 12235888999999999999999999998 9999999999999 456789999999998
Q ss_pred cccccCC--ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 663 LFKERHD--TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 663 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
....... .......+|+.|+|||++.+. .++.++||||+||+++||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 7654322 223345689999999998764 589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=275.74 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=199.9
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CCh------HHHHHHHHHHhcC-CCCcccceeeeEEeCCee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGD------AEFWAEVSIIGRI-NHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 582 (804)
+.-++.||+|..+.|-+...+ ++.+.|+|++.... +++ ++-..|+.+|+++ -||+|+.+.+++..+...
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 444678999999999998854 67889999986321 111 3456799999998 599999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++|+|.|+.|.|.++|. +...+++....+|+.|+.+|++|||.+. |+||||||+|||+|++.++||+|||++.
T Consensus 99 FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred hhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceee
Confidence 99999999999999995 4567999999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccccccCCCccchhhhcc------CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHH
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMN------LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVA 736 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (804)
.+... ......+||++|+|||.++- ..|+...|+|+.||+||-|+.|..||-... + -.+.
T Consensus 172 ~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk----------Q--mlML 237 (411)
T KOG0599|consen 172 QLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK----------Q--MLML 237 (411)
T ss_pred ccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH----------H--HHHH
Confidence 87653 34456789999999998852 458889999999999999999999985322 0 1122
Q ss_pred HHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 737 KQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 737 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+.+.+|..+ +-.+ .-.+....+.+|+.+|++.||.+|.|++|+++
T Consensus 238 R~ImeGkyq-F~sp-----eWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 238 RMIMEGKYQ-FRSP-----EWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHhcccc-cCCc-----chhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 333333322 1111 12234457889999999999999999999864
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=301.28 Aligned_cols=197 Identities=20% Similarity=0.211 Sum_probs=163.5
Q ss_pred cccccccc--CcceEEEEEe-cCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 516 FKQEVGKG--GFGSVFRGVL-DDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 516 ~~~~LG~G--~fg~Vykg~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+.++||+| +|++||++.. .+++.||+|++..... ..+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 7899999986 4688999999974322 2345778999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999999643 2234889999999999999999999998 99999999999999999999999986554321111
Q ss_pred c------cccccccCCCccchhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 670 T------KFSRVRGTRGYLAPEWMMN--LKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 670 ~------~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
. ......++..|+|||++.. ..++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 0112345678999999875 4689999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=292.56 Aligned_cols=247 Identities=25% Similarity=0.406 Sum_probs=197.0
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
..+.+.+.||+|+||.||++.. .++.+|+|.++... ..+.+.+|+.++.+++|+|++++++++... ..++++||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 4567788999999999999985 56679999986432 346788999999999999999999998764 57999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999999753 2345889999999999999999999988 9999999999999999999999999998643221
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
.....+..|+|||.+....++.++|+||||++++||++ |+.||.... ..+ .......+...
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----------~~~-~~~~~~~~~~~----- 216 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----------LKE-VKECVEKGYRM----- 216 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----------HHH-HHHHHhCCCCC-----
Confidence 12234567999999998899999999999999999998 998885422 111 11111111110
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
.........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 217 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 ----EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111233568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.76 Aligned_cols=242 Identities=21% Similarity=0.297 Sum_probs=190.3
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+++.. +++.+|+|+++... ...+.+.+|+.++.++ +|+||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 57889999997432 2234578899999888 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 999988853 345899999999999999999999998 9999999999999999999999999997532211 22
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ............... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~------~ 221 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-----NTEDYLFQVILEKPI------R 221 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-----ccHHHHHHHHHhCCC------C
Confidence 23456899999999999999999999999999999999999999643221111 111122222221111 1
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPM 782 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 782 (804)
+... ....+.+++.+|++.||.+||++
T Consensus 222 ~p~~----~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 222 IPRF----LSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCC----CCHHHHHHHHHHhccCHHHcCCC
Confidence 1111 22357899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=310.66 Aligned_cols=197 Identities=26% Similarity=0.351 Sum_probs=168.3
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.||+|+||.||+++.. +++.+|+|.+.... .....+.+|++++++++|+||+++++.+.++...++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 455678999999999999964 57889999987432 2235688899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.+++.. ...++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 83 IPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999864 235788888999999999999999998 9999999999999999999999999986432100
Q ss_pred C----------------------------------------------ccccccccCCCccchhhhccCCCCcccchHHHH
Q 038103 669 D----------------------------------------------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYG 702 (804)
Q Consensus 669 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~G 702 (804)
. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 001224689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCcc
Q 038103 703 IVLLELLTGKSASDY 717 (804)
Q Consensus 703 vll~el~tg~~p~~~ 717 (804)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=291.29 Aligned_cols=248 Identities=24% Similarity=0.420 Sum_probs=196.9
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCcCC-------ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ-------GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
+...+.||+|+||.||+|...+++.+|||.++.... ....+.+|++++++++|+||+++++++.+....++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 345678999999999999988899999999873321 1245788999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 82 EFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999964 235788999999999999999999988 99999999999999999999999999986532
Q ss_pred cC-----CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 667 RH-----DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 667 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
.. ........++..|+|||.+.+..++.++||||||++++||++|+.||..... ... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----------~~~-~~~~~~~ 223 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR----------LAA-MFYIGAH 223 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh----------HHH-HHHhhhc
Confidence 11 1122234578899999999988899999999999999999999999864220 000 0000000
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.. ..+.+.. .....+.+++.+|++.+|++||++.++++
T Consensus 224 ~~----~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 RG----LMPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred cC----CCCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 1111112 22346789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=293.82 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=199.4
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
.+...++||.|+||.||+|... +++.||+|.+.... .....+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3455678999999999999965 57889999987432 23467889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999853 34788889999999999999999988 99999999999999999999999999986543221
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......++..|+|||.+.+..++.++|+||||+++|||++|+.|+...... .. . .....
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~---~-~~~~~-------- 215 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RV---L-FLIPK-------- 215 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hH---h-hhhhc--------
Confidence 222345788899999999888999999999999999999999998642210 00 0 00010
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.............+.+++..|++.+|++||++.++++.
T Consensus 216 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 216 -NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11122233455678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=292.33 Aligned_cols=245 Identities=27% Similarity=0.388 Sum_probs=198.9
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
+.+.+.||.|+||.||+|+.. +++.||+|.+.... ....++.+|++++++++|+|++++++++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 456678999999999999965 58899999987432 234578899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 83 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 153 (274)
T cd06609 83 GGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S 153 (274)
T ss_pred CCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence 9999999854 26899999999999999999999998 9999999999999999999999999998765432 2
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
......++..|+|||.+.+..++.++||||||+++|||++|+.||....+ .. .......... +
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-----------~~-~~~~~~~~~~-----~ 216 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-----------MR-VLFLIPKNNP-----P 216 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-----------HH-HHHHhhhcCC-----C
Confidence 22334678899999999988899999999999999999999999864220 00 0111111111 1
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+... .....+.+++..|++.+|++||+++++++
T Consensus 217 ~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 217 SLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111 02346788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=314.19 Aligned_cols=249 Identities=22% Similarity=0.264 Sum_probs=190.5
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
|.+.++||+|+||.||++.. .+++.||||.+.... ...+++.+|++++.+++||||+++++++.+....++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 45668899999999999985 468899999986422 2235678899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 83 ~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 83 LPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999864 345788889999999999999999999 9999999999999999999999999996432110
Q ss_pred Cc----------------------------------------------cccccccCCCccchhhhccCCCCcccchHHHH
Q 038103 669 DT----------------------------------------------KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYG 702 (804)
Q Consensus 669 ~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~G 702 (804)
.. ......||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00124589999999999998999999999999
Q ss_pred HHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCC---
Q 038103 703 IVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTR--- 779 (804)
Q Consensus 703 vll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R--- 779 (804)
|++|||++|+.||..... ... ............+ + .. ......+.+++..|++ +|.+|
T Consensus 236 vil~elltG~~Pf~~~~~--------~~~---~~~i~~~~~~~~~--p---~~--~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 236 AIMFECLIGWPPFCSENS--------HET---YRKIINWRETLYF--P---DD--IHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred hhhhhhhcCCCCCCCCCH--------HHH---HHHHHccCCccCC--C---CC--CCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 999999999999964220 000 0111100000000 0 00 0112357788888887 66665
Q ss_pred CCHHHHHHH
Q 038103 780 PPMSKVVKL 788 (804)
Q Consensus 780 Ptm~~Vv~~ 788 (804)
|++.++++.
T Consensus 297 ~~~~~~l~h 305 (377)
T cd05629 297 GGAHEIKSH 305 (377)
T ss_pred CCHHHHhcC
Confidence 699888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=303.33 Aligned_cols=240 Identities=26% Similarity=0.320 Sum_probs=187.3
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHH-HHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVS-IIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+++.. +++.||+|.+.... ....++..|.. +++.++|+||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 57789999987422 22234444544 56788999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.+++.. ...+.......++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGT 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCC
Confidence 999999864 234777888889999999999999998 999999999999999999999999999754322 122
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+.. ........ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~-~~i~~~~~------~ 214 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----------AEMY-DNILNKPL------Q 214 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----------HHHH-HHHHhCCc------C
Confidence 3345689999999999999999999999999999999999999964220 1111 11111111 0
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+.. .....+.+++.+|++.+|.+||++.+.++
T Consensus 215 ~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 215 LKP----NITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCC----CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 111 12346789999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=304.48 Aligned_cols=239 Identities=26% Similarity=0.302 Sum_probs=187.9
Q ss_pred ccccccCcceEEEEEe-cCCcEEEEEEecCcC----CChHHHHHHHH-HHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL----QGDAEFWAEVS-IIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+++. .+++.+|+|++.... ....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4689999999999995 468899999986421 22344555654 46778999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 999988853 345889999999999999999999998 9999999999999999999999999987532221 22
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+. ........+ .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----------~~~~-~~~~~~~~~--~~~-- 216 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----------VAEM-YDNILHKPL--VLR-- 216 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----------HHHH-HHHHHcCCc--cCC--
Confidence 234568999999999999999999999999999999999999986422 1111 111111111 011
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVV 786 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv 786 (804)
.. ....+.+++..|++.+|.+||++.+.+
T Consensus 217 --~~----~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 217 --PG----ASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred --CC----CCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 11 234577899999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=297.03 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=195.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+...+.||+|+||+||++... +++.+|+|.+.... .....+.+|++++++++|+|++++.+.+..++..++++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 344577999999999999964 68899999986432 1234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999888642 2345899999999999999999999998 9999999999999999999999999997653321
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||..... ......+........ .
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~--------~~~~~~~~~~~~~~~--~-- 222 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE--------KVKREEVDRRVLETE--E-- 222 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhhhccc--c--
Confidence 22334689999999999988999999999999999999999999964220 001111111111111 0
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPP-----MSKVVK 787 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~~Vv~ 787 (804)
.. .......+.+|+..|++.+|++||+ +.++++
T Consensus 223 --~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 --VY----SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --cc----CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11 1112335788999999999999999 566655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=293.94 Aligned_cols=239 Identities=23% Similarity=0.402 Sum_probs=186.7
Q ss_pred ccccccCcceEEEEEecC--------CcEEEEEEecCcCC-ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 518 QEVGKGGFGSVFRGVLDD--------ERVVAVKRLEGVLQ-GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~--------~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.||+|+||.||+|.... ...+++|.+..... ..+++.+|+.++++++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998542 23488888764332 345788899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC--------eEEeecCC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE--------PKVTDFGL 660 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~kl~Dfgl 660 (804)
+++|+|..++... +..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +|++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999752 336889999999999999999999998 999999999999987765 69999998
Q ss_pred cccccccCCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCC-CCCcccccccCCccchhhHHHHHHHH
Q 038103 661 SKLFKERHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGK-SASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 661 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
+..... .....++..|+|||.+.+. .++.++||||||+++|||++|. .|+..... ... ...
T Consensus 155 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-----------~~~-~~~ 217 (258)
T cd05078 155 SITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-----------QKK-LQF 217 (258)
T ss_pred ccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-----------HHH-HHH
Confidence 875432 1234577889999999764 5789999999999999999985 44432110 000 000
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
.... ..+.. .....+.+|+.+|++.+|++||+++++++.|+
T Consensus 218 -~~~~------~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 218 -YEDR------HQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -HHcc------ccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0100 01111 12246889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=310.39 Aligned_cols=264 Identities=22% Similarity=0.255 Sum_probs=198.3
Q ss_pred HHHHHHhcccccccccCcceEEEEEec---CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 508 ELKRATRNFKQEVGKGGFGSVFRGVLD---DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 508 ~l~~~t~~~~~~LG~G~fg~Vykg~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
.+....|.+.+.||+|+||.||++... .++.||||.+... ....+|++++++++|+||+++++++......++
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 334456788899999999999999853 3577999987642 345689999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
+||++. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 164 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999996 58888883 3456899999999999999999999998 999999999999999999999999999865
Q ss_pred cccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 665 KERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 665 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
..... .......||+.|+|||++....++.++|||||||++|||++|+.||....... ....+.. +.+......
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~l~~-i~~~~~~~~ 310 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS----SSSQLRS-IIRCMQVHP 310 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC----cHHHHHH-HHHHhccCc
Confidence 54322 22234568999999999999999999999999999999999999986432111 0111111 111110000
Q ss_pred c-----------------ccccCCcCC--Ccc-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 744 L-----------------EKIIDPRLN--DVY-DREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 744 ~-----------------~~~~d~~l~--~~~-~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
. .....+... ... .......+.+++.+|++.+|++||++.+++..
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000000000 000 00112457789999999999999999999864
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.79 Aligned_cols=195 Identities=31% Similarity=0.418 Sum_probs=171.4
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCC-C-----CcccceeeeEEeCCeeEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-H-----RNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~lV 585 (804)
+|.+.+.||+|.||.|.|+... +++.||||++++...-..+...|+.+|..|+ | -|+|++++++...++++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 6778899999999999999954 5899999999977666677888999999996 4 3899999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC--CCeEEeecCCccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH--FEPKVTDFGLSKL 663 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kl~Dfgla~~ 663 (804)
+|.+.. +|.++|+.+.- ..++...+..++.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.+..
T Consensus 267 fELL~~-NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhhhh-hHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999977 99999987643 34889999999999999999999998 9999999999999654 4699999999997
Q ss_pred ccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
..... .....+..|+|||++.+.+|+.+.||||||||+.||++|...|..
T Consensus 341 ~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 341 ESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 54422 245568899999999999999999999999999999999877753
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.06 Aligned_cols=236 Identities=27% Similarity=0.309 Sum_probs=185.9
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHH-HHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVS-IIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+++.. +++.||+|.+.... ....++.+|.. +++.++|+||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 57899999986322 12334555554 57889999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|..++.. ...++......++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EET 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCc
Confidence 999988853 345778888899999999999999998 999999999999999999999999998753222 122
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....|++.|+|||.+....++.++||||||+++|||++|+.||.... .... ...+.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----------~~~~-~~~i~~~~~------- 213 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----------VSQM-YDNILHKPL------- 213 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----------HHHH-HHHHhcCCC-------
Confidence 334568999999999999899999999999999999999999986421 1111 111111110
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMS 783 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~ 783 (804)
..+......+.+++.+|++.+|.+||+..
T Consensus 214 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 ---QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11112234688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.37 Aligned_cols=258 Identities=23% Similarity=0.341 Sum_probs=191.0
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcC---CCCcccceeeeEEe-----CCe
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRI---NHRNLVKLQGFCAE-----NEH 581 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~~ 581 (804)
|.+.++||+|+||.||+++.. +++.||+|.++... .....+.+|+.++.++ +|+||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456788999999999999965 58899999987422 1234566777777665 79999999998864 345
Q ss_pred eEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCc
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 661 (804)
.++++||+++ +|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred EEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 7999999985 888888653 2345889999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 662 KLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..+.. +......
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-------~~~~~-~~~~~~~ 225 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-------DQLGK-IFDLIGL 225 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-------HHHHH-HHHHhCC
Confidence 8764322 223356789999999999889999999999999999999999998542210 00100 1110000
Q ss_pred ---cCc-------ccccCCcCC---CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 742 ---EGL-------EKIIDPRLN---DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 742 ---~~~-------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
... .....+... .....+..+.+.+++.+|++.||++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000000000 0111223456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.72 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=195.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCC----ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ----GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+...+.||+|+||.||++... +++.+|||.+..... ..+.+.+|+.++++++|++++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 345578999999999999965 588999999864321 234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999998643 2235889999999999999999999988 9999999999999999999999999997654322
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
. .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... . ............ .
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-----~---~~~~~~~~~~~~--~--- 221 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-----I---KREEVERLVKEV--Q--- 221 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc-----c---hHHHHHhhhhhh--h---
Confidence 1 22346899999999999999999999999999999999999999643210 0 000011110100 0
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPP-----MSKVVK 787 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~~Vv~ 787 (804)
...... ....+.+|+..|++.+|++||+ +.++++
T Consensus 222 -~~~~~~----~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 -EEYSEK----FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hhcCcc----CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011111 2235789999999999999999 778875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=292.02 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=197.4
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
..+.+.+.||+|+||.||+++.. +++.||+|.++... .....+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 45667788999999999999964 58889999987433 33456788999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 99999999854 345889999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccccccccCCCccchhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 670 TKFSRVRGTRGYLAPEWMM---NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.......|+..|+|||.+. ...++.++||||||+++|||++|+.|+....+. .. ... .......
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-------~~----~~~-~~~~~~~- 227 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-------RA----LFL-MTKSNFQ- 227 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-------hh----HHh-hhccCCC-
Confidence 2223456889999999874 456889999999999999999999998532210 00 000 0111111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+..... ......+.+++.+|++.+|++||++++|++.
T Consensus 228 --~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 228 --PPKLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --CCccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1111110 0112357899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=298.89 Aligned_cols=246 Identities=20% Similarity=0.326 Sum_probs=197.7
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.+.+.||.|+||.||+|+. .+++.|++|.+.... ...+.+.+|+.++++++|+|++++++++......++|+||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 45567899999999999985 568899999987433 3456788999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|..++.. ..+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ .
T Consensus 101 ~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 101 GSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 999999853 34899999999999999999999998 99999999999999999999999999886544322 1
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....++..|+|||.+....++.++||||||+++|||++|+.||..... ...... ........+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-----------~~~~~~-~~~~~~~~~~--- 236 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----------LRALYL-IATNGTPELQ--- 236 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHH-HHhcCCcccC---
Confidence 2234578899999999988899999999999999999999999864221 000111 1111110000
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+......+.+++.+|++.+|++||++.+|++
T Consensus 237 ----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 ----NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ----CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11122346788999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=293.20 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=196.7
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC----------hHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG----------DAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~----------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
+.+...||+|+||.||+|... +++.+|+|.+...... .+.+.+|+.++++++|+||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 456678999999999999964 5788999988643211 14578899999999999999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++
T Consensus 82 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999954 245788899999999999999999988 9999999999999999999999999998
Q ss_pred cccccCC-----ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHH
Q 038103 663 LFKERHD-----TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAK 737 (804)
Q Consensus 663 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (804)
....... .......++..|+|||.+....++.++||||||+++|||++|+.||..... ...+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~~ 223 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-----------LQAIFK 223 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-----------HHHHHH
Confidence 7653211 111234578899999999988899999999999999999999999864210 000111
Q ss_pred HhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 738 QMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 738 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
... ...+.+ +....+.+.+++.+|++.+|.+||++.+|++
T Consensus 224 -~~~-----~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 -IGE-----NASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -Hhc-----cCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111 111111 2223457889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=305.52 Aligned_cols=190 Identities=25% Similarity=0.318 Sum_probs=162.3
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
..|.+.+.||+|+||.||+|+.. .++.||+|..... ....|+.++++++|+||+++++++......++|+|++.
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 34667789999999999999975 4678999975422 23569999999999999999999999999999999995
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
++|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 141 -~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~ 211 (357)
T PHA03209 141 -SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--P 211 (357)
T ss_pred -CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--c
Confidence 588888864 3456899999999999999999999998 999999999999999999999999999753322 1
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSAS 715 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~ 715 (804)
......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 223456899999999999999999999999999999999966554
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=303.86 Aligned_cols=239 Identities=22% Similarity=0.303 Sum_probs=189.9
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEe
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 587 (804)
+++.+.||+|+||.||++... +++.||+|.+.... ...+.+..|..++..+. |++|+++.+++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 467788999999999999964 58899999987421 22345778888888885 5778889999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 82 YVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999854 345889999999999999999999998 999999999999999999999999998854322
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ... ...+.....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~----~~~i~~~~~--- 218 (323)
T cd05615 155 G-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DEL----FQSIMEHNV--- 218 (323)
T ss_pred C-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHH----HHHHHhCCC---
Confidence 1 122345689999999999998999999999999999999999999964320 111 111111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPM 782 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 782 (804)
.+.. .....+.+++.+|++.+|.+|++.
T Consensus 219 ---~~p~----~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ---SYPK----SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCc----cCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111 123467889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=290.84 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=201.7
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
|.+.+.||.|+||.||.++. .+++.+++|.+.... ....++.+|++++++++|+||+++++++.+....+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 45678899999999999984 457889999886432 33467889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 82 NGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred CCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999997532 346889999999999999999999988 99999999999999999999999999987644332
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......++..|+|||.+.+..++.++||||||++++||++|+.||+... ..+..... ..+.....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----------~~~~~~~~-~~~~~~~~-- 221 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----------PLNLVVKI-VQGNYTPV-- 221 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----------HHHHHHHH-HcCCCCCC--
Confidence 2234567899999999988889999999999999999999999986421 11111111 11221111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L 789 (804)
.......+.+++.+|++.+|.+||++.++++.+
T Consensus 222 -------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 -------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -------ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112234688999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.70 Aligned_cols=249 Identities=30% Similarity=0.501 Sum_probs=199.2
Q ss_pred cccccccccCcceEEEEEecC-----CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 515 NFKQEVGKGGFGSVFRGVLDD-----ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~~-----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.||.|+||.||+++..+ +..||+|.+..... ..+.+..|+.++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 356789999999999999654 47899999975443 45688999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999996521 122899999999999999999999998 999999999999999999999999999876544
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.........++..|+|||.+....++.++||||+|++++||++ |+.|+.... ...+ .+....+....
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--------~~~~----~~~~~~~~~~~ 224 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--------NEEV----LEYLKKGYRLP 224 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------HHHH----HHHHhcCCCCC
Confidence 2222212336789999999988889999999999999999998 777775321 0111 11111111111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L 789 (804)
........+.+++.+|++.+|++|||+.++++.|
T Consensus 225 ---------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 ---------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111344688999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=289.66 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=200.2
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.+.+.+.||.|+||.||++... +++.+++|.+.... ...+.+.+|++++++++|+||+++++.+......+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 4566788999999999999964 57789999987433 345678999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++.. ....++...+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 84 ~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 84 GGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 9999999865 2346889999999999999999999988 99999999999999999999999999986544221
Q ss_pred cccccccCCCccchhhhccC---CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 671 KFSRVRGTRGYLAPEWMMNL---KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~---~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
......++..|+|||.+... .++.++||||||+++|||++|+.|+...... .. .. ......+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-------~~----~~-~~~~~~~--- 221 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-------RA----LF-LISKSNF--- 221 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------HH----HH-HHHhccC---
Confidence 22334678889999999776 8899999999999999999999998642200 00 00 0111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..+.+. ........+.+++.+|++.+|.+||++++|+.
T Consensus 222 ~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 PPPKLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCcccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111111 12233457899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=286.45 Aligned_cols=260 Identities=21% Similarity=0.329 Sum_probs=194.9
Q ss_pred cccccccCcceEEEEEe-cCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEe-----CCeeEEEEe
Q 038103 517 KQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAE-----NEHKLLVYE 587 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~lV~E 587 (804)
.+.||+|+||.|.++.. ++|+.||||++....+ ..++..+|+++|+.++|+||+.+..++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 46799999999999995 4689999999974433 34677899999999999999999998865 347899999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
+|+. +|...++. +..|+.....-++.|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|+.....
T Consensus 107 lMet-DL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 107 LMET-DLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred HHhh-HHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc
Confidence 9955 89999953 445899999999999999999999999 999999999999999999999999999987543
Q ss_pred -CCccccccccCCCccchhhhc-cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCC--------ccchhhHH----H
Q 038103 668 -HDTKFSRVRGTRGYLAPEWMM-NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASD--------SSYCNHLV----Q 733 (804)
Q Consensus 668 -~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~--------~~~~~~~~----~ 733 (804)
.....+....|..|+|||.+. ...|+.+.||||.|||+.||++|+..|........- ......+. +
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 223345677899999999875 467999999999999999999999998653311100 00000000 0
Q ss_pred HHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 734 WVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+...++... ......+...++ ......++|+.+||..||.+|+|++|.++
T Consensus 259 ~ar~yi~slp--~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 259 KARPYIKSLP--QIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHHhCC--CCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0111111100 000000000111 22346788999999999999999999975
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=298.77 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=208.5
Q ss_pred HHHhcccccccccCcceEEEEEecC-CcEEEEEEecCcCC----ChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQ----GDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 584 (804)
...|.+.++||+|.||.||+++.+. |+.+|+|.+.+... ..+...+|+++|+++. |||||.+.+.+......++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4557777999999999999999765 89999999974332 3367999999999998 9999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC----CCeEEeecCC
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH----FEPKVTDFGL 660 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~Dfgl 660 (804)
|||++.+|.|.+.|... .++......++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999753 3899999999999999999999999 9999999999999533 5799999999
Q ss_pred cccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 661 SKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 661 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
+..... .......+||+.|+|||.+...+|+..+||||+|+++|.|++|..||..... ... ...+.
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~-------~~~-----~~~i~ 251 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE-------FEI-----FLAIL 251 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh-------hHH-----HHHHH
Confidence 998776 5566778999999999999999999999999999999999999999975321 011 11222
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+.+ ......-....+.+.+++..++..||.+|+++.++++.
T Consensus 252 ~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 252 RGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 2322 11122223335578899999999999999999999985
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=297.54 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=196.2
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
+.+.++||+|+||.||++... ++..+|+|.+..... ...++.+|++++.+++||||+++++.+..++..++|+||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 456788999999999999965 577899998864322 23568899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
+++|.+++.. ...+++..+..++.|+++||.|||+. + ++|+||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 83 GGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999999964 24588999999999999999999984 5 9999999999999999999999999987653321
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccc----------------------
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSY---------------------- 727 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~---------------------- 727 (804)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+............
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence 22346788999999998888999999999999999999999998532210000000
Q ss_pred ---hhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 038103 728 ---CNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789 (804)
Q Consensus 728 ---~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L 789 (804)
.....+........ ..+.+. .......+.+++.+|++.+|++||++.+|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~------~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 233 SPRPMAIFELLDYIVNE------PPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred ccchhhHHHHHHHHhcC------CCccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000000000 000000 011234588999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=291.58 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=194.3
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+.+.+.||+|++|.||+|+.. +++.||+|+++... ...+.+.+|+.++.+++|+||+++++++.++...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 455678999999999999965 68899999986432 22467889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
+ ++|.+++...+ ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 82 S-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred C-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 7 58988886532 2356899999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH-------hh-
Q 038103 670 TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ-------ME- 740 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~- 740 (804)
.......++..|+|||.+.+. .++.++||||||++++||+||+.||...... .......... +.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-------DQLFRIFRILGTPTEDVWPG 228 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHHhCCCChhhhhc
Confidence 122233568889999988654 5789999999999999999999998642110 0000000000 00
Q ss_pred -------hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 741 -------QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 741 -------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...........+.. ........+.+++.+|++.||++|||+.+|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 229 VTSLPDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred chhhHHHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000000 00112346779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=290.62 Aligned_cols=248 Identities=24% Similarity=0.337 Sum_probs=198.2
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEe-CCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAE-NEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~ 588 (804)
|.+.+.||+|++|.||++... +++.+|+|++.... ...+.+.+|++++++++|+|++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 567789999999999999964 57889999986432 234568889999999999999999988764 4467899999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++... ....+++..+..++.+++.|++|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 82 CEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999999653 2345899999999999999999999998 9999999999999999999999999998764422
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
. ......+++.|+|||.+.+..++.++||||||++++||++|+.||+... ...... ....+.+.
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----------~~~~~~-~~~~~~~~--- 220 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----------MNSLVY-RIIEGKLP--- 220 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----------HHHHHH-HHHhcCCC---
Confidence 2 2234557889999999999899999999999999999999999986321 111111 11111111
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
..+......+.+++.+|++.+|++||++.++++.
T Consensus 221 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 ------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1122334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.37 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=196.3
Q ss_pred HHhcccccccccCcceEEEEEecC-CcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
..|.+.++||.|+||.||+|+... ++.+++|.+.... ...+++.+|++++++++|+|++++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 456677889999999999999754 7889999987433 23466888999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|..++.+ ....+++..+..++.|++.+|+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 92 PGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 99999888754 2345899999999999999999999988 9999999999999999999999999987543321
Q ss_pred ccccccccCCCccchhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 670 TKFSRVRGTRGYLAPEWMM-----NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
.......++..|+|||++. ...++.++||||||+++|||++|+.|+.... ........ .....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----------~~~~~~~~-~~~~~ 232 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----------PMRVLLKI-AKSEP 232 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-----------HHHHHHHH-hcCCC
Confidence 1223345788999999884 3457889999999999999999999985421 01111111 11111
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.... .+......+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTLS-------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccCC-------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1110 01122335788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.76 Aligned_cols=252 Identities=27% Similarity=0.361 Sum_probs=196.6
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEeC-----CeeEEEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAEN-----EHKLLVY 586 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-----~~~~lV~ 586 (804)
+.+.+.||+|+||.||++.. .+++.+|+|.+.......+++.+|+.+++++ +|+|++++++++... ...++|+
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 103 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVL 103 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEE
Confidence 44567899999999999996 4688999999875544456788899999999 899999999998754 3589999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++++|.+++.........+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 104 ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 104 ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 999999999998653334556899999999999999999999988 99999999999999999999999999986543
Q ss_pred cCCccccccccCCCccchhhhccC-----CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNL-----KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
... ......++..|+|||.+... .++.++||||||+++|||++|+.|+..... ...+.. ...
T Consensus 181 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-----------~~~~~~-~~~ 247 (291)
T cd06639 181 TRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-----------VKTLFK-IPR 247 (291)
T ss_pred ccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-----------HHHHHH-Hhc
Confidence 221 11234578899999988643 368899999999999999999999864220 010111 111
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.....+.+ .......+.+++.+|++.+|++||++.++++.
T Consensus 248 ~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 248 NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111111 11223468899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=295.62 Aligned_cols=267 Identities=21% Similarity=0.302 Sum_probs=196.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+.+.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|++++++++|+|++++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 556778999999999999976 58899999986332 23356789999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
+++.|..++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 83 DHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred CccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99888887643 335899999999999999999999988 99999999999999999999999999987654321
Q ss_pred ccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHH---HHhhhcC-c
Q 038103 670 TKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVA---KQMEQEG-L 744 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-~ 744 (804)
......++..|+|||.+.+ ..++.++||||||++++||++|+.||......+........+..+.. ....... .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1223456788999999876 45889999999999999999999998643211000000000000000 0000000 0
Q ss_pred ccccCCcCCCccC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 745 EKIIDPRLNDVYD-----REKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 745 ~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.....+......+ ......+.+|+.+|++.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0011111111111 1124578899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=296.12 Aligned_cols=195 Identities=26% Similarity=0.440 Sum_probs=159.6
Q ss_pred ccccccCcceEEEEEecC---CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeEEEEeeccCC
Q 038103 518 QEVGKGGFGSVFRGVLDD---ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAE--NEHKLLVYEYVENG 592 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~---~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~g 592 (804)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 479999999999999653 4689999987432 23467889999999999999999999854 4578999999875
Q ss_pred ChhhhhccCC-----CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE----cCCCCeEEeecCCccc
Q 038103 593 SLDKLLFNDP-----GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL----DDHFEPKVTDFGLSKL 663 (804)
Q Consensus 593 sL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfgla~~ 663 (804)
+|.+++.... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 7777764321 12235788999999999999999999998 9999999999999 5667899999999987
Q ss_pred ccccCC--ccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 664 FKERHD--TKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 664 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
...... .......+|..|+|||.+.+ ..++.++||||||+++|||+||+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 654322 12234567899999999876 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=301.69 Aligned_cols=198 Identities=25% Similarity=0.322 Sum_probs=169.9
Q ss_pred hcccccccccCcceEEEEEecC-CcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.++||+|+||.||+++... ++.+|+|.+.+.. .....+.+|+.++..++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 5567889999999999999754 7789999986321 2234578899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 83 YVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999965 2345889999999999999999999998 9999999999999999999999999998654433
Q ss_pred CccccccccCCCccchhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 669 DTKFSRVRGTRGYLAPEWMM-----NLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
........||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 33333456899999999986 34688999999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=290.21 Aligned_cols=245 Identities=27% Similarity=0.365 Sum_probs=196.8
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC------CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL------QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
+...+.||+|+||.||+|... +++.|++|.+.... ...+.+.+|+.++++++|+||+++++++..+...++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 345678999999999999976 78899999886432 13356889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 82 ELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999642 35889999999999999999999998 99999999999999999999999999986544
Q ss_pred cCCccccccccCCCccchhhhccCC-CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLK-IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.... ...............
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-----------~~~~~~~~~~~~~~~ 221 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-----------GVAAVFKIGRSKELP 221 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-----------HHHHHHHHHhcccCC
Confidence 32 223455788999999987766 8999999999999999999999986422 011111111101111
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+ +......+.+++.+|++.+|.+||++.++++
T Consensus 222 -----~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 -----PI----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -----Cc----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11 1122346788999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.20 Aligned_cols=265 Identities=20% Similarity=0.291 Sum_probs=193.2
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCC------e
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENE------H 581 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~ 581 (804)
..|.+.+.||+|+||.||++... +++.||||++.... ....++.+|+.+++.++||||+++++++.... .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 45667789999999999999964 58899999997432 23456789999999999999999999986443 5
Q ss_pred eEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCc
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 661 (804)
.++||||+++ +|...+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 101 VYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 7999999976 56666532 3778888999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccC-----------Cccchhh
Q 038103 662 KLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASAS-----------DSSYCNH 730 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~-----------~~~~~~~ 730 (804)
+..... .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......
T Consensus 171 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 854332 222345678999999999999999999999999999999999999964321000 0000000
Q ss_pred HHHHHHHHhhhc-C-----cccccCCcCC---CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 731 LVQWVAKQMEQE-G-----LEKIIDPRLN---DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 731 ~~~~~~~~~~~~-~-----~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+...+....... . +.+....... ...+......+.+|+.+|++.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000011110000 0 0000000000 00111223568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=325.61 Aligned_cols=263 Identities=22% Similarity=0.322 Sum_probs=199.5
Q ss_pred HHHHHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEe--CC
Q 038103 507 AELKRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAE--NE 580 (804)
Q Consensus 507 ~~l~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~ 580 (804)
.++....|.+.++||+|+||.||++... .+..+|+|.+.... .....+..|+.++.+++|||||++++++.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3444556778899999999999999965 46789999887432 234568899999999999999999998854 35
Q ss_pred eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCC----CcEEecccccCeEEEcC-------
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL----EWVLHCDVKPQNILLDD------- 649 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~----~~ivH~Dlkp~NILl~~------- 649 (804)
..+|||||+++++|.++|.........+++..++.|+.||+.||+|||+.+. ..|+|+||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999999999999996533334568999999999999999999998542 23999999999999964
Q ss_pred ----------CCCeEEeecCCcccccccCCccccccccCCCccchhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 650 ----------HFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN--LKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 650 ----------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
...+||+|||++..+.... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2348999999998654322 2234568999999999864 4588999999999999999999999963
Q ss_pred cccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH--HHhccC
Q 038103 718 LSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVV--KLLTAH 792 (804)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv--~~L~~~ 792 (804)
.. .+...+ ..+.... .+.. ......+.+|+..||+.+|.+||++.+++ +.+..+
T Consensus 246 ~~----------~~~qli-~~lk~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 AN----------NFSQLI-SELKRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CC----------cHHHHH-HHHhcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 21 111111 1111111 0100 01134688999999999999999999998 445433
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=293.09 Aligned_cols=243 Identities=23% Similarity=0.331 Sum_probs=195.0
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecC-cCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCChh
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEG-VLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLD 595 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 595 (804)
.+||+|+||.||++... +++.||+|.+.. .....+.+.+|+.++..++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 46999999999999964 688999999863 2334567889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcccccc
Q 038103 596 KLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRV 675 (804)
Q Consensus 596 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 675 (804)
.++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ .....
T Consensus 107 ~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 177 (297)
T cd06659 107 DIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSL 177 (297)
T ss_pred HHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccce
Confidence 98743 45889999999999999999999998 99999999999999999999999999976543322 22335
Q ss_pred ccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCc
Q 038103 676 RGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDV 755 (804)
Q Consensus 676 ~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 755 (804)
.++..|+|||++.+..++.++||||||++++||++|+.||..... .+.. ..+...... ....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----------~~~~-~~~~~~~~~-----~~~~- 239 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-----------VQAM-KRLRDSPPP-----KLKN- 239 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHH-HHHhccCCC-----Cccc-
Confidence 678999999999988999999999999999999999999864220 0111 111111100 0000
Q ss_pred cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 756 YDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.......+.+++.+|++.+|++||++++|++.
T Consensus 240 -~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 -AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11123457889999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=290.67 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=189.7
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCC------ChHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ------GDAEFWAEVSIIGRINHRNLVKLQGFCAE--NEHKLL 584 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 584 (804)
+...+.||+|+||.||++... .++.|++|++..... ....+.+|+.++++++|+||+++++++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 345678999999999999964 588999998863221 12457889999999999999999998875 357789
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
++||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++...
T Consensus 84 ~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 84 FMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 9999999999999964 234788999999999999999999988 999999999999999999999999999865
Q ss_pred cccC--CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 665 KERH--DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 665 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
.... ........++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----------~~~~~~~~~~- 224 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----------MAAIFKIATQ- 224 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----------HHHHHHHhcC-
Confidence 4321 1112234578899999999988899999999999999999999999864210 0111111110
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...+.+ +......+..++ .|+..+|++||+|++|++
T Consensus 225 ----~~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 ----PTNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CCCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 011222 112223444554 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=303.99 Aligned_cols=198 Identities=24% Similarity=0.309 Sum_probs=170.8
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.||+|+||.||+++.. +++.||+|.+.... .....+.+|..++..++|+||+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 556788999999999999965 57889999986421 2234578899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 83 YVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999965 2346888899999999999999999998 9999999999999999999999999998765433
Q ss_pred CccccccccCCCccchhhhcc-----CCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMN-----LKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
........|++.|+|||++.. +.++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 333334568999999999875 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=292.78 Aligned_cols=254 Identities=21% Similarity=0.348 Sum_probs=195.6
Q ss_pred cccccccccCcceEEEEEec----CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCC------e
Q 038103 515 NFKQEVGKGGFGSVFRGVLD----DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENE------H 581 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~----~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~ 581 (804)
.+.+.||+|+||.||+|... .++.||||++..... ..+++.+|++++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 45678999999999999853 367899999874332 3456889999999999999999999886532 2
Q ss_pred eEEEEeeccCCChhhhhccCCC--CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 582 KLLVYEYVENGSLDKLLFNDPG--TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
.++++||+.+|+|..++..... ....+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECccc
Confidence 4788999999999988753221 2235788899999999999999999988 9999999999999999999999999
Q ss_pred CcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHH
Q 038103 660 LSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAK 737 (804)
Q Consensus 660 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (804)
+++....... .......++..|++||.+....++.++||||||+++|||++ |+.|+.... ...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~--------~~~~~~---- 226 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE--------NSEIYN---- 226 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC--------HHHHHH----
Confidence 9986543221 11122334678999999998889999999999999999999 888875322 011111
Q ss_pred HhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 738 QMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 738 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
........ . .+......+.+++.+|++.+|++||++.++++.|+++
T Consensus 227 ~~~~~~~~-----~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 YLIKGNRL-----K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHcCCcC-----C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111100 0 0112335799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=291.08 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=199.6
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeEEEEe
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAE--NEHKLLVYE 587 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E 587 (804)
|.+.+.||.|+||.||++.. .+++.+|+|.+.... ...+++.+|++++++++|+||+++++++.. +...++++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 45667899999999999985 467889999987432 233568889999999999999999998764 456799999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHH-----hhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH-----EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-----~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
|+++++|.+++.........+++..++.++.|++.||+||| +.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccc
Confidence 99999999999754334567899999999999999999999 555 9999999999999999999999999999
Q ss_pred cccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
........ .....++..|+|||.+....++.++||||||+++++|++|+.|+.... ...+ ......+
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~----~~~~~~~ 225 (265)
T cd08217 159 ILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQL----ASKIKEG 225 (265)
T ss_pred cccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHH----HHHHhcC
Confidence 76543321 233467899999999998889999999999999999999999986422 0111 1122222
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
... ..+......+.+++.+|++.+|++||++.+|++.
T Consensus 226 ~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 KFR---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 1122334578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=293.39 Aligned_cols=250 Identities=24% Similarity=0.411 Sum_probs=195.1
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEe------CCeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAE------NEHKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~------~~~~~ 583 (804)
..+.+.+.||.|+||.||+|.. .+++.+|+|.+........++..|+.++.++ +|+||+++++++.. ....+
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 4456678899999999999996 4578899999876555556788999999998 69999999999853 45789
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
++|||+++|+|.+++... ....+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++..
T Consensus 96 iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 999999999999999653 2345788889999999999999999998 99999999999999999999999999886
Q ss_pred ccccCCccccccccCCCccchhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMM-----NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
...... ......++..|+|||.+. ...++.++||||||+++|||++|+.||....+. ......
T Consensus 171 ~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-----------~~~~~~ 238 (282)
T cd06636 171 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-----------RALFLI 238 (282)
T ss_pred hhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-----------hhhhhH
Confidence 543221 223356788999999875 346788999999999999999999998542210 000000
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
... ..+.+. .......+.+++..||+.+|.+||++.++++
T Consensus 239 -~~~-----~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 -PRN-----PPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hhC-----CCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 011111 1122346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=290.75 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=197.9
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.+.+.++||.|+||.||++... ++..+|+|.+.... ...+.+.+|++++++++|+|++++++.+..+...++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 4667788999999999999965 57889999987432 234578899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 86 ~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 86 GGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 9999999865 2346899999999999999999999998 99999999999999999999999999876543222
Q ss_pred cccccccCCCccchhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 671 KFSRVRGTRGYLAPEWMM-----NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
......++..|+|||.+. ...++.++||||||+++|||++|+.||..... ... ...+..+...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----------~~~-~~~~~~~~~~ 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----------MRV-LLKILKSEPP 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----------HHH-HHHHhcCCCC
Confidence 223345788999999975 34577899999999999999999999864220 011 1111111111
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+. .+......+.+++..|++.+|.+||++.+|++.
T Consensus 227 -----~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 -----TLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----CcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 110 011123367889999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=289.38 Aligned_cols=249 Identities=28% Similarity=0.395 Sum_probs=198.2
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
|...+.||+|+||.||+|... +++.|++|.++.... ..+++.+|++++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 456688999999999999964 688999999875433 3467899999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++.. ...+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 82 SGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999864 235788999999999999999999998 99999999999999999999999999987655333
Q ss_pred ccc---cccccCCCccchhhhccCC---CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 670 TKF---SRVRGTRGYLAPEWMMNLK---IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 670 ~~~---~~~~gt~~y~aPE~~~~~~---~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
... ....++..|+|||++.... ++.++||||||++++|+++|+.||..... . ...... ...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---------~-~~~~~~-~~~~~ 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---------E-FQIMFH-VGAGH 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---------h-HHHHHH-HhcCC
Confidence 221 1345788999999998766 88999999999999999999999864210 0 000111 11111
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+.+... ......+.+++.+|++.+|++||++.+++.
T Consensus 224 -----~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 -----KPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----CCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111 112346779999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.70 Aligned_cols=243 Identities=25% Similarity=0.344 Sum_probs=198.1
Q ss_pred cccccCcceEEEEEecC-CcEEEEEEecC-cCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCChhh
Q 038103 519 EVGKGGFGSVFRGVLDD-ERVVAVKRLEG-VLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDK 596 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~~-~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 596 (804)
.||+|.||+||.|+..+ ...+|||-+.. ..+...-+..|+.+-++|+|.|||+++|.|.+++..-+.||.+++|+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 49999999999999655 55799999873 33344557889999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCC--CHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc-CCCCeEEeecCCcccccccCCcccc
Q 038103 597 LLFNDPGTASIL--QWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFKERHDTKFS 673 (804)
Q Consensus 597 ~l~~~~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~ 673 (804)
+|+..- .++ ++...--+..||++||.|||++. |||||||-+|||++ -.|.+||+|||-++.+.. -+..+.
T Consensus 662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TE 734 (1226)
T KOG4279|consen 662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTE 734 (1226)
T ss_pred HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc-CCcccc
Confidence 997532 234 56777788899999999999988 99999999999996 468899999999987654 234456
Q ss_pred ccccCCCccchhhhccCC--CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 674 RVRGTRGYLAPEWMMNLK--IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 674 ~~~gt~~y~aPE~~~~~~--~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.+.||..|||||++..++ |..++|||||||++.||.||++||-..... +.+.-++ | --+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-----------qAAMFkV--G------myK 795 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-----------QAAMFKV--G------MYK 795 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-----------hHhhhhh--c------cee
Confidence 678999999999998664 889999999999999999999999543311 1111111 1 112
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.....+.+...+...++++|+.++|.+||++.++++
T Consensus 796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 234566777788999999999999999999999974
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.53 Aligned_cols=247 Identities=27% Similarity=0.421 Sum_probs=198.4
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.++||+|+||.||+|.. .+++.+|+|.+.... ...+.+.+|+.++.+++|+||+++++++..+...++|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3455677899999999999986 467899999886332 2345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++.. ..+++.....++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 999999999853 35889999999999999999999988 9999999999999999999999999988654322
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......++..|+|||.+....++.++||||||++++||++|+.|+..... .. ..........
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----------~~-~~~~~~~~~~---- 218 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----------MK-VLFLIPKNNP---- 218 (277)
T ss_pred -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----------HH-HHHHHhcCCC----
Confidence 122234578899999999888899999999999999999999999863210 00 0111111111
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+.+.. .....+.+++.+|++.+|++||++.++++.
T Consensus 219 -~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 -PTLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCCCc----ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11111 223467889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=296.29 Aligned_cols=259 Identities=20% Similarity=0.317 Sum_probs=195.0
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
.|.+.++||+|+||.||+|+.. +++.||+|.++... .....+.+|+.++++++|+||+++++++......++|+||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 4566788999999999999965 57889999987332 23456788999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
+ ++|..++.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 87 ~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 87 D-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred c-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 7 589888864 2345788999999999999999999998 99999999999999999999999999986433221
Q ss_pred ccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh--------
Q 038103 670 TKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME-------- 740 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 740 (804)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+.....
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--------~~~~~~~~~~~~~~~~~~~ 230 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--------EQLHFIFRILGTPTEETWP 230 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHcCCCChhhch
Confidence 2223456889999998865 45788999999999999999999998643210 01111111000
Q ss_pred ----hcCcccccCCcCCCc----cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 741 ----QEGLEKIIDPRLNDV----YDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 741 ----~~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.......-.+..... ........+.+|+.+|++.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000110000 01112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=302.53 Aligned_cols=265 Identities=20% Similarity=0.275 Sum_probs=193.6
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeC------Ce
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN------EH 581 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 581 (804)
..|.+.+.||+|+||.||++... .++.||||++.... ....++.+|+.+++.++|+||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 45667788999999999999954 57889999997432 2335678899999999999999999987543 35
Q ss_pred eEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCc
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 661 (804)
.++||||+++ +|..++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred EEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 7999999976 77777632 3778889999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCC-----------ccchhh
Q 038103 662 KLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASD-----------SSYCNH 730 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~-----------~~~~~~ 730 (804)
+...... ......+|..|+|||++.+..++.++||||||+++|||++|+.||......... ......
T Consensus 174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 8654321 223456899999999999999999999999999999999999999643210000 000000
Q ss_pred HHHHHHHHhhhc-Cc-----ccccCCcCC---CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 731 LVQWVAKQMEQE-GL-----EKIIDPRLN---DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 731 ~~~~~~~~~~~~-~~-----~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+...+....... .. ..+....+. ..........+.+|+.+|++.||.+|||+.++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000 00 000000000 00111123568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=289.90 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=195.6
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEecCcC---CC--------hHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QG--------DAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~--------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
...+.||+|+||.||+|... +++.+|+|.++... .. .+.+.+|+.++.+++|+|++++++++......
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 34578999999999999854 68899999885311 11 13578899999999999999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred EEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999642 46888999999999999999999988 9999999999999999999999999998
Q ss_pred cccccCCc-cccccccCCCccchhhhccCC--CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 663 LFKERHDT-KFSRVRGTRGYLAPEWMMNLK--IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 663 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
........ ......++..|+|||.+.... ++.++|+||||++++|+++|+.|+.... . .....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----------~-~~~~~~~~ 225 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----------A-IAAMFKLG 225 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----------h-HHHHHHhh
Confidence 65432221 223355788999999987654 8899999999999999999999985321 0 01111111
Q ss_pred hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.......+.... .......+.+++.+|++.+|++||++.+|++.
T Consensus 226 -~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 226 -NKRSAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -ccccCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111111111 11234578889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=286.47 Aligned_cols=248 Identities=24% Similarity=0.324 Sum_probs=199.6
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCc---CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV---LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
|.+.+.||+|+||.||++.. .+++.+|+|++... ....+++.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 45678899999999999995 46889999998732 223457899999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++... ....+++..+.+++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 82 EGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999998642 2235788999999999999999999988 99999999999999999999999999986544221
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......++..|+|||++.+..++.++|+||||++++||++|+.|+.... ..+.+... ..+....
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----------~~~~~~~~-~~~~~~~--- 220 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----------MKNLVLKI-IRGSYPP--- 220 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----------HHHHHHHH-hcCCCCC---
Confidence 1223457888999999998889999999999999999999999986321 11111111 1111111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+......+.+++.+|++.+|++||+|.+|++.
T Consensus 221 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 ------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 112234468899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=297.42 Aligned_cols=263 Identities=22% Similarity=0.351 Sum_probs=196.2
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
++.+.+.||+|+||.||++... +++.||+|++..... ..+.+.+|+++++.++|+||+++++++..+...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 3556788999999999999975 478999998863322 245688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|..+... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 82 VDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred CCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999887643 234899999999999999999999998 9999999999999999999999999998654432
Q ss_pred CccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH-------HHHHhh
Q 038103 669 DTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW-------VAKQME 740 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 740 (804)
.......++..|+|||.+.+ ..++.++||||||++++||++|+.||....... ....+... ......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID----QLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH----HHHHHHHHhCCCchhhHHHhc
Confidence 22233457889999999875 457889999999999999999998885322100 00000000 000000
Q ss_pred hcCc-ccccCCcCCCc-----cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 741 QEGL-EKIIDPRLNDV-----YDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 741 ~~~~-~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.... .....+..... ........+.+++.+|++.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 00000100000 01123457899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=291.95 Aligned_cols=258 Identities=23% Similarity=0.280 Sum_probs=199.1
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~ 588 (804)
+.+.++||.|++|.||++... +++.+|+|.+..... ...++.+|++++++++|+||+++++++... ...++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 445678999999999999975 578899999874322 346789999999999999999999998653 478999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++.........++......++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 9999999987643334456889999999999999999999998 9999999999999999999999999987654322
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
. ....++..|+|||.+.+..++.++||||||+++|||++|+.|++...... ........++ .......+
T Consensus 160 ~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~----~~~~~~~~- 228 (287)
T cd06621 160 A---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSYI----VNMPNPEL- 228 (287)
T ss_pred c---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC---CChHHHHHHH----hcCCchhh-
Confidence 1 23456788999999998899999999999999999999999987532100 0111111111 11111111
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...... .....+.+.+++.+|++.+|++|||+.||++
T Consensus 229 ~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 KDEPGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ccCCCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111110 1123457899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=291.42 Aligned_cols=253 Identities=27% Similarity=0.393 Sum_probs=199.2
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEeCC------eeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENE------HKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------~~~ 583 (804)
..+.+.+.||+|+||.||+|... +++.+++|.+.......+++.+|+.+++++ +|+||+++++++.... ..+
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 45667788999999999999975 578899999886655667899999999999 7999999999997644 489
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+||||+++++|.+++.........+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcccee
Confidence 999999999999998654323467899999999999999999999998 99999999999999999999999999986
Q ss_pred ccccCCccccccccCCCccchhhhcc-----CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMN-----LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
..... .......++..|+|||.+.. ..++.++||||||++++||++|+.||..... ...+ ..
T Consensus 163 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~----~~- 229 (275)
T cd06608 163 LDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-------MRAL----FK- 229 (275)
T ss_pred cccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-------HHHH----HH-
Confidence 54322 22233457889999998753 3467899999999999999999999863210 0001 11
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
....... .+. ........+.+|+.+|++.||++|||+.+|++
T Consensus 230 ~~~~~~~-----~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNPPP-----TLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccCCC-----CCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111111 111 11223457889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=311.89 Aligned_cols=194 Identities=24% Similarity=0.337 Sum_probs=160.1
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCC------CcccceeeeEEeC-CeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINH------RNLVKLQGFCAEN-EHKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~~~-~~~~ 583 (804)
..|.+.++||+|+||.||++... .++.||||+++.......++..|++++.+++| .++++++.++... .+.+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 44667789999999999999964 57889999997544444556778877777754 4588888888754 5788
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEEcCCC-----------
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILLDDHF----------- 651 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl~~~~----------- 651 (804)
+|+|++ +++|.+++.. ...+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred EEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccccc
Confidence 999988 6688888854 24589999999999999999999984 7 99999999999998665
Q ss_pred -----CeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 652 -----EPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 652 -----~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 281 ~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred CCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999886432 222346789999999999999999999999999999999999999964
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=301.99 Aligned_cols=265 Identities=20% Similarity=0.273 Sum_probs=193.4
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeC------Ce
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAEN------EH 581 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 581 (804)
..|.+.+.||+|+||.||++... .++.||||++..... ....+.+|+.+++.++|+||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 35666788999999999999854 578899999974332 235677899999999999999999988643 35
Q ss_pred eEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCc
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 661 (804)
.++||||+++ +|.+.+.. .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred eEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccc
Confidence 7999999976 67666632 3788889999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCC-----------ccchhh
Q 038103 662 KLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASD-----------SSYCNH 730 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~-----------~~~~~~ 730 (804)
+..... .......+|..|+|||++.+..++.++||||||+++|||++|+.||......... ......
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 865432 2223456899999999999989999999999999999999999998642210000 000000
Q ss_pred HHHHHHHHhhhc-CcccccCCc-----C---CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 731 LVQWVAKQMEQE-GLEKIIDPR-----L---NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 731 ~~~~~~~~~~~~-~~~~~~d~~-----l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+...+....... ....+..+. + ...........+.+|+.+|++.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000001110000 000000000 0 001112234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=304.35 Aligned_cols=197 Identities=25% Similarity=0.340 Sum_probs=169.9
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.||+|+||.||+++.. +++.||+|.+.... .....+.+|+.++.+++|+||+++++.+......++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 445678999999999999965 58899999997321 2345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.+++.. ...++......++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 83 LPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999964 345889999999999999999999998 9999999999999999999999999987543211
Q ss_pred C----------------------------------ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 038103 669 D----------------------------------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSA 714 (804)
Q Consensus 669 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p 714 (804)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001234689999999999999999999999999999999999999
Q ss_pred Ccc
Q 038103 715 SDY 717 (804)
Q Consensus 715 ~~~ 717 (804)
|..
T Consensus 236 f~~ 238 (360)
T cd05627 236 FCS 238 (360)
T ss_pred CCC
Confidence 964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=291.26 Aligned_cols=243 Identities=23% Similarity=0.379 Sum_probs=194.6
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCChh
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLD 595 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 595 (804)
.+||+|+||.||++... ++..||||.+.... ...+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999964 57899999987433 33456889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcccccc
Q 038103 596 KLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRV 675 (804)
Q Consensus 596 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 675 (804)
+++.. ..+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||++........ .....
T Consensus 108 ~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 178 (292)
T cd06658 108 DIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSL 178 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCcee
Confidence 98843 34889999999999999999999998 99999999999999999999999999976543222 22234
Q ss_pred ccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCc
Q 038103 676 RGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDV 755 (804)
Q Consensus 676 ~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 755 (804)
.++..|+|||.+....++.++||||||+++|||++|+.||..... ... . ..... .+.+.+...
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~---~-~~~~~-----~~~~~~~~~ 241 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--------LQA---M-RRIRD-----NLPPRVKDS 241 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHH---H-HHHHh-----cCCCccccc
Confidence 578899999999888899999999999999999999999863210 000 0 11111 111111111
Q ss_pred cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 756 YDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
......+..++.+|++.+|.+|||++++++.
T Consensus 242 --~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 --HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1123357788999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=289.99 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=199.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
|.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456788999999999999964 68899999987433 23467899999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
+++|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 -~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 82 -PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred -CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999998652 356899999999999999999999998 99999999999999999999999999987755433
Q ss_pred ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc------
Q 038103 670 TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE------ 742 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 742 (804)
.......++..|+|||.+... .++.++||||+|++++||++|+.++..... ......+.......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--------IEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--------HHHHHHHHHHcCCCChHHHh
Confidence 333445688999999988654 468999999999999999999777753210 01111111110000
Q ss_pred ------CcccccCCcCC----CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 743 ------GLEKIIDPRLN----DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 743 ------~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
....+..+.-. .....+....+.+++.+|++.+|++||+++++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00111234688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=271.81 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=200.2
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecC---cCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEG---VLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
..+.+.++||+|.|+.||+... +.|+.+|+|.+.. ...+.+++.+|+.|-+.|+|||||++.....+....+||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 4566778899999999999984 5688899998862 33467889999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC---CCCeEEeecCCcccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD---HFEPKVTDFGLSKLF 664 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~ 664 (804)
+|.++.|-.-|-. +...++...-..+.||+++|.|.|.++ |+|||+||+|+|+.. ..-+||+|||+|..+
T Consensus 91 ~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 91 LVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred cccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999998766632 345677778889999999999999999 999999999999943 345899999999987
Q ss_pred cccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
. .........||++|||||+++..+|+..+|||+-||+||-|+.|..||-... ...+.+.+..+.+
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~------------~~rlye~I~~g~y 229 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------------QHRLYEQIKAGAY 229 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc------------HHHHHHHHhcccc
Confidence 7 3344456789999999999999999999999999999999999999996421 1112233333332
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
. +++. .-....+...+|+.+|+..||.+|.|+.|.++
T Consensus 230 d--~~~~----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 230 D--YPSP----EWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred C--CCCc----ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 2 1111 11122346778999999999999999998764
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.30 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=196.2
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
+++.+.||+|+||.||++... .++.||+|.++.... ...++.+|++++.+++|+||+++++.+......++|+||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 566788999999999999975 688999998874322 23578899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
+++|..++.... ....+++..+..++.+++.||.|||+. + |+|+||||+||+++.++.+||+|||++..+....
T Consensus 83 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 83 AGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999886421 234689999999999999999999974 5 9999999999999999999999999998653321
Q ss_pred ccccccccCCCccchhhhccC------CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNL------KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~------~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
.....++..|+|||.+... .++.++||||||+++|||++|+.||..... ....... .....+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~~~~~-~~~~~~~ 226 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--------ANIFAQL-SAIVDGD 226 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--------hhHHHHH-HHHhhcC
Confidence 1223577889999998554 357899999999999999999999864210 0111111 1111111
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
. + ..+......+.+++.+|++.+|++||++.++++.
T Consensus 227 ~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 P-----P----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred C-----C----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1 1 1122344578899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=286.59 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=200.7
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
+.+.+.||.|+||.||+|... ++..+++|++.... ...+.+.+|+++++.++|+|++++++.+......++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 566788999999999999954 57889999986432 245678999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++.... ....+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+......
T Consensus 83 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 83 GGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999996531 1246889999999999999999999998 999999999999999999999999999876543322
Q ss_pred ---cccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 671 ---KFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 671 ---~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
......++..|+|||.+... .++.++|+||||++++||++|+.|+...... ..+ ...... .
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~~----~~~~~~-~--- 223 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-------KVL----MLTLQN-D--- 223 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-------hhH----HHHhcC-C---
Confidence 22334578899999998876 7899999999999999999999998643210 011 111111 0
Q ss_pred ccCCcCCCcc-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 747 IIDPRLNDVY-DREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 747 ~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+.+.... .......+.+++..|++.+|++||++.+|++
T Consensus 224 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 --PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111111 1123456889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=288.84 Aligned_cols=246 Identities=26% Similarity=0.388 Sum_probs=196.2
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCc--CCChHHHHHHHHHHhcCC---CCcccceeeeEEeCCeeEEEEe
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV--LQGDAEFWAEVSIIGRIN---HRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E 587 (804)
|.+.+.||+|+||.||+|+. .+++.+|+|.+... ....+++.+|+.++++++ |+|++++++++..+...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 44567899999999999996 56889999998743 233467889999999986 9999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.. ..+++.....++.|+++||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 83 YAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred cCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999999853 25889999999999999999999998 999999999999999999999999999876543
Q ss_pred CCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.. ......|+..|+|||.+..+ .++.++||||||+++|+|++|+.||..... .... .... .
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----------~~~~-~~~~-----~ 216 (277)
T cd06917 155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----------FRAM-MLIP-----K 216 (277)
T ss_pred cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----------hhhh-hccc-----c
Confidence 32 22334688899999988754 478999999999999999999999864321 0000 0000 0
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...+.+... .....+.+++.+|++.+|++||++.++++.
T Consensus 217 ~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 217 SKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 011111111 133468899999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=295.23 Aligned_cols=249 Identities=22% Similarity=0.239 Sum_probs=196.6
Q ss_pred hcccccccccCcceEEEEEecC-CcEEEEEEecCcCC----ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQ----GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.||+|+||.||++...+ ++.+|+|.+..... ..+.+.+|++++.+++|+||+++++.+......++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 4556789999999999999764 88999999874322 335688899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+.+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 83 CPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred cCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999998643 2356899999999999999999999998 9999999999999999999999999987653221
Q ss_pred Cc----------------------------cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCccccc
Q 038103 669 DT----------------------------KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSA 720 (804)
Q Consensus 669 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~ 720 (804)
.. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11124578899999999988899999999999999999999999864321
Q ss_pred ccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 038103 721 SASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPP----MSKVVK 787 (804)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt----m~~Vv~ 787 (804)
. ..+ ... . +..............+.+++.+|++.+|++||+ +.++++
T Consensus 238 ~-------~~~----~~~-~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 D-------ETF----SNI-L--------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H-------HHH----HHH-h--------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 0 000 111 1 111110111113457999999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.96 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=199.5
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
+.+.+.||+|+||.||++... +++.+|+|++.... ...+++.+|++++++++|+||+++++.+......++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 345678999999999999976 58889999987543 334678899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHh-hCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE-ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
+++|.+++... ...++......++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||.+........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 83 GGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999653 2568889999999999999999999 77 99999999999999999999999999876543221
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
. ...++..|+|||.+.+..++.++||||||+++++|++|+.|+....... ......+.... ... .
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~~-~~~-----~ 221 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP------DGIFELLQYIV-NEP-----P 221 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc------ccHHHHHHHHh-cCC-----C
Confidence 1 1567889999999998899999999999999999999999986432100 11111111111 111 0
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+.+.. ......+.+++..|+..+|++||++.++++.
T Consensus 222 ~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRLPS---GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCh---hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11111 1134468899999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=290.59 Aligned_cols=261 Identities=22% Similarity=0.346 Sum_probs=199.7
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
++.+.+.||+|+||.||++... +++.||+|+++... ...+.+.+|++++++++|+||+++++++..++..++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 3566788999999999999975 57889999987432 2346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
++++.+..++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 82 VERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 998777665532 344889999999999999999999998 9999999999999999999999999998766544
Q ss_pred CccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh--------
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM-------- 739 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 739 (804)
........++..|+|||++... .++.++||||||+++|||++|+.|+...... ..+.. .....
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-------~~~~~-~~~~~~~~~~~~~ 226 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-------DQLYL-IQKCLGPLPPSHQ 226 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH-HHHHhCCCCHHHh
Confidence 3233445678899999999887 7899999999999999999999988642210 00000 00000
Q ss_pred ---h-hcCcc--cccCCcC----CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 740 ---E-QEGLE--KIIDPRL----NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 740 ---~-~~~~~--~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
. ..... +..+... ...++......+.+++.+|++.+|++||+++++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 00000 0000000 001112225678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.28 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=191.5
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHH-HhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSI-IGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+.+.+.||+|+||.||+++.. +++.||+|+++.... ...++..|+.+ ++.++|+||+++++++..+...++++||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 456678999999999999965 589999999875432 33456667665 56678999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+ ++|.+++.........+++..++.++.|++.||+|||++ + ++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 7 588888765333446789999999999999999999987 6 9999999999999999999999999998654321
Q ss_pred CccccccccCCCccchhhhcc----CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMN----LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+..... . .+...... .+..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~----~~~~~~~~-~~~~ 225 (283)
T cd06617 159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------P----FQQLKQVV-EEPS 225 (283)
T ss_pred --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------C----HHHHHHHH-hcCC
Confidence 1223457888999998864 4568899999999999999999999863210 0 01111111 1111
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..+.. . .....+.+++.+|++.+|++||++.+|++
T Consensus 226 ~~~~~----~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLPA----E----KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCc----c----ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 1 12346889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=291.51 Aligned_cols=249 Identities=20% Similarity=0.281 Sum_probs=199.4
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCc-CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV-LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
.++.+.+.||+|+||.||++.. .+++.||+|.+... ....+.+.+|+.++++++|||++++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 4566778899999999999985 46788999998643 234567889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999853 34788999999999999999999998 99999999999999999999999999876544322
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......+++.|+|||.+....++.++||||||+++||+++|+.||........ +......
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-----------~~~~~~~-------- 230 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----------LYLIATN-------- 230 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-----------eeehhcC--------
Confidence 22234578889999999888899999999999999999999999964321100 0000000
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+.............+.+++.+|++.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 231 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000001112233468899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=280.10 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=207.6
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
+.+++.++||+|+||.|||+.++ .|+.+|||.+.. .....++.+|+.++++.+.+++|+++|.+.....+++|||||.
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 34556789999999999999965 589999999863 3456788999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
-|+..+.++. ++++|+...+..++...++||+|||... -+|||||+.|||++.+|.+||+|||.|..+.+. -.
T Consensus 112 AGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MA 184 (502)
T KOG0574|consen 112 AGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MA 184 (502)
T ss_pred CCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh-HH
Confidence 9999999976 6788999999999999999999999987 699999999999999999999999999876542 12
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
....+.||+.|||||++..-.|+.++||||+|++..||..|+.|+....+... +. ++..
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------------------IF-MIPT 243 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------------------IF-MIPT 243 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce--------------------eE-eccC
Confidence 33457899999999999999999999999999999999999999975431110 00 1111
Q ss_pred cCCC--ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 751 RLND--VYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 751 ~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.... ..+.+-.....+++..|+-..|++|-|+.++++.
T Consensus 244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1111 2244556788899999999999999999888653
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=293.03 Aligned_cols=259 Identities=21% Similarity=0.287 Sum_probs=193.2
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
|.+.+.||+|+||.||+++.. +|+.+|+|+++... .....+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 456688999999999999965 58899999986322 22356788999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++ +|.+++.. ....+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 82 DQ-DLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 75 78887754 2345899999999999999999999998 99999999999999999999999999986543221
Q ss_pred ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc------
Q 038103 670 TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE------ 742 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 742 (804)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ..............
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-------DDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-------HHHHHHHHHHhCCCChHHhH
Confidence 22234568899999998764 4789999999999999999999986421100 00000000000000
Q ss_pred CcccccCCc----CCC-----ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 743 GLEKIIDPR----LND-----VYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 743 ~~~~~~d~~----l~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+....+.. ... .........+.+++.+|++.||.+|||++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000000 000 011122356789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=280.71 Aligned_cols=249 Identities=22% Similarity=0.265 Sum_probs=201.0
Q ss_pred hcccccccccCcceEEEEEecC-CcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
.++.+.||.|.-|+||++++++ +..+|+|++.+.. ....+.+.|-+||+.++||.|..|++.+......+|+|||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 4456789999999999999876 5889999997432 3345677899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc--
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE-- 666 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~-- 666 (804)
|+||+|..+++.. ..+.++...+.-++..++-||+|||-.| ||.|||||+||||.++|++-|+||.|+.....
T Consensus 159 CpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred CCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999999775 4567889999999999999999999999 99999999999999999999999998764310
Q ss_pred -------------------------------c-CC---------------------ccccccccCCCccchhhhccCCCC
Q 038103 667 -------------------------------R-HD---------------------TKFSRVRGTRGYLAPEWMMNLKID 693 (804)
Q Consensus 667 -------------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~~~s 693 (804)
. .. .....++||..|+|||++++...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 00 001125689999999999999999
Q ss_pred cccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhccc
Q 038103 694 AKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVA 773 (804)
Q Consensus 694 ~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~ 773 (804)
.+.|.|+|||+||||+.|+.||..... +..+..++-..+.-.-.++....+.+||...|.
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~--------------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNN--------------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCc--------------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence 999999999999999999999975331 111222222222222222445678899999999
Q ss_pred CCCCCCCC----HHHHHH
Q 038103 774 ENRDTRPP----MSKVVK 787 (804)
Q Consensus 774 ~~P~~RPt----m~~Vv~ 787 (804)
.||.+|.. +.||-+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999998 777754
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=286.89 Aligned_cols=247 Identities=23% Similarity=0.289 Sum_probs=191.9
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC--C----ChHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--Q----GDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EHKLL 584 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 584 (804)
+.+.+.||+|+||.||++... +++.||||.+.... . ..+.+.+|+.++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 445678999999999999964 58899999885321 1 124678899999999999999999988764 46789
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
++||+++++|.+++.. ...+++....+++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 84 FMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 9999999999999864 234788889999999999999999998 999999999999999999999999999865
Q ss_pred cccCC--ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 665 KERHD--TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 665 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||.... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----------~~~~~~~~~~~- 224 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-----------AMAAIFKIATQ- 224 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-----------hHHHHHHHhcC-
Confidence 43211 12233457889999999988889999999999999999999999986321 00111111110
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
... ...+......+..++..|+. +|++||++++|++.
T Consensus 225 ----~~~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 225 ----PTN----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ----CCC----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 011 11233344567788888885 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.74 Aligned_cols=239 Identities=24% Similarity=0.257 Sum_probs=184.3
Q ss_pred ccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcC---CCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 520 VGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRI---NHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 520 LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
||+|+||.||+++.. +++.||||++.... .....+..|..++.+. +||||++++..+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999964 58899999986322 1223345566666655 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 999998864 345889999999999999999999998 9999999999999999999999999997543221 22
Q ss_pred ccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 672 FSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+ ....+..+... +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----------~~~-~~~~i~~~~~~-~~~- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----------TQQ-MYRNIAFGKVR-FPK- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----------HHH-HHHHHHcCCCC-CCC-
Confidence 2345689999999998764 48999999999999999999999986421 011 11122211111 100
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPP----MSKVVK 787 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt----m~~Vv~ 787 (804)
. .....+.+++.+|++.+|.+||+ +.++++
T Consensus 219 ---~----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 ---N----VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---c----cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1 12346788999999999999985 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=282.50 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=197.7
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
|.+.+.||+|+||.||++... +++.+|||.+.... ....++.+|++++++++|+|++++++.+..++..++|+||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 456788999999999999964 67889999987432 23457889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC-CCeEEeecCCcccccccC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH-FEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~~~ 668 (804)
++++|.+++... ....+++..+..++.++++||+|||+++ ++|+||+|+||+++++ ..+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 82 PGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999653 2345889999999999999999999998 9999999999999865 458999999998765432
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
......++..|+|||.+....++.++||||||+++++|++|+.|++... ....+... ..+....+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-----------~~~~~~~~-~~~~~~~~~ 222 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-----------LPALVLKI-MSGTFAPIS 222 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-----------hHHHHHHH-HhcCCCCCC
Confidence 2223457889999999998889999999999999999999999986422 11111111 111111111
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
......+.+++.+|++.+|++|||+.++++.
T Consensus 223 ---------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 ---------DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---------CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1123468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=298.29 Aligned_cols=256 Identities=23% Similarity=0.356 Sum_probs=190.0
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeC------Ce
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAEN------EH 581 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 581 (804)
..|.+.+.||+|+||.||++.. .+++.||||++..... ..+++.+|+.++++++|+||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 3456678899999999999995 4678999999874322 335677899999999999999999987543 35
Q ss_pred eEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCc
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 661 (804)
.++++|++ +++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 95 ~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred EEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccc
Confidence 68999988 679988874 235889999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHH-----
Q 038103 662 KLFKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV----- 735 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----- 735 (804)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+....
T Consensus 166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~ 234 (343)
T cd07878 166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-------DQLKRIMEVVGT 234 (343)
T ss_pred eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHHhCC
Confidence 865432 233467899999999876 56899999999999999999999998542100 0000000
Q ss_pred -----HHHhhhcC-------cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 736 -----AKQMEQEG-------LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 736 -----~~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...+.... +.......+... -......+.+|+.+|++.||.+|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKI-FRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000000000000 00112347899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=289.39 Aligned_cols=267 Identities=20% Similarity=0.303 Sum_probs=199.5
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC------hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG------DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
+.+.+.||+|+||.||+|... +++.||||.+...... ...+..|++++.+++|+||+++++++.+....++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 455678999999999999965 5889999999743322 345678999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+ +++|.+++... ...+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 82 e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 82 EFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred ccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999 88999999652 236899999999999999999999998 99999999999999999999999999987654
Q ss_pred cCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh----
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ---- 741 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 741 (804)
... ......++..|+|||.+.+ ..++.++||||||++++||++|..+|..... . ............
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~----~----~~~~~~~~~~~~~~~~ 225 (298)
T cd07841 155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD----I----DQLGKIFEALGTPTEE 225 (298)
T ss_pred CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc----H----HHHHHHHHHcCCCchh
Confidence 322 2223345788999998864 4678999999999999999999777653210 0 000001000000
Q ss_pred -----cCcccccCCcCCCcc-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hccCCCCC
Q 038103 742 -----EGLEKIIDPRLNDVY-----DREKLDRMVKVALLCVAENRDTRPPMSKVVKL--LTAHDHES 796 (804)
Q Consensus 742 -----~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~--L~~~~~~~ 796 (804)
..+............ .......+.+++.+|++.+|++||++.+|++. +++-....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 000000000000111 12234678899999999999999999999975 55544333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=291.99 Aligned_cols=252 Identities=23% Similarity=0.246 Sum_probs=196.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.||+|+||.||++... .++.|++|.+.... ...+.+.+|+++++.++|+||+++++.+..+...++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 455688999999999999965 47889999987432 2235678899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 83 VEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999964 245889999999999999999999988 9999999999999999999999999987421100
Q ss_pred C--------------ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH
Q 038103 669 D--------------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 669 ~--------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
. .......++..|+|||.+....++.++||||||+++|||++|+.||.... ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-----------~~~- 223 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-----------PEE- 223 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------HHH-
Confidence 0 01112457889999999988889999999999999999999999985321 011
Q ss_pred HHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 735 VAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
+......+.. ..+.... .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 224 LFGQVISDDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHhccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111111111 1111111 123467899999999999999997777766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=293.67 Aligned_cols=270 Identities=20% Similarity=0.309 Sum_probs=196.6
Q ss_pred hcccccccccCcceEEEEEec---CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD---DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EHKLL 584 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~---~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 584 (804)
+.+.++||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++.+++||||+++++++... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 456788999999999999964 47899999997532 2235678899999999999999999999988 78999
Q ss_pred EEeeccCCChhhhhccCCCCC-CCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC----CCCeEEeecC
Q 038103 585 VYEYVENGSLDKLLFNDPGTA-SILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD----HFEPKVTDFG 659 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~Dfg 659 (804)
||||+++ +|.+++....... ..++...+..++.|++.||+|||+.+ |+|+||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999976 6777664432222 36889999999999999999999998 999999999999999 8999999999
Q ss_pred CcccccccCC--ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCC-ccch-hhHHHH
Q 038103 660 LSKLFKERHD--TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASD-SSYC-NHLVQW 734 (804)
Q Consensus 660 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~-~~~~-~~~~~~ 734 (804)
++........ .......++..|+|||.+.+. .++.++||||||++++||++|+.||......... .... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987644322 122334578899999988764 5889999999999999999999999754322100 0000 011111
Q ss_pred HHHHhhh------------cCcccccC---------CcCCCccCH--HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 735 VAKQMEQ------------EGLEKIID---------PRLNDVYDR--EKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 735 ~~~~~~~------------~~~~~~~d---------~~l~~~~~~--~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...+.. .......+ ..+...... .....+.+++.+|++.+|++|||+.++++.
T Consensus 238 -~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 -FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred -HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111100 00000000 000000001 233568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=289.55 Aligned_cols=249 Identities=22% Similarity=0.364 Sum_probs=200.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
+.+.+.||+|+||.||++..+ +++.+++|.+.......+++.+|++++++++|+|++++++.+......++++||++++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 445578999999999999976 6888999999855445677899999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 672 (804)
+|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 101 ~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 173 (286)
T cd06614 101 SLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KR 173 (286)
T ss_pred cHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hh
Confidence 9999997532 46899999999999999999999988 99999999999999999999999999876543221 22
Q ss_pred cccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcC
Q 038103 673 SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRL 752 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 752 (804)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... . ..... ..........+
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~----------~-~~~~~-~~~~~~~~~~~--- 238 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP----------L-RALFL-ITTKGIPPLKN--- 238 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH----------H-HHHHH-HHhcCCCCCcc---
Confidence 234577899999999888899999999999999999999999864220 0 00111 11111111111
Q ss_pred CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 753 NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.......+.+++.+|++.+|.+||++.+|++.
T Consensus 239 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 ----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ----hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11123568899999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=286.40 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=196.4
Q ss_pred cccccccccCcceEEEEEe-cCCcEEEEEEecCcCC-------ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 515 NFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ-------GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
...+.||+|+||.||++.. .+++.+|+|.+..... ..+++.+|++++++++|+||+++++++.+.+..++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 3457799999999999995 5688999999864321 1356889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC-CeEEeecCCccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF-EPKVTDFGLSKLFK 665 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~ 665 (804)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++ .+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 83 EWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred eccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999864 235789999999999999999999998 99999999999998776 59999999998765
Q ss_pred ccCC---ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 666 ERHD---TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 666 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
.... .......++..|+|||.+....++.++||||+|++++||++|+.|+...... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~- 226 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--------NHLALIFKIASA- 226 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--------chHHHHHHHhcc-
Confidence 4321 1112345788999999998888999999999999999999999998632210 001111111000
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
......+......+.+++.+|++.+|++||++.++++
T Consensus 227 --------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 --------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011222334457889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=288.60 Aligned_cols=259 Identities=20% Similarity=0.322 Sum_probs=196.8
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEEEEee
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EHKLLVYEY 588 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~ 588 (804)
.+.++||+|+||.||+|+.. +++.+|+|++.... .....+.+|++++++++|+|++++++++... ...++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 45678999999999999965 47899999998542 2335688999999999999999999999988 899999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++ +|.+++... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 82 MDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 975 888888642 246899999999999999999999998 9999999999999999999999999998765543
Q ss_pred CccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc---C-
Q 038103 669 DTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE---G- 743 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~- 743 (804)
........++..|+|||.+.+ ..++.++||||||++++||++|+.||...... .....+....... .
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--------EQLEKIFELCGSPTDENW 226 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHHHhCCCchhhc
Confidence 323334456788999998764 45789999999999999999999998642210 0011111110000 0
Q ss_pred -------------cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 744 -------------LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 744 -------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
........+.......+...+.+++.+|++.+|++||+++++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000011111125678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=284.75 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=195.8
Q ss_pred cccccccCcceEEEEEe-cCCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCCh
Q 038103 517 KQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
-+.||+|++|.||++.. .+++.+++|++.... ...+.+.+|+.++++++|+|++++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 36899999999999995 468889999986433 3345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccccc
Q 038103 595 DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR 674 (804)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 674 (804)
.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++......... ...
T Consensus 104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~ 174 (285)
T cd06648 104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKS 174 (285)
T ss_pred HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-ccc
Confidence 999854 35889999999999999999999998 999999999999999999999999998765443221 223
Q ss_pred cccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCC
Q 038103 675 VRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLND 754 (804)
Q Consensus 675 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 754 (804)
..++..|+|||.+.+..++.++||||||++++||++|+.||.... ...... ....... +.+..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-----------~~~~~~-~~~~~~~-----~~~~~ 237 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-----------PLQAMK-RIRDNLP-----PKLKN 237 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----------HHHHHH-HHHhcCC-----CCCcc
Confidence 457889999999998889999999999999999999999985321 011111 1111111 11111
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 755 VYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.......+.+++.+|++.+|++||++.++++
T Consensus 238 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 --LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1112347899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=289.49 Aligned_cols=260 Identities=20% Similarity=0.317 Sum_probs=192.8
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
.+.+.+.||+|++|.||+|... +++.||||.+.... .....+.+|++++++++|+||+++++++.+....++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 3556788999999999999965 67899999987432 22345778999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
.+ +|.+++... ...+++.....++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 86 DT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 85 999988653 336889999999999999999999998 99999999999999999999999999875432111
Q ss_pred ccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc---C--
Q 038103 670 TKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE---G-- 743 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 743 (804)
......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... ..........+... .
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-------EDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-------HHHHHHHHHhcCCCChhhhh
Confidence 1122345788999998875 45889999999999999999999998642200 00111011100000 0
Q ss_pred -------ccc----cc-CCcCCCcc-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 744 -------LEK----II-DPRLNDVY-DREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 744 -------~~~----~~-d~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
... .. ...+.... .......+.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 00 00000000 0111256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=282.07 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=198.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCc---CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV---LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+.+.+.||+|+||.||++... ++..+|+|.+... ....+.+.+|++++++++|+||+++++.+......++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 456788999999999999965 4788999998643 234457889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC-CeEEeecCCcccccccC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF-EPKVTDFGLSKLFKERH 668 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~ 668 (804)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 82 DGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999653 2345799999999999999999999988 99999999999998885 46999999998765432
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
. ......|+..|+|||++....++.++||||||++++||++|+.|+.... ....+.... .+.....
T Consensus 157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----------~~~~~~~~~-~~~~~~~- 222 (257)
T cd08225 157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----------LHQLVLKIC-QGYFAPI- 222 (257)
T ss_pred c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHHHHh-cccCCCC-
Confidence 2 2223457889999999988889999999999999999999999986321 112222211 1111111
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.......+.+++.+|++.+|++||++.+|++.
T Consensus 223 --------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 --------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11123468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=290.45 Aligned_cols=244 Identities=27% Similarity=0.364 Sum_probs=193.0
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC----ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ----GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.++||+|+||.||+|+.. +++.||+|.+..... ...++.+|+++++.++|||++++.++|......++|+|
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 4666788999999999999965 588999999863321 22468899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 96 ~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 96 YCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred hhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 997 577777653 2345899999999999999999999988 999999999999999999999999998764332
Q ss_pred CCccccccccCCCccchhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMM---NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+.... ........ .....
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-----------~~~~~~~~-~~~~~ 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----------AMSALYHI-AQNDS 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-----------HHHHHHHH-hcCCC
Confidence 2345778899999874 4568899999999999999999999985422 00111111 11100
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+.+ ........+.+++.+||+.+|++||++.+|++.
T Consensus 232 -----~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 -----PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111 112234568999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=313.09 Aligned_cols=200 Identities=21% Similarity=0.315 Sum_probs=159.2
Q ss_pred HHHhcccccccccCcceEEEEEecC--CcEEEEE------------------EecCcCCChHHHHHHHHHHhcCCCCccc
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDD--ERVVAVK------------------RLEGVLQGDAEFWAEVSIIGRINHRNLV 570 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~--~~~vavK------------------~l~~~~~~~~~~~~E~~~l~~l~H~niv 570 (804)
...|.+.++||+|+||.||++..+. +...++| ++........++.+|+.++++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4567888999999999999987542 2222222 2221222235678999999999999999
Q ss_pred ceeeeEEeCCeeEEEEeeccCCChhhhhccCCC-CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC
Q 038103 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPG-TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD 649 (804)
Q Consensus 571 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~ 649 (804)
++++++...+..++|+|++.. +|.+++..... ............++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 999999999999999999854 77777654211 1122345567789999999999999998 999999999999999
Q ss_pred CCCeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 038103 650 HFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSA 714 (804)
Q Consensus 650 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p 714 (804)
++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999987755433333446789999999999999999999999999999999998754
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=291.01 Aligned_cols=248 Identities=27% Similarity=0.356 Sum_probs=194.5
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC-C---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL-Q---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~-~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
+.+...+.||+|+||.||+++.. ++..+|+|++.... . ...++.+|++++++++|+|++++++++.++...++|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 33555678999999999999954 67899999986432 1 2246888999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+.+ +|.+.+.. ....+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99975 78777754 3445899999999999999999999998 99999999999999999999999999875433
Q ss_pred cCCccccccccCCCccchhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMM---NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
. ....++..|+|||++. .+.++.++||||||+++|||++|+.|+.... ....... +....
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----------~~~~~~~-~~~~~ 240 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----------AMSALYH-IAQNE 240 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHHH-HHhcc
Confidence 2 2345788999999973 4568899999999999999999999985321 0000111 11111
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
... .........+.+++.+|++.+|.+||++.+|++.+.-
T Consensus 241 ~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 241 SPT--------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCC--------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 100 0111233468899999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=277.18 Aligned_cols=248 Identities=29% Similarity=0.453 Sum_probs=201.0
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCC-ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ-GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+...+.||+|++|.||++... +++.+++|++..... ...++.+|++++++++|+|++++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 345678999999999999975 688899999975433 557899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.+++... ...+++..+..++.++++||+|||..+ ++|+||+|+||++++++.+||+|||.+........
T Consensus 82 ~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 82 GSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999998653 246899999999999999999999988 99999999999999999999999999987655332
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....++..|+|||.+....++.++||||||+++++|++|+.|+..... ..... ............+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~-~~~~~~~~~~~~~- 220 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----------MKALF-KIATNGPPGLRNP- 220 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----------HHHHH-HHHhcCCCCcCcc-
Confidence 2345678899999999988899999999999999999999999864220 01011 1111111111111
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
......+.+++.+|++.+|++|||+.++++.
T Consensus 221 ------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 ------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ------cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1113468899999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=286.59 Aligned_cols=263 Identities=21% Similarity=0.292 Sum_probs=195.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EHKLLVY 586 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 586 (804)
.+.+.+.||+|+||.||+|... +++.+|+|.++.... ....+.+|+.++.+++||||+++++++... ...++|+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 4566788999999999999975 578899999974322 223567899999999999999999999877 8899999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 86 EYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred hhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99975 998888652 236899999999999999999999998 99999999999999999999999999987654
Q ss_pred cCCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH-------HHHH
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW-------VAKQ 738 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~ 738 (804)
... ......++..|+|||.+.+. .++.++|+||||++++||++|+.||...... .....+... .+..
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI----DQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCchHHHHH
Confidence 321 22234567889999998754 4689999999999999999999998643210 000000000 0000
Q ss_pred h------hhcCcccccCCcCCCccCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 739 M------EQEGLEKIIDPRLNDVYDRE-KLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 739 ~------~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
. ............+...++.. ....+.+++.+|++.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 00000111111111112111 2456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=317.76 Aligned_cols=263 Identities=23% Similarity=0.392 Sum_probs=209.5
Q ss_pred HHHHHHHhcccccccccCcceEEEEEecC--------CcEEEEEEecCcC--CChHHHHHHHHHHhcC-CCCcccceeee
Q 038103 507 AELKRATRNFKQEVGKGGFGSVFRGVLDD--------ERVVAVKRLEGVL--QGDAEFWAEVSIIGRI-NHRNLVKLQGF 575 (804)
Q Consensus 507 ~~l~~~t~~~~~~LG~G~fg~Vykg~~~~--------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~ 575 (804)
-|+.+....+.+.||+|.||.|++|...+ ...||||.++... ...+.+..|+++|..+ +|+|++.++|.
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34445555667799999999999998531 4579999998443 3457799999999999 69999999999
Q ss_pred EEeCCeeEEEEeeccCCChhhhhccCC---C---C----C--CCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccC
Q 038103 576 CAENEHKLLVYEYVENGSLDKLLFNDP---G---T----A--SILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQ 643 (804)
Q Consensus 576 ~~~~~~~~lV~E~~~~gsL~~~l~~~~---~---~----~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 643 (804)
|......++|.||+..|+|.++|+..+ . . . ..++...++.++.|||.|++||++.. ++||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999998754 0 0 1 24889999999999999999999988 999999999
Q ss_pred eEEEcCCCCeEEeecCCcccccccCCccccccc--cCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCccccc
Q 038103 644 NILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR--GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSA 720 (804)
Q Consensus 644 NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~ 720 (804)
|||+.++..+||+|||+++............-. -...|||||.+....|+.|+|||||||+||||+| |..|+....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~- 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP- 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-
Confidence 999999999999999999965443333222212 3456999999999999999999999999999999 888875321
Q ss_pred ccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 721 SASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
...+. .+.+++|... ..+..+..++.++++.||+.+|++||++.++++.|+.+
T Consensus 527 ---------~~~~l-~~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 ---------PTEEL-LEFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ---------cHHHH-HHHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 01111 3344444322 22333456789999999999999999999999999884
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=283.83 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=201.8
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+.+.++||+|+||.||+++.. +++.+++|.+.... ....++.+|++++++++|+||+++++++......++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 456788999999999999854 67889999987432 22356788999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++.........+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 999999998664333466899999999999999999999998 999999999999999999999999999876554
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......++..|+|||.+.+..++.++|+||||++++||++|+.|+.... ..+ .......+...
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----------~~~-~~~~~~~~~~~---- 219 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----------MQD-LRYKVQRGKYP---- 219 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------HHH-HHHHHhcCCCC----
Confidence 2223457889999999999899999999999999999999999986422 011 11111111111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
..+......+.+++.+|++.+|++||++.++++.
T Consensus 220 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 -----PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1122344578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=285.61 Aligned_cols=259 Identities=21% Similarity=0.299 Sum_probs=193.4
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
++..+.||.|++|.||+|+.. +++.||||++..... ....+.+|++++++++|+||+++++++.+....++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 345678999999999999965 588999999874322 2357889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
. ++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 82 H-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred c-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 6 5898888653 2356899999999999999999999998 99999999999999999999999999986543221
Q ss_pred ccccccccCCCccchhhhccCC-CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH----------
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLK-IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ---------- 738 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 738 (804)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||..... ...+.......
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-------IDQLFRIFRTLGTPDEVVWPG 227 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHHHhCCCChhhhhh
Confidence 122334678899999887644 68899999999999999999999853210 00111100000
Q ss_pred hh-----hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 739 ME-----QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 739 ~~-----~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.. ...........+.. ........+.+++.+|++.||++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 228 VTSLPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhHHHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 00000000000000 00112245778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=283.33 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=202.4
Q ss_pred hcccccccccCcceEEEEEecC-CcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
+.+.+.||+|++|.||+++..+ ++.|+||++.... ....++.+|+.++.+++|+|++++++++......++|+||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 4566889999999999999764 8899999987543 235679999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHh-hCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE-ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
+++|.+++... ..++...+..++.|+++|++|||+ .+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 83 GGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999642 568999999999999999999999 88 99999999999999999999999999987654332
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
. .....++..|+|||.+....++.++||||||+++|||++|+.|+..... ....+...... ....
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--------~~~~~~~~~~~-~~~~----- 220 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--------PSFFELMQAIC-DGPP----- 220 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--------cCHHHHHHHHh-cCCC-----
Confidence 2 1234578899999999998999999999999999999999999865321 01111111111 1111
Q ss_pred CcCCCccCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 750 PRLNDVYDRE-KLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 750 ~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+.+ +.. ....+.+++.+|++.+|++||++.++++.
T Consensus 221 ~~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSL----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCC----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 111 34578999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=284.79 Aligned_cols=245 Identities=26% Similarity=0.339 Sum_probs=196.0
Q ss_pred ccccCcceEEEEEecC-CcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCCh
Q 038103 520 VGKGGFGSVFRGVLDD-ERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 520 LG~G~fg~Vykg~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
||+|+||.||+++... ++.+++|.+.... ...+.+.+|++++.+++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 8899999987432 2345788899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC-----
Q 038103 595 DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD----- 669 (804)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~----- 669 (804)
.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999642 26899999999999999999999998 99999999999999999999999999886433211
Q ss_pred --ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 670 --TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 670 --~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.......++..|+|||.+.....+.++||||||++++||++|+.||.... ..+. ......+....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----------~~~~-~~~~~~~~~~~- 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----------PEEI-FQNILNGKIEW- 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----------HHHH-HHHHhcCCcCC-
Confidence 12233457889999999988889999999999999999999999986422 0111 11111111110
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
.. .......+.+++.+|++.+|.+||++.+|.+.|+.
T Consensus 221 -----~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 221 -----PE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred -----Cc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00 00124578899999999999999999777777753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=283.54 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=193.7
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.+.++||.|++|.||+|... +++.||+|++.... ...+.+.+|++++++++|+|++++++++.++...++++||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 45678999999999999964 68999999987432 223568899999999999999999999999999999999995
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
++|.+++...+ ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 82 -~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 82 -LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred -cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 68999986532 246899999999999999999999988 99999999999999999999999999986543221
Q ss_pred cccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh--------
Q 038103 671 KFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ-------- 741 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 741 (804)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ...+..........
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-------IDQLFRIFRTLGTPDEDVWPGV 227 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHHhCCCChHHhhhh
Confidence 12223467889999987654 578999999999999999999999864221 00111100000000
Q ss_pred -------cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 742 -------EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 742 -------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
........... ..........+.+++.+|++.+|++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 228 TSLPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhchhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000000 0011112356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=285.62 Aligned_cols=240 Identities=25% Similarity=0.291 Sum_probs=195.5
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|++++++++||||+++++++.++...++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 456788999999999999965 58899999986422 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++.. ...++...+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 83 VPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999864 246889999999999999999999988 999999999999999999999999999876543
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.....+++.|+|||.+.....+.++||||||++++||++|+.||.... ..........+..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------------~~~~~~~~~~~~~---- 215 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN------------PIQIYEKILEGKV---- 215 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------------HHHHHHHHhcCCc----
Confidence 233457899999999988889999999999999999999999986422 0011111111111
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVV 786 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv 786 (804)
.+ +......+.+++.+|++.+|.+|| ++++++
T Consensus 216 --~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 --RF----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred --cC----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 11 111235788999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=287.25 Aligned_cols=251 Identities=29% Similarity=0.422 Sum_probs=191.0
Q ss_pred ccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEeeccC
Q 038103 516 FKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 516 ~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.++||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++. |+||+++++++..+...++++||+..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 4567999999999999965 57899999987432 23456889999999996 99999999999999999999999865
Q ss_pred CChhhhhccC-CCCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 592 GSLDKLLFND-PGTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 592 gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
+|.++.... ......+++.....++.+++.||+|||+. + ++||||||+||+++.++.+||+|||++........
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 555543211 11235688999999999999999999985 6 99999999999999999999999999986543221
Q ss_pred ccccccccCCCccchhhhccC---CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 670 TKFSRVRGTRGYLAPEWMMNL---KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~---~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.....++..|+|||.+... .++.++||||||+++|||++|+.||.... ...+.+.+... +.
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----------~~~~~~~~~~~-~~--- 227 (288)
T cd06616 164 --KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----------SVFDQLTQVVK-GD--- 227 (288)
T ss_pred --cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----------hHHHHHhhhcC-CC---
Confidence 1233578899999998766 68999999999999999999999986321 11111111111 11
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+.+...........+.+|+.+|++.+|++||++.+|++.
T Consensus 228 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 --PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112111112234578999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=280.11 Aligned_cols=247 Identities=25% Similarity=0.341 Sum_probs=201.0
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEEEEee
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EHKLLVYEY 588 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~ 588 (804)
...+.||+|++|.||+|... +++.|++|.+.... ...+.+.+|++++++++|+||+++++.+... ...++++||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34578999999999999976 68899999987544 3456789999999999999999999999988 899999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+.......
T Consensus 83 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 83 VSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999653 27899999999999999999999988 9999999999999999999999999998765543
Q ss_pred Cc-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 669 DT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 669 ~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.. ......++..|+|||.+.....+.++||||||+++++|++|+.|+.... .....+.....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----------~~~~~~~~~~~------- 218 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----------NPMAALYKIGS------- 218 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----------chHHHHHhccc-------
Confidence 21 1234567889999999998889999999999999999999999986432 01111111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.......+......+.+++.+|++.+|++||++.++++
T Consensus 219 --~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 --SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 00111112222457899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=283.37 Aligned_cols=245 Identities=23% Similarity=0.341 Sum_probs=206.1
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
-|++.+.||+|.|..|-++++ =.|..||||++.++.-. ...+.+|++.|+.++|||||+++.+......+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 467778999999999999884 47889999999865533 35788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc-CCCCeEEeecCCccccccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~~ 667 (804)
-++|+|.+||.. +..-+.+....+++.||+.|+.|+|+.. +|||||||+||.+- .-|-+||.|||++..+...
T Consensus 99 GD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999976 3455899999999999999999999988 99999999999874 5678999999999977653
Q ss_pred CCccccccccCCCccchhhhccCCCC-cccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKID-AKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
......+|+..|-|||++.+..|. ++.||||||||||-|++|+.||+... + .+.+..
T Consensus 173 --~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----D----------------SETLTm 230 (864)
T KOG4717|consen 173 --KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----D----------------SETLTM 230 (864)
T ss_pred --chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----c----------------hhhhhh
Confidence 344567899999999999998886 58999999999999999999997432 1 112333
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
++|=+. ..+.....++.+|+..||+.||.+|.+.++|+.
T Consensus 231 ImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 231 IMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 444333 234455668999999999999999999999974
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=282.12 Aligned_cols=241 Identities=24% Similarity=0.313 Sum_probs=192.8
Q ss_pred ccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCCh
Q 038103 520 VGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 520 LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
||.|+||.||+++.. +++.+|+|.+.... ...+.+.+|++++++++|+||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 47899999986432 2346789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccccc
Q 038103 595 DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR 674 (804)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 674 (804)
.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9999642 34889999999999999999999988 9999999999999999999999999998765432 2223
Q ss_pred cccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCC
Q 038103 675 VRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLND 754 (804)
Q Consensus 675 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 754 (804)
..++..|+|||.+....++.++|+||||+++|||++|+.|+..... ......... ..+ ....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~-~~~--------~~~~ 213 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---------DPMEIYNDI-LKG--------NGKL 213 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---------CHHHHHHHH-hcc--------CCCC
Confidence 4578899999999888899999999999999999999999864321 011111111 100 0011
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038103 755 VYDREKLDRMVKVALLCVAENRDTRPP-----MSKVVK 787 (804)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~~Vv~ 787 (804)
..+......+.+++.+|++.+|++||+ +.|+++
T Consensus 214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 112222457899999999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=285.49 Aligned_cols=256 Identities=19% Similarity=0.261 Sum_probs=191.4
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCC-CCcccceeeeEEeC--CeeEEEEee
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRIN-HRNLVKLQGFCAEN--EHKLLVYEY 588 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E~ 588 (804)
.+.++||+|+||.||++... +++.||+|+++.... ......+|+.++.++. |+|++++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 45678999999999999954 688999999875322 2334567888999885 99999999999987 889999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
++ ++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++. +.+||+|||++.......
T Consensus 82 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 82 MD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred CC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 97 488888754 2346899999999999999999999998 999999999999999 999999999998664322
Q ss_pred CccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHH-----------
Q 038103 669 DTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVA----------- 736 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 736 (804)
. .....++..|+|||.+.. ..++.++||||||+++|||++|+.||...... .......
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~ 223 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--------DQIAKIHDVLGTPDAEVL 223 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--------HHHHHHHHHcCCCCHHHH
Confidence 2 123457889999997654 55788999999999999999999998642211 0111111
Q ss_pred HHhhhcCcccccCCcCCC----ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 737 KQMEQEGLEKIIDPRLND----VYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 737 ~~~~~~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.............+.... .........+.+++.+|++.+|++||+++++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 111111111110000000 0011235689999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=283.48 Aligned_cols=260 Identities=20% Similarity=0.297 Sum_probs=191.4
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
.|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++++++|+||+++.+++..+...++|+||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 3556788999999999999864 58899999987432 22346788999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
. ++|..++... ...+.+..+..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 86 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 86 H-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred c-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 6 5777776542 234778888899999999999999998 99999999999999999999999999986433221
Q ss_pred ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh--------
Q 038103 670 TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME-------- 740 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 740 (804)
......++..|+|||++.+. .++.++||||||+++|||++|+.||+..... ...+.. ++....
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~------~~~~~~-~~~~~~~~~~~~~~ 230 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV------FEQLEK-IWTVLGVPTEDTWP 230 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH------HHHHHH-HHHHcCCCChhhhh
Confidence 12233468899999998754 5788999999999999999999998643210 000100 000000
Q ss_pred -----hcCcccccC----CcCCCcc-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 741 -----QEGLEKIID----PRLNDVY-DREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 741 -----~~~~~~~~d----~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
......... ..+.... .......+.+++.+|++.+|.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000 0000000 0011346778999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=284.40 Aligned_cols=261 Identities=20% Similarity=0.261 Sum_probs=191.8
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCC-CCcccceeeeEEeCCe-----eE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEH-----KL 583 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~-----~~ 583 (804)
+.+.+.||+|+||.||+|... +++.||||.++.... ....+.+|+.++++++ |+||+++++++..... .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 456678999999999999965 688999998864322 2357888999999995 6999999999987665 89
Q ss_pred EEEeeccCCChhhhhccCCCC-CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-CCCeEEeecCCc
Q 038103 584 LVYEYVENGSLDKLLFNDPGT-ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-HFEPKVTDFGLS 661 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla 661 (804)
+||||+++ +|.+++...... ...+++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999986 888888653222 356899999999999999999999998 999999999999998 889999999999
Q ss_pred ccccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 662 KLFKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
........ ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||..... ...+... ...+.
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-------~~~~~~~-~~~~~ 229 (295)
T cd07837 159 RAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-------LQQLLHI-FKLLG 229 (295)
T ss_pred eecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHH-HHHhC
Confidence 86533211 1122346788999998865 4578999999999999999999999864220 0011110 00000
Q ss_pred hcCc---ccc---cC----CcCC----CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 741 QEGL---EKI---ID----PRLN----DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 741 ~~~~---~~~---~d----~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.... ... .+ +... ..........+.+++..|++.+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 000 00 0000 0001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=277.17 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=203.3
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+.+.+.||.|+||.||++... +++.+++|++.... ...+++.+|++++++++|+|++++++.+......++|+|++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 455678999999999999965 58899999997433 34467889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++.........+++..+..++.++++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 999999999764333567999999999999999999999998 9999999999999999999999999998765543
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
.......+++.|+|||.+....++.++||||+|+++++|++|+.|++... ...... .........
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----------~~~~~~-~~~~~~~~~--- 222 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----------LLELAL-KILKGQYPP--- 222 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----------HHHHHH-HHhcCCCCC---
Confidence 12233467889999999998889999999999999999999999986422 111111 111111111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+ +......+.+++.+|++.+|++||++.++++.
T Consensus 223 --~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 --I----PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 11233568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=281.32 Aligned_cols=242 Identities=22% Similarity=0.370 Sum_probs=193.6
Q ss_pred ccccccCcceEEEEEe-cCCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCChh
Q 038103 518 QEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLD 595 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 595 (804)
.+||+|+||.||++.. .+++.||||++.... ...+.+.+|+.++++++|+|++++++.+..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 468899999986322 34566889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcccccc
Q 038103 596 KLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRV 675 (804)
Q Consensus 596 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 675 (804)
+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 98743 34789999999999999999999998 99999999999999999999999999876543222 22334
Q ss_pred ccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCc
Q 038103 676 RGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDV 755 (804)
Q Consensus 676 ~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 755 (804)
.++..|+|||.+....++.++||||||+++|||++|+.|+..... ..... ..... ..+.+..
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~~----~~~~~-----~~~~~~~- 238 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMK----MIRDN-----LPPKLKN- 238 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH----HHHhh-----CCcccCC-
Confidence 578899999999888899999999999999999999999864210 01111 11111 0111111
Q ss_pred cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 756 YDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.......+.+++.+|++.+|.+||++.+|++
T Consensus 239 -~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred -cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0112335778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=282.22 Aligned_cols=245 Identities=23% Similarity=0.293 Sum_probs=197.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.||.|+||.||++... +++.+|+|.+.... ...+.+.+|++++++++||||+++++.+.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456788999999999999975 58889999987432 3356789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+.+++|.+++... ..++......++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 82 LLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999642 46889999999999999999999998 9999999999999999999999999998764432
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
......++..|+|||.+....++.++|+||||+++|+|++|+.|+...... ........... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~~--~~--- 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---------IRDQIRAKQET--AD--- 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---------HHHHHHHHhcc--cc---
Confidence 223455788999999999888999999999999999999999998753211 01111111111 00
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPM--SKVV 786 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm--~~Vv 786 (804)
+ ..+......+.+++.+|++.+|.+||++ +++.
T Consensus 219 -~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 -V----LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -c----cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1 1111223578899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=280.98 Aligned_cols=257 Identities=20% Similarity=0.291 Sum_probs=197.0
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.+.+.||+|++|.||++... +++.+++|++..... ....+.+|++++++++|+||+++++++..+...++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 34578999999999999964 688899999874332 24678889999999999999999999999999999999997
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+ +|.+++.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||.+....... .
T Consensus 82 ~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 82 T-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred C-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 6 88888854 2246899999999999999999999998 9999999999999999999999999998765543 1
Q ss_pred cccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh---cCccc
Q 038103 671 KFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ---EGLEK 746 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 746 (804)
......++..|+|||.+... .++.++||||||+++++|++|+.||...... .......+.... .....
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI--------DQLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHcCCCchHhccc
Confidence 22334577889999998776 7899999999999999999999998542210 000001111000 00000
Q ss_pred ccC-----------CcC--CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 747 IID-----------PRL--NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 747 ~~d-----------~~l--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+.+ ... ......+....+.+++..|++.+|.+||++++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 000 01112234568899999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=283.01 Aligned_cols=263 Identities=22% Similarity=0.327 Sum_probs=195.6
Q ss_pred HHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCC-----
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENE----- 580 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 580 (804)
....+.+.+.||+|+||.||+|... +++.||+|+++... .....+.+|++++++++|||++++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3455677889999999999999975 57899999997432 22356788999999999999999999987654
Q ss_pred -----eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEE
Q 038103 581 -----HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKV 655 (804)
Q Consensus 581 -----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 655 (804)
..++|+||+++ +|..++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 77777754 2346899999999999999999999998 999999999999999999999
Q ss_pred eecCCcccccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH
Q 038103 656 TDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 656 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
+|||++...............++..|+|||.+.. ..++.++||||||++++||++|+.||..... ......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--------~~~~~~ 229 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--------LAQLEL 229 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHH
Confidence 9999998765443322233446778999998864 4578999999999999999999999863210 011111
Q ss_pred HHHHhhhcC---cccc--------cCC------cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 735 VAKQMEQEG---LEKI--------IDP------RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 735 ~~~~~~~~~---~~~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+........ ...+ .++ ...... ......+.+++..|++.+|.+||++.+|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111110000 0000 000 000000 0123578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=288.04 Aligned_cols=250 Identities=22% Similarity=0.381 Sum_probs=198.1
Q ss_pred HHHhcccccccccCcceEEEEEecCCcEEEEEEecCcC---CChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVL---QGDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 586 (804)
...|.+.++||+||.+.|||+...+.+.+|+|++.... +...-|.+|+..|.+|+ |.+||++++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 34456678899999999999999998999999886332 33466999999999995 999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
|+-+- +|..+|... ......| .+..+..|++.++.++|.++ |||.||||.|.|+-. |.+||+|||+|..+..
T Consensus 440 E~Gd~-DL~kiL~k~--~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECGDI-DLNKILKKK--KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred ecccc-cHHHHHHhc--cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 99654 999999763 3333445 77888999999999999999 999999999999865 5899999999998876
Q ss_pred cCCc-cccccccCCCccchhhhccC-----------CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH
Q 038103 667 RHDT-KFSRVRGTRGYLAPEWMMNL-----------KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 667 ~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
+... ......||+.||+||.+... +.++++||||+|||||+|+-|+.||+... . .+
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----------n--~~ 579 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----------N--QI 579 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----------H--HH
Confidence 5543 33457899999999998532 25679999999999999999999996421 0 11
Q ss_pred HHHHhhhcCcccccCCcCCCccC-HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 735 VAKQMEQEGLEKIIDPRLNDVYD-REKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..+..+.||...-+++ ......++++++.||+.||.+||+..++++
T Consensus 580 -------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 -------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1244556664322221 111123999999999999999999999985
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=290.13 Aligned_cols=265 Identities=19% Similarity=0.291 Sum_probs=194.6
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeC------Ce
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN------EH 581 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 581 (804)
..|...+.||+|+||.||++... +++.||+|.+.... ....++.+|+.++.+++|+||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 45666788999999999999954 68899999986432 2235677899999999999999999988643 35
Q ss_pred eEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCc
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 661 (804)
.++|+||+.+ +|.+.+.. .++...+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 96 VYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred EEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 7999999965 88887743 1788889999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccC----------C-ccchhh
Q 038103 662 KLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASAS----------D-SSYCNH 730 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~----------~-~~~~~~ 730 (804)
+...... ......++..|+|||.+.+..++.++||||||+++++|++|+.||........ . ......
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 8654322 12334578899999999999999999999999999999999999864321000 0 000000
Q ss_pred HHHHHHHHhhhc------CcccccCCcC----CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 731 LVQWVAKQMEQE------GLEKIIDPRL----NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 731 ~~~~~~~~~~~~------~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+........... .+.++....+ ...........+.+++.+|++.||++||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000000 0011111111 111122345678899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=283.92 Aligned_cols=260 Identities=16% Similarity=0.224 Sum_probs=182.3
Q ss_pred HHHHHhcccccccccCcceEEEEEecC----CcEEEEEEecCcCCC---h---------HHHHHHHHHHhcCCCCcccce
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVLQG---D---------AEFWAEVSIIGRINHRNLVKL 572 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~----~~~vavK~l~~~~~~---~---------~~~~~E~~~l~~l~H~niv~l 572 (804)
+....+.+.+.||+|+||.||+|...+ +..+|+|........ + .....+...+..++|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 334567788899999999999999654 345666653321111 0 112233345567789999999
Q ss_pred eeeEEeCC----eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc
Q 038103 573 QGFCAENE----HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD 648 (804)
Q Consensus 573 ~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~ 648 (804)
++++.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||+|||+.+ |+||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~ 160 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVD 160 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc
Confidence 99776543 34677777644 56555532 123567788999999999999999998 99999999999999
Q ss_pred CCCCeEEeecCCcccccccCC------ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCccccccc
Q 038103 649 DHFEPKVTDFGLSKLFKERHD------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASA 722 (804)
Q Consensus 649 ~~~~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~ 722 (804)
.++.+||+|||+++.+..... .......||+.|+|||.+.+..++.++||||||++++||++|+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 999999999999987643221 11223468999999999999999999999999999999999999997532110
Q ss_pred CCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 723 SDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
.+........ +..+..+.+.. ......+.+++..|++.+|++||++.++++.|+
T Consensus 241 -------~~~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 -------NLIHAAKCDF----IKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred -------HHHHHhHHHH----HHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111100000 01111111100 011356889999999999999999999999874
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=285.65 Aligned_cols=258 Identities=19% Similarity=0.245 Sum_probs=191.2
Q ss_pred cccccc--CcceEEEEEe-cCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKG--GFGSVFRGVL-DDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G--~fg~Vykg~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
++||+| +||+||+++. ..++.||+|.+...... .+.+.+|+.+++.++|+||+++++++..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 8999999996 46899999998743322 35688899999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987532 235888999999999999999999988 9999999999999999999999998654332211110
Q ss_pred ------ccccccCCCccchhhhccC--CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHH-------
Q 038103 672 ------FSRVRGTRGYLAPEWMMNL--KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVA------- 736 (804)
Q Consensus 672 ------~~~~~gt~~y~aPE~~~~~--~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------- 736 (804)
.....++..|+|||++.+. .++.++||||||++++||++|+.||....... .......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~ 231 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-------MLLQKLKGPPYSPL 231 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-------HHHHHhcCCCCCCc
Confidence 0112245679999998763 47899999999999999999999986432100 0000000
Q ss_pred ---------HH-------h---------hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 737 ---------KQ-------M---------EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 737 ---------~~-------~---------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.. . .......+.+..+...........+.+|+.+|++.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 0 000000111122222223445678899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=290.21 Aligned_cols=239 Identities=28% Similarity=0.408 Sum_probs=196.5
Q ss_pred ccccccCcceEEEEEe-cCCcEEEEEEecCc-CCCh---HHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 518 QEVGKGGFGSVFRGVL-DDERVVAVKRLEGV-LQGD---AEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~-~~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
.+||.|+||.||-++. .+...||||++.-+ .+.. .++.+|+..|++++|||++.+.|++..+...+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 4699999999999994 56788999999743 2332 4688999999999999999999999999999999999965
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 672 (804)
+-.++|.- ..+++....+..|..+.+.||+|||+.+ .||||||+.|||+.+.+.+||+|||.|.+... .
T Consensus 111 SAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----A 179 (948)
T KOG0577|consen 111 SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----A 179 (948)
T ss_pred cHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-----h
Confidence 87888765 4567889999999999999999999999 89999999999999999999999999997654 3
Q ss_pred cccccCCCccchhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 673 SRVRGTRGYLAPEWMM---NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
..++||+.|||||++. .+.|+-|+||||+||+..||...++|.-.+... .+...+... -.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM------------SALYHIAQN-----es 242 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------------SALYHIAQN-----ES 242 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH------------HHHHHHHhc-----CC
Confidence 3478999999999974 578999999999999999999999997543310 011222211 12
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
|.+. ..+-.+...+++-.||+.-|.+|||.+++++.
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 2222 34556678899999999999999999988753
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=282.60 Aligned_cols=243 Identities=24% Similarity=0.358 Sum_probs=190.6
Q ss_pred ccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCCh
Q 038103 520 VGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 520 LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
||+|+||+||++... +++.+|+|.+.... .....+.+|++++++++|||++++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 58899999986321 2334567899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccccc
Q 038103 595 DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR 674 (804)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 674 (804)
.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...... .....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 99996532 235889999999999999999999998 999999999999999999999999999865432 22223
Q ss_pred cccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCC
Q 038103 675 VRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLND 754 (804)
Q Consensus 675 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 754 (804)
..++..|+|||.+.+..++.++||||||+++++|++|+.||....... . . ..+....... ..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~----~----~~~~~~~~~~--~~---- 215 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----E----K----EELKRRTLEM--AV---- 215 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----c----H----HHHHhccccc--cc----
Confidence 456789999999988889999999999999999999999986432100 0 0 0011110100 00
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 755 VYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
..+......+.+++.+||+.+|.+|| ++.++++
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 11112244688999999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=283.44 Aligned_cols=259 Identities=18% Similarity=0.215 Sum_probs=190.7
Q ss_pred cccccccCcceEEEEEecCCcEEEEEEecCc---CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCC
Q 038103 517 KQEVGKGGFGSVFRGVLDDERVVAVKRLEGV---LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGS 593 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 593 (804)
.+.+|.|+++.||++.. +++.||||++... ....+.+.+|++++++++|+||+++++++.+....+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34456666666666665 6889999998743 2334678999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC----
Q 038103 594 LDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD---- 669 (804)
Q Consensus 594 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~---- 669 (804)
|.+++... ....+++.....++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99999753 2335788889999999999999999998 99999999999999999999999999875532211
Q ss_pred --ccccccccCCCccchhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH----hhh
Q 038103 670 --TKFSRVRGTRGYLAPEWMMN--LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ----MEQ 741 (804)
Q Consensus 670 --~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 741 (804)
.......++..|+|||.+.. ..++.++||||||++++||++|+.||...... ....+..... +..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-------QMLLEKVRGTVPCLLDK 233 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccCcccccc
Confidence 11123446778999999875 35889999999999999999999999642210 0111100000 000
Q ss_pred -------cCccc----ccCCcC----CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 742 -------EGLEK----IIDPRL----NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 742 -------~~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
..... ..++.. ...........+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 001111 011122334578899999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=282.78 Aligned_cols=261 Identities=21% Similarity=0.329 Sum_probs=195.8
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
+.+.++||.|++|.||+|+.. +++.||||.++... ...+.+.+|++++++++|+||+++++++...+..++|+||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 456788999999999999975 58899999987432 234567889999999999999999999999999999999998
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+ +|.+++.... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 82 ~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 82 K-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred c-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 5 8888886532 2346899999999999999999999998 99999999999999999999999999986543221
Q ss_pred cccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH-------HHHHhhhc
Q 038103 671 KFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW-------VAKQMEQE 742 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 742 (804)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ......... .++.+.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~-- 229 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE----DQLLKIFRIMGTPTESTWPGIS-- 229 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCChhhHHHHh--
Confidence 12234568889999988654 5788999999999999999999998643210 000000000 000000
Q ss_pred CcccccCCcCC-------CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 743 GLEKIIDPRLN-------DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 743 ~~~~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...... .... ..........+.+++..|++.+|.+||++.++++
T Consensus 230 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYK-PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhc-ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0000 0011123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=282.50 Aligned_cols=241 Identities=22% Similarity=0.295 Sum_probs=185.5
Q ss_pred cccccCcceEEEEEec-CCcEEEEEEecCcCC----ChHHHHHHHHHHh---cCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 519 EVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ----GDAEFWAEVSIIG---RINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~---~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.||+|+||.||++... +++.+|+|.+..... ....+.+|..++. ..+|+|++++.+.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999964 588999998864321 1233445544433 3479999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999999864 345899999999999999999999998 9999999999999999999999999997554321
Q ss_pred cccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 671 KFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
.....|+..|+|||.+.. ..++.++||||||++++||++|+.||...... . . ........ ...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~---~-~~~~~~~~------~~~ 215 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----D---K-HEIDRMTL------TVN 215 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----C---H-HHHHHHhh------cCC
Confidence 123458999999998864 56899999999999999999999999643211 0 0 00111100 011
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVKL 788 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~~ 788 (804)
..+ +......+.+++..|++.+|++|| +++++++.
T Consensus 216 ~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 VEL----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCC----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 111 222334688999999999999999 59999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=283.51 Aligned_cols=254 Identities=22% Similarity=0.269 Sum_probs=198.2
Q ss_pred hcccccccccCcceEEEEEe----cCCcEEEEEEecCcC-----CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeE
Q 038103 514 RNFKQEVGKGGFGSVFRGVL----DDERVVAVKRLEGVL-----QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 583 (804)
+.+.+.||+|+||.||+++. .+++.||||.++... ...+.+.+|++++.++ +|+||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 34567899999999999984 356789999987422 2235688899999999 5999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+||||+++++|.+++.. ...+++.....++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 82 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 82 LILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999853 245888999999999999999999988 99999999999999999999999999987
Q ss_pred ccccCCccccccccCCCccchhhhccCC--CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNLK--IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
.............++..|+|||.+.+.. .+.++||||||++++||++|..|+...... ....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~~~~~~~- 226 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-------NSQSEISRRILK- 226 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-------chHHHHHHHHHc-
Confidence 6543333333456788999999987655 788999999999999999999998532110 011111111111
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
. .+.... .....+.+++.+|++.+|++|||+.+|.+.|+..
T Consensus 227 ~------~~~~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 227 S------KPPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred c------CCCCCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 111111 1224578899999999999999999998888653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=281.44 Aligned_cols=258 Identities=21% Similarity=0.295 Sum_probs=190.9
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+.+.++||+|++|.||+|+.. +++.||+|++.... ...+.+.+|++++++++|+||+++++++......++|+||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 556788999999999999965 68899999986432 22356889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-CCCeEEeecCCcccccccC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-HFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~ 668 (804)
+ ++|.+++... ....+++.....++.||+.||+|||+++ ++|+||+|+||+++. +..+||+|||++.......
T Consensus 84 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 84 D-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred c-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 6 4788877542 2233578888899999999999999998 999999999999985 5679999999998654321
Q ss_pred CccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||...... ..+.. +....... ....
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-------~~~~~-~~~~~~~~-~~~~ 227 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-------DELFK-IFRILGTP-NEET 227 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH-HHHHhCCC-Chhh
Confidence 11223456889999998866 45789999999999999999999998642210 00100 00000000 0000
Q ss_pred cC------------CcCC----CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 748 ID------------PRLN----DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 748 ~d------------~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+ +... ..........+.+++.+|++.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0000 0001122346889999999999999999999986
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=276.48 Aligned_cols=243 Identities=24% Similarity=0.271 Sum_probs=188.3
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcCC----ChHHHHHHHHHH-hcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ----GDAEFWAEVSII-GRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||+|... +++.||+|.+..... ....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999964 578999999864321 122344555444 455899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999964 235888999999999999999999988 99999999999999999999999999885433
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..... .. .......+... ....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~----~~~~~~~~~~~--~~~~ 215 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DA----VFDNILSRRIN--WPEE 215 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HH----HHHHHHhcccC--CCCc
Confidence 2234578899999999888899999999999999999999999864220 01 11111111111 0111
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
........+.+++.+|++.+|++||++.++.+.|+
T Consensus 216 ----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 216 ----VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ----ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 11123357899999999999999998877766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=281.57 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=190.9
Q ss_pred HhcccccccccCcceEEEEEecC-CcEEEEEEecCcCC--ChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
.+.+.+.||+|+||.||++...+ ++.||||+++.... ...++..|+.++.+.. |+||+++++++......+++|||
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 35667899999999999999765 88999999974332 3345677887777775 99999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
+.+ +|..++.. ....+++..+..++.|+++||+|||+. + |+|+||+|+||++++++.+||+|||++..+...
T Consensus 96 ~~~-~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 96 MST-CLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred cCc-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 854 77777654 234689999999999999999999974 6 999999999999999999999999999865432
Q ss_pred CCccccccccCCCccchhhhccCC----CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLK----IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
.. .....++..|+|||.+.... ++.++||||||+++|||++|+.||..... ..+........ .
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~~~~~~~~~-~ 235 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT----------EFEVLTKILQE-E 235 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh----------HHHHHHHHhcC-C
Confidence 22 12334678899999987543 78899999999999999999999864210 01111111111 1
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...+... ......+.+++.+|++.+|++||++.++++.
T Consensus 236 ~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 PPSLPPN-------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111000 0123468999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=285.21 Aligned_cols=248 Identities=26% Similarity=0.347 Sum_probs=193.2
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
..++...+.||+|+||.||+|+.. ++..+|+|.+.... ....++.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344555678999999999999964 57889999886321 1234678899999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
+||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99996 588777753 2345789999999999999999999988 9999999999999999999999999988654
Q ss_pred ccCCccccccccCCCccchhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMM---NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
.. ....++..|+|||.+. ...++.++||||||+++|||++|+.|+..... .... .....+
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~-~~~~~~ 229 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSAL-YHIAQN 229 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----------HHHH-HHHhhc
Confidence 32 2345788999999974 35678899999999999999999999753210 0000 111111
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~ 790 (804)
... .. ........+.+|+.+|++.+|++||++.+|++...
T Consensus 230 ~~~-----~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 230 ESP-----AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred CCC-----Cc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 111 10 11123346889999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=288.23 Aligned_cols=265 Identities=24% Similarity=0.322 Sum_probs=195.5
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEeC-----CeeEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAEN-----EHKLL 584 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l 584 (804)
.|.+.++||+|+||.||+|+. .+++.||||.+... ......+.+|+.++++++|+||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 456678899999999999985 46889999998632 22345678899999999999999999987654 35799
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
++||+.+ +|..++. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 86 VQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred Eehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 9999975 8877774 345899999999999999999999998 999999999999999999999999999865
Q ss_pred cccCCc--cccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 665 KERHDT--KFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 665 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
...... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--------~~~~~~~~~~~~~ 228 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--------LHQLNLILGVLGT 228 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHcCC
Confidence 432221 1223467889999998754 5689999999999999999999999854210 0000001010000
Q ss_pred c---CcccccCCc-------C--CCc-----cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hccCCC
Q 038103 742 E---GLEKIIDPR-------L--NDV-----YDREKLDRMVKVALLCVAENRDTRPPMSKVVKL--LTAHDH 794 (804)
Q Consensus 742 ~---~~~~~~d~~-------l--~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~--L~~~~~ 794 (804)
. ....+.+.. + ... ........+.+++.+|++.+|++||++.++++. ++....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0 000000000 0 000 001124568899999999999999999999976 665544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=277.11 Aligned_cols=246 Identities=23% Similarity=0.294 Sum_probs=192.5
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC------CChHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL------QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EHKLL 584 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 584 (804)
+.+.+.||+|+||.||++... +++.+|+|.+.... +....+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 556788999999999999964 58899999875221 1234688899999999999999999998764 46889
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
++||+++++|.+++.. ...+++....+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 84 FVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 9999999999999864 234788889999999999999999998 999999999999999999999999999865
Q ss_pred cccC--CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 665 KERH--DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 665 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
.... ........++..|+|||.+.+..++.++||||||++++||++|+.||.... ....+..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----------~~~~~~~~~~-~ 224 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-----------AMAAIFKIAT-Q 224 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-----------HHHHHHHHHc-C
Confidence 4321 112233557889999999998889999999999999999999999986421 0011111111 0
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
. .....+....+.+.+++.+|++ +|.+||+..+++.
T Consensus 225 ~--------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 P--------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred C--------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0 1111222334568899999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=286.59 Aligned_cols=264 Identities=24% Similarity=0.374 Sum_probs=194.1
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCc---CCChHHHHHHHHHHhcC-CCCcccceeeeEEeC--CeeEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV---LQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAEN--EHKLL 584 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~l 584 (804)
..+.+.+.||+|+||.||+|... +++.+|+|++... ......+.+|+.++.++ +|+||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 45667788999999999999965 5788999988532 22345677899999999 999999999998653 36899
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
|+||+++ +|..++.. ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~-~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 87 VFEYMET-DLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred Eeccccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999974 99888853 26789999999999999999999988 999999999999999999999999999876
Q ss_pred cccCC----ccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH-----
Q 038103 665 KERHD----TKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW----- 734 (804)
Q Consensus 665 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~----- 734 (804)
..... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||........ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~----~~~~~~~~~~~~ 233 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ----LEKIIEVIGPPS 233 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCC
Confidence 44322 22334567889999998754 4578999999999999999999999854221100 0000000
Q ss_pred --HHHHhhhcCcccccC----CcCC--CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 735 --VAKQMEQEGLEKIID----PRLN--DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 735 --~~~~~~~~~~~~~~d----~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
....+.......+++ .... .....+....+.+++.+|++.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000111 0000 00011134578999999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=283.69 Aligned_cols=257 Identities=21% Similarity=0.318 Sum_probs=190.5
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCC--------
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENE-------- 580 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 580 (804)
.|.+.++||+|+||.||+++.. +++.||||.+.... .....+.+|++++++++||||++++++|....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4667788999999999999965 58899999886322 12345678999999999999999999987654
Q ss_pred eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCC
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGL 660 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 660 (804)
..++|+||+.+ +|.+++.. ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999975 88887754 2346899999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCC---ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHH
Q 038103 661 SKLFKERHD---TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVA 736 (804)
Q Consensus 661 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (804)
+........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+..... ......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--------~~~~~~~~ 237 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--------QHQLTLIS 237 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence 986644222 122334568889999988664 478899999999999999999998864221 00111111
Q ss_pred HHhh---hcC------------------cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 737 KQME---QEG------------------LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 737 ~~~~---~~~------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.... ... ....+...+. +..+...+.+|+.+|++.+|.+||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK---PYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcc---cccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 1000 000 0000000000 0012245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=280.66 Aligned_cols=262 Identities=22% Similarity=0.339 Sum_probs=194.7
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEeecc
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.+.+.||+|+||.||+|+.. +++.|+||++..... ......+|+..+.+++ |+|++++++++..+...++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45678999999999999976 478899999875433 2334567999999999 999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 78999888653 2346899999999999999999999998 99999999999999999999999999986543221
Q ss_pred cccccccCCCccchhhhc-cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHH---------HHHHHHhh
Q 038103 671 KFSRVRGTRGYLAPEWMM-NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLV---------QWVAKQME 740 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 740 (804)
.....++..|+|||.+. ...++.++|+||||++++||++|+.||........ ..... .|......
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ----LYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH----HHHHHHhcCCCChhhhhhHhhh
Confidence 22345788899999875 44578999999999999999999998854321100 00000 00000000
Q ss_pred hcCcccccCCcCCC---ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 741 QEGLEKIIDPRLND---VYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 741 ~~~~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.......+...... .........+.+++.+|++.+|++||+++|++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 01111111000000 0001113578899999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=265.81 Aligned_cols=272 Identities=21% Similarity=0.311 Sum_probs=197.2
Q ss_pred HhcccccccccCcceEEEEEec---CC--cEEEEEEecCcCC--C-hHHHHHHHHHHhcCCCCcccceeeeEEe-CCeeE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD---DE--RVVAVKRLEGVLQ--G-DAEFWAEVSIIGRINHRNLVKLQGFCAE-NEHKL 583 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~---~~--~~vavK~l~~~~~--~-~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 583 (804)
.|+...+||+|.||.|||++-. +. ..+|+|+++.... + .....+|+.+++.++|+|++.+..++.+ +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 3566788999999999999743 22 3799999985432 2 2456789999999999999999999887 77899
Q ss_pred EEEeeccCCChhhhhccCC-CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC----CCeEEeec
Q 038103 584 LVYEYVENGSLDKLLFNDP-GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH----FEPKVTDF 658 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~Df 658 (804)
|++||.+. +|.+.|+-+. ...+.++-..+..|+.||+.|+.|||++. |+||||||.|||+..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999987 8888875432 23457888999999999999999999988 9999999999999877 89999999
Q ss_pred CCcccccccCCc--cccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCc-cchhhHHHH
Q 038103 659 GLSKLFKERHDT--KFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDS-SYCNHLVQW 734 (804)
Q Consensus 659 gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~-~~~~~~~~~ 734 (804)
|+++++...-.. ....+.-|..|+|||.+.+. .|+++.|||+.|||+.||+|-+..|.....+-... ++...-...
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999988764332 33456679999999999875 59999999999999999999888775432211111 111112222
Q ss_pred HHHHhhhcCcccccC------C---------cCCCccC--------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 735 VAKQMEQEGLEKIID------P---------RLNDVYD--------REKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d------~---------~l~~~~~--------~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+.+.+.......+.+ - +...... ........+|...+++.||.+|.|+++.++.
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 222221111110000 0 0000000 0011236788889999999999999998864
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=272.62 Aligned_cols=245 Identities=25% Similarity=0.400 Sum_probs=199.0
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+.+.+.||+|++|.||+++.. +++.+++|.+..... ..+++.+|++++.+++|+|++++++++......++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 456788999999999999865 578899999985443 3467899999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 82 ENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999998642 46899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
. .....++..|+|||......++.++||||+|+++++|++|+.|+.... .... .... .....
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----------~~~~-~~~~-~~~~~----- 216 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----------PMAA-LFRI-VQDDH----- 216 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----------HHHH-HHHH-hccCC-----
Confidence 1 233457889999999988888999999999999999999999986422 0000 1111 11111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+.+ +....+.+.+++.+|++.+|++||++.+++.
T Consensus 217 ~~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPL----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCC----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111 1122357889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=288.16 Aligned_cols=249 Identities=25% Similarity=0.419 Sum_probs=198.7
Q ss_pred HhcccccccccCcceEEEEEecCCc-EEEEEEec-CcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDER-VVAVKRLE-GVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~~-~vavK~l~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.+++..+||.|+||.|||++.++.. ..|.|.+. ......++|.-|++||....||+||++++.+...+.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 3556778999999999999976543 45667776 333445789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
||-++..+.. -+..|...++.-+..+++.||.|||++. |||||||+.|||++-+|.++|+|||.+..... ...
T Consensus 113 GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~q 185 (1187)
T KOG0579|consen 113 GGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQ 185 (1187)
T ss_pred CchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HHh
Confidence 9999988765 4567999999999999999999999998 99999999999999999999999999875432 123
Q ss_pred cccccccCCCccchhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 671 KFSRVRGTRGYLAPEWMM-----NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
....+.||+.|||||+++ ..+|+.++|||||||+|.||..+.+|..... ... +.-++......
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-----------pMR-VllKiaKSePP 253 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-----------PMR-VLLKIAKSEPP 253 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-----------hHH-HHHHHhhcCCC
Confidence 334578999999999874 6789999999999999999999998864322 111 11222222222
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.++.| ..-.....+++..||..||..||++.++++
T Consensus 254 TLlqP-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 254 TLLQP-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cccCc-------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 22221 223346778999999999999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=281.35 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=192.1
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EHKLLVY 586 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 586 (804)
.+.+.+.||+|+||.||+|... +++.||+|.++.... ....+.+|+.++++++|+||+++++++... +..++|+
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 4566788999999999999965 588999999873322 223567899999999999999999998755 4689999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+.+ +|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 88 e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 88 EYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred ecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 99975 888888642 356899999999999999999999999 99999999999999999999999999987654
Q ss_pred cCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc---
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE--- 742 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 742 (804)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+.......
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--------~~~~~~~~~~~~~~~~~ 231 (309)
T cd07845 161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--------IEQLDLIIQLLGTPNES 231 (309)
T ss_pred ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhcCCCChh
Confidence 321 2222345778999999865 4578999999999999999999999864221 01111111110000
Q ss_pred --------Cccccc--CCcCCCcc---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 743 --------GLEKII--DPRLNDVY---DREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 743 --------~~~~~~--d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...... ........ .......+.+++.+|++.||++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 00000000 00123456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=276.08 Aligned_cols=257 Identities=22% Similarity=0.334 Sum_probs=191.5
Q ss_pred cccccccccCcceEEEEEecC-CcEEEEEEecCcCCC---hHHHHHHHHHHhcC---CCCcccceeeeEEeCCe-----e
Q 038103 515 NFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQG---DAEFWAEVSIIGRI---NHRNLVKLQGFCAENEH-----K 582 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~~---~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~-----~ 582 (804)
.+.+.||+|+||.||+|+... ++.+|+|+++..... ...+.+|+.++.++ +|+|++++++++..... .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 456789999999999999764 889999999733221 24566787776655 69999999999988776 8
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
+++|||+.+ +|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred EEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999975 8988886532 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh-
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ- 741 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 741 (804)
....... .....++..|+|||.+.+..++.++||||||++++||++|+.||...... ..+.. +......
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-------~~~~~-~~~~~~~~ 225 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-------DQLDK-IFDVIGLP 225 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-------HHHHH-HHHHcCCC
Confidence 7644322 12334688899999999989999999999999999999999888642210 01111 1110000
Q ss_pred cCc---------ccccCCcCC---CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 742 EGL---------EKIIDPRLN---DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 742 ~~~---------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
... ......... .....+....+.+++.+|++.+|.+||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 000000000 1111223467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=277.70 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=193.3
Q ss_pred hcccccccccCcceEEEEEecC-CcEEEEEEecCc------CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGV------LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
|.+.++||+|+||.||+++... +..+++|.++.. .....++..|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5667899999999999998643 344555555421 122345678999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++++|..++.........+++..+..++.|+++||.|||+.+ ++|+||+|+||+++. +.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999998654334567999999999999999999999998 999999999999976 4699999999986543
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
... ......++..|+|||.+....++.++|+||||+++++|++|+.|+.... ........ ..+.
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----------~~~~~~~~-~~~~--- 221 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----------FLSVVLRI-VEGP--- 221 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHHHH-HcCC---
Confidence 222 2223457889999999988889999999999999999999999985311 11111111 1111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+. .+......+.+++.+|++.+|++||++.++++
T Consensus 222 --~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 --TPS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111 12233457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=288.04 Aligned_cols=265 Identities=21% Similarity=0.322 Sum_probs=196.5
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCc---CCChHHHHHHHHHHhcCCCCcccceeeeEEeC-----CeeE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV---LQGDAEFWAEVSIIGRINHRNLVKLQGFCAEN-----EHKL 583 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 583 (804)
.|.+.+.||+|+||.||+++. .+++.||||.+... .....++.+|+.++++++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 355567899999999999995 46889999998743 22345677899999999999999999988654 3579
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+|+||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 86 IVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 9999996 588888853 345899999999999999999999998 99999999999999999999999999986
Q ss_pred ccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh--
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME-- 740 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 740 (804)
..... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... ...........
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~ 228 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--------HQLKLITELLGSP 228 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--------HHHHHHHHHhCCC
Confidence 54322 22233457889999998865 46899999999999999999999998642100 00000000000
Q ss_pred ---------hcC-------cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hccCCCC
Q 038103 741 ---------QEG-------LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL--LTAHDHE 795 (804)
Q Consensus 741 ---------~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~--L~~~~~~ 795 (804)
... +....++.... ........+.+++.+|++.+|++||+++++++. ++.+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred ChHHhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 000 00000110000 011234568899999999999999999999976 6555443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=306.27 Aligned_cols=244 Identities=26% Similarity=0.408 Sum_probs=183.3
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEe----------------
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAE---------------- 578 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------------- 578 (804)
+.||+||||.|||++.+ ||+.+|||++... ......+.+|++.+++|+|||+|+++..+.+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 35999999999999965 7999999999744 3334568899999999999999998844200
Q ss_pred --------------------------------------------------------------------------------
Q 038103 579 -------------------------------------------------------------------------------- 578 (804)
Q Consensus 579 -------------------------------------------------------------------------------- 578 (804)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ---------------C--------CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcE
Q 038103 579 ---------------N--------EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWV 635 (804)
Q Consensus 579 ---------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i 635 (804)
+ ..+||-||||+..+|.+++.++.-. -.-...++++.+|++||+|+|+++ |
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaYIH~~g---i 718 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAYIHDQG---I 718 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHHHHhCc---e
Confidence 0 1347889999987888877543211 145678899999999999999999 9
Q ss_pred EecccccCeEEEcCCCCeEEeecCCccccc----c-------------cCCccccccccCCCccchhhhccC---CCCcc
Q 038103 636 LHCDVKPQNILLDDHFEPKVTDFGLSKLFK----E-------------RHDTKFSRVRGTRGYLAPEWMMNL---KIDAK 695 (804)
Q Consensus 636 vH~Dlkp~NILl~~~~~~kl~Dfgla~~~~----~-------------~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k 695 (804)
|||||||.||+++++..+||+|||+|.... . ......+...||.-|+|||++.+. +|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999999721 0 111234567899999999998754 59999
Q ss_pred cchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCC
Q 038103 696 ADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAEN 775 (804)
Q Consensus 696 ~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~ 775 (804)
+|+||+||+++||+. ||+..- -...+...++.+.+..- ..+..++...=.+++.|+++.|
T Consensus 799 iDmYSLGIVlFEM~y---PF~TsM-----------ERa~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTSM-----------ERASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCchH-----------HHHHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCC
Confidence 999999999999986 454210 11112233333333322 1223334445568999999999
Q ss_pred CCCCCCHHHHHH
Q 038103 776 RDTRPPMSKVVK 787 (804)
Q Consensus 776 P~~RPtm~~Vv~ 787 (804)
|.+|||+.|+++
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 999999999874
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=280.12 Aligned_cols=240 Identities=28% Similarity=0.387 Sum_probs=188.6
Q ss_pred cccccccCcceEEEEEec-CCcEEEEEEecCcCC----ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 517 KQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ----GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
.++||+|+||.||+|+.. +++.|++|++..... ...++.+|++++++++|+|++++++++.+....++|+||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 467999999999999964 578899999863222 22467889999999999999999999999999999999996
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 105 ~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 105 GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 577777754 2346899999999999999999999998 99999999999999999999999999874322
Q ss_pred ccccccCCCccchhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 672 FSRVRGTRGYLAPEWMM---NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.....++..|+|||++. ...++.++||||||+++|||++|+.|+..... ....... .........
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----------~~~~~~~-~~~~~~~~~ 241 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHI-AQNDSPTLQ 241 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHH-HhcCCCCCC
Confidence 22346788999999974 45688999999999999999999999854220 1111111 111111111
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
. ......+.+++.+|++.+|.+||++.++++.
T Consensus 242 ~--------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 S--------NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred c--------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1122357889999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=280.68 Aligned_cols=245 Identities=22% Similarity=0.328 Sum_probs=197.7
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEe
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 587 (804)
|.+.+.||+|+||.||+++.. +++.||+|.+... ....+.+.+|++++.+++ |+||+++++++......++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 456788999999999999965 6889999998742 223466888999999998 9999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
++++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 83 YAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999642 36999999999999999999999998 999999999999999999999999999876543
Q ss_pred CC-------------------ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccch
Q 038103 668 HD-------------------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYC 728 (804)
Q Consensus 668 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~ 728 (804)
.. .......++..|+|||.+....++.++||||||++++++++|+.|+.... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~- 227 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-------E- 227 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-------H-
Confidence 21 12223457889999999988889999999999999999999999986432 0
Q ss_pred hhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 038103 729 NHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPM----SKVVK 787 (804)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm----~~Vv~ 787 (804)
.... ...... ....+......+.+++.+|++.+|++||++ +++++
T Consensus 228 ~~~~----~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 YLTF----QKILKL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHH----HHHHhc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0011 111110 001111224578999999999999999999 76654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=277.46 Aligned_cols=249 Identities=24% Similarity=0.301 Sum_probs=193.6
Q ss_pred hcccccccccCcceEEEEEe----cCCcEEEEEEecCcC-----CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeE
Q 038103 514 RNFKQEVGKGGFGSVFRGVL----DDERVVAVKRLEGVL-----QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 583 (804)
+.+.+.||+|+||.||++.. .+++.||+|++.... ...+++.+|++++.++ +|+||+++++.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 34567899999999999985 367899999987422 2235678899999999 5999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+|+||+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++|+||+|+|||++.++.+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 82 LILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999864 245788899999999999999999988 99999999999999999999999999987
Q ss_pred ccccCCccccccccCCCccchhhhccC--CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNL--KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
.............++..|+|||.+... .++.++||||||+++|+|++|+.|+...... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~~~~~~~~~~~~ 227 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-------NSQAEISRRILKS 227 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-------ccHHHHHHHhhcc
Confidence 654333333345688999999998753 4678999999999999999999998642110 0111111111111
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
.+. .+......+.+++.+|++.+|++|| ++.++.+
T Consensus 228 -------~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 -------EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 011 1112234678999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=285.51 Aligned_cols=244 Identities=24% Similarity=0.335 Sum_probs=198.7
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCCh---HHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGD---AEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
-|.+...||+|.|++|..++.. .+..||||.+.++.-+. ..+.+|+++|..++|||||+++.+......+|+||||
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 3556788999999999999954 58899999998655432 4478999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
..+|.+.++|..+ ..+.......++.|+.+|++|+|+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 137 a~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 137 ASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred ccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc--
Confidence 9999999999753 33555788899999999999999999 99999999999999999999999999998874
Q ss_pred CccccccccCCCccchhhhccCCC-CcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.......+|++.|.|||++.+.+| .+++|+||+|++||-|++|..||+.-.-. .+. ...
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------~Lr------------~rv 267 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------ELR------------PRV 267 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--------ccc------------chh
Confidence 344556789999999999998876 57999999999999999999999852200 000 001
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+-.+++- +.-....+.+|+.+.+-.+|.+|++++++.+
T Consensus 268 l~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 268 LRGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeeeecc--cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1111111 1111235678888899999999999999864
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=285.03 Aligned_cols=265 Identities=17% Similarity=0.294 Sum_probs=194.6
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEe----CCeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAE----NEHKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 583 (804)
..+.+.+.||+|+||.||+++.. +++.||+|++.... .....+.+|+.++.+++|+||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 34556678999999999999954 58899999987432 234567889999999999999999998753 34689
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+|+||+. ++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999996 589888853 344899999999999999999999988 99999999999999999999999999986
Q ss_pred ccccCCc---cccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHH------
Q 038103 664 FKERHDT---KFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQ------ 733 (804)
Q Consensus 664 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~------ 733 (804)
....... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||....... ....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~----~~~~~~~~~g~~~ 232 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH----QLKLILSVLGSPS 232 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH----HHHHHHHHhCCCh
Confidence 5442221 1223467889999999865 468899999999999999999999996422100 0000000
Q ss_pred -HHHHHhhhcCcccccCC---cCC---CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 734 -WVAKQMEQEGLEKIIDP---RLN---DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 734 -~~~~~~~~~~~~~~~d~---~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...+......+.+..+. ... ..........+.+++..|++.+|++||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000111110000 000 00112235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=273.72 Aligned_cols=241 Identities=23% Similarity=0.308 Sum_probs=185.5
Q ss_pred cccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHH---HHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 519 EVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVS---IIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.||+|+||.||++... +++.||+|.+.... .....+..|.. .++...|++|+++++.+.+.+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999864 57899999886432 11223444443 3445579999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|..++.. ...+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++..+.....
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 9999998853 346899999999999999999999988 99999999999999999999999999986543221
Q ss_pred cccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 671 KFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
....|+..|+|||.+..+ .++.++||||+|+++|||++|+.||....... . ......... .+
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~--------~-~~~~~~~~~------~~ 215 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--------K-HEIDRMTLT------MA 215 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc--------h-HHHHHHhhc------cC
Confidence 234588999999998754 68999999999999999999999986432110 0 001111100 11
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVKL 788 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~~ 788 (804)
..+... ....+.+++.+|++.+|.+|| ++.++++.
T Consensus 216 ~~~~~~----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 216 VELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCCc----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 111111 234788999999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=275.24 Aligned_cols=256 Identities=23% Similarity=0.304 Sum_probs=195.4
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.+.+.||+|+||.||+|+.. +++.+|+|.+.... ...+.+..|+.++++++|+|++++++++.+....++|+||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 34577999999999999965 48899999998532 234678889999999999999999999999999999999998
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
++|.+++... ...+++..+..++.++++||+|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 82 -~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 82 -MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred -cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 4999999653 246899999999999999999999998 99999999999999999999999999987644322
Q ss_pred cccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh---------
Q 038103 671 KFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME--------- 740 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 740 (804)
......++..|+|||.+... .++.++||||||++++||++|+.||...... .....+.....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--------DQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHHHhCCCcHHHHHh
Confidence 22233456789999998776 7899999999999999999999998542210 00000000000
Q ss_pred -------hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 741 -------QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 741 -------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.............. ........+.+++..|++.+|++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hcccccccccccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000000 01112457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=257.56 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=192.2
Q ss_pred cccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 517 KQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
...||.|..|.|+|.+.+ .|..+|||.+..+.. +.+++.+.+.++.+-+ +|.||+.+|+|..+....+.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 467999999999999965 488999999985433 3456777888777765 89999999999999999999999965
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 672 (804)
.++.++.. ...++++..+-++...+++||.||.++.. |+|||+||+|||+|+.|++|++|||++..+-+. ...
T Consensus 176 C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAh 248 (391)
T KOG0983|consen 176 CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAH 248 (391)
T ss_pred HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeecc--ccc
Confidence 67777765 34457888888999999999999998764 999999999999999999999999999876553 233
Q ss_pred cccccCCCccchhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 673 SRVRGTRGYLAPEWMMN---LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~~---~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
+...|.+.|||||.+.. ..|+.++||||||+.|+||.||+.||..-.. -.+.+... .+.. .
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t----------dFe~ltkv-ln~e-P---- 312 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT----------DFEVLTKV-LNEE-P---- 312 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc----------cHHHHHHH-HhcC-C----
Confidence 44568899999999864 4688899999999999999999999975321 11112222 1111 1
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
|.+.+.. .......+++..||+.|+.+||...++++.
T Consensus 313 P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2222211 123467889999999999999999998753
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=283.02 Aligned_cols=262 Identities=23% Similarity=0.371 Sum_probs=190.9
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeC------CeeE
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN------EHKL 583 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 583 (804)
+...+.||+|+||.||+|+. .+++.||||++.... .....+.+|+.++++++|+||+++++++... ...+
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 33456799999999999995 468899999987432 2235678999999999999999999998754 3468
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+|+||+.. +|..++. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 97 lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 97 LVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 99999965 6766552 24788999999999999999999998 99999999999999999999999999986
Q ss_pred ccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHH------
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVA------ 736 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------ 736 (804)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+.....
T Consensus 167 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~ 235 (342)
T cd07879 167 ADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-------DQLTQILKVTGVPG 235 (342)
T ss_pred CCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHhcCCCC
Confidence 432 1223456888999999876 46889999999999999999999999642210 00000000
Q ss_pred ----HHhhhcCcccccC--Cc-CCCcc---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hccCCCCC
Q 038103 737 ----KQMEQEGLEKIID--PR-LNDVY---DREKLDRMVKVALLCVAENRDTRPPMSKVVKL--LTAHDHES 796 (804)
Q Consensus 737 ----~~~~~~~~~~~~d--~~-l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~--L~~~~~~~ 796 (804)
............. +. ..... .......+.+++.+|++.+|++||++.++++. ++...+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 0000000000000 00 00000 01123467899999999999999999999844 66665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=280.15 Aligned_cols=261 Identities=23% Similarity=0.303 Sum_probs=190.6
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCC-------
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENE------- 580 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 580 (804)
..+.+.++||+|+||.||+|+.. +++.+|||++..... ....+.+|++++++++|+||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 34666788999999999999965 578899999863221 2346788999999999999999999875433
Q ss_pred -eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 581 -HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 581 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
..++|+||+.. +|...+.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999875 67777654 2346899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccCCc----------cccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccch
Q 038103 660 LSKLFKERHDT----------KFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYC 728 (804)
Q Consensus 660 la~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~ 728 (804)
++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~------- 233 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI------- 233 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-------
Confidence 99865432211 11234567889999987654 5889999999999999999999998642210
Q ss_pred hhHHHHHHHHhhh---------cCccccc----CCcCCCcc---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 729 NHLVQWVAKQMEQ---------EGLEKII----DPRLNDVY---DREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 729 ~~~~~~~~~~~~~---------~~~~~~~----d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...+........ ..+.... ........ .......+.+++.+|++.+|++|||+.++++
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 234 -DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred -HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000111110000 0000000 00000000 0112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=269.69 Aligned_cols=257 Identities=23% Similarity=0.307 Sum_probs=203.3
Q ss_pred HHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeC-Ce
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN-EH 581 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~ 581 (804)
+.+...+..+-+|.||.||+|.++ +.+.|-||.++... .....+..|.-++..+.|||+..+.+++.+. ..
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 444455567999999999999754 34567788776322 2335678888899999999999999999765 46
Q ss_pred eEEEEeeccCCChhhhhcc----CCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEee
Q 038103 582 KLLVYEYVENGSLDKLLFN----DPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTD 657 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~----~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 657 (804)
.+.+|.++.-|+|..||.. .+.....++..+...++.|++.|++|||.++ |+|.||.++|.+||+..++||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEecc
Confidence 7899999999999999972 2334566788889999999999999999999 99999999999999999999999
Q ss_pred cCCcccccc-cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHH
Q 038103 658 FGLSKLFKE-RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWV 735 (804)
Q Consensus 658 fgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 735 (804)
=.+++.+-. +...-....-....||+||.+....|+.++||||||++||||+| |+.|+...++ ..+
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------------fEm 507 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------------FEM 507 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH------------HHH
Confidence 999986433 33222223335678999999999999999999999999999999 9999864331 112
Q ss_pred HHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 736 AKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 736 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
..++++| .+-..+.++++++..++.=||...|++||+.+|+++-|..
T Consensus 508 ~~ylkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 508 EHYLKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHHhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 2233332 2223355677889999999999999999999999998864
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=282.36 Aligned_cols=256 Identities=22% Similarity=0.265 Sum_probs=191.6
Q ss_pred ccccccccCcceEEEEEec-CCcEEEEEEecCcCCC---------------hHHHHHHHHHHhcCCCCcccceeeeEEeC
Q 038103 516 FKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG---------------DAEFWAEVSIIGRINHRNLVKLQGFCAEN 579 (804)
Q Consensus 516 ~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~---------------~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 579 (804)
+.+.||+|+||.||+++.. +++.||||.++..... ...+.+|++++++++|+||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3467999999999999965 6889999998643221 12477899999999999999999999999
Q ss_pred CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
...++||||+. ++|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcc
Confidence 99999999997 589988853 345889999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccC-------------CccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCc
Q 038103 660 LSKLFKERH-------------DTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDS 725 (804)
Q Consensus 660 la~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~ 725 (804)
++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~----- 239 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE----- 239 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence 998664110 1111223467889999998764 478999999999999999999999864321
Q ss_pred cchhhHHHHHHHHhhhcCcc---c------------ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 726 SYCNHLVQWVAKQMEQEGLE---K------------IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~---~------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
......+.......... . ...+.+.. ........+.+++..|++.+|++||++.+++..
T Consensus 240 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 ---IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred ---HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 01111111111110000 0 00000000 011124568899999999999999999999863
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=264.67 Aligned_cols=263 Identities=27% Similarity=0.366 Sum_probs=199.3
Q ss_pred CccccchHHHHHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcC-CCCcccceeee
Q 038103 500 GFKRFTYAELKRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRI-NHRNLVKLQGF 575 (804)
Q Consensus 500 ~~~~~~~~~l~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~ 575 (804)
....|+-++|.. ...||.|+||+|+|-.++ .|+..|||+++... .++.++..|.+...+- +.||||+++|.
T Consensus 57 ~~~~F~~~~Lqd-----lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 57 HLHTFTSDNLQD-----LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccccchHHH-----HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 345566666655 357999999999999964 68999999998433 4567788898876555 79999999999
Q ss_pred EEeCCeeEEEEeeccCCChhhhhccC-CCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeE
Q 038103 576 CAENEHKLLVYEYVENGSLDKLLFND-PGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPK 654 (804)
Q Consensus 576 ~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 654 (804)
+..++.-++.||.|+- ||+.+-... ......+++.-+-.|....+.||.||.+.-. |||||+||+|||++..|.+|
T Consensus 132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEe
Confidence 9999999999999976 776654211 1134568888888899999999999998754 99999999999999999999
Q ss_pred EeecCCcccccccCCccccccccCCCccchhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHH
Q 038103 655 VTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN--LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLV 732 (804)
Q Consensus 655 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~ 732 (804)
|+|||++..+.... ..+.-.|...|||||.+.. ..|..++||||||++|+|+.||+.|+.... .+.
T Consensus 209 LCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~----------svf 276 (361)
T KOG1006|consen 209 LCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD----------SVF 276 (361)
T ss_pred eecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH----------HHH
Confidence 99999998765422 2334467889999999863 358899999999999999999999986422 222
Q ss_pred HHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 733 QWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+.+.. +..++...+..+. ...+....+..++..|+..|..+||...++.+
T Consensus 277 eql~~-Vv~gdpp~l~~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 277 EQLCQ-VVIGDPPILLFDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHH-HHcCCCCeecCcc----cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 32222 2223222222111 11223457889999999999999999998864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=269.32 Aligned_cols=239 Identities=21% Similarity=0.285 Sum_probs=183.0
Q ss_pred ccccc--ccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeecc
Q 038103 515 NFKQE--VGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 515 ~~~~~--LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.+.+. ||+|+||.||++... +++.+|+|.+........ |+.....+ +|+|++++++.+...+..++||||++
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~ 92 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIK 92 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCC
Confidence 34444 599999999999964 578899998864322221 22222222 79999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC-CeEEeecCCcccccccCC
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF-EPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~ 669 (804)
+++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++ .++|+|||++......
T Consensus 93 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 93 DGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 99999999642 36899999999999999999999998 99999999999999998 9999999998865432
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
....++..|+|||.+....++.++||||||++++||++|+.||....... .....+... . .. ..
T Consensus 164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-~-~~---~~-- 227 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE------LDLESLLKR-Q-QK---KL-- 227 (267)
T ss_pred ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch------hhHHHHHHh-h-cc---cC--
Confidence 12357889999999998899999999999999999999999997322110 011111111 1 00 00
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPP-MSKVVK 787 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-m~~Vv~ 787 (804)
.........+.+++.+|++.+|.+||+ ++++++
T Consensus 228 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 -----PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 001123346889999999999999996 688874
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=288.26 Aligned_cols=196 Identities=33% Similarity=0.512 Sum_probs=170.0
Q ss_pred cccccccCcceEEEEEe-cCCcEEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEeC------CeeEEEEe
Q 038103 517 KQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAEN------EHKLLVYE 587 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E 587 (804)
.+.||+|+||.||+|+. ..|+.||||.++.. ....+...+|++++++++|+|||+++++=.+. ....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 56799999999999995 56999999999853 34557788999999999999999999985543 35689999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE--cCCC--CeEEeecCCccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL--DDHF--EPKVTDFGLSKL 663 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl--~~~~--~~kl~Dfgla~~ 663 (804)
||.+|+|+..|.. |....-|+....+.+..+++.||.|||+++ |+||||||.||++ .+++ .-||+|||.|+.
T Consensus 98 yC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 98 YCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred ecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 9999999999975 345556999999999999999999999988 9999999999998 2333 469999999998
Q ss_pred ccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCccc
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYL 718 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~ 718 (804)
+.++. ......||..|.+||.+.. ..|+...|.|||||++||.+||..||...
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 77644 5667889999999999984 78999999999999999999999999753
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=280.88 Aligned_cols=265 Identities=22% Similarity=0.322 Sum_probs=200.5
Q ss_pred hcccccccccCcceEEEEEecC-CcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCC-----eeEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENE-----HKLL 584 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~l 584 (804)
+.+.+.||+|+||.||+++... ++.+|||++.... ...+.+.+|+.++++++|+||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 5567889999999999999754 8899999987533 23467889999999999999999999998775 7899
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
++||+++ +|.+++.. ...+++..+..++.++++||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 82 v~e~~~~-~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 82 VTELMET-DLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred Eecchhh-hHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999985 88888854 237899999999999999999999998 999999999999999999999999999976
Q ss_pred cccCC--ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh-
Q 038103 665 KERHD--TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME- 740 (804)
Q Consensus 665 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 740 (804)
..... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||...... .....+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~~ 225 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--------DQLNLIVEVLGT 225 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--------HHHHHHHHhcCC
Confidence 55331 223344578899999999887 7899999999999999999999998643210 00000000000
Q ss_pred ----------hcCcccccC---CcCC---CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hccCCC
Q 038103 741 ----------QEGLEKIID---PRLN---DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL--LTAHDH 794 (804)
Q Consensus 741 ----------~~~~~~~~d---~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~--L~~~~~ 794 (804)
.......+. .... ..........+.+++.+||+.+|++||++.++++. +++...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000000 0000 00011134568899999999999999999999874 544433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=275.03 Aligned_cols=243 Identities=24% Similarity=0.336 Sum_probs=194.8
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEecC----cCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEG----VLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
..-..||+||||.||-.+.+ +|+.+|.|++.+ ..+++.-..+|-.+|.+++.+.||.+--.+...+.++||+..|
T Consensus 188 ~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM 267 (591)
T KOG0986|consen 188 RVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM 267 (591)
T ss_pred eeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence 33467999999999999855 589999998863 3456667888999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
.+|+|.-+|.+.. ..-++.....-++.+|+-||++||.+. ||.||+||+|||+|+.|+++|+|+|||..+.....
T Consensus 268 NGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 268 NGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred cCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence 9999999998753 245888899999999999999999998 99999999999999999999999999998766443
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
. ....||.+|||||++..+.|+...|.||+||+||||+.|+.||..... +.+.+.+...+-
T Consensus 343 ~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-----------------Kvk~eEvdrr~~ 403 (591)
T KOG0986|consen 343 I--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-----------------KVKREEVDRRTL 403 (591)
T ss_pred c--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-----------------hhhHHHHHHHHh
Confidence 2 334799999999999999999999999999999999999999964321 111111111000
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPM 782 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 782 (804)
. -...++....+....|....|+.||.+|..-
T Consensus 404 ~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 404 E-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred c-chhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 0 0112233344456677777888999998643
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=281.17 Aligned_cols=263 Identities=21% Similarity=0.246 Sum_probs=188.1
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeC----------
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN---------- 579 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------- 579 (804)
.++.+.+.||.|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++|+||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 34666788999999999999964 58899999987433 3456788999999999999999999776543
Q ss_pred ----CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc-CCCCeE
Q 038103 580 ----EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD-DHFEPK 654 (804)
Q Consensus 580 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~k 654 (804)
...++|+||++ ++|.+++.. ..+++.....++.||++||.|||+.+ |+||||||+||+++ ++..+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 488888743 35889999999999999999999998 99999999999997 456789
Q ss_pred EeecCCcccccccCCc--cccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhH
Q 038103 655 VTDFGLSKLFKERHDT--KFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHL 731 (804)
Q Consensus 655 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~ 731 (804)
|+|||++......... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||....... .....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~----~~~~~ 231 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE----QMQLI 231 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH
Confidence 9999999865432211 1122356888999998754 568889999999999999999999996432100 00000
Q ss_pred HHH-------HHHHhhhcCcccccCCcCCC-----ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 732 VQW-------VAKQMEQEGLEKIIDPRLND-----VYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 732 ~~~-------~~~~~~~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..- .................... .........+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 00000000000000000000 001112346889999999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=309.64 Aligned_cols=242 Identities=29% Similarity=0.395 Sum_probs=193.4
Q ss_pred ccccccCcceEEEEE-ecCCcEEEEEEecC---cCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCC
Q 038103 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEG---VLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGS 593 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~-~~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 593 (804)
.+||.|.||.||-+. .++|...|+|-++. .....+...+|+.++..++|||+|+++|+=.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 469999999999999 55688899997762 22344678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC---c
Q 038103 594 LDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD---T 670 (804)
Q Consensus 594 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~---~ 670 (804)
|.+.+.. +...++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|..+..... .
T Consensus 1321 La~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1321 LASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9999964 444566666678899999999999999 99999999999999999999999999998766432 3
Q ss_pred cccccccCCCccchhhhccC---CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHH-HHHhhhcCccc
Q 038103 671 KFSRVRGTRGYLAPEWMMNL---KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV-AKQMEQEGLEK 746 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~---~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 746 (804)
......||+.|||||.+.+. ....++||||+||+.+||+||++|+.... .+|+ +.++.-|...+
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d------------ne~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD------------NEWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc------------chhHHHhHHhccCCCC
Confidence 34467899999999999754 35568999999999999999999986433 1222 22222222222
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+ +......-.+++.+|++.||++|-++.|+++
T Consensus 1462 -----~----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1462 -----I----PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred -----C----chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1 2223445678999999999999977765554
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=267.96 Aligned_cols=235 Identities=27% Similarity=0.338 Sum_probs=190.7
Q ss_pred ccccCcceEEEEEec-CCcEEEEEEecCcCC----ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCCh
Q 038103 520 VGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ----GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 520 LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
||+|+||.||++... +++.+|+|.+..... ..+++..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 488999999874322 345788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccccc
Q 038103 595 DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR 674 (804)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 674 (804)
.+++... ..+++.....++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 9999642 35899999999999999999999988 9999999999999999999999999998764432 12334
Q ss_pred cccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCC
Q 038103 675 VRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLND 754 (804)
Q Consensus 675 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 754 (804)
..++..|+|||...+...+.++|+||||+++||+++|+.||..... ... ........ ..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~----~~~~~~~~------~~--- 211 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEI----YEKILKDP------LR--- 211 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHH----HHHHhcCC------CC---
Confidence 5678899999999888899999999999999999999999864220 011 11111110 11
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 038103 755 VYDREKLDRMVKVALLCVAENRDTRPPMSK 784 (804)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~ 784 (804)
.+......+.+++.+|++.+|++||++.+
T Consensus 212 -~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 212 -FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11112456889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=277.72 Aligned_cols=265 Identities=21% Similarity=0.313 Sum_probs=191.6
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCC------ee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENE------HK 582 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~ 582 (804)
+|.+.+.||+|+||.||++.. .+++.||||++..... ....+.+|+.++++++|+||+++++++.... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 455667899999999999985 4688999999864322 2356789999999999999999999987543 45
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++|+||+ +++|..++.. ..+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 96 ~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred EEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 8999998 6689888743 35889999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccch----hhHHHHHHH
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYC----NHLVQWVAK 737 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~----~~~~~~~~~ 737 (804)
..... .....++..|+|||.+.. ..++.++|+||||++++++++|+.||............. .....+ ..
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~ 241 (343)
T cd07880 167 QTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF-VQ 241 (343)
T ss_pred ccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH-HH
Confidence 65432 223456889999999876 458899999999999999999999986422100000000 000000 00
Q ss_pred HhhhcCc-------ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH--HHhccC
Q 038103 738 QMEQEGL-------EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVV--KLLTAH 792 (804)
Q Consensus 738 ~~~~~~~-------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv--~~L~~~ 792 (804)
.+..... .......+ ..........+.+++.+|++.+|++|||+.+++ ..++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0000000 00000000 000112234578999999999999999999998 344443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=277.48 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=190.1
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEe-CCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAE-NEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 587 (804)
.|.+.+.||.|+||.||++... +++.||||++.... ...+.+.+|++++.+++||||+++.+++.. ....++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 3555688999999999999854 68899999886322 234668899999999999999999999865 557899999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+ +++|..++.. ..+++.....++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 91 ~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 91 LL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred hh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 98 4589888843 34778888899999999999999998 999999999999999999999999999854321
Q ss_pred CCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH-------HHHHh
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW-------VAKQM 739 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~ 739 (804)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||....... ....+.+. ..+..
T Consensus 162 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 162 ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN----QFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred ----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCHHHHHhc
Confidence 123356788999998765 568999999999999999999999985422100 00000000 00000
Q ss_pred hhcCccccc-CCcCCCccC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 740 EQEGLEKII-DPRLNDVYD-----REKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 740 ~~~~~~~~~-d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
..+...+++ ........+ ......+.+++.+|++.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 000001111 1123578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=276.59 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=187.4
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeC------CeeE
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAEN------EHKL 583 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 583 (804)
+.+.+.||+|+||.||++.. .+++.||+|++..... ..+.+.+|+.++.+++|+||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 98 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence 44557899999999999985 5688999999874322 235678899999999999999999988643 3467
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||++..
T Consensus 99 lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 99 LVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred EEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccc
Confidence 888876 6799888743 35899999999999999999999998 99999999999999999999999999986
Q ss_pred ccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHH-------
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV------- 735 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 735 (804)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+....
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~ 238 (345)
T cd07877 170 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-------DQLKLILRLVGTPG 238 (345)
T ss_pred cccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHhCCCC
Confidence 4332 223457889999998866 56889999999999999999999998532210 0000000
Q ss_pred ---HHHhhhcC-------cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 736 ---AKQMEQEG-------LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 736 ---~~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...+.... +........... .......+.+++.+|++.+|.+||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000 000000000000 00123467899999999999999999998853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=277.88 Aligned_cols=257 Identities=22% Similarity=0.339 Sum_probs=190.2
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCe------eE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEH------KL 583 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~ 583 (804)
|.+.+.||+|+||.||+|+.. +++.||||++.... ...+++.+|+.++++++|+|++++++++..... .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 456678999999999999975 57889999986432 223567789999999999999999998766554 89
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 97 lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 97 LVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccc
Confidence 999998 5699998853 45899999999999999999999998 99999999999999999999999999986
Q ss_pred ccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHH-------HH
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQ-------WV 735 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~-------~~ 735 (804)
.... .....++..|+|||.+.. ..++.++||||||+++||+++|+.||....... ....+.. ..
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID----QLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHhcCCCCHHH
Confidence 5432 223456888999999865 367899999999999999999999986422100 0000000 00
Q ss_pred HHHhhhcCcccccCC---cCCCcc---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 736 AKQMEQEGLEKIIDP---RLNDVY---DREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 736 ~~~~~~~~~~~~~d~---~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...+.......++.. .-...+ .......+.+++.+|++.+|++|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000000000 000000 0112457889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=274.37 Aligned_cols=256 Identities=23% Similarity=0.298 Sum_probs=188.1
Q ss_pred hcccccccccCcceEEEEEec-C--CcEEEEEEecCcCC---ChHHHHHHHHHHhcC-CCCcccceeeeEEeC----Cee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-D--ERVVAVKRLEGVLQ---GDAEFWAEVSIIGRI-NHRNLVKLQGFCAEN----EHK 582 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~--~~~vavK~l~~~~~---~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~~ 582 (804)
+.+.+.||+|+||.||+++.. . +..||+|++..... ..+.+.+|+.++.++ +|+||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456788999999999999964 3 67899999874322 245678899999999 599999999976433 456
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++++|++. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 82 YLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 88888886 589888853 345889999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCC---ccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH
Q 038103 663 LFKERHD---TKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 663 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
....... .......|+..|+|||.+.+ ..++.++||||||++++++++|+.||...... .....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--------~~~~~~~~~ 225 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--------DQLNQILQV 225 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--------HHHHHHHHH
Confidence 6543222 11233568899999998765 46899999999999999999999998642210 000000000
Q ss_pred -----------hhhcC-------cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038103 739 -----------MEQEG-------LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVV 786 (804)
Q Consensus 739 -----------~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv 786 (804)
+.... ........+. .........+.+++.+|++.+|++||++.+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred hCCCCHHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000 0000000000 00111234688999999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=276.60 Aligned_cols=238 Identities=23% Similarity=0.297 Sum_probs=190.6
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeec
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
..+.+...+|.|+|+.|-++.. .+.+..+||++... ..+-.+|+.++... +|+||+++.+.+.++.+.++|||.+
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 4466777899999999999985 46788999999754 22334577666555 7999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE-cCCCCeEEeecCCcccccccC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL-DDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl-~~~~~~kl~Dfgla~~~~~~~ 668 (804)
.++-|.+.+...+ ... ..+..|+.+|+.|+.|||+++ ++||||||+|||+ ++.++++|+|||.++.....
T Consensus 399 ~g~ell~ri~~~~----~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 399 DGGELLRRIRSKP----EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred cccHHHHHHHhcc----hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9998877775432 122 677789999999999999999 9999999999999 68999999999999987665
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
....+-|..|.|||++....+++++|+||||++||+|++|+.||..-.. . ..+...+..+...
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~-------~----~ei~~~i~~~~~s--- 532 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA-------G----IEIHTRIQMPKFS--- 532 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc-------h----HHHHHhhcCCccc---
Confidence 2233458899999999999999999999999999999999999974221 1 1122222222222
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
....+...+|+.+||+.||.+||+|.++..
T Consensus 533 ---------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ---------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 233346789999999999999999999874
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=260.68 Aligned_cols=220 Identities=21% Similarity=0.171 Sum_probs=175.3
Q ss_pred cCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCChhhhhccC
Q 038103 523 GGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFND 601 (804)
Q Consensus 523 G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~ 601 (804)
|.+|.||+++.. +++.+|+|++.... ++..|...+....||||+++++++.+....++|+||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 889999999964 67899999987532 2334555566667999999999999999999999999999999998642
Q ss_pred CCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccccccccCCCc
Q 038103 602 PGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681 (804)
Q Consensus 602 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y 681 (804)
..+++.....++.|+++||+|||+.+ |+||||||+||+++.++.++++|||++...... .....++..|
T Consensus 80 ----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 80 ----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred ----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 34889999999999999999999998 999999999999999999999999988765432 1223456779
Q ss_pred cchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHH
Q 038103 682 LAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKL 761 (804)
Q Consensus 682 ~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 761 (804)
+|||.+....++.++||||+|+++|||++|+.|+...... ........+ +....
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------------------~~~~~~~~~----~~~~~ 202 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------------------INTHTTLNI----PEWVS 202 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------------------cccccccCC----cccCC
Confidence 9999998888999999999999999999999876431100 000000011 11123
Q ss_pred HHHHHHHHhcccCCCCCCCCHH
Q 038103 762 DRMVKVALLCVAENRDTRPPMS 783 (804)
Q Consensus 762 ~~l~~l~~~Cl~~~P~~RPtm~ 783 (804)
..+.+++.+|++.||++||++.
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCC
Confidence 4688999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=291.56 Aligned_cols=142 Identities=27% Similarity=0.362 Sum_probs=126.5
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCC----ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ----GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
|.+.++||+|+||.||+|... +++.||||+++.... ...++..|+.++..++|+||+++++.+......++||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 556788999999999999975 688999999974321 125688899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
+.+++|.+++.. ...+++...+.++.||+.||+|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999964 235788899999999999999999988 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=255.85 Aligned_cols=237 Identities=26% Similarity=0.371 Sum_probs=191.6
Q ss_pred CcceEEEEEecC-CcEEEEEEecCcCC-C-hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCChhhhhcc
Q 038103 524 GFGSVFRGVLDD-ERVVAVKRLEGVLQ-G-DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFN 600 (804)
Q Consensus 524 ~fg~Vykg~~~~-~~~vavK~l~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 600 (804)
+||.||+++..+ ++.+++|++..... . .+.+.+|++.+++++|+|++++++++......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 88999999974332 2 57899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccccccccCCC
Q 038103 601 DPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG 680 (804)
Q Consensus 601 ~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~ 680 (804)
.. .+++..++.++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 32 2889999999999999999999998 9999999999999999999999999999765532 2334557889
Q ss_pred ccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHH
Q 038103 681 YLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREK 760 (804)
Q Consensus 681 y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 760 (804)
|+|||.+....++.++||||||+++++|++|..|+.... . .....+............ ....
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-------~----~~~~~~~~~~~~~~~~~~-------~~~~ 213 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-------Q----LLELFKKIGKPKPPFPPP-------EWKI 213 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------c----HHHHHHHHhccCCCCccc-------cccC
Confidence 999999998889999999999999999999999986421 0 011111212111111000 0003
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 761 LDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 761 ~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...+.+++.+|+..+|++||++.++++
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhh
Confidence 357889999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=238.46 Aligned_cols=198 Identities=27% Similarity=0.384 Sum_probs=168.4
Q ss_pred cccccccCcceEEEEEe-cCCcEEEEEEecCc--CCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 517 KQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV--LQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
.++||+|++|.|-+-++ .+|+..|||++... .+.+++..+|+.+..+- .+|.+|+++|........++.||.|+.
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t- 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT- 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence 46799999999999985 57999999999844 34556788888876655 799999999999999999999999977
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 672 (804)
||+.+-...-..+..+++..+-+|+..++.||.|||++-. ++|||+||+||||+.+|++|++|||++..+.+.- ..
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi--Ak 205 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDSI--AK 205 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhhh--HH
Confidence 8888865544567789999999999999999999999865 9999999999999999999999999999875532 22
Q ss_pred cccccCCCccchhhhc----cCCCCcccchHHHHHHHHHHHhCCCCCcccc
Q 038103 673 SRVRGTRGYLAPEWMM----NLKIDAKADVYSYGIVLLELLTGKSASDYLS 719 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~----~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~ 719 (804)
+...|...|||||.+. ...|+.|+||||||+.+.||.+++.|++...
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 3345778899999885 3468999999999999999999999997543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=247.20 Aligned_cols=267 Identities=20% Similarity=0.325 Sum_probs=199.1
Q ss_pred chHHHHHHHhcccccccccCcceEEEEE-ecCCcEEEEEEecCcC-CChHHHHHHHHHHhcCC-CCcccceeeeEEeCCe
Q 038103 505 TYAELKRATRNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVL-QGDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEH 581 (804)
Q Consensus 505 ~~~~l~~~t~~~~~~LG~G~fg~Vykg~-~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 581 (804)
++.++-+-| .+.||+|+|+.|--++ +.++.++|||++.+.. ....+..+|++++.+.+ |+||+.++.+|.++..
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 345555444 3569999999999888 7889999999998653 34567889999999985 9999999999999999
Q ss_pred eEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC---eEEeec
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE---PKVTDF 658 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Df 658 (804)
.|||||-|.+|+|..+|+. ++.+++....++..+||.||.|||.++ |.|||+||+|||-..... +||+||
T Consensus 151 FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred EEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999974 456889999999999999999999999 999999999999865544 799999
Q ss_pred CCcccccccCC------ccccccccCCCccchhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCccccccc-C-C-
Q 038103 659 GLSKLFKERHD------TKFSRVRGTRGYLAPEWMM-----NLKIDAKADVYSYGIVLLELLTGKSASDYLSASA-S-D- 724 (804)
Q Consensus 659 gla~~~~~~~~------~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~-~-~- 724 (804)
.|..-...... .......|+..|||||++. ...|+.+.|.||||||||-|++|-.||......+ + +
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 98875433221 2233467899999999874 2357889999999999999999999997644221 1 1
Q ss_pred ccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 725 SSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
......=...+.+.+.+|.+ ++.|... ....+...+++...+-.++.+|.++.+|++
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkY-eFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKY-EFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCC-cCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11111111222333333322 2222211 112234445556666689999999998876
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=260.23 Aligned_cols=276 Identities=21% Similarity=0.288 Sum_probs=207.2
Q ss_pred cccchHHHHHHHhcccccccccCcceEEEEEecC-CcEEEEEEecCcCCChHHHHHHHHHHhcCCC--C----cccceee
Q 038103 502 KRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGDAEFWAEVSIIGRINH--R----NLVKLQG 574 (804)
Q Consensus 502 ~~~~~~~l~~~t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~g 574 (804)
..|...+....+|.+...+|+|.||.|-+...+. +..||||+++....-.+..+-|+++++++.+ | -+|.+.+
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 4566667778888899999999999999999654 6889999999776666777889999999942 2 3778888
Q ss_pred eEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc------
Q 038103 575 FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD------ 648 (804)
Q Consensus 575 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~------ 648 (804)
++.-.++.++|+|.| +-|+.++|..+ .-.+.+...+..|+.|++++++|||+.. ++|.||||+|||+-
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEE
Confidence 899999999999998 44899999763 4456778899999999999999999998 99999999999983
Q ss_pred --------------CCCCeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 038103 649 --------------DHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSA 714 (804)
Q Consensus 649 --------------~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p 714 (804)
.+..+||.|||.|..-.... +.+..|..|+|||++.+..++..+||||+||||.|+.||...
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 13458999999999754433 445678999999999999999999999999999999999998
Q ss_pred CcccccccC---CccchhhHHHHHHH------HhhhcCcc-----------cccCCcC----CCccCHHHHHHHHHHHHh
Q 038103 715 SDYLSASAS---DSSYCNHLVQWVAK------QMEQEGLE-----------KIIDPRL----NDVYDREKLDRMVKVALL 770 (804)
Q Consensus 715 ~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~~~-----------~~~d~~l----~~~~~~~~~~~l~~l~~~ 770 (804)
|..-...+. -...-..++..+.. ....+.+. ...++-. .......+...+++|+..
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 864221000 00000011111111 11111111 0000000 011234567789999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 038103 771 CVAENRDTRPPMSKVVK 787 (804)
Q Consensus 771 Cl~~~P~~RPtm~~Vv~ 787 (804)
+|..||.+|+|+.|+++
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 99999999999999875
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=250.13 Aligned_cols=196 Identities=26% Similarity=0.328 Sum_probs=171.0
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC----ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ----GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
++|.+.||+|.||+|-+++- ..++.+|+|++++... +.+.-..|-++|+..+||.+..+.-.+...++++.||||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 45668899999999999994 4689999999985432 223456688999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
..+|.|.-+|.+ ...++.....-.-..|+.||.|||+++ ||.||||.+|.|+|.+|++||+|||+++.--. .
T Consensus 250 anGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~ 321 (516)
T KOG0690|consen 250 ANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-Y 321 (516)
T ss_pred ccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc-c
Confidence 999999998853 455777777778899999999999988 99999999999999999999999999985322 2
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
...+..++||+.|+|||++....|..+.|.|.+||+||||++|+.||-.
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 3456678999999999999999999999999999999999999999964
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=281.12 Aligned_cols=258 Identities=19% Similarity=0.213 Sum_probs=167.3
Q ss_pred HHhcccccccccCcceEEEEEec-C----CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeee------EEeCC
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-D----ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGF------CAENE 580 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~----~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~~~~ 580 (804)
..+.+.+.||+|+||.||+|++. + +..||||++...... +....| .+....+.+++.++.. +..+.
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 34566788999999999999975 4 688999988642211 111111 1222223333332222 24566
Q ss_pred eeEEEEeeccCCChhhhhccCCCC----------------CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCe
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPGT----------------ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQN 644 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 644 (804)
..++|+||+.+++|.+++...... ........+..++.|++.||+|||+++ |+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHH
Confidence 889999999999999998642100 011123345679999999999999998 9999999999
Q ss_pred EEEcC-CCCeEEeecCCcccccccCCccccccccCCCccchhhhccC----------------------CCCcccchHHH
Q 038103 645 ILLDD-HFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL----------------------KIDAKADVYSY 701 (804)
Q Consensus 645 ILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~k~DV~S~ 701 (804)
||+++ ++.+||+|||+++.+............+++.|+|||.+... .+..++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 57999999999987655444444556789999999965322 23456799999
Q ss_pred HHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC-----cccccCCcCCCc----c--CHHHHHHHHHHHHh
Q 038103 702 GIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG-----LEKIIDPRLNDV----Y--DREKLDRMVKVALL 770 (804)
Q Consensus 702 Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~d~~l~~~----~--~~~~~~~l~~l~~~ 770 (804)
||+||||+++..+.+.. +.... ..+.... ....+.+..... + .........+|+.+
T Consensus 366 GviL~el~~~~~~~~~~------------~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN------------LIQFN-RQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred HHHHHHHHhCcCCCchH------------HHHHH-HHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 99999999977654321 00000 0000000 000111110000 0 00012245589999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 038103 771 CVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 771 Cl~~~P~~RPtm~~Vv~~ 788 (804)
|++.||++|||+.++++.
T Consensus 433 mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 433 MMRFKGRQRISAKAALAH 450 (566)
T ss_pred HccCCcccCCCHHHHhCC
Confidence 999999999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=273.29 Aligned_cols=264 Identities=19% Similarity=0.273 Sum_probs=178.4
Q ss_pred HHhcccccccccCcceEEEEEe-----------------cCCcEEEEEEecCcCCC-hHH--------------HHHHHH
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-----------------DDERVVAVKRLEGVLQG-DAE--------------FWAEVS 559 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-----------------~~~~~vavK~l~~~~~~-~~~--------------~~~E~~ 559 (804)
..+.+.++||+|+||.||+|.. .+++.||||++....+. .++ ...|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 3456678899999999999964 23567999998743321 222 334667
Q ss_pred HHhcCCCCcc-----cceeeeEEe--------CCeeEEEEeeccCCChhhhhccCCC--------------------CCC
Q 038103 560 IIGRINHRNL-----VKLQGFCAE--------NEHKLLVYEYVENGSLDKLLFNDPG--------------------TAS 606 (804)
Q Consensus 560 ~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~ 606 (804)
++.+++|.++ ++++++|.. ....+|||||+++++|.++++.... ...
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7777766654 778888753 3467999999999999999864211 112
Q ss_pred CCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccccccccCCCccchhh
Q 038103 607 ILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686 (804)
Q Consensus 607 ~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~ 686 (804)
.++|..+..++.|++++|+|||+.+ |+||||||+|||++.++.+||+|||++...............+++.|+|||.
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 3567888999999999999999988 9999999999999999999999999997654432222222334789999998
Q ss_pred hccCCC----------------------CcccchHHHHHHHHHHHhCCC-CCcccccccCC-ccchhhHHHHHHHHhhhc
Q 038103 687 MMNLKI----------------------DAKADVYSYGIVLLELLTGKS-ASDYLSASASD-SSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 687 ~~~~~~----------------------s~k~DV~S~Gvll~el~tg~~-p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 742 (804)
+..... ..+.||||+||+++||++|.. |+......... ......+..|. .....
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~~~ 459 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYKGQ 459 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhccc
Confidence 754321 134799999999999999875 55422110000 00011111111 11111
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCC---CCCCCHHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENR---DTRPPMSKVVKL 788 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P---~~RPtm~~Vv~~ 788 (804)
.. +-.. .....+...+|+..++..+| .+|+|++|+++.
T Consensus 460 ~~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KY----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CC----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11 1111 11123467788888888765 689999999853
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=224.96 Aligned_cols=191 Identities=27% Similarity=0.455 Sum_probs=162.7
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcCC--C-hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--G-DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGS 593 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 593 (804)
++||+|.||+|||++.. .++.||+|+++.... + .....+|+-+++.++|+|||++++....+..+.+|+|||.. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 67999999999999965 478899999874332 2 35678999999999999999999999999999999999976 8
Q ss_pred hhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcccc
Q 038103 594 LDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFS 673 (804)
Q Consensus 594 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 673 (804)
|..+... -...++......++.|+.+||.+.|+++ +.|||+||+|.||+.+|++|++|||+++.++-.- ...+
T Consensus 87 lkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-rcys 159 (292)
T KOG0662|consen 87 LKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYS 159 (292)
T ss_pred HHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-Eeee
Confidence 8888754 3456888889999999999999999999 9999999999999999999999999999776532 2333
Q ss_pred ccccCCCccchhhhccCC-CCcccchHHHHHHHHHHHh-CCCCCc
Q 038103 674 RVRGTRGYLAPEWMMNLK-IDAKADVYSYGIVLLELLT-GKSASD 716 (804)
Q Consensus 674 ~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvll~el~t-g~~p~~ 716 (804)
...-|..|++|+++.+.+ |++..|+||-||++.|+.. |+..|.
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 445689999999988765 8999999999999999998 554443
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=264.79 Aligned_cols=241 Identities=23% Similarity=0.368 Sum_probs=188.2
Q ss_pred cccccccCcceEEEEEec-CCcEEEEEEecCc---CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 517 KQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV---LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
.+.||+|.||+||-|+.+ +|+.||||.+.+. ...+.++++|+.||++++||.||.+.-.|+..+..++|||-+.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 357999999999999965 6999999999753 34567899999999999999999999999999999999999966
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC---CCeEEeecCCcccccccCC
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH---FEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~Dfgla~~~~~~~~ 669 (804)
++.+.|... +..+|+...-.-+..||+.||.|||.++ |+|+||||+|||+... -++||+|||.|++++....
T Consensus 648 DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 648 DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 555555432 4567888888888999999999999999 9999999999999644 4799999999999876433
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
...+.||+.|+|||+++...|+..-|+||.|||+|--++|..||+... . + .+++.+-.+. .
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE------d----I----ndQIQNAaFM--y- 783 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE------D----I----NDQIQNAAFM--Y- 783 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc------c----h----hHHhhccccc--c-
Confidence 235789999999999999999999999999999999999999996321 0 1 1111111110 0
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKV 785 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~V 785 (804)
....-.+.....++|+...+|..-.+|=+..+-
T Consensus 784 ---Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 784 ---PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred ---CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 111112233456677777777777777776554
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=272.86 Aligned_cols=250 Identities=22% Similarity=0.363 Sum_probs=206.0
Q ss_pred HhcccccccccCcceEEEEE-ecCCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEe-----CCeeEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAE-----NEHKLLV 585 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~-~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-----~~~~~lV 585 (804)
++.|.+.+|.|.+|.||+++ .++++.+|||++.-....++++..|.++++.+ .|||++.++|++.. ++.++||
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 45677899999999999999 56789999999987777788899999999988 69999999999863 5689999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
||||.+||..++++... +..+.|..+..|+..++.|+.+||... ++|||||-.|||+++++.+|+.|||++..+.
T Consensus 100 MEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 99999999999998764 677999999999999999999999988 9999999999999999999999999999765
Q ss_pred ccCCccccccccCCCccchhhhcc-----CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMN-----LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
... .......||+.|||||++.. ..|+..+|+||||++..||.-|..|+-.+.+. ..+
T Consensus 175 sT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------------raL-- 237 (953)
T KOG0587|consen 175 STV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------------RAL-- 237 (953)
T ss_pred ccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------------hhh--
Confidence 532 23345679999999999863 34677999999999999999999998543211 000
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+.-.-.|......+..-.+++.+++..|+..|-++||++.++++
T Consensus 238 ---F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 ---FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ---ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 00111222222235566778999999999999999999998875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=258.33 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=189.7
Q ss_pred HHHHHHhcccccccccCcceEEEEEecC-CcEEEEEEecCcC--CC--hHHHHHHHHHHhcC-CCCcccceeeeEEeCCe
Q 038103 508 ELKRATRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVL--QG--DAEFWAEVSIIGRI-NHRNLVKLQGFCAENEH 581 (804)
Q Consensus 508 ~l~~~t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~--~~--~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 581 (804)
-++.+.++|...||+|+||.|.++..++ ...+|||++++.. +. .+--+.|-++|+.. +-|.++.++.++..-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4555668999999999999999999765 5679999998543 21 12234566666665 57899999999999999
Q ss_pred eEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCc
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 661 (804)
+|.||||+.+|+|--++++. ....+....-+|..||-||-+||+++ |+.||||.+|||+|.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccc
Confidence 99999999999999888753 33666777888999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 662 KLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
+.--- ...++....||+.|+|||++..++|+..+|.|||||+||||+.|+.||+... ...+...+.+
T Consensus 498 KEni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD--------E~elF~aI~e---- 564 (683)
T KOG0696|consen 498 KENIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQAIME---- 564 (683)
T ss_pred ccccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHH----
Confidence 85222 2234556899999999999999999999999999999999999999998533 1122222221
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPP 781 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt 781 (804)
... .++.....+...+...-+...|.+|..
T Consensus 565 --------hnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 565 --------HNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --------ccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 111 122223335556666677788888853
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=253.52 Aligned_cols=256 Identities=26% Similarity=0.364 Sum_probs=193.0
Q ss_pred HHHHhcccccccccCcceEEEEE-ecCCcEEEEEEecCcC--CC------hHHHHHHHHHHhcCCCCcccceeeeEEe-C
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVL--QG------DAEFWAEVSIIGRINHRNLVKLQGFCAE-N 579 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~-~~~~~~vavK~l~~~~--~~------~~~~~~E~~~l~~l~H~niv~l~g~~~~-~ 579 (804)
...+|-+...||+|||+.|||+. +...+.||||+-.... .+ .+...+|..|-..|.||.||++++++.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 34455556679999999999999 5567889999764222 21 1346779999999999999999999874 4
Q ss_pred CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc---CCCCeEEe
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD---DHFEPKVT 656 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~ 656 (804)
+..+-|+|||++.+|+-||..+ +.++......|+.||+.||.||.+.. +||||-||||.|||+- .-|.+||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 5778999999999999999753 45899999999999999999999976 6799999999999994 45789999
Q ss_pred ecCCcccccccCCc------cccccccCCCccchhhhcc----CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCcc
Q 038103 657 DFGLSKLFKERHDT------KFSRVRGTRGYLAPEWMMN----LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSS 726 (804)
Q Consensus 657 Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~ 726 (804)
||||++++..+... -++...||..|++||.+-- .+++.|.||||.|||+|+.+.|+.||+.....
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ----- 690 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ----- 690 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-----
Confidence 99999998765433 2345679999999998753 35889999999999999999999999853210
Q ss_pred chhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038103 727 YCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVV 786 (804)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv 786 (804)
+.+ +....+.....-.+ ...+........++.+||+...++|....++.
T Consensus 691 --QdI-------LqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 691 --QDI-------LQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred --HHH-------HhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111 11111111111001 11122234567888999999888887766653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-29 Score=274.91 Aligned_cols=241 Identities=25% Similarity=0.317 Sum_probs=182.6
Q ss_pred ccccccCcc-eEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeeccCCChh
Q 038103 518 QEVGKGGFG-SVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSLD 595 (804)
Q Consensus 518 ~~LG~G~fg-~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 595 (804)
+.+|.|.-| .||+|..+ ++.||||++-. .-.+-.++|+..++.- +||||||+++.=.+...+|+..|.|.- +|.
T Consensus 515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~--e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~ 590 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE-GREVAVKRLLE--EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQ 590 (903)
T ss_pred HHcccCCCCcEEEEEeeC-CceehHHHHhh--HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHH
Confidence 458888886 57999984 57899999852 2234567899999888 699999999888888899999999966 999
Q ss_pred hhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-----CCCeEEeecCCcccccccCC-
Q 038103 596 KLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-----HFEPKVTDFGLSKLFKERHD- 669 (804)
Q Consensus 596 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~Dfgla~~~~~~~~- 669 (804)
+++...........-.....+..|+++||++||+.+ ||||||||+||||+. ..+++|+|||+++.+..+..
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 999763111111222345778899999999999988 999999999999965 35799999999998866443
Q ss_pred -ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhC-CCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 670 -TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG-KSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 670 -~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.......||-+|+|||++....-+.++||||+||++|+.++| ++||+....-+ +.-.-.+..+..+
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~------------~NIl~~~~~L~~L 735 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ------------ANILTGNYTLVHL 735 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh------------hhhhcCccceeee
Confidence 335567799999999999998888899999999999999995 99998532100 0000000011111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVV 786 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv 786 (804)
.. ..++ ...+|+.+|++++|..||++.+|+
T Consensus 736 -----~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 736 -----EP--LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -----cc--CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 01 1111 678999999999999999999995
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=279.56 Aligned_cols=252 Identities=24% Similarity=0.281 Sum_probs=200.4
Q ss_pred HHHHhcccccccccCcceEEEEEec-CCcEEEEEEecC---c-CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEG---V-LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~---~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
.+..+.+.+.||+|+||.|..++.+ .++.+|.|++.+ . .....-|..|-.+|..-+.+=|+.++-.|.++.++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 3556677788999999999999965 588999999975 2 2344568888899998889999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
|||||+||+|-.++... . .++.....-++..|+-||.-||+.| +|||||||+|||||..|++||+|||.+-.+
T Consensus 153 VMdY~pGGDlltLlSk~---~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKF---D-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred EEecccCchHHHHHhhc---C-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhc
Confidence 99999999999999542 2 6888888888999999999999999 999999999999999999999999999998
Q ss_pred cccCCccccccccCCCccchhhhc----c-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMM----N-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
..+..-.....+|||.|++||++. + +.|.+..|.||+||++|||+.|..||-.. .+.+.....+
T Consensus 226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----------slveTY~KIm 294 (1317)
T KOG0612|consen 226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----------SLVETYGKIM 294 (1317)
T ss_pred CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----------HHHHHHHHHh
Confidence 877777777789999999999985 2 57899999999999999999999999532 1222222222
Q ss_pred hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 038103 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPP---MSKVVK 787 (804)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt---m~~Vv~ 787 (804)
.......+.+ ..+..+...+|+..-+. +|+.|.. ++++-.
T Consensus 295 ~hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 NHKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred chhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 2211111111 12234466677776554 7888877 777753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-29 Score=239.98 Aligned_cols=260 Identities=22% Similarity=0.350 Sum_probs=189.2
Q ss_pred cccccccCcceEEEEEec-CCcEEEEEEec--CcCCC-hHHHHHHHHHHhcCCCCcccceeeeEEeC--------CeeEE
Q 038103 517 KQEVGKGGFGSVFRGVLD-DERVVAVKRLE--GVLQG-DAEFWAEVSIIGRINHRNLVKLQGFCAEN--------EHKLL 584 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~-~~~~vavK~l~--~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~l 584 (804)
..++|+|.||.||+++.. +++.||+|++- ....+ .....+|+++|..++|+|++.++.+|... ...+|
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 357999999999999965 47778988764 22222 34568999999999999999999998632 24799
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
|+.+|+. +|..+|.+ ....++...+.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+++.+
T Consensus 102 Vf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccce
Confidence 9999987 88888854 3456889999999999999999999988 999999999999999999999999999876
Q ss_pred cccCC---ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh-
Q 038103 665 KERHD---TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM- 739 (804)
Q Consensus 665 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 739 (804)
....+ ...+...-|..|++||.+.+. .++++.|||.-||+|.||+|+.+.+.... .....+++....-..
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt-----eqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT-----EQQQLHLISQLCGSIT 249 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh-----HHHHHHHHHHHhccCC
Confidence 54332 234445569999999998764 69999999999999999999998775432 111112221111000
Q ss_pred -------hhcCccccc--CCcCCCcc--------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 740 -------EQEGLEKII--DPRLNDVY--------DREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 740 -------~~~~~~~~~--d~~l~~~~--------~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+-.+.+-+ .|-..+.+ +........+|+..++..||.+||.+.+++..
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 000011111 00000000 01112356788888999999999999988753
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=240.31 Aligned_cols=246 Identities=22% Similarity=0.241 Sum_probs=191.6
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEe----CCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAE----NEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lV~E~~~~ 591 (804)
+.||-|-.|.|.....+ +++.+|+|.+.... ..++|+++--.. .|+|||.+++++.. ...+++|||.|++
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 57999999999999864 67889999887432 345677765444 69999999999764 3467899999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC---CCCeEEeecCCcccccccC
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD---HFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~ 668 (804)
|.|...++.. ....+++.+.-+|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||+|+....
T Consensus 144 GeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~-- 216 (400)
T KOG0604|consen 144 GELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE-- 216 (400)
T ss_pred hHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCC--
Confidence 9999999764 3356889999999999999999999999 999999999999954 45789999999996543
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......+-|+.|.|||++...+|+...|+||+||++|-|++|-.||-.... ..+..-+...+..+.+. +.
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--------~aispgMk~rI~~gqy~-FP 287 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--------LAISPGMKRRIRTGQYE-FP 287 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--------ccCChhHHhHhhccCcc-CC
Confidence 3344556779999999999999999999999999999999999999854221 11222234444443322 11
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
++ .-....+...+++...|..+|.+|.|+.+++..
T Consensus 288 ~p-----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 288 EP-----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred Ch-----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11 112345667788888999999999999999753
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-29 Score=224.96 Aligned_cols=103 Identities=45% Similarity=0.705 Sum_probs=76.5
Q ss_pred CCeEEEeeCCCCCCCCC--CceEEEeeCccEEEeCCCCCeEEEe-cccCC--cceEEEEecCCCeEEEecCCCceeeccC
Q 038103 74 NRTVVWMANRDRPVNGK--RSKLTLQRNGNLALTDKDSSVVWST-NTFTD--EGVQAQLLETGNLVLVNEANTTIWKSFD 148 (804)
Q Consensus 74 ~~t~vW~ANr~~p~~~~--~~~l~~~~~G~L~l~~~~~~~vWst-~~~~~--~~~~a~LldsGNlVl~~~~~~~lWqSFd 148 (804)
++||||+|||++|+.+. ..+|.|+.||||+|+|.+++++|+| ++.+. .+..|+|+|+|||||++..+.+||||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 47999999999999543 4899999999999999999999999 55544 4789999999999999999999999999
Q ss_pred CCCCccCCCcccCCC------CeEEecCCCCCCc
Q 038103 149 SPTDTLLPSQLLTKN------TTLVSMRSPGTYL 176 (804)
Q Consensus 149 ~PTDtllpg~~l~~~------~~L~S~~s~~dps 176 (804)
|||||+||+|+|+.+ ..|+||++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999762 4599999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=236.38 Aligned_cols=244 Identities=22% Similarity=0.289 Sum_probs=193.9
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEecCcCCC----hHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEee
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG----DAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
++...||+|+|.+|..+++. +.+.+|+|++++..-. .+=.+.|-.+..+. +||.+|.+..++..+..++.|.||
T Consensus 253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 34578999999999999975 4678999998753322 22356677777766 799999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|--++++ ...|+.....-+...|+-||.|||+++ |+.||||..|||+|.++++||+|+|+++.--. .
T Consensus 333 v~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~-~ 404 (593)
T KOG0695|consen 333 VNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-P 404 (593)
T ss_pred ecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC-C
Confidence 999999877754 345788888888899999999999999 99999999999999999999999999985333 2
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
...++.++||+.|+|||.+++..|....|.|++||+|+||+.|+.||+....+..+......+.+.+.++.-
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-------- 476 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-------- 476 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--------
Confidence 344567899999999999999999999999999999999999999999877666555555555554443211
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCC
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRP 780 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 780 (804)
+ ++....-+...+.+.-++.||.+|.
T Consensus 477 ----r--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 ----R--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----c--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1 1111122445666777888888874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=228.84 Aligned_cols=210 Identities=34% Similarity=0.585 Sum_probs=183.7
Q ss_pred ccccCcceEEEEEecC-CcEEEEEEecCcCCC--hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCChhh
Q 038103 520 VGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQG--DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDK 596 (804)
Q Consensus 520 LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 596 (804)
||+|.+|.||++...+ ++.+++|++...... .+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999765 889999999854442 5679999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-CCCeEEeecCCcccccccCCcccccc
Q 038103 597 LLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-HFEPKVTDFGLSKLFKERHDTKFSRV 675 (804)
Q Consensus 597 ~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 675 (804)
++... ...+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 99642 145889999999999999999999998 999999999999999 89999999999987654321 22334
Q ss_pred ccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCC
Q 038103 676 RGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLND 754 (804)
Q Consensus 676 ~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 754 (804)
.+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 567889999999887 788999999999999998
Q ss_pred ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 038103 755 VYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789 (804)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L 789 (804)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3688999999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-28 Score=254.59 Aligned_cols=236 Identities=23% Similarity=0.311 Sum_probs=189.6
Q ss_pred cccccccCcceEEEEEecCCc-EEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 517 KQEVGKGGFGSVFRGVLDDER-VVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~~~~-~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
...||-||||.|=++...... .+|+|.+++. ...++....|-.+|...+.|.||+++--+.+....|++||-|-+
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 456999999999999876544 4888888642 23346678899999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|.|-..|.. +..++.....-++..+.+|++|||+++ ||.|||||+|.+++.+|-+||.|||+|+.++.. ..
T Consensus 505 GElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~K 575 (732)
T KOG0614|consen 505 GELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RK 575 (732)
T ss_pred chhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC--Cc
Confidence 999999964 445777777788899999999999999 999999999999999999999999999987764 34
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
+-.++||+.|.|||.+.+...+.++|.||||+++|||++|++||....+.. . ...+..| +..+
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-------t-----Yn~ILkG-id~i---- 638 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-------T-----YNLILKG-IDKI---- 638 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-------H-----HHHHHhh-hhhh----
Confidence 557899999999999999999999999999999999999999997643110 0 0111111 1111
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCC
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPP 781 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt 781 (804)
.++........+|++.....+|.+|..
T Consensus 639 ---~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 ---EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 112223345667778778889999976
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-28 Score=237.13 Aligned_cols=193 Identities=26% Similarity=0.453 Sum_probs=166.6
Q ss_pred cccccccCcceEEEEEe-cCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCC-----eeEEEEe
Q 038103 517 KQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENE-----HKLLVYE 587 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E 587 (804)
.+.||.|+||.||.... ++|+.||.|++....+. .+.+.+|++++.-++|.|++..+++..-.. +.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 46799999999999995 57999999998755443 467889999999999999999998865432 5678899
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
.|.. +|.+.|- +...++-+.+.-+..||++||+|||+.+ |.||||||.|.|++.+..+||+|||+++....+
T Consensus 138 LmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 9976 8888774 4566888888889999999999999999 999999999999999999999999999987776
Q ss_pred CCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
....++...-|..|+|||.+++. .|+.+.||||.|||+.||+..+..|..
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 66666666678899999999875 599999999999999999998888764
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=206.87 Aligned_cols=109 Identities=42% Similarity=0.699 Sum_probs=100.0
Q ss_pred CCCEEEcCCCeeEeeEeecCCCc-eEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeCCCCCeEEEeccc
Q 038103 40 ENDFLVSPNGTFSSGFYKVGTNA-YCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTF 118 (804)
Q Consensus 40 ~~~~l~S~~g~F~lGFf~~~~~~-~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~~~vWst~~~ 118 (804)
++++|+|++|.|++|||++.... .+.+|||.+++ +++||+|||+.|. ...++|.|+.||+|+|+|.+|.++|+|++.
T Consensus 6 ~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~ 83 (116)
T cd00028 6 SGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSSNTT 83 (116)
T ss_pred CCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEeccc
Confidence 57899999999999999998776 88999999887 8899999999994 566899999999999999999999999986
Q ss_pred C-CcceEEEEecCCCeEEEecCCCceeeccCCC
Q 038103 119 T-DEGVQAQLLETGNLVLVNEANTTIWKSFDSP 150 (804)
Q Consensus 119 ~-~~~~~a~LldsGNlVl~~~~~~~lWqSFd~P 150 (804)
+ ....+|+|+|+|||||++.++.+||||||||
T Consensus 84 ~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 84 RVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred CCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 5 5677899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-26 Score=236.06 Aligned_cols=145 Identities=23% Similarity=0.401 Sum_probs=123.0
Q ss_pred ecCccccchHHHHH-HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcCC-----C---C
Q 038103 498 ALGFKRFTYAELKR-ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-----H---R 567 (804)
Q Consensus 498 ~~~~~~~~~~~l~~-~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----H---~ 567 (804)
..+++.....|... ++|-+.++||-|.|++||++.. ++.+.||+|+.+....-.+....|+++|++++ | .
T Consensus 63 kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~ 142 (590)
T KOG1290|consen 63 KGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKK 142 (590)
T ss_pred cCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence 45677777777777 8899999999999999999994 56789999999877666677889999999883 3 3
Q ss_pred cccceeeeEEe----CCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccC
Q 038103 568 NLVKLQGFCAE----NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQ 643 (804)
Q Consensus 568 niv~l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 643 (804)
.||+|+++|.. +.+.+||+|++-. +|..+|... .-+-++...+.+|+.||+.||.|||.++. |||.||||+
T Consensus 143 ~VV~LlD~FkhsGpNG~HVCMVfEvLGd-nLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPE 217 (590)
T KOG1290|consen 143 CVVQLLDHFKHSGPNGQHVCMVFEVLGD-NLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPE 217 (590)
T ss_pred eeeeeeccceecCCCCcEEEEEehhhhh-HHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcc
Confidence 69999999974 4599999999944 888888654 23347889999999999999999999986 999999999
Q ss_pred eEEE
Q 038103 644 NILL 647 (804)
Q Consensus 644 NILl 647 (804)
|||+
T Consensus 218 NvLl 221 (590)
T KOG1290|consen 218 NVLL 221 (590)
T ss_pred eeee
Confidence 9999
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=240.87 Aligned_cols=245 Identities=26% Similarity=0.364 Sum_probs=188.6
Q ss_pred ccchHHHHHHHhc---cc--ccccccCcceEEEEEe-cCCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccce
Q 038103 503 RFTYAELKRATRN---FK--QEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKL 572 (804)
Q Consensus 503 ~~~~~~l~~~t~~---~~--~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l 572 (804)
.-.|--|+++..+ |. +.||-|+||.|.++.- ++...+|.|.|++.. ......++|-.||.....+=||+|
T Consensus 615 ESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrL 694 (1034)
T KOG0608|consen 615 ESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRL 694 (1034)
T ss_pred hhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEE
Confidence 3445566666543 32 4599999999999984 456679999987432 233567889999999999999999
Q ss_pred eeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC
Q 038103 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE 652 (804)
Q Consensus 573 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 652 (804)
+-.|.+.+.+|+||+|+++|++-.+|.+ -..+.+....-++..+..|+++.|..| +|||||||+|||||.+|+
T Consensus 695 yySFQDkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGH 767 (1034)
T KOG0608|consen 695 YYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGH 767 (1034)
T ss_pred EEEeccCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCc
Confidence 9999999999999999999999999864 344667777777888999999999999 999999999999999999
Q ss_pred eEEeecCCcccccccCC----------c-------------------------------cccccccCCCccchhhhccCC
Q 038103 653 PKVTDFGLSKLFKERHD----------T-------------------------------KFSRVRGTRGYLAPEWMMNLK 691 (804)
Q Consensus 653 ~kl~Dfgla~~~~~~~~----------~-------------------------------~~~~~~gt~~y~aPE~~~~~~ 691 (804)
+||+||||+.-++-.++ . ......||+.|+|||++....
T Consensus 768 IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g 847 (1034)
T KOG0608|consen 768 IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG 847 (1034)
T ss_pred eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC
Confidence 99999999975421000 0 001245999999999999999
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHH
Q 038103 692 IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVA 768 (804)
Q Consensus 692 ~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 768 (804)
++...|.||.|||||||+.|+.||-...+.+.. .+-......++-......+.+....+.+|+
T Consensus 848 ~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq--------------~kv~nw~~~l~~~~~~~ls~e~~~li~kLc 910 (1034)
T KOG0608|consen 848 YTQLCDWWSVGVILYEMLVGQPPFLADTPGETQ--------------YKVINWRNFLHIPYQGNLSKEALDLIQKLC 910 (1034)
T ss_pred ccccchhhHhhHHHHHHhhCCCCccCCCCCcce--------------eeeeehhhccccccccccCHHHHHHHHHHh
Confidence 999999999999999999999999654322211 111223344555555666777766666653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-27 Score=245.70 Aligned_cols=212 Identities=28% Similarity=0.313 Sum_probs=182.1
Q ss_pred ecCccccchHHHHHHHhcccccccccCcceEEEEEecC-CcEEEEEEecCcCCChHHHHHHHHHHhcCC------CCccc
Q 038103 498 ALGFKRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGDAEFWAEVSIIGRIN------HRNLV 570 (804)
Q Consensus 498 ~~~~~~~~~~~l~~~t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~------H~niv 570 (804)
..++.++.+.|+...+|.+....|+|-|++|.+|.... |..||||+|.+...-.+.=++|+++|.+|+ --+++
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 35677888999999999999999999999999999654 779999999876555566678999999995 34799
Q ss_pred ceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC
Q 038103 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH 650 (804)
Q Consensus 571 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~ 650 (804)
+++..|...+++|||+|-+.- +|.+.|... +...-|....+..++.|+.-||..|...+ |+|.||||.|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~Lsl-NLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLSL-NLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHhhhcceeEEEehhhhc-hHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccC
Confidence 999999999999999999865 999999753 23345778889999999999999999988 9999999999999976
Q ss_pred C-CeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 651 F-EPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 651 ~-~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
. .+||+|||.|.......- +...-+..|.|||++.+.+|+...|+||.||+||||.||+..|..
T Consensus 573 k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 5 579999999987655332 333446789999999999999999999999999999999998864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-25 Score=223.27 Aligned_cols=197 Identities=32% Similarity=0.466 Sum_probs=170.9
Q ss_pred cccccccccCcceEEEEEecC-CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 515 NFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
.+.+.||+|++|.||++...+ ++.+++|.+..... ..+.+.+|++.+++++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 456789999999999999875 88899999985433 457789999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.+++.... ..+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 82 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 82 GDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 99999996421 12789999999999999999999998 9999999999999999999999999999775543122
Q ss_pred ccccccCCCccchhhh-ccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 672 FSRVRGTRGYLAPEWM-MNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~-~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
.....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 3345577889999998 677788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-26 Score=240.48 Aligned_cols=192 Identities=23% Similarity=0.299 Sum_probs=164.0
Q ss_pred hcccccccccCcceEEEEEecC-CcEEEEEEecCcCCChH---------HHHHHHHHHhcCC---CCcccceeeeEEeCC
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGDA---------EFWAEVSIIGRIN---HRNLVKLQGFCAENE 580 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~~~~---------~~~~E~~~l~~l~---H~niv~l~g~~~~~~ 580 (804)
|.-.+++|+|+||.|+.++++. ...|+||.+.+.+.-.+ ..-.|++||..++ |+||+|++.+|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 4445679999999999999764 56799998875432221 2456999999997 999999999999999
Q ss_pred eeEEEEeecc-CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 581 HKLLVYEYVE-NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 581 ~~~lV~E~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
..||++|-.. +-+|.++|.. ...+++....-|+.|++.|+++||+++ |+|||||-+||.++.+|-+||.|||
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred eeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence 9999999764 5589999965 345889999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCccchhhhccCCCC-cccchHHHHHHHHHHHhCCCCC
Q 038103 660 LSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKID-AKADVYSYGIVLLELLTGKSAS 715 (804)
Q Consensus 660 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DV~S~Gvll~el~tg~~p~ 715 (804)
.+...+. .....++||.+|.|||++.+.+|- ..-|||++|++||.++....||
T Consensus 716 saa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 716 SAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred chhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9997654 344567899999999999998875 4579999999999999888776
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-25 Score=198.11 Aligned_cols=108 Identities=43% Similarity=0.681 Sum_probs=99.1
Q ss_pred CCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeCCCCCeEEEeccc-
Q 038103 40 ENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTF- 118 (804)
Q Consensus 40 ~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~~~vWst~~~- 118 (804)
++++|+|++|.|++|||++.....+.+|||.+.+ +++||+|||+.|+.+. +.|.+..||+|+|+|.+|.++|+|++.
T Consensus 6 ~~~~l~s~~~~f~~G~~~~~~q~dgnlV~~~~~~-~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~S~t~~ 83 (114)
T smart00108 6 SGQTLVSGNSLFELGFFTLIMQNDYNLILYKSSS-RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWSSNTTG 83 (114)
T ss_pred CCCEEecCCCcEeeeccccCCCCCEEEEEEECCC-CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCCCEEEEecccC
Confidence 5789999999999999999877888999999887 8899999999998653 899999999999999999999999986
Q ss_pred CCcceEEEEecCCCeEEEecCCCceeeccCC
Q 038103 119 TDEGVQAQLLETGNLVLVNEANTTIWKSFDS 149 (804)
Q Consensus 119 ~~~~~~a~LldsGNlVl~~~~~~~lWqSFd~ 149 (804)
+....+|+|+|+|||||++..+.+|||||||
T Consensus 84 ~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 84 ANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred CCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 5567789999999999999999999999997
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=207.48 Aligned_cols=254 Identities=20% Similarity=0.341 Sum_probs=187.4
Q ss_pred HHhcccccccccCcceEEEEE-ecCCcEEEEEEecCcCCChHHHHHHHHHHhcCC-CCcccceeeeEEeCC--eeEEEEe
Q 038103 512 ATRNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-HRNLVKLQGFCAENE--HKLLVYE 587 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~-~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lV~E 587 (804)
..|.+.+++|+|.++.||.|. ..+...++||.++.. ..+.+.+|+++|..|. ||||++++++..+.. ...||+|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 345667889999999999999 566788999999843 3466889999999997 999999999987654 5689999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC-CCeEEeecCCcccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH-FEPKVTDFGLSKLFKE 666 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~ 666 (804)
|..+.+...+-. .++...+...+.++++||.|+|+.| |.|||+||.|++||.. -.++|.|+|+|..+..
T Consensus 116 ~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 116 YVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 999977665542 3677778889999999999999999 9999999999999865 4699999999998755
Q ss_pred cCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHH--------H
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVA--------K 737 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~ 737 (804)
.... .....+..|--||.+-. ..|+..-|+|||||+|.+|+..+.||-.-. ....++..-+. .
T Consensus 186 ~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~------dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 186 GKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH------DNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred Ccee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC------CCHHHHHHHHHHhChHHHHH
Confidence 3332 22234566789998864 458889999999999999999999985421 11122222111 1
Q ss_pred HhhhcCcccccCCcCCC----------------ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 738 QMEQEGLEKIIDPRLND----------------VYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 738 ~~~~~~~~~~~d~~l~~----------------~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+..-.+ -+|+++.+ .-..-...+.++++-..+..|-++|||+.|.+.
T Consensus 258 Yl~KY~i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 258 YLNKYQI--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHcc--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111111 12332211 000111246778888889999999999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=217.40 Aligned_cols=257 Identities=20% Similarity=0.293 Sum_probs=188.5
Q ss_pred cccccCcceEEEEEe-cCCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeC------CeeEEEEee
Q 038103 519 EVGKGGFGSVFRGVL-DDERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN------EHKLLVYEY 588 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~ 588 (804)
.+|.|+- .|--+.. -.++.||+|++.... ...++..+|...+..++|+|+++++.++.-. .+.|+|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 4677766 4444442 247889999886433 3446778999999999999999999998643 366999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
|.. +|...+.. .++-.....|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+....+
T Consensus 103 m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 103 MDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred hhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc-
Confidence 966 88888752 3666778899999999999999999 999999999999999999999999999964433
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCccccccc-----------CCccchhhHHHHHHH
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASA-----------SDSSYCNHLVQWVAK 737 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~-----------~~~~~~~~~~~~~~~ 737 (804)
...+....|..|.|||.+.+-.+.+.+||||.||++.||++|+..|.....-+ .+......+...+..
T Consensus 172 -~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred -cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 45667778999999999998889999999999999999999998875322111 112223333333333
Q ss_pred Hhhhc------Cccccc-CCcCCC--ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 738 QMEQE------GLEKII-DPRLND--VYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 738 ~~~~~------~~~~~~-d~~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
..+.. ...+.+ |..... ..++-.......++.+||-.+|++|-+..++++.
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 32211 011111 111111 1122334567889999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-25 Score=236.90 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=196.0
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecC-cCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEG-VLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
|.+.+.+|+|.||.|||++. +.+...|||.++. ......-.+.|+-+++.-+|+|||.++|.+.....+++.||||.+
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 44567899999999999994 5688999999983 333455677899999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|.+.-+. ...+++.++..+.+...+||+|||+.+ -+|||||-.|||+++.+.+|++|||.+..+...- ..
T Consensus 97 gslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-~K 168 (829)
T KOG0576|consen 97 GSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK 168 (829)
T ss_pred Ccccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence 999987753 456888888999999999999999999 6999999999999999999999999998654321 22
Q ss_pred ccccccCCCccchhhh---ccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 672 FSRVRGTRGYLAPEWM---MNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~---~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
...+.||+.|||||+. +.+.|..++|||+.|+...|+-.-+.|..... .-.+...+......
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh------------pmr~l~LmTkS~~q--- 233 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH------------PMRALFLMTKSGFQ--- 233 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc------------hHHHHHHhhccCCC---
Confidence 3457899999999987 45679999999999999999988877753221 11111222221111
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+.+.+ ...-.+.+.++++.|+..+|.+||+++.+++
T Consensus 234 pp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 122221 1223456789999999999999999987653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=261.10 Aligned_cols=196 Identities=17% Similarity=0.238 Sum_probs=139.2
Q ss_pred cCCC-CcccceeeeE-------EeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCc
Q 038103 563 RINH-RNLVKLQGFC-------AENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634 (804)
Q Consensus 563 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ 634 (804)
.++| .||+++++.| .+....++++|++ .++|.++|.. ....+++..++.++.||++||+|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4456 6888888887 2334567888987 5599999964 2345899999999999999999999998
Q ss_pred EEecccccCeEEEcC-------------------CCCeEEeecCCcccccccCC---------------ccccccccCCC
Q 038103 635 VLHCDVKPQNILLDD-------------------HFEPKVTDFGLSKLFKERHD---------------TKFSRVRGTRG 680 (804)
Q Consensus 635 ivH~Dlkp~NILl~~-------------------~~~~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~ 680 (804)
|+||||||+||||+. ++.+||+|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 44566666666654211000 00111357888
Q ss_pred ccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHH
Q 038103 681 YLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREK 760 (804)
Q Consensus 681 y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 760 (804)
|+|||++.+..++.++|||||||+||||++|..|+.... ..+ ..+... .+.+.. ...
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~-----~~~~~~----~~~~~~-----~~~ 237 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------RTM-----SSLRHR----VLPPQI-----LLN 237 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHH-----HHHHHh----hcChhh-----hhc
Confidence 999999999999999999999999999999887754210 000 001100 111111 111
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 761 LDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 761 ~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
......++.+||+.+|.+||+|.||++.
T Consensus 238 ~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 238 WPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred CHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 2345688889999999999999999853
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=204.64 Aligned_cols=250 Identities=17% Similarity=0.295 Sum_probs=183.0
Q ss_pred HhcccccccccCcceEEEEEecC-CcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeee-EEeCCeeEEEEeec
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGF-CAENEHKLLVYEYV 589 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E~~ 589 (804)
.|++.+.||+|.||.+.+++++. .+.+++|.+.......++|.+|..---.| .|.||+.-+.. +...+.++.++||+
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 46778899999999999999765 67899999988777889999998765555 58999987765 55566788999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE-c-CCCCeEEeecCCccccccc
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL-D-DHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl-~-~~~~~kl~Dfgla~~~~~~ 667 (804)
+.|+|.+-+.. .-+-+....+++.|+++|+.|||+++ +||||||.+|||| + +..++||+|||+.+..+.
T Consensus 105 P~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 105 PRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred ccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 99999998854 23566777889999999999999999 9999999999998 3 345899999999986433
Q ss_pred CCccccccccCCCccchhhhccC-----CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNL-----KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
......-+..|.|||..... ...+.+|||.|||+++.++||+.|+..... ..+...+ +..+..+
T Consensus 176 ---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~------~d~~Y~~--~~~w~~r 244 (378)
T KOG1345|consen 176 ---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI------MDKPYWE--WEQWLKR 244 (378)
T ss_pred ---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc------cCchHHH--HHHHhcc
Confidence 12222345679999976432 346789999999999999999999973221 1112222 2333333
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
....+ |+.-..+ .+++.++.++-+..+|++|=-..++.++
T Consensus 245 k~~~~--P~~F~~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 245 KNPAL--PKKFNPF----SEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cCccC--chhhccc----CHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 22211 1111122 2356677778888999998555555444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=202.19 Aligned_cols=168 Identities=21% Similarity=0.196 Sum_probs=125.5
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|.+++.. .+..+++..++.++.|+++||+|||+++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence 689999964 3456999999999999999999999975 999999999999999 99998754422
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... .............. . ++.
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-------~~~~~~~~~~~~~~-----~-~~~ 127 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-------LSAILEILLNGMPA-----D-DPR 127 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-------hcHHHHHHHHHhcc-----C-Ccc
Confidence 2578999999999999999999999999999999999999864221 00111111111110 0 000
Q ss_pred CCCccCHHHH--HHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 752 LNDVYDREKL--DRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 752 l~~~~~~~~~--~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
-. ....... ..+.+++.+|++.+|.+||++.++++.+....
T Consensus 128 ~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 128 DR-SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred cc-ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 00 0111122 26899999999999999999999999886543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-24 Score=206.95 Aligned_cols=253 Identities=19% Similarity=0.311 Sum_probs=193.5
Q ss_pred HHHhcccccccccCcceEEEEEecCCcEEEEEEecC---cCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEG---VLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
-...++..+|.+...|..|+|+++++. +++|++.. +....++|..|.-.|+-+.||||+.++|.|....++.++..
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 344566778999999999999998765 55576652 23345679999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
||+-|+|...|+.. .....+-.+..+++.++|+|++|||+..+ -|..--|.+..|++|++.+++|+- +-+++
T Consensus 268 ~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kf---- 339 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKF---- 339 (448)
T ss_pred eccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-cccee----
Confidence 99999999999763 45667888999999999999999999763 344557899999999999988852 11111
Q ss_pred CCccccccccCCCccchhhhccCCCC---cccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKID---AKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s---~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
........-.+.|++||.+...+-+ .++|+|||.+++|||.|...||....+.+- ..++.
T Consensus 340 -sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec------------gmkia---- 402 (448)
T KOG0195|consen 340 -SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC------------GMKIA---- 402 (448)
T ss_pred -eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh------------hhhhh----
Confidence 0011111225789999999776543 478999999999999999999976542211 11111
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
-..++..+++.....+.+|+.-|++.||.+||.+..|+-.||...
T Consensus 403 ----leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 ----LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 123333445555567899999999999999999999999998764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-23 Score=213.64 Aligned_cols=194 Identities=25% Similarity=0.415 Sum_probs=161.0
Q ss_pred hcccccccccCcceEEEEEec----CCcEEEEEEecCcCCChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD----DERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~----~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+...++||+|.|++||++.+. ..+.||+|.+..+ .....+.+|+++|..+. +.||+++.+++..++...+|+||
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeecccc-cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 345678999999999999953 3678999998743 34456889999999994 89999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC-CCeEEeecCCccccccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH-FEPKVTDFGLSKLFKER 667 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~~ 667 (804)
++.-...++... ++...+...+..+..||+++|.++ ||||||||+|+|.+.. ++-.|.|||+|......
T Consensus 117 ~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 117 FEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred cCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 999888888854 678888999999999999999999 9999999999999754 56799999999822100
Q ss_pred C-------------------------------------------CccccccccCCCccchhhhcc-CCCCcccchHHHHH
Q 038103 668 H-------------------------------------------DTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGI 703 (804)
Q Consensus 668 ~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gv 703 (804)
. ........||+||+|||++.. ..-+++.||||-||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 000112459999999998864 55789999999999
Q ss_pred HHHHHHhCCCCCccc
Q 038103 704 VLLELLTGKSASDYL 718 (804)
Q Consensus 704 ll~el~tg~~p~~~~ 718 (804)
|++.+++++.||-..
T Consensus 267 I~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKA 281 (418)
T ss_pred eeehhhccccccccC
Confidence 999999999998643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.8e-21 Score=204.40 Aligned_cols=161 Identities=20% Similarity=0.194 Sum_probs=125.2
Q ss_pred HHhcccccccccCcceEEEEEec--CCcEEEEEEecCcC------CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD--DERVVAVKRLEGVL------QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~--~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
..|.+.+.||+|+||+||+|... +++.+|||++.... ...+.+.+|++++.+++|+|+++.+.. ....+
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~ 94 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG 94 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence 34667889999999999999864 57778999875321 123568999999999999999863322 24679
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEeccc-ccCeEEEcCCCCeEEeecCCcc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDV-KPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~Dfgla~ 662 (804)
+||||+++++|.... . .. ...++.+++++|.|||+.+ |+|||| ||+|||++.++++||+|||+++
T Consensus 95 LVmE~~~G~~L~~~~-~---~~-------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 95 LVRGWTEGVPLHLAR-P---HG-------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred EEEEccCCCCHHHhC-c---cc-------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 999999999996321 1 11 1467889999999999998 999999 9999999999999999999999
Q ss_pred cccccCC-------ccccccccCCCccchhhhcc
Q 038103 663 LFKERHD-------TKFSRVRGTRGYLAPEWMMN 689 (804)
Q Consensus 663 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~ 689 (804)
.+..... .......+++.|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 7755321 11234667888999998853
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-19 Score=193.99 Aligned_cols=260 Identities=21% Similarity=0.302 Sum_probs=190.0
Q ss_pred HhcccccccccCcceEEEEEecCC--cEEEEEEecCcC-CChHHHHHHHHHHhcCCC----CcccceeeeE-EeCCeeEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDE--RVVAVKRLEGVL-QGDAEFWAEVSIIGRINH----RNLVKLQGFC-AENEHKLL 584 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~--~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 584 (804)
.+.+.++||+|+||.||++..... ..+|+|.-.... .....+..|+.++..+.+ +++.+++... ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 566788999999999999996553 478888766432 222378889999988873 5788888888 46778899
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC-----CCeEEeecC
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH-----FEPKVTDFG 659 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-----~~~kl~Dfg 659 (804)
||+.+ +.+|.++....+ ...++......|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99987 559999886543 467899999999999999999999999 9999999999999754 469999999
Q ss_pred Cccccc--ccCC------cc-ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhh
Q 038103 660 LSKLFK--ERHD------TK-FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNH 730 (804)
Q Consensus 660 la~~~~--~~~~------~~-~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~ 730 (804)
+++... .... .. ....+||..|+++....+...+.+.|+||++.++.|++.|..|+........
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~------- 245 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL------- 245 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-------
Confidence 999332 2211 11 2346699999999999999999999999999999999999999854321110
Q ss_pred HHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 731 LVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
......... ...... .....+. .+.++..-+-..+..++|....+.+.|+.....
T Consensus 246 -~~~~~~~~~----~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 246 -KSKFEKDPR----KLLTDR--FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred -HHHHHHHhh----hhcccc--ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 111111111 111111 1112222 344444445558999999999999887665443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-20 Score=200.93 Aligned_cols=221 Identities=24% Similarity=0.422 Sum_probs=168.8
Q ss_pred HhcCCCCcccceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEeccc
Q 038103 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDV 640 (804)
Q Consensus 561 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dl 640 (804)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.....+..+|+.||+|||...- ..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPI--GYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcc--eeeeee
Confidence 4578999999999999999999999999999999999976 45669999999999999999999999661 399999
Q ss_pred ccCeEEEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccC-------CCCcccchHHHHHHHHHHHhCC
Q 038103 641 KPQNILLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNL-------KIDAKADVYSYGIVLLELLTGK 712 (804)
Q Consensus 641 kp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-------~~s~k~DV~S~Gvll~el~tg~ 712 (804)
+++|.++|....+||+|||+......... .......-..-|.|||.++.. ..+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999987753111 111112234569999998763 2467899999999999999999
Q ss_pred CCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 713 SASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 713 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
.||+........ ..++.. ++. .....+.|.+.... +....+..++..||..+|++||++++|-..++.+
T Consensus 156 ~~~~~~~~~~~~----~eii~~----~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 156 GPFDLRNLVEDP----DEIILR----VKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred CccccccccCCh----HHHHHH----HHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999753322111 122222 222 12222333332111 3344799999999999999999999999999887
Q ss_pred CCCCC
Q 038103 793 DHESS 797 (804)
Q Consensus 793 ~~~~~ 797 (804)
.....
T Consensus 225 ~~~~~ 229 (484)
T KOG1023|consen 225 NKGGS 229 (484)
T ss_pred ccccc
Confidence 76554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-18 Score=186.75 Aligned_cols=260 Identities=30% Similarity=0.395 Sum_probs=195.6
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCcCC----ChHHHHHHHHHHhcCCCC-cccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ----GDAEFWAEVSIIGRINHR-NLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.+.+.||.|+|+.||++... ..+++|.+..... ....+.+|+.+++.+.|+ +++++...+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 345678999999999999977 7789999874332 256799999999999988 799999999777778999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC-CeEEeecCCccccccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF-EPKVTDFGLSKLFKER 667 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~ 667 (804)
+.++++.+++...... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++... .+++.|||+++.+...
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777542211 36888899999999999999999999 99999999999999998 7999999999865543
Q ss_pred CCc-----cccccccCCCccchhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 668 HDT-----KFSRVRGTRGYLAPEWMMN---LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 668 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
... ......++..|+|||.+.. ...+...|+||+|++++++++|..|+...... .........+
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--------~~~~~~~~~~ 227 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--------SATSQTLKII 227 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--------ccHHHHHHHH
Confidence 322 3456779999999999987 57889999999999999999999996543210 0011111111
Q ss_pred hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...... .................+.+++..|+..+|..|.++.+....
T Consensus 228 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 228 LELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HhcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111111 000011111012223467788888999999999999887753
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.81 E-value=6e-20 Score=164.18 Aligned_cols=76 Identities=39% Similarity=0.819 Sum_probs=65.8
Q ss_pred ceEEEeccCCCcceEEEEEccCCcEEEEEEccCCCceEEeecCCCCCcccCCcCCCCCcccccCCCCcccCCCCCCCcCC
Q 038103 238 TFKFNASDYGVGPKRRLTLDYDGILRLYSFDESTRLWKISWLPAGLDYCTVHGLCGPNGICVNRPRQKTCICPNGFRRND 317 (804)
Q Consensus 238 ~~~~~~~~~~~~~~~rl~Ld~dG~l~~y~w~~~~~~W~~~w~~~~~~~Cd~~~~CG~~g~C~~~~~~~~C~C~~GF~~~~ 317 (804)
+++|... ..+.++|++||.+|++|+|.|.+.++.|...|. +|.|+||+|+.||+||+|+. +..+.|+||+||+|++
T Consensus 35 ~~t~~~~--~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~-~p~d~Cd~y~~CG~~g~C~~-~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 35 YYTYSLS--NSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWS-APKDQCDVYGFCGPNGICNS-NNSPKCSCLPGFEPKN 110 (110)
T ss_pred EEEEecC--CCceEEEEEEeeeeEEEEEEEecCCCcEEEEEE-ecccCCCCccccCCccEeCC-CCCCceECCCCcCCCc
Confidence 3455444 346799999999999999999999999999997 89999999999999999964 4566899999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-19 Score=207.04 Aligned_cols=248 Identities=22% Similarity=0.255 Sum_probs=180.3
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCc--CCChHHHHHHHHH--HhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGV--LQGDAEFWAEVSI--IGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~--~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
..+.+.||++.|=+|.+++.+.|. |+||.+-+. ....+.|.++++- ...++|||.+++.-.-......|||-+|.
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 445678999999999999998887 889987532 2233444444433 55568999999988877777778998998
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc--ccc
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF--KER 667 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~--~~~ 667 (804)
.+ +|.+.|. .+..+...+...|+.|++.||.-+|..+ |+|||||.+||||+.-..+.|+||...+.. ..+
T Consensus 104 kh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 104 KH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred hh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 77 8888884 4556788888999999999999999999 999999999999999999999999887743 222
Q ss_pred CCcc----ccccccCCCccchhhhcc----------CC-CCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhH
Q 038103 668 HDTK----FSRVRGTRGYLAPEWMMN----------LK-IDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHL 731 (804)
Q Consensus 668 ~~~~----~~~~~gt~~y~aPE~~~~----------~~-~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~ 731 (804)
.... ...-+.-.+|+|||.+-. .+ .+++-||||+||++.||++ |+.+|+..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------------- 242 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------------- 242 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------------
Confidence 2211 122233457999998743 12 5778999999999999999 67777631
Q ss_pred HHHHHHHhhh-cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 732 VQWVAKQMEQ-EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 732 ~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
+....+-.. ...+..+ ..+ +...+.++++.|++.||++|.+++++++.-.++
T Consensus 243 -QL~aYr~~~~~~~e~~L-e~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 243 -QLLAYRSGNADDPEQLL-EKI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -HHHhHhccCccCHHHHH-HhC-------cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 111111110 0000000 001 112578999999999999999999999875543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-19 Score=172.03 Aligned_cols=205 Identities=20% Similarity=0.325 Sum_probs=168.0
Q ss_pred HHHHHhcccccccccCcceEEEEE-ecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCC-CcccceeeeEEeCCeeEEEE
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINH-RNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~-~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 586 (804)
|....+.+.++||.|+||.+|.|. ...|..||||.=. ......++.-|.++.+.|+| ..|..+.-+..+...-.+||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es-~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES-SKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeec-ccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 345567888999999999999999 6779999999754 33445677889999999976 67888888888888999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC---CCCeEEeecCCccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD---HFEPKVTDFGLSKL 663 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~ 663 (804)
+.+ +-+|+++..- -....+..+.+-++-|++.-++|+|.++ ++||||||+|.|+.- ...+.++|||+++.
T Consensus 91 dLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 998 4488877632 2234777888999999999999999999 999999999999954 35689999999998
Q ss_pred ccccCC------ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccc
Q 038103 664 FKERHD------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSAS 721 (804)
Q Consensus 664 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~ 721 (804)
+.+... .......||.+|.+-....+...+.+.|+=|+|.+|..+.-|..|+....+.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 765322 2233466899999988777778889999999999999999999999876543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-19 Score=208.05 Aligned_cols=250 Identities=19% Similarity=0.238 Sum_probs=184.0
Q ss_pred cccccccCcceEEEEEec-CCcEEEEEEec----CcCCCh---HHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 517 KQEVGKGGFGSVFRGVLD-DERVVAVKRLE----GVLQGD---AEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~-~~~~vavK~l~----~~~~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
...+|.|++|.|+..... .....+.|... ...... ..+..|+-+-..++|+|++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 457999999977777632 23333333322 111111 1144566677788999999988888777766666999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
++. +|..++.. ...+....+..++.|+..|+.|||+.+ |.|||+|++|++++.++.+||+|||.+..+....
T Consensus 403 ~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 403 CPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred ccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 999 99999854 235778888999999999999999999 9999999999999999999999999999876544
Q ss_pred C---ccccccccCCCccchhhhccCCCCcc-cchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 669 D---TKFSRVRGTRGYLAPEWMMNLKIDAK-ADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 669 ~---~~~~~~~gt~~y~aPE~~~~~~~s~k-~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
. .......|+..|+|||.+....|.+. .||||.|+++..|++|+.|+......+.. + ......
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~------~-------~~~~~~ 541 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS------F-------KTNNYS 541 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc------h-------hhhccc
Confidence 4 34556789999999999999999874 79999999999999999998653321110 0 000000
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+.-...-........+.+...++.++++.+|.+|-||++|++
T Consensus 542 ~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 542 DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 1111111112223445667888999999999999999999975
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=171.76 Aligned_cols=138 Identities=14% Similarity=0.168 Sum_probs=107.6
Q ss_pred cccccccCcceEEEEEecCCcEEEEEEecCcCC---C-------hHHH-----------------HHHHHHHhcCCCCcc
Q 038103 517 KQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ---G-------DAEF-----------------WAEVSIIGRINHRNL 569 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~---~-------~~~~-----------------~~E~~~l~~l~H~ni 569 (804)
...||+|+||.||+|..++|+.||||+++.... . ...| ..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999988899999999974321 1 1122 349999999988776
Q ss_pred cceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHH-HhhCCCcEEecccccCeEEEc
Q 038103 570 VKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL-HEECLEWVLHCDVKPQNILLD 648 (804)
Q Consensus 570 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivH~Dlkp~NILl~ 648 (804)
.....+.. ...+|||||++++++..... ....++.....+++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence 44333222 23489999999877765432 223578889999999999999999 6878 99999999999998
Q ss_pred CCCCeEEeecCCcccc
Q 038103 649 DHFEPKVTDFGLSKLF 664 (804)
Q Consensus 649 ~~~~~kl~Dfgla~~~ 664 (804)
+ +.++|+|||++...
T Consensus 153 ~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 D-GKLYIIDVSQSVEH 167 (190)
T ss_pred C-CcEEEEEccccccC
Confidence 4 78999999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-18 Score=173.54 Aligned_cols=174 Identities=12% Similarity=0.118 Sum_probs=134.3
Q ss_pred HHHHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHH----------HHHHHHHHhcCCCCcccceeeeE
Q 038103 507 AELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAE----------FWAEVSIIGRINHRNLVKLQGFC 576 (804)
Q Consensus 507 ~~l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~----------~~~E~~~l~~l~H~niv~l~g~~ 576 (804)
.++.+..+...+.||.|+||.||.... +++.+|||.+.......+. +.+|+..+.+++|++|..+..++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 345567778888999999999999655 5668999999743332222 57899999999999999998886
Q ss_pred EeC--------CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc
Q 038103 577 AEN--------EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD 648 (804)
Q Consensus 577 ~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~ 648 (804)
... ...+|+|||+++.+|.++.. ++. ....+++.++..+|..+ ++|||++|+||+++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~ 169 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVS 169 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEe
Confidence 533 35789999999999988742 121 34568999999999999 99999999999999
Q ss_pred CCCCeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh
Q 038103 649 DHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710 (804)
Q Consensus 649 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t 710 (804)
.++ ++|.|||.......+... ..++....+..++|+|+||+.+.-+..
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 988 999999998765322111 113444456789999999999876543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=172.43 Aligned_cols=200 Identities=21% Similarity=0.322 Sum_probs=166.5
Q ss_pred hcccccccccCcceEEEEE-ecCCcEEEEEEecCcCCChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEeeccC
Q 038103 514 RNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~-~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.+.++||+|.||.++.|+ +-++++||||.=. ......++..|.+..+.|. .++|...+-+-.++.+-.||+|++ +
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 5567899999999999999 5678999999532 2334567888888888885 688999888888888999999998 4
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-----CCCeEEeecCCcccccc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-----HFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~Dfgla~~~~~ 666 (804)
-||+++..- -+..++...+.-+|.|++.-++|+|++. +|.|||||+|.||.. ...+.|.|||+|+.+.+
T Consensus 108 PSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 108 PSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred cCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 488887643 3556899999999999999999999999 999999999999953 34589999999998765
Q ss_pred cCCc------cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccc
Q 038103 667 RHDT------KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSAS 721 (804)
Q Consensus 667 ~~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~ 721 (804)
.... ......||.+||+---..+...+.+.|+=|+|-++.+++-|..|+.....+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 3321 223356999999998888889999999999999999999999999876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.1e-18 Score=166.84 Aligned_cols=140 Identities=15% Similarity=0.140 Sum_probs=110.1
Q ss_pred cccccccCcceEEEEEecCCcEEEEEEecCcCCC---------------------------hHHHHHHHHHHhcCCCCcc
Q 038103 517 KQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQG---------------------------DAEFWAEVSIIGRINHRNL 569 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~---------------------------~~~~~~E~~~l~~l~H~ni 569 (804)
...||+|+||.||+|...+|+.||||+++..... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999878999999998743211 1123578899999999987
Q ss_pred cceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHh-hCCCcEEecccccCeEEEc
Q 038103 570 VKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE-ECLEWVLHCDVKPQNILLD 648 (804)
Q Consensus 570 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dlkp~NILl~ 648 (804)
.....+... ..+|||||++++++..... ....++......++.+++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence 554444333 3489999999876543321 12346778889999999999999999 88 99999999999999
Q ss_pred CCCCeEEeecCCcccccc
Q 038103 649 DHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 649 ~~~~~kl~Dfgla~~~~~ 666 (804)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=171.80 Aligned_cols=229 Identities=20% Similarity=0.185 Sum_probs=147.6
Q ss_pred cccccccCcceEEEEEecC-CcEEEEEEecCcC----CChHHHHHHHHHHhcCCC----------CcccceeeeE-----
Q 038103 517 KQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVL----QGDAEFWAEVSIIGRINH----------RNLVKLQGFC----- 576 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H----------~niv~l~g~~----- 576 (804)
.+.||.|+++.||.++... ++.+|||...... ...+++++|.-.+..+.+ -.++..++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4579999999999999765 8899999885222 234567777766655432 1222222221
Q ss_pred ----EeCC--------eeEEEEeeccCCChhhhhc---cCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccc
Q 038103 577 ----AENE--------HKLLVYEYVENGSLDKLLF---NDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVK 641 (804)
Q Consensus 577 ----~~~~--------~~~lV~E~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlk 641 (804)
.... ..+++|+-+.. +|..++. ........+....++.+..|+++.+++||..+ ++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-S
T ss_pred CcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccc
Confidence 1111 23677777744 8877753 22222334556677888899999999999999 9999999
Q ss_pred cCeEEEcCCCCeEEeecCCcccccccCCccccccccCCCccchhhhcc--------CCCCcccchHHHHHHHHHHHhCCC
Q 038103 642 PQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN--------LKIDAKADVYSYGIVLLELLTGKS 713 (804)
Q Consensus 642 p~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DV~S~Gvll~el~tg~~ 713 (804)
|+|++++.+|.++|+||+.....+..... ...+..|.|||.... -.++.+.|.|++|+++|.|++++.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999877754432221 234577999997743 247889999999999999999999
Q ss_pred CCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCC
Q 038103 714 ASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTR 779 (804)
Q Consensus 714 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R 779 (804)
||+.......... .-..+. +.++.+..|+...|+.+|.+|
T Consensus 249 Pf~~~~~~~~~~~-------------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW-------------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG-------------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc-------------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9986432211100 112344 667789999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.4e-17 Score=160.14 Aligned_cols=181 Identities=16% Similarity=0.106 Sum_probs=138.4
Q ss_pred cccccccCcceEEEEEecCCcEEEEEEecCcCCChH-----HHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEeecc
Q 038103 517 KQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDA-----EFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~-----~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
...|++|+||+||.+.- +++.++.+.+.....-.+ .+.+|+++|++++ |+++.+++++ ...+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 45799999999997665 677788887775443222 4789999999995 5788888886 44699999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEeccc-ccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDV-KPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
+.+|...+.. ....++.+++++|+++|+.+ |+|||| ||+|||++.++.++|+|||++........
T Consensus 82 G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 82 GAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred CccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9888654311 11357789999999999999 999999 79999999999999999999996544321
Q ss_pred c----c--------ccccccCCCccchhhhccC-CCC-cccchHHHHHHHHHHHhCCCCCc
Q 038103 670 T----K--------FSRVRGTRGYLAPEWMMNL-KID-AKADVYSYGIVLLELLTGKSASD 716 (804)
Q Consensus 670 ~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~k~DV~S~Gvll~el~tg~~p~~ 716 (804)
. . ..-...++.|+.|+..+-. ..+ ...+.++-|..+|.++|++.+.-
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 0 0112257888888865432 333 67899999999999999988763
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=155.73 Aligned_cols=134 Identities=18% Similarity=0.215 Sum_probs=102.9
Q ss_pred cccccccCcceEEEEEecCCcEEEEEEecCc-CCChHHHHHHHHHHhcC-----CCCcccceeeeEEeCC---eeE-EEE
Q 038103 517 KQEVGKGGFGSVFRGVLDDERVVAVKRLEGV-LQGDAEFWAEVSIIGRI-----NHRNLVKLQGFCAENE---HKL-LVY 586 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~~~-lV~ 586 (804)
.+.||+|+||.||. ...+.. .+||++... ....+++.+|+.++.++ .||||++++|++..+. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 35799999999996 323344 468887642 33457799999999999 5799999999998764 333 789
Q ss_pred ee--ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHH-HHHHhhCCCcEEecccccCeEEEcC----CCCeEEeecC
Q 038103 587 EY--VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGL-SYLHEECLEWVLHCDVKPQNILLDD----HFEPKVTDFG 659 (804)
Q Consensus 587 E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~Dfg 659 (804)
|| +.+++|.+++.+. .++.. ..++.+++.++ +|||+++ |+||||||+|||++. +.+++|+||+
T Consensus 85 e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred cCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 99 5579999999542 24444 35677788777 9999999 999999999999973 3489999954
Q ss_pred Ccc
Q 038103 660 LSK 662 (804)
Q Consensus 660 la~ 662 (804)
.+.
T Consensus 155 G~~ 157 (210)
T PRK10345 155 GES 157 (210)
T ss_pred CCc
Confidence 444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.3e-16 Score=159.16 Aligned_cols=196 Identities=20% Similarity=0.248 Sum_probs=136.5
Q ss_pred CCCcccceeeeEE---------------------------eCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHH
Q 038103 565 NHRNLVKLQGFCA---------------------------ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIA 617 (804)
Q Consensus 565 ~H~niv~l~g~~~---------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 617 (804)
+|||||++.++|. ++..+|+||.-.+. +|++++.. ...+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 6899998887753 23467899988866 99999954 345666777888
Q ss_pred HHHHHHHHHHHhhCCCcEEecccccCeEEE--cCC--CCeEEeecCCcccccc-----cCCccccccccCCCccchhhhc
Q 038103 618 VGTAKGLSYLHEECLEWVLHCDVKPQNILL--DDH--FEPKVTDFGLSKLFKE-----RHDTKFSRVRGTRGYLAPEWMM 688 (804)
Q Consensus 618 ~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl--~~~--~~~kl~Dfgla~~~~~-----~~~~~~~~~~gt~~y~aPE~~~ 688 (804)
.|+++|+.|||.++ |.|||+|++|||+ |++ -.+.|+|||.+---+. ......-...|...-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 9999999999998 444 3578999998764222 1112222345788899999875
Q ss_pred cCC--C----CcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHH
Q 038103 689 NLK--I----DAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLD 762 (804)
Q Consensus 689 ~~~--~----s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 762 (804)
..+ . -.|+|.|+.|.+.||+++...||-.....- .+. +..++.++ |.+....+ .
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---------L~~--r~Yqe~qL-----Palp~~vp----p 484 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---------LDT--RTYQESQL-----PALPSRVP----P 484 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---------ech--hhhhhhhC-----CCCcccCC----h
Confidence 432 1 258999999999999999999985422110 000 00111112 22222233 3
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHh
Q 038103 763 RMVKVALLCVAENRDTRPPMSKVVKLL 789 (804)
Q Consensus 763 ~l~~l~~~Cl~~~P~~RPtm~~Vv~~L 789 (804)
.+.+|+...++.||.+||+..-....|
T Consensus 485 ~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHHHHhcCCccccCCccHHHhHH
Confidence 577888899999999999875544443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-15 Score=178.52 Aligned_cols=198 Identities=24% Similarity=0.288 Sum_probs=158.1
Q ss_pred HHHHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCC---CCcccceeeeEEeCCeeE
Q 038103 507 AELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN---HRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 507 ~~l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~ 583 (804)
-++...++-+.++||+|+||+||+|...+|+.||+|.=+..... +|.-=.+++.+|+ -+.|+.+.....-.+.-+
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 34555666777889999999999999888999999986633222 2323334444554 233444444455566778
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc-------CCCCeEEe
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD-------DHFEPKVT 656 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~-------~~~~~kl~ 656 (804)
||+||.+-|+|.+++. ..+.++|.....++.|+++.++.||..+ |||+||||+|.||. +...++|+
T Consensus 771 lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 9999999999999996 4567999999999999999999999999 99999999999994 33468999
Q ss_pred ecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCC
Q 038103 657 DFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKS 713 (804)
Q Consensus 657 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~ 713 (804)
|||-+-.+.--.+ .......+|-.+-.+|...+.+++..+|.|.++-+++-|+.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999986654333 46667778999999999999999999999999999999999874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-16 Score=171.21 Aligned_cols=173 Identities=21% Similarity=0.317 Sum_probs=131.1
Q ss_pred eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCC
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGL 660 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 660 (804)
.+++.|+++...+|.++|...+ .....++...++++.|++.|++| ++ .+|+|+||.||+...+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999997533 45668899999999999999999 56 89999999999999999999999999
Q ss_pred cccccccC-----CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHH
Q 038103 661 SKLFKERH-----DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 661 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
........ ....+...||..||+||++.+..|+.|+||||||++|+|++. -...++-. .
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---------------~ 467 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---------------A 467 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---------------H
Confidence 99776654 334556789999999999999999999999999999999998 22222110 0
Q ss_pred HHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 038103 735 VAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSK 784 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~ 784 (804)
...-++++.+. +....+++ .=..|+.+++..+|.+||+..+
T Consensus 468 t~~d~r~g~ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 468 TLTDIRDGIIP----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhhhhhcCCCC----hHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 11122222222 11111122 2246778899999999994443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=153.90 Aligned_cols=141 Identities=15% Similarity=0.134 Sum_probs=108.3
Q ss_pred hcccccccccCcceEEEEE--ecCCcEEEEEEecCcCCC-------------------------hHHHHHHHHHHhcCCC
Q 038103 514 RNFKQEVGKGGFGSVFRGV--LDDERVVAVKRLEGVLQG-------------------------DAEFWAEVSIIGRINH 566 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~--~~~~~~vavK~l~~~~~~-------------------------~~~~~~E~~~l~~l~H 566 (804)
+.+.+.||+|+||.||+|. ..+|+.||||.++..... ...+..|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4567889999999999998 568999999998743210 0125679999999975
Q ss_pred Cc--ccceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCe
Q 038103 567 RN--LVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQN 644 (804)
Q Consensus 567 ~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 644 (804)
.. +.++++. ...++||||+++.+|...... ...+.......++.|++.++++||+.+. |+|+||||+|
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhh
Confidence 32 3334432 235899999999888766532 2234555667899999999999999874 9999999999
Q ss_pred EEEcCCCCeEEeecCCccccc
Q 038103 645 ILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 645 ILl~~~~~~kl~Dfgla~~~~ 665 (804)
|+++ ++.++|+|||++....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999988543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.7e-15 Score=150.36 Aligned_cols=136 Identities=15% Similarity=0.148 Sum_probs=107.7
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCcCCC-----------------------hHHHHHHHHHHhcCCCCc--
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQG-----------------------DAEFWAEVSIIGRINHRN-- 568 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~-----------------------~~~~~~E~~~l~~l~H~n-- 568 (804)
+.+.+.||+|+||.||++..++++.||||++...... ...+..|..++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5667889999999999999888999999987632211 112567888888888774
Q ss_pred ccceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc
Q 038103 569 LVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD 648 (804)
Q Consensus 569 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~ 648 (804)
+.+.++ ....++||||+++++|...... .....++.+++.++.++|+.+ |+|+||||+||+++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~ 159 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVD 159 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEc
Confidence 444443 2345899999999998765421 234678899999999999988 99999999999999
Q ss_pred CCCCeEEeecCCcccccc
Q 038103 649 DHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 649 ~~~~~kl~Dfgla~~~~~ 666 (804)
+++.++|+|||++.....
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.1e-15 Score=151.58 Aligned_cols=133 Identities=17% Similarity=0.279 Sum_probs=112.5
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcC-CC--------hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVL-QG--------DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~-~~--------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+.||+|++|.||+|.. .+..+++|+..... .. ...+.+|++++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 55678899765322 11 13577899999999999998888888777888999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+++++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998531 12 77899999999999999998 99999999999999 78999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.9e-17 Score=175.06 Aligned_cols=184 Identities=28% Similarity=0.283 Sum_probs=151.4
Q ss_pred ccccCcceEEEEE----ecCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEeeccC
Q 038103 520 VGKGGFGSVFRGV----LDDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 520 LG~G~fg~Vykg~----~~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+|+|.||.|+.++ .+.+..+|.|.+++... .......|..++...+ ||.+|++.-.+..+...+++.++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7899999999876 23466788887763221 1124556788888887 99999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|.|...+.. ...............++-+++++|+.+ |+|+|+|++||+++.+|++|+.|||+.+..-.....
T Consensus 82 g~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999888753 333455555566677889999999999 999999999999999999999999999976443222
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7899999999998 677899999999999999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.3e-15 Score=147.88 Aligned_cols=129 Identities=18% Similarity=0.273 Sum_probs=106.2
Q ss_pred cccccCcceEEEEEecCCcEEEEEEecC-cCCC--------hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 519 EVGKGGFGSVFRGVLDDERVVAVKRLEG-VLQG--------DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~~~~~vavK~l~~-~~~~--------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
.||+|+||.||+|.. ++..+++|.... .... ..++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999995 557789998652 2111 245678999999999888766666666777789999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
++++|.+++... . ..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~----~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG----N-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc----H-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887431 0 078999999999999998 99999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.6e-15 Score=171.27 Aligned_cols=133 Identities=19% Similarity=0.257 Sum_probs=109.7
Q ss_pred ccccccccCcceEEEEEecCCcEEEEEEecCcCC--------ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ--------GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 516 ~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
..+.||+|+||.||+|.+.+...++.+++..... ..+++.+|++++.+++|++++....++......++|||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred ccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 4578999999999999976655433333322111 12457889999999999999988888888778899999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
|+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999998883 34678999999999999998 9999999999999 6779999999999853
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.4e-14 Score=141.04 Aligned_cols=137 Identities=18% Similarity=0.178 Sum_probs=96.6
Q ss_pred cccccccCcceEEEEEecCCcEEEEEEecCcCCChHH---H----------------------HHHHHHHhcCCCCc--c
Q 038103 517 KQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAE---F----------------------WAEVSIIGRINHRN--L 569 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~---~----------------------~~E~~~l~~l~H~n--i 569 (804)
.+.||+|+||.||++...+++.||||++........+ + ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999988743221111 1 23445555553332 3
Q ss_pred cceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHh-hCCCcEEecccccCeEEEc
Q 038103 570 VKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE-ECLEWVLHCDVKPQNILLD 648 (804)
Q Consensus 570 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dlkp~NILl~ 648 (804)
.+.++. ...++||||++++.+........ ... .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 333332 24689999999965432211100 011 5667899999999999999 77 99999999999999
Q ss_pred CCCCeEEeecCCcccccc
Q 038103 649 DHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 649 ~~~~~kl~Dfgla~~~~~ 666 (804)
++.++|+|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 88999999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.2e-14 Score=114.77 Aligned_cols=61 Identities=34% Similarity=0.774 Sum_probs=52.4
Q ss_pred CCcceEEcCCCCccCcceeeeccCCCHHHHHHHhccCCceeeEEeecC-CCCeeeec-ccccc
Q 038103 336 NELDFMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCKGFGYSTD-GQGECFPK-GNLLN 396 (804)
Q Consensus 336 ~~~~f~~l~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ay~y~~~-g~g~C~~~-~~l~~ 396 (804)
.+++|++|+++++|++....++.++++++|++.||+||||+||+|.+. +++.|++| ++|+|
T Consensus 3 ~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 3 SGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 457899999999999877776677999999999999999999999742 56789988 67765
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.2e-13 Score=129.49 Aligned_cols=134 Identities=22% Similarity=0.213 Sum_probs=113.2
Q ss_pred cccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCC--CcccceeeeEEeCCeeEEEEeeccCCCh
Q 038103 517 KQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINH--RNLVKLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
.+.||+|.++.||++...+ ..+++|....... ..++.+|+.++..++| .++.+++++....+..++++||++++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 3579999999999999866 6799998865433 5678999999999976 5899999888877889999999988766
Q ss_pred hhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 595 DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
..+ +......++.++++++++||......++|+|++|+||+++..+.+++.|||.+..
T Consensus 81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 543 4556678899999999999996544599999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-13 Score=158.10 Aligned_cols=95 Identities=33% Similarity=0.424 Sum_probs=82.7
Q ss_pred HHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC--------------CccccccccCCCccchhh
Q 038103 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH--------------DTKFSRVRGTRGYLAPEW 686 (804)
Q Consensus 621 a~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~--------------~~~~~~~~gt~~y~aPE~ 686 (804)
+.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+.+...... ......++||+.|+|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 78999999999 9999999999999999999999999998542111 112234689999999999
Q ss_pred hccCCCCcccchHHHHHHHHHHHhCCCCCccc
Q 038103 687 MMNLKIDAKADVYSYGIVLLELLTGKSASDYL 718 (804)
Q Consensus 687 ~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~ 718 (804)
+....|....|.|++|+|+||.+-|+.||...
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 99999999999999999999999999999753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.5e-13 Score=136.42 Aligned_cols=133 Identities=19% Similarity=0.185 Sum_probs=103.3
Q ss_pred cccc-ccCcceEEEEEecCCcEEEEEEecCcC--------------CChHHHHHHHHHHhcCCCCcc--cceeeeEEeCC
Q 038103 518 QEVG-KGGFGSVFRGVLDDERVVAVKRLEGVL--------------QGDAEFWAEVSIIGRINHRNL--VKLQGFCAENE 580 (804)
Q Consensus 518 ~~LG-~G~fg~Vykg~~~~~~~vavK~l~~~~--------------~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~ 580 (804)
..|| .||.|+||++... +..++||++.... .....+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4587 8899999999885 5568889875210 122457889999999998775 67777654332
Q ss_pred ----eeEEEEeeccC-CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEE
Q 038103 581 ----HKLLVYEYVEN-GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKV 655 (804)
Q Consensus 581 ----~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 655 (804)
..++|+|++++ .+|.+++.. ..++. ..+.+++.+|.+||+.+ |+|+||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-----APLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-----CCCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 23599999997 689888853 12333 24678999999999999 999999999999999889999
Q ss_pred eecCCccc
Q 038103 656 TDFGLSKL 663 (804)
Q Consensus 656 ~Dfgla~~ 663 (804)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99999885
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.6e-14 Score=163.16 Aligned_cols=250 Identities=24% Similarity=0.304 Sum_probs=182.3
Q ss_pred HhcccccccccCcceEEEEEecC--CcEEEEEEecCcCCCh---HHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDD--ERVVAVKRLEGVLQGD---AEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~--~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 586 (804)
.+.+.+.||+|+|+.|-...... ...+|+|.+....... +....|..+=..+. |+|++++++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 35566779999999999888643 4457777766433222 33344666666665 999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHH-hhCCCcEEecccccCeEEEcCCC-CeEEeecCCcccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH-EECLEWVLHCDVKPQNILLDDHF-EPKVTDFGLSKLF 664 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~ 664 (804)
++..++++.+.+... .....+....-..+.|+..++.|+| ..+ +.|+||||+|.+++..+ ..|++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~~~--~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHP--DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred CcccccccccccccC--CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999998888311 1113444555678899999999999 777 99999999999999999 9999999999987
Q ss_pred cc--cCCcccccccc-CCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 665 KE--RHDTKFSRVRG-TRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 665 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
.. ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|.+........
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~---------------- 239 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR---------------- 239 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc----------------
Confidence 66 33344455667 9999999998874 4567899999999999999999998764422211
Q ss_pred hcCcccccCCcCC--CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038103 741 QEGLEKIIDPRLN--DVYDREKLDRMVKVALLCVAENRDTRPPMSKVV 786 (804)
Q Consensus 741 ~~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv 786 (804)
...+.+.... ............++...++..+|..|.+.+++.
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 240 ---YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ---ceeecccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 1111111100 011111223566777788889999999988764
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.3e-13 Score=113.56 Aligned_cols=80 Identities=28% Similarity=0.611 Sum_probs=62.9
Q ss_pred cccccCC--CcceEEcCCCCccCcceeeeccCCCHHHHHHHhccCCceeeEEeecCCCCeeeecc-ccccCcccCCCcce
Q 038103 330 NLSCDRN--ELDFMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCKGFGYSTDGQGECFPKG-NLLNGHNMPGKYVS 406 (804)
Q Consensus 330 ~l~C~~~--~~~f~~l~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ay~y~~~g~g~C~~~~-~l~~~~~~~~~~~~ 406 (804)
+++|+.+ ...|++++++++|++.... .+.++++|++.||+||+|.||+|.+ ++|.|++|. .+.+.+.....+.+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~-~~~~C~~~~~~~~~~~~~~~~~~~ 78 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN-GSGGCLLWNGLLNNLRSLSSGGGT 78 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC-CCCeEEEEeceecceEeecCCCcE
Confidence 4567655 3689999999999775543 6789999999999999999999985 578899885 45554544445689
Q ss_pred EEEEec
Q 038103 407 MHIKIP 412 (804)
Q Consensus 407 ~yik~~ 412 (804)
+||||+
T Consensus 79 ~yiKv~ 84 (84)
T cd01098 79 LYLRLA 84 (84)
T ss_pred EEEEeC
Confidence 999985
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.8e-13 Score=134.18 Aligned_cols=154 Identities=19% Similarity=0.283 Sum_probs=121.1
Q ss_pred HHHhcCCCCcccceeeeEEeC-----CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCC
Q 038103 559 SIIGRINHRNLVKLQGFCAEN-----EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633 (804)
Q Consensus 559 ~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~ 633 (804)
.-|-++.|.|||+++.|+.+. .+..++.|||..|+|..+|++.+...+.+......++..||..||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 445566799999999998643 3568999999999999999887767778888888999999999999999976 7
Q ss_pred cEEecccccCeEEEcCCCCeEEeecCCccccc---ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh
Q 038103 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK---ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710 (804)
Q Consensus 634 ~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t 710 (804)
+|+|+++..+.|++..++-+||+--.-...-. .........-.+-++|.+||+-.....+.++|||+||+..+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 79999999999999999999985321111100 001111223346789999998877778889999999999999988
Q ss_pred CCC
Q 038103 711 GKS 713 (804)
Q Consensus 711 g~~ 713 (804)
+..
T Consensus 278 lEi 280 (458)
T KOG1266|consen 278 LEI 280 (458)
T ss_pred hee
Confidence 654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.27 E-value=2e-11 Score=136.28 Aligned_cols=140 Identities=21% Similarity=0.262 Sum_probs=99.2
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCC---------------------------h--------------HHHHH
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQG---------------------------D--------------AEFWA 556 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~---------------------------~--------------~~~~~ 556 (804)
+.||.|++|.||+|++.+|+.||||+.+..... . -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 359999999999999999999999998632100 0 01344
Q ss_pred HHHHHhcC----CCCcccceeeeEE-eCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHH-HHHHHHhh
Q 038103 557 EVSIIGRI----NHRNLVKLQGFCA-ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK-GLSYLHEE 630 (804)
Q Consensus 557 E~~~l~~l----~H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~l~yLH~~ 630 (804)
|+..+.++ +|.+-+.+-.++. .....+|||||+++++|.++...... .. .+.+++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHhC
Confidence 55444444 2333333333332 23457999999999999887643111 11 24567777666 47888998
Q ss_pred CCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 631 ~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
+ ++|+|++|.||++++++++++.|||++..+..
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=2e-11 Score=100.82 Aligned_cols=67 Identities=15% Similarity=0.107 Sum_probs=55.8
Q ss_pred cceEEcCCCCccCcceeeeccCCCHHHHHHHhcc---CCceeeEEeecCCCCeeeec-ccc-ccCcccCCCcceEEEEe
Q 038103 338 LDFMELPNTDYYGYDLVTYGIGISLQECRNRCLS---DCKCKGFGYSTDGQGECFPK-GNL-LNGHNMPGKYVSMHIKI 411 (804)
Q Consensus 338 ~~f~~l~~~~~~~~~~~~~~~~~s~~~C~~~Cl~---nCsC~Ay~y~~~g~g~C~~~-~~l-~~~~~~~~~~~~~yik~ 411 (804)
..|+++.+++.|++.. +++++|+++|++ ||||+||+|.+.+ ++|++| ++| ++.++.+..+.++|+|.
T Consensus 9 g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~~-~gC~~W~~~l~~d~~~~~~~g~~Ly~r~ 80 (80)
T cd00129 9 GTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKAR-KQCLWFPFNSMSGVRKEFSHGFDLYENK 80 (80)
T ss_pred CeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCCC-CCeEEecCcchhhHHhccCCCceeEeEC
Confidence 4699999999887643 689999999999 9999999997644 468777 777 78888887899999983
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-10 Score=113.65 Aligned_cols=130 Identities=18% Similarity=0.051 Sum_probs=97.3
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccc-eeeeEEeCCeeEEEEeeccCCChhh
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVK-LQGFCAENEHKLLVYEYVENGSLDK 596 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~E~~~~gsL~~ 596 (804)
+.|+.|.++.||++... ++.+++|...........+.+|+.++..+.+.++++ ++.+. ....++||||+++.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 46889999999999975 667999987644323345678999999887655544 44332 334589999999987754
Q ss_pred hhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhC--CCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 597 LLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC--LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 597 ~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
.- .....++.+++++|+.||... ...++|+|++|.||+++ ++.+++.||+.+..
T Consensus 81 ~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 31 011345678999999999987 23369999999999999 66899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.1e-11 Score=131.64 Aligned_cols=252 Identities=21% Similarity=0.212 Sum_probs=178.8
Q ss_pred hHHHHHHHhcccccccc--cCcceEEEEEe---cCCcEEEEEEecCcC---CChHHHHHHHHHHhcC-CCCcccceeeeE
Q 038103 506 YAELKRATRNFKQEVGK--GGFGSVFRGVL---DDERVVAVKRLEGVL---QGDAEFWAEVSIIGRI-NHRNLVKLQGFC 576 (804)
Q Consensus 506 ~~~l~~~t~~~~~~LG~--G~fg~Vykg~~---~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 576 (804)
..+....+..+.+.+|. |.+|.||++.. .++..+|+|+-+... .....-.+|+..-.++ .|+|.++....+
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 34455667778889999 99999999986 457789999854222 2223334566666666 499999999999
Q ss_pred EeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHH----HHHHHHhhCCCcEEecccccCeEEEcCC-C
Q 038103 577 AENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK----GLSYLHEECLEWVLHCDVKPQNILLDDH-F 651 (804)
Q Consensus 577 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~ 651 (804)
...+..++-+|++. .+|..+... ....+.....+....+..+ ||.++|... ++|-|+||.||++..+ .
T Consensus 188 e~~~~lfiqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 188 EGSGILFIQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWT 260 (524)
T ss_pred ccCCcceeeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccc
Confidence 99999999999986 588888754 2223455556666666666 999999988 9999999999999999 8
Q ss_pred CeEEeecCCcccccccCCc----cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccc
Q 038103 652 EPKVTDFGLSKLFKERHDT----KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSY 727 (804)
Q Consensus 652 ~~kl~Dfgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~ 727 (804)
..+++|||+...+...... ......+...|++||...+ .++.+.|+|++|.+++|..++.+..-.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------ 333 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------ 333 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------
Confidence 8999999999988764421 1123357788999997654 6788999999999999999987765321100
Q ss_pred hhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038103 728 CNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVV 786 (804)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv 786 (804)
. |...+.+. +..++-..-...+..+..++++.+|..|++.+.+.
T Consensus 334 -----~--W~~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 334 -----S--WSQLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred -----C--cccccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 0 11111111 11111111122344588889999999999876554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.1e-09 Score=119.26 Aligned_cols=166 Identities=18% Similarity=0.180 Sum_probs=123.2
Q ss_pred ecCCcEEEEEEecCcCCC-hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHH
Q 038103 533 LDDERVVAVKRLEGVLQG-DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWD 611 (804)
Q Consensus 533 ~~~~~~vavK~l~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~ 611 (804)
..++.+|.|...+..... .+...+-++.++.++||||++++....+....|||+|-+. .|..++.+ +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 456788888888743332 2446778889999999999999999999999999999874 46666643 2344
Q ss_pred hHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccccccccCCCccchhhhccCC
Q 038103 612 QRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK 691 (804)
Q Consensus 612 ~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 691 (804)
...--+.||+.||.|||+.+. ++|++|..+.|++++.|+.||++|.++........ ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 555677899999999998775 99999999999999999999999988864332211 011111123456666443222
Q ss_pred CCcccchHHHHHHHHHHHhCC
Q 038103 692 IDAKADVYSYGIVLLELLTGK 712 (804)
Q Consensus 692 ~s~k~DV~S~Gvll~el~tg~ 712 (804)
-..|.|-||++++|++.|.
T Consensus 182 --~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred --cchhhhhHHHHHHHHhCcc
Confidence 3569999999999999993
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.3e-10 Score=129.15 Aligned_cols=140 Identities=14% Similarity=0.185 Sum_probs=88.9
Q ss_pred ccccccCcceEEEEEecC-CcEEEEEEecCcCC---------------------------Ch--------------HHHH
Q 038103 518 QEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQ---------------------------GD--------------AEFW 555 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~---------------------------~~--------------~~~~ 555 (804)
+.||+|++|.||+|++++ |+.||||+++.... .. -++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 359999999999999987 99999999963210 00 0133
Q ss_pred HHHHHHhcC----CCCcccceeeeEEe-CCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHH-HHHHHHh
Q 038103 556 AEVSIIGRI----NHRNLVKLQGFCAE-NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK-GLSYLHE 629 (804)
Q Consensus 556 ~E~~~l~~l----~H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~l~yLH~ 629 (804)
+|+..+.++ .+.+.+.+-.++.+ ....+|||||++++.+.++-.-. ..+ .+ +..++...++ -+.-+..
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g--~d---~~~la~~~v~~~~~Qif~ 278 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAG--TD---MKLLAERGVEVFFTQVFR 278 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcC--CC---HHHHHHHHHHHHHHHHHh
Confidence 344444433 23333443333332 34678999999999997742110 011 11 1122222222 1233345
Q ss_pred hCCCcEEecccccCeEEEcCCC----CeEEeecCCcccccc
Q 038103 630 ECLEWVLHCDVKPQNILLDDHF----EPKVTDFGLSKLFKE 666 (804)
Q Consensus 630 ~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgla~~~~~ 666 (804)
.+ ++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 279 ~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 279 DG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 66 99999999999999888 999999999987754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.9e-09 Score=106.82 Aligned_cols=141 Identities=18% Similarity=0.213 Sum_probs=109.3
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCC--CcccceeeeEEeCC---eeEEEEeecc
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINH--RNLVKLQGFCAENE---HKLLVYEYVE 590 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~E~~~ 590 (804)
+.|+.|..+.||++...+|+.+++|....... ...++..|+++++.+++ .++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999987777899998764332 35678899999999976 44567777776543 5689999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhC---------------------------------------
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC--------------------------------------- 631 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--------------------------------------- 631 (804)
+.++...+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888776521 23666777788888888888888521
Q ss_pred --------------CCcEEecccccCeEEEcC--CCCeEEeecCCccc
Q 038103 632 --------------LEWVLHCDVKPQNILLDD--HFEPKVTDFGLSKL 663 (804)
Q Consensus 632 --------------~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~ 663 (804)
...++|+|+++.||++++ ++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 133899999999999998 56689999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.8e-08 Score=98.96 Aligned_cols=135 Identities=16% Similarity=0.125 Sum_probs=95.6
Q ss_pred ccccccCcceEEEEEecC-------CcEEEEEEecCcC---CC--------------------hHHH----HHHHHHHhc
Q 038103 518 QEVGKGGFGSVFRGVLDD-------ERVVAVKRLEGVL---QG--------------------DAEF----WAEVSIIGR 563 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~-------~~~vavK~l~~~~---~~--------------------~~~~----~~E~~~l~~ 563 (804)
..||.|.=+.||.|.-.+ +..+|||..+... ++ ...+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998553 4789999874211 00 0112 268888888
Q ss_pred CCC--CcccceeeeEEeCCeeEEEEeeccCCChhh-hhccCCCCCCCCCHHhHHHHHHHHHHHHHHH-HhhCCCcEEecc
Q 038103 564 INH--RNLVKLQGFCAENEHKLLVYEYVENGSLDK-LLFNDPGTASILQWDQRYNIAVGTAKGLSYL-HEECLEWVLHCD 639 (804)
Q Consensus 564 l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivH~D 639 (804)
+.. -++.+++.+ ...+|||||+.+..+.. .+.. ..++.....++..+++.+|..| |..+ ++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 843 345555543 46689999997654322 2211 1234455667889999999999 7877 99999
Q ss_pred cccCeEEEcCCCCeEEeecCCccccc
Q 038103 640 VKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 640 lkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|++.|||+++ +.++|+|||.+....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.5e-09 Score=119.52 Aligned_cols=243 Identities=22% Similarity=0.267 Sum_probs=169.6
Q ss_pred hcccccccccCcceEEEEEe--cCCcEEEEEEecCcCCCh-H--HHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEe
Q 038103 514 RNFKQEVGKGGFGSVFRGVL--DDERVVAVKRLEGVLQGD-A--EFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~--~~~~~vavK~l~~~~~~~-~--~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 587 (804)
..+...||.|.|+.|++... .++..+++|.+.+..... . .-..|+.+...+ .|.+.++....+....+.++--|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 34456799999999999874 467889999887443322 1 123455555555 58899998888888888899999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC-CCeEEeecCCcccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH-FEPKVTDFGLSKLFKE 666 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~ 666 (804)
|++++++...+. ....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +.-+++|||.+..+.-
T Consensus 347 ~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 347 FCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred hhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccce
Confidence 999998776662 3445778888999999999999999988 9999999999999876 7889999999974221
Q ss_pred cCCccccccccCCCc-cchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 667 RHDTKFSRVRGTRGY-LAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y-~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
... .-...+..| .+|+......+..+.|+||||.-+.|.+++........ . +..+..+..
T Consensus 420 ~~~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------------~--~~~i~~~~~- 480 (524)
T KOG0601|consen 420 SSG---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------------Q--SLTIRSGDT- 480 (524)
T ss_pred ecc---cccccccccccchhhccccccccccccccccccccccccCcccCcccc-------------c--ceeeecccc-
Confidence 111 011122334 35666667788999999999999999999875433211 0 001111111
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
+.+.+ ..+....++..+...++..||.+.+...+.+-
T Consensus 481 ----p~~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 481 ----PNLPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ----cCCCc-----hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11111 11345566677888999999998887766543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.2e-08 Score=94.74 Aligned_cols=129 Identities=19% Similarity=0.269 Sum_probs=100.2
Q ss_pred cccccCcceEEEEEecCCcEEEEE-EecCcCCCh--------HHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 519 EVGKGGFGSVFRGVLDDERVVAVK-RLEGVLQGD--------AEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~~~~~vavK-~l~~~~~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
.+++|+=..+|.+.+-+.. +++| ++.+..... +.-.+|+.++.+++--.|.-..-+..+.....|+|||.
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4778999999999765544 4444 444443322 34677999999987666655566677788889999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
++..|.+.+... +..++..+-.-+.-||..+ |+|+||.++||++..+. +.+.||||+..
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888542 3567777888888999999 99999999999998875 99999999985
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.82 E-value=7.1e-08 Score=103.89 Aligned_cols=169 Identities=19% Similarity=0.296 Sum_probs=130.2
Q ss_pred cceEEEEEe-cCCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEE----eCCeeEEEEeeccC-CChhhh
Q 038103 525 FGSVFRGVL-DDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCA----ENEHKLLVYEYVEN-GSLDKL 597 (804)
Q Consensus 525 fg~Vykg~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~ 597 (804)
-.+.||+.. .||..+++||+...+ +.......-+++++++.|.|+|++..++. .+..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357899984 578999999995322 22223345678899999999999999876 34578999999986 477777
Q ss_pred hccCCC-----------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 598 LFNDPG-----------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 598 l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
-+..+. .+..+.+..+|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 655432 2344667899999999999999999999 77799999999999999999999998887655
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSA 714 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p 714 (804)
+... | + .--.+-|.=.||.+++.|.||...
T Consensus 446 d~~~-------------~--l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTE-------------P--L---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCc-------------c--h---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 4311 0 1 112467899999999999999765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.2e-08 Score=93.08 Aligned_cols=142 Identities=16% Similarity=0.250 Sum_probs=103.6
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCC--------hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQG--------DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~--------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
..+-+|+-+.|+++..++...+.-+++.+.... ..+.++|++.+.+++--.|.-..-++.+...-.|+|||+
T Consensus 13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 457889999999999876554444455443322 245778999999987656655555677777888999999
Q ss_pred cC-CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC---CeEEeecCCcccc
Q 038103 590 EN-GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF---EPKVTDFGLSKLF 664 (804)
Q Consensus 590 ~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfgla~~~ 664 (804)
++ .++.+++...-. ....-.....++..|-+.+.-||... |+|+||..+||++..++ .+.+.|||++...
T Consensus 93 ~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 93 DGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred cchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 77 478888865211 11222223678888999999999999 99999999999996544 3589999998853
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.4e-06 Score=91.80 Aligned_cols=262 Identities=14% Similarity=0.119 Sum_probs=152.6
Q ss_pred ccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeE-------EeCCeeEEEEe
Q 038103 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFC-------AENEHKLLVYE 587 (804)
Q Consensus 516 ~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~-------~~~~~~~lV~E 587 (804)
....||+|+-+.+|-.--- +. -+.|+........+ .+.+..|.+. .||-+-.-+.+= ......-++|.
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecchh-hc-hhheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 3567999999999954311 11 23366553322111 1223333333 455433312110 11222456667
Q ss_pred eccCC-ChhhhhccC--CCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 588 YVENG-SLDKLLFND--PGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 588 ~~~~g-sL~~~l~~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
.+++. ....+.... ..+-...+|+..++.+..+|.+.+-||+.| .+-+|+.++|+|+.+++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence 66654 222222211 112245789999999999999999999999 688999999999999999999986554433
Q ss_pred cccCCccccccccCCCccchhhhc-----cCCCCcccchHHHHHHHHHHHhC-CCCCcccccccCC-ccchhhHHHHHHH
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMM-----NLKIDAKADVYSYGIVLLELLTG-KSASDYLSASASD-SSYCNHLVQWVAK 737 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvll~el~tg-~~p~~~~~~~~~~-~~~~~~~~~~~~~ 737 (804)
..........|...|.+||... +..-+...|-|.+|+++++++.| ++||.....-... ...+..+
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I------ 239 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI------ 239 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh------
Confidence 2233334466889999999865 23346789999999999999986 9999764321111 0111011
Q ss_pred HhhhcCcccccCCcC-----CCccCH-HHHHHHHHHHHhcccC--CCCCCCCHHHHHHHhccCCC
Q 038103 738 QMEQEGLEKIIDPRL-----NDVYDR-EKLDRMVKVALLCVAE--NRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 738 ~~~~~~~~~~~d~~l-----~~~~~~-~~~~~l~~l~~~Cl~~--~P~~RPtm~~Vv~~L~~~~~ 794 (804)
..+.+...-+.+. ....+. -....+--|..+|+.. ++.-|||++..+..|..+.+
T Consensus 240 --a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 240 --AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred --hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 1111111111000 000111 1122445566677764 36689999999888865544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.3e-07 Score=88.36 Aligned_cols=125 Identities=22% Similarity=0.231 Sum_probs=81.6
Q ss_pred eEEEEEecCCcEEEEEEecCcCCC---------------------------hHHHHHHHHHHhcCCCC--cccceeeeEE
Q 038103 527 SVFRGVLDDERVVAVKRLEGVLQG---------------------------DAEFWAEVSIIGRINHR--NLVKLQGFCA 577 (804)
Q Consensus 527 ~Vykg~~~~~~~vavK~l~~~~~~---------------------------~~~~~~E~~~l~~l~H~--niv~l~g~~~ 577 (804)
.||.|...++..+|||..+..... .....+|.+.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999999999999987421100 02356799999999765 44555543
Q ss_pred eCCeeEEEEeecc--CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHH-HHhhCCCcEEecccccCeEEEcCCCCeE
Q 038103 578 ENEHKLLVYEYVE--NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY-LHEECLEWVLHCDVKPQNILLDDHFEPK 654 (804)
Q Consensus 578 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~y-LH~~~~~~ivH~Dlkp~NILl~~~~~~k 654 (804)
....|||||++ +..+..+... .++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence 23479999998 5445443321 11134456677888886655 56877 9999999999999988 999
Q ss_pred EeecCCccccc
Q 038103 655 VTDFGLSKLFK 665 (804)
Q Consensus 655 l~Dfgla~~~~ 665 (804)
|.|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=8.5e-07 Score=92.24 Aligned_cols=132 Identities=14% Similarity=0.060 Sum_probs=95.6
Q ss_pred ceEEEEEecCCcEEEEEEecCcCC------------ChHHHHHHHHHHhcCCC--CcccceeeeEEe-----CCeeEEEE
Q 038103 526 GSVFRGVLDDERVVAVKRLEGVLQ------------GDAEFWAEVSIIGRINH--RNLVKLQGFCAE-----NEHKLLVY 586 (804)
Q Consensus 526 g~Vykg~~~~~~~vavK~l~~~~~------------~~~~~~~E~~~l~~l~H--~niv~l~g~~~~-----~~~~~lV~ 586 (804)
..|++..+ +|+.+.||+...... ....+.+|...+.++.. -...+++++... ...-+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34667666 556799997743221 11247789999888843 334455556543 23568999
Q ss_pred eeccCC-ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-------CCCeEEeec
Q 038103 587 EYVENG-SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-------HFEPKVTDF 658 (804)
Q Consensus 587 E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~-------~~~~kl~Df 658 (804)
|++++. +|.+++.... ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +..+.++||
T Consensus 115 e~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 115 EDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred eeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 999886 8988884321 123455677789999999999999999 999999999999975 468999999
Q ss_pred CCccc
Q 038103 659 GLSKL 663 (804)
Q Consensus 659 gla~~ 663 (804)
+.+..
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.2e-08 Score=115.92 Aligned_cols=192 Identities=22% Similarity=0.230 Sum_probs=132.1
Q ss_pred CCCcccceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCe
Q 038103 565 NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQN 644 (804)
Q Consensus 565 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 644 (804)
+||-+++..--+......+|+++|..+++|...|+..+ ..+..........+..+++|||... +.|+|++|.|
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~ 934 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDS 934 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccc
Confidence 44555555544455668899999999999999987643 2333334445566788999999987 8999999999
Q ss_pred EEEcCCCCeEEeecCCccccccc--------------------------CC----ccccccccCCCccchhhhccCCCCc
Q 038103 645 ILLDDHFEPKVTDFGLSKLFKER--------------------------HD----TKFSRVRGTRGYLAPEWMMNLKIDA 694 (804)
Q Consensus 645 ILl~~~~~~kl~Dfgla~~~~~~--------------------------~~----~~~~~~~gt~~y~aPE~~~~~~~s~ 694 (804)
+|+..+++.+++||+........ .. .......+|+.|.+||...+.....
T Consensus 935 ~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs 1014 (1205)
T KOG0606|consen 935 LLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGS 1014 (1205)
T ss_pred hhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCC
Confidence 99999999999999844322100 00 1122356899999999999999999
Q ss_pred ccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCC-ccCHHHHHHHHHHHHhccc
Q 038103 695 KADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLND-VYDREKLDRMVKVALLCVA 773 (804)
Q Consensus 695 k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~ 773 (804)
.+|.|+.|++++|.++|..||+...+. .+. ..++...+.. .-+.+......+++..-+.
T Consensus 1015 ~ad~~~~g~~l~e~l~g~pp~na~tpq------------~~f--------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~ 1074 (1205)
T KOG0606|consen 1015 AADWWSSGVCLFEVLTGIPPFNAETPQ------------QIF--------ENILNRDIPWPEGPEEGSYEAQDLINRLLT 1074 (1205)
T ss_pred cchhhhhhhhhhhhhcCCCCCCCcchh------------hhh--------hccccCCCCCCCCccccChhhhhhhhhhhc
Confidence 999999999999999999999753311 011 1111111111 1122223345566666777
Q ss_pred CCCCCCCCHH
Q 038103 774 ENRDTRPPMS 783 (804)
Q Consensus 774 ~~P~~RPtm~ 783 (804)
.+|.+|-.|.
T Consensus 1075 ~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1075 EEPTQRLGAK 1084 (1205)
T ss_pred cCchhccCcc
Confidence 8888887765
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.2e-06 Score=79.05 Aligned_cols=74 Identities=31% Similarity=0.459 Sum_probs=56.7
Q ss_pred EEeeCccEEEeCCC-CCeEEEecccC--CcceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccCCCCeEEecCC
Q 038103 95 TLQRNGNLALTDKD-SSVVWSTNTFT--DEGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSMRS 171 (804)
Q Consensus 95 ~~~~~G~L~l~~~~-~~~vWst~~~~--~~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~~~~~L~S~~s 171 (804)
....+|+||+++.. +.+||++|+.. ..+..+.|.++|||||++.++.++|+| +|
T Consensus 25 ~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S-----~t------------------ 81 (114)
T smart00108 25 IMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSS-----NT------------------ 81 (114)
T ss_pred CCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEe-----cc------------------
Confidence 34578999999765 58999999743 234688999999999999989999996 11
Q ss_pred CCCCcccccEEEecCCCcceee
Q 038103 172 PGTYLSGFYNLKFDDNNILDLI 193 (804)
Q Consensus 172 ~~dps~G~y~~~~~~~~~~~~~ 193 (804)
....|.+.+.++++|.+.++
T Consensus 82 --~~~~~~~~~~L~ddGnlvl~ 101 (114)
T smart00108 82 --TGANGNYVLVLLDDGNLVIY 101 (114)
T ss_pred --cCCCCceEEEEeCCCCEEEE
Confidence 11346788999998877654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.6e-06 Score=85.77 Aligned_cols=133 Identities=20% Similarity=0.191 Sum_probs=94.2
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCcCC-----------------------ChHHHHHHHHHHhcCCCC--c
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ-----------------------GDAEFWAEVSIIGRINHR--N 568 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~-----------------------~~~~~~~E~~~l~~l~H~--n 568 (804)
+.+.++||.|.=+.||.|..+.|.++|||.=+.... .....++|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456788999999999999999999999995321000 012356788888888644 5
Q ss_pred ccceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc
Q 038103 569 LVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD 648 (804)
Q Consensus 569 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~ 648 (804)
+.+.+++ +...+|||+.++-.|...- ++-...-.++..|++-+.-+-..+ ++|+|+++-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 5555544 4568999999886554332 122233345555555555555667 99999999999999
Q ss_pred CCCCeEEeecCCcc
Q 038103 649 DHFEPKVTDFGLSK 662 (804)
Q Consensus 649 ~~~~~kl~Dfgla~ 662 (804)
+++.+.+.||--+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 99999999996554
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.3e-06 Score=72.63 Aligned_cols=71 Identities=31% Similarity=0.605 Sum_probs=54.0
Q ss_pred cceEEcCCCCccCcceeeeccCCCHHHHHHHhcc-CCceeeEEeecCCCCeeeecc--ccccCcccCCCcceEEEE
Q 038103 338 LDFMELPNTDYYGYDLVTYGIGISLQECRNRCLS-DCKCKGFGYSTDGQGECFPKG--NLLNGHNMPGKYVSMHIK 410 (804)
Q Consensus 338 ~~f~~l~~~~~~~~~~~~~~~~~s~~~C~~~Cl~-nCsC~Ay~y~~~g~g~C~~~~--~l~~~~~~~~~~~~~yik 410 (804)
..|++++++.+++..... ....++++|++.|++ +|+|.||.|.. +++.|++|. .+.+....+..+.++|.|
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~-~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN-GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC-CCCEEEEeeCCccccceecccCCceeEEe
Confidence 459999999998655433 346799999999999 99999999976 678899885 444445455556677655
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.5e-06 Score=78.55 Aligned_cols=73 Identities=32% Similarity=0.454 Sum_probs=56.4
Q ss_pred Eee-CccEEEeCCC-CCeEEEecccC--CcceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccCCCCeEEecCC
Q 038103 96 LQR-NGNLALTDKD-SSVVWSTNTFT--DEGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSMRS 171 (804)
Q Consensus 96 ~~~-~G~L~l~~~~-~~~vWst~~~~--~~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~~~~~L~S~~s 171 (804)
... +|+|++++.. +++||++|+.. .....+.|.++|||||++.++.++|||=-
T Consensus 26 ~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~----------------------- 82 (116)
T cd00028 26 MQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNT----------------------- 82 (116)
T ss_pred CCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecc-----------------------
Confidence 344 8999999765 58999999753 35678899999999999999999999611
Q ss_pred CCCCcccccEEEecCCCcceee
Q 038103 172 PGTYLSGFYNLKFDDNNILDLI 193 (804)
Q Consensus 172 ~~dps~G~y~~~~~~~~~~~~~ 193 (804)
..+.+.+.+.++++|.+.++
T Consensus 83 --~~~~~~~~~~L~ddGnlvl~ 102 (116)
T cd00028 83 --TRVNGNYVLVLLDDGNLVLY 102 (116)
T ss_pred --cCCCCceEEEEeCCCCEEEE
Confidence 11247788999888876654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=2e-07 Score=104.21 Aligned_cols=150 Identities=19% Similarity=0.306 Sum_probs=100.6
Q ss_pred HHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccc--------cccccCCCccchhhhc
Q 038103 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF--------SRVRGTRGYLAPEWMM 688 (804)
Q Consensus 617 ~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~--------~~~~gt~~y~aPE~~~ 688 (804)
+.+++.|+.|+|..-. +||++|.|++|.+++++..||+.|+.+........... .-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3456689999998754 99999999999999999999999998875543211110 1122456899999999
Q ss_pred cCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHH
Q 038103 689 NLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKV 767 (804)
Q Consensus 689 ~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 767 (804)
....+.++|+||+|+++|-+.. |+.-+........ .. ......+.- ...++.+.+.++.+=
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~----------~~----~~~~~~~~~----~~~~s~~~p~el~~~ 244 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS----------YS----FSRNLLNAG----AFGYSNNLPSELRES 244 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcch----------hh----hhhcccccc----cccccccCcHHHHHH
Confidence 9888999999999999999995 5544433211100 00 000111111 111223344566677
Q ss_pred HHhcccCCCCCCCCHHHHH
Q 038103 768 ALLCVAENRDTRPPMSKVV 786 (804)
Q Consensus 768 ~~~Cl~~~P~~RPtm~~Vv 786 (804)
+.+.+..++..||++.++.
T Consensus 245 l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 245 LKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHhcCCcccCcchhhhh
Confidence 7778889999999877663
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.2e-05 Score=79.30 Aligned_cols=137 Identities=18% Similarity=0.125 Sum_probs=102.8
Q ss_pred ccccCcceEEEEEecCCcEEEEEEecC----c---CCChHHHHHHHHHHhcCCC--CcccceeeeEEeC-----CeeEEE
Q 038103 520 VGKGGFGSVFRGVLDDERVVAVKRLEG----V---LQGDAEFWAEVSIIGRINH--RNLVKLQGFCAEN-----EHKLLV 585 (804)
Q Consensus 520 LG~G~fg~Vykg~~~~~~~vavK~l~~----~---~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~-----~~~~lV 585 (804)
-|+||-+.|++-.+.+. .+-+|+-.+ + ..+...|.+|...|.++.. -.+.+.. ++... ..-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56799999999887665 588887652 1 2356789999999999853 3344444 33211 245799
Q ss_pred EeeccC-CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC--eEEeecCCcc
Q 038103 586 YEYVEN-GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE--PKVTDFGLSK 662 (804)
Q Consensus 586 ~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~Dfgla~ 662 (804)
+|-+++ .+|.+++... ...+.+...+..+..++++.++-||..+ +.|+|+.+.||+++.++. +++.||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 4898888542 2234677778899999999999999999 999999999999986666 8999997666
Q ss_pred c
Q 038103 663 L 663 (804)
Q Consensus 663 ~ 663 (804)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.3e-05 Score=80.46 Aligned_cols=106 Identities=20% Similarity=0.217 Sum_probs=84.3
Q ss_pred hHHHHHHHHHHhcCC--CCcccceeeeEEeCC----eeEEEEeeccCC-ChhhhhccCCCCCCCCCHHhHHHHHHHHHHH
Q 038103 551 DAEFWAEVSIIGRIN--HRNLVKLQGFCAENE----HKLLVYEYVENG-SLDKLLFNDPGTASILQWDQRYNIAVGTAKG 623 (804)
Q Consensus 551 ~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~ 623 (804)
.....+|...+.++. .-...+.+++..... .-+||+|++++. +|.+++.... .++......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 456788888888874 445566677765532 448999999884 7999986421 15566778899999999
Q ss_pred HHHHHhhCCCcEEecccccCeEEEcCCC---CeEEeecCCccc
Q 038103 624 LSYLHEECLEWVLHCDVKPQNILLDDHF---EPKVTDFGLSKL 663 (804)
Q Consensus 624 l~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfgla~~ 663 (804)
++-||..+ |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999 99999999999998887 899999988775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1e-05 Score=91.25 Aligned_cols=140 Identities=19% Similarity=0.252 Sum_probs=90.6
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCCh-------------------------------H----------HHHH
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGD-------------------------------A----------EFWA 556 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~-------------------------------~----------~~~~ 556 (804)
+-|+.++-|.||+|++++|+.||||+.+...... + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 3499999999999999999999999985211110 0 1222
Q ss_pred HHHHHhcC----CCCcccceeeeEE-eCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHH-HHHHHhh
Q 038103 557 EVSIIGRI----NHRNLVKLQGFCA-ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKG-LSYLHEE 630 (804)
Q Consensus 557 E~~~l~~l----~H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-l~yLH~~ 630 (804)
|..-+.++ ++..-+++=.++. -.....|+|||++|-.+.+...... ...+ +..++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHhc
Confidence 33333333 2222233333333 2457789999999988888853211 1122 23344444443 2333334
Q ss_pred CCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 631 ~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
+ +.|.|..|-||+++.++++.+.|||+...+..
T Consensus 285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred C---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 5 99999999999999999999999999987654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.01 E-value=7.1e-05 Score=76.28 Aligned_cols=139 Identities=13% Similarity=0.141 Sum_probs=84.9
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCc--ccceeeeEEeCCeeEEEEeeccCCC-h
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN--LVKLQGFCAENEHKLLVYEYVENGS-L 594 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gs-L 594 (804)
..||+|..+.||+. .+..+++|.... ........+|.+++..+..-. +.+.+.++...+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 244567787654 223456788999999886443 4667777777778889999998863 2
Q ss_pred hhhh---------------------ccCCCCCCCCCHHhHHH-HHH----------HHHH-HHHHHHhh-CCCcEEeccc
Q 038103 595 DKLL---------------------FNDPGTASILQWDQRYN-IAV----------GTAK-GLSYLHEE-CLEWVLHCDV 640 (804)
Q Consensus 595 ~~~l---------------------~~~~~~~~~l~~~~~~~-i~~----------~ia~-~l~yLH~~-~~~~ivH~Dl 640 (804)
...+ +..+.... ....+.. +.. .+.+ ...+|... ....++|+|+
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~--~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTS--TFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCC--cHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 11100111 1111000 000 0011 12222211 1234789999
Q ss_pred ccCeEEEcCCCCeEEeecCCccc
Q 038103 641 KPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 641 kp~NILl~~~~~~kl~Dfgla~~ 663 (804)
.|.||++++++ +.|.||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999988763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00011 Score=65.98 Aligned_cols=98 Identities=26% Similarity=0.420 Sum_probs=62.5
Q ss_pred EEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEee-CCCCCCCCCCceEEEeeCccEEEeCCCCCeEEEecccCCc
Q 038103 43 FLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMA-NRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDE 121 (804)
Q Consensus 43 ~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~A-Nr~~p~~~~~~~l~~~~~G~L~l~~~~~~~vWst~~~~~~ 121 (804)
.+.+.+|.+.|-|-.-|+ |.| |.. ..+++|.. +....-. ....+.|..+|||||+|..+.++|+|.. ...
T Consensus 13 p~~~~s~~~~L~l~~dGn----Lvl-~~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~-~pt 83 (114)
T PF01453_consen 13 PLTSSSGNYTLILQSDGN----LVL-YDS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFD-YPT 83 (114)
T ss_dssp EEEECETTEEEEEETTSE----EEE-EET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT-SSS
T ss_pred ccccccccccceECCCCe----EEE-EcC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecC-CCc
Confidence 444444666666654432 333 222 25679999 4343321 4578999999999999999999999943 234
Q ss_pred ceEEEEec--CCCeEEEecCCCceeeccCCC
Q 038103 122 GVQAQLLE--TGNLVLVNEANTTIWKSFDSP 150 (804)
Q Consensus 122 ~~~a~Lld--sGNlVl~~~~~~~lWqSFd~P 150 (804)
.+.+..++ .||++ +.....+.|.|=+.|
T Consensus 84 dt~L~~q~l~~~~~~-~~~~~~~sw~s~~dp 113 (114)
T PF01453_consen 84 DTLLPGQKLGDGNVT-GKNDSLTSWSSNTDP 113 (114)
T ss_dssp -EEEEEET--TSEEE-EESTSSEEEESS---
T ss_pred cEEEeccCcccCCCc-cccceEEeECCCCCC
Confidence 45566666 88988 766678899986666
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.88 E-value=4.9e-05 Score=74.86 Aligned_cols=105 Identities=27% Similarity=0.332 Sum_probs=83.4
Q ss_pred HHHHHHhcCCC-CcccceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCc
Q 038103 556 AEVSIIGRINH-RNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634 (804)
Q Consensus 556 ~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ 634 (804)
.|.-+++.+++ +++.+++|.|-. +++.||...+++...-.. -..--..+|..|.+||.++++.+++|++.-...
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47888888876 699999999954 789999987655321000 001123689999999999999999999977667
Q ss_pred EEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 635 ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
+..+|++++|+-+++++++|+.|...+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 9999999999999999999999998876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=5.4e-06 Score=91.89 Aligned_cols=182 Identities=19% Similarity=0.174 Sum_probs=132.7
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCc-ccceeeeEEeCCeeEEEEeeccCC-Chh
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN-LVKLQGFCAENEHKLLVYEYVENG-SLD 595 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~g-sL~ 595 (804)
+.++++++++++|.+....+...++.+... .+..-++++|.+++||| .++.++-+..+....++++++..+ +-.
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 568889999999988655555556655422 44567899999999999 777777777778888999999876 221
Q ss_pred hhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcccccc
Q 038103 596 KLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRV 675 (804)
Q Consensus 596 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 675 (804)
..... ....+...+...+...-.++++|||+.. -+|+| ||+..+ ...|..||+....+.... .....
T Consensus 324 ~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~ 390 (829)
T KOG0576|consen 324 LEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTA 390 (829)
T ss_pred ccCCh---hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--ccccC
Confidence 11100 1122333344455566678899999864 37888 777666 588999999988766543 33446
Q ss_pred ccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCc
Q 038103 676 RGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASD 716 (804)
Q Consensus 676 ~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~ 716 (804)
.+++.++|||......+..+.|+|+.|.-..++.-|-.|..
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 68999999999999999999999999988778877777754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00026 Score=72.43 Aligned_cols=144 Identities=19% Similarity=0.202 Sum_probs=84.9
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCC--cccceeeeEEe---CCeeEEEEeeccCC
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR--NLVKLQGFCAE---NEHKLLVYEYVENG 592 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~---~~~~~lV~E~~~~g 592 (804)
+.|+.|..+.||+....+ +.+++|..... ....++..|..+++.+... .+.+++..+.. ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 458899999999999888 57999987644 3456788899998888533 34566664433 23568999999998
Q ss_pred Chhh----------------hh---ccCCCCCCCCCHHh---------HHHH------------HHHHHH-HHHHHHhh-
Q 038103 593 SLDK----------------LL---FNDPGTASILQWDQ---------RYNI------------AVGTAK-GLSYLHEE- 630 (804)
Q Consensus 593 sL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~ia~-~l~yLH~~- 630 (804)
.+.. .+ +..+.......+.. .... ...+.+ .+..++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 7777 11 11100111111110 0000 112222 33444432
Q ss_pred ---CCCcEEecccccCeEEEc-CCCCeEEeecCCccc
Q 038103 631 ---CLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKL 663 (804)
Q Consensus 631 ---~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~ 663 (804)
....++|+|+.|.|||++ +++.+.|.||+.+..
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 334599999999999999 666668999988763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00036 Score=69.95 Aligned_cols=134 Identities=19% Similarity=0.191 Sum_probs=86.9
Q ss_pred cccccCcceEEEEEecCCcEEEEEEecCcCCCh----------HH---------------HHHHHHHHhcCC--CCcccc
Q 038103 519 EVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGD----------AE---------------FWAEVSIIGRIN--HRNLVK 571 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~----------~~---------------~~~E~~~l~~l~--H~niv~ 571 (804)
.|..|.-..||+|.-.++..+|||+.+...... .. ..+|..-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 477888899999998889999999986322211 11 123555555442 223333
Q ss_pred eeeeEEeCCeeEEEEeeccCCC-hhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHh-hCCCcEEecccccCeEEEcC
Q 038103 572 LQGFCAENEHKLLVYEYVENGS-LDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE-ECLEWVLHCDVKPQNILLDD 649 (804)
Q Consensus 572 l~g~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dlkp~NILl~~ 649 (804)
.+++. +-.|||||+.... -.-.|.. ..+.......+..++++.+.-|-. .+ +||+||+.-|||+.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~- 201 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH- 201 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-
Confidence 33332 3379999996531 1111211 112222455667777787777776 44 99999999999999
Q ss_pred CCCeEEeecCCccccc
Q 038103 650 HFEPKVTDFGLSKLFK 665 (804)
Q Consensus 650 ~~~~kl~Dfgla~~~~ 665 (804)
++.+.|+|++-|....
T Consensus 202 ~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 DGEPYIIDVSQAVTID 217 (268)
T ss_pred CCeEEEEECccccccC
Confidence 7899999999888654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00041 Score=71.82 Aligned_cols=141 Identities=16% Similarity=0.084 Sum_probs=85.1
Q ss_pred ccccCc-ceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEeeccCCChhhh
Q 038103 520 VGKGGF-GSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYEYVENGSLDKL 597 (804)
Q Consensus 520 LG~G~f-g~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~ 597 (804)
|-.|.. ..||+...++ ..+.||+..... ..+..+|++++..+. +--+.+++++....+..++|||++++.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444555 7889998654 678888776432 345678999888884 44455677777666678999999998877643
Q ss_pred h-------------------ccCCCCCCCCC--HHhHHHHHH--------------------HHHHHHHHHHhh----CC
Q 038103 598 L-------------------FNDPGTASILQ--WDQRYNIAV--------------------GTAKGLSYLHEE----CL 632 (804)
Q Consensus 598 l-------------------~~~~~~~~~l~--~~~~~~i~~--------------------~ia~~l~yLH~~----~~ 632 (804)
. +..+....... ...+..... .+...+..|-.. ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 11111010110 000000000 011112222111 12
Q ss_pred CcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 633 ~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+.++|+|+.|.|||++++..+.|.||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 3489999999999999987788999988763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.64 E-value=7.2e-05 Score=61.30 Aligned_cols=53 Identities=34% Similarity=0.621 Sum_probs=41.2
Q ss_pred eEEcCCCCccCcceeeeccCCCHHHHHHHhccCCceeeEEeecCCCCeeeecccc
Q 038103 340 FMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCKGFGYSTDGQGECFPKGNL 394 (804)
Q Consensus 340 f~~l~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ay~y~~~g~g~C~~~~~l 394 (804)
|..++++.+++++.... ...+.++|++.|+.||+|.||+|.. +.+.|+++...
T Consensus 6 ~~~~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~-~~~~C~lk~~~ 58 (73)
T cd01100 6 FRQGSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT-KSKKCFLKSSE 58 (73)
T ss_pred ccccCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC-CCCeEEcccCC
Confidence 34456777777665543 3568999999999999999999974 67899988654
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00074 Score=67.06 Aligned_cols=138 Identities=14% Similarity=0.147 Sum_probs=85.6
Q ss_pred HHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCC-hH---------HHHHHHHHHhcCCC---Ccccceeee
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQG-DA---------EFWAEVSIIGRINH---RNLVKLQGF 575 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~-~~---------~~~~E~~~l~~l~H---~niv~l~g~ 575 (804)
+....+...+.+-......|.+-..++ +.+++|..+..... ++ +..+++..+.+++. ...+.++..
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~-~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDG-KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECC-cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 334444455556666666677666644 56888876532221 11 12333443444422 223332222
Q ss_pred EE-----eCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC
Q 038103 576 CA-----ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH 650 (804)
Q Consensus 576 ~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~ 650 (804)
.. -....+|+|||++|..|.++.. ++. .++..+++++.-||..| ++|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 22 2234568999999988766542 111 35567888899999999 9999999999999865
Q ss_pred CCeEEeecCCccc
Q 038103 651 FEPKVTDFGLSKL 663 (804)
Q Consensus 651 ~~~kl~Dfgla~~ 663 (804)
.+++.||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 499999987664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00037 Score=78.50 Aligned_cols=142 Identities=20% Similarity=0.226 Sum_probs=88.6
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCCh----------------------------H----------HHHHHHH
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGD----------------------------A----------EFWAEVS 559 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~----------------------------~----------~~~~E~~ 559 (804)
+.||..+.|.||++++++|+.||||.-+...... + +|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4599999999999999999999999875321111 0 1333433
Q ss_pred HHhc----CCCCcc---cceeeeEE-eCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHH-HHHhh
Q 038103 560 IIGR----INHRNL---VKLQGFCA-ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS-YLHEE 630 (804)
Q Consensus 560 ~l~~----l~H~ni---v~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~-yLH~~ 630 (804)
-..+ +.|-++ |++-.++. -...+.|+||||+|..+.+.-.- ....++-. +++..+.++.. -+=..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~---~i~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPH---DILNKLVEAYLEQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHH---HHHHHHHHHHHHHHHhc
Confidence 3222 235551 11222222 23478999999999877666422 11123333 34444444322 22223
Q ss_pred CCCcEEecccccCeEEEc----CCCCeEEeecCCcccccccC
Q 038103 631 CLEWVLHCDVKPQNILLD----DHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 631 ~~~~ivH~Dlkp~NILl~----~~~~~kl~Dfgla~~~~~~~ 668 (804)
| ++|+|=.|-||+++ .+.++.+-|||+........
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~ 359 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT 359 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence 4 89999999999998 36789999999998765543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0012 Score=80.56 Aligned_cols=147 Identities=16% Similarity=0.247 Sum_probs=91.7
Q ss_pred ccccccCcceEEEEEecCC---cEEEEEEecCcC--CChHHHHHHHHHHhcCC-CCcc--cceeeeEEeC---CeeEEEE
Q 038103 518 QEVGKGGFGSVFRGVLDDE---RVVAVKRLEGVL--QGDAEFWAEVSIIGRIN-HRNL--VKLQGFCAEN---EHKLLVY 586 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV~ 586 (804)
+.++.|.+..+|+....++ ..+++|+..... .....+.+|+++++.+. |.++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5688999999999887654 357777764322 23456889999999995 6654 7788888764 3678999
Q ss_pred eeccCCChhhh-----------------------hccCCCC-------CCCCC--------HHhHHHH---------HHH
Q 038103 587 EYVENGSLDKL-----------------------LFNDPGT-------ASILQ--------WDQRYNI---------AVG 619 (804)
Q Consensus 587 E~~~~gsL~~~-----------------------l~~~~~~-------~~~l~--------~~~~~~i---------~~~ 619 (804)
||+++..+.+- |+..... +.+.. |...+.- ...
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 99988653221 1111000 01111 1111110 112
Q ss_pred HHHHHHHHHhhCC--------CcEEecccccCeEEEcCC-CC-eEEeecCCcccc
Q 038103 620 TAKGLSYLHEECL--------EWVLHCDVKPQNILLDDH-FE-PKVTDFGLSKLF 664 (804)
Q Consensus 620 ia~~l~yLH~~~~--------~~ivH~Dlkp~NILl~~~-~~-~kl~Dfgla~~~ 664 (804)
+.+.+++|..+-+ ..++|+|+++.|||++.+ .+ .-|.||.++..-
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 3344667755332 239999999999999853 33 579999988753
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.002 Score=63.71 Aligned_cols=129 Identities=17% Similarity=0.244 Sum_probs=89.0
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcC-----------------CChHHHHHHHHHHhcCC------CCcccceee
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVL-----------------QGDAEFWAEVSIIGRIN------HRNLVKLQG 574 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~-----------------~~~~~~~~E~~~l~~l~------H~niv~l~g 574 (804)
..||+|+.-.||. +++.....||+..... ...++..+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4699999999994 4455556778776433 22456677776655554 889999999
Q ss_pred eEEeCCeeEEEEeeccC------CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc
Q 038103 575 FCAENEHKLLVYEYVEN------GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD 648 (804)
Q Consensus 575 ~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~ 648 (804)
+...+.-.-+|+|.+.+ -+|.+++.. ..++. . +...+-+-..||-+.. |+.+|++|+||++.
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 99999999999998754 267888843 22443 2 2333334456777766 99999999999995
Q ss_pred CCC----CeEEee-cCC
Q 038103 649 DHF----EPKVTD-FGL 660 (804)
Q Consensus 649 ~~~----~~kl~D-fgl 660 (804)
... .+.|.| ||-
T Consensus 153 ~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ecCCCceEEEEEeCCCC
Confidence 332 466666 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0018 Score=66.56 Aligned_cols=74 Identities=16% Similarity=0.175 Sum_probs=47.7
Q ss_pred ccccccCcceEEEEEecC--CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCccc-ceeeeEEeCCeeEEEEeeccCCCh
Q 038103 518 QEVGKGGFGSVFRGVLDD--ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLV-KLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~--~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
+.|..|-...+|+....+ +..+++|..........+..+|+.++..+...+++ ++++.+. ..++|||+++.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 456778888999998764 56788887653322222345788888888544443 3433322 2479999998766
Q ss_pred h
Q 038103 595 D 595 (804)
Q Consensus 595 ~ 595 (804)
.
T Consensus 80 ~ 80 (235)
T cd05157 80 E 80 (235)
T ss_pred C
Confidence 3
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0027 Score=67.70 Aligned_cols=75 Identities=7% Similarity=0.049 Sum_probs=56.3
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCC---CcccceeeeEEeC---CeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINH---RNLVKLQGFCAEN---EHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~E~~~~ 591 (804)
+.||+|..+.||+....+++ +.+|..+. ......+.+|.+.++.+.. ..+.+++++|..+ +..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 46999999999999876665 66676432 2234578899999988853 4677888887543 568999999998
Q ss_pred CCh
Q 038103 592 GSL 594 (804)
Q Consensus 592 gsL 594 (804)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0016 Score=61.84 Aligned_cols=130 Identities=17% Similarity=0.171 Sum_probs=87.8
Q ss_pred ccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCChh
Q 038103 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLD 595 (804)
Q Consensus 516 ~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 595 (804)
..+.|++|.+|.||+|.+.++ .+|+|.-+. ......+..|++++..++-.++-+=+-.+.+ -++.|||..+-.|.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L~ 100 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-eEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcchh
Confidence 356799999999999998766 577776542 3345678899999999886665543322222 24459999887776
Q ss_pred hhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEeccccc-CeEEEcCCCCeEEeecCCcccc
Q 038103 596 KLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKP-QNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 596 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp-~NILl~~~~~~kl~Dfgla~~~ 664 (804)
+.-.. .+ .+-...+++.---|...+ |-|+.|.- ...+|-.+..+.|.||.-|+..
T Consensus 101 ~~~~~-------~~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 101 KLEIG-------GD----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhc-------cc----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 65421 01 223445666655566667 88998864 4444444449999999999843
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0017 Score=66.76 Aligned_cols=73 Identities=16% Similarity=0.189 Sum_probs=44.7
Q ss_pred ccccccCcc-eEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCC---cccceeeeEEeC---CeeEEEEeecc
Q 038103 518 QEVGKGGFG-SVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR---NLVKLQGFCAEN---EHKLLVYEYVE 590 (804)
Q Consensus 518 ~~LG~G~fg-~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~E~~~ 590 (804)
+.++.|+.. .||+. +..+++|.... .....++.+|.+++..+... .+.+.++..... ...+++||+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 456766665 58875 23466776543 23345788999999887532 233344433322 23478999999
Q ss_pred CCChh
Q 038103 591 NGSLD 595 (804)
Q Consensus 591 ~gsL~ 595 (804)
+.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0017 Score=63.68 Aligned_cols=132 Identities=27% Similarity=0.379 Sum_probs=92.1
Q ss_pred ccccchHHHHHHHhcccccccccCc-ceEEEEEecCCcEEEEEEecC-----c------CC-----------ChHHHHHH
Q 038103 501 FKRFTYAELKRATRNFKQEVGKGGF-GSVFRGVLDDERVVAVKRLEG-----V------LQ-----------GDAEFWAE 557 (804)
Q Consensus 501 ~~~~~~~~l~~~t~~~~~~LG~G~f-g~Vykg~~~~~~~vavK~l~~-----~------~~-----------~~~~~~~E 557 (804)
+.+|+.. .+...|.+.||.|.- |.|||+++.+ +.+|+|.++. . .. ...-|..|
T Consensus 29 L~~F~~h---~~~I~flefLg~g~~~~~V~kv~I~g-~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~E 104 (207)
T PF13095_consen 29 LEPFTHH---GDDIEFLEFLGHGSHDGYVFKVEIDG-RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCE 104 (207)
T ss_pred cCCcCCC---CCcEeeeeecCCCCceeEEEEEEECC-eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHH
Confidence 3455552 266778899999999 9999999854 5899999421 0 00 01247889
Q ss_pred HHHHhcCC---CCcc--cceeeeEEeC------------------CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHH
Q 038103 558 VSIIGRIN---HRNL--VKLQGFCAEN------------------EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRY 614 (804)
Q Consensus 558 ~~~l~~l~---H~ni--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~ 614 (804)
++..++|+ +.++ |+.+|+..-. ..+.||.||.+... .+ ..
T Consensus 105 CRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~----~~ 167 (207)
T PF13095_consen 105 CRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL----QI 167 (207)
T ss_pred HHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc----ch
Confidence 99988885 4456 8899987322 12356777765522 11 22
Q ss_pred HHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCc
Q 038103 615 NIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661 (804)
Q Consensus 615 ~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 661 (804)
+-+.+|.+-+..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 168 ~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 34566777888899999 999999999986 6689999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.003 Score=65.89 Aligned_cols=139 Identities=15% Similarity=0.071 Sum_probs=78.9
Q ss_pred cccccCcceEEEEEecCCcEEEEEEecCcCCCh-HHHHHHHHHHhcCCCCccc-ceeeeEEeCCeeEEEEeeccCCChhh
Q 038103 519 EVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGD-AEFWAEVSIIGRINHRNLV-KLQGFCAENEHKLLVYEYVENGSLDK 596 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~-~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL~~ 596 (804)
.+..|-...+|+... +++.+++|+........ .+..+|.++++.+....++ ++++... ..+|+||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 355677889998874 45568888754322221 2457788888888654443 3343322 368999999876543
Q ss_pred h-----------------hccCCCCCCCCCHHhH-HHHHH---------HHHHHHHHHHhh-----CCCcEEecccccCe
Q 038103 597 L-----------------LFNDPGTASILQWDQR-YNIAV---------GTAKGLSYLHEE-----CLEWVLHCDVKPQN 644 (804)
Q Consensus 597 ~-----------------l~~~~~~~~~l~~~~~-~~i~~---------~ia~~l~yLH~~-----~~~~ivH~Dlkp~N 644 (804)
. |+..+.....++...+ ..... .+...+..+... ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 1221111112222111 11110 111112222221 12348999999999
Q ss_pred EEEcCCCCeEEeecCCccc
Q 038103 645 ILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 645 ILl~~~~~~kl~Dfgla~~ 663 (804)
|++++++ ++|.||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999988874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0055 Score=65.60 Aligned_cols=141 Identities=21% Similarity=0.220 Sum_probs=83.0
Q ss_pred cccccCcceEEEEEecC-------CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCccc-ceeeeEEeCCeeEEEEeecc
Q 038103 519 EVGKGGFGSVFRGVLDD-------ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLV-KLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~~-------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~ 590 (804)
.|..|-...+|+....+ ++.+++|+.........+..+|.+++..+....+. ++++++.. .+|+||++
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~ 80 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP 80 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence 45566667899988765 47788998765433434567888888888543333 44554432 35899998
Q ss_pred CCChhhhh-----------------ccCCCC--C-----CCCCHHhHHH--------------------------HHHHH
Q 038103 591 NGSLDKLL-----------------FNDPGT--A-----SILQWDQRYN--------------------------IAVGT 620 (804)
Q Consensus 591 ~gsL~~~l-----------------~~~~~~--~-----~~l~~~~~~~--------------------------i~~~i 620 (804)
+..+.... +..+.. . ...-|..+.. +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 87664321 111111 0 0001111111 11122
Q ss_pred HHHHHHHHh------hCCCcEEecccccCeEEEcCC----CCeEEeecCCccc
Q 038103 621 AKGLSYLHE------ECLEWVLHCDVKPQNILLDDH----FEPKVTDFGLSKL 663 (804)
Q Consensus 621 a~~l~yLH~------~~~~~ivH~Dlkp~NILl~~~----~~~kl~Dfgla~~ 663 (804)
..-+..|.. .....++|+|+.+.|||++++ +.+++.||..+..
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 222334432 123458999999999999985 7899999988874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.02 Score=63.06 Aligned_cols=73 Identities=19% Similarity=0.177 Sum_probs=51.8
Q ss_pred ccccccCcceEEEEEecCC-cEEEEEEecCc--------CCChHHHHHHHHHHhcCC---CCcccceeeeEEeCCeeEEE
Q 038103 518 QEVGKGGFGSVFRGVLDDE-RVVAVKRLEGV--------LQGDAEFWAEVSIIGRIN---HRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~-~~vavK~l~~~--------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 585 (804)
+.||.|.+..||++...+| +.++||.-... ....+++..|.+.|..+. ...+.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998877 48999975311 113456777888888763 2345556655 34567899
Q ss_pred EeeccCC
Q 038103 586 YEYVENG 592 (804)
Q Consensus 586 ~E~~~~g 592 (804)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0027 Score=75.82 Aligned_cols=195 Identities=17% Similarity=0.182 Sum_probs=132.8
Q ss_pred HHHHHHHhcCCCCcccceeeeEEeCCeeE----EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh
Q 038103 555 WAEVSIIGRINHRNLVKLQGFCAENEHKL----LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630 (804)
Q Consensus 555 ~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~ 630 (804)
..|...+.++.|+|+++++.+-.+....- +..|++..-++...+.. -..++....+.+..++.+||+|+|+.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 44677888899999999999977654332 44567777777777753 34577788888999999999999998
Q ss_pred CCCcEEecccccC---eEEEcCCCCeEEe--ecCCcccccccCCccccccccCCCccchhhhccCCCCc--ccchHHHHH
Q 038103 631 CLEWVLHCDVKPQ---NILLDDHFEPKVT--DFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDA--KADVYSYGI 703 (804)
Q Consensus 631 ~~~~ivH~Dlkp~---NILl~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--k~DV~S~Gv 703 (804)
. ..|.-+..+ +--.+.++...++ ||+..+.+........ ...+..+.+||......+.. ..|+|.+|.
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHH
Confidence 6 555555554 5555667777777 8988887655332221 12345577788776554443 479999999
Q ss_pred HHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 038103 704 VLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMS 783 (804)
Q Consensus 704 ll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~ 783 (804)
.+..+..|..+..... ....+++... ...+......|+..++++|++..
T Consensus 381 l~~~~~~~~~i~~~~~-----------------------~~~~~l~~~~--------~~~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA-----------------------VPVSLLDVLS--------TSELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHhhhhhcCccccccc-----------------------chhhhhcccc--------chhhhhhhhhhcchhhhhccchh
Confidence 9999999876643211 0011111110 01355677789999999999999
Q ss_pred HHHHHh
Q 038103 784 KVVKLL 789 (804)
Q Consensus 784 ~Vv~~L 789 (804)
+++...
T Consensus 430 ~ll~~~ 435 (1351)
T KOG1035|consen 430 ELLTHP 435 (1351)
T ss_pred hhhhch
Confidence 998654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0096 Score=63.50 Aligned_cols=143 Identities=15% Similarity=0.138 Sum_probs=86.1
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCc--ccceeee------EEeCCeeEEEEeec
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN--LVKLQGF------CAENEHKLLVYEYV 589 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E~~ 589 (804)
+.+..|....+|+....++ .+++|+... ...++...|++++..+.+.+ +.+++.. ...++..++|++++
T Consensus 20 ~~i~~G~~n~~y~v~~~~~-~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDSG-RYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCCC-cEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 3577787789999876555 588888764 34456777888888875332 3444432 12344568999999
Q ss_pred cCCChhhh----h----------ccC----CC---CCCCCCHHhHH----------HHHHHHHHHHHHHHhh----CCCc
Q 038103 590 ENGSLDKL----L----------FND----PG---TASILQWDQRY----------NIAVGTAKGLSYLHEE----CLEW 634 (804)
Q Consensus 590 ~~gsL~~~----l----------~~~----~~---~~~~l~~~~~~----------~i~~~ia~~l~yLH~~----~~~~ 634 (804)
++..+... . +.. .. ......|.... .....+..++.++... .+..
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 98765330 0 100 00 00112232211 1112233445555542 1234
Q ss_pred EEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 635 ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
++|+|+.|.|||++++..+.|.||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 89999999999999987778999988764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.035 Score=59.90 Aligned_cols=143 Identities=13% Similarity=0.113 Sum_probs=77.4
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCC--cccceee------eEEeCCeeEEEEeec
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR--NLVKLQG------FCAENEHKLLVYEYV 589 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g------~~~~~~~~~lV~E~~ 589 (804)
+.++.|....+|+....+| .+++|+.. ....++...|+.++..|... .+.+.+. +....+..++++||+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 3466777789999887666 57888875 22334444566666655322 2223332 112345678999999
Q ss_pred cCCChhh-----------hh---ccCC-C---C---CCCCCH-HhHHH------------HH-HHHHHHHHHHHhh----
Q 038103 590 ENGSLDK-----------LL---FNDP-G---T---ASILQW-DQRYN------------IA-VGTAKGLSYLHEE---- 630 (804)
Q Consensus 590 ~~gsL~~-----------~l---~~~~-~---~---~~~l~~-~~~~~------------i~-~~ia~~l~yLH~~---- 630 (804)
++..+.. .| +... . . ...+.| ..... .. ..+...++.+...
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 8865421 11 1100 0 0 011112 11111 11 1111122333211
Q ss_pred CCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 631 ~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
-+..++|+|+.|.||+++++...-|.||+.+..
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 123499999999999999775568999998874
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.037 Score=58.33 Aligned_cols=72 Identities=19% Similarity=0.248 Sum_probs=46.8
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCC---CCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN---HRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
+.++.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. -..+.+.+++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 458889999999988 567779999866 233456788888888773 455778888887777779999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.086 Score=56.53 Aligned_cols=144 Identities=17% Similarity=0.167 Sum_probs=82.4
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCC--cccceeeeE------EeCCeeEEEEeec
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR--NLVKLQGFC------AENEHKLLVYEYV 589 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~------~~~~~~~lV~E~~ 589 (804)
+.++.|....+|+....+++ +++|+.... ...++...|++++..|... .+.+++... ...+..++++||+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~~-~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVGR-YILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCCc-EEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 34677777899998866664 667876532 2344566677777777422 233443321 1235678999999
Q ss_pred cCCChhhh--------------hccC-CC---CC----CCCCHHhHH------------HHHHHHHHHHHHHHhh----C
Q 038103 590 ENGSLDKL--------------LFND-PG---TA----SILQWDQRY------------NIAVGTAKGLSYLHEE----C 631 (804)
Q Consensus 590 ~~gsL~~~--------------l~~~-~~---~~----~~l~~~~~~------------~i~~~ia~~l~yLH~~----~ 631 (804)
++..+... ++.. .. .. ....|.... .....+.+.++++... .
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 88554211 1110 00 00 011222111 0112233455555431 2
Q ss_pred CCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 632 ~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+..++|+|+.+.||++++++...|.||+.+..
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 23499999999999999887778999998863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.066 Score=57.46 Aligned_cols=141 Identities=21% Similarity=0.300 Sum_probs=87.4
Q ss_pred ccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCC---Cc---ccceeee----EEeCCeeEEEEeec
Q 038103 520 VGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINH---RN---LVKLQGF----CAENEHKLLVYEYV 589 (804)
Q Consensus 520 LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H---~n---iv~l~g~----~~~~~~~~lV~E~~ 589 (804)
|.+ .-..+|+....+|+. ++|..+.. ....++..|+..+..|.- += +..+=|- ...+...+-+++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 456889999888886 88888765 666777888888887731 11 1222121 11223778899999
Q ss_pred cCCChhh-hh------------------c----cCCCCCCCCCHHh-------------HHHHHHHHHHHHHHHHhhC--
Q 038103 590 ENGSLDK-LL------------------F----NDPGTASILQWDQ-------------RYNIAVGTAKGLSYLHEEC-- 631 (804)
Q Consensus 590 ~~gsL~~-~l------------------~----~~~~~~~~l~~~~-------------~~~i~~~ia~~l~yLH~~~-- 631 (804)
+|..+.. .. . .++.....+.|.. ......++...+..+++.-
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9987773 11 0 0222223445541 0123334444455554432
Q ss_pred --CCc---EEecccccCeEEEcCCCC-eEEeecCCccc
Q 038103 632 --LEW---VLHCDVKPQNILLDDHFE-PKVTDFGLSKL 663 (804)
Q Consensus 632 --~~~---ivH~Dlkp~NILl~~~~~-~kl~Dfgla~~ 663 (804)
+.. +||+|+.|.||+++++.. +.+.||+-+..
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 222 899999999999999985 89999988763
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.068 Score=58.24 Aligned_cols=141 Identities=16% Similarity=0.176 Sum_probs=79.5
Q ss_pred cccccCcceEEEEEecC-----CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCccc-ceeeeEEeCCeeEEEEeeccCC
Q 038103 519 EVGKGGFGSVFRGVLDD-----ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLV-KLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~~-----~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~g 592 (804)
.|-.|-.-.+|+....+ ++.+++|+........-+..+|..++..+...++. ++++.+..+ .|+||+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 34456677889887532 35788887764332222336788888888644444 455555332 579999876
Q ss_pred Chhhh-----------------hccCC--CCCCCCCHHhHHHHHHH-----------------HHHHHHHHHh-----hC
Q 038103 593 SLDKL-----------------LFNDP--GTASILQWDQRYNIAVG-----------------TAKGLSYLHE-----EC 631 (804)
Q Consensus 593 sL~~~-----------------l~~~~--~~~~~l~~~~~~~i~~~-----------------ia~~l~yLH~-----~~ 631 (804)
+|... ++..+ ......-|....++..+ +...+..|.. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 66422 11111 01111113322222211 1112222221 11
Q ss_pred CCcEEecccccCeEEEcC-CCCeEEeecCCccc
Q 038103 632 LEWVLHCDVKPQNILLDD-HFEPKVTDFGLSKL 663 (804)
Q Consensus 632 ~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~ 663 (804)
...++|+|+++.|||+++ +..+++.||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 234899999999999986 46899999988874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.11 Score=54.80 Aligned_cols=30 Identities=27% Similarity=0.526 Sum_probs=25.5
Q ss_pred cEEecccccCeEEEcCCCC-eEEeecCCccc
Q 038103 634 WVLHCDVKPQNILLDDHFE-PKVTDFGLSKL 663 (804)
Q Consensus 634 ~ivH~Dlkp~NILl~~~~~-~kl~Dfgla~~ 663 (804)
.++|+|+++.|||++++++ .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 46999998875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.083 Score=53.20 Aligned_cols=30 Identities=33% Similarity=0.486 Sum_probs=21.6
Q ss_pred cEEecccccCeEEE-cCCCCeEEeecCCccc
Q 038103 634 WVLHCDVKPQNILL-DDHFEPKVTDFGLSKL 663 (804)
Q Consensus 634 ~ivH~Dlkp~NILl-~~~~~~kl~Dfgla~~ 663 (804)
.+.|+|+.+.|||+ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 38999999999999 8889999999988874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.18 Score=53.61 Aligned_cols=138 Identities=19% Similarity=0.249 Sum_probs=78.3
Q ss_pred ceEEEEEecCCcEEEEEEecC---cCCChHHHHHHHHHHhcCCC--CcccceeeeEEeCC--eeEEEEeeccCCChhhhh
Q 038103 526 GSVFRGVLDDERVVAVKRLEG---VLQGDAEFWAEVSIIGRINH--RNLVKLQGFCAENE--HKLLVYEYVENGSLDKLL 598 (804)
Q Consensus 526 g~Vykg~~~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l 598 (804)
-.+|..... ++.+++. ... .........+|.++|+.+.- .-..+.++.|.++. ..+.||+|.++..+...+
T Consensus 39 n~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~ 116 (321)
T COG3173 39 NDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSAL 116 (321)
T ss_pred cceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcC
Confidence 344444433 5666666 221 11223455678888887742 34556677787776 679999999884322222
Q ss_pred cc---------------------CCC-------------CCCCCCHHhHHHHH--------HHHHHHHHHHHhhCC----
Q 038103 599 FN---------------------DPG-------------TASILQWDQRYNIA--------VGTAKGLSYLHEECL---- 632 (804)
Q Consensus 599 ~~---------------------~~~-------------~~~~l~~~~~~~i~--------~~ia~~l~yLH~~~~---- 632 (804)
.. -+. .++.-.|...++.+ -....-..+|+....
T Consensus 117 ~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~ 196 (321)
T COG3173 117 PPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAG 196 (321)
T ss_pred CcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCC
Confidence 11 000 00111122222111 111223445554432
Q ss_pred -CcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 633 -EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 633 -~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
..++|+|+.+.||+++.+.-+-|.||+++..-.
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 349999999999999998889999999998643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.0088 Score=73.26 Aligned_cols=158 Identities=13% Similarity=0.018 Sum_probs=110.9
Q ss_pred HHHHHhcCCCCcccceeeeEE--eCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhC--C
Q 038103 557 EVSIIGRINHRNLVKLQGFCA--ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC--L 632 (804)
Q Consensus 557 E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~ 632 (804)
|...++...|+++.+...-.. +..+.+.+++++..|.+.+.|-....+...++.........+......-.|+.. .
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 444555667887766544332 334568889999999999998765444444444444444444344444444432 3
Q ss_pred CcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCC
Q 038103 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712 (804)
Q Consensus 633 ~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~ 712 (804)
...+|+++|+-|.+|..+.++|++++|+.++..+.. .......+++-|+.|++...-.++.++|+|..|+.+|+..-|.
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhccc
Confidence 347999999999999999999999999999533322 2223345677899999988888999999999999999987776
Q ss_pred CCC
Q 038103 713 SAS 715 (804)
Q Consensus 713 ~p~ 715 (804)
.++
T Consensus 1438 ~~f 1440 (2724)
T KOG1826|consen 1438 AYF 1440 (2724)
T ss_pred HHH
Confidence 664
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.037 Score=57.69 Aligned_cols=130 Identities=15% Similarity=0.140 Sum_probs=86.7
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCcCC-------C----------------hHHHHHHHHHHhcCC-CC-c
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ-------G----------------DAEFWAEVSIIGRIN-HR-N 568 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~-------~----------------~~~~~~E~~~l~~l~-H~-n 568 (804)
+.+.+.||-|.-+.||.+....|++.++|.=+..+. . .-...+|..-|..|. |. .
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 456788999999999999999999888884211000 0 012345777777763 22 2
Q ss_pred ccceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc
Q 038103 569 LVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD 648 (804)
Q Consensus 569 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~ 648 (804)
+.+.+. .+..++|||++.+-.|...-+ ..+...+.. .+..-+.-|..+| +||+|..-=||+++
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~---~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVRH-------VEDPPTLYD---DLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeeee-------cCChHHHHH---HHHHHHHHHHHcC---ceecccchheeEEe
Confidence 333333 345689999998877654432 122333333 3334445666777 99999999999999
Q ss_pred CCCCeEEeecCC
Q 038103 649 DHFEPKVTDFGL 660 (804)
Q Consensus 649 ~~~~~kl~Dfgl 660 (804)
++..++++||--
T Consensus 237 dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 237 DDDKIVVIDFPQ 248 (465)
T ss_pred cCCCEEEeechH
Confidence 999999999943
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.33 Score=53.37 Aligned_cols=79 Identities=19% Similarity=0.169 Sum_probs=50.9
Q ss_pred cccccccCcceEEEEEecCCcEEEEEEecC-----cC---CChHHHHHHHHHHhcCC---CCcccceeeeEEeCCeeEEE
Q 038103 517 KQEVGKGGFGSVFRGVLDDERVVAVKRLEG-----VL---QGDAEFWAEVSIIGRIN---HRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~~~~~vavK~l~~-----~~---~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 585 (804)
.+.||.|....||+.... ++.++||+-.. .. ....+-..|.+.|+.+. ...+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 357899999999998865 44688997651 11 12233344566665553 346777888777 446788
Q ss_pred EeeccC--CChhhhh
Q 038103 586 YEYVEN--GSLDKLL 598 (804)
Q Consensus 586 ~E~~~~--gsL~~~l 598 (804)
||++++ ..+.+-+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 2344444
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.063 Score=59.29 Aligned_cols=49 Identities=20% Similarity=0.334 Sum_probs=37.4
Q ss_pred hHHHHHHHHHHhcCCCCcccceeeeEEeC-CeeEEEEeeccCCChhhhhcc
Q 038103 551 DAEFWAEVSIIGRINHRNLVKLQGFCAEN-EHKLLVYEYVENGSLDKLLFN 600 (804)
Q Consensus 551 ~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~~~gsL~~~l~~ 600 (804)
..++.....+++.++|+|+...+.+-... ....+|+|++.. ||++.+..
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~ 75 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKT 75 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHh
Confidence 34566677888889999999988876543 356788999854 99988854
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.59 Score=50.55 Aligned_cols=80 Identities=26% Similarity=0.146 Sum_probs=48.9
Q ss_pred ccccccCcceEEEEEecCC-cEEEEEEecC----c----CCChHHHHHHHHHHhcCC--CCcccceeeeEEeCCeeEEEE
Q 038103 518 QEVGKGGFGSVFRGVLDDE-RVVAVKRLEG----V----LQGDAEFWAEVSIIGRIN--HRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~-~~vavK~l~~----~----~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 586 (804)
+++|.|....||++..+++ +.|+||.-.. . .-..++..-|.+.|.... .|..|+-+- ..+.....+||
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~D~e~~~~vM 79 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HFDTEMAVTVM 79 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EEccccceehH
Confidence 3689999999999998765 5799997541 1 112244556777776653 344444332 23445556899
Q ss_pred eeccCC-Chhhhh
Q 038103 587 EYVENG-SLDKLL 598 (804)
Q Consensus 587 E~~~~g-sL~~~l 598 (804)
|+++.. .|+..|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 998653 243444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 804 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-55 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-21 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-21 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 8e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 399 bits (1028), Expect = e-134
Identities = 125/310 (40%), Positives = 186/310 (60%), Gaps = 12/310 (3%)
Query: 502 KRFTYAELKRATRNFKQE--VGKGGFGSVFRGVLDDERVVAVKRL-EGVLQG-DAEFWAE 557
KRF+ EL+ A+ NF + +G+GGFG V++G L D +VAVKRL E QG + +F E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 558 VSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIA 617
V +I HRNL++L+GFC +LLVY Y+ NGS+ L P + L W +R IA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 618 VGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG 677
+G+A+GL+YLH+ C ++H DVK NILLD+ FE V DFGL+KL + + VRG
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAK 737
T G++APE++ K K DV+ YG++LLEL+TG+ A D + D L+ WV
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM---LLDWVKG 254
Query: 738 QMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA-----H 792
++++ LE ++D L Y E+++++++VALLC + RP MS+VV++L
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAER 314
Query: 793 DHESSQDESI 802
E ++E
Sbjct: 315 WEEWQKEEMF 324
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 378 bits (973), Expect = e-125
Identities = 111/292 (38%), Positives = 160/292 (54%), Gaps = 12/292 (4%)
Query: 502 KRFTYAELKRATRNFKQE--VGKGGFGSVFRGVLDDERVVAVKRL-EGVLQGDAEFWAEV 558
R +L+ AT NF + +G G FG V++GVL D VA+KR QG EF E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 559 SIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV 618
+ H +LV L GFC E +L+Y+Y+ENG+L + L+ + W+QR I +
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 619 GTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFS-RVRG 677
G A+GL YLH ++H DVK NILLD++F PK+TDFG+SK E T S V+G
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203
Query: 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAK 737
T GY+ PE+ + ++ K+DVYS+G+VL E+L +SA S +L +W +
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ-----SLPREMVNLAEWAVE 258
Query: 738 QMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
LE+I+DP L D E L + A+ C+A + + RP M V+ L
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 368 bits (946), Expect = e-122
Identities = 107/309 (34%), Positives = 167/309 (54%), Gaps = 29/309 (9%)
Query: 496 VLALGFKRFTYAELKRATRNFKQE--------VGKGGFGSVFRGVLDDERVVAVKRLE-- 545
V F F++ ELK T NF + +G+GGFG V++G +++ VAVK+L
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAM 65
Query: 546 ---GVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDP 602
+ +F E+ ++ + H NLV+L GF ++ + LVY Y+ NGSL L
Sbjct: 66 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 603 GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662
GT L W R IA G A G+++LHE +H D+K NILLD+ F K++DFGL++
Sbjct: 126 GTPP-LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 663 LFKERHDTKFS-RVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSAS 721
++ T + R+ GT Y+APE + +I K+D+YS+G+VLLE++TG A D
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE---- 236
Query: 722 ASDSSYCNHLVQWVAK-QMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRP 780
L+ + + E++ +E ID ++ND D ++ M VA C+ E ++ RP
Sbjct: 237 ---HREPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 781 PMSKVVKLL 789
+ KV +LL
Sbjct: 293 DIKKVQQLL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 6e-69
Identities = 70/313 (22%), Positives = 132/313 (42%), Gaps = 36/313 (11%)
Query: 504 FTYAELKRATRNFK--QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSII 561
L + + + +G FG V++ L +E V AVK + + EV +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDKQSWQNEYEVYSL 72
Query: 562 GRINHRNLVKLQGFCAENEH----KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIA 617
+ H N+++ G L+ + E GSL L + + W++ +IA
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIA 127
Query: 618 VGTAKGLSYLHEECLEW-------VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670
A+GL+YLHE+ + H D+K +N+LL ++ + DFGL+ F+
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 671 KFSRVR-GTRGYLAPEWM---MNLKIDA--KADVYSYGIVLLELLTGKSASDYLSASASD 724
+ + GTR Y+APE + +N + DA + D+Y+ G+VL EL + +A+D
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV----- 242
Query: 725 SSYCNHLVQWVAKQMEQEGLEKII-----DPRL-NDVYDREKLDRMVKVALLCVAENRDT 778
Y + + + E +++++ P L + + + + C + +
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 779 RPPMSKVVKLLTA 791
R V + +T
Sbjct: 303 RLSAGCVGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-56
Identities = 80/292 (27%), Positives = 137/292 (46%), Gaps = 27/292 (9%)
Query: 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRL-EGVLQGDA--EFWAEVSIIGRINHRNLVKL 572
K+++G G FG+V R VAVK L E + EF EV+I+ R+ H N+V
Sbjct: 41 IKEKIGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
G + + +V EY+ GSL +LL + G L +R ++A AKG++YLH
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI 692
++H ++K N+L+D + KV DFGLS+ K GT ++APE + +
Sbjct: 159 P-IVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 693 DAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRL 752
+ K+DVYS+G++L EL T + L+ + +V V + ++ + + ++P++
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQ--------VVAAVGFKCKRLEIPRNLNPQV 268
Query: 753 NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQDESISD 804
+ + C RP + ++ LL + + SD
Sbjct: 269 AAIIEG------------CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-56
Identities = 68/336 (20%), Positives = 122/336 (36%), Gaps = 47/336 (13%)
Query: 504 FTYAELKRATRNFK--QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSI- 560
+E N K + +G+G +G+V++G LD+ VAVK F E +I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER-PVAVKVFS--FANRQNFINEKNIY 59
Query: 561 -IGRINHRNLVKLQGFCAENE-----HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRY 614
+ + H N+ + LLV EY NGSL K L W
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSC 114
Query: 615 NIAVGTAKGLSYLHEECLEW------VLHCDVKPQNILLDDHFEPKVTDFGLSKLF---- 664
+A +GL+YLH E + H D+ +N+L+ + ++DFGLS
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 665 ---KERHDTKFSRVRGTRGYLAPEWMMNL-------KIDAKADVYSYGIVLLELLTGKSA 714
D GT Y+APE + + D+Y+ G++ E+ +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 715 SDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID-----PRLNDVY--DREKLDRMVKV 767
L S Y V E ++ ++ P+ + + + + + +
Sbjct: 235 ---LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 768 ALLCVAENRDTRPPMSKVVKLLTAHDHESSQDESIS 803
C ++ + R + + +++S+S
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 4e-56
Identities = 74/286 (25%), Positives = 127/286 (44%), Gaps = 34/286 (11%)
Query: 506 YAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN 565
Y E++ ++ VG+G FG V + + VA+K++E F E+ + R+N
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWRAK-DVAIKQIE-SESERKAFIVELRQLSRVN 59
Query: 566 HRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
H N+VKL G C LV EY E GSL +L + + + ++G++
Sbjct: 60 HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFE-PKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
YLH + ++H D+KP N+LL K+ DFG + T + +G+ ++AP
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAP 172
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744
E K DV+S+GI+L E++T + D + A + W + L
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-------IMWAVHNGTRPPL 225
Query: 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790
K + + + R C +++ RP M ++VK++T
Sbjct: 226 IKNLPKPIESLMTR------------CWSKDPSQRPSMEEIVKIMT 259
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-53
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDA-----EFWAEVSIIGRINHRNLV 570
++ +G GGFG V+R + VAVK D E + + H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
L+G C + + LV E+ G L+++L + D N AV A+G++YLH+E
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDE 124
Query: 631 CLEWVLHCDVKPQNILLDDHFEP--------KVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
+ ++H D+K NIL+ E K+TDFGL+ +E H T G ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA---REWHRTTKMSAAGAYAWM 181
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGK 712
APE + +DV+SYG++L ELLTG+
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 8e-51
Identities = 61/297 (20%), Positives = 113/297 (38%), Gaps = 40/297 (13%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGD-AEFWAEVSIIGRIN 565
+ + + +GKG FG + + V+ +K L + F EV ++ +
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE 65
Query: 566 HRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
H N++K G +++ + EY++ G+L ++ + W QR + A A G++
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMA 122
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR----------- 674
YLH ++H D+ N L+ ++ V DFGL++L +
Sbjct: 123 YLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 675 --VRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLV 732
V G ++APE + D K DV+S+GIVL E++ +A
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR----------- 228
Query: 733 QWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
+ L++ P + + C + + RP K+ L
Sbjct: 229 TMDFGLNVRGFLDRYCPPNCP--------PSFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-49
Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 44/292 (15%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGD--------AEFWAEVSIIGRINH 566
+++++GKGGFG V +G + D+ VVA+K L EF EV I+ +NH
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
N+VKL G +V E+V G L L + ++W + + + A G+ Y
Sbjct: 83 PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDIALGIEY 137
Query: 627 LHEECLEWVLHCDVKPQNILLD-----DHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
+ ++H D++ NI L KV DFGLS+ S + G +
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192
Query: 682 LAPEWMM--NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739
+APE + KAD YS+ ++L +LTG+ D S + + ++
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK------FINMIREEG 246
Query: 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791
+ + + PRL +V + C + + RP S +VK L+
Sbjct: 247 LRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVKELSE 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-48
Identities = 63/292 (21%), Positives = 117/292 (40%), Gaps = 45/292 (15%)
Query: 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDA---EFWAEVSIIGRINHRNLVKL 572
+ +GKG FG V+ G E VA++ ++ + F EV + H N+V
Sbjct: 37 IGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
G C H ++ + +L ++ + L ++ IA KG+ YLH +
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIV---LDVNKTRQIAQEIVKGMGYLHAKG- 150
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKL----FKERHDTKFSRVRGTRGYLAPEWMM 688
+LH D+K +N+ D+ + +TDFGL + R + K G +LAPE +
Sbjct: 151 --ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 689 NLKIDA---------KADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739
L D +DV++ G + EL + A A ++ + M
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--------IIWQMGTGM 259
Query: 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791
+ + + ++D+ ++ C A ++ RP +K++ +L
Sbjct: 260 KPNLSQIGMGKEISDI--------LLF----CWAFEQEERPTFTKLMDMLEK 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-48
Identities = 50/283 (17%), Positives = 108/283 (38%), Gaps = 38/283 (13%)
Query: 515 NFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDA---EFWAEVSIIGRINHRNLVK 571
NF ++ + G +++G + VK L+ +F E + +H N++
Sbjct: 13 NFLTKLNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 572 LQGFCAE--NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
+ G C H L+ ++ GSL +L + Q A+ A+G+++LH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHT 129
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
+ + +++++D+ +++ + F+ ++APE +
Sbjct: 130 -LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQK 182
Query: 690 LKIDA---KADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746
D AD++S+ ++L EL+T + LS + VA + + +
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME--------IGMKVALEGLRPTIPP 234
Query: 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
I P ++ + C+ E+ RP +V +L
Sbjct: 235 GISPHVSKLMKI------------CMNEDPAKRPKFDMIVPIL 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-47
Identities = 66/281 (23%), Positives = 122/281 (43%), Gaps = 32/281 (11%)
Query: 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRL-EGVLQGD--AEFWAEVSIIGRINHRNLVKL 572
Q +G G FG+V++G + VAVK L F EV ++ + H N++
Sbjct: 28 VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
G+ +V ++ E SL L + + +IA TA+G+ YLH +
Sbjct: 86 MGYSTA-PQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKS- 140
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH-DTKFSRVRGTRGYLAPEWMMN-- 689
++H D+K NI L + K+ DFGL+ +F ++ G+ ++APE +
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 690 -LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748
++DVY++GIVL EL+TG+ ++ + + + + L +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----------RDQIIEMVGRGSLSPDL 247
Query: 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
++ RM ++ C+ + RD RP +++ +
Sbjct: 248 SKVRSNC-----PKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 6e-46
Identities = 66/301 (21%), Positives = 115/301 (38%), Gaps = 30/301 (9%)
Query: 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFW--AEVSIIGRINHRNLVKLQ 573
+++GKG +G V+ G E+V AVK +A ++ E+ + H N++
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEKV-AVKVFFT--TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 574 GFCAENEHK----LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
+ L+ +Y ENGSL L + L +A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHT 152
Query: 630 ECLEW-----VLHCDVKPQNILLDDHFEPKVTDFGLSKLF---KERHDTKFSRVRGTRGY 681
E + H D+K +NIL+ + + D GL+ F D + GT+ Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 682 LAPE------WMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV 735
+ PE + + AD+YS+G++L E+ + +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS-DPS 271
Query: 736 AKQMEQEGLEKIIDPRLNDVYDREKLDR-MVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794
+ M + K + P + + ++ R M K+ C A N +R +V K L
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
Query: 795 E 795
Sbjct: 332 S 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-45
Identities = 66/304 (21%), Positives = 118/304 (38%), Gaps = 48/304 (15%)
Query: 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSI--IGRINHRNLVKLQ 573
+ VGKG +G V+RG E V AVK + + ++ E + + H N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQGENV-AVKIFSS--RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 574 GFCAENEHK----LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
+ H L+ Y E GSL L L I + A GL++LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHI 123
Query: 630 ECLEW-----VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH---DTKFSRVRGTRGY 681
E + H D+K +NIL+ + + + D GL+ + + D + GT+ Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 682 LAPEWMMNLKIDA-------KADVYSYGIVLLELLTGKSASD--------YLSASASDSS 726
+APE +++ I + D++++G+VL E+ ++ + +D S
Sbjct: 184 MAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 727 YCNHLVQWVAKQMEQEGLEKIIDPRL-NDVYDREKLDRMVKVALLCVAENRDTRPPMSKV 785
+ M + P + N + L + K+ C +N R ++
Sbjct: 243 FE---------DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 786 VKLL 789
K L
Sbjct: 294 KKTL 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 78/310 (25%), Positives = 126/310 (40%), Gaps = 48/310 (15%)
Query: 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSI--IGRINHRNLVKLQ 573
++ +GKG FG V+RG E V AVK + + ++ E I + H N++
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEEV-AVKIFSS--REERSWFREAEIYQTVMLRHENILGFI 102
Query: 574 GFCAENEHK----LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
++ LV +Y E+GSL L + + +A+ TA GL++LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 157
Query: 630 ECLEW-----VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF----SRVRGTRG 680
E + + H D+K +NIL+ + + D GL+ DT RV GT+
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKR 216
Query: 681 YLAPEWMMNLKIDA-------KADVYSYGIVLLELLTGKSASD--------YLSASASDS 725
Y+APE +++ I+ +AD+Y+ G+V E+ S Y SD
Sbjct: 217 YMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275
Query: 726 SYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKV 785
S + + V +Q L I R E L M K+ C N R ++
Sbjct: 276 SVEE-MRKVVCEQ----KLRPNIPNRWQ---SCEALRVMAKIMRECWYANGAARLTALRI 327
Query: 786 VKLLTAHDHE 795
K L+ +
Sbjct: 328 KKTLSQLSQQ 337
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 53/202 (26%), Positives = 80/202 (39%), Gaps = 16/202 (7%)
Query: 518 QEVGKGGFGSVFRG---VLDDERVVAVKRLEGVLQGDAEFWA----EVSIIGRINHRNLV 570
+ VG+GG G V+ V + R+VA+K + L D F E GR+ ++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRE--RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+ F + + + L +L G L + I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGP---LAPPRAVAIVRQIGSALDAAHAA 153
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
H DVKP+NIL+ + DFG++ + T+ GT Y+APE
Sbjct: 154 GA---THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 691 KIDAKADVYSYGIVLLELLTGK 712
+AD+Y+ VL E LTG
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 518 QEVGKGGFGSVFRG---VLDDERVVAVKRLEGVLQGDAEFWA----EVSIIGRINHRNLV 570
++G GG +V+ +L+ VA+K + + E EV +++H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+ E++ LV EY+E +L + + G L D N G+ + H+
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGP---LSVDTAINFTNQILDGIKHAHDM 130
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
++H D+KPQNIL+D + K+ DFG++K E T+ + V GT Y +PE
Sbjct: 131 R---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 691 KIDAKADVYSYGIVLLELLTGK 712
D D+YS GIVL E+L G+
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGE 209
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-36
Identities = 64/265 (24%), Positives = 114/265 (43%), Gaps = 24/265 (9%)
Query: 457 YLISLAGSFAVIETV-FISLG---WWYVFRRHVHEELANLGCIVLALGFKRFTYAELKRA 512
++I + +E F S+ + L +VL + + L
Sbjct: 59 FIIQSLDNLYRLEGEGFPSIPLLIDHL---LSTQQPLTKKSGVVLHRAVPKDKW-VLNHE 114
Query: 513 TRNFKQEVGKGGFGSVFRGVLDDERV-VAVKRL-EGVLQGD-AEFWAEVSIIGRINHRNL 569
+++G+G FG VF G L + VAVK E + A+F E I+ + +H N+
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 570 VKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
V+L G C + + +V E V+ G L + L+ + A G+ YL
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLES 231
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY----LAPE 685
+C +H D+ +N L+ + K++DFG+S+ D ++ G R APE
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA---DGVYAASGGLRQVPVKWTAPE 285
Query: 686 WMMNLKIDAKADVYSYGIVLLELLT 710
+ + +++DV+S+GI+L E +
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFS 310
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
+ + F QE+G G FG V G ++ VA+K + + +F E ++ +++H
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 63
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LV+L G C E LV E++E+G L L G + + + +G++YL
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL 120
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE-----RHDTKFSRVRGTRGYL 682
E C V+H D+ +N L+ ++ KV+DFG+++ + TKF V+
Sbjct: 121 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-VKWA---- 172
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLT 710
+PE + +K+DV+S+G+++ E+ +
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 49/202 (24%), Positives = 96/202 (47%), Gaps = 9/202 (4%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQGDA--EFWAEVSIIGRINHRNLVKL 572
+++G+G F V+R L D VA+K ++ ++ A + E+ ++ ++NH N++K
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
E+ +V E + G L +++ + ++ + V L ++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR- 156
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI 692
V+H D+KP N+ + K+ D GL + F + S V GT Y++PE +
Sbjct: 157 --VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 213
Query: 693 DAKADVYSYGIVLLELLTGKSA 714
+ K+D++S G +L E+ +S
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSP 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL----DDERVVAVKRL-EGVLQGDA-EFWAEVSII 561
E++ + + ++ +G G G V G L + VA+K L G + +F +E SI+
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTA 621
G+ +H N+++L+G ++V EY+ENGSLD L G Q + G
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVG 161
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG---- 677
G+ YL + +H D+ +N+L+D + KV+DFGLS++ ++ D ++ G
Sbjct: 162 AGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218
Query: 678 --TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
T APE + + +DV+S+G+V+ E+L
Sbjct: 219 RWT----APEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 518 QEVGKGGFGSVFRG---VLDDERVVAVKRLEGVLQGDAEFWA----EVSIIGRINHRNLV 570
+ +G GG V R VAVK L L D F+ E +NH +V
Sbjct: 18 EILGFGGMSEVHLARDLRDH--RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 571 KL--QGFCAENEHKL--LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
+ G L +V EYV+ +L ++ + G + + + + L++
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGP---MTPKRAIEVIADACQALNF 131
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD--TKFSRVRGTRGYLAP 684
H+ + +H DVKP NI++ KV DFG+++ + + T+ + V GT YL+P
Sbjct: 132 SHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGK 712
E +DA++DVYS G VL E+LTG+
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
ELKR +E+G G FG V G + VAVK ++ + EF+ E + +++H
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHP 63
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LVK G C++ +V EY+ NG L L + L+ Q + +G+++L
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL 120
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE-----RHDTKFSRVRGTRGYL 682
+H D+ +N L+D KV+DFG+++ + TKF V+ +
Sbjct: 121 ESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP-VKWS---- 172
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLT 710
APE K +K+DV+++GI++ E+ +
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
E+ F +E+G G FG V G + VA+K ++ + EF E ++ ++H
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LV+L G C + ++ EY+ NG L L Q Q + + + YL
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL 136
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE-----RHDTKFSRVRGTRGYL 682
+ LH D+ +N L++D KV+DFGLS+ + +KF VR +
Sbjct: 137 ESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-VRWS---- 188
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLT 710
PE +M K +K+D++++G+++ E+ +
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-33
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 6/203 (2%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
E+ R + + ++G+G FG V+ G + VA+K L+ F E ++ ++ H
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LV+L +E E +V EY+ GSL L + G L+ Q ++A A G++Y+
Sbjct: 240 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYV 296
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
+H D++ NIL+ ++ KV DFGL++L ++ T + + APE
Sbjct: 297 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 353
Query: 688 MNLKIDAKADVYSYGIVLLELLT 710
+ + K+DV+S+GI+L EL T
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTT 376
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 23/216 (10%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL-----DDERVVAVKRL-EGVLQGDA-EFWAEVSI 560
E+ + ++ +G G FG V++G+L E VA+K L G + +F E I
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT 620
+G+ +H N+++L+G ++ + +++ EY+ENG+LDK L G Q + G
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGI 156
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG--- 677
A G+ YL +H D+ +NIL++ + KV+DFGLS++ ++ + ++ G
Sbjct: 157 AAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 678 ---TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
T APE + K + +DV+S+GIV+ E++T
Sbjct: 214 IRWT----APEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-33
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 6/204 (2%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERV-VAVKRLEGVLQGDAEFWAEVSIIGRINH 566
E++R K ++G G +G V+ GV + VAVK L+ EF E +++ I H
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 275
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
NLV+L G C ++ E++ G+L L + +A + + Y
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEY 333
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
L ++ +H ++ +N L+ ++ KV DFGLS+L T + + + APE
Sbjct: 334 LEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 390
Query: 687 MMNLKIDAKADVYSYGIVLLELLT 710
+ K K+DV+++G++L E+ T
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-33
Identities = 55/208 (26%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
E+ R + ++++G G FG V+ + VAVK ++ F AE +++ + H
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LVKL + E ++ E++ GSL L +D G+ + + + A+G++++
Sbjct: 244 KLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFI 300
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE-----RHDTKFSRVRGTRGYL 682
+ +H D++ NIL+ K+ DFGL+++ ++ R KF ++ T
Sbjct: 301 EQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWT---- 352
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLT 710
APE + K+DV+S+GI+L+E++T
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-33
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 6/203 (2%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
E+ R + + ++G+G FG V+ G + VA+K L+ F E ++ ++ H
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LV+L +E E +V EY+ GSL L + G L+ Q ++A A G++Y+
Sbjct: 323 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYV 379
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
+H D++ NIL+ ++ KV DFGL++L ++ T + + APE
Sbjct: 380 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 436
Query: 688 MNLKIDAKADVYSYGIVLLELLT 710
+ + K+DV+S+GI+L EL T
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTT 459
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 58/221 (26%), Positives = 85/221 (38%), Gaps = 33/221 (14%)
Query: 507 AELKRATRNFK--QEVGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQGDAEFWAEVSII 561
E + VG+G FG V R AVK RLE E+
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV------EELVAC 104
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNI 616
++ +V L G E + E +E GSL +L+ + L Q
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG--Q---- 158
Query: 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFKE----RHDTK 671
+GL YLH +LH DVK N+LL D + DFG + + +
Sbjct: 159 ---ALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
+ GT ++APE +M DAK D++S ++L +L G
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 510 KRATRNFK--QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINH 566
KR +FK + +G GGFG VF+ D + +KR++ + + EV + +++H
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK---YNNEKAEREVKALAKLDH 63
Query: 567 RNLVKLQGFCAENEHKL----------------LVYEYVENGSLDKLLFNDPGTASILQW 610
N+V G ++ + E+ + G+L++ + G L
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--KLDK 121
Query: 611 DQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670
+ KG+ Y+H + +++ D+KP NI L D + K+ DFGL K +D
Sbjct: 122 VLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLK--NDG 176
Query: 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKS 713
K +R +GT Y++PE + + + D+Y+ G++L ELL
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL--------DDERVVAVKRL-EGVLQGDAEFWAEV 558
+++ F + +G+G F +F+GV E V +K L + F+
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63
Query: 559 SIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV 618
S++ +++H++LV G C + +LV E+V+ GSLD L + + + +A
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAK 120
Query: 619 GTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP--------KVTDFGLSKLFKERHDT 670
A + +L E L +H +V +NILL + K++D G+S +
Sbjct: 121 QLAAAMHFLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 671 KFSRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLT 710
+ R+ PE + N K + D +S+G L E+ +
Sbjct: 178 QE-RIPWV----PPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLD-----DERVVAVKRL-EGVLQGDAEFWAEVSII 561
+ + F Q++GKG FGSV D VVAVK+L + +F E+ I+
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 562 GRINHRNLVKLQGFCAENEHK--LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVG 619
+ H N+VK +G C + L+ EY+ GSL L + +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQ 122
Query: 620 TAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG-- 677
KG+ YL + +H D+ +NIL+++ K+ DFGL+K+ + + + G
Sbjct: 123 ICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 678 ----TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
APE + K +DV+S+G+VL EL T
Sbjct: 180 PIFWY----APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA---EVSIIGRINHRNLVKLQGF 575
+GKG +G V+ G L ++ +A+K + + E+++ + H+N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTA---KGLSYLHEECL 632
+EN + E V GSL LL + G L+ +++ I T +GL YLH+
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGP---LKDNEQT-IGFYTKQILEGLKYLHDNQ- 142
Query: 633 EWVLHCDVKPQNILLDDHF-EPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK 691
++H D+K N+L++ + K++DFG SK + + GT Y+APE +
Sbjct: 143 --IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGP 199
Query: 692 I--DAKADVYSYGIVLLELLTGK 712
AD++S G ++E+ TGK
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-33
Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 22/215 (10%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL----DDERVVAVKRL-EGVLQGDA-EFWAEVSII 561
EL + + VG G FG V G L E VA+K L G + +F E SI+
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTA 621
G+ +H N+++L+G +++ ++V EY+ENGSLD L Q + G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 157
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG---- 677
G+ YL + +H D+ +NIL++ + KV+DFGL ++ ++ + ++ G
Sbjct: 158 SGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 678 --TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
T +PE + K + +DV+SYGIVL E+++
Sbjct: 215 RWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 54/201 (26%), Positives = 82/201 (40%), Gaps = 15/201 (7%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE---FWAEVSIIGRI-NHRNLVKL 572
+G G +G VF+ +D R+ AVKR +G + AEV ++ H V+L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
+ E L E SL + + L Q + T L++LH +
Sbjct: 123 EQAWEEGGILYLQTELCG-PSLQQHCEAWGAS---LPEAQVWGYLRDTLLALAHLHSQG- 177
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI 692
++H DVKP NI L K+ DFGL + + G Y+APE +
Sbjct: 178 --LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE-VQE-GDPRYMAPELLQG-SY 232
Query: 693 DAKADVYSYGIVLLELLTGKS 713
ADV+S G+ +LE+
Sbjct: 233 GTAADVFSLGLTILEVACNME 253
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLD-----DERVVAVKRL-EGVLQGDAEFWAEVSII 561
+ + F Q++GKG FGSV D VVAVK+L + +F E+ I+
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 562 GRINHRNLVKLQGFCAENEHK--LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVG 619
+ H N+VK +G C + L+ EY+ GSL L + +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQ 153
Query: 620 TAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG-- 677
KG+ YL + +H D+ +NIL+++ K+ DFGL+K+ + + + G
Sbjct: 154 ICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210
Query: 678 ----TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
APE + K +DV+S+G+VL EL T
Sbjct: 211 PIFWY----APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE---FWAEVSIIGRINHRNLVK 571
F E+G+G F +V++G+ + VA L+ +E F E ++ + H N+V+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 572 LQGFC---AENEHKLLVY-EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
+ + +++ E + +G+L L I + KGL +L
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLR---SWCRQILKGLQFL 145
Query: 628 HEECLEWVLHCDVKPQNILLDDHF-EPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
H ++H D+K NI + K+ D GL+ L + + V GT ++APE
Sbjct: 146 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPE- 200
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGK 712
M K D DVY++G+ +LE+ T +
Sbjct: 201 MYEEKYDESVDVYAFGMCMLEMATSE 226
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 24/217 (11%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDER-----VVAVKRL-EGVLQGDAEFWAEVSII 561
+ + ++GKG FGSV D +VAVK+L +F E+ I+
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 562 GRINHRNLVKLQGFCAENEHK--LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVG 619
++ +VK +G + LV EY+ +G L L L + +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQ 135
Query: 620 TAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG-- 677
KG+ YL +H D+ +NIL++ K+ DFGL+KL D R G
Sbjct: 136 ICKGMEYLGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 678 ----TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
APE + + ++DV+S+G+VL EL T
Sbjct: 193 PIFWY----APESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 16/208 (7%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
E+ R T + +G G FG V+ G + VAVK L+ F AE +++ ++ H+
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LV+L + E ++ EY+ENGSL L G L ++ ++A A+G++++
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFI 125
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE-----RHDTKFSRVRGTRGYL 682
E +H D++ NIL+ D K+ DFGL++L ++ R KF ++ T
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWT---- 177
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLT 710
APE + K+DV+S+GI+L E++T
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-32
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLE-GVLQGDAEFWA-EVSIIGRINHRNLVKL 572
K+ +G GGFG V R + D VA+K+ + + E W E+ I+ ++NH N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 573 ------QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
A N+ LL EY E G L K L N L+ + + L Y
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFSRVRGTRGYLA 683
LHE ++H D+KP+NI+L + K+ D G +K + + GT YLA
Sbjct: 137 LHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQYLA 191
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLTGK 712
PE + K D +S+G + E +TG
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-32
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRL-EGVLQGDAEFWAEVSIIGRINH 566
L Q +GKG FG V G +V AVK + F AE S++ ++ H
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQA--FLAEASVMTQLRH 245
Query: 567 RNLVKLQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
NLV+L G E + L +V EY+ GSL L + + L D ++ + +
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAME 303
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK-LFKERHDTKFSRVRGTRGYLAP 684
YL +H D+ +N+L+ + KV+DFGL+K + K V+ T AP
Sbjct: 304 YLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VKWT----AP 355
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLT 710
E + K K+DV+S+GI+L E+ +
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYS 381
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-32
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE---FWAEVSIIGRINHRNLVKLQ 573
Q++G+G FG +D R +K + E EV+++ + H N+V+ +
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGT----ASILQWDQRYNIAVGTAKGLSYLHE 629
EN +V +Y E G L K + G IL W V L ++H+
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVHD 143
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
+LH D+K QNI L ++ DFG++++ + + + GT YL+PE N
Sbjct: 144 RK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICEN 199
Query: 690 LKIDAKADVYSYGIVLLELLTGKSA 714
+ K+D+++ G VL EL T K A
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHA 224
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLD-----DERVVAVKRL-EGVLQGD-AEFWAEVSI 560
++ +++G+G FG V D VAVK L A+ E+ I
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 561 IGRINHRNLVKLQGFCAENEHK--LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV 618
+ + H N+VK +G C E+ L+ E++ +GSL + L + + Q+ AV
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAV 133
Query: 619 GTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG- 677
KG+ YL +H D+ +N+L++ + K+ DFGL+K + + +
Sbjct: 134 QICKGMDYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 678 -----TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
APE +M K +DV+S+G+ L ELLT
Sbjct: 191 SPVFWY----APECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERV-VAVKRL-EGVLQGDAEFWAEVSIIGRIN 565
E++R K ++G G +G V+ GV + VAVK L E ++ + EF E +++ I
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 566 HRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
H NLV+L G C ++ E++ G+L L + +A + +
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAME 125
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE-----RHDTKFSRVRGTRG 680
YL ++ +H D+ +N L+ ++ KV DFGLS+L KF ++ T
Sbjct: 126 YLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWT-- 179
Query: 681 YLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
APE + K K+DV+++G++L E+ T
Sbjct: 180 --APESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 9/205 (4%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE---FWAEVSIIGRINHRNLVKLQ 573
+G G +G + D +++ K L+ +AE +EV+++ + H N+V+
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 574 G-FCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
L +V EY E G L ++ L + + L H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 632 LEW--VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
VLH D+KP N+ LD K+ DFGL+++ + V GT Y++PE M
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 690 LKIDAKADVYSYGIVLLELLTGKSA 714
+ + K+D++S G +L EL
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLE-GVLQGDAEFWA-EVSIIGRINHRNLVK 571
+G+G +VFRG + A+K + E ++ ++NH+N+VK
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 572 LQGF--CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
L HK+L+ E+ GSL +L +P A L + + G+++L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 630 ECLEWVLHCDVKPQNILL----DDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPE 685
++H ++KP NI+ D K+TDFG ++ ++ D +F + GT YL P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLYGTEEYLHPD 185
Query: 686 --------WMMNLKIDAKADVYSYGIVLLELLTGK 712
K A D++S G+ TG
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 55/217 (25%), Positives = 84/217 (38%), Gaps = 25/217 (11%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL----DDERVVAVKRL-EGVLQGDA---EFWAEVS 559
+ +++G G FG V RG VAVK L VL +F EV+
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 560 IIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVG 619
+ ++HRNL++L G +V E GSL L G AV
Sbjct: 74 AMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQ 129
Query: 620 TAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG-- 677
A+G+ YL + +H D+ +N+LL K+ DFGL + + D +
Sbjct: 130 VAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 678 ----TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
APE + +D + +G+ L E+ T
Sbjct: 187 PFAWC----APESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRL-EGVLQGDAEFWAEVSIIGRINH 566
L Q +GKG FG V G +V AVK + F AE S++ ++ H
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDAT--AQAFLAEASVMTQLRH 73
Query: 567 RNLVKLQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
NLV+L G E + L +V EY+ GSL L + S+L D ++ + +
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAME 131
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK-LFKERHDTKFSRVRGTRGYLAP 684
YL +H D+ +N+L+ + KV+DFGL+K + K V+ T AP
Sbjct: 132 YLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VKWT----AP 183
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLT 710
E + K K+DV+S+GI+L E+ +
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYS 209
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 50/220 (22%), Positives = 87/220 (39%), Gaps = 33/220 (15%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE---FWAEVSIIGRI-NHRNLVKL 572
+++G G FGSVF+ V D + A+KR + L G + EV + H ++V+
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
AE++H L+ EY GSL + + S + + ++ + +GL Y+H
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS- 135
Query: 633 EWVLHCDVKPQNILLDDHFEP-------------------KVTDFGLSKLFKERHDTKFS 673
++H D+KP NI + P K+ D G
Sbjct: 136 --LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV---- 189
Query: 674 RVRGTRGYLAPE-WMMNLKIDAKADVYSYGIVLLELLTGK 712
G +LA E N KAD+++ + ++ +
Sbjct: 190 -EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 517 KQEVGKGGFGSVFRGVL---DDERVVAVKRL-EGVLQGD-AEFWAEVSIIGRINHRNLVK 571
E+G G FGSV +GV + VA+K L +G + D E E I+ ++++ +V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
L G C +LV E G L K L + + + G+ YL E+
Sbjct: 75 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKN 130
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG------TRGYLAPE 685
+H D+ +N+LL + K++DFGLSK +R G APE
Sbjct: 131 F---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APE 183
Query: 686 WMMNLKIDAKADVYSYGIVLLELLT 710
+ K +++DV+SYG+ + E L+
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-31
Identities = 51/205 (24%), Positives = 81/205 (39%), Gaps = 31/205 (15%)
Query: 520 VGKGGFGSVFRG---VLDDERVVAVKRLEGVLQGDAEFWA----EVSIIGRINHRNLVKL 572
+ GG G ++ ++ R V +K L V GDAE A E + + H ++V++
Sbjct: 88 IAHGGLGWIYLALDRNVNG-RPVVLKGL--VHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 573 QGFCAENEHKL-----LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
F + +V EYV SL + L + + LSYL
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-GQK-----LPVAEAIAYLLEILPALSYL 198
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
H L ++ D+KP+NI+L + + K+ D G F + GT G+ APE +
Sbjct: 199 HSIGL---VYNDLKPENIMLTEE-QLKLIDLGAV-----SRINSFGYLYGTPGFQAPEIV 249
Query: 688 MNLKIDAKADVYSYGIVLLELLTGK 712
D+Y+ G L L
Sbjct: 250 RT-GPTVATDIYTVGRTLAALTLDL 273
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 52/225 (23%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
+G+G FG V + D R A+K++ + + +EV ++ +NH+ +V+
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 575 F------------CAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTA 621
+ + L + EY ENG+L L+ ++ D+ + +
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR---DEYWRLFRQIL 126
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE-------------RH 668
+ LSY+H + ++H D+KP NI +D+ K+ DFGL+K
Sbjct: 127 EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 669 DTKFSRVRGTRGYLAPEWMMNLK--IDAKADVYSYGIVLLELLTG 711
+ GT Y+A E +++ + K D+YS GI+ E++
Sbjct: 184 SDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 30/226 (13%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL-EGVLQGDAEFWAEVSI 560
+KR K E+G+G FG VF D+ +VAVK L E +F E +
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL-----------FNDPGTASILQ 609
+ + H+++V+ G C E L+V+EY+ +G L++ L + L
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 610 WDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669
Q +A A G+ YL +H D+ +N L+ K+ DFG+S+
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213
Query: 670 TKFSRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
+ G R L PE ++ K ++DV+S+G+VL E+ T
Sbjct: 214 YR----VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLE-GVLQGDAEFWA-EVSIIGRINHRNLVK 571
+G+G +VFRG + A+K + E ++ ++NH+N+VK
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 572 LQGF--CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
L HK+L+ E+ GSL +L +P A L + + G+++L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 630 ECLEWVLHCDVKPQNILL----DDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPE 685
++H ++KP NI+ D K+TDFG ++ ++ D +F + GT YL P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLYGTEEYLHPD 185
Query: 686 --------WMMNLKIDAKADVYSYGIVLLELLTGK 712
K A D++S G+ TG
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-30
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 19/212 (8%)
Query: 509 LKRATRNFKQEVGKGGFGSVFRGVLDDER-----VVAVKRL-EGVLQGD-AEFWAEVSII 561
LK + +G G FG+V++G+ E VA+K L E E E ++
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTA 621
+++ ++ +L G C L+ + + G L + + N V A
Sbjct: 72 ASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIA 127
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR-- 679
KG++YL + L +H D+ +N+L+ K+TDFGL+KL + K G +
Sbjct: 128 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVP 182
Query: 680 -GYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
++A E +++ ++DV+SYG+ + EL+T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL----DDERVVAVKRL-EGVLQGD-AEFWAEVSII 561
+ R + +G+G FG V+ GV ++ VAVK + + +F +E I+
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTA 621
++H ++VKL G E E ++ E G L L + + L+ ++
Sbjct: 68 KNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQIC 123
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE-----RHDTKFSRVR 676
K ++YL +H D+ +NIL+ K+ DFGLS+ ++ T+ ++
Sbjct: 124 KAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IK 179
Query: 677 GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
+PE + + +DV+ + + + E+L+
Sbjct: 180 WM----SPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 27/203 (13%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVKRL--EGVLQGDAE--FWAEVSIIGRINHRNLVKLQGF 575
GKG FG+V+ + ++A+K L + + E EV I + H N+++L G+
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 576 CAENEHKLLVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+ L+ EY G++ + L F++ TA+ + + A LSY H +
Sbjct: 78 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT--E-------LANALSYCHSK 128
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK-ERHDTKFSRVRGTRGYLAPEWMMN 689
V+H D+KP+N+LL E K+ DFG S R + GT YL PE +
Sbjct: 129 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPPEMIEG 181
Query: 690 LKIDAKADVYSYGIVLLELLTGK 712
D K D++S G++ E L GK
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGK 204
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 30/219 (13%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
Q +G+GGFG VF D+ A+K RL + EV + ++ H +V+
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 575 FCAENE---------HKLLVY---EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK 622
E K+ +Y + +L + N T + +I + A+
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-NGRCTIEERERSVCLHIFLQIAE 129
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR------ 676
+ +LH + ++H D+KP NI KV DFGL + + +
Sbjct: 130 AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 677 -----GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
GT+ Y++PE + K D++S G++L ELL
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 78/315 (24%), Positives = 127/315 (40%), Gaps = 44/315 (13%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDD-----ERVVAVKRL--EGVLQGDAEFWAEVSI 560
+ +++G+G FG V D +VAVK L + Q + + E+ I
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 561 IGRINHRNLVKLQGFCAENEHK--LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV 618
+ + H +++K +G C + LV EYV GSL L + Q A
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQ 141
Query: 619 GTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGT 678
+G++YLH + +H D+ +N+LLD+ K+ DFGL+K E H+ + RVR
Sbjct: 142 QICEGMAYLHAQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE--YYRVR-E 195
Query: 679 RGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSS--YCNH 730
G APE + K +DV+S+G+ L ELLT S+ +
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255
Query: 731 LVQWVAKQMEQEG-LEKIIDPRL--NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787
V + + +E+ L + P +VY + C RP ++
Sbjct: 256 TVLRLTELLERGERLPR---PDKCPAEVYH---------LMKNCWETEASFRPTFENLIP 303
Query: 788 LLTA-HDHESSQDES 801
+L H+ Q S
Sbjct: 304 ILKTVHEKYQGQAPS 318
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 31/227 (13%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL-EGVLQGDAEFWAEVSI 560
+KR K+E+G+G FG VF D+ +VAVK L + L +F E +
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL------------FNDPGTASIL 608
+ + H ++VK G C + + ++V+EY+++G L+K L L
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 609 QWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668
Q +IA A G+ YL +V H D+ +N L+ + K+ DFG+S+ +
Sbjct: 131 GLSQMLHIASQIASGMVYL--ASQHFV-HRDLATRNCLVGANLLVKIGDFGMSRDV---Y 184
Query: 669 DTKFSRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
T + RV G L PE +M K ++DV+S+G++L E+ T
Sbjct: 185 STDYYRVGG-HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 19/213 (8%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDER-----VVAVKRL-EGVLQGD-AEFWAEVSI 560
K + +G G FG+V +GV E V +K + + + +
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT 620
IG ++H ++V+L G C LV +Y+ GSL + G L N V
Sbjct: 69 IGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQI 124
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR- 679
AKG+ YL E + +H ++ +N+LL + +V DFG++ L D K +
Sbjct: 125 AKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPP--DDKQLLYSEAKT 179
Query: 680 --GYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
++A E + K ++DV+SYG+ + EL+T
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 22/216 (10%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDD----ERVVAVKRL-EGVLQGD-AEFWAEVSII 561
+F + +G+G FG V+ G L D + AVK L G+ ++F E I+
Sbjct: 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 562 GRINHRNLVKLQGFCAENEHKLL-VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT 620
+H N++ L G C +E L V Y+++G L + N+ +
Sbjct: 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQV 137
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG 680
AKG+ YL + +H D+ +N +LD+ F KV DFGL++ +D ++ V G
Sbjct: 138 AKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTG 191
Query: 681 YL------APEWMMNLKIDAKADVYSYGIVLLELLT 710
A E + K K+DV+S+G++L EL+T
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 48/213 (22%), Positives = 91/213 (42%), Gaps = 21/213 (9%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL----DDERVVAVKRL-EGVLQGD-AEFWAEVSII 561
E++R + +G+G FG V +G+ + VA+K +F E +
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTA 621
+ +H ++VKL G E ++ E G L L + L A +
Sbjct: 71 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLS 126
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR----VRG 677
L+YL + +H D+ +N+L+ + K+ DFGLS+ ++ K S+ ++
Sbjct: 127 TALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
APE + + + +DV+ +G+ + E+L
Sbjct: 184 M----APESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDD----ERVVAVKRL-EGVLQGD-AEFWAEVSII 561
+F + +G+G FG V+ G L D + AVK L G+ ++F E I+
Sbjct: 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144
Query: 562 GRINHRNLVKLQGFCAENEHKLL-VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT 620
+H N++ L G C +E L V Y+++G L + N+ ++ +
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK---DLIGFGLQV 201
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG 680
AKG+ +L + +H D+ +N +LD+ F KV DFGL++ +D +F V G
Sbjct: 202 AKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKTG 255
Query: 681 YL------APEWMMNLKIDAKADVYSYGIVLLELLT 710
A E + K K+DV+S+G++L EL+T
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 518 QEVGKGGFGSVFRGVLDDERV---VAVKRL-EGVLQGDA--EFWAEVSIIGRINHRNLVK 571
+E+G G FG+V +G ++V VAVK L E AE +++ ++++ +V+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
+ G C E E +LV E E G L+K L + ++ + + G+ YL E
Sbjct: 83 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEESN 137
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG------TRGYLAPE 685
+H D+ +N+LL K++DFGLSK + + ++ G APE
Sbjct: 138 F---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APE 190
Query: 686 WMMNLKIDAKADVYSYGIVLLELLT 710
+ K +K+DV+S+G+++ E +
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 22/217 (10%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLE-GVLQGDAEFWAEVSIIGRINHRNLVKLQ 573
F Q++G+GGF V L D A+KR+ Q E E + NH N+++L
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 574 GFCAE----NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
+C L+ + + G+L + + L DQ + +G +GL +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR--------GTRGY 681
+ H D+KP NILL D +P + D G + + T Y
Sbjct: 153 KG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 682 LAPEWMMNLK----IDAKADVYSYGIVLLELLTGKSA 714
APE + +++ ID + DV+S G VL ++ G+
Sbjct: 210 RAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 19/212 (8%)
Query: 509 LKRATRNFKQEVGKGGFGSVFRGVLDDER-----VVAVKRL-EGVLQGD-AEFWAEVSII 561
LK + +G G FG+V++G+ E VA+K L E E E ++
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTA 621
+++ ++ +L G C L+ + + G L + + N V A
Sbjct: 72 ASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIA 127
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR-- 679
KG++YL + L +H D+ +N+L+ K+TDFGL+KL + K G +
Sbjct: 128 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVP 182
Query: 680 -GYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
++A E +++ ++DV+SYG+ + EL+T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 30/206 (14%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVKRL--EGVLQGDAE--FWAEVSIIGRINHRNLVKLQGF 575
GKG F V+R + VA+K + + + + EV I ++ H ++++L +
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 576 CAENEHKLLVYEYVENGSLDKLL------FNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
++ + LV E NG +++ L F++ + Q G+ YLH
Sbjct: 80 FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH--Q-------IITGMLYLHS 130
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK---ERHDTKFSRVRGTRGYLAPEW 686
+LH D+ N+LL + K+ DFGL+ K E+H T + GT Y++PE
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT----LCGTPNYISPEI 183
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGK 712
++DV+S G + LL G+
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 29/205 (14%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVKRL--EGVLQGDAE--FWAEVSIIGRINHRNLVKLQGF 575
GKGGF F D + V A K + +L+ E+SI + H+++V GF
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 576 CAENEHKLLVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+N+ +V E SL +L +P L+ G YLH
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---------QIVLGCQYLHRN 160
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK---ERHDTKFSRVRGTRGYLAPEWM 687
V+H D+K N+ L++ E K+ DFGL+ + ER + GT Y+APE +
Sbjct: 161 R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV----LCGTPNYIAPEVL 213
Query: 688 MNLKIDAKADVYSYGIVLLELLTGK 712
+ DV+S G ++ LL GK
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-29
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 501 FKRFTYAELKRATRNFKQEVGKGGFGSVFRGVL---DDERVVAVKRL-EGVLQGD-AEFW 555
K + E+G G FGSV +GV + VA+K L +G + D E
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 384
Query: 556 AEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYN 615
E I+ ++++ +V+L G C +LV E G L K L +
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAE 440
Query: 616 IAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRV 675
+ + G+ YL E+ +H ++ +N+LL + K++DFGLSK +R
Sbjct: 441 LLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497
Query: 676 RG------TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
G APE + K +++DV+SYG+ + E L+
Sbjct: 498 AGKWPLKWY----APECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 34/217 (15%), Positives = 68/217 (31%), Gaps = 23/217 (10%)
Query: 516 FKQEVGKGGFGSVFRGVLDDER------VVAVKRLEGVLQGDAE-FWAEVSIIGRINHRN 568
+G+G F V+ D +K + + + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSL-DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
+K +LV E G+L + + ++ + A+ + +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEP-----------KVTDFGLSKLFK-ERHDTKFSRV 675
H+ ++H D+KP N +L + F + D G S K T F+
Sbjct: 189 HDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 676 RGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
T G+ E + N + + D + + +L G
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 44/217 (20%), Positives = 90/217 (41%), Gaps = 36/217 (16%)
Query: 518 QEVGKGGFGSVFRGVLDDERVVAVKR--LEGVLQGDAE-FWAEVSIIGRINHRNL--VKL 572
+++G GG VF+ + + +++ A+K LE + + E++ + ++ + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGTAKGLSYL 627
+ +++ +V E N L+ L + S + + + +
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--N-------MLEAVHTI 143
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR-VRGTRGYLAPE- 685
H+ ++H D+KP N L+ D K+ DFG++ + + GT Y+ PE
Sbjct: 144 HQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 686 ----------WMMNLKIDAKADVYSYGIVLLELLTGK 712
KI K+DV+S G +L + GK
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 22/242 (9%), Positives = 55/242 (22%), Gaps = 44/242 (18%)
Query: 508 ELKRATRNFK--QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA----EVSI 560
L + R K + + G VF ++ A+K +
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 561 IGRINHRNLVKLQGFC--------------------------AENEHKLLVYEYV--ENG 592
R+ + + + + LL+ +
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175
Query: 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE 652
L L + + + + L + ++H P N+ +
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGR 232
Query: 653 PKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM--NLKIDAKADVYSYGIVLLELLT 710
+ D + T+ Y E++ + + G+ + +
Sbjct: 233 LMLGDVSALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 711 GK 712
Sbjct: 289 LF 290
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 26/222 (11%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL-EGVLQGD-AEFWAEVS 559
E+ R + +G G FG V+ G + VAVK L E + D +F E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 560 IIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFN---DPGTASILQWDQRYNI 616
II + NH+N+V+ G ++ + ++ E + G L L P S L ++
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFS 673
A A G YL E +H D+ +N LL K+ DFG+++ +
Sbjct: 146 ARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR-- 200
Query: 674 RVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
+G L PE M +K D +S+G++L E+ +
Sbjct: 201 --KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 29/205 (14%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVKRL--EGVLQGDAE--FWAEVSIIGRINHRNLVKLQGF 575
GKGGF F D + V A K + +L+ E+SI + H+++V GF
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 576 CAENEHKLLVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+N+ +V E SL +L +P L+ G YLH
Sbjct: 84 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---------QIVLGCQYLHRN 134
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK---ERHDTKFSRVRGTRGYLAPEWM 687
V+H D+K N+ L++ E K+ DFGL+ + ER + GT Y+APE +
Sbjct: 135 R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV----LCGTPNYIAPEVL 187
Query: 688 MNLKIDAKADVYSYGIVLLELLTGK 712
+ DV+S G ++ LL GK
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 57/228 (25%), Positives = 102/228 (44%), Gaps = 32/228 (14%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL-EGVLQGD-AEFWAEVS 559
E+ + F +E+G+ FG V++G L + + VA+K L + EF E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 560 IIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL------------FNDPGTASI 607
+ R+ H N+V L G +++ +++ Y +G L + L +D S
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 608 LQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667
L+ ++ A G+ YL V H D+ +N+L+ D K++D GL +
Sbjct: 125 LEPPDFVHLVAQIAAGMEYL--SSHHVV-HKDLATRNVLVYDKLNVKISDLGLFREV--- 178
Query: 668 HDTKFSRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
+ + ++ G L APE +M K +D++SYG+VL E+ +
Sbjct: 179 YAADYYKLLG-NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL-EGVLQGD-AEFWAEVS 559
E+ R +E+G+G FG V+ GV + E VA+K + E + EF E S
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 560 IIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL------FNDPGTASILQWDQR 613
++ N ++V+L G ++ + L++ E + G L L + + +
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 614 YNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFS 673
+A A G++YL+ +H D+ +N ++ + F K+ DFG+++ E +
Sbjct: 141 IQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-- 195
Query: 674 RVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
+G +G L +PE + + +DV+S+G+VL E+ T
Sbjct: 196 --KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 44/217 (20%), Positives = 90/217 (41%), Gaps = 36/217 (16%)
Query: 518 QEVGKGGFGSVFRGVLDDERVVAVKR--LEGVLQGDAE-FWAEVSIIGRINHRNL--VKL 572
+++G GG VF+ + + +++ A+K LE + + E++ + ++ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGTAKGLSYL 627
+ +++ +V E N L+ L + S + + + +
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--N-------MLEAVHTI 124
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR-VRGTRGYLAPE- 685
H+ ++H D+KP N L+ D K+ DFG++ + + GT Y+ PE
Sbjct: 125 HQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 686 ----------WMMNLKIDAKADVYSYGIVLLELLTGK 712
KI K+DV+S G +L + GK
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 48/213 (22%), Positives = 91/213 (42%), Gaps = 21/213 (9%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL----DDERVVAVKRL-EGVLQGD-AEFWAEVSII 561
E++R + +G+G FG V +G+ + VA+K +F E +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTA 621
+ +H ++VKL G E ++ E G L L + L A +
Sbjct: 446 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLS 501
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR----VRG 677
L+YL + +H D+ +N+L+ + K+ DFGLS+ ++ K S+ ++
Sbjct: 502 TALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
APE + + + +DV+ +G+ + E+L
Sbjct: 559 M----APESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 27/203 (13%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVKRL--EGVLQGDAE--FWAEVSIIGRINHRNLVKLQGF 575
GKG FG+V+ ++ ++A+K L + + E E+ I + H N++++ +
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82
Query: 576 CAENEHKLLVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+ + L+ E+ G L K L F++ +A+ ++ + A L Y HE
Sbjct: 83 FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME--E-------LADALHYCHER 133
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK-ERHDTKFSRVRGTRGYLAPEWMMN 689
V+H D+KP+N+L+ E K+ DFG S R T GT YL PE +
Sbjct: 134 K---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEG 186
Query: 690 LKIDAKADVYSYGIVLLELLTGK 712
D K D++ G++ E L G
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 26/222 (11%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL-EGVLQGD-AEFWAEVS 559
E+ R + +G G FG V+ G + VAVK L E + D +F E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 560 IIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFN---DPGTASILQWDQRYNI 616
II + NH+N+V+ G ++ + ++ E + G L L P S L ++
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFS 673
A A G YL E +H D+ +N LL K+ DFG+++ +
Sbjct: 187 ARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-- 241
Query: 674 RVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
+G L PE M +K D +S+G++L E+ +
Sbjct: 242 --KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-28
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLE--GVLQGDAE-FWAEVSIIGRINHRNLVK 571
+++G G +G V A+K + V EV+++ ++H N++K
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 572 LQGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVGTAKGLSY 626
L F + + LV E + G L D+++ FN+ A I++ + G++Y
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK-----QV----LSGVTY 151
Query: 627 LHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLA 683
LH+ ++H D+KP+N+LL + K+ DFGLS +F+ K GT Y+A
Sbjct: 152 LHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERLGTAYYIA 206
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLTGK 712
PE ++ K D K DV+S G++L LL G
Sbjct: 207 PE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-28
Identities = 43/217 (19%), Positives = 89/217 (41%), Gaps = 36/217 (16%)
Query: 518 QEVGKGGFGSVFRGVLDDERVVAVKR--LEGVLQGDAE-FWAEVSIIGRINHRNL--VKL 572
+++G GG VF+ + + +++ A+K LE + + E++ + ++ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGTAKGLSYL 627
+ +++ +V E N L+ L + S + + + +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--N-------MLEAVHTI 171
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR-VRGTRGYLAPE- 685
H+ ++H D+KP N L+ D K+ DFG++ + + G Y+ PE
Sbjct: 172 HQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 686 ----------WMMNLKIDAKADVYSYGIVLLELLTGK 712
KI K+DV+S G +L + GK
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 516 FKQEVGKGGFGSVFRGVLDD----ERVVAVKRL-EGVLQGD-AEFWAEVSIIGRINHRNL 569
+ +GKG FG V+ G D A+K L F E ++ +NH N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 570 VKLQGFCAENE-HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
+ L G E ++ Y+ +G L + + + + + A+G+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARGMEYLA 141
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYL------ 682
E+ +H D+ +N +LD+ F KV DFGL++ D ++ V+ R
Sbjct: 142 EQKF---VHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWT 195
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLT 710
A E + + K+DV+S+G++L ELLT
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL---DDERVVAVKRL-EGVLQGD-AEFWAEVSIIG 562
L F+ +G+G FG V + + A+KR+ E + D +F E+ ++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80
Query: 563 RI-NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL------------FNDPGTASILQ 609
++ +H N++ L G C + L EY +G+L L TAS L
Sbjct: 81 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 610 WDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK---LFKE 666
Q + A A+G+ YL ++ +H D+ +NIL+ +++ K+ DFGLS+ ++ +
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 197
Query: 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
+ + VR A E + +DV+SYG++L E+++
Sbjct: 198 KTMGRLP-VRWM----AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 27/209 (12%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLE--GVLQGDAE-FWAEVSIIGRINHRNLV 570
N +GKG FG V + ++ AVK + D EV ++ +++H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 571 KLQGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVGTAKGLS 625
KL ++ +V E G L D+++ F++ A I++ + G++
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-----QV----FSGIT 135
Query: 626 YLHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
Y+H+ ++H D+KP+NILL + + K+ DFGLS F++ +TK GT Y+
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYI 190
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTG 711
APE ++ D K DV+S G++L LL+G
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 22/203 (10%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKR--LEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
+++GKG FG VF+G+ ++VVA+K LE + E++++ + + + K G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 575 FCAENEHKL-LVYEYVENGSLDKLL----FNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
+ KL ++ EY+ GS LL ++ A+IL+ KGL YLH
Sbjct: 88 -SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---------EILKGLDYLHS 137
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
E +H D+K N+LL +H E K+ DFG++ + + + V GT ++APE +
Sbjct: 138 EK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 193
Query: 690 LKIDAKADVYSYGIVLLELLTGK 712
D+KAD++S GI +EL G+
Sbjct: 194 SAYDSKADIWSLGITAIELARGE 216
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 49/214 (22%), Positives = 89/214 (41%), Gaps = 32/214 (14%)
Query: 515 NFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-HRNLVKLQ 573
K +G G G++ + D R VAVKR+ + + + EV ++ + H N+++
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRI--LPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 574 GFCAENEHKLLVYEYVENGSLDKLL------FNDPGTASILQWDQRYNIAVGTAKGLSYL 627
+ + + + E +L + + ++LQ Q T GL++L
Sbjct: 85 CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ--Q-------TTSGLAHL 134
Query: 628 HEECLEWVLHCDVKPQNILLDDHFE-----PKVTDFGLSKLFK--ERHDTKFSRVRGTRG 680
H ++H D+KP NIL+ ++DFGL K ++ S V GT G
Sbjct: 135 HSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 681 YLAPE---WMMNLKIDAKADVYSYGIVLLELLTG 711
++APE D++S G V +++
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 26/222 (11%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDD----ERVVAVKRL--EGVLQGD-AEFWAEVSI 560
+ R + +G+G FGSV G L VAVK + + Q + EF +E +
Sbjct: 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89
Query: 561 IGRINHRNLVKLQGFCAENE-----HKLLVYEYVENGSLDKLL--FNDPGTASILQWDQR 613
+ +H N+++L G C E +++ +++ G L L +
Sbjct: 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 614 YNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFS 673
V A G+ YL LH D+ +N +L D V DFGLSK +
Sbjct: 150 LKFMVDIALGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR-- 204
Query: 674 RVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
+G + A E + + +K+DV+++G+ + E+ T
Sbjct: 205 --QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLE--GVLQGDAE--FWAEVSIIGRINHRNL 569
++ +GKG FG V + AVK + V Q + EV ++ +++H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 570 VKLQGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVGTAKGL 624
+KL F + + LV E G L D+++ F++ A I++ + G+
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-----QV----LSGI 139
Query: 625 SYLHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
+Y+H+ ++H D+KP+N+LL ++ DFGLS F+ K GT Y
Sbjct: 140 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYY 194
Query: 682 LAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
+APE +++ D K DV+S G++L LL+G
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-27
Identities = 23/233 (9%), Positives = 61/233 (26%), Gaps = 42/233 (18%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA----EVSIIGRI---------- 564
+G+ + + V + + EV + +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 565 ---------------NHRNLVKLQG----FCAENEHKLLVYEYVENGSLDKLLFNDPGTA 605
+ +++++ + L + ++L + T
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 606 SILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665
L R + + + L+ LH ++H ++P +I+LD +T F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 666 ERHDTKFSRVRGTRGYLAPEWM-----MNLKIDAKADVYSYGIVLLELLTGKS 713
+ R A + + D ++ G+ + +
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 38/219 (17%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRL-------------EGVLQGDAE-FWAEVSI 560
+++G G +G V + A+K + ++ E + E+S+
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYN 615
+ ++H N++KL + ++ LV E+ E G L ++++ F++ A+I++
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK-----Q 154
Query: 616 IAVGTAKGLSYLHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFKERHDTKF 672
I G+ YLH+ ++H D+KP+NILL + K+ DFGLS F + D K
Sbjct: 155 I----LSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKL 205
Query: 673 SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
GT Y+APE ++ K + K DV+S G+++ LL G
Sbjct: 206 RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 29/252 (11%), Positives = 70/252 (27%), Gaps = 55/252 (21%)
Query: 508 ELKRATRNFKQ--EVGKGGFGSVFRGV-LDDERVVAVK---------------------- 542
EL R + +G+ + + V
Sbjct: 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126
Query: 543 -------RLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG----FCAENEHKLLVYEYVEN 591
+ + + F ++ + +++++ + L
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186
Query: 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF 651
+ ++L + T L R + + + L+ LH ++H ++P +I+LD
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRG 243
Query: 652 EPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM-----------NLKIDAKADVYS 700
+T F R + +RG+ PE + D ++
Sbjct: 244 GVFLTGFEHLVRDGARVVS-----SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 701 YGIVLLELLTGK 712
G+V+ +
Sbjct: 299 LGLVIYWIWCAD 310
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKR--LEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
+ +G G V + VA+KR LE E E+ + + +H N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 575 FCAENEHKL-LVYEYVENGSLDKLL--FNDPGTASILQWDQRYNIAV---GTAKGLSYLH 628
+ +L LV + + GS+ ++ G D+ IA +GL YLH
Sbjct: 81 -SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATILREVLEGLEYLH 138
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR----GTRGYLAP 684
+ +H DVK NILL + ++ DFG+S D ++VR GT ++AP
Sbjct: 139 KNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 685 EWMMNLKI-DAKADVYSYGIVLLELLTGK 712
E M ++ D KAD++S+GI +EL TG
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-FWAEVSIIGRINHRNLVKLQGF 575
+++G+G G+V+ + + + VA++++ Q E E+ ++ + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD- 84
Query: 576 CAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
+L +V EY+ GSL ++ T + + Q + + L +LH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ--- 136
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDA 694
V+H D+K NILL K+TDFG + + V GT ++APE +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 195
Query: 695 KADVYSYGIVLLELLTGK 712
K D++S GI+ +E++ G+
Sbjct: 196 KVDIWSLGIMAIEMIEGE 213
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 37/232 (15%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL-EGVLQGD-AEFWAEVS 559
E R +F + +G G FG V D VAVK L + +E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 560 IIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL--------------FNDPGT 604
++ + NH N+V L G C L++ EY G L L
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 605 ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL- 663
L + + + AKG+++L + +H D+ +NILL K+ DFGL++
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 664 -----FKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT 710
+ + + + V+ APE + N ++DV+SYGI L EL +
Sbjct: 196 KNDSNYVVKGNARL-PVKWM----APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLE-GVLQGDAE-FWAEVSIIGRINHRNLVK 571
FK+++G G FG V +K + Q E AE+ ++ ++H N++K
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 572 LQGFCAENEHKLLVYEYVENGSL-DKLLFNDPGTASILQWDQRYN--IAVGTAK----GL 624
+ + + +V E E G L ++++ S + + K L
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIV-------SAQARGKALSEGYVAELMKQMMNAL 137
Query: 625 SYLHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
+Y H + V+H D+KP+NIL H K+ DFGL++LFK D + GT Y
Sbjct: 138 AYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAAGTALY 192
Query: 682 LAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
+APE + + K D++S G+V+ LLTG
Sbjct: 193 MAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 27/209 (12%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLE--GVLQGDAE-FWAEVSIIGRINHRNLV 570
N +GKG FG V + ++ AVK + D EV ++ +++H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 571 KLQGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVGTAKGLS 625
KL ++ +V E G L D+++ F++ A I++ + G++
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-----QV----FSGIT 135
Query: 626 YLHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
Y+H+ ++H D+KP+NILL + + K+ DFGLS F++ +TK GT Y+
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYI 190
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTG 711
APE ++ D K DV+S G++L LL+G
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-FWAEVSIIGRINHRNLVKLQGF 575
++G+G G V R VAVK ++ Q E + EV I+ H N+V++
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWV 635
E ++ E+++ G+L ++ + L +Q + + L+YLH + V
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQG---V 162
Query: 636 LHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAK 695
+H D+K +ILL K++DFG + + S V GT ++APE + +
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATE 221
Query: 696 ADVYSYGIVLLELLTGK 712
D++S GI+++E++ G+
Sbjct: 222 VDIWSLGIMVIEMVDGE 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 54/209 (25%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-FWAEVSIIGRINHRNLVKLQGF 575
E+G G FG V++ + + A K +E + + E + E+ I+ +H +VKL G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG- 83
Query: 576 CAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV---GTAKGLSYLHEEC 631
++ KL ++ E+ G++D ++ L Q I V + L++LH +
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQ---IQVVCRQMLEALNFLHSKR 137
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLS---KLFKERHDTKFSRVRGTRGYLAPEWMM 688
++H D+K N+L+ + ++ DFG+S ++ D+ GT ++APE +M
Sbjct: 138 ---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS----FIGTPYWMAPEVVM 190
Query: 689 NLKI-----DAKADVYSYGIVLLELLTGK 712
+ D KAD++S GI L+E+ +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 48/223 (21%), Positives = 88/223 (39%), Gaps = 27/223 (12%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVLQGDAE---FWAEVSI 560
+ + +GKG FGSV L VAVK L+ + ++ F E +
Sbjct: 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78
Query: 561 IGRINHRNLVKLQGFCAENE------HKLLVYEYVENGSLDKLL--FNDPGTASILQWDQ 612
+ +H ++ KL G + +++ ++++G L L L
Sbjct: 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 613 RYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672
V A G+ YL +H D+ +N +L + V DFGLS+ + +
Sbjct: 139 LVRFMVDIACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKI---YSGDY 192
Query: 673 SRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
R +G L A E + + +DV+++G+ + E++T
Sbjct: 193 YR-QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVK-----RLEGVLQGD--AEFWAEVSIIGRINH 566
+ +E+G G F V + A K + +G E EVSI+ ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGSL-----DKLLFNDPGTASILQWDQRYNIAVGTA 621
N++ L +L+ E V G L K ++ S ++ Q
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--Q-------IL 125
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEP----KVTDFGLSKLFKERHDTKFSRVRG 677
G++YLH + + H D+KP+NI+L D P K+ DFGL+ ++ +F + G
Sbjct: 126 DGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFG 180
Query: 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKS 713
T ++APE + + +AD++S G++ LL+G S
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 44/224 (19%), Positives = 84/224 (37%), Gaps = 33/224 (14%)
Query: 515 NFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQ 573
++ +G G G+V R VAVKR+ + E+ ++ +H N+++
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 574 GFCAENEHKLLVYEYVENGSLDKLL---FNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+ + E +L L+ + + ++ A G+++LH
Sbjct: 76 CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 631 CLEWVLHCDVKPQNILLDDHFEP-------------KVTDFGLSKLFKERHDTKFSRVR- 676
++H D+KPQNIL+ ++DFGL K + + +
Sbjct: 135 K---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 677 --GTRGYLAPE-------WMMNLKIDAKADVYSYGIVLLELLTG 711
GT G+ APE ++ D++S G V +L+
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVK-----RLEGVLQGD--AEFWAEVSIIGRINH 566
+ +E+G G F V + A K + +G E EVSI+ ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGSL-----DKLLFNDPGTASILQWDQRYNIAVGTA 621
N++ L +L+ E V G L K ++ S ++ I
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QI----L 125
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEP----KVTDFGLSKLFKERHDTKFSRVRG 677
G++YLH + + H D+KP+NI+L D P K+ DFGL+ ++ +F + G
Sbjct: 126 DGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFG 180
Query: 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKS 713
T ++APE + + +AD++S G++ LL+G S
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLE--GVLQGDAE-FWAEVSIIGRINHRNLV 570
+ K+E+GKG F V R V A K + + D + E I ++ H N+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 571 KLQGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVGTAKGLS 625
+L E LV++ V G L + ++ +++ + +Q I + ++
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-----QI----LESIA 119
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
Y H ++H ++KP+N+LL + K+ DFGL+ + + GT GYL
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYL 174
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTG 711
+PE + D+++ G++L LL G
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 55/211 (26%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVK---- 571
+ VG G +G V++G + ++ A+K ++ + E E++++ + +HRN+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 572 -LQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV---GTAKGLSY 626
++ + +L LV E+ GS+ L+ + L+ + IA +GLS+
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEW---IAYICREILRGLSH 144
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
LH+ V+H D+K QN+LL ++ E K+ DFG+S + + GT ++APE
Sbjct: 145 LHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEV 200
Query: 687 MMNLKI-----DAKADVYSYGIVLLELLTGK 712
+ + D K+D++S GI +E+ G
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVK-----RLEGVLQGD--AEFWAEVSIIGRINH 566
+E+G G F V + + A K RL +G E EV+I+ I H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGSL-----DKLLFNDPGTASILQWDQRYNIAVGTA 621
N++ L +L+ E V G L +K + L+ I
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-----QI----L 118
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEP----KVTDFGLSKLFKERHDTKFSRVRG 677
G+ YLH + + H D+KP+NI+L D P K+ DFG++ + +F + G
Sbjct: 119 DGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFKNIFG 173
Query: 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKS 713
T ++APE + + +AD++S G++ LL+G S
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 55/227 (24%), Positives = 88/227 (38%), Gaps = 31/227 (13%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL-EGVLQGD-AEFWAEVS 559
E R F + +G G FG V D VAVK L + +E+
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 560 IIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL----------FNDPGTASIL 608
I+ + H N+V L G C L++ EY G L L S
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 609 QWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668
+ + A+G+++L + +H DV +N+LL + K+ DFGL++
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 669 DTKFSRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
+ L APE + + ++DV+SYGI+L E+ +
Sbjct: 219 NYI----VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQGDAEFWAEVSIIGR-INHRNLVKLQ 573
E+G G G V++ V+AVK R G + + ++ ++ + + +V+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
G + + E + +KL G + + V K L YL E+
Sbjct: 91 G-TFITNTDVFIAMELM-GTCAEKLKKRMQGP---IPERILGKMTVAIVKALYYLKEK-- 143
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLS-KLFKERHDTKFSRVRGTRGYLAPEWMMNLK 691
V+H DVKP NILLD+ + K+ DFG+S +L ++ + + G Y+APE +
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCAAYMAPERIDPPD 200
Query: 692 I-----DAKADVYSYGIVLLELLTGK 712
D +ADV+S GI L+EL TG+
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQ 226
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 40/236 (16%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL-EGVLQGD-AEFWAEVS 559
E R + +++G+G FG VF+ + +VAVK L E A+F E +
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 560 IIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL--------------------F 599
++ ++ N+VKL G CA + L++EY+ G L++ L
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 600 NDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659
L ++ IA A G++YL ++V H D+ +N L+ ++ K+ DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFV-HRDLATRNCLVGENMVVKIADFG 219
Query: 660 LSKLFKERHDTKFSRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
LS + + + + G + PE + + ++DV++YG+VL E+ +
Sbjct: 220 LS---RNIYSADYYKADG-NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-FWAEVSIIGRINHRNLVKL 572
F + +G G F VF ++ A+K ++ E++++ +I H N+V L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 573 QGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVGTAKGLSYL 627
+ H LV + V G L D++L + + + ++Q + + YL
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-----QV----LSAVKYL 122
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
HE ++H D+KP+N+L E +TDFGLSK+ + + S GT GY+AP
Sbjct: 123 HENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTACGTPGYVAP 176
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTG 711
E + D +S G++ LL G
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 55/220 (25%), Positives = 89/220 (40%), Gaps = 38/220 (17%)
Query: 521 GKGGFGSVFRGVLDDERVVAVKRLE-GVLQGDAEFWA-----------------EVSIIG 562
+G F + D + A+K+ E +L+ +F E+ II
Sbjct: 40 NQGKFNKI-ILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 563 RINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK 622
I + + +G + ++YEY+EN S+ +L + I + K
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSI----LKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 623 --------GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR 674
SY+H E + + H DVKP NIL+D + K++DFG S+ D K
Sbjct: 155 CIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKIKG 209
Query: 675 VRGTRGYLAPEWMMNLKI--DAKADVYSYGIVLLELLTGK 712
RGT ++ PE+ N AK D++S GI L +
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 518 QEVGKGGFGSVFRGVL-DDERVVAVK--RLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
E+G G G VF+ V+A K LE + E+ ++ N +V G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 575 FCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
++ ++ + E+++ GSLD++L A + +++ KGL+YL E+
Sbjct: 99 -AFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK- 152
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKID 693
++H DVKP NIL++ E K+ DFG+S + D+ + GTR Y++PE +
Sbjct: 153 -IMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSPERLQGTHYS 208
Query: 694 AKADVYSYGIVLLELLTGK 712
++D++S G+ L+E+ G+
Sbjct: 209 VQSDIWSMGLSLVEMAVGR 227
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 56/236 (23%), Positives = 104/236 (44%), Gaps = 40/236 (16%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL-EGVLQGD-AEFWAEVS 559
E R + +G+G FG V + VAVK L E + + +E +
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 560 IIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL--------------------DKLLF 599
++ ++NH +++KL G C+++ LL+ EY + GSL
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 600 NDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659
D L + A ++G+ YL ++ V H D+ +NIL+ + + K++DFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL--AEMKLV-HRDLAARNILVAEGRKMKISDFG 195
Query: 660 LSKLFKERHDTKFSRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
LS+ E + ++G + A E + + ++DV+S+G++L E++T
Sbjct: 196 LSRDVYEEDSYV----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 19/201 (9%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-FWAEVSIIGRINHRNLVKLQGF 575
+++G+G +GSV++ + + ++VA+K++ ++ D + E+SI+ + + ++VK G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYG- 91
Query: 576 CAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV---GTAKGLSYLHEEC 631
L +V EY GS+ ++ T L D+ IA T KGL YLH
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDE---IATILQSTLKGLEYLHFMR 145
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK 691
+H D+K NILL+ K+ DFG++ + + + + GT ++APE + +
Sbjct: 146 ---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 201
Query: 692 IDAKADVYSYGIVLLELLTGK 712
+ AD++S GI +E+ GK
Sbjct: 202 YNCVADIWSLGITAIEMAEGK 222
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 37/219 (16%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVK-----RLEGVLQGDAE-----FWAEVSIIGRI 564
K+ +G+G V R + + AVK + + EV I+ ++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 565 N-HRNLVKLQGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAV 618
+ H N+++L+ N LV++ ++ G L D L ++ T I++ +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR-----ALL- 134
Query: 619 GTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGT 678
+ + LH+ ++H D+KP+NILLDD K+TDFG S K V GT
Sbjct: 135 ---EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGT 186
Query: 679 RGYLAPE------WMMNLKIDAKADVYSYGIVLLELLTG 711
YLAPE + + D++S G+++ LL G
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQGDAEFWAEVSIIGR-INHRNLVKLQ 573
E+G+G +GSV + V +++AVK R + + ++ ++ R + +V+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLL-FNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
G E + E + + S DK + ++ + I + T K L++L E
Sbjct: 88 G-ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN- 144
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLS-KLFKERHDTKFSRVRGTRGYLAPE----W 686
++H D+KP NILLD K+ DFG+S +L T+ + G R Y+APE
Sbjct: 145 -LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA---GCRPYMAPERIDPS 200
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGK 712
D ++DV+S GI L EL TG+
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQGDAEFWAEVSIIGR-INHRNLVKLQ 573
E+G+G +G V + + +++AVK R Q ++ I R ++ V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
G E + + E + + SLDK + D IAV K L +LH +
Sbjct: 73 G-ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK-- 128
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLS-KLFKERHDTKFSRVRGTRGYLAPE----WM 687
V+H DVKP N+L++ + K+ DFG+S L + + G + Y+APE +
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERINPEL 185
Query: 688 MNLKIDAKADVYSYGIVLLELLTGK 712
K+D++S GI ++EL +
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILR 210
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 48/215 (22%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVK-----RLEGVLQGDAE-FWAEVSIIGRINHRN 568
+ +GKG F V R + + + AVK + E E SI + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSL-DKLL--------FNDPGTASILQWDQRYNIAVG 619
+V+L + + +V+E+++ L +++ +++ + ++ I
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR-----QIL-- 140
Query: 620 TAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFSRVR 676
+ L Y H+ ++H DVKP +LL K+ FG++ E RV
Sbjct: 141 --EALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV- 194
Query: 677 GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
GT ++APE + DV+ G++L LL+G
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVK-----RLEGVLQGD--AEFWAEVSIIGRINH 566
+ +E+G G F V + A K R + +G + EVSI+ I H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVGTA 621
N++ L +L+ E V G L D L + L+ I
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-----QI----L 124
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEP----KVTDFGLSKLFKERHDTKFSRVRG 677
G+ YLH + H D+KP+NI+L D P K+ DFGL+ +F + G
Sbjct: 125 NGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFG 179
Query: 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKS 713
T ++APE + + +AD++S G++ LL+G S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLE-GVLQGDAEFWAEVSIIGRINHRNLVKL 572
+ +G+G +G V V A K++ ++ F E+ I+ ++H N+++L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 573 QGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVGTAKGLSYL 627
+N LV E G L ++++ F + A I++ ++ ++Y
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK-----DV----LSAVAYC 122
Query: 628 HEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
H+ V H D+KP+N L K+ DFGL+ FK GT Y++P
Sbjct: 123 HKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGTPYYVSP 177
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTG 711
+ ++ + D +S G+++ LL G
Sbjct: 178 Q-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 24/209 (11%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-FWAEVSIIGRINHRNLVKL 572
+ +E+G G FG V R V RV K + D E+SI+ +++H L+ L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYN--IAVGTAK----GLSY 626
+ +L+ E++ G LF+ I D + + + + GL +
Sbjct: 114 HDAFEDKYEMVLILEFLSGGE----LFDR-----IAAEDYKMSEAEVINYMRQACEGLKH 164
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEP--KVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
+HE ++H D+KP+NI+ + K+ DFGL+ D T + AP
Sbjct: 165 MHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAP 219
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGKS 713
E + + D+++ G++ LL+G S
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLS 248
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 44/208 (21%), Positives = 82/208 (39%), Gaps = 23/208 (11%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQ 573
+++G+G FG V R V ++ K ++ E+SI+ HRN++ L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYN--IAVGTAK----GLSYL 627
E ++++E++ +F I N V L +L
Sbjct: 68 ESFESMEELVMIFEFISGLD----IFER-----INTSAFELNEREIVSYVHQVCEALQFL 118
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEP--KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPE 685
H + H D++P+NI+ K+ +FG ++ K F + Y APE
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPE 173
Query: 686 WMMNLKIDAKADVYSYGIVLLELLTGKS 713
+ + D++S G ++ LL+G +
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 23/202 (11%), Positives = 49/202 (24%), Gaps = 46/202 (22%)
Query: 518 QEVGKGGFGSVFRG---VLDDERVVAVKRLEGVLQGDAEFWA----EVSIIGRINHRNLV 570
G ++ LD R VA+ ++ + + RI+ +
Sbjct: 37 IFHGGVPPLQFWQALDTALD--RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
++ L+V E++ GSL ++ + A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
V P + + + + +
Sbjct: 149 ---GVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA----- 179
Query: 691 KIDAKADVYSYGIVLLELLTGK 712
+ + D+ G L LL +
Sbjct: 180 --NPQDDIRGIGASLYALLVNR 199
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 48/231 (20%), Positives = 100/231 (43%), Gaps = 35/231 (15%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL--------DDERVVAVKRL-EGVLQGD-AEFWAE 557
E R + +G+G FG V + VAVK L + + D ++ +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 558 VSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSL------------DKLLFNDPGT 604
+ ++ I H+N++ L G C ++ ++ EY G+L + +
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 605 ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664
+ + + A+G+ YL + +H D+ +N+L+ ++ K+ DFGL++
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 665 KERHDTKFSRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
++ + + G L APE + + ++DV+S+G+++ E+ T
Sbjct: 208 ---NNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 57/247 (23%), Positives = 95/247 (38%), Gaps = 53/247 (21%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVK-----RLEGVLQGDAE-FWAEVSIIGRINHRN 568
K +G+G +G V + + A+K ++ + D E EV ++ +++H N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSL-DKLLFNDPGTASILQWDQRYNIAVGTAK----- 622
+ +L + ++ LV E G L DKL + D +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 623 ------------------------------GLSYLHEECLEWVLHCDVKPQNILL--DDH 650
L YLH + + H D+KP+N L +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKS 206
Query: 651 FEPKVTDFGLSKLFKERHDTKFSRVR---GTRGYLAPE--WMMNLKIDAKADVYSYGIVL 705
FE K+ DFGLSK F + ++ ++ + GT ++APE N K D +S G++L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 706 LELLTGK 712
LL G
Sbjct: 267 HLLLMGA 273
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 40/236 (16%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL-EGVLQGD-AEFWAEVS 559
E R F + +G G FG V VAVK L E + +E+
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 560 IIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSL-------------------DKLLF 599
++ ++ +H N+V L G C + L++EY G L ++
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 600 NDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659
+ ++L ++ A AKG+ +L E V H D+ +N+L+ K+ DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFL--EFKSCV-HRDLAARNVLVTHGKVVKICDFG 217
Query: 660 LSKLFKERHDTKFSRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
L++ + L APE + K+DV+SYGI+L E+ +
Sbjct: 218 LARDIMSDSNYV----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL-EGVLQGD-AEFWAEVS 559
E R + +G+G FG V R VAVK L EG + +E+
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 560 IIGRI-NHRNLVKLQGFC-AENEHKLLVYEYVENGSL------------DKLLFNDPGTA 605
I+ I +H N+V L G C +++ E+ + G+L + +
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 606 SILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665
L + + AKG+ +L +H D+ +NILL + K+ DFGL++
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 666 ERHDTKFSRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
+ VR L APE + + ++DV+S+G++L E+ +
Sbjct: 200 KDP----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 24/209 (11%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-FWAEVSIIGRINHRNLVKL 572
+ +E+G G FG V R A K + + D E E+ + + H LV L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYN--IAVGTAK----GLSY 626
++ +++YE++ G LF + + + AV + GL +
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGE----LFEK-----VADEHNKMSEDEAVEYMRQVCKGLCH 270
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEP--KVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
+HE +H D+KP+NI+ K+ DFGL+ GT + AP
Sbjct: 271 MHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAP 325
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGKS 713
E + D++S G++ LL+G S
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLS 354
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-24
Identities = 48/231 (20%), Positives = 100/231 (43%), Gaps = 35/231 (15%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL--------DDERVVAVKRL-EGVLQGD-AEFWAE 557
E R + +G+G FG V + VAVK L + + D ++ +E
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 558 VSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSL------------DKLLFNDPGT 604
+ ++ I H+N++ L G C ++ ++ EY G+L + +
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 605 ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664
+ + + A+G+ YL + + H D+ +N+L+ ++ K+ DFGL++
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 665 KERHDTKFSRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
++ + + G L APE + + ++DV+S+G+++ E+ T
Sbjct: 254 ---NNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRL---------EGVLQGDAEFWAEVSIIGRI- 564
K +G+G V R V AVK + E + + E I+ ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 565 NHRNLVKLQGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVG 619
H +++ L + LV++ + G L D L ++ T SI++ ++
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR-----SLL-- 210
Query: 620 TAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTR 679
+ +S+LH ++H D+KP+NILLDD+ + +++DFG S + K + GT
Sbjct: 211 --EAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLRELCGTP 263
Query: 680 GYLAPE------WMMNLKIDAKADVYSYGIVLLELLTG 711
GYLAPE + + D+++ G++L LL G
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVK-----RLEGVLQGDAEFWAEVSIIGRINHRNL 569
K+E+GKG F V R V A K +L E I ++ H N+
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK--LEREARICRKLQHPNI 90
Query: 570 VKLQGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVGTAKGL 624
V+L E LV++ V G L + ++ +++ + +Q I + +
Sbjct: 91 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-----QI----LESI 141
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFSRVRGTRGY 681
+Y H ++H ++KP+N+LL + K+ DFGL+ + + GT GY
Sbjct: 142 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGY 196
Query: 682 LAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
L+PE + D+++ G++L LL G
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 51/217 (23%), Positives = 78/217 (35%), Gaps = 35/217 (16%)
Query: 518 QEVGKG--GFGSVFRGV-LDDERVVAVKR--LEGVLQGDAEF-WAEVSIIGRINHRNLVK 571
+GKG +V V V+R LE F E+ + NH N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLL-------FNDPGTASILQWDQRYNIAVGTAKGL 624
+ + +V ++ GS L+ N+ A ILQ G K L
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ---------GVLKAL 141
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS-KLFKE------RHDTKFSRVRG 677
Y+H +H VK +IL+ + ++ + + HD V
Sbjct: 142 DYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV-K 197
Query: 678 TRGYLAPEWMMNLKI--DAKADVYSYGIVLLELLTGK 712
+L+PE + DAK+D+YS GI EL G
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 54/231 (23%), Positives = 97/231 (41%), Gaps = 35/231 (15%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL--------DDERVVAVKRL-EGVLQGD-AEFWAE 557
EL R + +G+G FG V + VAVK L + D ++ +E
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 558 VSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSL------------DKLLFNDPGT 604
+ ++ I H+N++ L G C ++ ++ EY G+L +
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 605 ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664
L + A A+G+ YL + + H D+ +N+L+ + K+ DFGL++
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 665 KERHDTKFSRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
K + T G L APE + + ++DV+S+G++L E+ T
Sbjct: 242 HHIDYYK----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 517 KQEVGKGGFGSVFRGVLDDER----VVAVKRLEG-VLQGDAEFWAEVSIIGRINHRNLVK 571
+ +G G FG V + E +A K ++ ++ E E+S++ +++H NL++
Sbjct: 94 TEILGGGRFGQVHKCE---ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYN--IAVGTAK----GLS 625
L +LV EYV+ G LF+ I+ + K G+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGE----LFDR-----IIDESYNLTELDTILFMKQICEGIR 201
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEP--KVTDFGLSKLFKERHDTKFSRVRGTRGYLA 683
++H+ ++LH D+KP+NIL + K+ DFGL++ +K K GT +LA
Sbjct: 202 HMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--REKLKVNFGTPEFLA 256
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLTGKS 713
PE + + D++S G++ LL+G S
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 24/205 (11%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
+ E+G+G V+R ++ A+K L+ + E+ ++ R++H N++KL+
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-VRTEIGVLLRLSHPNIIKLKE 115
Query: 575 FCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
LV E V G L D+++ +++ A ++ I + ++YLHE
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK-----QI----LEAVAYLHE 166
Query: 630 ECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
++H D+KP+N+L K+ DFGLSK+ + V GT GY APE
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPEI 221
Query: 687 MMNLKIDAKADVYSYGIVLLELLTG 711
+ + D++S GI+ LL G
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 60/253 (23%), Positives = 112/253 (44%), Gaps = 21/253 (8%)
Query: 476 GWWYVFRRHVHEELAN--LGCIVLALGFKRFT---YAELKRATRN---FKQEVGKGGFGS 527
G + R V L + +L F RF + E + + + +G+GGFG
Sbjct: 141 GLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGE 200
Query: 528 VFRG-VLDDERVVAVKRL--EGVLQGDAEFWA--EVSIIGRINHRNLVKLQGFCAENEHK 582
VF + ++ A K+L + + + A E I+ +++ R +V L + E +
Sbjct: 201 VFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTD 259
Query: 583 L-LVYEYVENGSLDKLLFNDPGTASILQWDQ-RYNIAVGTAKGLSYLHEECLEWVLHCDV 640
L LV + G + ++N Q + + A GL +LH+ +++ D+
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLHQRN---IIYRDL 315
Query: 641 KPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYS 700
KP+N+LLDD +++D GL+ K GT G++APE ++ + D D ++
Sbjct: 316 KPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFA 374
Query: 701 YGIVLLELLTGKS 713
G+ L E++ +
Sbjct: 375 LGVTLYEMIAARG 387
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA----EVSIIGRINHRNLVKL 572
+E+G G FG+V+ + + VVA+K++ + E W EV + ++ H N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 573 QGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAV---GTAKGLSYLH 628
+G C EH LV EY + D LL ++ IA G +GL+YLH
Sbjct: 120 RG-CYLREHTAWLVMEYCLGSASD-LLEVHKKPLQEVE------IAAVTHGALQGLAYLH 171
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM 688
++H DVK NILL + K+ DFG + + + GT ++APE ++
Sbjct: 172 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVIL 223
Query: 689 NLKI---DAKADVYSYGIVLLELLTGK 712
+ D K DV+S GI +EL K
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 42/238 (17%)
Query: 501 FKRFTYAELKRATRNFKQ------EVGKGGFGSVFRGV-LDDERVVAVKRL--------E 545
F T + + + +G G G V + VA++ +
Sbjct: 118 FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS 177
Query: 546 GVLQGDAE-FWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL-DKLL----F 599
A E+ I+ ++NH ++K++ F + E +V E +E G L DK++
Sbjct: 178 AREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL 236
Query: 600 NDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP---KVT 656
+ Y + + YLHE ++H D+KP+N+LL E K+T
Sbjct: 237 KEATCKLYF-----YQML----LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284
Query: 657 DFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI---DAKADVYSYGIVLLELLTG 711
DFG SK+ E + + GT YLAPE ++++ + D +S G++L L+G
Sbjct: 285 DFGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 37/216 (17%)
Query: 517 KQEVGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQGDAE-FWAEVSIIGRINHR-NLVK 571
+E+G+G F V + + + A K + Q E++++ ++
Sbjct: 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 572 LQGFCAENEHKLLVYEYVENGSL-DKLLFNDPGTAS----------ILQWDQRYNIAVGT 620
L +L+ EY G + L S IL+
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE----------- 142
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFSRVRG 677
G+ YLH+ ++H D+KPQNILL + K+ DFG+S+ + + G
Sbjct: 143 --GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--ACELREIMG 195
Query: 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKS 713
T YLAPE + I D+++ GI+ LLT S
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTS 231
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 520 VGKGGFGSVFRG-VLDDERVVAVKRL--EGVLQGDAEFWA--EVSIIGRINHRNLVKLQG 574
+GKGGFG V V ++ A K+L + + + E A E I+ ++N R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 575 FCAENEHKL-LVYEYVENGSL-------DKLLFNDPG----TASILQWDQRYNIAVGTAK 622
+ E + L LV + G L + F + A I
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC------------- 297
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
GL LH E +++ D+KP+NILLDDH +++D GL+ E K RV GT GY+
Sbjct: 298 GLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-GRV-GTVGYM 352
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGKS 713
APE + N + D ++ G +L E++ G+S
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-23
Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLE--GVLQGDAE-FWAEVSIIGRINHRNLVK 571
+E+GKG F V R V + + A + + D + E I + H N+V+
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 572 LQGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVGTAKGLSY 626
L +E H L+++ V G L + ++ +++ + +Q I + + +
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-----QI----LEAVLH 125
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFSRVRGTRGYLA 683
H+ V+H ++KP+N+LL + K+ DFGL+ + F GT GYL+
Sbjct: 126 CHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLS 181
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLTG 711
PE + D+++ G++L LL G
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 36/218 (16%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRL--------EGVLQGDAE-FWAEVSIIGRI 564
+ +G G G V + VA+K + A E+ I+ ++
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 565 NHRNLVKLQGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVG 619
NH ++K++ F + E +V E +E G L DK++ + Q
Sbjct: 73 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY--Q------- 122
Query: 620 TAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFSRVR 676
+ YLHE ++H D+KP+N+LL E K+TDFG SK+ E + +
Sbjct: 123 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLC 177
Query: 677 GTRGYLAPEWMMNLKI---DAKADVYSYGIVLLELLTG 711
GT YLAPE ++++ + D +S G++L L+G
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 48/205 (23%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 517 KQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQG 574
+ +G+G F + V + AVK + ++ + + E++ + H N+VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHE 73
Query: 575 FCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
+ H LV E + G L +++ F++ + I++ + +S++H+
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-----KL----VSAVSHMHD 124
Query: 630 ECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
V+H D+KP+N+L D + K+ DFG ++L + T Y APE
Sbjct: 125 VG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCFTLHYAAPEL 180
Query: 687 MMNLKIDAKADVYSYGIVLLELLTG 711
+ D D++S G++L +L+G
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 41/225 (18%)
Query: 508 ELKRATRNFKQ------EVGKGGFGSVFRGV-LDDERVVAVK----RLEGVLQGDAEFWA 556
+L R + F ++G G + R + AVK +
Sbjct: 12 QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE------- 64
Query: 557 EVSIIGR-INHRNLVKLQGFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQW 610
E+ I+ R H N++ L+ + ++ +V E ++ G L DK+L F++ +++L
Sbjct: 65 EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF- 123
Query: 611 DQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP----KVTDFGLSKLFKE 666
I K + YLH + V+H D+KP NIL D ++ DFG +K +
Sbjct: 124 ----TI----TKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
+ T ++APE + DA D++S G++L +LTG
Sbjct: 173 -ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 8e-23
Identities = 46/221 (20%), Positives = 87/221 (39%), Gaps = 30/221 (13%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGV-LQGDAEFWAEVSIIGRI-NHRNLVKLQGFC 576
+ +GGF V+ + R A+KRL + + EV + ++ H N+V+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 577 AENEHK--------LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
+ + + LL+ E + ++ L + L D I T + + ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR-----------VRG 677
++H D+K +N+LL + K+ DFG + D +S
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 678 TRGYLAPEWMMNLK----IDAKADVYSYGIVLLELLTGKSA 714
T Y PE +++L I K D+++ G +L L +
Sbjct: 213 TPMYRTPE-IIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVKRLE-------GVLQGDAEFWAEVSIIGRINHR--NLV 570
G GGFGSV+ G+ + D VA+K +E G L EV ++ +++ ++
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111
Query: 571 KLQGFCAENEHKLLVYEYVEN-GSL-DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
+L + + +L+ E E L D + LQ + + + + + H
Sbjct: 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERGA-----LQEELARSFFWQVLEAVRHCH 166
Query: 629 EECLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
VLH D+K +NIL+D + E K+ DFG L K DT ++ GTR Y PEW+
Sbjct: 167 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 220
Query: 688 MNLKIDA-KADVYSYGIVLLELLTGK 712
+ A V+S GI+L +++ G
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 7e-22
Identities = 33/174 (18%), Positives = 66/174 (37%), Gaps = 15/174 (8%)
Query: 553 EFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQ 612
++ + + +N V + + + + +L + +
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR-EHGV 165
Query: 613 RYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK- 671
+I + A+ + +LH + ++H D+KP NI KV DFGL + + +
Sbjct: 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 672 ----------FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSAS 715
+ GT+ Y++PE + K D++S G++L ELL S
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 27/207 (13%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVKRLE-------GVLQGDAEFWAEVSIIGRIN----HRN 568
GKGGFG+VF G L D VA+K + L EV+++ ++ H
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 569 LVKLQGFCAENEHKLLVYEYVENGS--LDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
+++L + E +LV E D + P L + +
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-----LGEGPSRCFFGQVVAAIQH 154
Query: 627 LHEECLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPE 685
H V+H D+K +NIL+D K+ DFG L D ++ GTR Y PE
Sbjct: 155 CHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFDGTRVYSPPE 208
Query: 686 WMMNLKID-AKADVYSYGIVLLELLTG 711
W+ + A V+S GI+L +++ G
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCG 235
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-21
Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 36/213 (16%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-FWAEVSIIGRI-NHRNLVKL 572
Q +G G G V + + A+K L+ D EV + R ++V++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRI 120
Query: 573 QGFC----AENEHKLLVYEYVENGSL-DKLL------FNDPGTASILQWDQRYNIAVGTA 621
A + L+V E ++ G L ++ F + + I++ +I
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-----SIG---- 171
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFSRVRGT 678
+ + YLH + H DVKP+N+L K+TDFG +K + T
Sbjct: 172 EAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYT 226
Query: 679 RGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
Y+APE + K D D++S G+++ LL G
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-21
Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 35/211 (16%)
Query: 517 KQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQG 574
KQ +G G G V + A+K +L + EV + ++V +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK----LLYDSPKARQEVDHHWQASGGPHIVCILD 89
Query: 575 FCAENEHK----LLVYEYVENGSL-DKLL------FNDPGTASILQWDQRYNIAVGTAKG 623
H L++ E +E G L ++ F + A I++ +I
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR-----DIG----TA 140
Query: 624 LSYLHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG 680
+ +LH + H DVKP+N+L + K+TDFG +K + T
Sbjct: 141 IQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPCYTPY 194
Query: 681 YLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
Y+APE + K D D++S G+++ LL G
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 34/217 (15%)
Query: 517 KQEVGKGGFGSVFRGV-LDDERVVAVKRLE-GVLQGDAEFWAEVSIIGRI-NHRNLVKLQ 573
+ +G+G V + L + AVK +E + + EV ++ + HRN+++L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 574 GFCAENEHKLLVYEYVENGSL-DKLL----FNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
F E + LV+E + GS+ + FN+ + ++Q ++ A L +LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-----DV----ASALDFLH 128
Query: 629 EECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFSRVR------GTR 679
+ + H D+KP+NIL + + K+ DF L K D G+
Sbjct: 129 NKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 680 GYLAPE-----WMMNLKIDAKADVYSYGIVLLELLTG 711
Y+APE D + D++S G++L LL+G
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 518 QEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWA-EVSIIGRINHRNLVKLQGF 575
+ +G G FG V++ L D +VA+K+ VLQ D F E+ I+ +++H N+V+L+ F
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKK---VLQ-DKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 576 -----CAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQ----RYNIAVGTAKGLS 625
++E L LV +YV ++ ++ + L Y + + L+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL----FRSLA 170
Query: 626 YLHEECLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
Y+H + H D+KPQN+LLD D K+ DFG +K S + +R Y AP
Sbjct: 171 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYI-CSRYYRAP 225
Query: 685 EWMMNLKI-DAKADVYSYGIVLLELLTGK 712
E + + DV+S G VL ELL G+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVKRLE-GVLQGDAE-FWAEVSIIGRINHRNLVKLQGFCA 577
G+G +G V V E VAVK ++ E E+ I +NH N+VK G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 578 ENEHKLLVYEYVENGSL-DKLLFNDPGTASILQWDQ--RY---NIAVGTAKGLSYLHEEC 631
E + L EY G L D++ + + R+ +A G+ YLH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMA-----GVVYLHGIG 125
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR-GTRGYLAPEWMMNL 690
+ H D+KP+N+LLD+ K++DFGL+ +F+ + + GT Y+APE +
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 691 KID-AKADVYSYGIVLLELLTG 711
+ DV+S GIVL +L G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAG 204
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 520 VGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWA-EVSIIGRINHRNLVKLQGF--- 575
+G G FG VF+ L + VA+K+ VLQ D F E+ I+ + H N+V L+ F
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKK---VLQ-DKRFKNRELQIMRIVKHPNVVDLKAFFYS 103
Query: 576 --CAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQ----RYNIAVGTAKGLSYLH 628
++E L LV EYV ++ + + + Y + + L+Y+H
Sbjct: 104 NGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL----LRSLAYIH 158
Query: 629 EECLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
+ H D+KPQN+LLD K+ DFG +K+ + S + +R Y APE +
Sbjct: 159 S---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYI-CSRYYRAPELI 213
Query: 688 MNLKI-DAKADVYSYGIVLLELLTGK 712
D++S G V+ EL+ G+
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVK-----RLEGVLQGDAEFWAEVSIIGRINHRNLVKL-Q 573
G+G +G V + + AVK +L + G+A E+ ++ R+ H+N+++L
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK------GLSY 626
E + K+ +V EY G + + + S+ + +R+ + GL Y
Sbjct: 74 VLYNEEKQKMYMVMEYCVCGMQE--MLD-----SVPE--KRFPVCQAHGYFCQLIDGLEY 124
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE-RHDTKFSRVRGTRGYLAPE 685
LH + ++H D+KP N+LL K++ G+++ D +G+ + PE
Sbjct: 125 LHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 686 WMMNLKI--DAKADVYSYGIVLLELLTGK 712
L K D++S G+ L + TG
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVKRLE-GVLQGDAE-FWAEVSIIGRINHRNLVKLQGFCA 577
G+G +G V V E VAVK ++ E E+ I +NH N+VK G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 578 ENEHKLLVYEYVENGSL-DKLLFNDPGTASILQWDQ--RY---NIAVGTAKGLSYLHEEC 631
E + L EY G L D++ + + R+ +A G+ YLH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMA-----GVVYLHGIG 125
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR-GTRGYLAPEWMMNL 690
+ H D+KP+N+LLD+ K++DFGL+ +F+ + + GT Y+APE +
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 691 KID-AKADVYSYGIVLLELLTG 711
+ DV+S GIVL +L G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAG 204
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-19
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 39/213 (18%)
Query: 520 VGKGGFGSVFRG-VLDDERVVAVKRLE--GVLQGDAEFWA--EVSIIGRIN---HRNLVK 571
+G+GGFG V+ D ++ A+K L+ + E A E ++ ++ +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 572 LQGFCAENEHKL-LVYEYVENGSLDKLLFNDPG---------TASILQWDQRYNIAVGTA 621
+ + KL + + + G L L A I+
Sbjct: 257 MS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL------------ 303
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
GL ++H V++ D+KP NILLD+H +++D GL+ F + + V GT GY
Sbjct: 304 -GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASV-GTHGY 356
Query: 682 LAPEWMM-NLKIDAKADVYSYGIVLLELLTGKS 713
+APE + + D+ AD +S G +L +LL G S
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 510 KRATRNFKQ--EVGKGGFGSVFRGV-LDDERVVAVK--RLEGVLQGDAEFWA----EVSI 560
AT ++ E+G G +G+V++ VA+K R+ G EV++
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 561 ---IGRINHRNLVKL----QGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQ 612
+ H N+V+L + E K+ LV+E+V+ L L P L +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAET 121
Query: 613 RYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF 672
++ +GL +LH ++H D+KP+NIL+ K+ DFGL++++ +
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMAL 176
Query: 673 SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
+ V T Y APE ++ D++S G + E+ K
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 43/219 (19%)
Query: 515 NFKQEVGKGGFGSVFRG------------VLDDERVVAVKRLEGVLQGDAEFWAEVSIIG 562
F + +G+G F +V +L+ ++ ++ V E ++
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-------RERDVMS 85
Query: 563 RINHRNLVKLQGFCAENEHKL-LVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNI 616
R++H VKL F +++ KL Y +NG L K + F++ T R+
Sbjct: 86 RLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT--------RFYT 136
Query: 617 A-VGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK--FS 673
A + +A L YLH + ++H D+KP+NILL++ ++TDFG +K+ S
Sbjct: 137 AEIVSA--LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191
Query: 674 RVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
V GT Y++PE + +D+++ G ++ +L+ G
Sbjct: 192 FV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 7e-19
Identities = 47/205 (22%), Positives = 83/205 (40%), Gaps = 25/205 (12%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVK-----RLEGVLQGDAEFWA----EVSIIGRINHRNLV 570
G G FG V+ V + + V VK ++ + E++I+ R+ H N++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 571 KLQGFCAENEHKL-LVYEYVENGS--LDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
K+ EN+ LV E +G + + L I + YL
Sbjct: 93 KVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPR-----LDEPLASYIFRQLVSAVGYL 146
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
+ ++H D+K +NI++ + F K+ DFG + + F GT Y APE +
Sbjct: 147 RLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFYTFCGTIEYCAPEVL 201
Query: 688 MNLKID-AKADVYSYGIVLLELLTG 711
M + +++S G+ L L+
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 38/210 (18%)
Query: 520 VGKGGFGSVFRG-VLDDERVVAVKRL-----EGV----LQGDAEFWAEVSIIGRINHRNL 569
+G+G + +V++G + +VA+K + EG ++ EVS++ + H N+
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLKHANI 62
Query: 570 VKLQGFCAENEHKLLVYEYVENGSLDKLL------FNDPGTASILQWDQRYNIAVGTAKG 623
V L + LV+EY++ L + L N L Q +G
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLF--Q-------LLRG 112
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLA 683
L+Y H + VLH D+KPQN+L+++ E K+ DFGL++ T + V T Y
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRP 168
Query: 684 PEWMMNLKI-DAKADVYSYGIVLLELLTGK 712
P+ ++ + D++ G + E+ TG+
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 38/210 (18%)
Query: 520 VGKGGFGSVFRGVLDDERVVAVKRL------EGV----LQGDAEFWAEVSIIGRINHRNL 569
VG+G +G V++ R+VA+KR+ EG+ ++ E+S++ ++H N+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-------EISLLKELHHPNI 81
Query: 570 VKLQGFCAENEHKLLVYEYVENGSLDKLL------FNDPGTASILQWDQRYNIAVGTAKG 623
V L LV+E++E L K+L D L Q +G
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLY--Q-------LLRG 131
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLA 683
+++ H+ +LH D+KPQN+L++ K+ DFGL++ F + V T Y A
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRA 187
Query: 684 PEWMMNLKI-DAKADVYSYGIVLLELLTGK 712
P+ +M K D++S G + E++TGK
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-19
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 47/221 (21%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRL------EGVLQGDAEFWA--EVSIIGRINHRNLV 570
+G+G FG VF+ + VA+K++ EG A E+ I+ + H N+V
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-----PITALREIKILQLLKHENVV 79
Query: 571 KLQGFCAENEHKL--------LVYEYVENGSLDKLL------FNDPGTASILQWDQRYNI 616
L C LV+++ E+ L LL F ++Q
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQ--M---- 132
Query: 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF---- 672
GL Y+H +LH D+K N+L+ K+ DFGL++ F +++
Sbjct: 133 ---LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 673 SRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGK 712
+RV T Y PE ++ + D++ G ++ E+ T
Sbjct: 187 NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 42/229 (18%)
Query: 517 KQEVGKGGFGSVFRGV-LDDERVVAVK-----RLEGVLQGDAEFWA-------------- 556
K E+GKG +G V +D A+K +L
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 557 --------EVSIIGRINHRNLVKL-QGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTAS 606
E++I+ +++H N+VKL + NE L +V+E V G + ++ P
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---- 133
Query: 607 ILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666
L DQ KG+ YLH + ++H D+KP N+L+ + K+ DFG+S F +
Sbjct: 134 -LSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-K 188
Query: 667 RHDTKFSRVRGTRGYLAPEWMMNLKID---AKADVYSYGIVLLELLTGK 712
D S GT ++APE + + DV++ G+ L + G+
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 510 KRATRNFKQ--EVGKGGFGSVFRG--VLDDERVVAVKRL------EGV----LQGDAEFW 555
RA + ++ E+G+G +G VF+ + + R VA+KR+ EG+ ++
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------ 60
Query: 556 AEVSI---IGRINHRNLVKL----QGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASI 607
EV++ + H N+V+L + E KL LV+E+V+ L L P
Sbjct: 61 -EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEP--G 116
Query: 608 LQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667
+ + ++ +GL +LH V+H D+KPQNIL+ + K+ DFGL++++
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS-- 171
Query: 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
+ V T Y APE ++ D++S G + E+ K
Sbjct: 172 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 16/198 (8%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA---EVSIIGRINHRNLVKLQGFC 576
GKG F V + R VA+K ++ EV I+ +NH N+VKL
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 577 AENEHKLLVYEYVENGSL-DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWV 635
+ L+ EY G + D L+ + ++ + + + Y H++ +
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLVAHGR-----MKEKEARSKFRQIVSAVQYCHQKR---I 135
Query: 636 LHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKID-A 694
+H D+K +N+LLD K+ DFG S F K G Y APE K D
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAFCGAPPYAAPELFQGKKYDGP 193
Query: 695 KADVYSYGIVLLELLTGK 712
+ DV+S G++L L++G
Sbjct: 194 EVDVWSLGVILYTLVSGS 211
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRL------EGVLQGDAEFWA--EVSIIGRINHRNLV 570
VG+G +G V + D R+VA+K+ + V + A E+ ++ ++ H NLV
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV-----KKIAMREIKLLKQLRHENLV 87
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
L C + + LV+E+V++ ++ L P L + G+ + H
Sbjct: 88 NLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH 143
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
++H D+KP+NIL+ K+ DFG ++ + V TR Y APE ++
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-ATRWYRAPELLVGD 199
Query: 691 KIDAKA-DVYSYGIVLLELLTGK 712
KA DV++ G ++ E+ G+
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 47/213 (22%), Positives = 83/213 (38%), Gaps = 22/213 (10%)
Query: 515 NFKQEVGKGGFGSVF--RGVLDDERVVAVKRL--EGVLQGD--AEFWAEVSIIGRINHRN 568
+ +G+G F V + +V A+K + +L+ + F E ++ + R
Sbjct: 64 EILKVIGRGAFSEVAVVKMK-QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 569 LVKLQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
+ +L F ++E+ L LV EY G L LL + + Y + +
Sbjct: 123 ITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP-AEMARFY--LAEIVMAIDSV 178
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
H +H D+KP NILLD ++ DFG + + GT YL+PE +
Sbjct: 179 HRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 688 MNLKIDAKADVY-------SYGIVLLELLTGKS 713
+ Y + G+ E+ G++
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 47/217 (21%)
Query: 520 VGKGGFGSVFRG------------VLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
+GKG FG V ++ ++ V + V E+ I+ + H
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF-------KELQIMQGLEHP 75
Query: 568 NLVKLQGFCAENEHKL-LVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIA-VGT 620
LV L + ++E + +V + + G L L F + + I +
Sbjct: 76 FLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV--------KLFICELVM 126
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK-FSRVRGTR 679
A L YL + ++H D+KP NILLD+H +TDF ++ + + GT+
Sbjct: 127 A--LDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTK 178
Query: 680 GYLAPEWMMNLKI---DAKADVYSYGIVLLELLTGKS 713
Y+APE + K D +S G+ ELL G+
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 1e-18
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 26/204 (12%)
Query: 520 VGKGGFGSVFRGVLDDERVVAVKRL------EGV----LQGDAEFWAEVSIIGRINHRNL 569
+G+G +G V++ + A+K++ EG+ ++ E+SI+ + H N+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-------EISILKELKHSNI 62
Query: 570 VKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
VKL + +LV+E+++ L KLL G L+ + + G++Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD 118
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
VLH D+KPQN+L++ E K+ DFGL++ F + T Y AP+ +M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMG 174
Query: 690 LKI-DAKADVYSYGIVLLELLTGK 712
K D++S G + E++ G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRL------EGVLQGDAEFWA--EVSIIGRINHRNLV 570
+G+G +G VF+ D ++VA+K+ + + A E+ ++ ++ H NLV
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI-----KKIALREIRMLKQLKHPNLV 65
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
L LV+EY ++ ++ L + +I T + +++ H+
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH 121
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
+H DVKP+NIL+ H K+ DFG ++L D V TR Y +PE ++
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPELLVGD 177
Query: 691 KIDAKA-DVYSYGIVLLELLTGK 712
DV++ G V ELL+G
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGV 200
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 49/206 (23%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 520 VGKGGFGSVF--RGVLDDERVVAVKRL--EGVLQGD--AEFWAEVSIIGRINHRNLVKLQ 573
+G+G FG V + + ++V A+K L +L+ A F E ++ + + + L
Sbjct: 82 IGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
+ ++++ L LV +Y G L LL + + Y + A + +H+
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP-EEMARFYLAEMVIA--IDSVHQLH- 195
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI 692
+H D+KP NIL+D + ++ DFG E + S GT Y++PE + ++
Sbjct: 196 --YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 693 DAK-----ADVYSYGIVLLELLTGKS 713
D +S G+ + E+L G++
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 34/215 (15%)
Query: 518 QEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWA--EVSII---GRINHRNLVK 571
+ G+G FG+V G VA+K+ V+Q D F E+ I+ ++H N+V+
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQ-DPRF-RNRELQIMQDLAVLHHPNIVQ 83
Query: 572 L------QGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQ----RYNIAVGT 620
L G + L +V EYV + +L + N + +
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI--- 139
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDH-FEPKVTDFGLSK-LFKERHDTKFSRVRGT 678
+ + LH + V H D+KP N+L+++ K+ DFG +K L + + + +
Sbjct: 140 -RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV--AYI-CS 194
Query: 679 RGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGK 712
R Y APE + + D++S G + E++ G+
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 53/202 (26%), Positives = 82/202 (40%), Gaps = 27/202 (13%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAEN 579
G G FG + +VAVK +E D E+ + H N+V+ +
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTP 88
Query: 580 EHKLLVYEYVENGSL-DKLLFNDPGTASILQWDQRYNIAVGTAK------GLSYLHEECL 632
H ++ EY G L +++ R++ G+SY H
Sbjct: 89 THLAIIMEYASGGELYERICNA-----------GRFSEDEARFFFQQLLSGVSYCHSMQ- 136
Query: 633 EWVLHCDVKPQNILLDDHFEP--KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
+ H D+K +N LLD P K+ DFG SK ++ GT Y+APE ++
Sbjct: 137 --ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HSQPKSTVGTPAYIAPEVLLRQ 192
Query: 691 KID-AKADVYSYGIVLLELLTG 711
+ D ADV+S G+ L +L G
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVG 214
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRL-----EGV----LQGDAEFWAEVSIIGRINHRNL 569
+G G + +V++G+ VA+K + EG ++ E+S++ + H N+
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-------EISLMKELKHENI 65
Query: 570 VKLQGFCAENEHKLLVYEYVENGSLDKLL--FNDPGTASILQWDQRYNIAVGTAKGLSYL 627
V+L LV+E+++N L K + T L+ + +GL++
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
HE +LH D+KPQN+L++ + K+ DFGL++ F +T S V T Y AP+ +
Sbjct: 125 HEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVL 180
Query: 688 MNLKI-DAKADVYSYGIVLLELLTGK 712
M + D++S G +L E++TGK
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 55/224 (24%), Positives = 111/224 (49%), Gaps = 36/224 (16%)
Query: 508 ELKRATRNFKQE--VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-------- 556
++K + +++ +G+G F +V++ + ++VA+K+++ L +E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK--LGHRSEAKDGINRTALR 61
Query: 557 EVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTAS-------ILQ 609
E+ ++ ++H N++ L + LV++++E L+ ++ ++ + +L
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 610 WDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669
T +GL YLH+ W+LH D+KP N+LLD++ K+ DFGL+K F +
Sbjct: 121 ----------TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167
Query: 670 TKFSRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGK 712
+V TR Y APE + ++ D+++ G +L ELL
Sbjct: 168 AYTHQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 520 VGKGGFGSVF----RGVLDDERVVAVKRL--EGVLQGD-AEFWAEVSIIGRINHRNLVKL 572
+G+G FG VF D ++ A+K L + D E I+ +NH +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 573 QGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK--------G 623
+ + E KL L+ +++ G L F L + + K
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDL----FTR------LSKEVMFTEE--DVKFYLAELALA 138
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLA 683
L +LH +++ D+KP+NILLD+ K+TDFGLSK + +S GT Y+A
Sbjct: 139 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMA 194
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLTGKS 713
PE + AD +S+G+++ E+LTG
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 37/213 (17%)
Query: 520 VGKGGFGSVF--RGVLDDERVVAVKRL--EGVLQGD--AEFWAEVSIIGRINHRNLVKLQ 573
+G+G FG V R +V A+K L +++ A FW E I+ N +V+L
Sbjct: 77 IGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK--------GL 624
+ +++ L +V EY+ G L L+ Y++ A+ L
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDLVNLM-------------SNYDVPEKWARFYTAEVVLAL 181
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
+H +H DVKP N+LLD K+ DFG + + GT Y++P
Sbjct: 182 DAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 685 EWMMNLKIDAK----ADVYSYGIVLLELLTGKS 713
E + + D D +S G+ L E+L G +
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 6e-18
Identities = 61/237 (25%), Positives = 108/237 (45%), Gaps = 35/237 (14%)
Query: 501 FKRFTYAELKRATRNFKQE---VGKGGFGSVFRGVLDDE---RVVAVKRL--EGVLQGDA 552
FK +E +R F+ E VG+G +G V++ D + A+K++ G+
Sbjct: 7 FKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SM 63
Query: 553 EFWAEVSIIGRINHRNLVKLQG-FCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQW 610
E++++ + H N++ LQ F + + K+ L+++Y E+ L ++ + +
Sbjct: 64 SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKAN--- 119
Query: 611 DQRYNIAVGTAK--------GLSYLHEECLEWVLHCDVKPQNILLDDHFEP----KVTDF 658
+ + G K G+ YLH WVLH D+KP NIL+ K+ D
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 176
Query: 659 GLSKLFKE--RHDTKFSRVRGTRGYLAPEWMMNLKIDAKA-DVYSYGIVLLELLTGK 712
G ++LF + V T Y APE ++ + KA D+++ G + ELLT +
Sbjct: 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 32/212 (15%)
Query: 515 NFKQEVGKGGFGSVFRGVL-DDERVVAVKRL--EGVLQGD--AEFWAEVSIIGRINHRNL 569
+ + +G G FG V + A+K L + V++ E I+ +N L
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 570 VKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK------- 622
VKL+ +N + +V EYV G + F S L+ R++ A+
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEM----F------SHLRRIGRFSEP--HARFYAAQIV 151
Query: 623 -GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
YLH +++ D+KP+N+L+D +VTDFG +K K R T + GT
Sbjct: 152 LTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEA 204
Query: 682 LAPEWMMNLKIDAKADVYSYGIVLLELLTGKS 713
LAPE +++ + D ++ G+++ E+ G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 1e-17
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRL------EGV----LQGDAEFWAEVSIIGRINHRN 568
+G+G +G+VF+ + +VA+KR+ EGV L+ E+ ++ + H+N
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-------EICLLKELKHKN 62
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
+V+L ++ LV+E+ + L K + G L + + KGL + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCH 118
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM 688
VLH D+KPQN+L++ + E K+ +FGL++ F + V T Y P+ +
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174
Query: 689 NLKI-DAKADVYSYGIVLLELLTGKSA 714
K+ D++S G + EL
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 49/212 (23%), Positives = 83/212 (39%), Gaps = 43/212 (20%)
Query: 521 GKGGFGSVFRG------------VLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN 568
G G FG V G +L+ +++ ++ + + + E+ + H +
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-------EIQNLKLFRHPH 72
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSL-DKLLFNDPGTASILQWDQRYNIAVGTAK----- 622
++KL + +V EYV G L D + + R
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-----------GRVEEMEARRLFQQIL 121
Query: 623 -GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
+ Y H V+H D+KP+N+LLD H K+ DFGLS + + G+ Y
Sbjct: 122 SAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSCGSPNY 176
Query: 682 LAPEWMMNLKID-AKADVYSYGIVLLELLTGK 712
APE + + D++S G++L LL G
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 43/215 (20%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRL------EGV----LQGDAEFWAEVSIIGRINHRN 568
+G+G +G V++ + VA+KR+ EGV ++ EVS++ + HRN
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-------EVSLLKELQHRN 94
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGTAKG 623
+++L+ N L++EY EN L K + + S L Q G
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLY--Q-------LING 144
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEP-----KVTDFGLSKLFKERHDTKFSRVRGT 678
+++ H LH D+KPQN+LL K+ DFGL++ F + T
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-T 200
Query: 679 RGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGK 712
Y PE ++ + D++S + E+L
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 6e-17
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 40/214 (18%)
Query: 515 NFKQEVGKGGFGSVFRGVL----DDERVVAVKRL--EGVLQGD--AEFWAEVSIIGRINH 566
+ +G G FG V L + R A+K L E V++ E ++ + H
Sbjct: 9 QILRTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 567 RNLVKLQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK--- 622
++++ ++ ++ ++ +Y+E G L F S+L+ QR+ V AK
Sbjct: 66 PFIIRMW-GTFQDAQQIFMIMDYIEGGEL----F------SLLRKSQRFPNPV--AKFYA 112
Query: 623 -----GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG 677
L YLH + +++ D+KP+NILLD + K+TDFG +K + T + G
Sbjct: 113 AEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCG 165
Query: 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
T Y+APE + + D +S+GI++ E+L G
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 49/204 (24%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQG- 574
+++G+G + VF + + + V VK L+ V + E+ I+ + N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADI 99
Query: 575 FCAENEHKL-LVYEYVENGSLDKLL--FNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
LV+E+V N +L D + Y I K L Y H
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-----YEIL----KALDYCHSM- 149
Query: 632 LEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFKERHDTKFSRVR-GTRGYLAPEWMMN 689
++H DVKP N+++D +H + ++ D+GL++ + H + VR +R + PE +++
Sbjct: 150 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVASRYFKGPELLVD 204
Query: 690 LKI-DAKADVYSYGIVLLELLTGK 712
++ D D++S G +L ++ K
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRK 228
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 1e-16
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 35/212 (16%)
Query: 520 VGKGGFGSVF----RGVLDDERVVAVKRL--EGVLQGDAEF---WAEVSIIGRINHRNLV 570
+GKGG+G VF + ++ A+K L +++ + AE +I+ + H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 571 KLQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK------- 622
L + + KL L+ EY+ G L F L+ + + TA
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGEL----FMQ------LEREGIFMED--TACFYLAEIS 131
Query: 623 -GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
L +LH++ +++ D+KP+NI+L+ K+TDFGL K + GT Y
Sbjct: 132 MALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEY 187
Query: 682 LAPEWMMNLKIDAKADVYSYGIVLLELLTGKS 713
+APE +M + D +S G ++ ++LTG
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 26/206 (12%)
Query: 520 VGKGGFGSVFRGVL-DDERVVAVKRL--EGVLQGDAEFW--AEVSIIGRINHRNLVKLQG 574
+GKG FG V R A+K L E ++ D E ++ H L L+
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 575 FCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNI------AVGTAKGLSYL 627
+ + +L V EY G L F+ L ++ ++ L YL
Sbjct: 215 YSFQTHDRLCFVMEYANGGEL---FFH-------LSRERVFSEDRARFYGAEIVSALDYL 264
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
H E + V++ D+K +N++LD K+TDFGL K + T + GT YLAPE +
Sbjct: 265 HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVL 321
Query: 688 MNLKIDAKADVYSYGIVLLELLTGKS 713
+ D + G+V+ E++ G+
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 43/212 (20%)
Query: 521 GKGGFGSVFRG------------VLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN 568
G G FG V G +L+ +++ ++ + + + E+ + H +
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-------EIQNLKLFRHPH 77
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSL-DKLLFNDPGTASILQWDQRYNIAVGTAK----- 622
++KL + +V EYV G L D + N R +
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKN-----------GRLDEKESRRLFQQIL 126
Query: 623 -GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
G+ Y H V+H D+KP+N+LLD H K+ DFGLS + + G+ Y
Sbjct: 127 SGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSCGSPNY 181
Query: 682 LAPEWMMNLKID-AKADVYSYGIVLLELLTGK 712
APE + + D++S G++L LL G
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 37/215 (17%)
Query: 520 VGKGGFGSVF----RGVLDDERVVAVKRL--EGVLQGDAEFW---AEVSIIGRINHRN-L 569
+G G +G VF D ++ A+K L ++Q E ++ I L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 570 VKLQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK------ 622
V L + + E KL L+ +Y+ G L F + L +R+ +
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL----F------THLSQRERFTEH--EVQIYVGEI 168
Query: 623 --GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRG 680
L +LH+ +++ D+K +NILLD + +TDFGLSK F + GT
Sbjct: 169 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 681 YLAPEWMMNLKI--DAKADVYSYGIVLLELLTGKS 713
Y+AP+ + D D +S G+++ ELLTG S
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 39/219 (17%)
Query: 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWA------------EVSIIGRIN 565
+ + G +G+V GV + VA+KR+ + E+ ++ +
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 566 HRNLVKLQG-FCAENEHKL----LVYEYVENGSLDKLLFNDPGTASILQWDQR-----YN 615
H N++ L+ F E + LV E + L +++ + S Q Y+
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS----PQHIQYFMYH 142
Query: 616 IAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD-TKFSR 674
I GL LHE V+H D+ P NILL D+ + + DF L++ + T +
Sbjct: 143 I----LLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY-- 193
Query: 675 VRGTRGYLAPEWMMNLKIDAKA-DVYSYGIVLLELLTGK 712
V R Y APE +M K K D++S G V+ E+ K
Sbjct: 194 V-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 50/221 (22%), Positives = 95/221 (42%), Gaps = 45/221 (20%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEF----WAEVSIIGRIN---------- 565
G G F +V+ + + VA+K +++GD + E+ ++ R+N
Sbjct: 28 GWGHFSTVWLAKDMVNNTHVAMK----IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 566 -HRNLVKLQGF----CAENEHKLLVYEYVENGSLDKLL--FNDPG-TASILQWDQRYNIA 617
+++KL H ++V+E V +L L+ + G ++ I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK-----QIS 137
Query: 618 VGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP------KVTDFGLSKLFKERHDTK 671
GL Y+H C ++H D+KP+N+L++ P K+ D G + + E +
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
TR Y +PE ++ AD++S ++ EL+TG
Sbjct: 196 IQ----TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 520 VGKGGFGSVFRGVL-DDERVVAVKRL--EGVLQGDAEFW--AEVSIIGRINHRNLVKLQG 574
+GKG FG V R A+K L E ++ D E ++ H L L+
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 575 FCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK--------GLS 625
+ + +L V EY NG +L F+ L ++ + A+ L
Sbjct: 72 YAFQTHDRLCFVMEYA-NG--GELFFH-------LSRERVFTEE--RARFYGAEIVSALE 119
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPE 685
YLH V++ D+K +N++LD K+TDFGL K T + GT YLAPE
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPE 175
Query: 686 WMMNLKIDAKADVYSYGIVLLELLTGKS 713
+ + D + G+V+ E++ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 43/214 (20%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA----EVSIIGRINHR------N 568
+GKG FG V + + VA+K +++ + F E+ I+ + + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALK----MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 569 LVKLQGFCAENEHKLLV--------YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT 620
++ + H + YE ++ + +++ A
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGF------SLPLVR-----KFAHSI 209
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP--KVTDFGLSKLFKERHDTKFSRVRGT 678
+ L LH+ + +HCD+KP+NILL KV DFG S +R T +
Sbjct: 210 LQCLDALHKNRI---IHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ----S 262
Query: 679 RGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
R Y APE ++ + D++S G +L ELLTG
Sbjct: 263 RFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 44/212 (20%)
Query: 521 GKGGFGSVFRG------------VLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN 568
G+G FG V + + + V + E+S + + H +
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-------EISYLKLLRHPH 70
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSL-DKLLFNDPGTASILQWDQRYNIAVGTAK----- 622
++KL ++V EY G L D ++ +R G
Sbjct: 71 IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK-----------KRMTEDEGRRFFQQII 118
Query: 623 -GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
+ Y H ++H D+KP+N+LLDD+ K+ DFGLS + + G+ Y
Sbjct: 119 CAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--GNFLKTSCGSPNY 173
Query: 682 LAPEWMMNLKID-AKADVYSYGIVLLELLTGK 712
APE + + DV+S GIVL +L G+
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA----EVSIIGRINHR------N 568
+GKG FG V + ++ VA+K +++ F EV ++ +N
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIK----IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYY 117
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSLDKLL--FNDPGTASILQWDQRYNIAVGTAKGLSY 626
+V L+ H LV+E + +L LL N G + + A L +
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRG----VSLNLTRKFAQQMCTALLF 172
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEP--KVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
L L ++HCD+KP+NILL + K+ DFG S +R +R Y +P
Sbjct: 173 LATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ----SRFYRSP 227
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGK 712
E ++ + D D++S G +L+E+ TG+
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 32/209 (15%)
Query: 520 VGKGGFGSVFRGVL-DDERVVAVKRL--EGVLQGDAEFW--AEVSIIGR-INHRNLVKLQ 573
+GKG FG V +E AVK L + +L+ E +E +++ + + H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK--------GL 624
F + KL V +Y+ G L F LQ ++ + A+ L
Sbjct: 106 -FSFQTADKLYFVLDYINGGEL----FYH------LQRERCFLEP--RARFYAAEIASAL 152
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
YLH +++ D+KP+NILLD +TDFGL K E + T + GT YLAP
Sbjct: 153 GYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAP 208
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGKS 713
E + D D + G VL E+L G
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 520 VGKGGFGSVFRGVL-DDERVVAVKRL--EGVLQGDAEFW--AEVSIIGRI-NHRNLVKLQ 573
+G+G + V L +R+ A+K + E V + W E + + NH LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK--------GL 624
C + E +L V EYV G L+F+ +Q ++ A+ L
Sbjct: 77 -SCFQTESRLFFVIEYVNGG---DLMFH-------MQRQRKLPEE--HARFYSAEISLAL 123
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
+YLHE +++ D+K N+LLD K+TD+G+ K DT + GT Y+AP
Sbjct: 124 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAP 179
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGKS 713
E + D ++ G+++ E++ G+S
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 520 VGKGGFGSVFRGVL-DDERVVAVKRL--EGVLQGDAEFW--AEVSIIGRI-NHRNLVKLQ 573
+G+G + V L +R+ A++ + E V + W E + + NH LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK--------GL 624
C + E +L V EYV G L+F+ +Q ++ A+ L
Sbjct: 120 -SCFQTESRLFFVIEYVNGG---DLMFH-------MQRQRKLPEE--HARFYSAEISLAL 166
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
+YLHE +++ D+K N+LLD K+TD+G+ K DT + GT Y+AP
Sbjct: 167 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAP 222
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGKS 713
E + D ++ G+++ E++ G+S
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.8 bits (177), Expect = 3e-14
Identities = 51/290 (17%), Positives = 83/290 (28%), Gaps = 42/290 (14%)
Query: 23 SQGIPRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYS----IWFTNSVNRTVV 78
G L +L+ +L+SPN F G N +W N
Sbjct: 11 GVGTSVLPAYQTLSA---GQYLLSPNQRFKLLLQGDG-NLVIQDNGATVWVANEQQPFSS 66
Query: 79 WMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFT------DEGVQAQLLETGN 132
+ R++ + L L D VW T+ T L + GN
Sbjct: 67 TIPLRNKK-----APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGN 121
Query: 133 LVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNILDL 192
+VLV+ + S LL + L Y +G L F + L
Sbjct: 122 IVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSEL---VQGVVYGAGASKLVFQGDGNL-- 176
Query: 193 IFNGPLISSIYWPNSAFTVFLNGRTPYNSSRRAYVNASG---LFRSSDTFKFNASDYGVG 249
Y PN N T + RA G ++ + + +++ G
Sbjct: 177 --------VAYGPNG--AATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHA 226
Query: 250 PKRRLTLDYDGILRLYSFDESTRLWK-ISWLPAGLDYCTVHGLCGPNGIC 298
L L +G + + +W + P ++ P I
Sbjct: 227 S-AVLRLQANGSIAILD---EKPVWARFGFQPTYRHIRKINPDQKPIDIW 272
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 32/209 (15%)
Query: 520 VGKGGFGSVFRGVL-DDERVVAVKRL--EGVLQGDAEFW--AEVSIIGRI-NHRNLVKLQ 573
+GKG FG V + + + AVK L + +LQ D E I+ NH L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK--------GL 624
C + +L V E+V G L+F+ +Q +R++ A A+ L
Sbjct: 91 -CCFQTPDRLFFVMEFVNGG---DLMFH-------IQKSRRFDEA--RARFYAAEIISAL 137
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
+LH++ +++ D+K N+LLD K+ DFG+ K T + GT Y+AP
Sbjct: 138 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAP 193
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGKS 713
E + + D ++ G++L E+L G +
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-----EVSIIGRINHRNLVK 571
Q VG G +G+V V VA+K+L Q F A E+ ++ + H N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELF-AKRAYRELRLLKHMRHENVIG 88
Query: 572 LQG-FCAENEHKL-----LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
L F + LV ++ L KL+ ++ L D+ + KGL
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK-----LGEDRIQFLVYQMLKGLR 142
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPE 685
Y+H ++H D+KP N+ +++ E K+ DFGL++ D++ + TR Y APE
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPE 195
Query: 686 WMMNLKI-DAKADVYSYGIVLLELLTGK 712
++N D++S G ++ E++TGK
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 52/241 (21%), Positives = 96/241 (39%), Gaps = 60/241 (24%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-EVSIIGRINHRNLVKLQGF 575
+ +G G FG V ++ + A+K+ VLQ D + E+ I+ ++H N++KL +
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKK---VLQ-DPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 576 -------------------------------------CAENEHKL-LVYEYVENGSLDKL 597
L ++ EYV + +L K+
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127
Query: 598 LFNDPGTASILQWDQ----RYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD-DHFE 652
L + + + + Y + + + ++H + H D+KPQN+L++
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSLG---ICHRDIKPQNLLVNSKDNT 180
Query: 653 PKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTG 711
K+ DFG +K + + + +R Y APE M+ D++S G V EL+ G
Sbjct: 181 LKLCDFGSAKKLIP-SEPSVAYI-CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238
Query: 712 K 712
K
Sbjct: 239 K 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 32/210 (15%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-----EVSIIGRINHRNLVK 571
+ +G G G V ER VA+K+L Q + A E+ ++ +NH+N++
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTH-AKRAYRELVLMKCVNHKNIIG 88
Query: 572 LQG-FCAENEHKL-----LVYEYVENGSLDKLL---FNDPGTASILQWDQRYNIAVGTAK 622
L F + + +V E ++ +L +++ + + +L Y +
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLL-----YQML----C 138
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYL 682
G+ +LH ++H D+KP NI++ K+ DFGL++ V TR Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 193
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGK 712
APE ++ + D++S G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQ--GDAE-FWAEVSIIGRINHRNLVKL- 572
VG G +GSV + VA+K+L Q A+ + E+ ++ + H N++ L
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 573 -----QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LV +++ L K++ ++ + KGL Y+
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT-DLQKIM------GLKFSEEKIQYLVYQMLKGLKYI 142
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
H V+H D+KP N+ +++ E K+ DFGL++ D + + TR Y APE +
Sbjct: 143 HSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA----DAEMTGYVVTRWYRAPEVI 195
Query: 688 MNLKI-DAKADVYSYGIVLLELLTGK 712
++ + D++S G ++ E+LTGK
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 32/209 (15%)
Query: 520 VGKGGFGSVFRGVL-DDERVVAVKRL--EGVLQGDAEFW--AEVSIIGR-INHRNLVKLQ 573
+GKG FG VF + A+K L + VL D E ++ H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK--------GL 624
+ + L V EY+ G L +++ +Q +++++ A GL
Sbjct: 85 -CTFQTKENLFFVMEYLNGGDL---MYH-------IQSCHKFDLS--RATFYAAEIILGL 131
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
+LH + +++ D+K NILLD K+ DFG+ K + GT Y+AP
Sbjct: 132 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAP 187
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGKS 713
E ++ K + D +S+G++L E+L G+S
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 33/218 (15%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-----EVSIIGRINHRNL 569
K +G+G +G V +VA+K++E D +A E+ I+ H N+
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENI 71
Query: 570 VKLQG-FCAENEHKL----LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGL 624
+ + ++ ++ E ++ L +++ + +Q+ Y + +
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY-FIYQTL----RAV 125
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG------- 677
LH V+H D+KP N+L++ + + KV DFGL+++ E
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 678 --TRGYLAPEWMMNLKIDAKA-DVYSYGIVLLELLTGK 712
TR Y APE M+ ++A DV+S G +L EL +
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 48/207 (23%), Positives = 91/207 (43%), Gaps = 26/207 (12%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-----EVSIIGRINHRNLVK 571
+ +G G G V +R VA+K+L Q + A E+ ++ +NH+N++
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTH-AKRAYRELVLMKCVNHKNIIS 125
Query: 572 LQG-FCAENEHKL-----LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
L F + + LV E ++ +L +++ L ++ + G+
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI------QMELDHERMSYLLYQMLCGIK 178
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPE 685
+LH ++H D+KP NI++ K+ DFGL++ V TR Y APE
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPE 233
Query: 686 WMMNLKIDAKADVYSYGIVLLELLTGK 712
++ + D++S G ++ E++ K
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 32/209 (15%)
Query: 520 VGKGGFGSVFRGVL-DDERVVAVKRL--EGVLQGD--AEFWAEVSIIGRI-NHRNLVKLQ 573
+GKG FG V + + AVK L + V+Q D E ++ L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 574 GFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK--------GL 624
C + +L V EYV G L+++ +Q R+ A GL
Sbjct: 88 -SCFQTMDRLYFVMEYVNGG---DLMYH-------IQQVGRFKEP--HAVFYAAEIAIGL 134
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
+L + +++ D+K N++LD K+ DFG+ K T + GT Y+AP
Sbjct: 135 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAP 190
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGKS 713
E + D +++G++L E+L G++
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 55/237 (23%), Positives = 98/237 (41%), Gaps = 53/237 (22%)
Query: 517 KQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-----EVSIIGRINHRNLV 570
K +G+G +G V+ + E+ VA+K++ + + D E++I+ R+ ++
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLID-CKRILREITILNRLKSDYII 88
Query: 571 KLQG-FCAENEHKL----LVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGT 620
+L ++ K +V E ++ L KL + +IL YN+
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTIL-----YNLL--- 139
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG--- 677
G +++HE ++H D+KP N LL+ KV DFGL++ DT
Sbjct: 140 -LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 678 ------------------TRGYLAPEWMMNLKIDAKA-DVYSYGIVLLELLTGKSAS 715
TR Y APE ++ + K+ D++S G + ELL +
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 2e-13
Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 26/206 (12%)
Query: 520 VGKGGFGSVFRGVL-DDERVVAVKRL--EGVLQGD--AEFWAEVSIIGRIN-HRNLVKLQ 573
+GKG FG V + + AVK L + V+Q D E ++ L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 574 GFCAENEHKL-LVYEYVENGSL-----DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
C + +L V EYV G L F +P + A A GL +L
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA--------VFYAA-EIAIGLFFL 458
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
+ +++ D+K N++LD K+ DFG+ K T + GT Y+APE +
Sbjct: 459 QSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEII 514
Query: 688 MNLKIDAKADVYSYGIVLLELLTGKS 713
D +++G++L E+L G++
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-----EVSIIGRINHRNLVK 571
+G+G +G V ++ VA+K++ + + + E+ I+ R H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIG 89
Query: 572 LQG-FCAENEHKL----LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
+ A ++ +V + +E L KLL L D +GL Y
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDLMET-DLYKLL-----KTQHLSNDHICYFLYQILRGLKY 143
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR---VRGTRGYLA 683
+H VLH D+KP N+LL+ + K+ DFGL+++ HD V TR Y A
Sbjct: 144 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-ATRWYRA 199
Query: 684 PEWMMNLKIDAKA-DVYSYGIVLLELLTGK 712
PE M+N K K+ D++S G +L E+L+ +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 47/212 (22%), Positives = 81/212 (38%), Gaps = 55/212 (25%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQ 573
Q +G G G V + + A+K L+ + EV + R ++V++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 77
Query: 574 GFC----AENEHKLLVYEYVENGSL-DKLL------FNDPGTASILQWDQRYNIAVGTAK 622
A + L+V E ++ G L ++ F + + I++ +I +
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-----SIG----E 128
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFSRVRGTR 679
+ YLH + H DVKP+N+L K+TDFG + KE G
Sbjct: 129 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KE--------TTG-E 173
Query: 680 GYLAPEWMMNLKIDAKADVYSYGIVLLELLTG 711
Y D D++S G+++ LL G
Sbjct: 174 KY-----------DKSCDMWSLGVIMYILLCG 194
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 57/240 (23%), Positives = 98/240 (40%), Gaps = 54/240 (22%)
Query: 517 KQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQ--GDAE-FWAEVSIIGRINHRNLVKL 572
+ +G G +G V ++RVVA+K++ V + D + E++I+ R+NH ++VK+
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKV 117
Query: 573 ----QGFCAENEHKL-LVYEYVENGSLDKLL-----FNDPGTASILQWDQRYNIAVGTAK 622
E +L +V E ++ KL + ++L YN+
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLL-----YNL----LV 167
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG----- 677
G+ Y+H +LH D+KP N L++ KV DFGL++ +
Sbjct: 168 GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 678 ---------------------TRGYLAPEWMMNLKIDAKA-DVYSYGIVLLELLTGKSAS 715
TR Y APE ++ + +A DV+S G + ELL +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-FWAEVSIIGRINHRNLVKLQG- 574
+ +G GG G VF V D ++ VA+K++ + E+ II R++H N+VK+
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 575 FCAENEHKL-------------LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTA 621
+V EY+E L +L L +
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL-----EQGPLLEEHARLFMYQLL 130
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHF-EPKVTDFGLSKLFKERHDTKFSR---VRG 677
+GL Y+H VLH D+KP N+ ++ K+ DFGL+++ + K +
Sbjct: 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL-V 186
Query: 678 TRGYLAPEWMMNLKIDAKA-DVYSYGIVLLELLTGK 712
T+ Y +P +++ KA D+++ G + E+LTGK
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 66.5 bits (161), Expect = 3e-12
Identities = 37/231 (16%), Positives = 71/231 (30%), Gaps = 33/231 (14%)
Query: 66 SIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQA 125
+I F S + + + + + T+Q + NL L D D VW++NT G +A
Sbjct: 2 NILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSD-VRVWASNTAGATGCRA 60
Query: 126 QLLETGNLVLVNEANTTIWKS------------------------FDSPTDTLLPSQLLT 161
L G LV++ NT W S + T ++
Sbjct: 61 VLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVV 120
Query: 162 KNTTLVSMRSPGTYLSGFYNLKFDD---NNILDLIFNGPLISSIYWPNSAFTVFLNGRTP 218
N + S + L + L ++ + V+
Sbjct: 121 ANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDR--VWSTNTAG 178
Query: 219 YNSSRRAYVNASG---LFRSSDTFKFNASDYGVGPKRRLTLDYDGILRLYS 266
+ RA + +G + + + + + + + L D L +Y
Sbjct: 179 KGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG 229
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 9e-07
Identities = 31/135 (22%), Positives = 55/135 (40%), Gaps = 5/135 (3%)
Query: 22 WSQGIPRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYC---YSIWFTNSVNRTVV 78
WS G L ++ + + G + SG G+ SI ++ N
Sbjct: 79 WSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHP 138
Query: 79 WMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTF-TDEGVQAQLLETGNLVLVN 137
+ + + +L+++ + NL L D+D VWSTNT G +A L G + ++
Sbjct: 139 QTLHATQSLQLSPYRLSMETDCNLVLFDRDD-RVWSTNTAGKGTGCRAVLQPNGRMDVLT 197
Query: 138 EANTTIWKSFDSPTD 152
N +W S +S +
Sbjct: 198 NQNIAVWTSGNSRSA 212
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 4e-06
Identities = 20/102 (19%), Positives = 32/102 (31%), Gaps = 9/102 (8%)
Query: 46 SPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALT 105
+ Y++ C + F VW N G R LQ NG + +
Sbjct: 142 HATQSLQLSPYRLSMETDCNLVLFDRD---DRVWSTNTAGKGTGCR--AVLQPNGRMDVL 196
Query: 106 DKDSSVVWSTNTFTDEG-VQAQLLETGNLVLVNEANTTIWKS 146
+ VW++ G L NL + A +W +
Sbjct: 197 TNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGA---LWTT 235
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-----EVSIIGRINHRNLVK 571
VG G +GSV VAVK+L Q A E+ ++ + H N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIH-AKRTYRELRLLKHMKHENVIG 92
Query: 572 L------QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
L E LV + L+ ++ T +Q+ + +GL
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQF-----LIYQILRGLK 146
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKF--SRVRGTRGYLA 683
Y+H ++H D+KP N+ +++ E K+ DFGL+ RH V TR Y A
Sbjct: 147 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA-----RHTADEMTGYV-ATRWYRA 197
Query: 684 PEWMMNLKI-DAKADVYSYGIVLLELLTGK 712
PE M+N + D++S G ++ ELLTG+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 49/231 (21%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA-----EVSIIGRIN-HRN 568
+++GKG +G V++ + VVAVK++ Q ++ A E+ I+ ++ H N
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTD-AQRTFREIMILTELSGHEN 70
Query: 569 LVKLQG-FCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQR----YNIAVGTAK 622
+V L A+N+ + LV++Y+E L ++ A+IL+ + Y + K
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMET-DLHAVI-----RANILEPVHKQYVVYQLI----K 120
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRG----- 677
+ YLH +LH D+KP NILL+ KV DFGLS+ F +
Sbjct: 121 VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 678 ---------------TRGYLAPEWMMNLKIDAKA-DVYSYGIVLLELLTGK 712
TR Y APE ++ K D++S G +L E+L GK
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 3e-11
Identities = 31/112 (27%), Positives = 48/112 (42%), Gaps = 15/112 (13%)
Query: 42 DFLVSPNGTFSSGFYKVGTNAYCYSIWFT---NSV---NRTVVWMANRDRPVNGKRSKLT 95
+ L SPN F+ +VG + Y + N V + VW +N G +LT
Sbjct: 2 NSLSSPNSLFTGHSLEVGPS---YRLIMQGDCNFVLYDSGKPVWASNT--GGLGSGCRLT 56
Query: 96 LQRNGNLALTDKDSSVVWSTNTFTDEG-VQAQLLETGNLVLVNEANTTIWKS 146
L NGNL + D+ + V+W T T E L + N+V+ +W +
Sbjct: 57 LHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV---VWAT 105
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 4e-11
Identities = 21/87 (24%), Positives = 40/87 (45%), Gaps = 2/87 (2%)
Query: 61 NAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTF-T 119
N +S ++ + + + + + +Q + NL L D + + +W+TNT
Sbjct: 1 NNIIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDNN-NPIWATNTGGL 59
Query: 120 DEGVQAQLLETGNLVLVNEANTTIWKS 146
G +A L G LV++ N T+W+S
Sbjct: 60 GNGCRAVLQPDGVLVVITNENVTVWQS 86
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 4e-09
Identities = 16/74 (21%), Positives = 28/74 (37%), Gaps = 6/74 (8%)
Query: 74 NRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEG-VQAQLLETGN 132
N +W N G + LQ +G L + ++ VW + G L N
Sbjct: 47 NNNPIWATNT--GGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRN 104
Query: 133 LVLVNEANTTIWKS 146
+V+ +A +W +
Sbjct: 105 VVIYGDA---LWAT 115
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 50/231 (21%), Positives = 86/231 (37%), Gaps = 59/231 (25%)
Query: 520 VGKGGFGSVFRGV--LDDERVVAVKRLEGVLQGDAEFWA----EVSIIGRINHR------ 567
+G+G FG V + + VA+K +++ ++ E++++ +I +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALK----IIRNVGKYREAARLEINVLKKIKEKDKENKF 82
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLF-------NDPGTASILQWDQRYNIAVGT 620
V + + + H + +E L K F P ++ ++A
Sbjct: 83 LCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVR-----HMAYQL 132
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP-------------------KVTDFGLS 661
L +LHE L H D+KP+NIL + +V DFG +
Sbjct: 133 CHALRFLHENQL---THTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 662 KLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
E H T + TR Y PE ++ L DV+S G +L E G
Sbjct: 190 TFDHEHHTTIVA----TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 55/231 (23%), Positives = 86/231 (37%), Gaps = 61/231 (26%)
Query: 521 GKGGFGSVFRGVLD---DERVVAVKRLEGVLQGDAEFWA----EVSIIGRINHR------ 567
G+G FG V +D R VAVK +++ + E+ ++ +N
Sbjct: 23 GEGAFGKVVE-CIDHKAGGRHVAVK----IVKNVDRYCEAARSEIQVLEHLNTTDPNSTF 77
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLF-----ND--PGTASILQWDQRYNIAVGT 620
V++ + + H +V+E L + N P ++ +A
Sbjct: 78 RCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIR-----KMAYQI 127
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP-------------------KVTDFGLS 661
K +++LH L H D+KP+NIL KV DFG +
Sbjct: 128 CKSVNFLHSNKL---THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 662 KLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
E H T S TR Y APE ++ L DV+S G +L+E G
Sbjct: 185 TYDDEHHSTLVS----TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 63/234 (26%)
Query: 521 GKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWA----EVSIIGRINHR-----NLV 570
G G FG V +D+++ AVK V++ ++ E I+ +I + N+V
Sbjct: 44 GDGTFGRVLLCQHIDNKKYYAVK----VVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLLF-------NDPGTASILQWDQRYNIAVGTAKG 623
K G +H L++E L L+ + ++ + K
Sbjct: 100 KYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIK-----LYCIEILKA 149
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEP-------------------------KVTDF 658
L+YL + L H D+KP+NILLDD + K+ DF
Sbjct: 150 LNYLRKMSL---THTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 659 GLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
G + + H + + TR Y APE ++NL D +D++S+G VL EL TG
Sbjct: 207 GCATFKSDYHGSIIN----TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-09
Identities = 27/120 (22%), Positives = 46/120 (38%), Gaps = 17/120 (14%)
Query: 28 RLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPV 87
RL G+ L G+ + G Y C + + N+ VW + +
Sbjct: 3 RLNSGHQL----------DTGGSLAEGGYLFIIQNDCNLVLYDNN---RAVWASGTNG-- 47
Query: 88 NGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEG-VQAQLLETGNLVLVNEANTTIWKS 146
L +Q +GNL + S +W++NT G L N+V+ + +N IW +
Sbjct: 48 KASGCVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 3e-04
Identities = 17/70 (24%), Positives = 28/70 (40%), Gaps = 4/70 (5%)
Query: 79 WMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTF-TDEGVQAQLLETGNLVLVN 137
+ G +Q + NL L D + VW++ T G ++ GNLV+ +
Sbjct: 9 QLDTGGSLAEG-GYLFIIQNDCNLVLYDNN-RAVWASGTNGKASGCVLKMQNDGNLVIYS 66
Query: 138 EANTTIWKSF 147
+ IW S
Sbjct: 67 -GSRAIWASN 75
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-09
Identities = 24/112 (21%), Positives = 46/112 (41%), Gaps = 14/112 (12%)
Query: 41 NDFLVS-----PNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLT 95
++ L+S + + +G Y + C + + N +W +N G +LT
Sbjct: 2 DNVLLSGQTLHADHSLQAGAYTLTIQNKCNLVKYQNG---RQIWASNT--DRRGSGCRLT 56
Query: 96 LQRNGNLALTDKDSSVVWSTNTFTDEG-VQAQLLETGNLVLVNEANTTIWKS 146
L +GNL + D +++ VW + + D G L + G V+ +W
Sbjct: 57 LLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIY---GPVLWSL 105
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 3e-09
Identities = 22/104 (21%), Positives = 38/104 (36%), Gaps = 8/104 (7%)
Query: 46 SPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALT 105
+ Y C + + +S T VW +N K LQ +GN +
Sbjct: 11 YAGQSLDVEPYHFIMQEDCNLVLYDHS---TSVWASNTGILGKKG-CKAVLQSDGNFVVY 66
Query: 106 DKDSSVVWSTNTFTDEG-VQAQLLETGNLVLVNEANTTIWKSFD 148
D + +W++++ G L E GN+V+ IW +
Sbjct: 67 DAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWSTGT 107
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 606 SILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665
L + + AKG+ +L +H D+ +NILL + K+ DFGL++
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIY 244
Query: 666 ERHDTKFSRVRGTRGYL-----APEWMMNLKIDAKADVYSYGIVLLELLT 710
+ D VR L APE + + ++DV+S+G++L E+ +
Sbjct: 245 KDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 10/103 (9%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL-EGVLQGD-AEFWAEVS 559
E R + +G+G FG V R VAVK L EG + +E+
Sbjct: 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 77
Query: 560 IIGRI-NHRNLVKLQGFCAENEHKLLV-YEYVENGSLDKLLFN 600
I+ I +H N+V L G C + L+V E+ + G+L L +
Sbjct: 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-08
Identities = 22/102 (21%), Positives = 42/102 (41%), Gaps = 9/102 (8%)
Query: 46 SPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALT 105
SP ++G Y C + + +W N +R L++Q +GNL +
Sbjct: 11 SPGEFLNNGRYVFIMQEDCNLVLYDVD---KPIWATNTGG--LDRRCHLSMQSDGNLVVY 65
Query: 106 DKDSSVVWSTNTFTDEG-VQAQLLETGNLVLVNEANTTIWKS 146
++ +W++NT + G L + N+V+ A W +
Sbjct: 66 SPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA---RWAT 104
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-08
Identities = 20/103 (19%), Positives = 43/103 (41%), Gaps = 10/103 (9%)
Query: 45 VSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLAL 104
+ +G ++ +++ C + + W +N NG+ L L G L +
Sbjct: 15 LYGDGRLTAKNHQLVMQGDCNLVLY----GGKYGWQSNTHG--NGEHCFLRLNHKGELII 68
Query: 105 TDKDSSVVWSTNTFTDEGVQAQLLE-TGNLVLVNEANTTIWKS 146
D D +WS+ + + +G +L+ G V+ A I+++
Sbjct: 69 KDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGPA---IFET 108
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 7e-08
Identities = 25/102 (24%), Positives = 40/102 (39%), Gaps = 12/102 (11%)
Query: 46 SPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALT 105
G +G + + C N V W +N NG+ KLTL G L +
Sbjct: 13 DTEGHLKNGDFDLVMQDDC------NLVLYNGNWQSNT--ANNGRDCKLTLTDYGELVIK 64
Query: 106 DKDSSVVWSTNTFTDEG-VQAQLLETGNLVLVNEANTTIWKS 146
+ D S VW + + +G A + G LV+ +++K
Sbjct: 65 NGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVF---GPSVFKI 103
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 8e-08
Identities = 30/189 (15%), Positives = 47/189 (24%), Gaps = 46/189 (24%)
Query: 520 VGKGGFGSVFRGVLDDERVVAVK--RLEGVLQGD-------AEFWAEVSI---------I 561
+G+G FG VF+ + D VA+K +EG + E E+ I
Sbjct: 28 IGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 562 GRINHRNLVKL------QGFCAENEHKLLVYEYVENGSLDKLLFNDPGT----------- 604
+ L QG K + GS +
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 605 --------ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVT 656
+ +I L+ H D+ N+LL K+
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLH 204
Query: 657 DFGLSKLFK 665
K
Sbjct: 205 YTLNGKSST 213
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-07
Identities = 22/102 (21%), Positives = 41/102 (40%), Gaps = 7/102 (6%)
Query: 46 SPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALT 105
N ++ Y + C ++ T +VW + G+ + L +G L +T
Sbjct: 16 YDNAQLATRDYSLVMRDDC-NLVLTKGSKTNIVWESGTSG--RGQHCFMRLGHSGELDIT 72
Query: 106 DKDSSVVWSTNTFTDEGVQAQLLE-TGNLVLVNEANTTIWKS 146
D + V+ +NT EG +L+ G V+ A +W +
Sbjct: 73 DDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGPA---VWST 111
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 29/147 (19%), Positives = 47/147 (31%), Gaps = 55/147 (37%)
Query: 616 IAVGTAKGLSYLHEECLEWVLHCDVKPQNILL---------------------------- 647
I +GL YLH +C ++H D+KP+NILL
Sbjct: 151 IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 648 ---------------------DDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
+ + K+ D G + + TR Y + E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEV 264
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGKS 713
++ + AD++S + EL TG
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDY 291
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 4e-07
Identities = 61/451 (13%), Positives = 118/451 (26%), Gaps = 130/451 (28%)
Query: 408 HIKIPRGKINYSAE-----LEKARVNDLNC-----------SAAAVVLGGDNANGEKPTK 451
H+ G+ Y + E A V++ +C S + D+ K
Sbjct: 6 HMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEI----DHIIMSKDAV 61
Query: 452 NRYMKYLISLAGSFAVIETVFI------SLGWWY------------VFRRHV--HEELAN 491
+ ++ +L + F+ + + + R ++ + L N
Sbjct: 62 SGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN 121
Query: 492 LGCIVLALGFKRF-TYAELKRATRNFKQE-----VGKGGFG-SVFRG-VLDDERVVAVKR 543
+ R Y +L++A + G G G + V +V K
Sbjct: 122 DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQC-KM 180
Query: 544 LEGVLQGDAEFWAEVSIIGRINHRNLV--KLQGFCAENEHKLLVYEYVENGSLDKLLFND 601
+ FW + N V LQ + + ++ S KL +
Sbjct: 181 DFKI------FWLNL---KNCNSPETVLEMLQKLLYQIDPNWT--SRSDHSSNIKLRIHS 229
Query: 602 PGTA-SILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPK----VT 656
L + Y E CL VL +V+ + F +T
Sbjct: 230 IQAELRRLLKSKPY--------------ENCL-LVLL-NVQNAKAW--NAFNLSCKILLT 271
Query: 657 --DFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELL---TG 711
++ T S + E + LL
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDE-------------------VKSLLLKYLD 312
Query: 712 KSASDYLSASASDSS-------------YCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDR 758
D L ++ W K + + L II+ LN +
Sbjct: 313 CRPQD-LPREVLTTNPRRLSIIAESIRDGLATWDNW--KHVNCDKLTTIIESSLNVLEPA 369
Query: 759 EKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
E ++++ P + ++ L+
Sbjct: 370 EYRKMFDRLSVF----PPSAHIP-TILLSLI 395
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 1e-05
Identities = 83/589 (14%), Positives = 161/589 (27%), Gaps = 188/589 (31%)
Query: 7 FVLLILAPTVAWSQAWSQGIPRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYS 66
FV +L + + + R + ++ D L + N F+ Y V
Sbjct: 82 FVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK--YNV-------- 131
Query: 67 IWFTNSVNRTVVWMANRDRPVNGKRSKLT-LQRNGNLAL-----TDKDSSVVWSTNTFTD 120
+R +P R L L+ N+ + + K + V +
Sbjct: 132 ---------------SRLQPYLKLRQALLELRPAKNVLIDGVLGSGK-TWVA--LDVCLS 173
Query: 121 EGVQAQLLETGNLVLVNEANTTIWKSF---DSPTDTLLPSQLLTKNTTLVSMRSPGTYLS 177
VQ ++ W + +SP L Q L
Sbjct: 174 YKVQCKM-----------DFKIFWLNLKNCNSPETVLEMLQKL----------------- 205
Query: 178 GFYNLKFDDNNILDLIFNGPLISSIYWPNSAFTVFLNGRTPYNSSRRAYVNASGLF---- 233
Y + + + D N L I+ + L + Y N L
Sbjct: 206 -LYQIDPNWTSRSDHSSNIKL--RIHSIQAELRRLL--------KSKPYENC--LLVLLN 252
Query: 234 -RSSDTFK-FNAS--------DYGV----GPKRRLTLDYDGILRLYSFDESTRLWKISWL 279
+++ + FN S V + D + DE L + +L
Sbjct: 253 VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL-LKYL 311
Query: 280 PAGLDYCTVHGLCGPNGICVNRPRQKTCICPNG-FRRNDPSDWIKGCSPLFNLSCDR--- 335
C L P + PR+ + I R+ + W +++CD+
Sbjct: 312 D-----CRPQDL--PREVLTTNPRRLSII---AESIRDGLATW----DNWKHVNCDKLTT 357
Query: 336 ------NELDFMELPNTDYYG--------------------YDLVTYGIGISLQECRNRC 369
N L+ E + +D++ + + + +
Sbjct: 358 IIESSLNVLEPAEY--RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415
Query: 370 LSDCKCKGFGYSTDGQGECFPKGNLLNGHNMPGKYVSMHIKIPRGKINYSAELEKARVND 429
L + + K S +P Y+ + +K+ L ++ V+
Sbjct: 416 LVEKQPKESTIS------------------IPSIYLELKVKLEN-----EYALHRSIVDH 452
Query: 430 LNCSAAAVVLGGDNANGEKPTKNRYM-KYL------ISLAGSFAVIETVFISLGWWYVFR 482
N D+ + P ++Y ++ I + VF+ +
Sbjct: 453 YNIPKTF-----DSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKI 507
Query: 483 RHVHEELANLGCIVLALG----FKRF------TYAELKRATRNFKQEVG 521
RH G I+ L +K + Y L A +F ++
Sbjct: 508 RHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIE 556
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 45/215 (20%), Positives = 85/215 (39%), Gaps = 35/215 (16%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGF 575
+++G G FG + G L VA+K LE + + E ++ + + ++ F
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 576 CAENEHKLLVYEYVENG-SLDKLLFNDPGTASI---LQWDQRYNIAVGTAKGLSYLHEEC 631
++ +V E + G SL+ L T S+ L IA+ + Y+H +
Sbjct: 74 GPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLM------IAIQLISRMEYVHSKN 125
Query: 632 LEWVLHCDVKPQNILLDDHFEPK-----VTDFGLSKLFKE---------RHDTKFSRVRG 677
L ++ DVKP+N L+ + DF L+K + + R G
Sbjct: 126 L---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL---TG 179
Query: 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
T Y++ + + + D+ + G + + L G
Sbjct: 180 TARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 46/215 (21%), Positives = 81/215 (37%), Gaps = 35/215 (16%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGF 575
+ +G+G FG +F G L + + VA+K E + E + + + F
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 576 CAENEHKLLVYEYVENG-SLDKLLFNDPGTAS---ILQWDQRYNIAVGTAKGLSYLHEEC 631
E H +LV + + G SL+ LL S + A + +HE+
Sbjct: 75 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAM------AAKQMLARVQSIHEKS 126
Query: 632 LEWVLHCDVKPQNILLDDHFEPK-----VTDFGLSKLFKE---------RHDTKFSRVRG 677
L ++ D+KP N L+ V DFG+ K +++ R G
Sbjct: 127 L---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL---SG 180
Query: 678 TRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
T Y++ + + + D+ + G V + L G
Sbjct: 181 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 46/210 (21%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLV-KLQGF 575
+++G G FG ++ G + VA+K E V + E I + + ++ F
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 576 CAENEHKLLVYEYVENG-SLDKLLFNDPGTAS---ILQWDQRYNIAVGTAKGLSYLHEEC 631
E ++ +LV + + G SL+ L S +L +A + ++H +
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLM------LADQMINRVEFVHSKS 123
Query: 632 LEWVLHCDVKPQNILLDDHFEPK---VTDFGLSKLFKERHD------TKFSRVRGTRGYL 682
LH D+KP N L+ + DFGL+K +++ + + GT Y
Sbjct: 124 F---LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGK 712
+ + ++ + D+ S G VL+ L G
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >4a5v_A MIC4, micronemal protein 4; adhesion; NMR {Toxoplasma gondii} Length = 161 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 5e-05
Identities = 13/68 (19%), Positives = 27/68 (39%), Gaps = 1/68 (1%)
Query: 335 RNELDFMELPNTDYYGYDLVTYGIGISLQECRNRCLSDCKCKGFGYSTDGQGECFPKGNL 394
+ +L + N + +SL++C +C + C F Y+ D C K
Sbjct: 6 KLDLSCVHSDNKGSRAPTIGEPVPDVSLEQCAAQCKAVDGCTHFTYNDDS-KMCHVKEGK 64
Query: 395 LNGHNMPG 402
+ +++ G
Sbjct: 65 PDLYDLTG 72
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 42/244 (17%), Positives = 85/244 (34%), Gaps = 65/244 (26%)
Query: 514 RNFK--QEVGKGGFGSVFRGV---------LDDERVVAVKRLE---GVLQGDAEF----- 554
R +K + G ++ ++ ++K L+ G L + F
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 555 ----WAEVSIIGRINHRNLVKLQGF-CAENEHKLLVYEYVENG-SLDKLL-FNDPGTAS- 606
+ + + GF +++++ LV + G SL L + S
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSE 158
Query: 607 --ILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVT--DFGLSK 662
+LQ +A L +LHE +H +V +NI +D + +VT +G +
Sbjct: 159 RSVLQ------VACRLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
Query: 663 LFKE--RH----DTKFSRVRGTRGYLAPEWMMNLKIDA--------KADVYSYGIVLLEL 708
+ +H + S G +++ +D ++D+ S G +L+
Sbjct: 210 RYCPSGKHVAYVEGSRSPHEGDLEFIS--------MDLHKGCGPSRRSDLQSLGYCMLKW 261
Query: 709 LTGK 712
L G
Sbjct: 262 LYGF 265
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 12/59 (20%), Positives = 26/59 (44%), Gaps = 4/59 (6%)
Query: 90 KRSKLTLQRNGNLALTDKDSSVVWSTNTF-TDEGVQAQLLETGNLVLVN-EANTTIWKS 146
+ + +Q + NL L ++ + + +NT +L G L + + +NT +W
Sbjct: 20 ESAAFVMQGDCNLVLYNE--AGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVY 76
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 27/210 (12%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINH-RNLVKLQGF 575
+++G G FG ++ G + VA+K E V + E I + + ++
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 576 CAENEHKLLVYEYVENG-SLDKLLFNDPGTAS---ILQWDQRYNIAVGTAKGLSYLHEEC 631
AE ++ ++V E + G SL+ L S +L +A + Y+H +
Sbjct: 74 GAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLL------LADQMISRIEYIHSKN 125
Query: 632 LEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFKERHDTKFSRVR------GTRGYL 682
+H DVKP N L+ + DFGL+K +++ + R GT Y
Sbjct: 126 F---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGK 712
+ + ++ + D+ S G VL+ G
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 39/239 (16%), Positives = 78/239 (32%), Gaps = 69/239 (28%)
Query: 520 VGKGGFGSVFRGVLDDERVVAVK-------------------RLEGVLQGDAEFWAEVSI 560
+G+GGFG ++ ++ V + E +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAK-PEQIQKWIR 101
Query: 561 IGRINHRNLVKLQGF----CAENEHKLLVYEYVENG-SLDKLLFNDPGTAS---ILQWDQ 612
++ + + K G ++ ++ + G L K+ + S +LQ
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQ--- 156
Query: 613 RYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVT--DFGLSKLF------ 664
+++ L Y+HE +H D+K N+LL+ +V D+GL+ +
Sbjct: 157 ---LSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 665 ---KERHDTKFSRVRGTRGYLAPEWMMNLKIDA--------KADVYSYGIVLLELLTGK 712
GT + + IDA + D+ G +++ LTG
Sbjct: 211 KAYAADPKRCH---DGTIEFTS--------IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 31/173 (17%), Positives = 59/173 (34%), Gaps = 40/173 (23%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVK----------------RLEGVLQGDAEFWAEVSIIG 562
+G GGFG ++ + A + + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK-KDCIKKWIERK 103
Query: 563 RINHRNLVKLQGF----CAENEHKLLVYEYVENG-SLDKLLFNDPGTAS---ILQWDQRY 614
++++ + G ++ +V E + G L K+ GT +LQ
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKI-SGQNGTFKKSTVLQ----- 155
Query: 615 NIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVT--DFGLSKLFK 665
+ + L Y+HE +H D+K N+LL +V D+GLS +
Sbjct: 156 -LGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 804 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.82 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.8 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.8 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.78 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.75 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.71 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.62 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.59 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.54 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.54 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.52 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.51 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.48 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.4 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.35 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.23 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.19 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.12 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.0 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.99 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.93 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.84 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.84 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.82 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.81 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.59 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.13 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.11 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.02 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.99 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.76 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.63 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.49 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.35 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.34 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.83 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.69 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.63 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.44 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.43 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.33 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.32 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.24 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.86 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.59 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.49 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.41 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 91.18 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.8 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.35 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.94 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=443.66 Aligned_cols=267 Identities=24% Similarity=0.371 Sum_probs=217.7
Q ss_pred cchHHHHHHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeee
Q 038103 504 FTYAELKRATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGF 575 (804)
Q Consensus 504 ~~~~~l~~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~ 575 (804)
..+.|+..++.+|.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.++++++|||||+++|+
T Consensus 18 ~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 18 AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp -CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 3444555667788999999999999999963 46789999997432 345789999999999999999999999
Q ss_pred EEeCCeeEEEEeeccCCChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccC
Q 038103 576 CAENEHKLLVYEYVENGSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQ 643 (804)
Q Consensus 576 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 643 (804)
|.++...+||||||++|+|.++|..... ....++|..+.+|+.|||+||+|||+++ |+||||||+
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~ 174 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATR 174 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCcccc
Confidence 9999999999999999999999965321 1246899999999999999999999998 999999999
Q ss_pred eEEEcCCCCeEEeecCCcccccccC-CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccc
Q 038103 644 NILLDDHFEPKVTDFGLSKLFKERH-DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSAS 721 (804)
Q Consensus 644 NILl~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~ 721 (804)
||||++++++||+|||+++...... ........||+.|||||.+.++.++.++|||||||+||||+| |+.||....
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-- 252 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-- 252 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--
Confidence 9999999999999999999765433 233445679999999999999999999999999999999999 899996432
Q ss_pred cCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 722 ASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
... +...+..+.... .+.+.+..+.+|+.+||+.||++||||++|+++|+....
T Consensus 253 ------~~~----~~~~i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 253 ------NQD----VVEMIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp ------HHH----HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred ------HHH----HHHHHHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 111 222333332211 122334578999999999999999999999999987653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=433.47 Aligned_cols=260 Identities=28% Similarity=0.431 Sum_probs=211.6
Q ss_pred HHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
+..+.+.++||+|+||.||+|++. +++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 345567789999999999999864 47789999998543 34567999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCC---------CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeE
Q 038103 584 LVYEYVENGSLDKLLFNDP---------GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPK 654 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 654 (804)
||||||++|+|.++|+... .....++|..+.+++.|||+||+|||+++ |+||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999997531 23457999999999999999999999998 99999999999999999999
Q ss_pred EeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHH
Q 038103 655 VTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLV 732 (804)
Q Consensus 655 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~ 732 (804)
|+|||+++....... .......||+.|||||.+.+..++.++|||||||+||||+| |+.||.... ...
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--------~~~-- 238 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNE-- 238 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHH--
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHH--
Confidence 999999987654333 23334568999999999999999999999999999999999 899996532 111
Q ss_pred HHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 733 QWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
+...+..+.... .+...+..+.+|+.+||+.||++||||++|++.|+.+..
T Consensus 239 --~~~~i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 239 --VIECITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp --HHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 222333332211 112233478899999999999999999999999987654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=434.25 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=204.7
Q ss_pred HhcccccccccCcceEEEEEec------CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
...+.++||+|+||.||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+....+||
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3456789999999999999864 47889999998543 3356799999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCC-----------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeE
Q 038103 586 YEYVENGSLDKLLFNDPG-----------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPK 654 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 654 (804)
||||++|+|.++|+.... ....++|..+++|+.|||+||+|||+++ |+||||||+||||++++.+|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEE
Confidence 999999999999976421 2246999999999999999999999988 99999999999999999999
Q ss_pred EeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHH
Q 038103 655 VTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLV 732 (804)
Q Consensus 655 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~ 732 (804)
|+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||.... ...+
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--------~~~~- 269 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--------NTEA- 269 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--------HHHH-
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--------HHHH-
Confidence 999999997654332 33345679999999999999999999999999999999999 899996432 1111
Q ss_pred HHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 733 QWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
...+..+... .. +......+.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 270 ---~~~i~~g~~~-----~~----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 270 ---IDCITQGREL-----ER----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---HHHHHHTCCC-----CC----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---HHHHHcCCCC-----CC----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 2222332211 11 122334688999999999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=424.59 Aligned_cols=258 Identities=27% Similarity=0.436 Sum_probs=201.8
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
....+.++||+|+||+||+|++++ .||||+++.... ..++|.+|++++++++|||||+++|+|.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 344677899999999999999764 499999874333 23579999999999999999999999865 568999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
|++|+|.++|.. ....++|..+..|+.|||+||+|||+++ |+||||||+||||++++++||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 113 CEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred CCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999999975 3456999999999999999999999988 9999999999999999999999999999765432
Q ss_pred -CccccccccCCCccchhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 669 -DTKFSRVRGTRGYLAPEWMMN---LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 669 -~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
........||+.|||||++.. .+|+.++|||||||+||||+||+.||..... ...+...+..+..
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-----------~~~~~~~~~~~~~ 255 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-----------RDQIIFMVGRGYA 255 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----------HHHHHHHHHTTCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-----------HHHHHHHHhcCCC
Confidence 233455789999999999964 4689999999999999999999999964320 1111222222211
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.+.+. ..+.+....+.+|+.+||+.||++||||.+|++.|+.+..
T Consensus 256 ----~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 256 ----SPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp ----CCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred ----CCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11111 1122234578899999999999999999999999987654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=422.21 Aligned_cols=272 Identities=25% Similarity=0.298 Sum_probs=204.8
Q ss_pred HhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCC----eeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENE----HKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~ 588 (804)
++.+.++||+|+||.||+|++ .|+.||||+++........+.+|+..+.+++|||||+++|+|.+.+ .++|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 345678999999999999998 5788999999754333333445666777899999999999998754 67999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhC-----CCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC-----LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
|++|+|.++|+. ..++|..+.+++.|+++||+|||+++ .++|+||||||+||||+.++++||+|||+++.
T Consensus 83 ~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 83 HEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999964 35899999999999999999999872 23499999999999999999999999999997
Q ss_pred ccccCCc---cccccccCCCccchhhhccC------CCCcccchHHHHHHHHHHHhCCCCCcccccccCCc----cchhh
Q 038103 664 FKERHDT---KFSRVRGTRGYLAPEWMMNL------KIDAKADVYSYGIVLLELLTGKSASDYLSASASDS----SYCNH 730 (804)
Q Consensus 664 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~----~~~~~ 730 (804)
....... ......||+.|||||++.+. .++.++|||||||+||||+||+.|+.......... .....
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6553332 22346799999999999754 46789999999999999999988875432111000 00011
Q ss_pred HHHHHHHHhhhcCcccccCCcCCCc-cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 731 LVQWVAKQMEQEGLEKIIDPRLNDV-YDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
. +.+...... ..+++.+... .+.+....+.+|+.+||+.||++||||.||+++|+.+.+.
T Consensus 238 ~-~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 V-EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp H-HHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred H-HHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1 112222222 2233333322 2345667899999999999999999999999999887653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=428.63 Aligned_cols=267 Identities=24% Similarity=0.377 Sum_probs=214.1
Q ss_pred HHHHHHhcccccccccCcceEEEEEecC------CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCC-CcccceeeeEEe
Q 038103 508 ELKRATRNFKQEVGKGGFGSVFRGVLDD------ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINH-RNLVKLQGFCAE 578 (804)
Q Consensus 508 ~l~~~t~~~~~~LG~G~fg~Vykg~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H-~niv~l~g~~~~ 578 (804)
|+.+..+.+.++||+|+||.||+|+..+ ++.||||+++.... ..++|.+|+++|.+++| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 3455677788999999999999998643 36899999974332 34679999999999965 899999999976
Q ss_pred C-CeeEEEEeeccCCChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeE
Q 038103 579 N-EHKLLVYEYVENGSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNI 645 (804)
Q Consensus 579 ~-~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 645 (804)
. ...+||||||++|+|.++|+.... ....++|..+..++.|||+||+|||+++ |+||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccce
Confidence 5 578999999999999999975321 2345899999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccC
Q 038103 646 LLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASAS 723 (804)
Q Consensus 646 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~ 723 (804)
|+++++.+||+|||+|+.+..... .......||+.|||||.+.+..|+.++|||||||+||||+| |+.||.....
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~--- 293 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--- 293 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999997655433 23445678999999999999999999999999999999998 9999964321
Q ss_pred CccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 724 DSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
. +.+...+.++.... .... ....+.+|+.+||+.||++||||++|+++|+.+.+...
T Consensus 294 ----~----~~~~~~i~~g~~~~-----~p~~----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 294 ----D----EEFCRRLKEGTRMR-----APDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp ----S----HHHHHHHHHTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred ----H----HHHHHHHHcCCCCC-----CCcc----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 0 11222333332111 1122 23468899999999999999999999999988765443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=405.95 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=199.6
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
.|.+.++||+|+||.||+|+. .+++.||||++...... .+++.+|++++++++|||||++++++.+++..||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 466778999999999999996 46899999999754332 35689999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
|++|+|.++|... ....+++.....++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.+....
T Consensus 105 ~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 105 CEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999653 3445788999999999999999999999 9999999999999999999999999999765422
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......||+.|||||++.+..|+.++|||||||+||||+||+.||.... ..+. ...+..+....
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----------~~~~-~~~i~~~~~~~-- 244 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----------MKNL-VLKIISGSFPP-- 244 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----------HHHH-HHHHHHTCCCC--
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----------HHHH-HHHHHcCCCCC--
Confidence 22334679999999999999999999999999999999999999996422 1111 12222222211
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+...++ ..+.+|+.+||+.||++|||+.|+++
T Consensus 245 ---~~~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 ---VSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112222 46889999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=396.37 Aligned_cols=245 Identities=23% Similarity=0.368 Sum_probs=196.3
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEe----CCeeEEEE
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAE----NEHKLLVY 586 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 586 (804)
.|.++||+|+||.||+|+.. +++.||||++..... ..+.|.+|++++++++|||||++++++.. ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999965 588999999974332 23568999999999999999999999865 34689999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-CCCeEEeecCCccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-HFEPKVTDFGLSKLFK 665 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~ 665 (804)
|||++|+|.++|.. ...+++..+..++.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999964 346899999999999999999999986 35999999999999984 7899999999998643
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
. .......||+.|||||++.+ +|+.++|||||||+||||+||+.||.... . ...+...+..+...
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-------~----~~~~~~~i~~~~~~ 248 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------N----AAQIYRRVTSGVKP 248 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------S----HHHHHHHHTTTCCC
T ss_pred C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------c----HHHHHHHHHcCCCC
Confidence 3 23345689999999998865 69999999999999999999999996321 0 11122222222211
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..++ ...+ ..+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~----~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 ASFD----KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGG----GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCC----ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 1122 35789999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=404.36 Aligned_cols=247 Identities=22% Similarity=0.347 Sum_probs=204.4
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCc-CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV-LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.|.+.++||+|+||.||+|+.. +|+.||||++... ....+.+.+|+++|++++|||||++++++.+++..|||||||+
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3566788999999999999965 6899999999743 3345678999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.+.....
T Consensus 155 gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 155 GGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 9999999964 34899999999999999999999999 99999999999999999999999999997654322
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
......||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+ +...+..+. .+
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----------~~~-~~~~i~~~~-----~~ 288 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----------PLK-AMKMIRDNL-----PP 288 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----------HHH-HHHHHHHSS-----CC
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----------HHH-HHHHHHcCC-----CC
Confidence 3345789999999999999999999999999999999999999996422 111 112222211 11
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 289 ~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 289 RLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCSC--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 1112346889999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=404.56 Aligned_cols=248 Identities=23% Similarity=0.264 Sum_probs=198.8
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
+.+.++||+|+||.||+|+.. +|+.||||+++.... ..+|+.++++++|||||++++++.+++..+||||||++|
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 445678999999999999964 589999999974332 246999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC-CeEEeecCCcccccccCCc-
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF-EPKVTDFGLSKLFKERHDT- 670 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~- 670 (804)
+|.++|.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++ ++||+|||+|+.+......
T Consensus 136 ~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 136 SLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999964 346999999999999999999999999 99999999999999887 6999999999977543221
Q ss_pred ---cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 671 ---KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 671 ---~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
......||+.|||||++.+..|+.++|||||||+||||+||+.||....... +. ..+..+... .
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~----~~i~~~~~~-~ 275 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--------LC----LKIASEPPP-I 275 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--------CH----HHHHHSCCG-G
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HH----HHHHcCCCC-c
Confidence 2234679999999999999999999999999999999999999996432111 11 111111110 0
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
..+ +......+.+|+.+||+.||.+|||+.|+++.|..
T Consensus 276 --~~~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 --REI----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp --GGS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --hhc----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 011 12223468899999999999999999999887743
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=394.57 Aligned_cols=244 Identities=20% Similarity=0.302 Sum_probs=205.1
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.+.||+|+||+||+++. .+++.||||++.+. ....+.+.+|++++++++|||||++++++.+++..|||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 367788999999999999996 46899999999732 2345679999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|.++|.. ...+++.....++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+...
T Consensus 113 y~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 113 YAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred cCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999964 346899999999999999999999999 999999999999999999999999999987543
Q ss_pred CC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 668 HD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 668 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.. .......||+.|||||++.+..|+.++||||+||+||||++|+.||.... ... +...+..+.+.
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~----~~~~i~~~~~~- 252 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGL----IFAKIIKLEYD- 252 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHH----HHHHHHHTCCC-
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHH----HHHHHHcCCCC-
Confidence 32 34456789999999999999999999999999999999999999996422 111 12222222221
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKV 785 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~V 785 (804)
+....+ ..+.+|+.+||+.||++|||++|+
T Consensus 253 -----~p~~~s----~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 253 -----FPEKFF----PKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp -----CCTTCC----HHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred -----CCcccC----HHHHHHHHHHccCCHhHCcChHHH
Confidence 112223 357899999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=405.44 Aligned_cols=247 Identities=22% Similarity=0.345 Sum_probs=204.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.|.+.++||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+++.+|||||||+
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 3667789999999999999964 68999999997433 345678999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.+.... .
T Consensus 232 gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 302 (423)
T 4fie_A 232 GGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 302 (423)
T ss_dssp TEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-C
T ss_pred CCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-c
Confidence 9999999954 34899999999999999999999999 9999999999999999999999999999765432 2
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
......||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+ +...+..+.. +
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----------~~~-~~~~i~~~~~-----~ 365 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----------PLK-AMKMIRDNLP-----P 365 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----------HHH-HHHHHHHSCC-----C
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----------HHH-HHHHHHcCCC-----C
Confidence 3345689999999999999999999999999999999999999996422 111 1122222211 1
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 366 ~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 366 RLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CCSC--TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCcc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 0112236889999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=382.92 Aligned_cols=243 Identities=21% Similarity=0.341 Sum_probs=189.2
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.+.||+|+||.||+++. .+++.||||++.... ...+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 577888999999999999996 468999999997432 234578999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+ +|+|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 94 y~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 94 YA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp CC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred CC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 99 6799999864 346999999999999999999999999 999999999999999999999999999875542
Q ss_pred CCccccccccCCCccchhhhccCCC-CcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
. ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... ..+ +...+..+...
T Consensus 166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----------~~~-~~~~i~~~~~~- 230 (275)
T 3hyh_A 166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----------IPV-LFKNISNGVYT- 230 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHH-HHHHHHHTCCC-
T ss_pred C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----------HHH-HHHHHHcCCCC-
Confidence 2 2345679999999999998876 579999999999999999999996421 111 12222222211
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+....+ ..+.+|+.+||+.||++|||+.|+++
T Consensus 231 -----~p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 -----LPKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----CCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCCCCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112222 36789999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=388.20 Aligned_cols=245 Identities=24% Similarity=0.293 Sum_probs=194.0
Q ss_pred HhcccccccccCcceEEEEEec----CCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD----DERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~----~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
.|.+.+.||+|+||.||+++.. .++.||||.++... ....++.+|++++++++|||||++++++.+++..++|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4778899999999999999852 46789999997432 2334688999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
||||++|+|.++|.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+...
T Consensus 105 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp ECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999964 346899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
... .......||+.|||||++.+..|+.++||||+||+||||+||+.||.... ..+ +...+..+...
T Consensus 178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----------~~~-~~~~i~~~~~~ 244 (304)
T 3ubd_A 178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-----------RKE-TMTMILKAKLG 244 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHH-HHHHHHHCCCC
T ss_pred CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC-----------HHH-HHHHHHcCCCC
Confidence 322 23345679999999999999999999999999999999999999996422 111 11222222211
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPM-----SKVVK 787 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm-----~~Vv~ 787 (804)
+....+ ..+.+|+.+||+.||++|||+ +|+++
T Consensus 245 ------~p~~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 ------MPQFLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ------CCTTSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ------CCCcCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 112223 367899999999999999984 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=380.24 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=188.3
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCC---------
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENE--------- 580 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------- 580 (804)
.|.+.+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|++++++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 3667789999999999999964 689999999974332 2356899999999999999999999987544
Q ss_pred ---eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEee
Q 038103 581 ---HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTD 657 (804)
Q Consensus 581 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 657 (804)
..++|||||++|+|.+++.... .....++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 3689999999999999997532 2234567778899999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCc-----------cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCcc
Q 038103 658 FGLSKLFKERHDT-----------KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSS 726 (804)
Q Consensus 658 fgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~ 726 (804)
||+|+.+...... ..+...||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------- 231 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------- 231 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-------
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-------
Confidence 9999977543221 1234579999999999999999999999999999999996 664210
Q ss_pred chhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HhccC
Q 038103 727 YCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK--LLTAH 792 (804)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~--~L~~~ 792 (804)
.... ........... .........+.+|+.+||+.||++|||+.|+++ .++++
T Consensus 232 ---~~~~-~~~~~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 232 ---ERVR-TLTDVRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp ---HHHH-HHHHHHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred ---HHHH-HHHHHhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 0111 11111211111 111222345678999999999999999999987 45443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=380.91 Aligned_cols=298 Identities=41% Similarity=0.719 Sum_probs=253.0
Q ss_pred CccccchHHHHHHHhcc--cccccccCcceEEEEEecCCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeee
Q 038103 500 GFKRFTYAELKRATRNF--KQEVGKGGFGSVFRGVLDDERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGF 575 (804)
Q Consensus 500 ~~~~~~~~~l~~~t~~~--~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~ 575 (804)
....+++.++...+.+| .+.||+|+||.||+|+..+++.||||++.... ....++.+|++++.+++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 45678888888777655 56799999999999998889999999997432 234578999999999999999999999
Q ss_pred EEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEE
Q 038103 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKV 655 (804)
Q Consensus 576 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 655 (804)
+......++||||+++|+|.+++.........+++..+..++.|++.||+|||+...+.|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999999876656667999999999999999999999992222999999999999999999999
Q ss_pred eecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHH
Q 038103 656 TDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV 735 (804)
Q Consensus 656 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 735 (804)
+|||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||+....... .......++
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~ 252 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND---DDVMLLDWV 252 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT---SCSBHHHHH
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc---cchhHHHHH
Confidence 99999998765555555556799999999999988999999999999999999999999964321111 123455666
Q ss_pred HHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCCCC
Q 038103 736 AKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQDE 800 (804)
Q Consensus 736 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~~~ 800 (804)
........+..+.+..+......+....+.+++.+|++.||.+|||+.+|+++|++....+..+|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~ 317 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEE 317 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhh
Confidence 66666777888888888888899999999999999999999999999999999998777666554
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=369.77 Aligned_cols=274 Identities=38% Similarity=0.636 Sum_probs=235.5
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
+.+.+.||+|+||.||+|+.++++.||||++.... ...+++.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 44567899999999999998889999999987443 34567999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC-cc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD-TK 671 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~ 671 (804)
+|.+++.........+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 999999765444456999999999999999999999998 99999999999999999999999999986543222 22
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||....+. .......+.......+.+...+++.
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-----EMVNLAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS-----SCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH-----HHHHHHHHhhhccccccHHHhcChh
Confidence 33456899999999999999999999999999999999999999753322 1234555666666777788888888
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
+......+....+.+++.+|++.||++||++.+|++.|+.+...
T Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 88888889999999999999999999999999999999876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=372.48 Aligned_cols=259 Identities=19% Similarity=0.300 Sum_probs=197.2
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEe------CCee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAE------NEHK 582 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 582 (804)
.|.+.+.||+|+||.||+|+. .+|+.||||+++..... .+.+.+|+++|++++|||||++++++.. ....
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 466778999999999999996 46899999999754332 3567899999999999999999998764 3578
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
|||||||+ |+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 135 ~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 99999996 689999964 456999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccC---CccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH
Q 038103 663 LFKERH---DTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 663 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
.+.... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.... .......+...
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~--------~~~~l~~I~~~ 278 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--------YVHQLQLIMMV 278 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS--------HHHHHHHHHHH
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC--------HHHHHHHHHHh
Confidence 764422 2334557899999999998875 46999999999999999999999996422 11111111111
Q ss_pred hhhcCccc--------------ccCCcCCC---ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 739 MEQEGLEK--------------IIDPRLND---VYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 739 ~~~~~~~~--------------~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
........ .+.+.... .........+.+|+.+||+.||++|||+.|+++
T Consensus 279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11100000 00000000 000111246789999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=364.30 Aligned_cols=194 Identities=24% Similarity=0.379 Sum_probs=166.9
Q ss_pred HhcccccccccCcceEEEEEec----CCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD----DERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~----~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.++||+|+||+||+|+.+ .++.||||++... ....++.+|++++.++ +|||||++++++.+.++.++|||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 4677889999999999999853 4678999998743 3456788999999998 69999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC-CCeEEeecCCcccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH-FEPKVTDFGLSKLFKE 666 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~~ 666 (804)
|+++|+|.+++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 101 ~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 101 YLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp CCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 999999999983 2889999999999999999999999 9999999999999877 7999999999986543
Q ss_pred cCC---------------------------ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 667 RHD---------------------------TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 667 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 211 112345799999999999875 489999999999999999999999953
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=383.39 Aligned_cols=249 Identities=20% Similarity=0.303 Sum_probs=203.9
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.|.+.++||+|+||.||+++.. +|+.||+|.+.... ...+.+.+|+++|++++|||||++++++.+....+||||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 4677889999999999999964 68999999997543 234668899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC--CCeEEeecCCcccccccC
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH--FEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kl~Dfgla~~~~~~~ 668 (804)
+|+|.++|.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 238 gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 238 GGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred CCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999964 3456899999999999999999999999 9999999999999854 89999999999977543
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......||+.|+|||++.+..|+.++||||+||+||||++|+.||.... ..+ ....+...... +
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~-----------~~~-~~~~i~~~~~~--~ 375 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----------DDE-TLRNVKSCDWN--M 375 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----------HHH-HHHHHHTTCCC--C
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----------HHH-HHHHHHhCCCC--C
Confidence 23345679999999999999999999999999999999999999996432 011 11222222111 1
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
........ ...+.+|+.+||+.||.+|||+.|+++
T Consensus 376 ~~~~~~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 DDSAFSGI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CSGGGTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111112 246789999999999999999999987
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=349.76 Aligned_cols=221 Identities=21% Similarity=0.297 Sum_probs=167.0
Q ss_pred CCCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCC----CceEEEeeCcc
Q 038103 26 IPRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGK----RSKLTLQRNGN 101 (804)
Q Consensus 26 ~~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~----~~~l~~~~~G~ 101 (804)
.++|++|++|+ ++++|+|++|+|+||||.++ ..|+ |+ +.+ |||+|||++|++++ +++|+|+.||+
T Consensus 14 ~~~l~~g~~l~---~~~~l~S~~g~F~lgf~~~~--~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~ 82 (276)
T 3m7h_A 14 TSVLPAYQTLS---AGQYLLSPNQRFKLLLQGDG--NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQ 82 (276)
T ss_dssp SSEECTTEEBC---TTCEEECTTSSEEEEECTTS--CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEEES
T ss_pred CCEecCCCEec---CCCEEEcCCCcEEEEEECCC--CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCCCc
Confidence 48899999997 47999999999999999433 4455 76 677 99999999999875 78999999999
Q ss_pred EEE--eCCCCCeEEEecccC------CcceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcc----cCCCCeEEec
Q 038103 102 LAL--TDKDSSVVWSTNTFT------DEGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQL----LTKNTTLVSM 169 (804)
Q Consensus 102 L~l--~~~~~~~vWst~~~~------~~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~----l~~~~~L~S~ 169 (804)
|+| .|++|++||+||++. ..+++|+|+|+|||||+| +.+|||| |||||+||||| |..+++|
T Consensus 83 Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~L--- 155 (276)
T 3m7h_A 83 YGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSEL--- 155 (276)
T ss_dssp SSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEEE---
T ss_pred EEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCccc---
Confidence 999 788899999999754 346799999999999998 7899999 99999999999 7778888
Q ss_pred CCCCCCcccccEEEecCCCcceeecCCCCcccccccCCceeEEecCccccCCCcceEEeccccccccc--ceEEEeccCC
Q 038103 170 RSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNSAFTVFLNGRTPYNSSRRAYVNASGLFRSSD--TFKFNASDYG 247 (804)
Q Consensus 170 ~s~~dps~G~y~~~~~~~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 247 (804)
++.+||++|.|+++++++|.+.++..+ ...||.++.+.. .. ....++..|.+...+ ...+..+...
T Consensus 156 ~S~~dps~G~fsl~l~~dGnlvLy~~~---~~~yW~Sgt~~~--------~~-~~l~l~~dGnLvl~d~~~~~vWsS~t~ 223 (276)
T 3m7h_A 156 VQGVVYGAGASKLVFQGDGNLVAYGPN---GAATWNAGTQGK--------GA-VRAVFQGDGNLVVYGAGNAVLWHSHTG 223 (276)
T ss_dssp CTTCEEEETTEEEEECTTSCEEEECTT---SSEEEECCCTTT--------TC-CEEEECTTSCEEEECTTSCEEEECSCT
T ss_pred ccCCCCCCceEEEeecCCceEEEEeCC---CeEEEECCCCCC--------cc-EEEEEcCCCeEEEEeCCCcEEEEecCC
Confidence 568999999999999999965443332 367998765421 11 122333344322111 1111222221
Q ss_pred CcceEEEEEccCCcEEEEEEccCCCceEEeec
Q 038103 248 VGPKRRLTLDYDGILRLYSFDESTRLWKISWL 279 (804)
Q Consensus 248 ~~~~~rl~Ld~dG~l~~y~w~~~~~~W~~~w~ 279 (804)
....+|++|+.||++++|.| ...|..+|.
T Consensus 224 ~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~ 252 (276)
T 3m7h_A 224 GHASAVLRLQANGSIAILDE---KPVWARFGF 252 (276)
T ss_dssp TCTTCEEEECTTSCEEEEEE---EEEEESSSC
T ss_pred CCCCEEEEEcCCccEEEEcC---CCeEEccCc
Confidence 22358999999999999998 345665554
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=351.62 Aligned_cols=260 Identities=24% Similarity=0.419 Sum_probs=215.5
Q ss_pred HHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
...+.+.+.||+|+||.||++...++..||||+++......+++.+|++++.+++||||+++++++.+....++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 44567788999999999999999988899999998766677889999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 87 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 87 NGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999999965 3446899999999999999999999998 999999999999999999999999999876554443
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||+.... ... ......+. ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------~~~-~~~~~~~~--~~~~ 226 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-----------SEV-VLKVSQGH--RLYR 226 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-----------HHH-HHHHHTTC--CCCC
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-----------HHH-HHHHHcCC--CCCC
Confidence 3444556778999999999899999999999999999999 9999864320 111 11111111 1111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
+ .. ....+.+++.+|++.+|++|||+.++++.|+.+.+.+.
T Consensus 227 ~---~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k 267 (268)
T 3sxs_A 227 P---HL----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267 (268)
T ss_dssp C---TT----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred C---Cc----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence 1 11 12368899999999999999999999999999877543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.19 Aligned_cols=256 Identities=25% Similarity=0.474 Sum_probs=213.8
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
..+.+.+.||+|+||.||+++..+++.||+|++.......+++.+|++++++++||||+++++++.+....++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 34667789999999999999998889999999987767778899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..........
T Consensus 90 ~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 90 GCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 999999965 3446899999999999999999999999 9999999999999999999999999998765543333
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
.....+++.|+|||.+....++.++||||||+++|||++ |+.||.... ..+ ....+..+. ....+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-----------~~~-~~~~~~~~~--~~~~~ 229 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----------NSE-VVEDISTGF--RLYKP 229 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------HHH-HHHHHHTTC--CCCCC
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC-----------HHH-HHHHHhcCc--cCCCC
Confidence 444556788999999999999999999999999999999 999986432 011 111122111 01111
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.. ....+.+++..|++.+|++||++.+++++|+.+.+
T Consensus 230 ---~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 230 ---RL----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp ---TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---Cc----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11 23468899999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=355.86 Aligned_cols=269 Identities=29% Similarity=0.405 Sum_probs=200.8
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
..+.+.+.||+|+||.||+++. .++.||||++...... .+++.+|++++++++||||+++++++......++||||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 4566778999999999999987 5778999999754332 34688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 116 ~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 116 LSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred CCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 99999999997531 1234899999999999999999999987 349999999999999999999999999998654322
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ... ..........
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~---~~~~~~~~~~---- 257 (309)
T 3p86_A 194 -LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQV---VAAVGFKCKR---- 257 (309)
T ss_dssp ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------HHH---HHHHHHSCCC----
T ss_pred -cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHH---HHHHHhcCCC----
Confidence 223345689999999999999999999999999999999999999964321 111 1111111111
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCC
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQDESISD 804 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~~~~~~~ 804 (804)
..+.... ...+.+|+.+||+.+|.+||++.+|++.|+.+.....|+.+.+|
T Consensus 258 -~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~~~ 308 (309)
T 3p86_A 258 -LEIPRNL----NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308 (309)
T ss_dssp -CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----------
T ss_pred -CCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCccc
Confidence 1111222 24688999999999999999999999999998887777665543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=379.57 Aligned_cols=263 Identities=24% Similarity=0.381 Sum_probs=217.5
Q ss_pred HHHHHhcccccccccCcceEEEEEecC-CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
+....+.+.++||+|+||.||+|+... ++.||||.++......++|.+|+.++++++||||++++++|......++|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 334556778899999999999999765 7899999998766677889999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 297 ~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999753 3356899999999999999999999998 999999999999999999999999999976544
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.........++..|+|||.+....++.++||||||++||||++ |+.||..... ..+. +.+..+.
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--------~~~~----~~~~~~~--- 436 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVY----ELLEKDY--- 436 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHH----HHHHTTC---
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--------HHHH----HHHHcCC---
Confidence 3333334556788999999999999999999999999999999 9999864321 1111 1122111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
....+......+.+|+.+||+.+|++||++.+|+++|+.+.....
T Consensus 437 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~ 481 (495)
T 1opk_A 437 ------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481 (495)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSC
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccc
Confidence 111122233578899999999999999999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=358.07 Aligned_cols=268 Identities=24% Similarity=0.350 Sum_probs=207.5
Q ss_pred HhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCC----eeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENE----HKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~ 588 (804)
.+.+.+.||+|+||.||+|+.. ++.||||++.........+..|+.++.+++||||+++++++.... ..++||||
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred hchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 4556788999999999999976 688999999755444556677999999999999999999998754 46999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh----------CCCcEEecccccCeEEEcCCCCeEEeec
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE----------CLEWVLHCDVKPQNILLDDHFEPKVTDF 658 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~----------~~~~ivH~Dlkp~NILl~~~~~~kl~Df 658 (804)
+++|+|.+++.. ..+++..+..++.|+++||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 104 ~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 104 HEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccC
Confidence 999999999964 3489999999999999999999998 6 999999999999999999999999
Q ss_pred CCcccccccCC-ccccccccCCCccchhhhccC-----CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccc-----
Q 038103 659 GLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNL-----KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSY----- 727 (804)
Q Consensus 659 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~----- 727 (804)
|+++....... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||............
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 99987654332 223346789999999999863 4567899999999999999999999753321110000
Q ss_pred hhhHHHHHHHHhhhcCcccccCCcCCCc-cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 728 CNHLVQWVAKQMEQEGLEKIIDPRLNDV-YDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
...... .......... .+.+... ........+.+|+.+||+.||++|||+.+|+++|+.+.+
T Consensus 256 ~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 256 HPSLED-MQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SCCHHH-HHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCchhh-hhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 001111 1111111111 2222221 123456679999999999999999999999999987653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=353.87 Aligned_cols=257 Identities=24% Similarity=0.395 Sum_probs=206.9
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.+.+.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|++++++++||||+++++++.++...++||||++
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 4566788999999999999965 58899999986432 345678999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 91 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 91 GGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999976 2456899999999999999999999999 999999999999999999999999999876443221
Q ss_pred c-------------ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHH
Q 038103 671 K-------------FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAK 737 (804)
Q Consensus 671 ~-------------~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (804)
. .....||+.|+|||.+.+..++.++||||||+++|||++|..|+........... .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~--~~~~~~~~~ 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG--LNVRGFLDR 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS--BCHHHHHHH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh--hhhhccccc
Confidence 1 1145689999999999999999999999999999999999999865332221111 111111100
Q ss_pred HhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 738 QMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 738 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
..... ....+.+|+.+|++.||++||++.++++.|+.+..
T Consensus 243 -------------~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 243 -------------YCPPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp -------------TCCTT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------cCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00111 12358899999999999999999999999987653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=344.28 Aligned_cols=281 Identities=37% Similarity=0.638 Sum_probs=226.5
Q ss_pred CccccchHHHHHHHhcccc--------cccccCcceEEEEEecCCcEEEEEEecCcC-----CChHHHHHHHHHHhcCCC
Q 038103 500 GFKRFTYAELKRATRNFKQ--------EVGKGGFGSVFRGVLDDERVVAVKRLEGVL-----QGDAEFWAEVSIIGRINH 566 (804)
Q Consensus 500 ~~~~~~~~~l~~~t~~~~~--------~LG~G~fg~Vykg~~~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~H 566 (804)
....|++.++.+++.+|.+ .||+|+||.||+|.. +++.||||++.... ...+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 4578999999999999874 499999999999997 57789999987422 124678999999999999
Q ss_pred CcccceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEE
Q 038103 567 RNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNIL 646 (804)
Q Consensus 567 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIL 646 (804)
|||+++++++.+....++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 999999999999999999999999999999996432 2346899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeecCCcccccccCCc-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCc
Q 038103 647 LDDHFEPKVTDFGLSKLFKERHDT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDS 725 (804)
Q Consensus 647 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~ 725 (804)
++.++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.......
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--- 241 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--- 241 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS---
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH---
Confidence 999999999999999876543322 2334568999999998865 58999999999999999999999997533111
Q ss_pred cchhhHHHHHHHHh-hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 726 SYCNHLVQWVAKQM-EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 726 ~~~~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
....+ ..... ....+...+++.+. ..+......+.+++.+|++.+|.+||++.+|+++|+.+..
T Consensus 242 -~~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 242 -LLLDI---KEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp -BTTHH---HHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred -HHHHH---HHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11111 11111 12223444555443 3456677889999999999999999999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.30 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=211.6
Q ss_pred HHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
...+.+.+.||+|+||.||++...+++.||||+++......+++.+|++++.+++|+||+++++++.+....++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 34566778999999999999999999899999998776677889999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 103 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 103 NGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 9999999965 2456899999999999999999999998 999999999999999999999999999876554333
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......+|+.|+|||.+....++.++||||||+++|||++ |+.||..... .. ....+..+. .
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-----------~~-~~~~~~~~~-----~ 239 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------SE-TAEHIAQGL-----R 239 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----------HH-HHHHHHTTC-----C
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-----------hH-HHHHHhccc-----C
Confidence 3344556788999999999999999999999999999998 9999864320 11 111122111 0
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
...... ....+.+|+.+|++.+|.+||++.++++.|+.+.+.
T Consensus 240 ~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 240 LYRPHL----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCc----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 111111 124688999999999999999999999999876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=376.02 Aligned_cols=261 Identities=22% Similarity=0.389 Sum_probs=214.0
Q ss_pred HHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+....+.+.+.||+|+||.||+|...+++.||||+++......++|.+|+.++++++||||+++++++. ....++||||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 334556778899999999999999988899999999876667789999999999999999999999986 5678999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 264 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 264 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 9999999999642 2235888999999999999999999998 9999999999999999999999999998765432
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
........++..|+|||.+....++.++||||||++||||++ |+.||.... ...+ ...+..+...
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--------~~~~----~~~i~~~~~~-- 404 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEV----IRALERGYRM-- 404 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHH----HHHHHHTCCC--
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--------HHHH----HHHHHcCCCC--
Confidence 222333456788999999999999999999999999999999 999986432 1111 1222222111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
..+......+.+|+.+||+.||++|||+.+|+++|+.+....
T Consensus 405 -------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 405 -------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 011123347889999999999999999999999999986643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=361.90 Aligned_cols=262 Identities=21% Similarity=0.346 Sum_probs=210.4
Q ss_pred HHhcccccccccCcceEEEEEec--------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEEeCC
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD--------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCAENE 580 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~--------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 580 (804)
..+.+.+.||+|+||.||+|+.. ++..||||+++.... ..+++.+|+.+++++ +||||++++++|.+..
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 45667789999999999999852 356799999975432 335789999999999 8999999999999999
Q ss_pred eeEEEEeeccCCChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD 648 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~ 648 (804)
..++||||+++|+|.+++..... ....+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEEC
Confidence 99999999999999999976421 1245889999999999999999999998 99999999999999
Q ss_pred CCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCcc
Q 038103 649 DHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSS 726 (804)
Q Consensus 649 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~ 726 (804)
.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~------ 311 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------ 311 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 999999999999987654322 22334456889999999999999999999999999999999 9999864321
Q ss_pred chhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 727 YCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
..+. ..+..+... ..+......+.+|+.+||+.+|.+||++.++++.|+.+.....
T Consensus 312 --~~~~----~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 312 --EELF----KLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp --GGHH----HHHHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred --HHHH----HHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1111 122222111 1112233468899999999999999999999999988765433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.30 Aligned_cols=260 Identities=23% Similarity=0.311 Sum_probs=210.5
Q ss_pred ccccchHHHHHHHhc------------ccccccccCcceEEEEEec-CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCC
Q 038103 501 FKRFTYAELKRATRN------------FKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINH 566 (804)
Q Consensus 501 ~~~~~~~~l~~~t~~------------~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H 566 (804)
...+++++++.++.. +.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 356888888887753 3457999999999999976 68999999997433 445778999999999999
Q ss_pred CcccceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEE
Q 038103 567 RNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNIL 646 (804)
Q Consensus 567 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIL 646 (804)
|||+++++++......++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEE
Confidence 9999999999999999999999999999999853 35899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCcc
Q 038103 647 LDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSS 726 (804)
Q Consensus 647 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~ 726 (804)
++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~------- 245 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS------- 245 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------
Confidence 99999999999999987654322 2334578999999999999999999999999999999999999996422
Q ss_pred chhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 727 YCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
... ....+.... .+.+.. .......+.+++.+||+.||++||++.++++.
T Consensus 246 ----~~~-~~~~~~~~~-----~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 246 ----PVQ-AMKRLRDSP-----PPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ----HHH-HHHHHHHSS-----CCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----HHH-HHHHHhcCC-----CCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011 111122111 111111 11122468899999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=358.06 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=207.9
Q ss_pred HHHHhcccccccccCcceEEEEEec----CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLD----DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
....+.+.+.||+|+||.||+|+.. .+..||||+++... ...+++.+|+.++++++||||+++++++.++...+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3455667788999999999999974 35579999998532 23467899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 127 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999965 3346899999999999999999999998 99999999999999999999999999997
Q ss_pred ccccCCc--cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 664 FKERHDT--KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 664 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. +...+.
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~----~~~~~~ 268 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RD----VISSVE 268 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HH----HHHHHH
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HH----HHHHHH
Confidence 6553322 2223445778999999999999999999999999999999 9999864320 11 112222
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
.+... ..+......+.+|+..||+.||.+||++.+|+++|+.+....
T Consensus 269 ~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 269 EGYRL---------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred cCCCC---------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 21110 111123347889999999999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=373.21 Aligned_cols=262 Identities=26% Similarity=0.398 Sum_probs=208.8
Q ss_pred HHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
....+.+.++||+|+||.||+|...++..||||+++......++|.+|++++++++||||+++++++.+ ...++||||+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 344566778999999999999999888889999998666667889999999999999999999999876 6789999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++|+|.+++... .+..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 261 ~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 261 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred cCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 999999999642 2345899999999999999999999998 99999999999999999999999999997654433
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......++..|+|||.+....++.++||||||+++|||++ |+.||..... .. +...+..+..
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~----~~~~i~~~~~---- 399 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------RE----VLDQVERGYR---- 399 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HH----HHHHHHTTCC----
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HH----HHHHHHcCCC----
Confidence 33334556789999999999999999999999999999999 9999864320 11 1222222211
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCC
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQ 798 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~ 798 (804)
...+......+.+|+.+||+.+|++|||+.+|+++|+.+.....+
T Consensus 400 -----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 400 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 111122345788999999999999999999999999998765444
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=370.63 Aligned_cols=246 Identities=22% Similarity=0.329 Sum_probs=195.5
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHH---HHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWA---EVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~---E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
.|.+.+.||+|+||.||+++.. +|+.||||++.+. ........+ ++.++..++|||||++++++.+.+.+||
T Consensus 190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 3567788999999999999965 5899999999632 223333333 4667778899999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||+++|+|..+|.. ...+++.....++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.+
T Consensus 270 VmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999964 345899999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
.... .....||+.|||||++.. ..|+.++||||+||+||||++|+.||...... .... +........
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--------~~~~-i~~~i~~~~ 410 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--------DKHE-IDRMTLTMA 410 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--------CHHH-HHHHHHHCC
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHH-HHHhhcCCC
Confidence 5432 334689999999999964 57999999999999999999999999643211 0111 111111111
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPP-----MSKVVK 787 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~~Vv~ 787 (804)
+ .+...++ ..+.+|+.+||+.||.+|++ +.||.+
T Consensus 411 ~------~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 V------ELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp C------CCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred C------CCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1 1112223 36789999999999999998 577753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=340.80 Aligned_cols=247 Identities=19% Similarity=0.288 Sum_probs=203.1
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCc-CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV-LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.|.+.+.||+|+||.||++.. .+++.||||++... ....+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 466678899999999999995 56889999999743 3456678999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 101 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp TCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999964 24889999999999999999999998 99999999999999999999999999987654332
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ...........+. ....
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----------~~~~~~~~~~~~~-~~~~-- 237 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-----------PLRALYLIATNGT-PELQ-- 237 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----------HHHHHHHHHHHCS-CCCS--
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----------HHHHHHHHHhCCC-CCCC--
Confidence 2344678999999999999999999999999999999999999996422 0111111111111 1110
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+......+.+|+.+||+.||++|||+.++++
T Consensus 238 -----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 -----NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -----CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11122346889999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=365.81 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=196.4
Q ss_pred HHHhcccccccccCcceEEEEEec----CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD----DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~----~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
...+.+.+.||+|+||.||+|+.. ++..||||+++.... ..+++.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 345667788999999999999965 577899999974322 34578999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999975 3456899999999999999999999998 999999999999999999999999999976
Q ss_pred cccCCcc--ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 665 KERHDTK--FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 665 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
....... .....++..|+|||.+....++.++||||||+++|||++ |+.||.... ...+ ...+..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--------~~~~----~~~i~~ 265 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--------NQDV----IKAVDE 265 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--------HHHH----HHHHHT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--------HHHH----HHHHHc
Confidence 5533221 122335778999999999999999999999999999998 999986432 0111 111111
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
+. ....+......+.+|+.+|++.+|.+||++.+|+++|+.+..
T Consensus 266 ~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 266 GY---------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp TE---------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC---------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 10 011112234578999999999999999999999999987654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=343.92 Aligned_cols=267 Identities=25% Similarity=0.363 Sum_probs=210.5
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC----hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG----DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
..|.+.+.||+|+||.||+++.. +++.||+|.+...... .+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 35667789999999999999964 6889999998643322 256889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 91 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 91 EYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999964 245899999999999999999999998 99999999999999999999999999997765
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
..........||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ............ ...
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-----------~~~~~~~~~~~~-~~~ 231 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET-----------AVSIAIKHIQDS-VPN 231 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC-----------HHHHHHHHHSSC-CCC
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-----------hHHHHHHHhhcc-CCC
Confidence 44444455678999999999999999999999999999999999999996432 111111111111 111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhccCCCCCCCCCCC
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-PMSKVVKLLTAHDHESSQDESI 802 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-tm~~Vv~~L~~~~~~~~~~~~~ 802 (804)
. ...........+.+++.+|++.||.+|| +++++.+.|+.+.......|..
T Consensus 232 ~-----~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~ 283 (294)
T 4eqm_A 232 V-----TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDV 283 (294)
T ss_dssp H-----HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCCC
T ss_pred c-----chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcch
Confidence 0 0011112234788999999999999998 9999999999988887777654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=343.44 Aligned_cols=259 Identities=23% Similarity=0.351 Sum_probs=199.3
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhc--CCCCcccceeeeEEeC----CeeEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGR--INHRNLVKLQGFCAEN----EHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~lV 585 (804)
..+.+.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++... ...++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 4566778999999999999997 6788999998643 34555666666665 7999999999997643 468999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHH--------hhCCCcEEecccccCeEEEcCCCCeEEee
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH--------EECLEWVLHCDVKPQNILLDDHFEPKVTD 657 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 657 (804)
|||+++|+|.+++.. ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 85 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 85 THYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp ECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred hhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 999999999999943 45899999999999999999999 666 99999999999999999999999
Q ss_pred cCCcccccccCCcc---ccccccCCCccchhhhccC------CCCcccchHHHHHHHHHHHhC----------CCCCccc
Q 038103 658 FGLSKLFKERHDTK---FSRVRGTRGYLAPEWMMNL------KIDAKADVYSYGIVLLELLTG----------KSASDYL 718 (804)
Q Consensus 658 fgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~k~DV~S~Gvll~el~tg----------~~p~~~~ 718 (804)
||+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99998765433221 2334789999999999876 455799999999999999999 6666432
Q ss_pred ccccCCccchhhHHHHHHHHhhhcCcccccCCcCC-CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 719 SASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLN-DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
..... .... ......... ..+.+. ...+......+.+|+.+||+.||++|||+.+|+++|+.+
T Consensus 237 ~~~~~------~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDP------SFED-MRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSC------CHHH-HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCc------chhh-hhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 21111 1111 111111111 111111 122345677899999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=362.96 Aligned_cols=256 Identities=26% Similarity=0.413 Sum_probs=206.8
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
...+.+.+.||+|+||.||+|+.. +++.||||.++.... ..+++.+|++++++++||||+++++++......++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 345667789999999999999976 688999999874322 22468899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|.+++.. .+..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999965 3446899999999999999999999999 999999999999999999999999999864432
Q ss_pred CCcc-ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 668 HDTK-FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 668 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
.... .....++..|+|||.+....++.++||||||+++|||++ |+.||..... .. +...+..+...
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~----~~~~~~~~~~~ 334 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQ----TREFVEKGGRL 334 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HH----HHHHHHTTCCC
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HH----HHHHHHcCCCC
Confidence 2111 112235678999999999899999999999999999999 9999864320 11 12222222111
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
..+......+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 335 ---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 335 ---------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111122346889999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=340.30 Aligned_cols=256 Identities=24% Similarity=0.430 Sum_probs=212.3
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
..+.+.+.||+|+||.||++...+++.||+|++.......+++.+|++++.+++||||+++++++.+....++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 34567788999999999999998888999999987666778899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.+++.. ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 88 ~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 88 GCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 999999975 3346899999999999999999999998 9999999999999999999999999998765433233
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
.....++..|+|||.+....++.++||||||+++|||++ |+.||.... ..+ ....+..+.. .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----------~~~-~~~~i~~~~~-----~ 224 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----------NSE-VVEDISTGFR-----L 224 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------HHH-HHHHHHTTCC-----C
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC-----------HHH-HHHHHhcCCc-----C
Confidence 334556788999999998899999999999999999999 899986422 111 1112222111 0
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.... .....+.+++.+|++.+|++||++.++++.|+.+.+
T Consensus 225 ~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPR----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCc----cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0111 123468899999999999999999999999987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.09 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=215.5
Q ss_pred HHHHHhcccccccccCcceEEEEEecC-CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
+....+.+.+.||+|+||.||+|.... ++.||||.+.......+++.+|++++++++||||+++++++......++|||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 445567778899999999999999764 7889999998666666789999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++... ....+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999763 3456899999999999999999999999 999999999999999999999999999977655
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... .+....
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--------~~~~~----~~~~~~--- 229 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYE----LLEKDY--- 229 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHHH----HHHTTC---
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH----HHhccC---
Confidence 4444445567889999999999999999999999999999999 9999864321 11111 111111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
... .+......+.+|+.+|++.||.+||++.+|+++|+.+..
T Consensus 230 --~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 230 --RME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp --CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCC----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 111 111223478899999999999999999999999987654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=348.25 Aligned_cols=270 Identities=25% Similarity=0.373 Sum_probs=205.5
Q ss_pred HHHHhcccccccccCcceEEEEEe-----cCCcEEEEEEecCcCC-ChHHHHHHHHHHhcCCCCcccceeeeEEeC--Ce
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVL-----DDERVVAVKRLEGVLQ-GDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EH 581 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~-----~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~ 581 (804)
....+.+.+.||+|+||.||++++ .+++.||||++..... ..+++.+|++++.+++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 345677788999999999999984 3578999999974432 346789999999999999999999998653 56
Q ss_pred eEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCc
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 661 (804)
.++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp CEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred eEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 8999999999999999976 3445899999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCC--ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCccccccc----CCccchhhHHHHH
Q 038103 662 KLFKERHD--TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASA----SDSSYCNHLVQWV 735 (804)
Q Consensus 662 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~ 735 (804)
........ .......++..|+|||.+.+..++.++||||||+++|||++|..|+....... ............+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 97654322 22233456778999999999999999999999999999999999986432100 0001111111122
Q ss_pred HHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 736 AKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 736 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
......+... ..+......+.+|+.+||+.||++|||+.+|+++|+.+.+
T Consensus 242 ~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 242 IELLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhccCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 2222222111 1122233578899999999999999999999999987643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=337.41 Aligned_cols=251 Identities=27% Similarity=0.437 Sum_probs=193.9
Q ss_pred HhcccccccccCcceEEEEEecCCcEEEEEEecCcC-----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVL-----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||++... ++.||||+++... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 4566789999999999999975 7889999987432 224678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC--------CCCeEEeecC
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD--------HFEPKVTDFG 659 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~--------~~~~kl~Dfg 659 (804)
|+++++|.+++. ...+++..+..++.|+++||+|||+++..+|+||||||+|||++. ++.+||+|||
T Consensus 87 ~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 87 FARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp CCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred cCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999994 346899999999999999999999988656899999999999986 6789999999
Q ss_pred CcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 660 LSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 660 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
++........ ....|++.|+|||.+.+..++.++||||||++++||++|+.||..... ... ....
T Consensus 162 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~-~~~~ 226 (271)
T 3dtc_A 162 LAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-----------LAV-AYGV 226 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-----------HHH-HHHH
T ss_pred cccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHH-HHhh
Confidence 9986544322 234689999999999999999999999999999999999999964320 011 1111
Q ss_pred hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
....... . .+......+.+++.+|++.+|.+||++.+++++|+.+
T Consensus 227 ~~~~~~~----~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 AMNKLAL----P----IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HTSCCCC----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hcCCCCC----C----CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111111 1 1122234688999999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=375.87 Aligned_cols=263 Identities=26% Similarity=0.400 Sum_probs=214.9
Q ss_pred HHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+....+.+.++||+|+||.||+|...++..||||+++......++|.+|++++++++|+||+++++++.+ ...++||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 3445567788999999999999999888889999998666667889999999999999999999999876 678999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.++|... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 343 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 9999999999642 2245899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
........++..|+|||.+....++.++||||||++||||++ |+.||.... ... +...+..+...
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--------~~~----~~~~i~~~~~~-- 483 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NRE----VLDQVERGYRM-- 483 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--------HHH----HHHHHHTTCCC--
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHH----HHHHHHcCCCC--
Confidence 222233456788999999999999999999999999999999 999986432 011 12222222111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCC
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQ 798 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~ 798 (804)
..+......+.+|+.+||+.||++||++.+|+++|+.+.....+
T Consensus 484 -------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 484 -------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 11122334788999999999999999999999999998765443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=360.79 Aligned_cols=252 Identities=26% Similarity=0.374 Sum_probs=204.7
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCC-eeEEEEeecc
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENE-HKLLVYEYVE 590 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~ 590 (804)
..+.+.+.||+|+||.||+|... ++.||||+++... ..++|.+|++++++++||||+++++++.+.. ..++||||++
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 34566788999999999999986 6789999998543 5678999999999999999999999988765 7899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 271 ~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 271 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp TCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 99999999753 2334789999999999999999999998 9999999999999999999999999998543321
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ...+..+...
T Consensus 344 --~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~----~~~i~~~~~~---- 405 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDV----VPRVEKGYKM---- 405 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT--------TTH----HHHHHTTCCC----
T ss_pred --cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH----HHHHHcCCCC----
Confidence 22356889999999999999999999999999999999 9999865321 111 1222222111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
..+......+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus 406 -----~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 -----DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11122335788999999999999999999999999876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=341.45 Aligned_cols=245 Identities=24% Similarity=0.340 Sum_probs=202.3
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
.|.+.+.||+|+||.||+|+. .+++.||||++...... .+.+.+|++++++++||||+++++++......++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 456678899999999999996 57899999999754332 35688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 96 ASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp CTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 999999999964 245899999999999999999999998 999999999999999999999999999866443
Q ss_pred CccccccccCCCccchhhhccCCCC-cccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKID-AKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.......||+.|+|||.+.+..+. .++||||||+++|||++|+.||.... ... ....+..+...
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----------~~~-~~~~i~~~~~~-- 232 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----------LKE-LRERVLRGKYR-- 232 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHH-HHHHHHHCCCC--
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----------HHH-HHHHHHhCCCC--
Confidence 233456799999999999988875 79999999999999999999996432 111 12222222211
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+... ....+.+|+.+|++.||.+|||++++++.
T Consensus 233 ----~p~~----~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 ----IPFY----MSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CCTT----SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCC----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111 22367899999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=338.53 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=210.0
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
.++.+.+.||+|+||.||+|...+++.||||.+.......+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 91 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence 4567788999999999999999888899999998766677889999999999999999999999864 568999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++..........
T Consensus 92 ~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 92 GSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp CBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 9999999542 1235899999999999999999999998 9999999999999999999999999999776543333
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
.....++..|+|||.+....++.++||||||++++||++ |+.||.... .... ...+..+.. .
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~----~~~~~~~~~-----~ 229 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEV----IQNLERGYR-----M 229 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHH----HHHHHTTCC-----C
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--------HHHH----HHHHhcccC-----C
Confidence 344557889999999998899999999999999999999 899986422 0111 112222111 1
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.... .....+.+|+.+|++.+|++||++.+++++|+.+..
T Consensus 230 ~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 230 VRPD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcc----cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 1111 223478899999999999999999999999987643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=350.36 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=199.1
Q ss_pred HHhcccccccccCcceEEEEEec-CCc----EEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DER----VVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
..+.+.+.||+|+||.||+|+.. +++ .||+|.+... ....+++.+|+.++++++||||++++++|.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 45667789999999999999954 343 4688888632 245578999999999999999999999998754 789
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
|+||+.+|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999976 3456899999999999999999999998 999999999999999999999999999876
Q ss_pred cccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 665 KERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 665 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
..... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+ ...+..+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~----~~~~~~~ 235 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEI----SSILEKG 235 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGH----HHHHHTT
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--------HHH----HHHHHcC
Confidence 54332 22233456889999999999999999999999999999999 9999975321 111 1112211
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
... ..+......+.+|+.+||+.+|.+||++.+|++.|+.+.
T Consensus 236 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 236 ERL---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp CCC---------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred CCC---------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111 111223346889999999999999999999999997654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=356.88 Aligned_cols=263 Identities=23% Similarity=0.334 Sum_probs=211.7
Q ss_pred HHHHHhcccccccccCcceEEEEEec--------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEE
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLD--------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCA 577 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~--------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 577 (804)
+....+.+.+.||+|+||.||+|+.. .+..||||+++.... ..+++.+|++++.++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34456777889999999999999852 246799999975432 236788999999999 9999999999999
Q ss_pred eCCeeEEEEeeccCCChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeE
Q 038103 578 ENEHKLLVYEYVENGSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNI 645 (804)
Q Consensus 578 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 645 (804)
.....++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 99999999999999999999976431 1245899999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccC
Q 038103 646 LLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASAS 723 (804)
Q Consensus 646 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~ 723 (804)
|++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||++++||++ |+.||....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---- 298 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 298 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----
Confidence 999999999999999987654322 23334557889999999999999999999999999999999 999986432
Q ss_pred CccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 724 DSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
...+...+..+.... .... ....+.+|+.+||+.+|++||++.+|++.|+.+...
T Consensus 299 --------~~~~~~~~~~~~~~~-----~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 299 --------VEELFKLLKEGHRMD-----KPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp --------HHHHHHHHHTTCCCC-----CCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHHHHHHHHcCCCCC-----CCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111122222221111 1112 234688999999999999999999999999877544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.41 Aligned_cols=249 Identities=18% Similarity=0.280 Sum_probs=203.5
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
.|.+.+.||+|+||.||+++.. +++.+|+|.+.........+.+|+.++.+++||||+++++++.+....++||||+++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 4667789999999999999965 578999999985544556788999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC--CCCeEEeecCCcccccccCC
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD--HFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~ 669 (804)
++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++.......
T Consensus 86 ~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 86 LDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 999999964 3346899999999999999999999998 999999999999987 7899999999998765432
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .... ...+..+...
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~----~~~i~~~~~~---- 221 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQI----IENIMNAEYT---- 221 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHH----HHHHHHTCCC----
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--------HHHH----HHHHHcCCCC----
Confidence 2344568999999999999889999999999999999999999996422 1111 1111111111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
............+.+|+.+|++.||.+|||+.|+++
T Consensus 222 --~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 --FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000000112346889999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.95 Aligned_cols=262 Identities=23% Similarity=0.386 Sum_probs=209.2
Q ss_pred HHhcccccccccCcceEEEEEec------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
..+.+.+.||+|+||.||+++.. +++.||||.++.... ..+++.+|+.++++++||||+++++++.+....+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 45667788999999999999974 347899999974332 2457899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCCC--------------------CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccC
Q 038103 584 LVYEYVENGSLDKLLFNDPGT--------------------ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQ 643 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 643 (804)
+||||+++++|.+++...... ...+++..++.++.||++||+|||+++ |+||||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~ 203 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATR 203 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcc
Confidence 999999999999999763211 256899999999999999999999998 999999999
Q ss_pred eEEEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccc
Q 038103 644 NILLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSAS 721 (804)
Q Consensus 644 NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~ 721 (804)
|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-- 281 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-- 281 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC--
Confidence 99999999999999999987644322 22334567889999999999999999999999999999999 999986422
Q ss_pred cCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 722 ASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
. ......+..+..... .. .....+.+|+.+||+.+|++||++.+|+++|+.+.+...
T Consensus 282 ------~----~~~~~~~~~~~~~~~-----~~----~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 282 ------H----EEVIYYVRDGNILAC-----PE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp ------H----HHHHHHHHTTCCCCC-----CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred ------h----HHHHHHHhCCCcCCC-----CC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 0 111222233222111 11 223468899999999999999999999999999876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=342.93 Aligned_cols=260 Identities=25% Similarity=0.392 Sum_probs=208.3
Q ss_pred HHHhcccccccccCcceEEEEEe------cCCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
...+.+.+.||+|+||.||++.. .+++.||||++..... ..+++.+|++++++++||||+++++++.+....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 34566778899999999999985 2457899999974332 235788999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCC--------------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEeccccc
Q 038103 583 LLVYEYVENGSLDKLLFNDPG--------------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKP 642 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp 642 (804)
++||||+++++|.+++..... ....+++..++.++.||++||+|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976432 1234889999999999999999999998 99999999
Q ss_pred CeEEEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCccccc
Q 038103 643 QNILLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSA 720 (804)
Q Consensus 643 ~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~ 720 (804)
+|||++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654322 22233456788999999999899999999999999999999 9999864321
Q ss_pred ccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 721 SASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
..+ ...+..+... .. +......+.+|+.+|++.||++||++.+|++.|+.+..
T Consensus 259 --------~~~----~~~~~~~~~~-----~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 --------ERL----FNLLKTGHRM-----ER----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp --------GGH----HHHHHTTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HHH----HHHhhcCCcC-----CC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111 1222222111 11 11223468899999999999999999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=352.63 Aligned_cols=262 Identities=23% Similarity=0.355 Sum_probs=208.2
Q ss_pred HHHHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCC
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENE 580 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 580 (804)
+....+.+.+.||+|+||.||+|+.. +++.||||+++... ....++.+|+.++.+++||||+++++++....
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 33456677889999999999999953 46789999997432 23456889999999999999999999999999
Q ss_pred eeEEEEeeccCCChhhhhccCCC---CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC---CeE
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPG---TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF---EPK 654 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~k 654 (804)
..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999975321 2245899999999999999999999999 99999999999999554 599
Q ss_pred EeecCCcccccccC-CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHH
Q 038103 655 VTDFGLSKLFKERH-DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLV 732 (804)
Q Consensus 655 l~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~ 732 (804)
|+|||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ...
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--------~~~-- 294 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQE-- 294 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHH--
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHH--
Confidence 99999998654322 223334567899999999999999999999999999999998 999986432 111
Q ss_pred HHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 733 QWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
+...+..+.... .+......+.+|+.+||+.+|.+||++.+|++.|+.+.+
T Consensus 295 --~~~~i~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 295 --VLEFVTSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp --HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHcCCCCC---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 112222221111 111223468899999999999999999999999976544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=340.01 Aligned_cols=256 Identities=21% Similarity=0.327 Sum_probs=194.4
Q ss_pred HHHhcccccccccCcceEEEEEecC----CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
...+.+.+.||+|+||.||+|+... +..||+|++..... ..+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3567778899999999999999643 45799999874322 2456889999999999999999999984 567899
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999975 2346899999999999999999999998 999999999999999999999999999877
Q ss_pred cccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
............+++.|+|||.+....++.++||||||+++|||++ |+.||..... .... ..+..+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--------~~~~----~~i~~~~ 234 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVI----GRIENGE 234 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHH----HHHHTTC
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH--------HHHH----HHHHcCC
Confidence 5543333344556788999999999999999999999999999997 9999864321 1111 1122221
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
... +.. .....+.+++.+|++.||++||++.++++.|+.+.+
T Consensus 235 ~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 235 RLP-----MPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp CCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-----CCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111 111 223468899999999999999999999999987643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.95 Aligned_cols=264 Identities=23% Similarity=0.363 Sum_probs=208.0
Q ss_pred HHHHhcccccccccCcceEEEEEe------cCCcEEEEEEecCc--CCChHHHHHHHHHHhcC-CCCcccceeeeEEeCC
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGV--LQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENE 580 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~------~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 580 (804)
....+.+.+.||+|+||.||+|+. .+++.||||.+... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 345667788999999999999996 24568999999743 23456799999999999 8999999999999999
Q ss_pred eeEEEEeeccCCChhhhhccCCCC-------------------CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccc
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPGT-------------------ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVK 641 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlk 641 (804)
..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999764221 134799999999999999999999998 9999999
Q ss_pred cCeEEEcCCCCeEEeecCCcccccccCCc-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccc
Q 038103 642 PQNILLDDHFEPKVTDFGLSKLFKERHDT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLS 719 (804)
Q Consensus 642 p~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~ 719 (804)
|+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876554332 2334557889999999999999999999999999999998 999986532
Q ss_pred cccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 720 ASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
.. ..+ ......+. . .. .+......+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus 280 ~~-------~~~----~~~~~~~~-~----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 VD-------ANF----YKLIQNGF-K----MD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CS-------HHH----HHHHHTTC-C----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cH-------HHH----HHHHhcCC-C----CC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 10 111 11122211 1 11 11122346889999999999999999999999998876543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=345.28 Aligned_cols=265 Identities=15% Similarity=0.194 Sum_probs=202.7
Q ss_pred HHhcccccccccCcceEEEEEecC------CcEEEEEEecCcCC------------ChHHHHHHHHHHhcCCCCccccee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDD------ERVVAVKRLEGVLQ------------GDAEFWAEVSIIGRINHRNLVKLQ 573 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~------~~~vavK~l~~~~~------------~~~~~~~E~~~l~~l~H~niv~l~ 573 (804)
..|.+.+.||+|+||.||+|.... ++.||||++..... ....+..|+..+..++|+||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 456778899999999999999754 46899999864321 112234456667788899999999
Q ss_pred eeEEeC----CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc-
Q 038103 574 GFCAEN----EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD- 648 (804)
Q Consensus 574 g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~- 648 (804)
+++... ...++||||+ +++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 998765 4589999999 9999999975 3456999999999999999999999998 99999999999999
Q ss_pred -CCCCeEEeecCCcccccccCCc------cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccc
Q 038103 649 -DHFEPKVTDFGLSKLFKERHDT------KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSAS 721 (804)
Q Consensus 649 -~~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~ 721 (804)
.++.+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999876543221 113345999999999999999999999999999999999999999742211
Q ss_pred cCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 722 ASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.......... ....+.+++++.+... .....+.+++..|++.+|.+||++.+|+++|+.+..
T Consensus 268 -------~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 268 -------PKYVRDSKIR-YRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp -------HHHHHHHHHH-HHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred -------HHHHHHHHHH-hhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 1111111111 1122333333322211 113468899999999999999999999999977544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=332.66 Aligned_cols=270 Identities=21% Similarity=0.291 Sum_probs=209.9
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCC--eeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENE--HKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 587 (804)
.|.+.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 4567789999999999999975 48899999997432 44577889999999999999999999998765 7799999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE----cCCCCeEEeecCCccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL----DDHFEPKVTDFGLSKL 663 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfgla~~ 663 (804)
|+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 90 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 90 FCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp CCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred CCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 999999999997532 2233899999999999999999999998 9999999999999 7888899999999987
Q ss_pred ccccCCccccccccCCCccchhhhc--------cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHH
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMM--------NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV 735 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 735 (804)
..... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||....... ........+
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~ 239 (319)
T 4euu_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR----RNKEVMYKI 239 (319)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG----GCHHHHHHH
T ss_pred cCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc----hhHHHHHHH
Confidence 65432 223456899999999986 5788999999999999999999999996432111 111111111
Q ss_pred HHHhhhcCccccc-----------CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 736 AKQMEQEGLEKII-----------DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 736 ~~~~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
...........+. +..............+.+++.+||+.||++|||+.|+++.....
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1111111111100 01111234567778899999999999999999999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.24 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=198.8
Q ss_pred HhcccccccccCcceEEEEEecCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
.|.+.++||+|+||.||+++..+++.||||++...... ...+.+|++++++++||||+++++++......++||||+
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 101 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence 45667889999999999999988999999999743322 357889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++ +|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 102 EK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp SE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred CC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 85 88888865 3345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc----
Q 038103 670 TKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL---- 744 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 744 (804)
.......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+.........
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD--------DQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT--------THHHHHHHHHCCCCTTTSG
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHHHHCCCChHHhh
Confidence 22334568999999999876 56899999999999999999999999653211 111111111111100
Q ss_pred ------------ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 745 ------------EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 745 ------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
....+..............+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000110000011112346789999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=339.51 Aligned_cols=271 Identities=24% Similarity=0.341 Sum_probs=205.8
Q ss_pred cchHHHHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcC--CCCcccceeeeEEeC--
Q 038103 504 FTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI--NHRNLVKLQGFCAEN-- 579 (804)
Q Consensus 504 ~~~~~l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~-- 579 (804)
....+.....+.+.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT--EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc--ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 3344556678889999999999999999976 788999998643 234455566666554 899999999999887
Q ss_pred --CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh--------CCCcEEecccccCeEEEcC
Q 038103 580 --EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE--------CLEWVLHCDVKPQNILLDD 649 (804)
Q Consensus 580 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~--------~~~~ivH~Dlkp~NILl~~ 649 (804)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. + |+||||||+|||++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKK 177 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECT
T ss_pred CCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECC
Confidence 788999999999999999954 3589999999999999999999998 6 999999999999999
Q ss_pred CCCeEEeecCCcccccccCCc---cccccccCCCccchhhhccCCCCcc------cchHHHHHHHHHHHhC---------
Q 038103 650 HFEPKVTDFGLSKLFKERHDT---KFSRVRGTRGYLAPEWMMNLKIDAK------ADVYSYGIVLLELLTG--------- 711 (804)
Q Consensus 650 ~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~k------~DV~S~Gvll~el~tg--------- 711 (804)
++.+||+|||++......... ......||+.|+|||.+.+.....+ +||||||+++|||++|
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 999999999999866543322 1224568999999999987766665 9999999999999999
Q ss_pred -CCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCc-cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 038103 712 -KSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDV-YDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789 (804)
Q Consensus 712 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L 789 (804)
+.|+........ . ............ ..+.+... ...+....+.+|+.+||+.||.+||++.+|++.|
T Consensus 258 ~~~p~~~~~~~~~------~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 258 YQLPYHDLVPSDP------S-YEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp CCCTTTTTSCSSC------C-HHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccccHhhhcCCCC------c-hhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 445433211110 0 111111111111 12222211 1235677899999999999999999999999999
Q ss_pred ccCCCCC
Q 038103 790 TAHDHES 796 (804)
Q Consensus 790 ~~~~~~~ 796 (804)
+.+.+..
T Consensus 327 ~~l~~~~ 333 (337)
T 3mdy_A 327 AKMSESQ 333 (337)
T ss_dssp HHHHHTT
T ss_pred HHHHhhc
Confidence 8876554
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=340.77 Aligned_cols=250 Identities=27% Similarity=0.385 Sum_probs=199.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
.|.+.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 4566789999999999999965 68899999986332 23456889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 88 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 88 SGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp TTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999964 345899999999999999999999998 99999999999999999999999999987654322
Q ss_pred -ccccccccCCCccchhhhccCCC-CcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 670 -TKFSRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 670 -~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ...... +..... .
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~-----~~~~~~--~ 227 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSD-----WKEKKT--Y 227 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT------SHHHHH-----HHTTCT--T
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHH-----Hhcccc--c
Confidence 23345678999999999988775 77999999999999999999999653211 011111 111100 0
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
..+ .......+.+|+.+||+.||++|||+.|+++.
T Consensus 228 ~~~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 LNP------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp STT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCc------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000 11123467899999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.10 Aligned_cols=263 Identities=18% Similarity=0.234 Sum_probs=209.4
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeec
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
..|.+.+.||+|+||.||+|+. .+++.||||++... ...+++.+|+.++.++ +|+|++++++++.+....++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 3466778899999999999995 57899999998643 2345678899999999 7999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC-----eEEeecCCcccc
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE-----PKVTDFGLSKLF 664 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~Dfgla~~~ 664 (804)
+++|.+++... +..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 89 -~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 89 -GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred -CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99999999752 345899999999999999999999998 999999999999987766 999999999976
Q ss_pred cccCC------ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH
Q 038103 665 KERHD------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 665 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~ 236 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-----TNKQKYERIGEK 236 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-----CHHHHHHHHHHH
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc-----ccHHHHHHHHhh
Confidence 55332 1234567899999999999999999999999999999999999999753211 111111111111
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
.......... . .....+.+|+.+|++.+|++||++.+|++.|+.+....
T Consensus 237 ~~~~~~~~~~-----~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 237 KQSTPLRELC-----A----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHSCHHHHT-----T----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccCccHHHHH-----h----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 1111111110 1 12347889999999999999999999999998876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=330.54 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=193.9
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC---------------------------ChHHHHHHHHHHhcC
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---------------------------GDAEFWAEVSIIGRI 564 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---------------------------~~~~~~~E~~~l~~l 564 (804)
.|.+.+.||+|+||.||+|+.. +++.||||++..... ..+++.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 4667789999999999999964 688999999864321 125688999999999
Q ss_pred CCCcccceeeeEEe--CCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEeccccc
Q 038103 565 NHRNLVKLQGFCAE--NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKP 642 (804)
Q Consensus 565 ~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp 642 (804)
+||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 99999999999986 568899999999999988763 346899999999999999999999998 99999999
Q ss_pred CeEEEcCCCCeEEeecCCcccccccCCccccccccCCCccchhhhccCC---CCcccchHHHHHHHHHHHhCCCCCcccc
Q 038103 643 QNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK---IDAKADVYSYGIVLLELLTGKSASDYLS 719 (804)
Q Consensus 643 ~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DV~S~Gvll~el~tg~~p~~~~~ 719 (804)
+|||++.++.+||+|||++....... .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999998765432 2233457899999999997665 4788999999999999999999996421
Q ss_pred cccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 720 ASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
... ....+........ ..... ...+.+|+.+||+.||++||++.++++
T Consensus 245 -----------~~~-~~~~~~~~~~~~~----~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 -----------IMC-LHSKIKSQALEFP----DQPDI----AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -----------HHH-HHHHHHHCCCCCC----SSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----------HHH-HHHHHhcccCCCC----Ccccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 111 1122222211110 01112 246889999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=353.28 Aligned_cols=262 Identities=24% Similarity=0.390 Sum_probs=207.0
Q ss_pred HHHHhcccccccccCcceEEEEEe------cCCcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEEeCC
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCAENE 580 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 580 (804)
....+.+.+.||+|+||.||+|+. .+++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 345567788999999999999983 2467899999975332 235689999999999 7999999999998765
Q ss_pred -eeEEEEeeccCCChhhhhccCCCC-------------------------------------------------------
Q 038103 581 -HKLLVYEYVENGSLDKLLFNDPGT------------------------------------------------------- 604 (804)
Q Consensus 581 -~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------------------------- 604 (804)
..++||||+++|+|.+++......
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 489999999999999999764321
Q ss_pred -------CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC-ccccccc
Q 038103 605 -------ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD-TKFSRVR 676 (804)
Q Consensus 605 -------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~ 676 (804)
...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++........ .......
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 122889999999999999999999998 99999999999999999999999999987644322 2334456
Q ss_pred cCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCc
Q 038103 677 GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDV 755 (804)
Q Consensus 677 gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 755 (804)
+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .. +......+.... ....
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~----~~~~~~~~~~~~-----~~~~ 320 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EE----FCRRLKEGTRMR-----APDY 320 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-------HH----HHHHHHHTCCCC-----CCTT
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-------HH----HHHHHHcCCCCC-----CCCC
Confidence 7899999999999999999999999999999998 99998643210 11 122222221111 1111
Q ss_pred cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 756 YDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
. ...+.+++..|++.||.+||++.+|+++|+.+.+
T Consensus 321 ~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 321 T----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 2 2468899999999999999999999999987653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=358.00 Aligned_cols=252 Identities=20% Similarity=0.252 Sum_probs=201.3
Q ss_pred HhcccccccccCcceEEEEEecC-CcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||+++... ++.||||+++.. ....+.+.+|..++.+++||||+++++++.+....++|||
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence 45556789999999999999764 788999999642 2233458899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 155 y~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 155 YYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp CCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred cCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 9999999999975 2356899999999999999999999999 999999999999999999999999999876654
Q ss_pred CCccccccccCCCccchhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMM-----NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+......-
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKERF 300 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTHHHHC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--------hhHHHHhhhhccccc
Confidence 444445568999999999987 5678999999999999999999999996422 011111111110111
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDT--RPPMSKVVK 787 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPtm~~Vv~ 787 (804)
.+ +......+ ..+.+|+.+|++.+|++ ||+++++++
T Consensus 301 ~~-----p~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 301 QF-----PTQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CC-----CSSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cC-----CcccccCC----HHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11 11111122 36788999999888888 999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=334.60 Aligned_cols=266 Identities=25% Similarity=0.433 Sum_probs=199.2
Q ss_pred cchHHHHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCC
Q 038103 504 FTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENE 580 (804)
Q Consensus 504 ~~~~~l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 580 (804)
+...|+....+.+.+.||+|+||.||+|+..+ .||||+++..... .+.+.+|++++++++|+||+++++++ ...
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 44445666778888999999999999998654 4999999754433 35689999999999999999999965 456
Q ss_pred eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCC
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGL 660 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 660 (804)
..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred ccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEcccee
Confidence 78999999999999999965 3456899999999999999999999998 99999999999999999999999999
Q ss_pred cccccccC-CccccccccCCCccchhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHH
Q 038103 661 SKLFKERH-DTKFSRVRGTRGYLAPEWMM---NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVA 736 (804)
Q Consensus 661 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (804)
+....... ........||+.|+|||.+. ...++.++||||||+++|||++|+.||..... ...+.
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~ 235 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----------RDQII 235 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----------HHHHH
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-----------HHHHH
Confidence 98654322 23334466899999999986 66788999999999999999999999964321 11122
Q ss_pred HHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 737 KQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 737 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.....+.....+.. +... ....+.+|+.+|++.+|.+||++.+++++|+.+..
T Consensus 236 ~~~~~~~~~~~~~~-~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 236 EMVGRGSLSPDLSK-VRSN----CPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHTSCCCCTTS-SCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHhcccccCcchhh-cccc----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 22222222211111 1112 23478999999999999999999999999998765
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=338.56 Aligned_cols=250 Identities=21% Similarity=0.309 Sum_probs=197.4
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCC--------
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENE-------- 580 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 580 (804)
..|.+.+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45677889999999999999976 78999999997433 23467999999999999999999999986543
Q ss_pred -------------------------------------------------eeEEEEeeccCCChhhhhccCCCCCCCCCHH
Q 038103 581 -------------------------------------------------HKLLVYEYVENGSLDKLLFNDPGTASILQWD 611 (804)
Q Consensus 581 -------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~ 611 (804)
..++||||+++++|.+++.... .....++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhH
Confidence 3799999999999999997643 33446777
Q ss_pred hHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC-----------ccccccccCCC
Q 038103 612 QRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD-----------TKFSRVRGTRG 680 (804)
Q Consensus 612 ~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~ 680 (804)
.++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 88999999999999999998 99999999999999999999999999997655321 12234568999
Q ss_pred ccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHH
Q 038103 681 YLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREK 760 (804)
Q Consensus 681 y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 760 (804)
|+|||.+.+..++.++||||||+++|||++|..|+... .. ........... ......
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------------~~-~~~~~~~~~~~---------~~~~~~ 298 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------------VR-IITDVRNLKFP---------LLFTQK 298 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------------HH-HHHHHHTTCCC---------HHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------------HH-HHHHhhccCCC---------cccccC
Confidence 99999999999999999999999999999987664210 01 11111111111 112233
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 761 LDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 761 ~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...+.+|+.+||+.||++||++.++++.
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 4567899999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=343.66 Aligned_cols=270 Identities=24% Similarity=0.344 Sum_probs=208.2
Q ss_pred HHHHHHhcccccccccCcceEEEEEe-----cCCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeC-
Q 038103 508 ELKRATRNFKQEVGKGGFGSVFRGVL-----DDERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN- 579 (804)
Q Consensus 508 ~l~~~t~~~~~~LG~G~fg~Vykg~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~- 579 (804)
.+.+..+.+.+.||+|+||.||++++ .+++.||||++.... ...+.+.+|++++.+++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 33445577788999999999999983 468899999997432 3457899999999999999999999999876
Q ss_pred -CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeec
Q 038103 580 -EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDF 658 (804)
Q Consensus 580 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 658 (804)
...++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Df 170 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDF 170 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred CceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcc
Confidence 668999999999999999965 2345899999999999999999999998 999999999999999999999999
Q ss_pred CCcccccccCC--ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCccccccc---CCccchhhHHH
Q 038103 659 GLSKLFKERHD--TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASA---SDSSYCNHLVQ 733 (804)
Q Consensus 659 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~---~~~~~~~~~~~ 733 (804)
|++........ .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+....... ...........
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 99987655432 22334567888999999999999999999999999999999998864321000 00000011111
Q ss_pred HHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 734 WVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
........+... ..+......+.+|+.+||+.||.+|||+.+++++|+.+
T Consensus 251 ~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 251 RLVNTLKEGKRL---------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhccCCC---------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 112222221111 11122335788999999999999999999999999865
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=337.28 Aligned_cols=252 Identities=24% Similarity=0.263 Sum_probs=198.3
Q ss_pred ccchHHHHHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCCh---HHHHHHHHHHhcC-CCCcccceeeeEE
Q 038103 503 RFTYAELKRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGD---AEFWAEVSIIGRI-NHRNLVKLQGFCA 577 (804)
Q Consensus 503 ~~~~~~l~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l-~H~niv~l~g~~~ 577 (804)
.....++....+.+.++||+|+||+||+|+.. +++.||||++....... .++..|+..+.++ +|+||++++++|.
T Consensus 48 p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 48 PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp TTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 34445666778888999999999999999976 68999999987544332 3455566555555 8999999999999
Q ss_pred eCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEee
Q 038103 578 ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTD 657 (804)
Q Consensus 578 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 657 (804)
++...++||||+ +++|.+++.. .+..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~D 200 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGD 200 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECC
T ss_pred eCCEEEEEEecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEcc
Confidence 999999999999 6699998865 2346999999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHH
Q 038103 658 FGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAK 737 (804)
Q Consensus 658 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (804)
||++....... ......||+.|+|||++.+ .++.++||||||+++|||++|..++.... ...
T Consensus 201 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------------~~~ 262 (311)
T 3p1a_A 201 FGLLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------------GWQ 262 (311)
T ss_dssp CTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------------HHH
T ss_pred ceeeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------------HHH
Confidence 99998764422 2334568999999998876 79999999999999999999977664211 011
Q ss_pred HhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 738 QMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 738 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+..+.... .........+.+|+.+|++.||++|||+.++++
T Consensus 263 ~~~~~~~~~--------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 263 QLRQGYLPP--------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHTTTCCCH--------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhccCCCc--------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 122221111 111122357899999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.53 Aligned_cols=258 Identities=17% Similarity=0.202 Sum_probs=204.8
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.+.+.+.||+|+||.||+|+. .+++.||||.+.... ..+++.+|+++++++ +|+||+++++++......++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 456678899999999999995 578999999987432 234688999999999 9999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC-----eEEeecCCccccc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE-----PKVTDFGLSKLFK 665 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~Dfgla~~~~ 665 (804)
+++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.+.
T Consensus 88 ~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 88 GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 89999999752 456999999999999999999999998 999999999999998887 9999999999765
Q ss_pred ccCCc------cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 666 ERHDT------KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 666 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........+....
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~-----~~~~~~~~i~~~~ 236 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD-----TLKERYQKIGDTK 236 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS-----SHHHHHHHHHHHH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc-----cHHHHHHHHHhhh
Confidence 43221 124567999999999999999999999999999999999999999753211 1111111111111
Q ss_pred hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
........ . . ..+ .+.+++..|++.+|.+||++.+|++.|+.+.
T Consensus 237 ~~~~~~~~-~----~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 237 RATPIEVL-C----E----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHSCHHHH-T----T----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ccCCHHHH-h----c----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 11000000 0 0 012 6889999999999999999999999997543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=338.90 Aligned_cols=248 Identities=22% Similarity=0.315 Sum_probs=201.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC-------ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ-------GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
.|.+.+.||+|+||.||+++.. +++.||+|.++.... ..+++.+|+.++.+++||||+++++++.+....++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4667789999999999999965 588999999974322 24678999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC----CeEEeecCC
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF----EPKVTDFGL 660 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgl 660 (804)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 93 v~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 93 ILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999954 346899999999999999999999998 99999999999998877 799999999
Q ss_pred cccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 661 SKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 661 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .... ...+.
T Consensus 166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------~~~~----~~~i~ 231 (361)
T 2yab_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQET----LANIT 231 (361)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHH----HHHHH
T ss_pred ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHH----HHHHH
Confidence 98765432 2344679999999999999999999999999999999999999996422 0111 11111
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+... +++ .........+.+|+..||+.||.+|||+.++++
T Consensus 232 ~~~~~--~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 232 AVSYD--FDE----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TTCCC--CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCCC--CCc----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11110 000 000112346889999999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=331.74 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=203.3
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC-------ChHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ-------GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
...|.+.+.||+|+||.||+++.. +++.||||.+..... ..+++.+|+.++.+++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356778899999999999999965 588999999874321 346799999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC----CeEEeec
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF----EPKVTDF 658 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Df 658 (804)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999953 346899999999999999999999998 99999999999998887 8999999
Q ss_pred CCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH
Q 038103 659 GLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 659 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
|++....... ......||+.|+|||.+....++.++||||||+++|||++|+.||.... ..... ..
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~----~~ 228 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETL----AN 228 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHH----HH
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--------HHHHH----HH
Confidence 9998765422 2334568999999999999999999999999999999999999996422 01111 11
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+...... ............+.+|+.+||+.||++|||+.++++.
T Consensus 229 ~~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 229 VSAVNYE------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHTCCC------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhcCCC------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111110 0000001123468899999999999999999999873
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.59 Aligned_cols=255 Identities=18% Similarity=0.238 Sum_probs=204.2
Q ss_pred HHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCc------CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV------LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
....|.+.+.||+|+||.||+++.. +++.||||++... ....+++.+|+.++++++||||+++++++.+....
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3456888899999999999999964 6899999998621 12457799999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC---eEEeecC
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE---PKVTDFG 659 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Dfg 659 (804)
++||||+++++|.+++.........+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999999888653333456899999999999999999999998 999999999999986654 9999999
Q ss_pred CcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 660 LSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 660 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .. ....+
T Consensus 179 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~----~~~~i 244 (351)
T 3c0i_A 179 VAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ER----LFEGI 244 (351)
T ss_dssp TCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HH----HHHHH
T ss_pred ceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HH----HHHHH
Confidence 998765432 22334568999999999999999999999999999999999999996421 11 11112
Q ss_pred hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..+.... .+.... .....+.+|+.+||+.||++||++.++++
T Consensus 245 ~~~~~~~--~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 245 IKGKYKM--NPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHTCCCC--CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HcCCCCC--Cccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2221110 000001 12346889999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=342.85 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=209.5
Q ss_pred HHHhcccccccccCcceEEEEEe------cCCcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEEeCCe
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEH 581 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 581 (804)
...+.+.+.||+|+||.||+|+. .+++.||||+++.... ..+.+.+|+.++.++ +||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 34567788999999999999984 3467899999974432 346789999999999 99999999999999999
Q ss_pred eEEEEeeccCCChhhhhccCCC--------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE
Q 038103 582 KLLVYEYVENGSLDKLLFNDPG--------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL 647 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl 647 (804)
.++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+.+ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999976421 1235899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecCCcccccccCCc-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCc
Q 038103 648 DDHFEPKVTDFGLSKLFKERHDT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDS 725 (804)
Q Consensus 648 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~ 725 (804)
+.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 254 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---- 254 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch----
Confidence 99999999999999876554332 2233456788999999999999999999999999999999 99998643210
Q ss_pred cchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 726 SYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
..+ ....... ..... .. .....+.+|+.+|++.||.+||++.+|+++|+.+...
T Consensus 255 ---~~~----~~~~~~~-~~~~~----~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 255 ---SKF----YKMIKEG-FRMLS----PE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp ---HHH----HHHHHHT-CCCCC----CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---hHH----HHHhccC-CCCCC----cc----cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 111 1111111 11111 11 1234688999999999999999999999999876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=338.21 Aligned_cols=266 Identities=24% Similarity=0.325 Sum_probs=205.8
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCc-CCChHHHHHHHHHHhcCCCCcccceeeeEEe----CCeeEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV-LQGDAEFWAEVSIIGRINHRNLVKLQGFCAE----NEHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV 585 (804)
..|.+.+.||+|+||.||+++. .+++.||||++... ....+.+.+|++++++++||||+++++++.. ....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 3466778999999999999996 56899999998643 2345678999999999999999999999873 3478999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
+||+++++|.+++.........+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 9999999999999764334567999999999999999999999998 9999999999999999999999999988654
Q ss_pred ccCCc--------cccccccCCCccchhhhccCC---CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH
Q 038103 666 ERHDT--------KFSRVRGTRGYLAPEWMMNLK---IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 666 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
..... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||+....... .+.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~-- 257 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD------SVA-- 257 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS------CHH--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc------hhh--
Confidence 32111 112345799999999987554 68999999999999999999999864221110 011
Q ss_pred HHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCCC
Q 038103 735 VAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQD 799 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~~ 799 (804)
..... ... . .........+.+|+.+||+.||.+||++.+|++.|+.+.......
T Consensus 258 --~~~~~-~~~-~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 258 --LAVQN-QLS-I-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp --HHHHC-C---C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred --HHhhc-cCC-C-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 11111 110 0 001112346889999999999999999999999999987765544
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.46 Aligned_cols=253 Identities=32% Similarity=0.524 Sum_probs=200.6
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC--------hHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG--------DAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~--------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
..+.+.+.||+|+||.||+++. .+++.||||++...... .+++.+|++++.+++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 4566778999999999999996 46889999998643221 167899999999999999999999987655
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC-----eEEee
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE-----PKVTD 657 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~D 657 (804)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 699999999999998865 3456999999999999999999999986 34999999999999988776 99999
Q ss_pred cCCcccccccCCccccccccCCCccchhhhc--cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHH
Q 038103 658 FGLSKLFKERHDTKFSRVRGTRGYLAPEWMM--NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV 735 (804)
Q Consensus 658 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 735 (804)
||+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||...... -....
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------~~~~~ 239 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG---------KIKFI 239 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC---------HHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc---------HHHHH
Confidence 999985433 234467899999999984 456789999999999999999999999643211 01111
Q ss_pred HHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 736 AKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 736 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
......... +.+.. .....+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 240 -~~~~~~~~~----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 -NMIREEGLR----PTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -HHHHHSCCC----CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -HHHhccCCC----CCCCc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111111 11112 2234788999999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=330.60 Aligned_cols=253 Identities=20% Similarity=0.332 Sum_probs=202.7
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EHKLLVY 586 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 586 (804)
..+.+.+.||+|+||.||+|+.. ++.||||+++.... ..+++.+|+.++++++||||+++++++... ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 34667789999999999999985 78899999985432 235689999999999999999999999877 7889999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ .+|+||||||+|||++.++.+||.|||++.....
T Consensus 89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999763 2336899999999999999999999976 4489999999999999999999999988764322
Q ss_pred cCCccccccccCCCccchhhhccCCCCc---ccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDA---KADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~---k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||.... ...........+
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----------~~~~~~~~~~~~- 227 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-----------NMEIGMKVALEG- 227 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-----------HHHHHHHHHHSC-
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-----------hHHHHHHHHhcC-
Confidence 2345789999999998765544 7999999999999999999996432 111111111111
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.. +.+... ....+.+++..|++.||++|||+.++++.|+.+.+
T Consensus 228 ~~----~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 LR----PTIPPG----ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CC----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CC----CCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11 111122 23468899999999999999999999999987754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=335.32 Aligned_cols=245 Identities=22% Similarity=0.269 Sum_probs=201.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||+++.. +++.||+|+++.. ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 4566788999999999999965 5889999999742 3345678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 86 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 86 YANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp CCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999964 345889999999999999999999998 999999999999999999999999999864332
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ...+ ...+..+.+
T Consensus 159 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~----~~~i~~~~~--- 222 (337)
T 1o6l_A 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERL----FELILMEEI--- 222 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH----HHHHHHCCC---
T ss_pred C-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHH----HHHHHcCCC---
Confidence 2 22345678999999999999999999999999999999999999996422 0111 111222211
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
.+.... ...+.+|+.+||+.||++|| ++.+|++
T Consensus 223 ---~~p~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 ---RFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 111122 24688999999999999999 8999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.59 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=200.2
Q ss_pred HhcccccccccCcceEEEEEec-CCc----EEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DER----VVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
.+.+.+.||+|+||.||+|+.. +++ .||+|.+... .....++.+|+.++++++||||+++++++. +...++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 4556788999999999999964 343 3888887633 233456788999999999999999999986 5678999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
+||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999999975 3456899999999999999999999998 9999999999999999999999999999775
Q ss_pred ccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 666 ERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 666 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+ ...+..+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~----~~~~~~~~ 234 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--------AEV----PDLLEKGE 234 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--------THH----HHHHHTTC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--------HHH----HHHHHcCC
Confidence 5433 23344567889999999999999999999999999999999 9999975321 111 11222221
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.... + .. ....+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus 235 ~~~~--~---~~----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 RLAQ--P---QI----CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp BCCC--C---TT----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCC--C---Cc----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1110 1 11 12257789999999999999999999999977643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=341.48 Aligned_cols=263 Identities=25% Similarity=0.358 Sum_probs=204.5
Q ss_pred cccccccccCcceEEEEEec-----CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEEE
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-----DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN--EHKLLV 585 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 585 (804)
.+.+.||+|+||.||++.+. +++.||||+++... ...+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 67789999999999998743 57889999998543 2245689999999999999999999999874 678999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 114 ~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp ECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999964 23899999999999999999999999 9999999999999999999999999999765
Q ss_pred ccCC--ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccC---CccchhhHHHHHHHHhh
Q 038103 666 ERHD--TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASAS---DSSYCNHLVQWVAKQME 740 (804)
Q Consensus 666 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 740 (804)
.... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .................
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 5332 223345578889999999998999999999999999999999999864221000 00000000011111111
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.+ .....+......+.+|+.+||+.||.+||++.++++.|+.+.+
T Consensus 266 ~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 266 RG---------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc---------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11 1111122233578999999999999999999999999987643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=333.35 Aligned_cols=254 Identities=22% Similarity=0.359 Sum_probs=200.5
Q ss_pred HHHhcccccccccCcceEEEEEecC-C-------cEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDD-E-------RVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEH 581 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~-~-------~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 581 (804)
...+.+.+.||+|+||.||+|+... + +.||+|.+.... ...+++.+|++++++++||||+++++++.....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4456778899999999999998643 2 579999997443 345679999999999999999999999999999
Q ss_pred eEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC--------e
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE--------P 653 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~ 653 (804)
.++||||+++++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999975 3445899999999999999999999999 999999999999998887 9
Q ss_pred EEeecCCcccccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHH
Q 038103 654 KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLV 732 (804)
Q Consensus 654 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~ 732 (804)
||+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|..|+.... . ..
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~----~------~~ 225 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL----D------SQ 225 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS----C------HH
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc----c------hH
Confidence 99999999754322 23457889999999987 679999999999999999999655543211 0 00
Q ss_pred HHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 733 QWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
...........+. ... ...+.+|+.+||+.||++|||+.++++.|+.+.....
T Consensus 226 ~~~~~~~~~~~~~--------~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 226 RKLQFYEDRHQLP--------APK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HHHHHHHTTCCCC--------CCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred HHHHHhhccCCCC--------CCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 0011111111111 111 2257899999999999999999999999999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=341.28 Aligned_cols=277 Identities=22% Similarity=0.306 Sum_probs=198.9
Q ss_pred HhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHH--HhcCCCCcccceeeeEEe-----CCeeEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSI--IGRINHRNLVKLQGFCAE-----NEHKLLV 585 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~-----~~~~~lV 585 (804)
.+.+.+.||+|+||.||+|+. +++.||||++.... ..++..|.++ +..++|+||+++++.+.. ....++|
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred HhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 456678899999999999987 67889999997433 3344444444 556899999999986542 2367899
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh---------CCCcEEecccccCeEEEcCCCCeEEe
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE---------CLEWVLHCDVKPQNILLDDHFEPKVT 656 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~---------~~~~ivH~Dlkp~NILl~~~~~~kl~ 656 (804)
|||+++|+|.+++.. ...++..+..++.||++||+|||+. + |+||||||+|||++.++.+||+
T Consensus 91 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEEC
T ss_pred EecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEe
Confidence 999999999999964 2358899999999999999999998 6 9999999999999999999999
Q ss_pred ecCCcccccccC-------CccccccccCCCccchhhhcc-------CCCCcccchHHHHHHHHHHHhCCCCCccccccc
Q 038103 657 DFGLSKLFKERH-------DTKFSRVRGTRGYLAPEWMMN-------LKIDAKADVYSYGIVLLELLTGKSASDYLSASA 722 (804)
Q Consensus 657 Dfgla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~ 722 (804)
|||+++.+.... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999998765422 122234568999999999976 456679999999999999999987764322111
Q ss_pred CCccc-------hhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 723 SDSSY-------CNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 723 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
..... .... ...............+..... ........+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 243 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTF-EDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCTTHHHHCSSCCH-HHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhhhcccCCCchH-HHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 10000 0001 111111111111111111111 1234566799999999999999999999999999998877
Q ss_pred CCCCCCCC
Q 038103 796 SSQDESIS 803 (804)
Q Consensus 796 ~~~~~~~~ 803 (804)
....+.-+
T Consensus 320 ~~~~~~~~ 327 (336)
T 3g2f_A 320 WERNKSVS 327 (336)
T ss_dssp CCC-----
T ss_pred HHhcccCC
Confidence 76665543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.00 Aligned_cols=258 Identities=23% Similarity=0.398 Sum_probs=207.4
Q ss_pred HHHHHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEe-------
Q 038103 507 AELKRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAE------- 578 (804)
Q Consensus 507 ~~l~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------- 578 (804)
.......+.+.+.||+|+||.||+++.. +++.||+|++.... +.+.+|++++.+++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 3445667888899999999999999976 68999999987432 457789999999999999999998864
Q ss_pred ---------CCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC
Q 038103 579 ---------NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD 649 (804)
Q Consensus 579 ---------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~ 649 (804)
....++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+|||++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVD 157 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcC
Confidence 44679999999999999999653 2356899999999999999999999998 999999999999999
Q ss_pred CCCeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchh
Q 038103 650 HFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCN 729 (804)
Q Consensus 650 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~ 729 (804)
++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++|..|+....
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------- 225 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------- 225 (284)
T ss_dssp TTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----------
T ss_pred CCCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----------
Confidence 9999999999998765432 2234568999999999999999999999999999999999998864210
Q ss_pred hHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCCCC
Q 038103 730 HLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQDE 800 (804)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~~~ 800 (804)
. .......+. +...++ ..+.+++.+|++.||.+||++.++++.|+.+.......+
T Consensus 226 ---~-~~~~~~~~~--------~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 226 ---K-FFTDLRDGI--------ISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp ---H-HHHHHHTTC--------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred ---H-HHHHhhccc--------ccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 0 111122221 112222 357899999999999999999999999998876655443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.59 Aligned_cols=258 Identities=22% Similarity=0.333 Sum_probs=196.9
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
|.+.+.||+|+||.||+++..+++.||||++.... ...+.+.+|++++++++||||+++++++......++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 56678999999999999999889999999997432 234678899999999999999999999999999999999998
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+ +|.+++.. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 84 ~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (288)
T 1ob3_A 84 Q-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (288)
T ss_dssp E-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred C-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence 6 99998865 2345889999999999999999999998 9999999999999999999999999998654322 2
Q ss_pred cccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc----
Q 038103 671 KFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE---- 745 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 745 (804)
......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||..... ......+..........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--------ADQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHHCCCChhhchh
Confidence 22345679999999998764 589999999999999999999999964320 11111111111110000
Q ss_pred ----cccCCcCC-------CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 746 ----KIIDPRLN-------DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 746 ----~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...++... ..........+.+|+.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00011110 0011122346789999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.02 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=199.3
Q ss_pred HHhcccccccccCcceEEEEEecC-----CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDD-----ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~-----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
..+.+.+.||+|+||.||+|+... +..||||+++.... ...++.+|+.++++++||||+++++++......++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 344556789999999999998643 34699999974332 23568899999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||+++++|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 124 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999975 3356899999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCc--cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 665 KERHDT--KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 665 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
...... ......++..|+|||.+....++.++||||||+++|||++ |+.||.... ... +...+..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~----~~~~~~~ 265 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHE----VMKAIND 265 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHH----HHHHHHT
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------HHH----HHHHHHC
Confidence 543222 1223345778999999999999999999999999999999 999986422 011 1122222
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
+... ..+......+.+|+.+||+.+|++||++.+|+++|+.+...
T Consensus 266 ~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 266 GFRL---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp TCCC---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCcC---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 2110 01112234688999999999999999999999999876543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=337.14 Aligned_cols=272 Identities=25% Similarity=0.351 Sum_probs=213.0
Q ss_pred cccchHHHHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhc--CCCCcccceeeeEEeC
Q 038103 502 KRFTYAELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGR--INHRNLVKLQGFCAEN 579 (804)
Q Consensus 502 ~~~~~~~l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~ 579 (804)
..+...+.....+.+.+.||+|+||.||+|+. +++.||||++... ...++.+|++++.. ++||||+++++++...
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 34455666778899999999999999999998 4789999998642 34667888888887 7999999999999887
Q ss_pred C----eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHH--------hhCCCcEEecccccCeEEE
Q 038103 580 E----HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH--------EECLEWVLHCDVKPQNILL 647 (804)
Q Consensus 580 ~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~ivH~Dlkp~NILl 647 (804)
. ..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +.+ |+||||||+|||+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll 180 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV 180 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred CCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence 6 78999999999999999964 34899999999999999999999 666 9999999999999
Q ss_pred cCCCCeEEeecCCcccccccCCc---cccccccCCCccchhhhccCC------CCcccchHHHHHHHHHHHhC-------
Q 038103 648 DDHFEPKVTDFGLSKLFKERHDT---KFSRVRGTRGYLAPEWMMNLK------IDAKADVYSYGIVLLELLTG------- 711 (804)
Q Consensus 648 ~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~k~DV~S~Gvll~el~tg------- 711 (804)
+.++++||+|||++......... ......||+.|+|||.+.... ++.++||||||+++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 99999999999999876553322 234456899999999997652 34789999999999999999
Q ss_pred ---CCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCc-cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 712 ---KSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDV-YDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 712 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+.||........ .... ........ ...+.+... .+.+....+.+|+.+||+.||++||++.+|++
T Consensus 261 ~~~~~p~~~~~~~~~------~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDP------SVEE-MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp CCCCCTTTTTSCSSC------CHHH-HHHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCccccCcCcc------cHHH-HHHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 566643221111 1111 11222221 122222221 23466778999999999999999999999999
Q ss_pred HhccCCCC
Q 038103 788 LLTAHDHE 795 (804)
Q Consensus 788 ~L~~~~~~ 795 (804)
+|+.+.+.
T Consensus 330 ~L~~i~~~ 337 (342)
T 1b6c_B 330 TLSQLSQQ 337 (342)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHH
Confidence 99887654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.47 Aligned_cols=270 Identities=25% Similarity=0.301 Sum_probs=207.5
Q ss_pred HHhcccccccccCcceEEEEEe-----cCCcEEEEEEecCcCC-ChHHHHHHHHHHhcCCCCcccceeeeEE--eCCeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-----DDERVVAVKRLEGVLQ-GDAEFWAEVSIIGRINHRNLVKLQGFCA--ENEHKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-----~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 583 (804)
..+.+.+.||+|+||.||++++ .+++.||||++..... ..+.+.+|++++++++|+||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4566778999999999999984 4678999999975432 3456899999999999999999999987 456789
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999999965 2345899999999999999999999998 99999999999999999999999999997
Q ss_pred ccccCC--ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccC---CccchhhHHHHHHHH
Q 038103 664 FKERHD--TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASAS---DSSYCNHLVQWVAKQ 738 (804)
Q Consensus 664 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~ 738 (804)
...... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+........ ...............
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 654332 122335578889999999998999999999999999999999999864221000 000000011111122
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
...+. ....+......+.+|+.+|++.||++||++.+|+++|+.+....
T Consensus 257 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LEEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 22111 11112223457899999999999999999999999999876543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=343.28 Aligned_cols=252 Identities=23% Similarity=0.278 Sum_probs=193.8
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
..|.+.+.||+|+||.||+++.. +++.||||++.......+.+.+|+.++++++||||+++++++......++||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 35677889999999999999975 68899999998666666789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC--eEEeecCCcccccccC
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE--PKVTDFGLSKLFKERH 668 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~Dfgla~~~~~~~ 668 (804)
+|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 100 ~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 100 GGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 9999999964 345899999999999999999999999 999999999999987765 999999999853322
Q ss_pred CccccccccCCCccchhhhccCCCCcc-cchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAK-ADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k-~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.......||+.|+|||.+.+..++.+ +||||||+++|||++|+.||...... .......... ........
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~~~~~~-~~~~~~~~ 242 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------RDYRKTIQRI-LSVKYSIP 242 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-------CCHHHHHHHH-HTTCCCCC
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-------HHHHHHHHHH-hcCCCCCC
Confidence 22234568999999999988887765 89999999999999999999753211 0111111111 11111100
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+ ... ...+.+|+.+||+.||.+|||+.++++.
T Consensus 243 ~~----~~~----s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 DD----IRI----SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TT----SCC----CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred Cc----CCC----CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 011 2467899999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=329.63 Aligned_cols=264 Identities=22% Similarity=0.279 Sum_probs=197.8
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC----hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG----DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
..|.+.+.||+|+||.||+++.. +++.||||.+...... .+++.+|+.++.+++||||+++++++......++|+
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 34667789999999999999965 6889999999744322 256889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 114 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 114 RLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp ECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999964 245899999999999999999999998 99999999999999999999999999987655
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
..........+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ............ ..
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~~~~~~~-~~ 253 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ------------LSVMGAHINQAI-PR 253 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH------------HHHHHHHHHSCC-CC
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch------------HHHHHHHhccCC-CC
Confidence 44334445678999999999999999999999999999999999999996422 011112221111 10
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhccCCCCCCCCCC
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-PMSKVVKLLTAHDHESSQDES 801 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-tm~~Vv~~L~~~~~~~~~~~~ 801 (804)
. ..........+.+|+.+||+.||++|| +++++++.|+.......+++.
T Consensus 254 ~------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~~ 303 (309)
T 2h34_A 254 P------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRA 303 (309)
T ss_dssp G------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-------
T ss_pred c------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccch
Confidence 0 001111223688999999999999999 999999999988777665543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=333.56 Aligned_cols=253 Identities=26% Similarity=0.369 Sum_probs=203.9
Q ss_pred hcccc-cccccCcceEEEEEec---CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 514 RNFKQ-EVGKGGFGSVFRGVLD---DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 514 ~~~~~-~LG~G~fg~Vykg~~~---~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
+.+.+ .||+|+||.||+|+.. +++.||||+++... ...+++.+|++++.+++||||+++++++ +.+..++|||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 34444 8999999999999854 57789999998533 2346789999999999999999999999 5567899999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 90 MAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp CCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred eCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999964 3456899999999999999999999998 999999999999999999999999999976543
Q ss_pred CCc--cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 668 HDT--KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 668 ~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+ ...+..+..
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~----~~~i~~~~~ 231 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEV----MAFIEQGKR 231 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHH----HHHHHTTCC
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------HHH----HHHHhcCCc
Confidence 321 2223446889999999998899999999999999999999 9999864321 111 122222211
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
. .. +......+.+++..|++.+|++||++.+|++.|+.+..
T Consensus 232 ~-----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 232 M-----EC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp C-----CC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-----CC----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 11 12233478899999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=340.34 Aligned_cols=260 Identities=22% Similarity=0.331 Sum_probs=192.2
Q ss_pred HHHhcccccccccCcceEEEEEecCC----cEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCee-
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDDE----RVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK- 582 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~~----~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~- 582 (804)
...+.+.+.||+|+||.||+|+.... ..||||+++... ...+++.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 34577788999999999999996543 279999997432 2346789999999999999999999999877655
Q ss_pred -----EEEEeeccCCChhhhhccCC--CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEE
Q 038103 583 -----LLVYEYVENGSLDKLLFNDP--GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKV 655 (804)
Q Consensus 583 -----~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 655 (804)
++|+||+++++|.+++.... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 99999999999999996432 12235899999999999999999999998 999999999999999999999
Q ss_pred eecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHH
Q 038103 656 TDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQ 733 (804)
Q Consensus 656 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 733 (804)
+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~- 249 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--------AEIY- 249 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHH-
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh--------HHHH-
Confidence 99999987644322 22233456788999999999999999999999999999999 9999865321 1111
Q ss_pred HHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 734 WVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.....+.... .+......+.+|+.+|++.||++||++.++++.|+.+..
T Consensus 250 ---~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 250 ---NYLIGGNRLK---------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp ---HHHHTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHhcCCCCC---------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111110 111223468899999999999999999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=342.38 Aligned_cols=266 Identities=21% Similarity=0.347 Sum_probs=210.2
Q ss_pred HHHHHhcccccccccCcceEEEEEec--------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEE
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLD--------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCA 577 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~--------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 577 (804)
+....+.+.+.||+|+||.||+|+.. +++.||||+++.... ..+++.+|++++.++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 33456777889999999999999863 467899999974332 235688999999999 8999999999999
Q ss_pred eCCeeEEEEeeccCCChhhhhccCCCC------------CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeE
Q 038103 578 ENEHKLLVYEYVENGSLDKLLFNDPGT------------ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNI 645 (804)
Q Consensus 578 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 645 (804)
.....++||||+++++|.+++...... ...+++..++.++.||++||+|||+.+ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 999999999999999999999764321 234889999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccC
Q 038103 646 LLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASAS 723 (804)
Q Consensus 646 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~ 723 (804)
|++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---- 264 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 264 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC----
Confidence 999999999999999987654322 22233456788999999998899999999999999999999 999986432
Q ss_pred CccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCC
Q 038103 724 DSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQ 798 (804)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~ 798 (804)
... +...+..+.... .... ....+.+++.+|++.+|.+||++.+|++.|+.+......
T Consensus 265 ----~~~----~~~~~~~~~~~~-----~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 265 ----VEE----LFKLLKEGHRMD-----KPAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp ----HHH----HHHHHHHTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ----HHH----HHHHHhcCCCCC-----CCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 011 112222221111 1112 234688999999999999999999999999887654433
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=333.68 Aligned_cols=265 Identities=17% Similarity=0.199 Sum_probs=199.0
Q ss_pred HHHhcccccccccCcceEEEEEec----CCcEEEEEEecCcCC------------ChHHHHHHHHHHhcCCCCcccceee
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD----DERVVAVKRLEGVLQ------------GDAEFWAEVSIIGRINHRNLVKLQG 574 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~----~~~~vavK~l~~~~~------------~~~~~~~E~~~l~~l~H~niv~l~g 574 (804)
...|.+.+.||+|+||.||+|+.. .+..+|||++..... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 345677889999999999999975 567899999874322 1234667888999999999999999
Q ss_pred eEEe----CCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC
Q 038103 575 FCAE----NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH 650 (804)
Q Consensus 575 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~ 650 (804)
++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9988 67899999999 89999999652 36899999999999999999999998 9999999999999888
Q ss_pred C--CeEEeecCCcccccccCC------ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCccccccc
Q 038103 651 F--EPKVTDFGLSKLFKERHD------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASA 722 (804)
Q Consensus 651 ~--~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~ 722 (804)
+ .+||+|||+++.+..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~- 266 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD- 266 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC-
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc-
Confidence 7 999999999987654321 1224457899999999999999999999999999999999999999632100
Q ss_pred CCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 723 SDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.............. +...+..... .......+.+++..|++.||++||++.+|++.|+.+..
T Consensus 267 ------~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 267 ------PVAVQTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp ------HHHHHHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred ------cHHHHHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 01111111111111 1111100000 00123478999999999999999999999999988654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=364.78 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=198.0
Q ss_pred cccccCcceEEEEEec---CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCC
Q 038103 519 EVGKGGFGSVFRGVLD---DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGS 593 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~---~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 593 (804)
+||+|+||.||+|... ++..||||+++... ...+++.+|++++++++|||||+++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999864 46679999998532 345789999999999999999999999976 56899999999999
Q ss_pred hhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc--c
Q 038103 594 LDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT--K 671 (804)
Q Consensus 594 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--~ 671 (804)
|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .
T Consensus 422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 9999965 3456899999999999999999999998 999999999999999999999999999976543221 1
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
.....+++.|+|||++....++.++||||||++||||++ |+.||..... .. +...+..+...
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~----~~~~i~~~~~~----- 558 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PE----VMAFIEQGKRM----- 558 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--------HH----HHHHHHTTCCC-----
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HH----HHHHHHcCCCC-----
Confidence 222345689999999999999999999999999999998 9999965321 11 12222222211
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
..+......+.+|+..||+.+|++||++.+|+++|+.+
T Consensus 559 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 559 ----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ----CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11222345789999999999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=336.16 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=202.9
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
...|.+.+.||+|+||.||+++.. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+....++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456788899999999999999965 5889999999754332 356889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC---CeEEeecCCccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF---EPKVTDFGLSKL 663 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfgla~~ 663 (804)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++..
T Consensus 108 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999864 346899999999999999999999998 99999999999998654 599999999987
Q ss_pred ccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ... ....+..+.
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--------~~~----~~~~i~~~~ 246 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHR----LYAQIKAGA 246 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHH----HHHHHHHTC
T ss_pred ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHH----HHHHHHhCC
Confidence 65422 2334678999999999999999999999999999999999999986422 011 112222222
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.. ...+. .. .....+.+|+.+||+.||++||++.++++.
T Consensus 247 ~~-~~~~~-~~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 247 YD-YPSPE-WD----TVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CC-CCTTG-GG----GSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC-CCccc-cc----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 00100 01 123468899999999999999999999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=324.77 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=196.8
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
..+.+.++||+|+||.||++... +++.+|+|++.... ...+++.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56788899999999999999964 58899999987433 3457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE---cCCCCeEEeecCCccccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~ 665 (804)
+++++|.+++.........+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998653223456899999999999999999999998 9999999999999 456789999999998765
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||.... ... ...........
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~-----------~~~-~~~~~~~~~~~ 243 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-----------LEE-VQQKATYKEPN 243 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHH-HHHHHHHCCCC
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC-----------HHH-HHhhhccCCcc
Confidence 432 233456899999999886 578999999999999999999999996432 111 11111111111
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.... .... ...+.+|+.+|++.||++||++.||++
T Consensus 244 ~~~~---~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 YAVE---CRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC-----CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccc---cCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0111 236789999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=345.46 Aligned_cols=256 Identities=26% Similarity=0.423 Sum_probs=192.5
Q ss_pred hcccccccccCcceEEEEEec--C--CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEe-CCeeEEEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD--D--ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAE-NEHKLLVY 586 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~--~--~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~ 586 (804)
+.+.+.||+|+||.||+|+.. + +..||||.++.... ..+++.+|+.++++++||||++++++|.+ ....++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 445678999999999999963 2 24689999874332 34678999999999999999999999765 45789999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++|+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 171 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 171 PYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp ECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999999975 3456889999999999999999999998 99999999999999999999999999986644
Q ss_pred cCC---ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 667 RHD---TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 667 ~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ..... ....+
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~--------~~~~~----~~~~~ 312 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------FDITV----YLLQG 312 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS--------SCHHH----HHHTT
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH--------HHHHH----HHHcC
Confidence 221 12233456788999999999999999999999999999999 6666653221 11111 11222
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
... .. +......+.+++.+||+.+|++||++.+|++.|+.+....
T Consensus 313 ~~~--~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 313 RRL--LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp CCC--CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCC--CC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111 11 1112346889999999999999999999999998765443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=338.08 Aligned_cols=245 Identities=23% Similarity=0.294 Sum_probs=193.8
Q ss_pred cccccccCcceEEEEEe-cCCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCCh
Q 038103 517 KQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
.+.||+|+||.||+|+. .+++.||+|+++... ...+++.+|++++++++||||+++++++.+....++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 45799999999999996 468899999997533 3456799999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE--cCCCCeEEeecCCcccccccCCccc
Q 038103 595 DKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL--DDHFEPKVTDFGLSKLFKERHDTKF 672 (804)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl--~~~~~~kl~Dfgla~~~~~~~~~~~ 672 (804)
.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 999865 3456899999999999999999999999 9999999999999 6778999999999997654322 2
Q ss_pred cccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcC
Q 038103 673 SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRL 752 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 752 (804)
....||+.|+|||++....++.++||||||+++|||++|+.||.... ..+..... ...... + ....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----------~~~~~~~i-~~~~~~-~-~~~~ 311 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN-----------DAETLNNI-LACRWD-L-EDEE 311 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS-----------HHHHHHHH-HHTCCC-S-CSGG
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----------HHHHHHHH-HhccCC-C-Chhh
Confidence 33468999999999999899999999999999999999999996422 01111111 111110 0 0000
Q ss_pred CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 753 NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
... ....+.+|+.+||+.||.+||++.++++
T Consensus 312 ~~~----~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQD----ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hcc----CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111 2346889999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=336.49 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=202.5
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.|.+.+.||+|+||.||+|+.. +++.||+|.+.... .....+.+|++++.+++||||+++++++.+....++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 4677889999999999999965 58899999987443 234578899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC--CCCeEEeecCCcccccccC
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD--HFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~ 668 (804)
+|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. .+.+||+|||++.......
T Consensus 132 gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 132 GGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999964 3346899999999999999999999998 999999999999974 5779999999998765432
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..+. ...+...... .
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----------~~~~-~~~i~~~~~~--~ 269 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----------DLET-LQNVKRCDWE--F 269 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----------HHHH-HHHHHHCCCC--C
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC-----------HHHH-HHHHHhCCCC--C
Confidence 2234568999999999999999999999999999999999999996422 0111 1111221111 1
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
++...... ...+.+|+.+||+.||++|||+.++++.
T Consensus 270 ~~~~~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DEDAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSSTTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CccccccC----CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11111122 3468899999999999999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=328.48 Aligned_cols=263 Identities=22% Similarity=0.334 Sum_probs=189.4
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
..+.+.+.||+|+||.||+|... +++.||||+++... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 34667789999999999999964 58899999997432 2346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCC--CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 589 VENGSLDKLLFNDP--GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 589 ~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
++ ++|.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 98 59999886421 12245889999999999999999999998 99999999999999999999999999987643
Q ss_pred cCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC--
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG-- 743 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 743 (804)
... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+........
T Consensus 161 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~ 231 (317)
T 2pmi_A 161 PVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND--------EEQLKLIFDIMGTPNES 231 (317)
T ss_dssp CCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHHCSCCTT
T ss_pred Ccc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCChh
Confidence 222 2234568999999999976 4689999999999999999999999964321 111111111111000
Q ss_pred -cc---c--ccCCcCC------------CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 744 -LE---K--IIDPRLN------------DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 744 -~~---~--~~d~~l~------------~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.. . ...+.+. ..........+.+|+.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 0 0000000 0000112346889999999999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=324.47 Aligned_cols=259 Identities=21% Similarity=0.269 Sum_probs=197.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
|.+.++||+|+||.||+|+.. +++.||||++...... ...+.+|+.++++++||||+++++++.++...++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 566789999999999999975 5889999999743322 367889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++ +|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 84 DQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp SE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred CC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 86 56555543 2356899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccCCCccchhhhccCC-CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc---
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLK-IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE--- 745 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 745 (804)
.......+|+.|+|||.+.+.. ++.++||||||+++|||++|..|+.... ........+..........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~-------~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-------DVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-------SHHHHHHHHHHHHCCCCTTTCT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC-------CHHHHHHHHHHHhCCCChhhhh
Confidence 2233456899999999998766 8999999999999999999998863211 0111111122211111000
Q ss_pred ---cccCC---------cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 746 ---KIIDP---------RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 746 ---~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...+. .............+.+|+.+|++.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000 0000111223456889999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=334.59 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=194.6
Q ss_pred HhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
.+.+.+.||+|+||.||+++.. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||++++
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~ 84 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG 84 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence 4566788999999999999975 678999998642 335678999999999999999999998874 479999999999
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC-eEEeecCCcccccccCCcc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE-PKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~-~kl~Dfgla~~~~~~~~~~ 671 (804)
+|.+++.... ....+++..++.++.|+++||+|||+.+...|+||||||+|||++.++. +||+|||++......
T Consensus 85 ~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 85 SLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp BHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 9999997532 2235788999999999999999999933222999999999999998886 799999999865432
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ....+... .
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------~~~~~~-~~~~~~~~-----~ 224 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP---------AFRIMW-AVHNGTRP-----P 224 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS---------HHHHHH-HHHTTCCC-----C
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc---------HHHHHH-HHhcCCCC-----C
Confidence 22345899999999999999999999999999999999999999643210 011111 11111111 1
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
+.... ...+.+|+.+|++.||++|||+.+|+++|+.+.+
T Consensus 225 ~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 225 LIKNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CBTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred ccccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11122 2468899999999999999999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=343.83 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=202.4
Q ss_pred HHHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
...|.+.+.||+|+||.||++.. .+++.+|+|++..... ..+.+.+|++++++++||||+++++++.+....++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 35678889999999999999985 4688999999974332 2356889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc---CCCCeEEeecCCccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD---DHFEPKVTDFGLSKL 663 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~ 663 (804)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 90 E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999865 345899999999999999999999998 99999999999998 567899999999987
Q ss_pred ccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
..... .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.... ... ....+..+.
T Consensus 163 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--------~~~----~~~~i~~~~ 229 (444)
T 3soa_A 163 VEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--------QHR----LYQQIKAGA 229 (444)
T ss_dssp CCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHH----HHHHHHHTC
T ss_pred ecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--------HHH----HHHHHHhCC
Confidence 65432 22334679999999999999999999999999999999999999996422 111 122222222
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.. ...+.. ... ...+.+|+..||+.||.+|||+.|+++.
T Consensus 230 ~~-~~~~~~-~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 230 YD-FPSPEW-DTV----TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CC-CCTTTT-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC-CCcccc-ccC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 21 111110 112 2468899999999999999999999863
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.76 Aligned_cols=248 Identities=19% Similarity=0.311 Sum_probs=192.9
Q ss_pred HhcccccccccCcceEEEEEecCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCC--CcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINH--RNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.+.||+|+||.||++...+++.||||++...... .+++.+|+.++.+++| +||+++++++......++|||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 89 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence 35677899999999999999988999999999744332 3568899999999976 999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
+.+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 90 -~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 90 -CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp -CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred -CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 567899999975 345889999999999999999999998 99999999999997 578999999999976543
Q ss_pred CCc-cccccccCCCccchhhhcc-----------CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHH
Q 038103 668 HDT-KFSRVRGTRGYLAPEWMMN-----------LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV 735 (804)
Q Consensus 668 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 735 (804)
... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------~~~~~ 230 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------QISKL 230 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS----------HHHHH
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh----------HHHHH
Confidence 322 2335679999999999865 6789999999999999999999999964220 01111
Q ss_pred HHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 736 AKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 736 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
... +++......+......+.+|+..||+.||.+|||+.++++.
T Consensus 231 ~~~---------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 231 HAI---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHH---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHH---------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111 11111111111122468899999999999999999999854
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=349.04 Aligned_cols=250 Identities=22% Similarity=0.280 Sum_probs=200.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecC----cCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEG----VLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||+++.. +++.||+|+++. .....+.+.+|+.++..++||||+++++++.+....++|||
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4556688999999999999975 588999999964 12334568899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.....
T Consensus 150 ~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 150 YMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp CCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred CCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999999964 24889999999999999999999999 999999999999999999999999999876654
Q ss_pred CCccccccccCCCccchhhhccCC----CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLK----IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
.........||+.|+|||++.... ++.++||||||+++|||++|+.||.... .......+......
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~-- 291 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMNHKNS-- 291 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTHHHH--
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--------hhhHHHHHHhcccc--
Confidence 433444677999999999998765 7899999999999999999999996422 01111111110000
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDT--RPPMSKVVKL 788 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPtm~~Vv~~ 788 (804)
+ ...+ ....+ ..+.+|+.+||+.+|.+ ||++++|++.
T Consensus 292 ~-~~p~---~~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 292 L-TFPD---DNDIS----KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp C-CCCT---TCCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred c-cCCC---ccccc----HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 0000 01122 36889999999999988 9999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.43 Aligned_cols=256 Identities=26% Similarity=0.423 Sum_probs=199.3
Q ss_pred hcccccccccCcceEEEEEecC----CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEe-CCeeEEEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAE-NEHKLLVY 586 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~ 586 (804)
+.+.+.||+|+||.||+|+..+ ...+|+|.+..... ..+++.+|+.++++++||||+++++++.+ +...++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 5567889999999999999643 23689999874332 34678899999999999999999999654 55789999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 107 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 107 PYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp ECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred eCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999975 3456889999999999999999999998 99999999999999999999999999987654
Q ss_pred cCC---ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhC-CCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 667 RHD---TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTG-KSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 667 ~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..|+..... .... .....+
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--------~~~~----~~~~~~ 248 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------FDIT----VYLLQG 248 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--------TTHH----HHHHTT
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH--------HHHH----HHHhcC
Confidence 322 223345577899999999999999999999999999999995 445543210 1111 111111
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
... .. ... ....+.+++.+|++.+|++||++.+++++|+.+....
T Consensus 249 ~~~--~~---~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 249 RRL--LQ---PEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CCC--CC---CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CCC--CC---Ccc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 00 111 2246889999999999999999999999998876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=337.31 Aligned_cols=255 Identities=22% Similarity=0.353 Sum_probs=196.8
Q ss_pred HHhcccccccccCcceEEEEEec-CCc----EEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DER----VVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
..|.+.+.||+|+||.||+|+.. +++ .||+|.+... ....+++.+|+.++.+++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 34667789999999999999954 343 3688887632 345678999999999999999999999998754 789
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
|+|++.+|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999999976 3456899999999999999999999998 999999999999999999999999999876
Q ss_pred cccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 665 KERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 665 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+. ..+..+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~----~~~~~~ 235 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEIS----SILEKG 235 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHH----HHHHTT
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHH----HHHHcC
Confidence 54322 22233456788999999999999999999999999999999 9999975321 1111 111111
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
... ..+......+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 236 ~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 236 ERL---------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111 0111123368899999999999999999999999987653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.25 Aligned_cols=257 Identities=24% Similarity=0.328 Sum_probs=201.8
Q ss_pred cccccccccCcceEEEEEecC----CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCee-EEEEe
Q 038103 515 NFKQEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK-LLVYE 587 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV~E 587 (804)
...+.||+|+||.||+|+..+ +..+|+|.+..... ..+.+.+|+.++++++||||+++++++.+.+.. ++|+|
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 345789999999999998532 23799999974332 336788999999999999999999999876655 99999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+.+++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 104 YMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999975 3456899999999999999999999998 999999999999999999999999999865442
Q ss_pred C---CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 668 H---DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 668 ~---~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
. ........++..|+|||.+.+..++.++||||||+++|||++|..|+.... ....+. .....+..
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-------~~~~~~----~~~~~~~~ 246 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-------DPFDLT----HFLAQGRR 246 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-------CGGGHH----HHHHTTCC
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-------CHHHHH----HHhhcCCC
Confidence 2 122334567889999999999999999999999999999999666643211 011111 11111111
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
.. . +......+.+++.+|++.+|.+|||+.+++++|+.+.....
T Consensus 247 ~~-----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 247 LP-----Q----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp CC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CC-----C----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 10 1 11123468899999999999999999999999988755433
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=334.37 Aligned_cols=243 Identities=22% Similarity=0.321 Sum_probs=198.2
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.+.||+|+||.||+|+. .+++.||||++... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 466778999999999999996 56889999998632 2334678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+ +|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 90 ~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 90 YA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred CC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 99 6799888864 345899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccCCCccchhhhccCCC-CcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
. ......||+.|+|||.+.+..+ ++++||||||+++|||++|+.||+...... ....
T Consensus 162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--------------------~~~~ 219 (336)
T 3h4j_B 162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--------------------LFKK 219 (336)
T ss_dssp B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--------------------CBCC
T ss_pred c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--------------------HHHH
Confidence 2 2334568999999999988776 789999999999999999999997432110 0000
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+..... ..+......+.+|+.+|++.||.+|||+.|+++
T Consensus 220 i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 220 VNSCVY--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCSSCC--CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHcCCC--CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 100000 011112346789999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=331.12 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=200.7
Q ss_pred HHhcccccccccCcceEEEEEecC----CcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
..+.+.+.||+|+||.||+|+..+ +..||||.+.... ...+++.+|+.++++++||||+++++++.+ +..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence 356677889999999999998543 3469999987532 234678999999999999999999999865 456899
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 91 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 91 MELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999999965 2345899999999999999999999998 9999999999999999999999999998766
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
...........+++.|+|||.+....++.++||||||+++|||++ |+.||..... ..... ....+..
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--------~~~~~----~~~~~~~ 232 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--------KDVIG----VLEKGDR 232 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--------GGHHH----HHHHTCC
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--------HHHHH----HHhcCCC
Confidence 544333444567889999999999999999999999999999998 9999864321 11111 1121111
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.. .... ....+.+++.+|++.+|++||++.++++.|+.+.+
T Consensus 233 ~~-----~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 233 LP-----KPDL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-----CCCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 11 1111 22468899999999999999999999999987543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.11 Aligned_cols=262 Identities=21% Similarity=0.347 Sum_probs=198.5
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC----ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ----GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.+.||+|+||.||++.. .+++.||||++..... ..+++.+|+.++++++||||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 467788999999999999996 5688999999974221 23568899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.........+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 99999999998653334456899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.. ......+++.|+|||.+....++.++||||||+++|||++|+.||..... ..... ...+........
T Consensus 190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~-~~~~~~~~~~~~ 258 (310)
T 2wqm_A 190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------NLYSL-CKKIEQCDYPPL 258 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C---------CHHHH-HHHHHTTCSCCC
T ss_pred Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---------hHHHH-HHHhhcccCCCC
Confidence 22 22345689999999999999999999999999999999999999864210 11111 122222222211
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
.. .. ....+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus 259 ~~----~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 259 PS----DH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp CT----TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cc----cc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 11 11 2246889999999999999999999999998876543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=331.83 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=208.2
Q ss_pred HHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
...+.+.+.||+|+||.||+|+.. .++.||||.+..... ...++.+|++++++++|+||+++++++.+....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 345677889999999999999864 367899999974332 335688999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhhccCC------CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEe
Q 038103 583 LLVYEYVENGSLDKLLFNDP------GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVT 656 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 656 (804)
++||||+++++|.+++.... .....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEEC
Confidence 99999999999999986421 11245789999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHH
Q 038103 657 DFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 657 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... . ..
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----------~-~~ 248 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----------N-EQ 248 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----------H-HH
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-----------H-HH
Confidence 9999986644322 22233456889999999999999999999999999999999 888886432 0 11
Q ss_pred HHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 735 VAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.......+..... +......+.+|+.+|++.+|.+||++.++++.|+.+..
T Consensus 249 ~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 249 VLRFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1222222222111 11223468899999999999999999999999988755
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.52 Aligned_cols=242 Identities=23% Similarity=0.333 Sum_probs=200.5
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||+++.. +++.||+|.++.. ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 4566788999999999999965 6899999999742 2345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 87 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 87 YIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 9999999999964 245889999999999999999999998 999999999999999999999999999865432
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .... ...+....+
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----------~~~~-~~~i~~~~~--- 220 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----------TMKT-YEKILNAEL--- 220 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----------HHHH-HHHHHHCCC---
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----------HHHH-HHHHHhCCC---
Confidence 234578999999999999999999999999999999999999996422 0111 111222211
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
.+.... ...+.+|+.+|++.||.+|| ++++|++
T Consensus 221 ---~~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ---RFPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---CCCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 111122 24688999999999999999 8888873
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=327.98 Aligned_cols=265 Identities=22% Similarity=0.308 Sum_probs=199.2
Q ss_pred HHHHHHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcC------CChHHHHHHHHHHhcCC---CCcccceeeeEE
Q 038103 508 ELKRATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL------QGDAEFWAEVSIIGRIN---HRNLVKLQGFCA 577 (804)
Q Consensus 508 ~l~~~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~ 577 (804)
++....|.+.++||+|+||.||+|+. .+++.||||++.... .....+.+|+.++++++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34456778889999999999999995 568899999987322 12356778888877764 999999999998
Q ss_pred eCC-----eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC
Q 038103 578 ENE-----HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE 652 (804)
Q Consensus 578 ~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 652 (804)
... ..++||||+. ++|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGT 158 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSC
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCC
Confidence 755 5799999997 5999999763 2334899999999999999999999999 999999999999999999
Q ss_pred eEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHH
Q 038103 653 PKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLV 732 (804)
Q Consensus 653 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~ 732 (804)
+||+|||+++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .....
T Consensus 159 ~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--------~~~~~ 228 (308)
T 3g33_A 159 VKLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--------EADQL 228 (308)
T ss_dssp EEECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS--------HHHHH
T ss_pred EEEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 999999999876432 22345678999999999999999999999999999999999999996422 11111
Q ss_pred HHHHHHhhhcCcccc----------cCCcCC---CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 733 QWVAKQMEQEGLEKI----------IDPRLN---DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~----------~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
..+...........+ +.+... .....+..+.+.+|+.+||+.||++|||+.|+++.
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 111121111100000 000000 00111223578899999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=335.06 Aligned_cols=260 Identities=25% Similarity=0.391 Sum_probs=204.8
Q ss_pred HHhcccccccccCcceEEEEEec-CCcE--EEEEEecCc--CCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERV--VAVKRLEGV--LQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~--vavK~l~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 585 (804)
..+.+.+.||+|+||.||+++.. ++.. +|||+++.. ....+++.+|++++.++ +||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 45677889999999999999964 4554 599998742 23446789999999999 899999999999999999999
Q ss_pred EeeccCCChhhhhccCC------------CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCe
Q 038103 586 YEYVENGSLDKLLFNDP------------GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEP 653 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 653 (804)
|||+++++|.+++.... .....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997642 22356899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHH
Q 038103 654 KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLV 732 (804)
Q Consensus 654 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~ 732 (804)
||+|||+++...... ......+++.|+|||.+....++.++||||||+++|||++ |+.||.... ..
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-----------~~ 248 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----------CA 248 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------HH
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-----------HH
Confidence 999999998533221 1223456889999999998889999999999999999998 999986432 01
Q ss_pred HHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 733 QWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
+ ....+..+. ....... ....+.+|+.+|++.+|.+||++.++++.|+.+.....
T Consensus 249 ~-~~~~~~~~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 249 E-LYEKLPQGY-----RLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp H-HHHHGGGTC-----CCCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred H-HHHHhhcCC-----CCCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1 122222221 1111112 23468899999999999999999999999987655443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=337.27 Aligned_cols=249 Identities=21% Similarity=0.308 Sum_probs=197.0
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 586 (804)
.+.+.+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|..++.++ +||||+++++++......++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 4566789999999999999975 57889999997432 2234578899999887 8999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 133 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 133 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999964 345899999999999999999999999 99999999999999999999999999985332
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
. ........||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ......+.+.+....+.
T Consensus 206 ~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~---~~~~~~~~~~i~~~~~~- 280 (396)
T 4dc2_A 206 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD---QNTEDYLFQVILEKQIR- 280 (396)
T ss_dssp T-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------CCHHHHHHHHHHCCCC-
T ss_pred C-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc---hhhHHHHHHHHhccccC-
Confidence 2 223445679999999999999999999999999999999999999996533211111 01111122222222211
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPM 782 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 782 (804)
+.... ...+.+|+..||+.||.+||++
T Consensus 281 -----~p~~~----s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 -----IPRSL----SVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCTTS----CHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----CCCcC----CHHHHHHHHHHhcCCHhHcCCC
Confidence 11122 2368899999999999999995
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=337.35 Aligned_cols=201 Identities=20% Similarity=0.214 Sum_probs=173.7
Q ss_pred HHhccccccccc--CcceEEEEEec-CCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 512 ATRNFKQEVGKG--GFGSVFRGVLD-DERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G--~fg~Vykg~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
..|.+.+.||+| +||.||+++.. +++.||||++...... .+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 356678899999 99999999975 6899999999754322 35678899999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 105 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 105 TSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999763 2345899999999999999999999999 9999999999999999999999999987543
Q ss_pred ccCC------ccccccccCCCccchhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 666 ERHD------TKFSRVRGTRGYLAPEWMMN--LKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 666 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
.... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 3211 11223468899999999987 6799999999999999999999999964
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=333.99 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=186.4
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
.+.+.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++.+++||||+++++++......++||||+++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 4566788999999999999976 47889999997532 345688999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC---CCCeEEeecCCcccccccC
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD---HFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~ 668 (804)
++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 133 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 133 GELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 999999964 345899999999999999999999998 999999999999975 8899999999998764422
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . ......+...... ..
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~----~~~~~~i~~~~~~-~~ 271 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-------D----QFMFRRILNCEYY-FI 271 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-------H----HHHHHHHHTTCCC-CC
T ss_pred --ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-------c----HHHHHHHHhCCCc-cC
Confidence 22345689999999999999999999999999999999999999864220 0 1111222222111 11
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+ ... .....+.+|+.+||+.||++||++.++++.
T Consensus 272 ~~-~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 SP-WWD----EVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TT-TTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Cc-hhh----hCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 111 223468899999999999999999999873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.56 Aligned_cols=245 Identities=26% Similarity=0.355 Sum_probs=197.7
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC----hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG----DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
..+...+.||+|+||.||+|+. .+++.||||++...... .+++.+|++++++++||||+++++++......++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4466678899999999999995 57899999999743322 246889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+. |+|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 588888754 2356899999999999999999999998 99999999999999999999999999986543
Q ss_pred cCCccccccccCCCccchhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMM---NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
. ....||+.|+|||.+. ...++.++||||||+++|||++|+.||.... ........ ..+.
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-----------~~~~~~~~-~~~~ 269 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----------AMSALYHI-AQNE 269 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----------HHHHHHHH-HHSC
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----------hHHHHHHH-HhcC
Confidence 2 2356899999999984 5679999999999999999999999986422 11111111 1111
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...... ... ...+.+|+.+||+.+|++|||+.++++.
T Consensus 270 ~~~~~~----~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 SPALQS----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCCC----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCC----CCC----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111111 112 2467899999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.12 Aligned_cols=263 Identities=20% Similarity=0.292 Sum_probs=205.8
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeE-EeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFC-AENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E~~~ 590 (804)
.|.+.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+.++.+++|++++..+..+ .+....++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 456678899999999999996 578999999987433 345688999999999998877777666 5667889999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE---cCCCCeEEeecCCccccccc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~~ 667 (804)
+++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 88 ~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 88 GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 8899999964 2346899999999999999999999998 9999999999999 48889999999999976553
Q ss_pred CCc------cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 668 HDT------KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 668 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .....+......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~~~~ 236 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-----QKYERISEKKMS 236 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-----SHHHHHHHHHHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh-----hhhhhhcccccC
Confidence 321 224467899999999999999999999999999999999999999754322111 111111111111
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
..... +. ..+ ...+.+++.+|++.||++||++.+|++.|+.+.....
T Consensus 237 ~~~~~-~~----~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 237 TPIEV-LC----KGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp SCHHH-HT----TTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CchHH-HH----hhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 11100 00 111 2468899999999999999999999999987655433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=330.52 Aligned_cols=241 Identities=22% Similarity=0.311 Sum_probs=199.8
Q ss_pred HHHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC---------ChHHHHHHHHHHhcCCCCcccceeeeEEeCC
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ---------GDAEFWAEVSIIGRINHRNLVKLQGFCAENE 580 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 580 (804)
...|.+.+.||+|+||.||+++. .+++.||||++..... ....+.+|+.++++++||||+++++++.+..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 35677788999999999999995 5688999999975331 2345778999999999999999999999999
Q ss_pred eeEEEEeeccCC-ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 581 HKLLVYEYVENG-SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 581 ~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
..++||||+..| +|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 99999964 345899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCccchhhhccCCC-CcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH
Q 038103 660 LSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 660 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
++....... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......
T Consensus 176 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------- 236 (335)
T 3dls_A 176 SAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------- 236 (335)
T ss_dssp TCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred cceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence 998765432 2334568999999999988877 78999999999999999999999642210
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
....... .... ...+.+|+..||+.||++||++.++++.
T Consensus 237 -----~~~~~~~--~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----VEAAIHP--PYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTTCCCC--SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----HhhccCC--Cccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 1112 2368899999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=337.28 Aligned_cols=249 Identities=21% Similarity=0.267 Sum_probs=196.9
Q ss_pred HHHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCee
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 582 (804)
+....+.+.+.||+|+||.||+++.. +++.||||+++.. ....+.+.+|..++..+ +||||+++++++......
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 33445677889999999999999965 5889999999742 23446688899999988 799999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccccee
Confidence 999999999999999964 345899999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.... ... ....+..+
T Consensus 173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~----~~~~i~~~ 239 (353)
T 3txo_A 173 EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--------EDD----LFEAILND 239 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHH----HHHHHHHC
T ss_pred ecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--------HHH----HHHHHHcC
Confidence 54332 223345679999999999998899999999999999999999999996432 011 11222222
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPM------SKVVK 787 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm------~~Vv~ 787 (804)
... +... ....+.+|+.+|++.||.+||++ .++++
T Consensus 240 ~~~------~p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 240 EVV------YPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCC------CCTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCC------CCCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111 1111 22367899999999999999998 66653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.82 Aligned_cols=242 Identities=22% Similarity=0.257 Sum_probs=201.2
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 4566788999999999999965 6889999999632 2345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 122 YVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp CCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999642 35899999999999999999999999 999999999999999999999999999875432
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+ ....+..+.+.
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----------~~~-~~~~i~~~~~~-- 256 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----------PIQ-IYEKIVSGKVR-- 256 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHH-HHHHHHHCCCC--
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-----------HHH-HHHHHHcCCCC--
Confidence 234568999999999999999999999999999999999999996422 011 12222222211
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPP-----MSKVVK 787 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~~Vv~ 787 (804)
+...+ ...+.+|+.+||+.||.+||+ +++|++
T Consensus 257 ----~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 ----FPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11122 346889999999999999998 888864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=341.24 Aligned_cols=247 Identities=18% Similarity=0.307 Sum_probs=193.0
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCC--CCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRIN--HRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
|.+.+.||+|+||.||++...+++.||||++..... ..+++.+|+.++.+++ |+||+++++++......++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 667789999999999999988899999999974332 2367899999999996 5999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+.+++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+....
T Consensus 137 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 137 CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 5678999999752 35888899999999999999999998 99999999999996 5799999999999765433
Q ss_pred Cc-cccccccCCCccchhhhcc-----------CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHH
Q 038103 669 DT-KFSRVRGTRGYLAPEWMMN-----------LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVA 736 (804)
Q Consensus 669 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (804)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----------~~~~~~ 278 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------QISKLH 278 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC----------HHHHHH
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH----------HHHHHH
Confidence 22 2345679999999999865 4688999999999999999999999964210 011111
Q ss_pred HHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 737 KQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 737 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
... ++......+......+.+|+.+||+.||.+||++.+|++.
T Consensus 279 ~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 AII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHh---------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111 1111111111113468899999999999999999999853
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=322.16 Aligned_cols=262 Identities=20% Similarity=0.292 Sum_probs=203.6
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeE-EeCCeeEEEEeec
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFC-AENEHKLLVYEYV 589 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E~~ 589 (804)
..|.+.+.||+|+||.||+|+. .+++.||||++.... ...++.+|++++.+++|++++..+..+ ......++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 4577788999999999999996 568899999876432 234578899999999998888777766 5667889999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE---cCCCCeEEeecCCcccccc
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~ 666 (804)
+++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 88 -~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 88 -GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp -CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred -CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 8899999974 2345899999999999999999999999 9999999999999 7889999999999997655
Q ss_pred cCC------ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 667 RHD------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 667 ~~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~~~ 235 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-----QKYERISEKKM 235 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-----SHHHHHHHHHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-----hhhhhhhcccc
Confidence 332 1223467899999999999999999999999999999999999999754322111 11111111111
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
...... .. ..+ ...+.+|+..|++.+|++||++.+|++.|+.+...
T Consensus 236 ~~~~~~-~~----~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 236 STPIEV-LC----KGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HSCHHH-HT----TTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cchhhh-hh----ccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 111100 00 111 24688999999999999999999999999876553
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=333.24 Aligned_cols=268 Identities=25% Similarity=0.372 Sum_probs=206.2
Q ss_pred HHHhcccccccccCcceEEEEEe-----cCCcEEEEEEecCcCC-ChHHHHHHHHHHhcCCCCcccceeeeEEeCC--ee
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVL-----DDERVVAVKRLEGVLQ-GDAEFWAEVSIIGRINHRNLVKLQGFCAENE--HK 582 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~-----~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 582 (804)
...+.+.+.||+|+||.||+++. .+++.||||++..... ..+++.+|++++++++||||+++++++.... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34466778999999999999984 3688999999975432 3467899999999999999999999987654 78
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++|+||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999763 345899999999999999999999998 9999999999999999999999999999
Q ss_pred cccccCCc--cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccc----cCCccchhhHHHHHH
Q 038103 663 LFKERHDT--KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSAS----ASDSSYCNHLVQWVA 736 (804)
Q Consensus 663 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~ 736 (804)
........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .............+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 76543321 122345677899999999888999999999999999999999987532100 000000011111112
Q ss_pred HHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 737 KQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 737 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
+.+..+... ..+......+.+|+.+||+.||++||++.+|++.|+.+.
T Consensus 274 ~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 274 ELLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 222221111 111223357889999999999999999999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.35 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=203.7
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC-------ChHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ-------GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
...|.+.+.||+|+||.||+++.. +++.||||.+..... ..+++.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456788899999999999999965 588999999974321 246799999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC----CeEEeec
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF----EPKVTDF 658 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Df 658 (804)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999964 345889999999999999999999998 99999999999999887 7999999
Q ss_pred CCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH
Q 038103 659 GLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 659 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
|++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+.. ..
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------~~~~~-~~ 229 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----------KQETL-AN 229 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----------HHHHH-HH
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC-----------HHHHH-HH
Confidence 9998765432 2234568999999999999999999999999999999999999996422 01111 11
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+...... .++.... .....+.+|+.+|++.||++|||+.++++.
T Consensus 230 i~~~~~~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 230 ITSVSYD--FDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHTTCCC--CCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHhcccc--cChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111110 0000001 123468899999999999999999999873
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=337.85 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=207.7
Q ss_pred HHHhcccccccccCcceEEEEEe------cCCcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEEeCC-
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCAENE- 580 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~- 580 (804)
...+.+.+.||+|+||.||+++. .+++.||||+++.... ..+.+.+|+.++.++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 45567788999999999999984 3468899999975432 235688999999999 7999999999988755
Q ss_pred eeEEEEeeccCCChhhhhccCCCC------------CCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPGT------------ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD 648 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~ 648 (804)
..++|+||+++++|.+++...... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEEC
Confidence 589999999999999999764321 223889999999999999999999998 99999999999999
Q ss_pred CCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCcc
Q 038103 649 DHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSS 726 (804)
Q Consensus 649 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~ 726 (804)
.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----- 257 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----- 257 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-----
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh-----
Confidence 999999999999987654332 22334567889999999999999999999999999999998 99998643210
Q ss_pred chhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 727 YCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
.. ....+..+.... ..... ...+.+++.+||+.||.+||++.+|++.|+.+.+.
T Consensus 258 --~~----~~~~~~~~~~~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 258 --EE----FCRRLKEGTRMR-----APDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp --HH----HHHHHHHTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HH----HHHHhccCccCC-----CCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 11 112222221111 11112 24688999999999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=334.98 Aligned_cols=256 Identities=22% Similarity=0.282 Sum_probs=197.1
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCc------CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV------LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
...|.+.+.||+|+||.||+++.. +++.||+|++... ....+++.+|++++++++||||+++++++.+....+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 356888899999999999999964 5788999998632 233467899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCC------------------------------------CCCCCCHHhHHHHHHHHHHHHHHH
Q 038103 584 LVYEYVENGSLDKLLFNDPG------------------------------------TASILQWDQRYNIAVGTAKGLSYL 627 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~ia~~l~yL 627 (804)
+||||+++|+|.+++..... ....+++..+..++.||++||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999999852100 012245677889999999999999
Q ss_pred HhhCCCcEEecccccCeEEEcCCC--CeEEeecCCcccccccCC---ccccccccCCCccchhhhcc--CCCCcccchHH
Q 038103 628 HEECLEWVLHCDVKPQNILLDDHF--EPKVTDFGLSKLFKERHD---TKFSRVRGTRGYLAPEWMMN--LKIDAKADVYS 700 (804)
Q Consensus 628 H~~~~~~ivH~Dlkp~NILl~~~~--~~kl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S 700 (804)
|+.+ |+||||||+|||++.++ .+||+|||++..+..... .......||+.|+|||.+.. ..++.++||||
T Consensus 185 H~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 9998 99999999999998776 899999999987644222 22345678999999999975 67899999999
Q ss_pred HHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC
Q 038103 701 YGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRP 780 (804)
Q Consensus 701 ~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 780 (804)
||+++|||++|+.||.... ..+....... .... ...+ ........+.+|+.+|++.+|.+||
T Consensus 262 lG~il~el~~g~~pf~~~~-----------~~~~~~~~~~-~~~~-~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVN-----------DADTISQVLN-KKLC-FENP-----NYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHH-CCCC-TTSG-----GGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHCCCCCCCCC-----------hHHHHHHHHh-cccc-cCCc-----ccccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999996432 1111111111 1110 0001 0111234688999999999999999
Q ss_pred CHHHHHH
Q 038103 781 PMSKVVK 787 (804)
Q Consensus 781 tm~~Vv~ 787 (804)
++.++++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=363.57 Aligned_cols=246 Identities=26% Similarity=0.407 Sum_probs=197.0
Q ss_pred ccccccCcceEEEEEec---CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD---DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~---~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
++||+|+||.||+|.+. .++.||||+++.... ..+++.+|++++.+++|||||+++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 467899999985332 24789999999999999999999999964 568899999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC--
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD-- 669 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-- 669 (804)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999964 345899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......+|+.|+|||.+....++.++||||||+++|||++ |+.||..... ..+...+..+....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------------~~~~~~i~~~~~~~-- 592 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------------SEVTAMLEKGERMG-- 592 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------HHHHHHHHTTCCCC--
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCCC--
Confidence 22233456788999999999999999999999999999999 9999965321 11222222222111
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
.+......+.+|+..||+.||++||++.+|+++|+.+
T Consensus 593 -------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 593 -------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122335788999999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=327.87 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=200.4
Q ss_pred HHhcccc-cccccCcceEEEEEe---cCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 512 ATRNFKQ-EVGKGGFGSVFRGVL---DDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 512 ~t~~~~~-~LG~G~fg~Vykg~~---~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
..+.+.+ .||+|+||.||+|.. ..++.||||+++..... .+++.+|++++.+++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 3455566 899999999999964 24678999999744322 46789999999999999999999999 6677899
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 95 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999975 235889999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCc--cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 665 KERHDT--KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 665 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. +...+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~----~~~~~~~ 235 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SE----VTAMLEK 235 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HH----HHHHHHT
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HH----HHHHHHc
Confidence 543332 1222346788999999998889999999999999999999 9999864320 11 1222222
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
+... .. +......+.+++.+|++.||.+||++.+|++.|+.+.
T Consensus 236 ~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 236 GERM-----GC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp TCCC-----CC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2111 11 1122347889999999999999999999999998653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.97 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=200.1
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 585 (804)
..+.+.+.||+|+||.||+++.. +++.||||+++.. ....+.+..|..++.++ +||||+++++++.+....++|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 45667788999999999999975 5889999999743 23456788899999877 999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 97 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 999999999999964 245899999999999999999999998 9999999999999999999999999998643
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ...+ ...+..+.
T Consensus 170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~----~~~i~~~~-- 234 (345)
T 1xjd_A 170 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEEL----FHSIRMDN-- 234 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH----HHHHHHCC--
T ss_pred cCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--------HHHH----HHHHHhCC--
Confidence 222 22345679999999999999999999999999999999999999996422 0111 12222221
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMS-KVV 786 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~-~Vv 786 (804)
+.+.... ...+.+|+.+||+.||++||++. +|.
T Consensus 235 ----~~~p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ----PFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----CCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----CCCCccc----CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1111122 24688999999999999999997 664
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=321.52 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=180.6
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||+++. .+++.||||.+... ....+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 356678899999999999996 56899999999632 1234678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 92 MCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp CCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred cCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999975 3456899999999999999999999998 999999999999999999999999999876532
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ..... ..
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------------~~~~~---~~-- 227 (278)
T 3cok_A 166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------------LNKVV---LA-- 227 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------CC---SS--
T ss_pred CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------------HHHHh---hc--
Confidence 22 22335689999999999998999999999999999999999999964321100 00000 00
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+..+.... ...+.+|+.+|++.||++||++.++++
T Consensus 228 -~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 -DYEMPSFL----SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCCCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -ccCCcccc----CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11111122 346889999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.04 Aligned_cols=248 Identities=19% Similarity=0.283 Sum_probs=201.1
Q ss_pred HHhcccccccccCcceEEEEEecC-CcEEEEEEecCc-CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGV-LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
..|.+.+.||+|+||.||+|+... +..+|+|++... ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 457788899999999999999754 678999998743 345678999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE---cCCCCeEEeecCCcccccc
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~ 666 (804)
++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+ +.++.+||+|||++.....
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 89 TGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999999864 345899999999999999999999999 9999999999999 7889999999999987654
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.. ......+|+.|+|||.+.+ .++.++||||||+++|||++|+.||..... .+ ....+..+....
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~-~~~~~~~~~~~~ 226 (277)
T 3f3z_A 162 GK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD-----------SE-VMLKIREGTFTF 226 (277)
T ss_dssp TS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----------HH-HHHHHHHCCCCC
T ss_pred cc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH-----------HH-HHHHHHhCCCCC
Confidence 32 2334568999999998865 499999999999999999999999964320 11 112222221110
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...........+.+|+.+|++.||++||++.++++
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 ------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000012346889999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=322.97 Aligned_cols=259 Identities=22% Similarity=0.331 Sum_probs=203.8
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC-------ChHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ-------GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
...|.+.+.||+|+||.||+++.. +++.||+|.++.... ..+++.+|+.++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 456788899999999999999976 588999999874321 357799999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC----CeEEeec
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF----EPKVTDF 658 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Df 658 (804)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999964 345899999999999999999999998 99999999999998877 8999999
Q ss_pred CCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHH
Q 038103 659 GLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738 (804)
Q Consensus 659 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (804)
|++....... ......+++.|+|||.+....++.++||||||+++|||++|+.||..... ... ...
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~----~~~ 222 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QET----LTN 222 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHH----HHH
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHH----HHH
Confidence 9998764422 22345689999999999999999999999999999999999999864220 011 111
Q ss_pred hhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HhccCCCCC
Q 038103 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK--LLTAHDHES 796 (804)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~--~L~~~~~~~ 796 (804)
+...... ............+.+|+.+|++.||++||++.++++ .++.+....
T Consensus 223 ~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 223 ISAVNYD------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHTTCCC------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred hHhcccC------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 1111110 000001112346889999999999999999999986 344444333
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.96 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=201.6
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
..+.+.+.||+|+||.||+++.. +++.||||.+.... ...+.+.+|+.++++++||||+++++++.+....++|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45777889999999999999975 68899999987432 2346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 87 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999964 345899999999999999999999998 9999999999999999999999999998765432
Q ss_pred C-ccccccccCCCccchhhhccCCC-CcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 669 D-TKFSRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 669 ~-~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
. .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ..... .+......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-----~~~~~~~~- 227 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYS-----DWKEKKTY- 227 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT------SHHHH-----HHHTTCTT-
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH------HHHHH-----Hhhhcccc-
Confidence 2 22344668999999999987765 77999999999999999999999653211 01111 11111100
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..+ .. .....+.+|+.+|++.||++|||+.++++
T Consensus 228 -~~~--~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 -LNP--WK----KIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -STT--GG----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cCc--hh----hcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000 01 12346789999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=335.14 Aligned_cols=263 Identities=15% Similarity=0.203 Sum_probs=205.0
Q ss_pred HHhcccccccccCcceEEEEEecC---------CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccc-----------
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDD---------ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVK----------- 571 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~---------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~----------- 571 (804)
..|.+.+.||+|+||.||+|+... ++.||||.+... +.+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 356677899999999999999763 788999998743 46789999999999999998
Q ss_pred ----eeeeEEe-CCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEE
Q 038103 572 ----LQGFCAE-NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNIL 646 (804)
Q Consensus 572 ----l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIL 646 (804)
+++++.. +...++||||+ +++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 5677766 67889999999 99999999753 2356999999999999999999999998 999999999999
Q ss_pred EcCCC--CeEEeecCCcccccccCCc------cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCccc
Q 038103 647 LDDHF--EPKVTDFGLSKLFKERHDT------KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYL 718 (804)
Q Consensus 647 l~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~ 718 (804)
++.++ .+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876543221 223457899999999999999999999999999999999999999753
Q ss_pred ccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 719 SASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
... ...+.... ... ......+.+...... .....+.+|+.+|++.||++||++.+|+++|+.+...
T Consensus 272 ~~~------~~~~~~~~-~~~-~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 272 LPN------TEDIMKQK-QKF-VDKPGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TTC------HHHHHHHH-HHH-HHSCCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CcC------HHHHHHHH-Hhc-cCChhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 211 11111111 111 112222222221110 1124688999999999999999999999999876544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=328.96 Aligned_cols=259 Identities=23% Similarity=0.343 Sum_probs=194.3
Q ss_pred HHHhcccccccccCcceEEEEEec----CCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCe--
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD----DERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEH-- 581 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~----~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-- 581 (804)
...+.+.+.||+|+||.||+|... .++.||||+++..... .+++.+|+.++.+++||||+++++++.+...
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 345667788999999999999854 3458999998744322 3568899999999999999999999987653
Q ss_pred ---eEEEEeeccCCChhhhhccCC--CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEe
Q 038103 582 ---KLLVYEYVENGSLDKLLFNDP--GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVT 656 (804)
Q Consensus 582 ---~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 656 (804)
.++|+||+++++|.+++.... .....+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEe
Confidence 499999999999999985422 23456899999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHH
Q 038103 657 DFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 657 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~-- 259 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--------HEMY-- 259 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHH--
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHH--
Confidence 9999987654322 22233456889999999999999999999999999999999 8888864321 1111
Q ss_pred HHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 735 VAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
.....+... .. +......+.+++.+|++.+|.+||++.++++.|+.+.
T Consensus 260 --~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 260 --DYLLHGHRL-----KQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp --HHHHTTCCC-----CC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHcCCCC-----CC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111111 11 1122346889999999999999999999999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=331.30 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=180.6
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEeeccCCChh
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYEYVENGSLD 595 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 595 (804)
+.||+|+||.||+++.. +++.||||++... ....+.+|+.++.+++ ||||+++++++.+....++||||+++|+|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 67999999999999975 5889999998642 3467889999999997 999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC---CeEEeecCCcccccccCCccc
Q 038103 596 KLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF---EPKVTDFGLSKLFKERHDTKF 672 (804)
Q Consensus 596 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Dfgla~~~~~~~~~~~ 672 (804)
+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...... ...
T Consensus 95 ~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~ 166 (325)
T 3kn6_A 95 ERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPL 166 (325)
T ss_dssp HHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Ccc
Confidence 99975 346899999999999999999999998 99999999999997665 89999999998654432 223
Q ss_pred cccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcC
Q 038103 673 SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRL 752 (804)
Q Consensus 673 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 752 (804)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ... ..+...+..+... .
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~~-~~~~~~i~~~~~~------~ 235 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC----TSA-VEIMKKIKKGDFS------F 235 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C----CCH-HHHHHHHTTTCCC------C
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc----ccH-HHHHHHHHcCCCC------C
Confidence 3456799999999999999999999999999999999999999753311100 011 1122222222211 1
Q ss_pred CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 753 NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...........+.+|+.+||+.||.+|||++++++.
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 111111224578899999999999999999999843
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=333.18 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=200.2
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
..|.+.+.||+|+||.||+++.. +++.||+|.+... ....+.+.+|+.++.+++||||+++++++......++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 34667789999999999999965 5789999998632 234567889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+.+|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999964 345899999999999999999999999 99999999999999999999999999987654
Q ss_pred cCCccccccccCCCccchhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMN---LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
. .......||+.|+|||++.. ..++.++||||||+++|||++|+.||...... . ... .........
T Consensus 168 ~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----~---~~~-~~~~~~~~~ 236 (384)
T 4fr4_A 168 E--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-----S---SKE-IVHTFETTV 236 (384)
T ss_dssp T--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-----C---HHH-HHHHHHHCC
T ss_pred C--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-----c---HHH-HHHHHhhcc
Confidence 2 23345679999999999864 45899999999999999999999999643211 0 111 111111111
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPP-MSKVVK 787 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-m~~Vv~ 787 (804)
. ..... ....+.+|+.+||+.||.+||+ +++|.+
T Consensus 237 ~------~~p~~----~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 V------TYPSA----WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp C------CCCTT----SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred c------CCCCc----CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1 11111 2346889999999999999998 666654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=340.97 Aligned_cols=263 Identities=23% Similarity=0.376 Sum_probs=207.0
Q ss_pred HHHHHhcccccccccCcceEEEEEecC------CcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEEeC
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDD------ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCAEN 579 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 579 (804)
+....+.+.+.||+|+||.||+|.... ...||+|.+..... ..+.+.+|+.++.++ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 334556677889999999999999643 24799999975432 345688999999999 899999999999999
Q ss_pred CeeEEEEeeccCCChhhhhccCCC----------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPG----------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD 649 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~ 649 (804)
...++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 999999999999999999864210 1345789999999999999999999998 999999999999999
Q ss_pred CCCeEEeecCCcccccccCCc-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccc
Q 038103 650 HFEPKVTDFGLSKLFKERHDT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSY 727 (804)
Q Consensus 650 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~ 727 (804)
++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------ 273 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN------ 273 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS------
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh------
Confidence 999999999999876543322 2233456789999999999999999999999999999999 99998643210
Q ss_pred hhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 728 CNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
..+ ......+. . ..... .....+.+|+.+|++.||.+||++.+|++.|+.+..
T Consensus 274 -~~~----~~~~~~~~-~----~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 274 -SKF----YKLVKDGY-Q----MAQPA----FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp -HHH----HHHHHHTC-C----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHH----HHHHhcCC-C----CCCCC----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 111 11111111 1 00111 123468899999999999999999999999986543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=326.57 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=196.1
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeC-CeeEEEEeecc
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAEN-EHKLLVYEYVE 590 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~~ 590 (804)
..+.+.+.||+|+||.||++... ++.||||.++.. ...+.+.+|++++.+++||||+++++++.+. ...++|+||++
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch-hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 35667789999999999999875 788999998743 3456789999999999999999999997654 47899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 99 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp TEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 99999999642 1234789999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ......+..
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~----~~~~~~~~~----- 232 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDV----VPRVEKGYK----- 232 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGH----HHHHTTTCC-----
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHH----HHHHhcCCC-----
Confidence 22356889999999999999999999999999999998 9999864321 111 111222111
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
..... .....+.+++.+|++.||.+||++.++++.|+.+..
T Consensus 233 ~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 233 MDAPD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcc----cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 11111 223468899999999999999999999999987654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=343.95 Aligned_cols=251 Identities=19% Similarity=0.201 Sum_probs=198.7
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||+++.. +++.||||++++.. ...+.+.+|..++.+++||||+++++++.+....++|||
T Consensus 62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE 141 (412)
T 2vd5_A 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141 (412)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence 4555678999999999999975 68999999996421 223458889999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|.+++.. .+..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.....
T Consensus 142 ~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 142 YYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp CCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred CCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 9999999999965 2346899999999999999999999998 999999999999999999999999999876654
Q ss_pred CCccccccccCCCccchhhhc-------cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 668 HDTKFSRVRGTRGYLAPEWMM-------NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~-------~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+.....
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~ 287 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--------TAETYGKIVHYKE 287 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTHHH
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccc
Confidence 443344567999999999987 3568999999999999999999999996422 0111111111000
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCC---CCHHHHHH
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTR---PPMSKVVK 787 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Ptm~~Vv~ 787 (804)
... -+.+.... ...+.+|+.+||+ +|.+| |+++++++
T Consensus 288 ~~~-----~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 288 HLS-----LPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HCC-----CC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CcC-----CCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000 11111122 2468899999999 99998 68999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=328.54 Aligned_cols=254 Identities=26% Similarity=0.355 Sum_probs=192.0
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC----hHHHHHHHHHHhcCCCCcccceeeeEEeCCe----e
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG----DAEFWAEVSIIGRINHRNLVKLQGFCAENEH----K 582 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~ 582 (804)
..|.+.+.||+|+||.||+++. .+++.||||++...... ...+.+|++++.+++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 3566778999999999999996 56889999999754322 2468899999999999999999999876543 4
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 92 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 999999999999999964 245899999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCC--ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 663 LFKERHD--TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 663 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-----------~~~~~~~~~~ 233 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----------PVSVAYQHVR 233 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----------HHHHHHHHHH
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-----------hHHHHHHHhc
Confidence 7654322 22334568999999999999999999999999999999999999996432 1111112211
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HHhc
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVV-KLLT 790 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv-~~L~ 790 (804)
...... ..........+.+|+.+||+.||++||++.+++ +.|.
T Consensus 234 ~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 234 EDPIPP-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp CCCCCH-------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCCCCc-------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 111100 000111234688999999999999999766655 4443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=338.53 Aligned_cols=272 Identities=21% Similarity=0.292 Sum_probs=209.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCC--eeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENE--HKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 587 (804)
.|.+.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 4567789999999999999975 48899999997432 34577889999999999999999999998765 7799999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE----cCCCCeEEeecCCccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL----DDHFEPKVTDFGLSKL 663 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfgla~~ 663 (804)
|+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 90 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 90 FCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred cCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 999999999996532 2233899999999999999999999998 9999999999999 7888899999999987
Q ss_pred ccccCCccccccccCCCccchhhhcc--------CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHH
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMN--------LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV 735 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 735 (804)
..... ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||........ .......+
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~----~~~~~~~~ 239 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR----NKEVMYKI 239 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT----CHHHHHHH
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc----hHHHHHHH
Confidence 65432 2234568999999999865 5678899999999999999999999964321111 11111111
Q ss_pred HHHhhhcCcccc---c--------CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 736 AKQMEQEGLEKI---I--------DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 736 ~~~~~~~~~~~~---~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
........+..+ . +..............+.+++..||+.||++||++.++++.|+.+..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 111000001000 0 0111123456777889999999999999999999999999877544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.22 Aligned_cols=246 Identities=24% Similarity=0.306 Sum_probs=191.4
Q ss_pred HHhcccccccccCcceEEEEEe----cCCcEEEEEEecCcC-----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL----DDERVVAVKRLEGVL-----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
..+.+.+.||+|+||.||+++. .+++.||+|+++... .....+.+|+.++++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4567788999999999999996 468899999997432 2335678899999999999999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 97 YLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999964 245889999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .... ...+...
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~----~~~i~~~ 236 (327)
T 3a62_A 170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--------RKKT----IDKILKC 236 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHH----HHHHHHT
T ss_pred ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--------HHHH----HHHHHhC
Confidence 643322 22334578999999999999999999999999999999999999996422 0111 1111111
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
.. .+... ....+.+|+.+||+.||.+|| ++.++++
T Consensus 237 ~~------~~p~~----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 KL------NLPPY----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CC------CCCTT----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CC------CCCCC----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11 11111 234688999999999999999 6777764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=328.99 Aligned_cols=262 Identities=25% Similarity=0.359 Sum_probs=195.0
Q ss_pred HHhcccccccccCcceEEEEEec--CC--cEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD--DE--RVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~--~~--~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
..+.+.+.||+|+||.||+|+.. ++ ..||||+++... ...+++.+|++++.+++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 45667789999999999999853 23 368999987432 22467889999999999999999999998755 88
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+|+||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 97 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 99999999999999965 2356899999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCCc--cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 664 FKERHDT--KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 664 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
....... ......++..|+|||.+....++.++||||||+++|||++ |+.||.... ..+.... ..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----------~~~~~~~-~~ 238 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----------GSQILHK-ID 238 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------HHHHHHH-HH
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-----------HHHHHHH-HH
Confidence 6543321 2233456788999999998889999999999999999999 999986432 1111111 11
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCCCC
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQDE 800 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~~~ 800 (804)
...... .. +......+.+++.+|++.+|++||++.++++.|+.+.......|
T Consensus 239 ~~~~~~----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~e 290 (291)
T 1u46_A 239 KEGERL----PR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRAE 290 (291)
T ss_dssp TSCCCC----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-------
T ss_pred ccCCCC----CC----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchhhc
Confidence 111110 01 11223468899999999999999999999999998877655443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.45 Aligned_cols=249 Identities=21% Similarity=0.303 Sum_probs=197.0
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC----hHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG----DAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 586 (804)
.+.+.+.||+|+||.||+++.. +++.||+|+++..... .+.+.+|..++.++ +||||+++++++......++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 4566788999999999999975 5889999999754322 24578899999987 8999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 90 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 90 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999964 245899999999999999999999998 99999999999999999999999999986432
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ......+...+......
T Consensus 163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~~~~~~i~~~~~~- 237 (345)
T 3a8x_A 163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD---QNTEDYLFQVILEKQIR- 237 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------CHHHHHHHHHHCCCC-
T ss_pred CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc---cccHHHHHHHHHcCCCC-
Confidence 22 23345679999999999999999999999999999999999999996532111110 01111122222222211
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPM 782 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 782 (804)
+.... ...+.+|+.+||+.||.+||++
T Consensus 238 -----~p~~~----s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 -----IPRSL----SVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----CCTTS----CHHHHHHHHHHTCSSTTTSTTC
T ss_pred -----CCCCC----CHHHHHHHHHHhcCCHhHCCCC
Confidence 11122 2468899999999999999995
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.96 Aligned_cols=199 Identities=29% Similarity=0.420 Sum_probs=174.4
Q ss_pred HHHHHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcCC-----CCcccceeeeEEeCCee
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-----HRNLVKLQGFCAENEHK 582 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~ 582 (804)
+....|.+.++||+|+||.||+++. .+++.||||+++........+..|+.++.+++ ||||+++++++......
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 3345677788999999999999996 46889999999865555567888999999986 99999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-------------
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD------------- 649 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~------------- 649 (804)
++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp EEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred EEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcc
Confidence 9999999 88999999763 2335889999999999999999999998 999999999999975
Q ss_pred ------------CCCeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 650 ------------HFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 650 ------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 789999999999864432 2345689999999999999999999999999999999999999964
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=340.54 Aligned_cols=244 Identities=23% Similarity=0.356 Sum_probs=201.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4667788999999999999975 6899999999632 1234678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 97 YVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp CCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999964 346899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCccccccccCCCccchhhhccCCC-CcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
. ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+... ... ....+..+...
T Consensus 170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--------~~~----~~~~i~~~~~~- 234 (476)
T 2y94_A 170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--------VPT----LFKKICDGIFY- 234 (476)
T ss_dssp C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------SHH----HHHHHHTTCCC-
T ss_pred c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--------HHH----HHHHHhcCCcC-
Confidence 2 2334578999999999988776 689999999999999999999996422 011 11222222111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.....+ ..+.+|+.+||+.||.+|||+.++++
T Consensus 235 -----~p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 -----TPQYLN----PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -----CCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----CCccCC----HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 111122 36889999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=327.60 Aligned_cols=267 Identities=22% Similarity=0.307 Sum_probs=197.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
.|.+.++||+|+||.||+++.. +++.||||++...... .+.+.+|++++.+++||||+++++++......++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 3566789999999999999975 4889999998754433 35678899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 84 CDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999998864 345899999999999999999999998 9999999999999999999999999998765322
Q ss_pred CccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh--------
Q 038103 669 DTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM-------- 739 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 739 (804)
. ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+....
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~ 227 (311)
T 4agu_A 157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV--------DQLYLIRKTLGDLIPRHQ 227 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCSCCHHHH
T ss_pred c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhcccccccc
Confidence 2 2234568999999999876 67899999999999999999999999643211 1111111110
Q ss_pred ---hhcC-c--ccccCCcCCCc---cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hccCCCC
Q 038103 740 ---EQEG-L--EKIIDPRLNDV---YDREKLDRMVKVALLCVAENRDTRPPMSKVVKL--LTAHDHE 795 (804)
Q Consensus 740 ---~~~~-~--~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~--L~~~~~~ 795 (804)
.... . ..+.++.-... ........+.+|+.+|++.||.+|||++++++. ++++.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 0000 0 00111100000 001223468899999999999999999999853 4444433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.62 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=200.1
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
.|.+.+.||+|+||.||++... +++.||+|++...... .+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 4567789999999999999965 5889999999744332 35678899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC---eEEeecCCccccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE---PKVTDFGLSKLFK 665 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Dfgla~~~~ 665 (804)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++....
T Consensus 87 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 87 VTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999988864 345899999999999999999999998 999999999999986655 9999999998665
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ... .......+...
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~----~~~~~~~~~~~ 225 (284)
T 3kk8_A 160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHR----LYAQIKAGAYD 225 (284)
T ss_dssp SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHH----HHHHHHHTCCC
T ss_pred cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc--------hhH----HHHHHHhcccc
Confidence 422 2234568999999999999999999999999999999999999986422 011 11222222211
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
. ..+. ... ....+.+|+.+|++.||++|||+.++++
T Consensus 226 ~-~~~~-~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 Y-PSPE-WDT----VTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp C-CTTT-TTT----SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-Cchh-hcc----cCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 1110 011 2246889999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.64 Aligned_cols=263 Identities=24% Similarity=0.358 Sum_probs=204.5
Q ss_pred HHHHHHhcccccccccCcceEEEEEe------cCCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeC
Q 038103 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAEN 579 (804)
Q Consensus 508 ~l~~~t~~~~~~LG~G~fg~Vykg~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 579 (804)
++....+.+.+.||+|+||.||+|+. .+++.||||++.... ....++.+|+.++++++||||+++++++.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 34456777889999999999999984 246789999997432 2345788999999999999999999999999
Q ss_pred CeeEEEEeeccCCChhhhhccCCC---CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC---CCCe
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPG---TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD---HFEP 653 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~ 653 (804)
...++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999976432 2245889999999999999999999998 999999999999984 4569
Q ss_pred EEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhH
Q 038103 654 KVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHL 731 (804)
Q Consensus 654 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~ 731 (804)
||+|||++........ .......+++.|+|||.+....++.++||||||+++|||++ |+.||.... ...
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~- 253 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQE- 253 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHH-
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--------HHH-
Confidence 9999999986543222 22234557889999999999999999999999999999998 999986422 011
Q ss_pred HHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 732 VQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 732 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
+...+..+.... ... .....+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus 254 ---~~~~~~~~~~~~-----~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 254 ---VLEFVTSGGRMD-----PPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ---HHHHHHTTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHhcCCCCC-----CCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 112222221111 111 223468899999999999999999999999976543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.39 Aligned_cols=246 Identities=21% Similarity=0.263 Sum_probs=200.2
Q ss_pred HHhcccccccccCcceEEEEEecC-CcEEEEEEecCc----CCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGV----LQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 585 (804)
..+.+.+.||+|+||.||+++... ++.||||+++.. ....+.+..|..++..+ +||||+++++++......++|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 456677899999999999999764 788999999742 23456788999999988 899999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 100 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999964 235899999999999999999999998 9999999999999999999999999998643
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ...+ ...+....+.
T Consensus 173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~----~~~i~~~~~~ 239 (353)
T 2i0e_A 173 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDEL----FQSIMEHNVA 239 (353)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH----HHHHHHCCCC
T ss_pred cCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHH----HHHHHhCCCC
Confidence 222 23345679999999999999999999999999999999999999996422 1111 1222222111
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPP-----MSKVVK 787 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~~Vv~ 787 (804)
+.... ...+.+|+.+||+.||.+||+ +.+|++
T Consensus 240 ------~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 ------YPKSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------CCTTS----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------CCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11122 346889999999999999996 466653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=330.67 Aligned_cols=252 Identities=15% Similarity=0.175 Sum_probs=202.7
Q ss_pred HHhcccccccccCcceEEEEE------ecCCcEEEEEEecCcCCChHHHHHHHHHHhcCC---CCcccceeeeEEeCCee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGV------LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN---HRNLVKLQGFCAENEHK 582 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~------~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~ 582 (804)
..+.+.+.||+|+||.||+|+ ..+++.||||+++. ....++..|++++.+++ |+||+++++++...+..
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS--CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC--CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 446667889999999999994 45678899999974 34567888888888886 99999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCC-CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-----------C
Q 038103 583 LLVYEYVENGSLDKLLFNDPG-TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-----------H 650 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~-----------~ 650 (804)
++||||+++|+|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999964211 2456999999999999999999999998 999999999999998 8
Q ss_pred CCeEEeecCCccccccc-CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchh
Q 038103 651 FEPKVTDFGLSKLFKER-HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCN 729 (804)
Q Consensus 651 ~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~ 729 (804)
+.+||+|||+++.+... .........||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------- 292 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------- 292 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-------
Confidence 99999999999865432 2234455679999999999999999999999999999999999999985422100
Q ss_pred hHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCC-CCHHHHHHHhccCCC
Q 038103 730 HLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTR-PPMSKVVKLLTAHDH 794 (804)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R-Ptm~~Vv~~L~~~~~ 794 (804)
..+...+..... .+.+.+++..|++.+|.+| |++.++.+.|+...+
T Consensus 293 ----------------~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 293 ----------------CKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ----------------EEECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----------------eeechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 001111111111 3457788889999999998 688888888876544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.30 Aligned_cols=258 Identities=21% Similarity=0.306 Sum_probs=203.1
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeEEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAE--NEHKLLVY 586 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 586 (804)
.|.+.+.||+|+||.||+++.. +++.||+|.+..... ..+.+.+|++++++++||||+++++++.. ....++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 4566788999999999999975 688999999974332 23568899999999999999999998854 56889999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCC--CcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL--EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~--~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||+++++|.+++.........+++..++.++.|++.||+|||+.+. .+|+|+||||+|||++.++.+||+|||++...
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~ 166 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence 9999999999997543344568999999999999999999999872 34999999999999999999999999999876
Q ss_pred cccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
..... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ... +...+..+..
T Consensus 167 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~----~~~~i~~~~~ 233 (279)
T 2w5a_A 167 NHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKE----LAGKIREGKF 233 (279)
T ss_dssp ---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHH----HHHHHHHTCC
T ss_pred ccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--------HHH----HHHHHhhccc
Confidence 44321 1233568999999999999999999999999999999999999986432 011 1222333322
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
.. +... ....+.+++.+||+.+|++||++.+|++.+...
T Consensus 234 ~~-----~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 234 RR-----IPYR----YSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp CC-----CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred cc-----CCcc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 21 1112 234688999999999999999999999887543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.89 Aligned_cols=246 Identities=22% Similarity=0.347 Sum_probs=198.3
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 585 (804)
...|.+.+.||+|+||.||+++.. +++.||||++.... ....++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 356777889999999999999975 68999999997432 2345688899999999 999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC----------------
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD---------------- 649 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~---------------- 649 (804)
|||+++++|.+++.........+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999753222356899999999999999999999998 999999999999984
Q ss_pred ---CCCeEEeecCCcccccccCCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCc
Q 038103 650 ---HFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDS 725 (804)
Q Consensus 650 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~ 725 (804)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||++++||++|..++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 4479999999998765422 23489999999999866 56789999999999999999987764211
Q ss_pred cchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 726 SYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
. ...+..+... .+....+ ..+.+|+.+||+.||++||++.++++.
T Consensus 236 -----~----~~~~~~~~~~-----~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 -----Q----WHEIRQGRLP-----RIPQVLS----QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -----H----HHHHHTTCCC-----CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----H----HHHHHcCCCC-----CCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0 1122222221 1112222 468899999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=319.63 Aligned_cols=245 Identities=27% Similarity=0.433 Sum_probs=202.2
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
+.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 556788999999999999964 6889999999743 2345789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++....... .
T Consensus 104 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 174 (303)
T 3a7i_A 104 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 174 (303)
T ss_dssp TEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence 9999999943 45899999999999999999999998 9999999999999999999999999998765432 2
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ... ......... +
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~----~~~~~~~~~-----~ 237 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------MKV----LFLIPKNNP-----P 237 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHH----HHHHHHSCC-----C
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHH----HHHhhcCCC-----C
Confidence 22345689999999999999999999999999999999999999864220 011 111111111 1
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+...++ ..+.+|+..|++.+|.+||++.++++.
T Consensus 238 ~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 TLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCCSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCccccC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1222233 368899999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=343.44 Aligned_cols=245 Identities=22% Similarity=0.268 Sum_probs=191.4
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||+++. .+++.||||+++.. ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 456678899999999999996 46889999999732 2334567889999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHh-hCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE-ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
|+++|+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++....
T Consensus 229 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 229 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp CCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred eCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999964 3458999999999999999999998 77 99999999999999999999999999986433
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...+ ...+.....
T Consensus 302 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~----~~~i~~~~~-- 366 (446)
T 4ejn_A 302 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKL----FELILMEEI-- 366 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH----HHHHHHCCC--
T ss_pred CC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHH----HHHHHhCCC--
Confidence 22 23345679999999999999999999999999999999999999996422 1111 111111111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
.+.... ...+.+|+..||+.||.+|| ++.++++
T Consensus 367 ----~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ----RFPRTL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----CCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCccC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 111122 24688999999999999999 9999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=321.89 Aligned_cols=261 Identities=22% Similarity=0.304 Sum_probs=204.6
Q ss_pred ccchHHHHHHHhccc-ccccccCcceEEEEEec-CCcEEEEEEecCcC---CChHHHHHHHHHHhcC-CCCcccceeeeE
Q 038103 503 RFTYAELKRATRNFK-QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---QGDAEFWAEVSIIGRI-NHRNLVKLQGFC 576 (804)
Q Consensus 503 ~~~~~~l~~~t~~~~-~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 576 (804)
.|...+.....|.+. +.||+|+||.||+++.. +++.||||++.... ....++.+|+.++.++ +||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 355556666677776 78999999999999965 58899999997433 2357889999999999 469999999999
Q ss_pred EeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC---CCCe
Q 038103 577 AENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD---HFEP 653 (804)
Q Consensus 577 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~ 653 (804)
......++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 9999999999999999999998642 3456899999999999999999999998 999999999999988 7899
Q ss_pred EEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHH
Q 038103 654 KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQ 733 (804)
Q Consensus 654 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~ 733 (804)
||+|||++....... ......||+.|+|||.+....++.++||||||+++|||++|+.||..... ...
T Consensus 174 kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~-- 241 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--------QET-- 241 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH--
T ss_pred EEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------hHH--
Confidence 999999998765432 22345689999999999999999999999999999999999999964220 011
Q ss_pred HHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 734 WVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...+...... . ...........+.+|+.+||+.||.+|||+.++++.
T Consensus 242 --~~~i~~~~~~-~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 242 --YLNISQVNVD-Y-----SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --HHHHHHTCCC-C-----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --HHHHHhcccc-c-----CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111111111 0 011111223468899999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=324.54 Aligned_cols=262 Identities=21% Similarity=0.280 Sum_probs=195.3
Q ss_pred hcc-cccccccCcceEEEEEe-cCCcEEEEEEecCcC-CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNF-KQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL-QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~-~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
|.+ .+.||+|+||.||+++. .+++.||||++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence 444 36799999999999995 468899999997543 3457789999999885 7999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC---eEEeecCCcccccc
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE---PKVTDFGLSKLFKE 666 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Dfgla~~~~~ 666 (804)
++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++.....
T Consensus 94 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 94 RGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred CCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999964 245889999999999999999999998 999999999999988776 99999999986543
Q ss_pred cCC------ccccccccCCCccchhhhcc-----CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccc---hhhHH
Q 038103 667 RHD------TKFSRVRGTRGYLAPEWMMN-----LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSY---CNHLV 732 (804)
Q Consensus 667 ~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~---~~~~~ 732 (804)
... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||............ .....
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 12223458999999999875 56889999999999999999999999754322111000 00111
Q ss_pred HHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 733 QWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
......+..+... +.. .........+.+|+.+||+.||.+|||+.++++.
T Consensus 247 ~~~~~~i~~~~~~-~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGKYE-FPD-----KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCCCC-CCH-----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccCcc-cCc-----hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1122222222211 000 0000123468899999999999999999999973
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=334.15 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=200.9
Q ss_pred HhcccccccccCcceEEEEEe----cCCcEEEEEEecCcC-----CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL----DDERVVAVKRLEGVL-----QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 582 (804)
.|.+.+.||+|+||.||+++. .+++.||||+++... ...+.+.+|++++.++ +|+||+++++++......
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 466778999999999999997 368899999987421 3345677899999999 699999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++
T Consensus 135 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999964 245889999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCccccccccCCCccchhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMN--LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
.+............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... . ....... ..
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~---~~~~~~~-~~ 279 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----S---QAEISRR-IL 279 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----C---HHHHHHH-HH
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc----h---HHHHHHH-Hh
Confidence 765544444455679999999999985 347899999999999999999999996432111 1 1111111 11
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHh
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVKLL 789 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~~L 789 (804)
.. .+.+.. .....+.+|+.+||+.||.+|| ++.++++..
T Consensus 280 ~~------~~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 280 KS------EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HC------CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cc------CCCCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11 111111 2234688999999999999999 999998654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=315.71 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=196.8
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.+.||+|+||.||++... +++.||||++... .....++.+|+.++++++||||+++++++.+....++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 4566788999999999999965 4778999998632 2335678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 90 YAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999964 245889999999999999999999998 999999999999999999999999998654332
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ... ..........
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----------~~~-~~~~~~~~~~--- 224 (279)
T 3fdn_A 163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----------YQE-TYKRISRVEF--- 224 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----------HHH-HHHHHHHTCC---
T ss_pred ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc-----------HHH-HHHHHHhCCC---
Confidence 2234568999999999999999999999999999999999999996422 111 1111111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+... ....+.+|+..|++.+|.+||++.+|++.
T Consensus 225 ---~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 ---TFPDF----VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---CCCTT----SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCCCc----CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111 22467899999999999999999999854
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=324.75 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=197.4
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
..+.+.+.||+|+||.||+|+..+ .+|+|.++... ...+.+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred HHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 345677899999999999999765 39999987432 2335678899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||++.......
T Consensus 111 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 111 CKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred ccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999999965 3346899999999999999999999998 99999999999998 6799999999988653211
Q ss_pred ----CccccccccCCCccchhhhcc---------CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHH
Q 038103 669 ----DTKFSRVRGTRGYLAPEWMMN---------LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV 735 (804)
Q Consensus 669 ----~~~~~~~~gt~~y~aPE~~~~---------~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 735 (804)
........|++.|+|||.+.. ..++.++||||||+++|||++|+.||.... . ...
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----------~-~~~ 251 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-----------A-EAI 251 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-----------H-HHH
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------H-HHH
Confidence 122233458899999999874 457899999999999999999999996432 0 111
Q ss_pred HHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 736 AKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 736 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
......+........ .. ...+.+|+..|++.+|++||++.+|+++|+.+.....
T Consensus 252 ~~~~~~~~~~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 252 IWQMGTGMKPNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHHHHTTCCCCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred HHHhccCCCCCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 122222222111111 11 2358899999999999999999999999999876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=326.26 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=198.4
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEee
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
...|.+.+.||+|+||.||+++.. +++.||||+++..... ..+|++++.++ +||||+++++++.++...++||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 345777889999999999999975 5889999999754332 34688888887 799999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC----CCeEEeecCCcccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH----FEPKVTDFGLSKLF 664 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~Dfgla~~~ 664 (804)
+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999964 345899999999999999999999998 9999999999998543 35999999999976
Q ss_pred cccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .. ...+...+..+..
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~----~~~~~~~i~~~~~ 240 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-----DT----PEEILARIGSGKF 240 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-----SC----HHHHHHHHHHCCC
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-----CC----HHHHHHHHccCCc
Confidence 54322 23345789999999999888899999999999999999999999964210 01 1112222233322
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.. .. .........+.+|+.+||+.||++||++.++++
T Consensus 241 ~~--~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 SL--SG----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CC--CS----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cc--Cc----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11 11 111112346889999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=331.54 Aligned_cols=246 Identities=20% Similarity=0.251 Sum_probs=187.6
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHh-cCCCCcccceeeeEEe----CCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIG-RINHRNLVKLQGFCAE----NEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~----~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||++... +++.||||+++. ...+.+|+.++. ..+||||+++++++.. ....++||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 57999999999999965 588999999863 356778888874 4589999999999875 5678999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC---CCCeEEeecCCcccccccC
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD---HFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~ 668 (804)
|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 144 g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~- 217 (400)
T 1nxk_A 144 GELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH- 217 (400)
T ss_dssp EEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCC-
Confidence 9999999753 2346899999999999999999999998 999999999999997 789999999999865432
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .. ...+..+... ..
T Consensus 218 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----~~----~~~i~~~~~~-~~ 287 (400)
T 1nxk_A 218 -NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----GM----KTRIRMGQYE-FP 287 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC----SH----HHHHHHTCCC-CC
T ss_pred -CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH----HH----HHHHHcCccc-CC
Confidence 22335678999999999999999999999999999999999999996533111110 11 1111222211 11
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+. ... ....+.+|+..||+.||++|||+.++++.
T Consensus 288 ~~~-~~~----~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 288 NPE-WSE----VSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTT-TTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Ccc-ccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 110 011 23468899999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=324.57 Aligned_cols=260 Identities=22% Similarity=0.368 Sum_probs=196.0
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
.|.+.+.||+|+||.||+++.. +++.||||++...... .+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 4566788999999999999975 4889999998744333 34578899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 106 ~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 106 VDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred CCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999888753 345899999999999999999999998 9999999999999999999999999998654432
Q ss_pred CccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHH----------HH
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV----------AK 737 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------~~ 737 (804)
. ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...... ..+.... ..
T Consensus 179 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 179 E-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-------DQLYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHHCSCCHHHHH
T ss_pred c-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHHHhCCCChhhhh
Confidence 2 22345689999999999875 7899999999999999999999998643210 1111100 00
Q ss_pred Hhhh-cCcccccCCcCCCcc-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 738 QMEQ-EGLEKIIDPRLNDVY-----DREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 738 ~~~~-~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+.. ........+.+.... .......+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0010 111111111111111 1123457899999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=326.58 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=184.7
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC--h-HHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG--D-AEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~--~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
..+.+.+.||+|+||.||+++. .+++.||||+++..... . +.+.++...++.++||||+++++++.++...++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 4566778999999999999996 56899999999744322 2 234445556888899999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
|+++ +|.+++.........+++..+..++.|++.||+|||++ + |+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9975 88888754323456799999999999999999999998 8 99999999999999999999999999987654
Q ss_pred cCCccccccccCCCccchhhh----ccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWM----MNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||..... ............
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~~~~~~~~~~~~ 230 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT----------PFQQLKQVVEEP 230 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC----------HHHHHHHHHHSC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc----------hHHHHHHHhccC
Confidence 322 2234689999999996 556789999999999999999999999964220 011111221211
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...... .. ....+.+|+.+|++.||++|||+.++++
T Consensus 231 -~~~~~~----~~----~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 -SPQLPA----DK----FSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -CCCCCT----TT----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCccc----cc----CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111111 11 2346889999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=319.79 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=201.0
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
...|.+.+.||+|+||.||+++.. +++.||+|.++... ...+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456788899999999999999965 68899999997443 2346688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE---cCCCCeEEeecCCccccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~ 665 (804)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||++ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999864 235889999999999999999999998 9999999999999 788999999999998644
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ...+ ...+..+...
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~----~~~i~~~~~~ 225 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--------ESKL----FEKIKEGYYE 225 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHH----HHHHHHCCCC
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHH----HHHHHcCCCC
Confidence 32 2234568999999999999999999999999999999999999986422 0111 1222222211
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
. ...... .....+.+++.+|++.||++||++.++++
T Consensus 226 -~-~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 -F-ESPFWD----DISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -C-CTTTTT----TSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -C-Cccccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 111111 12346889999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=336.79 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=190.7
Q ss_pred HHHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC---------CChHHHHHHHHHHhcCCCCcccceeeeEEe
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---------QGDAEFWAEVSIIGRINHRNLVKLQGFCAE 578 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 578 (804)
.....|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34556778899999999999999964 57899999986422 11234789999999999999999999975
Q ss_pred CCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC---CCeEE
Q 038103 579 NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH---FEPKV 655 (804)
Q Consensus 579 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl 655 (804)
....++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.+ ..+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 4568999999999999999864 346899999999999999999999998 9999999999999654 45999
Q ss_pred eecCCcccccccCCccccccccCCCccchhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHH
Q 038103 656 TDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM---NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLV 732 (804)
Q Consensus 656 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~ 732 (804)
+|||+++..... .......||+.|+|||++. ...++.++||||||+++|||++|+.||...... ..+
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-------~~~- 353 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-------VSL- 353 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-------CCH-
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-------HHH-
Confidence 999999976542 2233467899999999985 367889999999999999999999999642211 111
Q ss_pred HHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 733 QWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...+..+..... + .........+.+|+.+||+.||++||++.++++.
T Consensus 354 ---~~~i~~~~~~~~--~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 354 ---KDQITSGKYNFI--P----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ---HHHHHTTCCCCC--H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---HHHHhcCCCCCC--c----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111122211100 0 0001123468899999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.15 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=198.7
Q ss_pred HHHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.....+.+.+.||+|+||.||+|+.. +++.||||.+... ...+++.+|+.++.+++||||+++++++......++|||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 34455777889999999999999975 4889999999753 345778999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999863 2346899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..... ..........
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~-~~~~~~~~~~ 245 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-----------MRAIF-MIPTNPPPTF 245 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHH-HHHHSCCCCC
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHH-HHhcCCCccc
Confidence 22 22345689999999999999999999999999999999999999864220 01111 1111111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
. .+......+.+|+.+|++.||.+||++.++++
T Consensus 246 ~-------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 R-------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp S-------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C-------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 01112346889999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=322.79 Aligned_cols=262 Identities=19% Similarity=0.270 Sum_probs=197.9
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEe--------C
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAE--------N 579 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 579 (804)
..|.+.+.||+|+||.||+++. .+++.||||++.... .....+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 3567778999999999999997 568899999986332 234578899999999999999999999987 4
Q ss_pred CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
...++||||+++ +|...+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999986 77777754 3345899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccC---CccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHH
Q 038103 660 LSKLFKERH---DTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV 735 (804)
Q Consensus 660 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 735 (804)
+++.+.... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.... .......+
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i 241 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--------EQHQLALI 241 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHH
Confidence 998765322 223344668999999999876 458999999999999999999999986432 11111112
Q ss_pred HHHhhhcC---cccccC--------CcCCCccC-HH------HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 736 AKQMEQEG---LEKIID--------PRLNDVYD-RE------KLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 736 ~~~~~~~~---~~~~~d--------~~l~~~~~-~~------~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
........ ....-. ........ .+ ....+.+|+.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11111100 000000 00000000 01 12457899999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=340.65 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=200.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||+++.. +++.||+|++... ......+.+|+.++.+++||||+++++++......++|||
T Consensus 186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 265 (543)
T 3c4z_A 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265 (543)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 3455678999999999999975 5899999999632 2345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|..++.........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+...
T Consensus 266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 99999999999765434557999999999999999999999998 999999999999999999999999999876543
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+ ...+.....
T Consensus 343 ~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~----~~~~~~----~~~i~~~~~--- 410 (543)
T 3c4z_A 343 QT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKEL----KQRVLEQAV--- 410 (543)
T ss_dssp CC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC----CCHHHH----HHHHHHCCC---
T ss_pred Cc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc----hhHHHH----HHHHhhccc---
Confidence 22 223457999999999999999999999999999999999999999753211 011111 111111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPM 782 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm 782 (804)
.+...+ ...+.+|+..||+.||.+||++
T Consensus 411 ---~~p~~~----s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 ---TYPDKF----SPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ---CCCTTS----CHHHHHHHHHHSCSSGGGSCCC
T ss_pred ---CCCccc----CHHHHHHHHHhccCCHhHCCCC
Confidence 111122 3468899999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=327.65 Aligned_cols=243 Identities=26% Similarity=0.319 Sum_probs=189.3
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHH-HhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSI-IGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
.+.+.+.||+|+||.||+++.. +++.||||+++... .....+.+|..+ ++.++||||+++++++......++||
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 4667789999999999999975 47889999997432 223456667776 56789999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 119 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 119 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999964 345888999999999999999999999 99999999999999999999999999986433
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
. ........||+.|+|||++.+..++.++||||||+++|||++|+.||.... .... ...+....+
T Consensus 192 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~----~~~i~~~~~-- 256 (373)
T 2r5t_A 192 H-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEM----YDNILNKPL-- 256 (373)
T ss_dssp C-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHH----HHHHHHSCC--
T ss_pred C-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHH----HHHHHhccc--
Confidence 2 223345679999999999999999999999999999999999999996422 0111 111222211
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKV 785 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~V 785 (804)
.+....+ ..+.+|+.+||+.||.+||++.+.
T Consensus 257 ----~~~~~~~----~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 257 ----QLKPNIT----NSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp ----CCCSSSC----HHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred ----CCCCCCC----HHHHHHHHHHcccCHHhCCCCCCC
Confidence 1112222 368899999999999999998543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=342.88 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=202.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||+++.. +++.||||++... ......+.+|++++.+++||||+++++++.+....++|||
T Consensus 185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 264 (576)
T 2acx_A 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 264 (576)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 4556688999999999999975 6899999999632 3345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 265 y~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 265 LMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp CCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred cCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999753 2345899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... +........
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----~~~~----i~~~i~~~~---- 405 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREE----VERLVKEVP---- 405 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----CHHH----HHHHHHHCC----
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch----hHHH----HHHHhhccc----
Confidence 2 2334579999999999999899999999999999999999999997532110 1111 111111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
..+...+ ...+.+|+.+||+.||.+|| ++.+|++
T Consensus 406 --~~~p~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 --EEYSERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCCTTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --ccCCccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1111122 24688999999999999999 6788864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=326.80 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=189.3
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
.|.+.+.||+|+||.||+++. .+++.||||+++.... ..+.+.+|++++++++||||+++++++.+....++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 466778999999999999995 4688999999974332 235678999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE-----cCCCCeEEeecCCccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL-----DDHFEPKVTDFGLSKL 663 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl-----~~~~~~kl~Dfgla~~ 663 (804)
+++ +|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 115 ~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 115 AEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp CSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred CCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 985 999999653 34899999999999999999999998 9999999999999 4555699999999987
Q ss_pred ccccCCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
..... .......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||..... ...+.. +.......
T Consensus 187 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~-~~~~~~~~ 257 (329)
T 3gbz_A 187 FGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-------IDQLFK-IFEVLGLP 257 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH-HHHHHCCC
T ss_pred cCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH-------HHHHHH-HHHHhCCC
Confidence 64322 223345679999999999874 489999999999999999999999964220 111111 11111100
Q ss_pred Cc----------------ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 743 GL----------------EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 743 ~~----------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.. .......+...........+.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 0000000000001112356889999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.35 Aligned_cols=259 Identities=20% Similarity=0.338 Sum_probs=192.3
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+|.+.+.||+|+||.||+|+.. +++.||||++..... ....+.+|++++++++||||+++++++......++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 3566788999999999999975 688999999974322 1224567999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++ +|.+++.. .+..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 83 DK-DLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp SE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 84 89998875 3456899999999999999999999999 9999999999999999999999999998654322
Q ss_pred ccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC---cc
Q 038103 670 TKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG---LE 745 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 745 (804)
.......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.... .......+........ ..
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST--------VEEQLHFIFRILGTPTEETWP 226 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhCCCChHhch
Confidence 22234567999999999876 568999999999999999999999996432 1111122222111100 00
Q ss_pred cccC---------CcCCC----ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 746 KIID---------PRLND----VYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 746 ~~~d---------~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.... +.... .........+.+|+.+||+.||.+|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 00000 001112346789999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=335.46 Aligned_cols=274 Identities=19% Similarity=0.259 Sum_probs=206.9
Q ss_pred cccchHHHHHHHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcCC--------CCcccce
Q 038103 502 KRFTYAELKRATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN--------HRNLVKL 572 (804)
Q Consensus 502 ~~~~~~~l~~~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~--------H~niv~l 572 (804)
..+...++....|.+.++||+|+||.||+++. .+++.||||+++......+.+.+|+.++++++ |+||+++
T Consensus 27 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 27 HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp CSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred eEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 34444455556788889999999999999985 46889999999855445577889999999985 7889999
Q ss_pred eeeEE----eCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEE
Q 038103 573 QGFCA----ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILL 647 (804)
Q Consensus 573 ~g~~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl 647 (804)
++++. .....++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ + |+||||||+|||+
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll 180 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILL 180 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEE
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeE
Confidence 99987 556889999999 55666666542 235689999999999999999999998 7 9999999999999
Q ss_pred cCCC-------------------------------------------------CeEEeecCCcccccccCCccccccccC
Q 038103 648 DDHF-------------------------------------------------EPKVTDFGLSKLFKERHDTKFSRVRGT 678 (804)
Q Consensus 648 ~~~~-------------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt 678 (804)
+.++ .+||+|||++...... .....||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt 256 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQT 256 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSC
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCC
Confidence 8775 7999999999876442 2334689
Q ss_pred CCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh--------cCc------
Q 038103 679 RGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ--------EGL------ 744 (804)
Q Consensus 679 ~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~------ 744 (804)
+.|+|||++.+..++.++||||||+++|||++|+.||......... ........+...... +..
T Consensus 257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 334 (397)
T 1wak_A 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYT--RDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334 (397)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSC--HHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBC
T ss_pred CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccC--chHHHHHHHHHhcCCCChHHhhcccccccccC
Confidence 9999999999999999999999999999999999999753321110 011111111111110 000
Q ss_pred -----ccccCCcC---------CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 745 -----EKIIDPRL---------NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 745 -----~~~~d~~l---------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..+.+... ....+.+....+.+|+.+||+.||++|||+.||++
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000000 01234667788999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.17 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=193.6
Q ss_pred ccccccCcceEEEEEe-cCCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCChh
Q 038103 518 QEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLD 595 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 595 (804)
..||+|+||.||+|+. .+++.||||.+.... ...+.+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999996 468899999997443 34567899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-CCCeEEeecCCcccccccCCccccc
Q 038103 596 KLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-HFEPKVTDFGLSKLFKERHDTKFSR 674 (804)
Q Consensus 596 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~ 674 (804)
+++.... ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++. ++.+||+|||++....... .....
T Consensus 108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 182 (295)
T 2clq_A 108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTET 182 (295)
T ss_dssp HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-Ccccc
Confidence 9997632 2335678889999999999999999998 999999999999987 8999999999998764422 12234
Q ss_pred cccCCCccchhhhccCC--CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcC
Q 038103 675 VRGTRGYLAPEWMMNLK--IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRL 752 (804)
Q Consensus 675 ~~gt~~y~aPE~~~~~~--~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 752 (804)
..|++.|+|||.+.... ++.++||||||+++|||++|+.||...... . .. ....... . ..+.+
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~-~~-~~~~~~~-~----~~~~~ 247 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--------Q-AA-MFKVGMF-K----VHPEI 247 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--------H-HH-HHHHHHH-C----CCCCC
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--------h-HH-HHhhccc-c----ccccc
Confidence 56899999999997654 889999999999999999999998642200 0 00 0110000 0 11112
Q ss_pred CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 753 NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.... ...+.+|+.+|++.||++||++.++++
T Consensus 248 ~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 PESM----SAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CTTS----CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2222 346889999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=330.20 Aligned_cols=198 Identities=30% Similarity=0.480 Sum_probs=159.2
Q ss_pred HHHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCC-CCcccceeeeEEeCC--eeE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG---DAEFWAEVSIIGRIN-HRNLVKLQGFCAENE--HKL 583 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~ 583 (804)
...|.+.+.||+|+||.||+|.. .+++.||||++...... ..++.+|+.++.++. ||||+++++++...+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 34577788999999999999996 46889999999744332 356788999999997 999999999997544 789
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+|||||+ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 9999998 589999854 35889999999999999999999999 99999999999999999999999999986
Q ss_pred cccc--------------------CCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 664 FKER--------------------HDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 664 ~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
+... .........||+.|+|||++.+ ..++.++|||||||+++||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 5321 1122334579999999999976 6799999999999999999999999964
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.01 Aligned_cols=246 Identities=23% Similarity=0.370 Sum_probs=194.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEe----CCeeEEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAE----NEHKLLV 585 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV 585 (804)
+.+.+.||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 456678999999999999964 578899999874332 23568899999999999999999999875 3568999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc-CCCCeEEeecCCcccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLF 664 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~ 664 (804)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ .+|+|+||||+|||++ .++.+||+|||++...
T Consensus 108 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999999964 245889999999999999999999986 3499999999999997 7899999999999754
Q ss_pred cccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||..... ... .......+..
T Consensus 183 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------~~~-~~~~~~~~~~ 247 (290)
T 1t4h_A 183 RAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN----------AAQ-IYRRVTSGVK 247 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----------HHH-HHHHHTTTCC
T ss_pred ccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc----------HHH-HHHHHhccCC
Confidence 432 223456899999999886 4699999999999999999999999964220 111 1122222211
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.... +......+.+|+..||+.||.+||++.+|++
T Consensus 248 ~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 PASF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CGGG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccc--------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111 1111236889999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=334.06 Aligned_cols=260 Identities=19% Similarity=0.288 Sum_probs=203.7
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcCCC-CcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRINH-RNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.|.+.++||+|+||.||+|+. .+++.||||++.... ...++..|++++..++| +++..+..++.+....+|||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 466788999999999999995 568899999876432 23457899999999987 55556666677888899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE---cCCCCeEEeecCCccccccc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla~~~~~~ 667 (804)
+++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++.+...
T Consensus 86 g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 8899999964 2346999999999999999999999998 9999999999999 68899999999999976553
Q ss_pred CCc------cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 668 HDT------KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 668 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
... ......||+.|+|||.+.+..++.++||||||++||||++|+.||...... ........+......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKISEKKVA 234 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-----SHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch-----hHHHHHHHHhhcccc
Confidence 321 123567999999999999999999999999999999999999999754311 111111111111111
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
..+..+.. . ....+.+|+..|++.+|++||++.+|+++|+.+..
T Consensus 235 ~~~~~l~~-----~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 235 TSIEALCR-----G----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp SCHHHHHT-----T----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccHHHHhc-----C----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11111111 1 12468999999999999999999999999987643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.07 Aligned_cols=240 Identities=14% Similarity=0.126 Sum_probs=185.3
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCc----CCChHHHHHHH---HHHhcCCCCccccee-------eeEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV----LQGDAEFWAEV---SIIGRINHRNLVKLQ-------GFCA 577 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~----~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~~~ 577 (804)
.+.+.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+ +++++++|||||+++ +++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 345568899999999999996 56899999999732 12346788999 555566899999998 5555
Q ss_pred eCC-----------------eeEEEEeeccCCChhhhhccC---CCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEe
Q 038103 578 ENE-----------------HKLLVYEYVENGSLDKLLFND---PGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLH 637 (804)
Q Consensus 578 ~~~-----------------~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH 637 (804)
..+ ..++||||+ +|+|.+++... +.....+++..++.++.||+.||+|||+++ |+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 443 278999999 67999999642 111234556889999999999999999998 999
Q ss_pred cccccCeEEEcCCCCeEEeecCCcccccccCCccccccccCCCccchhhhccC-----------CCCcccchHHHHHHHH
Q 038103 638 CDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL-----------KIDAKADVYSYGIVLL 706 (804)
Q Consensus 638 ~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DV~S~Gvll~ 706 (804)
|||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||+++|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999999999999999985332 2334567 999999999887 8999999999999999
Q ss_pred HHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038103 707 ELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVV 786 (804)
Q Consensus 707 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv 786 (804)
||++|+.||....... ....+... . ...+ ..+.+|+.+||+.||++||++.+++
T Consensus 305 elltg~~Pf~~~~~~~--------------------~~~~~~~~-~-~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 305 WIWCADLPITKDAALG--------------------GSEWIFRS-C-KNIP----QPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp HHHHSSCCC------C--------------------CSGGGGSS-C-CCCC----HHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred HHHHCCCCCccccccc--------------------chhhhhhh-c-cCCC----HHHHHHHHHHcCCCchhCCCHHHHh
Confidence 9999999986422110 11111110 0 1222 4688999999999999999999998
Q ss_pred H
Q 038103 787 K 787 (804)
Q Consensus 787 ~ 787 (804)
+
T Consensus 359 ~ 359 (377)
T 3byv_A 359 E 359 (377)
T ss_dssp T
T ss_pred h
Confidence 5
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=314.02 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=195.9
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.+.||+|+||.||+|+.. +++.||||.+... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4567788999999999999975 6889999998632 2345678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 92 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 92 YVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp CCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred ccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999642 35889999999999999999999999 999999999999999999999999999876542
Q ss_pred CCccccccccCCCccchhhhccCCC-CcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
. ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.... ... ....+..+...
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~----~~~~~~~~~~~- 229 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPT----LFKKIRGGVFY- 229 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHH----HHHHHHHCCCC-
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHH----HHHHhhcCccc-
Confidence 2 2233468899999999987765 689999999999999999999986421 011 11222222110
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hccCCCC
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL--LTAHDHE 795 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~--L~~~~~~ 795 (804)
+.... ...+.+++.+|++.||.+||++.+|++. +....+.
T Consensus 230 -----~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~ 271 (276)
T 2h6d_A 230 -----IPEYL----NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271 (276)
T ss_dssp -----CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred -----Cchhc----CHHHHHHHHHHccCChhhCCCHHHHHhChhhccCchh
Confidence 11112 2468899999999999999999999974 4444333
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=321.11 Aligned_cols=256 Identities=18% Similarity=0.307 Sum_probs=197.1
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcCC-CCcccceeeeEEe--CCeeEEEEe
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-HRNLVKLQGFCAE--NEHKLLVYE 587 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~E 587 (804)
..|.+.+.||+|+||.||+++. .+++.||||+++. ...+.+.+|++++++++ ||||+++++++.. ....++|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 4466778999999999999985 5688999999873 34577899999999997 9999999999987 667899999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC-CeEEeecCCcccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF-EPKVTDFGLSKLFKE 666 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~ 666 (804)
|+++++|.+++.. +++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 114 ~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 114 HVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999843 788999999999999999999999 99999999999999776 899999999987654
Q ss_pred cCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHH--------HH
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV--------AK 737 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------~~ 737 (804)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ....+.... ..
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~------~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD------NYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS------HHHHHHHHHHHHCHHHHHH
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc------hHHHHHHHHHhcCCchhhh
Confidence 322 234568899999999877 6789999999999999999999999853210 001111100 00
Q ss_pred HhhhcCcc------cc--------cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 738 QMEQEGLE------KI--------IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 738 ~~~~~~~~------~~--------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+...... .+ ................+.+|+.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11110000 00 0000001111112457899999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=330.65 Aligned_cols=197 Identities=26% Similarity=0.393 Sum_probs=172.2
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
...+.+.+.||+|+||.||++... +++.||+|++..... ..+.+.+|+.++.+++||||+++++++..+...++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 345667788999999999999975 688999999975422 23578899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999964 23588999999999999999999996 7 99999999999999999999999999976543
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 185 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp H---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred c---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2 22345689999999999999999999999999999999999999964
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.71 Aligned_cols=246 Identities=23% Similarity=0.321 Sum_probs=200.9
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC----ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ----GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.+.||+|+||.||++... +++.+|+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 4556788999999999999976 478899999874321 23568889999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 96 LCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp CCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999998864 345899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+. .........
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----------~~~~-~~~~~~~~~--- 232 (294)
T 2rku_A 169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-----------LKET-YLRIKKNEY--- 232 (294)
T ss_dssp TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-----------HHHH-HHHHHTTCC---
T ss_pred cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------HHHH-HHHHhhccC---
Confidence 22 2234568999999999999899999999999999999999999996432 1111 111111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+.... ...+.+++.+|++.||++||++.++++.
T Consensus 233 ---~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 ---SIPKHI----NPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCcccc----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111122 2468899999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=332.05 Aligned_cols=255 Identities=21% Similarity=0.264 Sum_probs=184.2
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC-CChHHHHHHHHHHhcCC-CCcccceeeeEE--------eCCe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL-QGDAEFWAEVSIIGRIN-HRNLVKLQGFCA--------ENEH 581 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~--------~~~~ 581 (804)
.+.+.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++.++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 4567789999999999999964 68899999986432 33467889999999996 999999999994 3345
Q ss_pred eEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCc
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 661 (804)
.++|+||+. |+|.+++.... ....+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||++
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred EEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccc
Confidence 799999996 69999886421 2345899999999999999999999976 34999999999999999999999999999
Q ss_pred ccccccCCc-----------cccccccCCCccchhhh---ccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccc
Q 038103 662 KLFKERHDT-----------KFSRVRGTRGYLAPEWM---MNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSY 727 (804)
Q Consensus 662 ~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~ 727 (804)
......... ......+|+.|+|||.+ ....++.++||||||+++|||++|+.||......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------ 259 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH------
Confidence 876543221 11134589999999998 5667899999999999999999999998642200
Q ss_pred hhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 728 CNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
. ...+..... .... ....+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 260 ---------~-~~~~~~~~~----~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 260 ---------R-IVNGKYSIP----PHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ----------------CCCC----TTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------H-hhcCcccCC----cccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 000111100 0111 11247789999999999999999999999977654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=322.98 Aligned_cols=245 Identities=23% Similarity=0.338 Sum_probs=200.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.+.||+|+||.||+++.. +++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 4556788999999999999975 47889999987432 123568899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 122 ~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 122 LCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp CCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred cCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999864 345899999999999999999999998 999999999999999999999999999876532
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ..+. ...+.....
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------~~~~-~~~~~~~~~--- 258 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-----------LKET-YLRIKKNEY--- 258 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-----------HHHH-HHHHHHTCC---
T ss_pred cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-----------HHHH-HHHHhcCCC---
Confidence 22 2234568999999999999999999999999999999999999996422 1111 111111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+....+ ..+.+|+.+||+.||++||++.++++
T Consensus 259 ---~~~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 ---SIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---CCCTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CCCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111222 36789999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.24 Aligned_cols=249 Identities=24% Similarity=0.413 Sum_probs=194.4
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEe------CCeeEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAE------NEHKLL 584 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~------~~~~~l 584 (804)
.|.+.+.||+|+||.||+|+. .+++.||||++.......+++.+|+.++.++ +||||+++++++.. ....++
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 355678899999999999996 4688999999986666678899999999999 89999999999987 468899
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 99999999999999753 2356889999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCccccccccCCCccchhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMM-----NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
..... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||..... ..... ..
T Consensus 180 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~-~~ 246 (326)
T 2x7f_A 180 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----------MRALF-LI 246 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHH-HH
T ss_pred CcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----------HHHHH-Hh
Confidence 43221 223456899999999987 56789999999999999999999999864220 11111 11
Q ss_pred hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.......... ..+ ...+.+|+.+||+.||.+||++.++++
T Consensus 247 ~~~~~~~~~~----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 247 PRNPAPRLKS----KKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHSCCCCCSC----SCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hcCccccCCc----ccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111111 112 236889999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.90 Aligned_cols=243 Identities=23% Similarity=0.341 Sum_probs=200.2
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.+.+.||+|+||.||+++.. +++.||||.+... ....+.+.+|++++.+++||||+++++++.+....++|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 4667788999999999999975 5788999998632 2335678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 95 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 95 FAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred eCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999964 235889999999999999999999998 999999999999999999999999999765432
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ... ...+....
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~~-~~~~~~~~---- 228 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-----------TET-HRRIVNVD---- 228 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHH-HHHHHTTC----
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-----------hHH-HHHHhccc----
Confidence 22345689999999999999999999999999999999999999964320 111 11111111
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..+.... ...+.+++.+|++.||.+||++.++++
T Consensus 229 --~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 --LKFPPFL----SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cCCCCcC----CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1111222 246889999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.06 Aligned_cols=261 Identities=22% Similarity=0.300 Sum_probs=197.2
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC------ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ------GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
..|.+.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|++++++++||||+++++++.+....++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 45677789999999999999965 588999999874221 12468899999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||+++ +|..++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 v~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999986 89888865 3456889999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
.... .......+|+.|+|||.+.+. .++.++||||||+++|||++|..||.... .......+........
T Consensus 163 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~--------~~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 163 GSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--------DLDQLTRIFETLGTPT 233 (346)
T ss_dssp TSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHHHCCCC
T ss_pred cCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHHHcCCCC
Confidence 5432 223345689999999999764 58999999999999999999999986422 1111111111111110
Q ss_pred ccccc------C---CcCCCccC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 744 LEKII------D---PRLNDVYD-----REKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 744 ~~~~~------d---~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
..... + .......+ ......+.+|+.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 0 00000001 1223578999999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=337.55 Aligned_cols=256 Identities=20% Similarity=0.275 Sum_probs=190.9
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeC------Cee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAEN------EHK 582 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 582 (804)
.|.+.+.||+|+||.||++... +++.||||++..... ..+++.+|+.+++.++||||+++++++... .+.
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 4666788999999999999954 588999999975432 245688999999999999999999999654 467
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 143 ~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred EEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 999999987 56666632 3889999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh---
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM--- 739 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 739 (804)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .....+.+..
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-------~-~~~~~i~~~lg~p 282 (464)
T 3ttj_A 213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-------I-DQWNKVIEQLGTP 282 (464)
T ss_dssp ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------H-HHHHHHHHHHCSC
T ss_pred ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-------H-HHHHHHHHhcCCC
Confidence 76542 233456789999999999999999999999999999999999999964321 0 0111111110
Q ss_pred ----------------hhcC------cccccCCcCC---CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 740 ----------------EQEG------LEKIIDPRLN---DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 740 ----------------~~~~------~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.... +...+...+. ..........+.+|+.+||+.||++|||++|+++.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000000000 01112235678999999999999999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=324.28 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=200.2
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC---------hHHHHHHHHHHhcC-CCCcccceeeeEEeC
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG---------DAEFWAEVSIIGRI-NHRNLVKLQGFCAEN 579 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~---------~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 579 (804)
...|.+.+.||+|+||.||+++.. +|+.||||++...... .+.+.+|+.++.++ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 355777789999999999999975 6899999998743321 24578899999999 799999999999999
Q ss_pred CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
...++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecC
Confidence 999999999999999999964 345899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCccchhhhcc------CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHH
Q 038103 660 LSKLFKERHDTKFSRVRGTRGYLAPEWMMN------LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQ 733 (804)
Q Consensus 660 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~ 733 (804)
++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ....
T Consensus 246 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--------~~~~-- 313 (365)
T 2y7j_A 246 FSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--------QILM-- 313 (365)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH--
T ss_pred cccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--------HHHH--
Confidence 998765432 2334678999999999863 358899999999999999999999996421 0111
Q ss_pred HHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 734 WVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...+..+..... .+.. . .....+.+|+.+|++.||++||++.++++
T Consensus 314 --~~~i~~~~~~~~-~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 --LRMIMEGQYQFS-SPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp --HHHHHHTCCCCC-HHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HHHHHhCCCCCC-Cccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111222211100 0000 0 11246889999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=334.18 Aligned_cols=250 Identities=10% Similarity=0.008 Sum_probs=177.4
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCC----ChHHHHHHHHHHhcC--CCCccccee-------eeEEeC
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ----GDAEFWAEVSIIGRI--NHRNLVKLQ-------GFCAEN 579 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l--~H~niv~l~-------g~~~~~ 579 (804)
+.+.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.++..+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 556788999999999999964 689999999985432 234567775444444 799988754 344322
Q ss_pred -----------------CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhH------HHHHHHHHHHHHHHHhhCCCcEE
Q 038103 580 -----------------EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQR------YNIAVGTAKGLSYLHEECLEWVL 636 (804)
Q Consensus 580 -----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~l~yLH~~~~~~iv 636 (804)
...++||||++ |+|.+++... +..+.+..+ ..++.||++||+|||+++ |+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 34799999999 8999999752 234556666 788899999999999999 99
Q ss_pred ecccccCeEEEcCCCCeEEeecCCcccccccCCccccccccCCCccchhhhcc--CCCCcccchHHHHHHHHHHHhCCCC
Q 038103 637 HCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN--LKIDAKADVYSYGIVLLELLTGKSA 714 (804)
Q Consensus 637 H~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvll~el~tg~~p 714 (804)
||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999865432 113456799999999987 6799999999999999999999999
Q ss_pred CcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 715 SDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
|.......... +............+...........+.+|+.+||+.||++|||+.++++
T Consensus 293 f~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGS-------------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTC-------------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccc-------------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 97543211100 0000000111111111111123457889999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=318.78 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=196.0
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCc-CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV-LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
..|.+.+.||+|+||.||+|+.. +++.||+|.+... ....+++.+|++++.+++||||+++++++......++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 34667788999999999999976 5889999998743 345678999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 99 PGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999999865 2345899999999999999999999998 9999999999999999999999999986432211
Q ss_pred ccccccccCCCccchhhh-----ccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 670 TKFSRVRGTRGYLAPEWM-----MNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~-----~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
.......|++.|+|||.+ ....++.++||||||+++|||++|+.|+.... ....... ......
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----------~~~~~~~-~~~~~~ 239 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----------PMRVLLK-IAKSDP 239 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-----------HHHHHHH-HHHSCC
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-----------HHHHHHH-HhccCC
Confidence 112234689999999998 36678999999999999999999999986432 0111111 111111
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..... +......+.+++.+|++.||.+|||+.++++
T Consensus 240 ~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 PTLLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCCSS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cccCC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11110 1112346889999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=318.19 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=192.9
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEe------------
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAE------------ 578 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------------ 578 (804)
..|.+.+.||+|+||.||+|+.. +++.||||++.......+++.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 45677889999999999999964 68899999997544455778999999999999999999998865
Q ss_pred -CCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEee
Q 038103 579 -NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTD 657 (804)
Q Consensus 579 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 657 (804)
....++||||+++++|.+++.. ....+++..++.++.|+++||+|||+++ |+|+||||+|||++.++.+||+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred cCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 4577999999999999999975 3346788999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccccC-------------CccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccC
Q 038103 658 FGLSKLFKERH-------------DTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASAS 723 (804)
Q Consensus 658 fgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~ 723 (804)
||++....... ........|++.|+|||.+.+. .++.++||||||+++|||++ |+....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---- 232 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---- 232 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch----
Confidence 99998764321 1122345689999999999864 68999999999999999998 443110
Q ss_pred CccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 724 DSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.... ....+.... ..+....+......+.+|+.+|++.||.+|||+.++++.
T Consensus 233 ------~~~~-~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 ------ERVN-ILKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ------HHHH-HHHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------hHHH-HHHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0111 111122111 111122233334568899999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=326.33 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=202.0
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCC----h--------------HHHHHHHHHHhcCCCCccccee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQG----D--------------AEFWAEVSIIGRINHRNLVKLQ 573 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~----~--------------~~~~~E~~~l~~l~H~niv~l~ 573 (804)
..|.+.+.||+|+||.||+++. +++.||||++...... . +.+.+|+.++.+++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3566778999999999999999 8999999999732211 1 7899999999999999999999
Q ss_pred eeEEeCCeeEEEEeeccCCChhhh------hccCCCCCCCCCHHhHHHHHHHHHHHHHHHHh-hCCCcEEecccccCeEE
Q 038103 574 GFCAENEHKLLVYEYVENGSLDKL------LFNDPGTASILQWDQRYNIAVGTAKGLSYLHE-ECLEWVLHCDVKPQNIL 646 (804)
Q Consensus 574 g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dlkp~NIL 646 (804)
+++.+.+..++||||+++++|.++ +... ....+++..+..++.|++.||+|||+ .+ |+|+||||+|||
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 999999999999999999999999 5331 24679999999999999999999999 88 999999999999
Q ss_pred EcCCCCeEEeecCCcccccccCCccccccccCCCccchhhhccC-CCCc-ccchHHHHHHHHHHHhCCCCCcccccccCC
Q 038103 647 LDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL-KIDA-KADVYSYGIVLLELLTGKSASDYLSASASD 724 (804)
Q Consensus 647 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-k~DV~S~Gvll~el~tg~~p~~~~~~~~~~ 724 (804)
++.++.+||+|||++...... ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---
Confidence 999999999999999876443 33445689999999999877 6666 999999999999999999999743210
Q ss_pred ccchhhHHHHHHHHhhhcCcccccC------CcCC---CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 725 SSYCNHLVQWVAKQMEQEGLEKIID------PRLN---DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~d------~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.. ....+..+......+ +... ..........+.+|+.+||+.||.+||++.++++
T Consensus 259 ----~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 ----VE----LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ----HH----HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----HH----HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 122222222111100 0000 0001223357889999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=323.21 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=183.6
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
..+.+.+.||+|+||.||++.. .+++.||||++... ....+++.+|+.++.+++||||+++++++...+..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 3456778999999999999995 46889999998643 23456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC----CCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 589 VENGSLDKLLFND----PGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 589 ~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
+++++|.+++... ......+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 9999999998631 112456899999999999999999999998 999999999999999999999999999866
Q ss_pred cccCC----ccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 665 KERHD----TKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 665 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
..... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...... ... ....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~----~~~~ 240 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-------KVL----MLTL 240 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-------GHH----HHHH
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-------hHH----HHHh
Confidence 43221 12234568999999999875 56899999999999999999999999653211 111 1111
Q ss_pred hhcCccc----ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 740 EQEGLEK----IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 740 ~~~~~~~----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
. ..... ..++.....++ ..+.+|+.+|++.||.+||++.++++
T Consensus 241 ~-~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 Q-NDPPSLETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp T-SSCCCTTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c-cCCCccccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1 11111 11111112222 46889999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=339.06 Aligned_cols=250 Identities=23% Similarity=0.314 Sum_probs=203.5
Q ss_pred HHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
....|.+.+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467888899999999999999975 6889999998633 2345779999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE---cCCCCeEEeecCCc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL---DDHFEPKVTDFGLS 661 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~Dfgla 661 (804)
|+||+.+++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999999864 345899999999999999999999998 9999999999999 56789999999999
Q ss_pred ccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 662 KLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
....... ......||+.|+|||.+.+ .++.++||||+|+++|||++|+.||.... ... ....+..
T Consensus 177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~----~~~~i~~ 241 (484)
T 3nyv_A 177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--------EYD----ILKKVEK 241 (484)
T ss_dssp HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHH----HHHHHHH
T ss_pred EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--------HHH----HHHHHHc
Confidence 8765432 2344568999999999876 79999999999999999999999996432 011 1222222
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+...... .........+.+|+.+||+.+|.+|||+.++++
T Consensus 242 ~~~~~~~------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 242 GKYTFEL------PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCCCCCS------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCC------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 2221100 001112346889999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=331.60 Aligned_cols=259 Identities=20% Similarity=0.256 Sum_probs=192.9
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeC-----------
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAEN----------- 579 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----------- 579 (804)
.+|.+.+.||+|+||.||+|+. .+++.||||++..... ...+|++++++++||||+++++++...
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 3566778999999999999996 5689999999864322 224699999999999999999998443
Q ss_pred ---------------------------CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCC
Q 038103 580 ---------------------------EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632 (804)
Q Consensus 580 ---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~ 632 (804)
...++||||+++ +|.+.+.........+++..+..++.||++||+|||+.+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g- 161 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG- 161 (383)
T ss_dssp --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc-
Confidence 347899999985 887777542224567999999999999999999999998
Q ss_pred CcEEecccccCeEEEc-CCCCeEEeecCCcccccccCCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHh
Q 038103 633 EWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLT 710 (804)
Q Consensus 633 ~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~t 710 (804)
|+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||.+.+. .++.++||||+|+++|||++
T Consensus 162 --i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 162 --ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp --EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred --CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 99999999999998 68899999999998764432 22345679999999998765 48999999999999999999
Q ss_pred CCCCCcccccccCCccchhhHHHHHHHHhhh----------cCcccc-----cCCcCCCccCHHHHHHHHHHHHhcccCC
Q 038103 711 GKSASDYLSASASDSSYCNHLVQWVAKQMEQ----------EGLEKI-----IDPRLNDVYDREKLDRMVKVALLCVAEN 775 (804)
Q Consensus 711 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~-----~d~~l~~~~~~~~~~~l~~l~~~Cl~~~ 775 (804)
|+.||..... ...+.. +...... ....+. .........+......+.+|+.+||+.|
T Consensus 238 g~~pf~~~~~-------~~~~~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 238 GKPLFSGETS-------IDQLVR-IIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp SSCSSCCSSH-------HHHHHH-HHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred CCCCCCCCCh-------HHHHHH-HHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999964321 111111 1111000 001111 0111111112223456899999999999
Q ss_pred CCCCCCHHHHHH
Q 038103 776 RDTRPPMSKVVK 787 (804)
Q Consensus 776 P~~RPtm~~Vv~ 787 (804)
|.+|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=336.52 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=197.4
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCc---CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV---LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
...|.+.+.||+|+||.||+++.. +++.||||++... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456788899999999999999975 6889999999743 234577899999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC---CCeEEeecCCccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH---FEPKVTDFGLSKL 663 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~Dfgla~~ 663 (804)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999998864 345889999999999999999999998 9999999999999764 4599999999987
Q ss_pred ccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
..... ......||+.|+|||++. ..++.++||||+|+++|+|++|+.||.... ... +...+..+.
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~----~~~~i~~~~ 253 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--------DQE----ILRKVEKGK 253 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHH----HHHHHHHTC
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------HHH----HHHHHHhCC
Confidence 65432 234457899999999886 579999999999999999999999996432 111 122222222
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
... ..+. .. .....+.+|+.+||+.+|.+|||+.++++
T Consensus 254 ~~~-~~~~-~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 254 YTF-DSPE-WK----NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCC-CSGG-GT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC-Cchh-cc----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 110 0110 01 12246889999999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=336.93 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=201.7
Q ss_pred HHHHhcccccccccCcceEEEEEec-CCcEEEEEEecC---cCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEG---VLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
....|.+.+.||+|+||.||+++.. +++.||||++.. .......+.+|++++++++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467888999999999999999965 688999999863 234567899999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc---CCCCeEEeecCCcc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD---DHFEPKVTDFGLSK 662 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~ 662 (804)
+||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999998864 245899999999999999999999999 99999999999995 45679999999998
Q ss_pred cccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
..... .......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||.... ... ....+..+
T Consensus 173 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~----~~~~i~~~ 237 (486)
T 3mwu_A 173 CFQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYD----ILKRVETG 237 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHH----HHHHHHHT
T ss_pred ECCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHH----HHHHHHhC
Confidence 76543 22334568999999999876 69999999999999999999999996422 011 11222222
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...... + ........+.+|+.+||+.+|.+|||+.++++.
T Consensus 238 ~~~~~~-~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 238 KYAFDL-P-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CCCSCS-G-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCC-c-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 211100 0 011123468899999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=333.64 Aligned_cols=195 Identities=26% Similarity=0.347 Sum_probs=169.9
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcC------CCCcccceeeeEEeCCeeEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRI------NHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~~lV 585 (804)
+|.+.+.||+|+||.||+|... +++.||||+++.......++.+|++++..+ +|+||+++++++......++|
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 4667789999999999999865 588999999986544456778888888877 577999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC--eEEeecCCccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE--PKVTDFGLSKL 663 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~Dfgla~~ 663 (804)
|||+. ++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 178 ~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 178 FELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp ECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 99996 5999998763 2345899999999999999999999998 999999999999999887 99999999976
Q ss_pred ccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 252 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 252 EHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 4332 2345689999999999999999999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=354.78 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=202.3
Q ss_pred HHHHhcccccccccCcceEEEEEecC----CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 510 KRATRNFKQEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 510 ~~~t~~~~~~LG~G~fg~Vykg~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
....+.+.+.||+|+||.||+|+... +..||||+++.... ..+++.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34567778899999999999999642 46799999874332 2367899999999999999999999985 45689
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 467 lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 99999999999999975 3345899999999999999999999998 99999999999999999999999999997
Q ss_pred ccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
.............+++.|+|||.+....++.++||||||+++|||++ |+.||..... ... ...+..+
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--------~~~----~~~i~~~ 608 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDV----IGRIENG 608 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHH----HHHHHHT
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--------HHH----HHHHHcC
Confidence 75544333344556789999999999999999999999999999997 9999864320 111 1122222
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
.... +.. .....+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 609 ~~~~-----~~~----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 609 ERLP-----MPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC-----CCc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111 111 22347889999999999999999999999998764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=335.81 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=197.6
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--------------CChHHHHHHHHHHhcCCCCcccceeeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--------------QGDAEFWAEVSIIGRINHRNLVKLQGFC 576 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~g~~ 576 (804)
..|.+.++||+|+||.||+++.. +++.||||++.... ...+++.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34667789999999999999965 57899999987432 2346789999999999999999999999
Q ss_pred EeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC---Ce
Q 038103 577 AENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF---EP 653 (804)
Q Consensus 577 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~ 653 (804)
.+....++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999999864 345899999999999999999999998 99999999999998775 69
Q ss_pred EEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHH
Q 038103 654 KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQ 733 (804)
Q Consensus 654 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~ 733 (804)
||+|||++....... ......||+.|+|||.+. ..++.++||||+|+++|+|++|+.||.... ...
T Consensus 189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~--- 254 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--------DQD--- 254 (504)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHH---
T ss_pred EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHH---
Confidence 999999998765432 234456899999999987 469999999999999999999999996432 111
Q ss_pred HHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 734 WVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+...+..+....... ........+.+|+.+||+.||.+|||+.++++
T Consensus 255 -~~~~i~~~~~~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 255 -IIKKVEKGKYYFDFN------DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -HHHHHHHCCCCCCHH------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHHcCCCCCCcc------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 122222222110000 00011246889999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=324.38 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=192.8
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCC------ee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENE------HK 582 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~ 582 (804)
.|.+.+.||+|+||.||+|+. .+++.||||++...... .+++.+|++++++++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 456678899999999999996 46899999999654333 356889999999999999999999997653 45
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 106 ~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp EEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 9999999 7799999864 35889999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
..... .....+|+.|+|||.+.+ ..++.++||||+||+++||++|+.||..... ......+......
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~l~~i~~~~g~ 244 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--------LDQLKEIMKVTGT 244 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHHHCC
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhcCC
Confidence 75432 234568999999999887 6799999999999999999999999964321 0111111110000
Q ss_pred c------------------CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HhccCCC
Q 038103 742 E------------------GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK--LLTAHDH 794 (804)
Q Consensus 742 ~------------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~--~L~~~~~ 794 (804)
. .+.......+. .........+.+|+.+||+.||.+|||+.++++ .++....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 0 00000001110 011122346889999999999999999999987 3555433
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=313.36 Aligned_cols=248 Identities=20% Similarity=0.285 Sum_probs=195.9
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCc-----CCChHHHHHHHHHHhcCCCCcccceeeeEE--eCCeeEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV-----LQGDAEFWAEVSIIGRINHRNLVKLQGFCA--ENEHKLL 584 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~l 584 (804)
.|.+.+.||+|+||.||++... +++.||||.+... ....+.+.+|++++++++|+||+++++++. +....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 4667889999999999999964 5789999999742 233467899999999999999999999984 4567899
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||++++ |.+++... ....+++..+..++.|++.||+|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 86 v~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 99999886 77777653 2456899999999999999999999998 999999999999999999999999999876
Q ss_pred cccC-CccccccccCCCccchhhhccCC--CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 665 KERH-DTKFSRVRGTRGYLAPEWMMNLK--IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 665 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
.... ........|+..|+|||.+.+.. ++.++||||||+++|||++|+.||.... ... ....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----------~~~-~~~~i~~ 227 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----------IYK-LFENIGK 227 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----------HHH-HHHHHHH
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----------HHH-HHHHHhc
Confidence 5322 22333456899999999997644 4789999999999999999999996422 111 1122222
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+.. .+.... ...+.+|+.+|++.||.+||++.++++.
T Consensus 228 ~~~------~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 228 GSY------AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCC------CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCC------CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 211 111222 2467899999999999999999999964
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=318.91 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=201.6
Q ss_pred HHHhcccccccccCcceEEEEEe--cCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCc------ccceeeeEEeCCee
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVL--DDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN------LVKLQGFCAENEHK 582 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~--~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~~ 582 (804)
...|.+.+.||+|+||.||++.. .+++.||||+++......+.+.+|++++.+++|++ ++++++++......
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 34677788999999999999986 36889999999865445567889999999887654 99999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-------------
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD------------- 649 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~------------- 649 (804)
++||||+ +++|.+++... ....+++..+..++.|+++||+|||+++ |+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 88999999753 2345889999999999999999999998 999999999999987
Q ss_pred ------CCCeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccC
Q 038103 650 ------HFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASAS 723 (804)
Q Consensus 650 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~ 723 (804)
++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--- 239 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS--- 239 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH---
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh---
Confidence 668999999999864432 2345689999999999999999999999999999999999999964321
Q ss_pred CccchhhHHHHHHHHhhh--------cCccccc---------------------CCcC-CCccCHHHHHHHHHHHHhccc
Q 038103 724 DSSYCNHLVQWVAKQMEQ--------EGLEKII---------------------DPRL-NDVYDREKLDRMVKVALLCVA 773 (804)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~--------~~~~~~~---------------------d~~l-~~~~~~~~~~~l~~l~~~Cl~ 773 (804)
......+...... ....... .+.. .........+.+.+|+.+||+
T Consensus 240 -----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 240 -----KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp -----HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred -----HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 0111111111000 0000000 0000 001123456789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 038103 774 ENRDTRPPMSKVVKL 788 (804)
Q Consensus 774 ~~P~~RPtm~~Vv~~ 788 (804)
.||.+|||+.||++.
T Consensus 315 ~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 315 YDPAKRITLREALKH 329 (339)
T ss_dssp SSTTTSCCHHHHTTS
T ss_pred cCcccccCHHHHhcC
Confidence 999999999999853
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.53 Aligned_cols=260 Identities=19% Similarity=0.259 Sum_probs=190.4
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCC------------hHHHHHHHHHHhcCCCCcccceeeeEEe-
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQG------------DAEFWAEVSIIGRINHRNLVKLQGFCAE- 578 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~------------~~~~~~E~~~l~~l~H~niv~l~g~~~~- 578 (804)
..|.+.+.||+|+||.||+|...+++.||||++...... .+.+.+|++++.+++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 345566889999999999999888999999999632221 1678999999999999999999999854
Q ss_pred ----CCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeE
Q 038103 579 ----NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPK 654 (804)
Q Consensus 579 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 654 (804)
....++||||++ |+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEE
Confidence 336799999998 588888864 3456899999999999999999999998 99999999999999999999
Q ss_pred EeecCCcccccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHH
Q 038103 655 VTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQ 733 (804)
Q Consensus 655 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~ 733 (804)
|+|||++....... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .....
T Consensus 175 l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~~~ 244 (362)
T 3pg1_A 175 ICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF--------YNQLN 244 (362)
T ss_dssp ECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHH
T ss_pred EEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH--------HHHHH
Confidence 99999998544322 2234568899999999876 6789999999999999999999999964220 11111
Q ss_pred HHHHHhhhcCc-----------ccccCCcCC-------CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 734 WVAKQMEQEGL-----------EKIIDPRLN-------DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 734 ~~~~~~~~~~~-----------~~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+......... ...+...+. ..........+.+|+.+||+.||.+|||+.++++.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 11111110000 000000000 01111223568899999999999999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=333.37 Aligned_cols=192 Identities=27% Similarity=0.436 Sum_probs=152.0
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeC-----CeeE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAEN-----EHKL 583 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 583 (804)
.|.+.+.||+|+||.||+|+.. +++.||||++...... .+++.+|++++++++|+||+++++++... ...+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 4677889999999999999965 6889999999754333 35688999999999999999999998543 5789
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 134 lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 134 VVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 9999985 689999864 346899999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCC--------------------------ccccccccCCCccchhhh-ccCCCCcccchHHHHHHHHHHHhCC
Q 038103 664 FKERHD--------------------------TKFSRVRGTRGYLAPEWM-MNLKIDAKADVYSYGIVLLELLTGK 712 (804)
Q Consensus 664 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~k~DV~S~Gvll~el~tg~ 712 (804)
...... .......||+.|+|||++ ....++.++|||||||+||||++|.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 643221 123445689999999986 5667999999999999999999943
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=328.63 Aligned_cols=196 Identities=25% Similarity=0.431 Sum_probs=164.7
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeC-----CeeE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAEN-----EHKL 583 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 583 (804)
.|.+.+.||+|+||.||+|+.. +++.||||++...... .+++.+|++++++++|+||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 5667789999999999999964 5788999999754333 35688999999999999999999999766 5789
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 9999987 499999964 345899999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCC---------------------ccccccccCCCccchhhh-ccCCCCcccchHHHHHHHHHHHhCCCCCc
Q 038103 664 FKERHD---------------------TKFSRVRGTRGYLAPEWM-MNLKIDAKADVYSYGIVLLELLTGKSASD 716 (804)
Q Consensus 664 ~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~s~k~DV~S~Gvll~el~tg~~p~~ 716 (804)
...... .......||+.|+|||.+ ....++.++|||||||++|||++|..|+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 654321 123556789999999986 56679999999999999999999766654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.97 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=195.6
Q ss_pred HHHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC---------CChHHHHHHHHHHhcCCCCcccceeeeEEe
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL---------QGDAEFWAEVSIIGRINHRNLVKLQGFCAE 578 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 578 (804)
.....|.+.+.||+|+||.||+++.. +++.||||.+.... .....+.+|++++.+++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34567888899999999999999965 57899999986422 112357899999999999999999999876
Q ss_pred CCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC---eEE
Q 038103 579 NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE---PKV 655 (804)
Q Consensus 579 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl 655 (804)
.. .++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEE
T ss_pred Cc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEE
Confidence 54 8999999999999999864 346899999999999999999999998 999999999999987654 999
Q ss_pred eecCCcccccccCCccccccccCCCccchhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHH
Q 038103 656 TDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM---NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLV 732 (804)
Q Consensus 656 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~ 732 (804)
+|||++...... .......||+.|+|||.+. ...++.++||||||+++|||++|+.||...... ..+.
T Consensus 159 ~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~ 229 (322)
T 2ycf_A 159 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-------VSLK 229 (322)
T ss_dssp CCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-------SCHH
T ss_pred ccCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-------HHHH
Confidence 999999876432 2223456899999999974 567899999999999999999999999643211 0111
Q ss_pred HHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 733 QWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..+..+..... +. ........+.+|+.+|++.||++||++.++++
T Consensus 230 ----~~~~~~~~~~~--~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 230 ----DQITSGKYNFI--PE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ----HHHHHTCCCCC--HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HHHHhCccccC--ch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11122211100 00 00112346889999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=329.07 Aligned_cols=270 Identities=20% Similarity=0.317 Sum_probs=182.6
Q ss_pred hcc-cccccccCcceEEEEEec---CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeEEEEe
Q 038103 514 RNF-KQEVGKGGFGSVFRGVLD---DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAE--NEHKLLVYE 587 (804)
Q Consensus 514 ~~~-~~~LG~G~fg~Vykg~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E 587 (804)
+.+ .++||+|+||.||+|+.. +++.||||++.... ....+.+|+.++++++||||+++++++.. ....++|||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 444 457999999999999965 47789999997432 34578899999999999999999999954 678999999
Q ss_pred eccCCChhhhhccCC-----CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE----cCCCCeEEeec
Q 038103 588 YVENGSLDKLLFNDP-----GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL----DDHFEPKVTDF 658 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Df 658 (804)
|+.+ +|.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 101 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp CCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred CCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 9975 8877774211 12235899999999999999999999999 9999999999999 77889999999
Q ss_pred CCcccccccCC--ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccC-CccchhhHHHH
Q 038103 659 GLSKLFKERHD--TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASAS-DSSYCNHLVQW 734 (804)
Q Consensus 659 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~-~~~~~~~~~~~ 734 (804)
|+++....... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ ...........
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 99997654322 233456789999999999874 589999999999999999999999965332110 00111111111
Q ss_pred HHHHhhhcCc---cccc------------CCcCCCccCH---------HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 735 VAKQMEQEGL---EKII------------DPRLNDVYDR---------EKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 735 ~~~~~~~~~~---~~~~------------d~~l~~~~~~---------~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+...+..... ..+. .......... .....+.+|+.+||+.||.+|||++|+++.
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111111000 0000 0000000000 013467899999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=331.33 Aligned_cols=258 Identities=23% Similarity=0.279 Sum_probs=190.8
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeC------CeeEEEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAEN------EHKLLVY 586 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~ 586 (804)
|.+.+.||+|+||.||+|+.. +++.||||++..... .+.+|++++++++|+||+++++++... ...++||
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 556788999999999999975 589999999864322 234699999999999999999998542 2367999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC-CCeEEeecCCccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH-FEPKVTDFGLSKLFK 665 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfgla~~~~ 665 (804)
||+++ +|.+.+.........+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99986 666665432223456899999999999999999999998 9999999999999965 568999999998764
Q ss_pred ccCCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHH-------
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAK------- 737 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 737 (804)
.... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+...+..
T Consensus 209 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~-------~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 209 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-------GVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp TTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHHHCSCCHH
T ss_pred cCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHHhCCCCHH
Confidence 4322 2345689999999998765 79999999999999999999999996422 11111111110
Q ss_pred Hhhh--cCcccccCCcCCCc-----cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 738 QMEQ--EGLEKIIDPRLNDV-----YDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 738 ~~~~--~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+.. ....+..-+.+... +.......+.+|+.+||+.||.+||++.|+++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000 11111111111110 11122357899999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=345.98 Aligned_cols=246 Identities=20% Similarity=0.260 Sum_probs=201.1
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 585 (804)
..+.+.+.||+|+||.||+++.. +++.||||+++.. ....+.+..|..++..+ +|++|+++++++.+....+||
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 44667788999999999999965 5788999999742 23456788899999988 799999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 421 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999974 245899999999999999999999998 9999999999999999999999999998643
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
... .......||+.|+|||++.+..++.++||||||++||||++|+.||.... ... +...+....+
T Consensus 494 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------~~~----~~~~i~~~~~- 559 (674)
T 3pfq_A 494 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDE----LFQSIMEHNV- 559 (674)
T ss_dssp CTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHH----HHHHHHSSCC-
T ss_pred cCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------HHH----HHHHHHhCCC-
Confidence 322 23445679999999999999999999999999999999999999996432 011 1122222211
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPM-----SKVVK 787 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm-----~~Vv~ 787 (804)
.+.. .....+.+|+..||+.||.+||++ ++|++
T Consensus 560 -----~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 -----AYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -----CCCT----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -----CCCc----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1111 223468899999999999999998 66653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=315.13 Aligned_cols=259 Identities=23% Similarity=0.332 Sum_probs=197.0
Q ss_pred HhcccccccccCcceEEEEEe--cCCcEEEEEEecCcC---CChHHHHHHHHHHhcC---CCCcccceeeeEE-----eC
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL--DDERVVAVKRLEGVL---QGDAEFWAEVSIIGRI---NHRNLVKLQGFCA-----EN 579 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~--~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~g~~~-----~~ 579 (804)
.|.+.+.||+|+||.||+++. .+++.||||++.... .....+.+|+.+++++ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 466778999999999999997 468899999987322 2234567788777766 8999999999987 55
Q ss_pred CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
...++|+||++ |+|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCc
Confidence 67899999998 5999999763 2335899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 660 LSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 660 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ......+....
T Consensus 166 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~ 235 (326)
T 1blx_A 166 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--------VDQLGKILDVI 235 (326)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHH
T ss_pred ccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHHHc
Confidence 998765322 23345689999999999999999999999999999999999999964321 11111111111
Q ss_pred hhcCcccc----------cC---CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 740 EQEGLEKI----------ID---PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 740 ~~~~~~~~----------~d---~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
........ .. ..............+.+|+.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 10000000 00 00000111123356889999999999999999999995
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=311.90 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=198.9
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC----------ChHHHHHHHHHHhcCC-CCcccceeeeEEeCC
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ----------GDAEFWAEVSIIGRIN-HRNLVKLQGFCAENE 580 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~----------~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 580 (804)
.|.+.+.||+|+||.||+++.. +++.||||.+..... ..+.+.+|++++.+++ ||||+++++++....
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 4566788999999999999975 588999999974321 1245788999999995 999999999999999
Q ss_pred eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCC
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGL 660 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 660 (804)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999964 345899999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCccccccccCCCccchhhhc------cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH
Q 038103 661 SKLFKERHDTKFSRVRGTRGYLAPEWMM------NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 661 a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
+....... ......+++.|+|||.+. ...++.++||||||++++||++|+.||.... ...
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~---- 236 (298)
T 1phk_A 171 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QML---- 236 (298)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHH----
T ss_pred hhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--------HHH----
Confidence 98765432 233456899999999985 4568899999999999999999999986422 011
Q ss_pred HHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 735 VAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
....+..+.... ..+. .......+.+|+.+|++.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 237 MLRMIMSGNYQF-GSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHHTCCCC-CTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhcCCccc-Cccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111222222111 0110 1122346889999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=327.54 Aligned_cols=266 Identities=22% Similarity=0.267 Sum_probs=193.5
Q ss_pred HhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCe------eEEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEH------KLLVY 586 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~lV~ 586 (804)
+|.+.+.||+|+||.||+++...+..+|+|++..... ...+|++++++++||||+++++++..... .++||
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 4667789999999999999987777799998864322 12369999999999999999999965443 78999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc-CCCCeEEeecCCccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~ 665 (804)
||++++.+. .+.........+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++...
T Consensus 118 e~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 118 EYVPETVYR-ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp ECCSEEHHH-HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCccHHH-HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 999875443 33211113456899999999999999999999998 99999999999999 79999999999998764
Q ss_pred ccCCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHH-------
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAK------- 737 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 737 (804)
.... .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ...+...+..
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-------~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 194 AGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-------IDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHHHCCCCHH
T ss_pred CCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHHhCCCCHH
Confidence 4322 2345679999999998765 589999999999999999999999964321 1111111110
Q ss_pred ---Hhhhc----CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hccCCC
Q 038103 738 ---QMEQE----GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL--LTAHDH 794 (804)
Q Consensus 738 ---~~~~~----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~--L~~~~~ 794 (804)
..... .+.......+...+.......+.+|+.+||+.||.+|||+.++++. ++++..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00000 0000000000001111233578999999999999999999999864 554433
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=320.79 Aligned_cols=264 Identities=20% Similarity=0.283 Sum_probs=188.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCC------ee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENE------HK 582 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~ 582 (804)
.|.+.+.||+|+||.||++... +++.||||++...... .+++.+|+.++++++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 4667788999999999999964 6889999999754332 356889999999999999999999997654 78
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++||||+++ +|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 106 ~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred EEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 999999975 78888742 3889999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccC-----------CccchhhH
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASAS-----------DSSYCNHL 731 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~-----------~~~~~~~~ 731 (804)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......+
T Consensus 176 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 176 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 65432 223345689999999999999999999999999999999999999964321000 00000000
Q ss_pred HHHHHHHhhhcC------cccccCCcCC---CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 732 VQWVAKQMEQEG------LEKIIDPRLN---DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 732 ~~~~~~~~~~~~------~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...+........ +......... ..........+.+|+.+||+.||.+|||++++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000000 0000000000 01112335678999999999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=321.08 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=179.0
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeC------Ce
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAEN------EH 581 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 581 (804)
..|.+.+.||+|+||.||+|.. .+++.||||++...... .+++.+|++++++++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 3466678899999999999995 46889999999754332 35688999999999999999999998754 56
Q ss_pred eEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCc
Q 038103 582 KLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLS 661 (804)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla 661 (804)
.++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred EEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 79999999 6799998853 45899999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 662 KLFKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
+..... .....+|+.|+|||.+.+ ..++.++||||||++++||++|+.||..... ......+.....
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~l~~i~~~~g 247 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--------IDQLKLILRLVG 247 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHHC
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhC
Confidence 865432 234578999999999877 6789999999999999999999999964321 111111111111
Q ss_pred hcC------------------cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 741 QEG------------------LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 741 ~~~------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
... +.......+. .........+.+|+.+||+.||.+|||+.++++.
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 0000000000 0001113468899999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=317.40 Aligned_cols=249 Identities=18% Similarity=0.307 Sum_probs=191.7
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCC--CCcccceeeeEEeCCeeEEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRIN--HRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 586 (804)
..|.+.+.||+|+||.||++...+++.||||.+..... ..+.+.+|++++.+++ |+||+++++++......++||
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 34667789999999999999988899999999974332 2356889999999997 599999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
| +.+++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++ +.+||+|||++.....
T Consensus 108 e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 108 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp C-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred e-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 9 567899999975 245889999999999999999999998 999999999999975 7999999999987654
Q ss_pred cCCc-cccccccCCCccchhhhcc-----------CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH
Q 038103 667 RHDT-KFSRVRGTRGYLAPEWMMN-----------LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 667 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
.... ......|++.|+|||.+.. ..++.++||||||+++|||++|+.||..... ....
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------~~~~ 248 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------QISK 248 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS----------HHHH
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH----------HHHH
Confidence 3221 2234568999999999875 4788899999999999999999999864220 0111
Q ss_pred HHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 735 VAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...... +......+......+.+|+.+||+.||.+||++.++++.
T Consensus 249 ~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 249 LHAIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHh---------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111 111111111113468899999999999999999999863
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=321.61 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=196.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeC-----CeeEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAEN-----EHKLL 584 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l 584 (804)
.|.+.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|++++.+++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 4667789999999999999964 688899999974332 236688999999999999999999999755 36899
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
|+||+.+ +|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~-~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 108 VQDLMET-DLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEECCSE-EHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEcccCc-CHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 9999975 99999854 34899999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCc--cccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 665 KERHDT--KFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 665 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
...... ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...... .....+......
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~~~ 250 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--------DQLNHILGILGS 250 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG--------GHHHHHHHHHCS
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH--------HHHHHHHHHhCC
Confidence 543322 2344678999999998754 45899999999999999999999999643211 111111111100
Q ss_pred cCc---------------ccccCCcCC--CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 742 EGL---------------EKIIDPRLN--DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 742 ~~~---------------~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
... .....+... ..........+.+|+.+||+.||++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000000000 0001112346889999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=328.42 Aligned_cols=248 Identities=21% Similarity=0.273 Sum_probs=185.1
Q ss_pred cccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeeccCCChh
Q 038103 517 KQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSLD 595 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 595 (804)
.+.||+|+||+||.+...+++.||||++... ..+.+.+|++++.++ +||||+++++++.+....++||||+. |+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 4679999999998776678999999998642 245678899999886 89999999999999999999999996 6999
Q ss_pred hhhccCCCCCCC---CCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC-------------CCeEEeecC
Q 038103 596 KLLFNDPGTASI---LQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH-------------FEPKVTDFG 659 (804)
Q Consensus 596 ~~l~~~~~~~~~---l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-------------~~~kl~Dfg 659 (804)
+++......... .++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 999764322211 234456789999999999999998 9999999999999654 489999999
Q ss_pred CcccccccCCc---cccccccCCCccchhhhcc-------CCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccch
Q 038103 660 LSKLFKERHDT---KFSRVRGTRGYLAPEWMMN-------LKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYC 728 (804)
Q Consensus 660 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~ 728 (804)
+++........ ......||+.|+|||.+.+ ..++.++|||||||++|||++ |+.||+....
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-------- 245 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS-------- 245 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT--------
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh--------
Confidence 99977553321 2234579999999999975 678999999999999999999 9999864210
Q ss_pred hhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 729 NHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.. ..+..+... .+.+....+......+.+|+.+|++.||.+||++.+|++
T Consensus 246 -~~-----~~i~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 -RE-----SNIIRGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HH-----HHHHHTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hH-----HHHhcCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00 011111111 011112224455678999999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.58 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=202.1
Q ss_pred HHHHHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCc---CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 038103 507 AELKRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV---LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHK 582 (804)
Q Consensus 507 ~~l~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 582 (804)
.......|.+.+.||+|+||.||+++.. +++.||||++... ....+.+.+|++++++++||||+++++++.+....
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3445567888999999999999999975 6889999998643 23457789999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCC---CCeEEeecC
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDH---FEPKVTDFG 659 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~Dfg 659 (804)
++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.+ ..+||+|||
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999998864 235899999999999999999999998 9999999999999764 469999999
Q ss_pred CcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 660 LSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 660 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
++........ .....+++.|+|||.+.+ .++.++||||||+++|||++|+.||.... ... ....+
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~----~~~~~ 234 (287)
T 2wei_A 170 LSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYD----ILKRV 234 (287)
T ss_dssp GGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHH----HHHHH
T ss_pred cceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC--------HHH----HHHHH
Confidence 9987654322 223457889999998875 58999999999999999999999986422 011 11222
Q ss_pred hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..+...... + .... ....+.+++.+|++.+|++|||+.++++
T Consensus 235 ~~~~~~~~~-~-~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 235 ETGKYAFDL-P-QWRT----ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHCCCCCCS-G-GGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCCCc-h-hhhh----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 222211100 0 0011 2346889999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=321.51 Aligned_cols=263 Identities=17% Similarity=0.172 Sum_probs=186.5
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCe-------eE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEH-------KL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-------~~ 583 (804)
..|.+.+.||+|+||.||+|+.. +++.||||++.........+.+|++.+..++||||+++++++..... .+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 45667789999999999999974 58899999987655555667788999999999999999999976443 78
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHH--hhCCCcEEecccccCeEEEcC-CCCeEEeecCC
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH--EECLEWVLHCDVKPQNILLDD-HFEPKVTDFGL 660 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgl 660 (804)
+||||+++ +|...+.........+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 103 VVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 99999987 555444322224556889999999999999999999 877 999999999999996 89999999999
Q ss_pred cccccccCCccccccccCCCccchhhhccCC-CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 661 SKLFKERHDTKFSRVRGTRGYLAPEWMMNLK-IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 661 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
+........ .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..... ......+.+..
T Consensus 179 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--------~~~~~~~~~~~ 248 (360)
T 3e3p_A 179 AKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS--------AGQLHEIVRVL 248 (360)
T ss_dssp CBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHHH
T ss_pred ceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh--------HHHHHHHHHHc
Confidence 987654322 23456899999999987654 89999999999999999999999964321 11111111110
Q ss_pred -----------hhcC-cccccCC-cC-----CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 740 -----------EQEG-LEKIIDP-RL-----NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 740 -----------~~~~-~~~~~d~-~l-----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.... .....+. .. ...........+.+|+.+||+.||.+|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 0000000 00 001111235678999999999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=313.81 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=187.7
Q ss_pred HhcccccccccCcceEEEEEecC-CcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEE-------------
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCA------------- 577 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~------------- 577 (804)
.|.+.+.||+|+||.||+|+... ++.||||++.... ...+++.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 45667889999999999999764 8899999987433 23467889999999999999999999873
Q ss_pred -eCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc-CCCCeEE
Q 038103 578 -ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD-DHFEPKV 655 (804)
Q Consensus 578 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl 655 (804)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++ +++.+||
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999998 599999943 45889999999999999999999998 99999999999997 5679999
Q ss_pred eecCCcccccccCC--ccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHH
Q 038103 656 TDFGLSKLFKERHD--TKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLV 732 (804)
Q Consensus 656 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~ 732 (804)
+|||++........ .......++..|+|||.+.. ..++.++||||||+++|||++|+.||..... ....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~~ 234 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE--------LEQM 234 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH--------HHHH
Confidence 99999997654221 22234557899999998865 6789999999999999999999999964321 0011
Q ss_pred HHHHHHhhh----------cCcccc-----cCCcCC-CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 733 QWVAKQMEQ----------EGLEKI-----IDPRLN-DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 733 ~~~~~~~~~----------~~~~~~-----~d~~l~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..+...... ..+... ..+... ..........+.+|+.+|++.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111000000 000000 000000 0001112357899999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=321.79 Aligned_cols=265 Identities=20% Similarity=0.313 Sum_probs=200.4
Q ss_pred HHHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcCC-----------CCcccceeeeEEe
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-----------HRNLVKLQGFCAE 578 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 578 (804)
...|.+.+.||+|+||.||+|+. .+++.||||++.......+.+.+|++++.+++ |+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 35677889999999999999996 56889999999855445567889999999886 8999999999986
Q ss_pred CC----eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEEc-----
Q 038103 579 NE----HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILLD----- 648 (804)
Q Consensus 579 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl~----- 648 (804)
.. ..++|||++ +++|.+++... ....+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 54 789999999 88999999763 234589999999999999999999998 8 99999999999994
Q ss_pred -CCCCeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccc
Q 038103 649 -DHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSY 727 (804)
Q Consensus 649 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~ 727 (804)
..+.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT-KD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----------CH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC-Ch
Confidence 4458999999999876442 23346899999999999999999999999999999999999999753211100 00
Q ss_pred hhhHHHHHHHHhhh--------cC-----------cccccCCcC---------CCccCHHHHHHHHHHHHhcccCCCCCC
Q 038103 728 CNHLVQWVAKQMEQ--------EG-----------LEKIIDPRL---------NDVYDREKLDRMVKVALLCVAENRDTR 779 (804)
Q Consensus 728 ~~~~~~~~~~~~~~--------~~-----------~~~~~d~~l---------~~~~~~~~~~~l~~l~~~Cl~~~P~~R 779 (804)
...+.. +...... +. +..+..... ....+......+.+|+.+||+.||++|
T Consensus 247 ~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 247 DDHIAQ-IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHH-HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHH-HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 111111 1111100 00 000000000 012345677889999999999999999
Q ss_pred CCHHHHHH
Q 038103 780 PPMSKVVK 787 (804)
Q Consensus 780 Ptm~~Vv~ 787 (804)
||+.+|++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.70 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=191.5
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCee------
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHK------ 582 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~------ 582 (804)
+|.+.+.||+|+||.||+|+.. +++.||||++...... .+++.+|+.++++++||||+++++++......
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 4566788999999999999964 6889999999754333 35688999999999999999999999877655
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++||||+. ++|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 123 ~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp EEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred EEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999998 58888873 23899999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+......
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~ 260 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQILKVTGV 260 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHHCC
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCC
Confidence 65432 234568999999999987 6899999999999999999999999964320 0111111110000
Q ss_pred cC--------------cccccCCcCCC---ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 742 EG--------------LEKIIDPRLND---VYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 742 ~~--------------~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.. ....+...... .........+.+|+.+||+.||++|||+.++++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 00000000000 0011123578899999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=316.84 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=175.1
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHH-HHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVS-IIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
.+.+.+.||+|+||.||++... +++.||||++..... ...++..|+. +++.++||||+++++++...+..++||||
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence 4556688999999999999974 688999999975432 2345556666 77788999999999999999999999999
Q ss_pred ccCCChhhhhccCC-CCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 589 VENGSLDKLLFNDP-GTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 589 ~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
+++ +|.+++.... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 986 8877774210 1245689999999999999999999998 8 99999999999999999999999999987654
Q ss_pred cCCccccccccCCCccchhhh----ccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWM----MNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
.. ......||+.|+|||.+ ....++.++||||||+++|||++|+.||....... .....
T Consensus 179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------------~~~~~- 241 (327)
T 3aln_A 179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--------------DQLTQ- 241 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------CC-
T ss_pred cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--------------HHHHH-
Confidence 32 22234689999999998 46678999999999999999999999996422100 00000
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
......+.+...........+.+|+.+||+.||++||++.+|++
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 242 -VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00000111111111122346889999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=318.02 Aligned_cols=263 Identities=21% Similarity=0.301 Sum_probs=196.5
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeC-----CeeEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAEN-----EHKLL 584 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l 584 (804)
.+.+.+.||+|+||.||+|+.. +++.||||++..... ...++.+|++++++++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 4566788999999999999965 688999999974322 235678999999999999999999998764 67899
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
|+||+. ++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 92 v~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 999997 589999854 35899999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCc---------cccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH
Q 038103 665 KERHDT---------KFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 665 ~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
...... ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||..... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~ 234 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY--------RHQLLL 234 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHH
Confidence 542211 1223568999999998764 6789999999999999999999999964320 011111
Q ss_pred HHHHhhhcC-------------------cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HhccCC
Q 038103 735 VAKQMEQEG-------------------LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK--LLTAHD 793 (804)
Q Consensus 735 ~~~~~~~~~-------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~--~L~~~~ 793 (804)
+........ +.......+ ..........+.+|+.+||+.||++|||+.++++ .+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcch-hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 111110000 000000000 0001122346889999999999999999999986 454443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=317.47 Aligned_cols=196 Identities=27% Similarity=0.382 Sum_probs=167.7
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCC-CC-----cccceeeeEEeCCeeEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-HR-----NLVKLQGFCAENEHKLL 584 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~~l 584 (804)
..|.+.+.||+|+||.||+|+.. +++.||||+++.......++..|+.++..++ |+ +|+++++++......++
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 45667789999999999999965 5789999999854444567788999888885 44 49999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHh--hCCCcEEecccccCeEEEc--CCCCeEEeecCC
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE--ECLEWVLHCDVKPQNILLD--DHFEPKVTDFGL 660 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~--~~~~~ivH~Dlkp~NILl~--~~~~~kl~Dfgl 660 (804)
||||+. ++|.+++... ....+++..+..++.|++.||+|||. .+ |+||||||+|||++ .++.+||+|||+
T Consensus 134 v~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999996 4999999763 22458999999999999999999995 45 99999999999994 578899999999
Q ss_pred cccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 661 SKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 661 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9876432 2345689999999999999999999999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.03 Aligned_cols=265 Identities=19% Similarity=0.281 Sum_probs=201.2
Q ss_pred HHHhcccccccccCcceEEEEEec-C-CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCc------ccceeeeEEeCCee
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-D-ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN------LVKLQGFCAENEHK 582 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~~ 582 (804)
...|.+.+.||+|+||.||+++.. + ++.||||+++......+.+.+|+.++++++|++ ++.+.+++......
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 356778889999999999999964 3 478999999865445567888999999997766 89999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE---------------
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL--------------- 647 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl--------------- 647 (804)
++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 9999999 55777777543 2346899999999999999999999998 9999999999999
Q ss_pred ----cCCCCeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccC
Q 038103 648 ----DDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASAS 723 (804)
Q Consensus 648 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~ 723 (804)
+.++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--- 244 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN--- 244 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---
Confidence 56789999999999864332 2345689999999999999999999999999999999999999964321
Q ss_pred CccchhhHHHHHHHHhhh--------cCccc-ccCCcC---------------------CCccCHHHHHHHHHHHHhccc
Q 038103 724 DSSYCNHLVQWVAKQMEQ--------EGLEK-IIDPRL---------------------NDVYDREKLDRMVKVALLCVA 773 (804)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~--------~~~~~-~~d~~l---------------------~~~~~~~~~~~l~~l~~~Cl~ 773 (804)
......+...... ..... ...... .......+...+.+|+.+||+
T Consensus 245 -----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 245 -----REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp -----HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred -----HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 1111111111000 00000 000000 001123345678999999999
Q ss_pred CCCCCCCCHHHHHH--HhccCC
Q 038103 774 ENRDTRPPMSKVVK--LLTAHD 793 (804)
Q Consensus 774 ~~P~~RPtm~~Vv~--~L~~~~ 793 (804)
.||++|||+.++++ .+.++.
T Consensus 320 ~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp SSTTTSCCHHHHTTSGGGGGCC
T ss_pred CChhhCcCHHHHhcChhhcCCC
Confidence 99999999999984 344443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=314.61 Aligned_cols=240 Identities=24% Similarity=0.386 Sum_probs=196.3
Q ss_pred HHHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC-------ChHHHHHHHHHHhcCC--CCcccceeeeEEeCC
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ-------GDAEFWAEVSIIGRIN--HRNLVKLQGFCAENE 580 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~ 580 (804)
...|.+.+.||+|+||.||+|+. .+++.||||++..... ..+.+.+|+.++.+++ |+||+++++++....
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 34567788999999999999995 5688999999974321 2245778999999996 599999999999999
Q ss_pred eeEEEEeeccC-CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc-CCCCeEEeec
Q 038103 581 HKLLVYEYVEN-GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD-DHFEPKVTDF 658 (804)
Q Consensus 581 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Df 658 (804)
..++|+|++.+ ++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++ +++.+||+||
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred cEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 99999999986 899999964 345889999999999999999999998 99999999999999 7889999999
Q ss_pred CCcccccccCCccccccccCCCccchhhhccCCC-CcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHH
Q 038103 659 GLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAK 737 (804)
Q Consensus 659 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (804)
|++...... ......||+.|+|||++....+ +.++||||||+++|||++|+.||.... .
T Consensus 195 g~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----------------~ 254 (320)
T 3a99_A 195 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------------E 254 (320)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------------H
T ss_pred ccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----------------h
Confidence 999876542 2234568999999999987776 678999999999999999999986421 0
Q ss_pred HhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 738 QMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 738 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
...+.. ......+ ..+.+|+.+||+.||++||++.+|++.
T Consensus 255 -~~~~~~------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 -IIRGQV------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -HHHCCC------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -hhcccc------cccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 0111222 368899999999999999999999873
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=311.13 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=191.7
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCe------e
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEH------K 582 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~ 582 (804)
+|.+.+.||+|+||.||+|+.. +++.||||++...... .+++.+|+.++++++||||+++++++..... .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 4566788999999999999964 6889999999754333 3568899999999999999999999987654 4
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++||||+. ++|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 105 ~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp EEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 99999997 588888732 3899999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+......
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~ 242 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQILKVTGV 242 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--------HHHHHHHHHHHCB
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhCC
Confidence 65432 234568999999999877 6789999999999999999999999964321 0111111110000
Q ss_pred ------------------cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 742 ------------------EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 742 ------------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
..+.....+.+. .........+.+|+.+|++.||++|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000011111 0111234578899999999999999999999853
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.88 Aligned_cols=250 Identities=19% Similarity=0.203 Sum_probs=169.8
Q ss_pred Hhccc-ccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEe----CCeeEEEE
Q 038103 513 TRNFK-QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAE----NEHKLLVY 586 (804)
Q Consensus 513 t~~~~-~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 586 (804)
.|.+. +.||+|+||.||+++.. +++.||||++.... .........+..++|+||+++++++.. ....++||
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 45553 45999999999999976 68999999986432 222223334667799999999999876 44689999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC---CCCeEEeecCCccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD---HFEPKVTDFGLSKL 663 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~ 663 (804)
||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++..
T Consensus 106 e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 106 ECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp ECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred eccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 999999999999753 2346899999999999999999999998 999999999999976 45599999999986
Q ss_pred ccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
.... ......+|+.|+|||.+....++.++||||||+++|||++|+.||........ ..........+.
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~~~ 249 (336)
T 3fhr_A 181 TTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI--------SPGMKRRIRLGQ 249 (336)
T ss_dssp C-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred cccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh--------hhhHHHhhhccc
Confidence 5432 22345679999999999888899999999999999999999999964321110 000001111110
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
. .. ...........+.+|+.+|++.||.+|||+.++++
T Consensus 250 ~-~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 250 Y-GF-----PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --CC-----CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c-cc-----CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00 00001122346889999999999999999999997
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.15 Aligned_cols=243 Identities=24% Similarity=0.361 Sum_probs=189.8
Q ss_pred HHHHHHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC-------ChHHHHHHHHHHhcC----CCCcccceeee
Q 038103 508 ELKRATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ-------GDAEFWAEVSIIGRI----NHRNLVKLQGF 575 (804)
Q Consensus 508 ~l~~~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l----~H~niv~l~g~ 575 (804)
+.....|.+.+.||+|+||.||+|+. .+++.||||++..... ....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34456788889999999999999986 4688999999974322 223456788888888 89999999999
Q ss_pred EEeCCeeEEEEee-ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc-CCCCe
Q 038103 576 CAENEHKLLVYEY-VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD-DHFEP 653 (804)
Q Consensus 576 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ 653 (804)
+...+..++|+|+ +.+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 9999999999999 789999999964 235899999999999999999999999 99999999999999 88999
Q ss_pred EEeecCCcccccccCCccccccccCCCccchhhhccCCCC-cccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHH
Q 038103 654 KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKID-AKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLV 732 (804)
Q Consensus 654 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~ 732 (804)
||+|||++....... .....|+..|+|||++....+. .++||||||+++|||++|+.||....
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------- 243 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------- 243 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------
Confidence 999999998765432 2345689999999999877764 58999999999999999999986421
Q ss_pred HHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 733 QWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
. ...... .+.... ...+.+|+.+|++.+|++||++.++++.
T Consensus 244 ----~-~~~~~~------~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 ----E-ILEAEL------HFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----H-HHHTCC------CCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----H-Hhhhcc------CCcccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011111 111122 2468899999999999999999999973
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=305.75 Aligned_cols=248 Identities=25% Similarity=0.337 Sum_probs=175.0
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCCh---HHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGD---AEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
.+.+.+.||+|+||.||+++.. +++.||||++....... +.+.++..+++.++||||+++++++.+....++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 3556688999999999999975 68899999997543222 2344455578888999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
+ ++.+..+... ....+++..+..++.|+++||+|||++ + |+|+||||+|||++.++.+||+|||++......
T Consensus 106 ~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 106 M-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp C-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred c-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9 4455555432 234689999999999999999999995 8 999999999999999999999999999865442
Q ss_pred CCccccccccCCCccchhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMM-----NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
. ......+++.|+|||.+. ...++.++||||||+++|||++|+.||..... ......... .+
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~~~~~~~~-~~ 245 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT----------DFEVLTKVL-QE 245 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS----------HHHHHHHHH-HS
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc----------cHHHHHHHh-cc
Confidence 2 223456899999999984 55688999999999999999999999864210 111111111 11
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
....+.. .... ...+.+|+.+||+.||.+||++.++++
T Consensus 246 ~~~~~~~---~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 246 EPPLLPG---HMGF----SGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCCCCS---SSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCc---cCCC----CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111100 0112 236889999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=322.93 Aligned_cols=246 Identities=22% Similarity=0.273 Sum_probs=183.4
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEeeccCC
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENG 592 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g 592 (804)
+.+.+.||+|+||+|+.....+++.||||++.... ...+.+|+++++++ +|||||++++++.+....++||||+. |
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 44567899999999765556678999999996432 23356899999999 79999999999999999999999996 5
Q ss_pred ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-----CCCeEEeecCCccccccc
Q 038103 593 SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-----HFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~Dfgla~~~~~~ 667 (804)
+|.+++... ...+....+..++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+++.....
T Consensus 103 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 103 TLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp EHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred CHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 999999753 223445567789999999999999998 999999999999943 346889999999876543
Q ss_pred CC--ccccccccCCCccchhhhc---cCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 668 HD--TKFSRVRGTRGYLAPEWMM---NLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 668 ~~--~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
.. .......||+.|+|||.+. ...++.++|||||||++|||++ |+.||+.... .........
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~------------~~~~~~~~~ 244 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ------------RQANILLGA 244 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT------------HHHHHHTTC
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH------------HHHHHHhcc
Confidence 22 2334567999999999997 4567889999999999999999 9999853210 001111111
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.... ... ........+.+|+.+||+.||.+||++.+|++
T Consensus 245 ~~~~-~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSLD-CLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCT-TSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcc-ccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111 111 11233456789999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=293.71 Aligned_cols=232 Identities=13% Similarity=0.068 Sum_probs=181.1
Q ss_pred HHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCCh----HHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGD----AEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~----~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
..+|.+.+.||+|+||.||+|+.. +++.||||.+....... +++.+|+.++.+++|+||+++++++...+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 345777889999999999999975 48999999998543332 6789999999999999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++++|.+++... .......+++.|++.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999999531 344567889999999999999999 9999999999999999999997432
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
|++ +++.++||||||+++|||++|+.||........... ..
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-----------------~~ 215 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----------------AE 215 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------------CC
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------------HH
Confidence 443 368999999999999999999999975332110000 00
Q ss_pred cccCCcCC--CccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 746 KIIDPRLN--DVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 746 ~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
..+..... ..........+.+|+.+||+.||.+| |+.++++.|+.+.....
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 216 RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 00000000 00111223468899999999999999 99999999988665543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=331.58 Aligned_cols=257 Identities=26% Similarity=0.350 Sum_probs=195.4
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEe------CCee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAE------NEHK 582 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 582 (804)
..|.+.+.||+|+||.||++.. .+++.||||++.... ...+.+.+|++++.+++||||+++++++.. +...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5688889999999999999996 458899999987432 234568899999999999999999998765 6778
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCC---eEEeecC
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFE---PKVTDFG 659 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Dfg 659 (804)
++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999997632 2335889999999999999999999998 999999999999987665 9999999
Q ss_pred CcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 660 LSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 660 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...|.....
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----------~~~~~~~i~ 237 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----------PVQWHGKVR 237 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----------HHHSSTTCC
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----------hhhhhhhhh
Confidence 999765432 22345789999999999999999999999999999999999999964210 000000000
Q ss_pred ----hhcCcccccCCc--------CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 038103 740 ----EQEGLEKIIDPR--------LNDVYDREKLDRMVKVALLCVAENRDTRPPMSK 784 (804)
Q Consensus 740 ----~~~~~~~~~d~~--------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~ 784 (804)
............ ............+.+++..|++.||++|||+.+
T Consensus 238 ~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp ------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred cccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000000000 011233445678999999999999999999976
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=332.46 Aligned_cols=236 Identities=22% Similarity=0.284 Sum_probs=188.9
Q ss_pred HHhcccccccccCcceEEEEEec--CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCe-----e
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD--DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEH-----K 582 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~--~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~ 582 (804)
..|.+.+.||+|+||.||++... +++.||||++..... ..+.+.+|++++.+++||||+++++++.+... .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 45677889999999999999975 589999999864322 23568899999999999999999999987665 6
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
+|||||+++++|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 999999999999987742 5899999999999999999999999 9999999999999986 99999999998
Q ss_pred cccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
..... ....||+.|+|||++.+.. +.++||||||++++||++|..|+.......
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------- 283 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------- 283 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------------
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------------
Confidence 75442 3456899999999987754 899999999999999999988875321000
Q ss_pred CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHhcc
Q 038103 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPP-MSKVVKLLTA 791 (804)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-m~~Vv~~L~~ 791 (804)
+. ...........+.+|+.+|++.||.+||+ ++++.+.|.+
T Consensus 284 ----~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 ----LP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ----CC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----cc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00 00011122356889999999999999995 5566666544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=310.52 Aligned_cols=236 Identities=14% Similarity=0.086 Sum_probs=176.0
Q ss_pred ccccccccCcceEEEEEe-cCCcEEEEEEecCcC----CChHHHHHHHHHHhcCCC-Ccccceee---------e-----
Q 038103 516 FKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL----QGDAEFWAEVSIIGRINH-RNLVKLQG---------F----- 575 (804)
Q Consensus 516 ~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H-~niv~l~g---------~----- 575 (804)
..+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.+++.++| +|...... .
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 456899999999999994 568999999987322 235779999999999987 32221111 1
Q ss_pred -------EEe-----CCeeEEEEeeccCCChhhhhccC---CCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEeccc
Q 038103 576 -------CAE-----NEHKLLVYEYVENGSLDKLLFND---PGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDV 640 (804)
Q Consensus 576 -------~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dl 640 (804)
... ....+++|+++ .++|.+++... ......+++..++.++.||++||+|||+++ |+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCc
Confidence 111 12356667765 56999888421 123556889999999999999999999999 999999
Q ss_pred ccCeEEEcCCCCeEEeecCCcccccccCCccccccccCCCccchhhh----------ccCCCCcccchHHHHHHHHHHHh
Q 038103 641 KPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM----------MNLKIDAKADVYSYGIVLLELLT 710 (804)
Q Consensus 641 kp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~k~DV~S~Gvll~el~t 710 (804)
||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999999865443 334566 999999999 55568889999999999999999
Q ss_pred CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038103 711 GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVV 786 (804)
Q Consensus 711 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv 786 (804)
|+.||....... ....++... ...+ +.+.+|+..||+.||++||++.+++
T Consensus 313 g~~Pf~~~~~~~--------------------~~~~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 313 ADLPNTDDAALG--------------------GSEWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp SSCCCCTTGGGS--------------------CSGGGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCCCCcchhh--------------------hHHHHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence 999996532111 111111111 1122 4688999999999999999977664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=290.88 Aligned_cols=222 Identities=20% Similarity=0.232 Sum_probs=174.2
Q ss_pred ccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHH-hcCCCCcccceeeeEEe----CCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSII-GRINHRNLVKLQGFCAE----NEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~ 591 (804)
+.||+|+||.||++.. .+++.||||+++. ...+.+|+.++ +.++||||+++++++.. ....++||||+++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 6699999999999996 4688999999863 35677888888 56699999999999987 6788999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC---CCCeEEeecCCcccccccC
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD---HFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~ 668 (804)
++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++....
T Consensus 100 ~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 100 GELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp CBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 9999999763 2346899999999999999999999999 999999999999998 7899999999987432
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
+..++.++||||||+++|||++|+.||....... ........+.
T Consensus 172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~----------------~~~~~~~~~~ 215 (299)
T 3m2w_A 172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------------ISPGMKTRIR 215 (299)
T ss_dssp --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------------CCSCCSSC
T ss_pred --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh----------------hhHHHHHHHh
Confidence 2346789999999999999999999996432110 0000001111
Q ss_pred CCcCCCc--cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 749 DPRLNDV--YDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 749 d~~l~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
....... ........+.+|+.+|++.||.+||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111000 00112457889999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=299.49 Aligned_cols=243 Identities=14% Similarity=0.149 Sum_probs=183.4
Q ss_pred HHHHHhcccccccccCcceEEEEEecCCcEEEEEEecCcC---------CChHHHHHHHHHHhcCC---------CCccc
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVL---------QGDAEFWAEVSIIGRIN---------HRNLV 570 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~---------H~niv 570 (804)
+....|.+.+.||+|+||.||+|+. +++.||||++.... ...+.+.+|+.++++++ |+||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3456788889999999999999998 67999999997432 12367889999988886 66666
Q ss_pred ceeee-----------------EEe-------------CCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHH
Q 038103 571 KLQGF-----------------CAE-------------NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT 620 (804)
Q Consensus 571 ~l~g~-----------------~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i 620 (804)
++.+. +.+ ....++||||+++|++.+.+.. ..+++..+..++.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQL 170 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHH
Confidence 66554 332 6789999999999977666632 458999999999999
Q ss_pred HHHHHHHH-hhCCCcEEecccccCeEEEcCCC--------------------CeEEeecCCcccccccCCccccccccCC
Q 038103 621 AKGLSYLH-EECLEWVLHCDVKPQNILLDDHF--------------------EPKVTDFGLSKLFKERHDTKFSRVRGTR 679 (804)
Q Consensus 621 a~~l~yLH-~~~~~~ivH~Dlkp~NILl~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~ 679 (804)
+.||+||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+
T Consensus 171 ~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~ 241 (336)
T 2vuw_A 171 TASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCC
T ss_pred HHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEee
Confidence 99999999 888 99999999999999887 8999999999976532 346899
Q ss_pred CccchhhhccCCCCcccchHHHHHH-HHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCH
Q 038103 680 GYLAPEWMMNLKIDAKADVYSYGIV-LLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDR 758 (804)
Q Consensus 680 ~y~aPE~~~~~~~s~k~DV~S~Gvl-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 758 (804)
.|+|||++.+.. +.++||||++++ .+++++|..||.... ........+..... ...........
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----------~~~~~~~~~~~~~~---~~~~~~~~~~~ 306 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-----------WLHYLTDKMLKQMT---FKTKCNTPAMK 306 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-----------HHHHHHHHHHHTCC---CSSCCCSHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-----------hhhHHHHhhhhhhc---cCcccchhhhh
Confidence 999999998766 899999998777 777888998874210 00111111111100 11111122234
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038103 759 EKLDRMVKVALLCVAENRDTRPPMSKVV 786 (804)
Q Consensus 759 ~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv 786 (804)
.....+.+|+.+||+.| |+.|++
T Consensus 307 ~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hcCHHHHHHHHHHhccC-----CHHHHH
Confidence 56678999999999966 888887
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=273.35 Aligned_cols=206 Identities=16% Similarity=0.233 Sum_probs=146.7
Q ss_pred CCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeC
Q 038103 27 PRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTD 106 (804)
Q Consensus 27 ~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~ 106 (804)
++|++|++|+ .+++| ++|.|+|||+.+++ +. +|.. +|+||+|||+.| ..++|+|+.||||||+|
T Consensus 9 ~~i~~g~~L~---~g~~l--~~g~f~l~f~~~gn----l~-ly~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 9 HEGSHPQTLH---AAQSL--ELSSFRFTMQSDCN----LV-LFDS---DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp SSSCSCSCCC---TTCEE--CSTTEEEEECTTSC----EE-EEES---SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred ceeCCCCEEC---CCCEE--EcCCEEEEECCCCc----EE-EEEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 7899999998 47888 59999999986653 22 3443 799999999998 56799999999999999
Q ss_pred CCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeeccCCCCCcc----------CCCcccCCC-CeEEecCCCCC
Q 038103 107 KDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTL----------LPSQLLTKN-TTLVSMRSPGT 174 (804)
Q Consensus 107 ~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtl----------lpg~~l~~~-~~L~S~~s~~d 174 (804)
++|++||+|++... ....|+|+|+|||||++. ++||||||||||+ +|||+++.+ ++|+| .+|
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s---~~d 146 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHA---TQS 146 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECS---SCC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEc---CcE
Confidence 99999999997543 346899999999999964 8999999998655 777776653 57874 789
Q ss_pred CcccccEEEecCCCcceeecCCCCcccccccCCceeEEecCccccCCCcceEEeccccc---ccccceEEEeccCCCcce
Q 038103 175 YLSGFYNLKFDDNNILDLIFNGPLISSIYWPNSAFTVFLNGRTPYNSSRRAYVNASGLF---RSSDTFKFNASDYGVGPK 251 (804)
Q Consensus 175 ps~G~y~~~~~~~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 251 (804)
|++|.|+++++++|.+. ++++. ..||+++.+... ......+...|.+ .......+..........
T Consensus 147 ~s~G~~~l~l~~dG~Lv-L~~~~---~~~W~s~~~~~~--------~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~~~ 214 (236)
T 1dlp_A 147 LQLSPYRLSMETDCNLV-LFDRD---DRVWSTNTAGKG--------TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGR 214 (236)
T ss_dssp CBCSSCEEEEETTTEEE-EEBTT---BCCSCCCCCSSC--------SSCEEEEETTTEEEEEETTTEEEEECCCCCSSSC
T ss_pred eecCcEEEEECCCCcEE-EEcCC---EeEEeCCCcCCC--------CceEEEECCCCcEEEEeCCCcEEEEeCCCCCCCC
Confidence 99999999999999433 34432 468987754210 0111223333321 111111222111111236
Q ss_pred EEEEEccCCcEEEEE
Q 038103 252 RRLTLDYDGILRLYS 266 (804)
Q Consensus 252 ~rl~Ld~dG~l~~y~ 266 (804)
+|++|++||++++|.
T Consensus 215 ~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 215 YVFVLQPDRNLAIYG 229 (236)
T ss_dssp CEEEECSSSCEEEEC
T ss_pred EEEEEcCCCcEEEeC
Confidence 899999999999994
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-26 Score=266.51 Aligned_cols=185 Identities=14% Similarity=0.061 Sum_probs=129.1
Q ss_pred ccccccCcceEEEEE-ecCCcEEEEEEecCcC-----------CChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEE
Q 038103 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVL-----------QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~-~~~~~~vavK~l~~~~-----------~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 584 (804)
...+.|++|.+.+++ .--|+.++||.+.... ...++|.+|+++|+++ .|+||+++++++.++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346677777766655 3347779999986431 1225699999999999 79999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||++|++|.++|.. ...++.. +|+.||+.||+|||+++ |+||||||+||||++++++||+|||+|+..
T Consensus 320 VMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999999975 2345543 58999999999999999 999999999999999999999999999976
Q ss_pred cccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSA 714 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p 714 (804)
..... ......||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 390 ~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 55332 2344679999999999875 567789999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.6e-24 Score=245.77 Aligned_cols=181 Identities=17% Similarity=0.174 Sum_probs=145.7
Q ss_pred cccccccCcceEEEEEecCCcEEEEEEecCcCC-C--------hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 517 KQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ-G--------DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 517 ~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~-~--------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.+.||+|+||.||++.. .++.+++|+...... . .+++.+|++++++++||||+++..++......++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 45799999999999954 456788888653221 1 2347899999999999999988777778888899999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. ++||+|||+++.....
T Consensus 420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999953 5689999999999999998 999999999999999 9999999999987553
Q ss_pred CCcc------ccccccCCCccchhhhcc--CCCCcccchHHHHHHHHHHHhCCCCC
Q 038103 668 HDTK------FSRVRGTRGYLAPEWMMN--LKIDAKADVYSYGIVLLELLTGKSAS 715 (804)
Q Consensus 668 ~~~~------~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvll~el~tg~~p~ 715 (804)
.... .....||+.|+|||++.. ..|+.+.|+|+..+-.++-+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2221 235679999999999976 56888899999999999988877654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.7e-21 Score=201.52 Aligned_cols=141 Identities=13% Similarity=0.079 Sum_probs=115.9
Q ss_pred ccccccccCcceEEEEEecCCcEEEEEEecCcCC-------------------ChHHHHHHHHHHhcCCCCcccceeeeE
Q 038103 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ-------------------GDAEFWAEVSIIGRINHRNLVKLQGFC 576 (804)
Q Consensus 516 ~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~-------------------~~~~~~~E~~~l~~l~H~niv~l~g~~ 576 (804)
+.+.||+|+||.||+|...+++.||||.++.... ....+.+|+.++.+++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 4578999999999999997799999999963221 1345889999999999 5 7777765
Q ss_pred EeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEe
Q 038103 577 AENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVT 656 (804)
Q Consensus 577 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 656 (804)
.. +..++||||+++++|.+ +.. .....++.|++.||+|||+.+ |+||||||+|||++ ++.+||+
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEEC
T ss_pred ec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEE
Confidence 44 56699999999999988 421 234579999999999999999 99999999999999 9999999
Q ss_pred ecCCcccccccCCccccccccCCCccchhhhcc
Q 038103 657 DFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689 (804)
Q Consensus 657 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 689 (804)
|||+++. +..+.|||++..
T Consensus 235 DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 235 DFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp CCTTCEE--------------TTSTTHHHHHHH
T ss_pred ECCCCeE--------------CCCCCHHHHHHH
Confidence 9999974 334789998753
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-19 Score=162.45 Aligned_cols=104 Identities=16% Similarity=0.291 Sum_probs=90.3
Q ss_pred CCcCCCcceeeecCCCEEE--cCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEE
Q 038103 27 PRLTRGNSLAVEKENDFLV--SPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLAL 104 (804)
Q Consensus 27 ~~~~~~~~l~~~~~~~~l~--S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l 104 (804)
++|++|++|. +|++|+ |++|.|+|+|+.+++ + +||++ +++||+|||+.| +.++.++|..+|||||
T Consensus 9 ~~l~~g~~L~---~g~~l~~~S~~g~~~L~~~~dgn----l-vly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 9 PDDNHPQILH---ATESLEILFGTHVYRFIMQTDCN----L-VLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp SSSCCCCEEE---TTCEEEEEETTEEEEEEECTTSC----E-EEEET---TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred cccCCCCEEc---CCCEEEEeCCCCCEEEEEecCCC----E-EEEEC---CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 7899999997 478999 999999999998764 2 57876 799999999977 4457999999999999
Q ss_pred eCCCCCeEEEecccC-CcceEEEEecCCCeEEEecCCCceeec
Q 038103 105 TDKDSSVVWSTNTFT-DEGVQAQLLETGNLVLVNEANTTIWKS 146 (804)
Q Consensus 105 ~~~~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWqS 146 (804)
+|.++.++|+|++.. .+...++|+|+|||||++ .++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 999999999998653 346689999999999998 389997
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.4e-19 Score=156.24 Aligned_cols=103 Identities=17% Similarity=0.304 Sum_probs=86.4
Q ss_pred CCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeC
Q 038103 27 PRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTD 106 (804)
Q Consensus 27 ~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~ 106 (804)
+.|.+||.|. .|++|+| |.|.|.|...++ |.++. ..++||+|||++|.. ..++|+++.||||||+|
T Consensus 2 n~L~~g~~L~---~g~~L~s--g~y~l~~q~DgN----Lvly~----~~~~vW~ant~~~~~-~~~~L~l~~dGnLvL~d 67 (105)
T 4h3o_A 2 NILDNNEGLY---AGQSLDV--EPYHFIMQDDCN----LVLYD----HSTSTWASNTEIGGK-SGCSAVLQSDGNFVVYD 67 (105)
T ss_dssp CEECTTEEEC---TTCEEEE--TTEEEEECTTSC----EEEEE----TTEEEEECCCCCTTC-CSCEEEECTTSCEEEEC
T ss_pred CCcCCCCEEc---CCCEEEE--CCEEEEECCCCe----EEEEE----CCEEEEEecCCCCCC-ccEEEEEeCCccEEEEC
Confidence 5678999997 4789988 889999986654 55543 358999999999975 35789999999999999
Q ss_pred CCCCeEEEecccC-CcceEEEEecCCCeEEEecCCCceeec
Q 038103 107 KDSSVVWSTNTFT-DEGVQAQLLETGNLVLVNEANTTIWKS 146 (804)
Q Consensus 107 ~~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWqS 146 (804)
+++++||+|++.. ....+|+|+|+|||||++. .||||
T Consensus 68 ~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 68 SSGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp TTCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred CCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 9999999999754 3467899999999999964 69997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.5e-19 Score=158.95 Aligned_cols=107 Identities=23% Similarity=0.382 Sum_probs=91.4
Q ss_pred CCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeC
Q 038103 27 PRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTD 106 (804)
Q Consensus 27 ~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~ 106 (804)
++|.+|+.|. .+++|+ ++|.|+|+|+..|+ + ++|+ .+++||+||++.|- ..++++|..+|||||+|
T Consensus 2 d~l~~g~~L~---~g~~l~-~~~~~~l~~~~dGn----l-vl~~---~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~ 67 (110)
T 3a0c_A 2 NSLSSPNSLF---TGHSLE-VGPSYRLIMQGDCN----F-VLYD---SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYD 67 (110)
T ss_dssp CEEETTCEEC---TTCEEE-ETTTEEEEECTTSC----E-EEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEEC
T ss_pred CEeCCCCEEC---CCCEEE-ECCCEEEEEcCCCc----E-EEEE---CCEEEEECCCCCCC--CcEEEEEeCCCCEEEEC
Confidence 6788999997 478999 99999999987664 2 6676 37899999999773 45789999999999999
Q ss_pred CCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeeccCCC
Q 038103 107 KDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKSFDSP 150 (804)
Q Consensus 107 ~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqSFd~P 150 (804)
.+|.++|+|++... +...++|+|+|||||++. .+||||+||
T Consensus 68 ~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~ 109 (110)
T 3a0c_A 68 QSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGP 109 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC
T ss_pred CCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcC
Confidence 99999999997543 456899999999999985 799999998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-18 Score=156.26 Aligned_cols=108 Identities=21% Similarity=0.404 Sum_probs=90.3
Q ss_pred CCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeC
Q 038103 27 PRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTD 106 (804)
Q Consensus 27 ~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~ 106 (804)
++|.+||+|. .+++|+ +|.|+|+|+..++ . ++|. ..++||+|||+.|. .+++|+|..+|||||+|
T Consensus 3 dtl~~gq~L~---~g~~L~--~g~~~L~~~~dgn--l---vly~---~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d 67 (115)
T 2dpf_A 3 NVLLSGQTLH---ADHSLQ--AGAYTLTIQNKCN--L---VKYQ---NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYD 67 (115)
T ss_dssp CEEETTCEEE---TTEEEE--ETTEEEEECTTSC--E---EEEE---TTEEEEECSCTTSC--SSCEEEECTTSCEEEEC
T ss_pred CEeCCCCEEC---CCCEEE--CCCEEEEEcCCCc--E---EEEe---CCEEEEeCCCCCCC--CceEEEECCCCcEEEEC
Confidence 6789999997 478998 8999999987653 2 2355 37899999999883 45799999999999999
Q ss_pred CCCCeEEEecccC-CcceEEEEecCCCeEEEecCCCceeeccCCCCC
Q 038103 107 KDSSVVWSTNTFT-DEGVQAQLLETGNLVLVNEANTTIWKSFDSPTD 152 (804)
Q Consensus 107 ~~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTD 152 (804)
.++.++|+|++.. ....+++|+|+|||||++. ++||||.+++.
T Consensus 68 ~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 68 HNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred CCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 9999999998753 3456899999999999964 89999998754
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.1e-18 Score=151.93 Aligned_cols=108 Identities=22% Similarity=0.424 Sum_probs=90.6
Q ss_pred CCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeC
Q 038103 27 PRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTD 106 (804)
Q Consensus 27 ~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~ 106 (804)
++|.+||+|. .+++| ++|.|+|+|+.+++ + ++|.+ +++||+||++.+ +.+++++|..+|||||+|
T Consensus 2 dtl~~gq~L~---~g~~L--~~~~~~L~~~~dgn----l-vl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d 66 (112)
T 1xd5_A 2 DRLNSGHQLD---TGGSL--AEGGYLFIIQNDCN----L-VLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS 66 (112)
T ss_dssp CEEETTEEEC---TTCEE--EETTEEEEECTTSC----E-EEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE
T ss_pred CCCCCCCEEC---CCCEE--eCCCEEEEEcCCCc----E-EEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc
Confidence 6789999997 47899 58999999998775 2 35765 689999999864 455799999999999999
Q ss_pred CCCCeEEEecccC-CcceEEEEecCCCeEEEecCCCceeeccCCC
Q 038103 107 KDSSVVWSTNTFT-DEGVQAQLLETGNLVLVNEANTTIWKSFDSP 150 (804)
Q Consensus 107 ~~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWqSFd~P 150 (804)
++.++|+|++.. .....++|+++|||||++..+.++||||+|.
T Consensus 67 -~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 -GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp -TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred -CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 888999998653 3456899999999999997788999999984
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=5.1e-17 Score=143.84 Aligned_cols=102 Identities=22% Similarity=0.417 Sum_probs=84.8
Q ss_pred CCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeC
Q 038103 27 PRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTD 106 (804)
Q Consensus 27 ~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~ 106 (804)
++|.+||.|. .|++|+ +|.|+|+|+..|+ +. .|.. .++||+||++.+ +..+.|+|..||||||+|
T Consensus 2 ntL~~gq~L~---~g~~L~--~g~~~L~~q~dGn----Lv-ly~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~ 66 (109)
T 3dzw_A 2 NILYSGETLS---PGEFLN--NGRYVFIMQEDCN----LV-LYDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYS 66 (109)
T ss_dssp CEEETTEEEC---TTCEEE--ETTEEEEECTTSC----EE-EEET---TEEEEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred CCcCCCCEeC---CCCEEE--CCCEEEEEcCCCc----EE-EEeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEEC
Confidence 5788999997 578996 7999999987764 22 2654 589999999986 345789999999999999
Q ss_pred CCCCeEEEecccCCc-ceEEEEecCCCeEEEecCCCceeec
Q 038103 107 KDSSVVWSTNTFTDE-GVQAQLLETGNLVLVNEANTTIWKS 146 (804)
Q Consensus 107 ~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWqS 146 (804)
.++.++|+|++.... ...|+|+|+|||||++. .+|||
T Consensus 67 ~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s 104 (109)
T 3dzw_A 67 PRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWAT 104 (109)
T ss_dssp TTSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCC
T ss_pred CCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeC
Confidence 999999999975443 46899999999999984 89997
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.2e-17 Score=171.33 Aligned_cols=134 Identities=18% Similarity=0.126 Sum_probs=104.4
Q ss_pred cccccccccCcceEEEEEe-cCCcE--EEEEEecCcCCC-------------------------hHHHHHHHHHHhcCCC
Q 038103 515 NFKQEVGKGGFGSVFRGVL-DDERV--VAVKRLEGVLQG-------------------------DAEFWAEVSIIGRINH 566 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~-~~~~~--vavK~l~~~~~~-------------------------~~~~~~E~~~l~~l~H 566 (804)
.+.+.||+|+||.||+|.. .+|+. ||||.++..... ...+.+|+.++.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999997 78888 999987532111 1257889999999988
Q ss_pred Ccc--cceeeeEEeCCeeEEEEeeccC-C----ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHH-hhCCCcEEec
Q 038103 567 RNL--VKLQGFCAENEHKLLVYEYVEN-G----SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH-EECLEWVLHC 638 (804)
Q Consensus 567 ~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~ivH~ 638 (804)
+++ .+++.. ...+|||||+.+ | +|.++... .++.....++.|++.+|.||| +.+ |+||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 764 333332 356899999952 4 56555422 234567889999999999999 888 9999
Q ss_pred ccccCeEEEcCCCCeEEeecCCcccc
Q 038103 639 DVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 639 Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||+|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999854
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.8e-15 Score=133.82 Aligned_cols=102 Identities=19% Similarity=0.280 Sum_probs=81.1
Q ss_pred CCCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEe
Q 038103 26 IPRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALT 105 (804)
Q Consensus 26 ~~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~ 105 (804)
.++|.+||.|. .|++|+| |.|.|-|...|+ |.+ |.. ++||++|++.. +..+.|++..+|||||+
T Consensus 6 ~dtL~~gq~L~---~g~~L~s--g~~~L~~q~dGn----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 6 NNLLFSGQVLY---GDGRLTA--KNHQLVMQGDCN----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp TTEEETTCEEE---TTEEEEC--SSCEEEECTTSC----EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred cCEECCCCEec---CCCEEEe--CCEEEEEcCCCe----EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 48899999997 4789998 458886643332 444 544 48999999863 34578999999999999
Q ss_pred CCCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeec
Q 038103 106 DKDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKS 146 (804)
Q Consensus 106 ~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqS 146 (804)
|.+++++|+|++... ....|+|+|+|||||++ ..+|+|
T Consensus 70 d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 70 DDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred eCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 999999999997533 34689999999999998 489996
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.59 E-value=1.1e-14 Score=129.49 Aligned_cols=105 Identities=18% Similarity=0.281 Sum_probs=84.4
Q ss_pred CCCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEe
Q 038103 26 IPRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALT 105 (804)
Q Consensus 26 ~~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~ 105 (804)
.++|.+||.|. .++.|.+ |.|.|-|...|+ |.++..+ ..++||.+|+..+ +....|.+..+|||||+
T Consensus 6 ~~tL~~gq~L~---~g~~L~~--g~~~L~~q~dGN----LvL~~~~--~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~ 72 (113)
T 3mez_B 6 RNVLFSSQVMY---DNAQLAT--RDYSLVMRDDCN----LVLTKGS--KTNIVWESGTSGR--GQHCFMRLGHSGELDIT 72 (113)
T ss_dssp SSEEETTCEEE---TTCEEEE--TTEEEEECTTSC----EEEEETT--TTEEEEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred CCEeCCCCEEC---CCCEeEc--CCEEEEEcCCCE----EEEEECC--CCEEEEECCcccC--CcCEEEEEeCCCcEEEE
Confidence 38899999997 4788874 888888865553 5554321 3689999999876 34578999999999999
Q ss_pred CCCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeec
Q 038103 106 DKDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKS 146 (804)
Q Consensus 106 ~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqS 146 (804)
|.+++++|+|++... ....|+|+|+|||||++ ..+|+|
T Consensus 73 d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 73 DDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp CTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred CCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 999999999997543 34689999999999997 689997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=8.9e-15 Score=129.51 Aligned_cols=88 Identities=25% Similarity=0.491 Sum_probs=71.4
Q ss_pred CCCceEEEeeCccEEEeCCCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccCCCCeEE
Q 038103 89 GKRSKLTLQRNGNLALTDKDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLV 167 (804)
Q Consensus 89 ~~~~~l~~~~~G~L~l~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~~~~~L~ 167 (804)
+...+|.|..||||+|++ .+++||++|+... ....++|+|+|||||++.++.++||||.
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t------------------- 78 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKT------------------- 78 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCC-------------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCC-------------------
Confidence 345789999999999998 5899999997543 3568999999999999998899999993
Q ss_pred ecCCCCCCcccccEEEecCCCcceeecCCCCcccccccCCc
Q 038103 168 SMRSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNSA 208 (804)
Q Consensus 168 S~~s~~dps~G~y~~~~~~~~~~~~~~~~~~~~~~yw~~~~ 208 (804)
++++|.|++.++++|.+.+ +.+ .||.++.
T Consensus 79 ------~~~~g~~~l~l~~dGnlvl-~~~-----~~W~S~~ 107 (110)
T 3a0c_A 79 ------NGKEDHYVLVLQQDRNVVI-YGP-----VVWATGS 107 (110)
T ss_dssp ------CCSSSCCEEEECTTSCEEE-ECS-----EEEECSC
T ss_pred ------CCCCCCEEEEEeCCccEEE-ECC-----CEecCCC
Confidence 4567999999999987443 332 5887654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.54 E-value=4.4e-15 Score=160.08 Aligned_cols=138 Identities=10% Similarity=0.044 Sum_probs=96.9
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCcCC---------------ChHHHHHHHHHHhcCCCCcccceeeeEE-
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQ---------------GDAEFWAEVSIIGRINHRNLVKLQGFCA- 577 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~---------------~~~~~~~E~~~l~~l~H~niv~l~g~~~- 577 (804)
|.+...||+|++|.||+|...+|+.||||+++.... .......++++.....|+||++++....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 566778999999999999999999999998753210 0112223333333333444444432211
Q ss_pred -----eCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC-
Q 038103 578 -----ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF- 651 (804)
Q Consensus 578 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~- 651 (804)
.....+|||||+++++|..+... .....++.|++.+|.|||+.+ ||||||||.|||+++++
T Consensus 177 vp~p~~~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEEETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCeeeeccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 11223799999999888765421 234568899999999999998 99999999999998776
Q ss_pred ---------CeEEeecCCcccc
Q 038103 652 ---------EPKVTDFGLSKLF 664 (804)
Q Consensus 652 ---------~~kl~Dfgla~~~ 664 (804)
.+.|+||+-+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 3899999977643
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.8e-14 Score=128.30 Aligned_cols=91 Identities=23% Similarity=0.398 Sum_probs=72.8
Q ss_pred CCCceEEEeeCccEEEeCCCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccCCCCeEE
Q 038103 89 GKRSKLTLQRNGNLALTDKDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLV 167 (804)
Q Consensus 89 ~~~~~l~~~~~G~L~l~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~~~~~L~ 167 (804)
+...+|.|..||||+|++. +++||++|+... .+.+|+|+|+|||||++ ++.++||||+
T Consensus 18 ~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~------------------- 76 (112)
T 1xd5_A 18 EGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT------------------- 76 (112)
T ss_dssp ETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC-------------------
T ss_pred CCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc-------------------
Confidence 4567899999999999987 789999997543 35789999999999999 7789999995
Q ss_pred ecCCCCCCcccccEEEecCCCcceeecCCCCcccccccCCce
Q 038103 168 SMRSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNSAF 209 (804)
Q Consensus 168 S~~s~~dps~G~y~~~~~~~~~~~~~~~~~~~~~~yw~~~~~ 209 (804)
+|++|.|++.++++|.+.+.... ...||.+..+
T Consensus 77 ------~~~~g~~~l~l~~dGnlvl~~~~---~~~~W~S~~~ 109 (112)
T 1xd5_A 77 ------NRQNGNYYLILQRDRNVVIYDNS---NNAIWATHTN 109 (112)
T ss_dssp ------CCSCCCCEEEECTTSCEEEECTT---SCEEEECCCC
T ss_pred ------cCCCCCEEEEEeCCCcEEEECCC---CceEEECCCc
Confidence 44678999999999975443322 2568987654
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.3e-14 Score=126.42 Aligned_cols=106 Identities=25% Similarity=0.437 Sum_probs=84.4
Q ss_pred CCCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEe
Q 038103 26 IPRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALT 105 (804)
Q Consensus 26 ~~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~ 105 (804)
.++|.+||.|. .|+.| .+|.|.|.|...++ +.+ |.. +|.+|+..+ +....|++..||||+|+
T Consensus 3 ~dtL~~gq~L~---~g~~L--~~g~~~L~~q~dGN----Lvl-~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~ 64 (109)
T 3r0e_A 3 TNYLLSGQTLD---TEGHL--KNGDFDLVMQDDCN----LVL-YNG------NWQSNTANN--GRDCKLTLTDYGELVIK 64 (109)
T ss_dssp CSEEETTCEEC---TTCEE--EETTEEEEECTTSC----EEE-ETT------TEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred cCCcCCCCCcC---CCCEe--ECCCEEEEEecCCe----EEE-EeC------eEEcCCCCC--CCcEEEEEcCCCeEEEE
Confidence 37899999997 47888 57999999876553 222 331 699999875 34579999999999999
Q ss_pred CCCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeeccCCCCCccCCC
Q 038103 106 DKDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPS 157 (804)
Q Consensus 106 ~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg 157 (804)
|.+++++|+|++... ....|+|+|+|||||++ ..+|+ |.|.+||
T Consensus 65 d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~-----s~t~~~~ 109 (109)
T 3r0e_A 65 NGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFK-----IDPWVRG 109 (109)
T ss_dssp CTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEE-----ECTTSCC
T ss_pred eCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEEC-----CCCccCC
Confidence 999999999997543 35689999999999997 68999 5777765
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.48 E-value=9.7e-14 Score=124.44 Aligned_cols=85 Identities=27% Similarity=0.490 Sum_probs=69.5
Q ss_pred ceEEEeeCccEEEeCCCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccCCCCeEEecC
Q 038103 92 SKLTLQRNGNLALTDKDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSMR 170 (804)
Q Consensus 92 ~~l~~~~~G~L~l~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~~~~~L~S~~ 170 (804)
.+|.+..||||+|++. +++||++|+... ....|+|+|+|||||+|.++.++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~----------------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP----------------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS-----------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC-----------------------
Confidence 5788899999999987 899999997543 347899999999999999899999999
Q ss_pred CCCCCcccccEEEecCCCcceeecCCCCcccccccCCc
Q 038103 171 SPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNSA 208 (804)
Q Consensus 171 s~~dps~G~y~~~~~~~~~~~~~~~~~~~~~~yw~~~~ 208 (804)
+||++|.|++.++++|.+.+ +. ..||.++.
T Consensus 88 --~~~~~g~~~l~l~~~Gnlvl-~~-----~~~W~Sg~ 117 (119)
T 1b2p_A 88 --VAGKAGHYVLVLQPDRNVVI-YG-----DALWATQT 117 (119)
T ss_dssp --CCCCSSCEEEEECTTSCEEE-EE-----SEEEECCC
T ss_pred --CCCCCCCEEEEEECCCcEEE-EC-----ccEeCCCC
Confidence 35578999999999987433 22 25887653
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=6.5e-13 Score=118.67 Aligned_cols=87 Identities=25% Similarity=0.448 Sum_probs=70.8
Q ss_pred CceEEEeeCccEEEeCCCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccCCCCeEEec
Q 038103 91 RSKLTLQRNGNLALTDKDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSM 169 (804)
Q Consensus 91 ~~~l~~~~~G~L~l~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~~~~~L~S~ 169 (804)
..+|.+..||||+|++ .+++||++|+... .+..++|+++|||||+|.++.++||||++|
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~------------------- 80 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWG------------------- 80 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCCC-------------------
Confidence 4678899999999998 5889999997533 356899999999999998889999999983
Q ss_pred CCCCCCcccccEEEecCCCcceeecCCCCcccccccCCce
Q 038103 170 RSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNSAF 209 (804)
Q Consensus 170 ~s~~dps~G~y~~~~~~~~~~~~~~~~~~~~~~yw~~~~~ 209 (804)
++|.|++.++++|.+.+ +.. .||.+..+
T Consensus 81 ------~~g~~~l~l~~dGnlvl-~~~-----~~W~S~~~ 108 (115)
T 2dpf_A 81 ------DNGKYALVLQKDGRFVI-YGP-----VLWSLGPN 108 (115)
T ss_dssp ------SSSCCEEEECTTSCEEE-ECS-----EEECSSTT
T ss_pred ------CCCCEEEEEeCCCeEEE-ECC-----CEEECCCC
Confidence 46889999999997443 332 58887654
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.35 E-value=2.5e-12 Score=113.75 Aligned_cols=101 Identities=16% Similarity=0.256 Sum_probs=79.0
Q ss_pred CCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeC
Q 038103 27 PRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTD 106 (804)
Q Consensus 27 ~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~ 106 (804)
++|.+||.|. .|+.| .+|.|.|-|...|+ +.+ |.. .. ||.+|+..+ +....+++..+|||||+|
T Consensus 3 ~~l~~gq~L~---~g~~L--~~g~~~L~~q~dGn----Lvl-~~~---~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~ 66 (111)
T 3mez_A 3 NVLLTGDVIH---TDNQL--SYESAAFVMQGDCN----LVL-YNE---AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHS 66 (111)
T ss_dssp TEEETTCEEC---TTCEE--EETTEEEEECTTSC----EEE-ECS---SC-CEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CEeCCCCEeC---CCCEE--ecCCEEEEEccCCe----EEE-ECC---CC-EEECCcccC--CcCEEEEEcCCCcEEEEe
Confidence 6788999997 47888 47899999865553 322 443 23 999999876 345789999999999999
Q ss_pred CCCC-eEEEeccc---CCcceEEEEecCCCeEEEecCCCceeec
Q 038103 107 KDSS-VVWSTNTF---TDEGVQAQLLETGNLVLVNEANTTIWKS 146 (804)
Q Consensus 107 ~~~~-~vWst~~~---~~~~~~a~LldsGNlVl~~~~~~~lWqS 146 (804)
.++. ++|+|++. ......+.|+++|||||++ ..+|+|
T Consensus 67 ~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 67 ANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp SSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred CCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 9876 59999953 2245689999999999997 789996
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.23 E-value=2.2e-11 Score=108.12 Aligned_cols=85 Identities=20% Similarity=0.275 Sum_probs=66.6
Q ss_pred CCCCCCCCceEEEeeCccEEEeCC-CCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccC
Q 038103 84 DRPVNGKRSKLTLQRNGNLALTDK-DSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLT 161 (804)
Q Consensus 84 ~~p~~~~~~~l~~~~~G~L~l~~~-~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~ 161 (804)
+.|+.+...+|.+..||||||++. .++++|++++... .+..++|+++|||||++.++.++|||=.+
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~------------ 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTV------------ 85 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCC------------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCc------------
Confidence 344445567999999999999998 5899999997543 35689999999999999988999997221
Q ss_pred CCCeEEecCCCCCCcccccEEEecCCCcceee
Q 038103 162 KNTTLVSMRSPGTYLSGFYNLKFDDNNILDLI 193 (804)
Q Consensus 162 ~~~~L~S~~s~~dps~G~y~~~~~~~~~~~~~ 193 (804)
-..|.|.+.++.+|.+.++
T Consensus 86 -------------~~~~~~~~~L~~dGnlvly 104 (113)
T 3mez_B 86 -------------GQEGDYVLILQINGQAVVY 104 (113)
T ss_dssp -------------CSSSCCEEEECTTSCEEEE
T ss_pred -------------CCCCCEEEEEcCCceEEEe
Confidence 0135689999999976654
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=6.5e-11 Score=122.40 Aligned_cols=115 Identities=19% Similarity=0.348 Sum_probs=86.8
Q ss_pred CCCCcCCCcceeee-cCCCEEEcCCCeeEeeEeecC--CCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCcc
Q 038103 25 GIPRLTRGNSLAVE-KENDFLVSPNGTFSSGFYKVG--TNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGN 101 (804)
Q Consensus 25 ~~~~~~~~~~l~~~-~~~~~l~S~~g~F~lGFf~~~--~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~ 101 (804)
..+++.||+.+... ..|+.|+| +.+++.|+|... .... +.+ |.+ ..+++|.+++.++ +. ..+.+..+|+
T Consensus 135 ptdtlLpg~~~~~~l~~g~~L~S-~~dps~G~fsl~l~~dGn-lvL-y~~--~~~~yW~Sgt~~~--~~-~~l~l~~dGn 206 (276)
T 3m7h_A 135 PAIPLVPGAIDSLLLAPGSELVQ-GVVYGAGASKLVFQGDGN-LVA-YGP--NGAATWNAGTQGK--GA-VRAVFQGDGN 206 (276)
T ss_dssp TTSCCCCSCTTCEEECSSEEECT-TCEEEETTEEEEECTTSC-EEE-ECT--TSSEEEECCCTTT--TC-CEEEECTTSC
T ss_pred cccccccccccccccccCccccc-CCCCCCceEEEeecCCce-EEE-EeC--CCeEEEECCCCCC--cc-EEEEEcCCCe
Confidence 34888899993210 14677865 467777877652 2222 334 333 2579999999887 23 6899999999
Q ss_pred EEEeCCCCCeEEEecccCCcceEEEEecCCCeEEEecCCCceeeccCC
Q 038103 102 LALTDKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNEANTTIWKSFDS 149 (804)
Q Consensus 102 L~l~~~~~~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~lWqSFd~ 149 (804)
|+++|.++.++|++++.......|+|+++|||||++. +.+||||||
T Consensus 207 Lvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 207 LVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp EEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred EEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 9999998899999997655567899999999999986 689999998
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.3e-10 Score=102.78 Aligned_cols=89 Identities=16% Similarity=0.271 Sum_probs=67.5
Q ss_pred CCCCceEEEeeCccEEEeCCCCCeEEEecccCC-cceEEEEecCCCeEEEecCCC-ceeeccCCCCCccCCCcccCCCCe
Q 038103 88 NGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANT-TIWKSFDSPTDTLLPSQLLTKNTT 165 (804)
Q Consensus 88 ~~~~~~l~~~~~G~L~l~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~-~lWqSFd~PTDtllpg~~l~~~~~ 165 (804)
++...+|.+..||||||++.++ +|++++... ....++|+++|||||++.++. ++|||.-+
T Consensus 18 ~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~---------------- 79 (111)
T 3mez_A 18 SYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS---------------- 79 (111)
T ss_dssp EETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS----------------
T ss_pred ecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc----------------
Confidence 3445789999999999999877 999997543 347899999999999998766 59998521
Q ss_pred EEecCCCCCCcccccEEEecCCCcceeecCCCCcccccccCC
Q 038103 166 LVSMRSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNS 207 (804)
Q Consensus 166 L~S~~s~~dps~G~y~~~~~~~~~~~~~~~~~~~~~~yw~~~ 207 (804)
.....|.|.+.++.+|.+.++- ..+|.++
T Consensus 80 -------~~~~~~~~~l~Lq~dGNlvly~------~~~W~s~ 108 (111)
T 3mez_A 80 -------VNTVRGNYAATLGPDQHVTIYG------PAIWSTP 108 (111)
T ss_dssp -------CCCCSSCCEEEECTTSCEEEEC------SEEEECC
T ss_pred -------cCCCCcCEEEEECCCCeEEEec------cCEEccC
Confidence 1113478999999999876542 3477654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=3.8e-10 Score=116.88 Aligned_cols=140 Identities=13% Similarity=0.028 Sum_probs=109.7
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCcC-CChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEeeccC
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVL-QGDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+.+...++.|+.+.||+.... ++.+++|+..... ....++.+|+.+++.+. |..+.++++++...+..++|||++++
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 445567888888999999855 5789999987422 23346889999999884 67788999999988899999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-----------------------------------------
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE----------------------------------------- 630 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~----------------------------------------- 630 (804)
.+|.+.+. +......++.+++++|+.||+.
T Consensus 95 ~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 95 VLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp EEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred eehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 99887642 1123357889999999999981
Q ss_pred ---------------CCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 631 ---------------CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 631 ---------------~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
....++|+|++|.|||++++..+.|.||+.+..
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 013489999999999998765667999988763
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=1e-09 Score=96.77 Aligned_cols=77 Identities=26% Similarity=0.368 Sum_probs=61.9
Q ss_pred CceEEEeeCccEEEeCCCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccCCCCeEEec
Q 038103 91 RSKLTLQRNGNLALTDKDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSM 169 (804)
Q Consensus 91 ~~~l~~~~~G~L~l~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~~~~~L~S~ 169 (804)
..+|.+..||||+|++. ++++|++|+... ....++|+++|||||++.++.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~------------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG------------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC-------------------
Confidence 46899999999999987 789999997543 357899999999999998889999974321
Q ss_pred CCCCCCcccccEEEecCCCcceee
Q 038103 170 RSPGTYLSGFYNLKFDDNNILDLI 193 (804)
Q Consensus 170 ~s~~dps~G~y~~~~~~~~~~~~~ 193 (804)
..+.|.+.++.+|.+.++
T Consensus 80 ------~~~~~~~~L~ddGNlvly 97 (109)
T 3dzw_A 80 ------ENGNYVCVLQKDRNVVIY 97 (109)
T ss_dssp ------SSSCEEEEECTTSCEEEE
T ss_pred ------CCCCEEEEEeCCCEEEEE
Confidence 135688999999876543
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.99 E-value=8.2e-10 Score=97.34 Aligned_cols=76 Identities=26% Similarity=0.385 Sum_probs=60.6
Q ss_pred CceEEEeeCccEEEeCCCCCeEEEecccCCc-ceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccCCCCeEEec
Q 038103 91 RSKLTLQRNGNLALTDKDSSVVWSTNTFTDE-GVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSM 169 (804)
Q Consensus 91 ~~~l~~~~~G~L~l~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~~~~~L~S~ 169 (804)
..+|.+..||||+|++. +++|++|+.... ...++|+++|||||++.++.++|||-.+
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~-------------------- 82 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSS-------------------- 82 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCC--------------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCc--------------------
Confidence 46899999999999987 589999975433 4689999999999999988999997331
Q ss_pred CCCCCCcccccEEEecCCCcceee
Q 038103 170 RSPGTYLSGFYNLKFDDNNILDLI 193 (804)
Q Consensus 170 ~s~~dps~G~y~~~~~~~~~~~~~ 193 (804)
-..|.|.+.++.+|.+.++
T Consensus 83 -----~~~~~~~~~L~~dGNlvly 101 (110)
T 3r0e_B 83 -----SKQGEYVLILQDDGFGVIY 101 (110)
T ss_dssp -----CSSSCCEEEECTTSCEEEE
T ss_pred -----CCCCCEEEEEcCCccEEEe
Confidence 0135689999999876543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.93 E-value=2.4e-09 Score=110.45 Aligned_cols=129 Identities=18% Similarity=0.053 Sum_probs=98.0
Q ss_pred cccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCc--ccceeeeEEeCCeeEEEEeeccCCChhhhh
Q 038103 521 GKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN--LVKLQGFCAENEHKLLVYEYVENGSLDKLL 598 (804)
Q Consensus 521 G~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l 598 (804)
+.|..+.||+....+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+++.+|. .
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 355669999998877888999987643 2345788999999886544 456888888777889999999998884 2
Q ss_pred ccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhC-----------------------------------------------
Q 038103 599 FNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC----------------------------------------------- 631 (804)
Q Consensus 599 ~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~----------------------------------------------- 631 (804)
.. . ....++.++++.|+.||+..
T Consensus 105 ~~-------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 105 SH-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp SC-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred Cc-------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 11 1 12357778888888888643
Q ss_pred --------CCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 632 --------LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 632 --------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
...++|+|++|.|||++++..++|.||+.+..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998876677999998874
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.84 E-value=4.8e-09 Score=92.25 Aligned_cols=80 Identities=25% Similarity=0.400 Sum_probs=61.6
Q ss_pred CCCCCCCceEEEeeCccEEEeCCCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccCCC
Q 038103 85 RPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKN 163 (804)
Q Consensus 85 ~p~~~~~~~l~~~~~G~L~l~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~~~ 163 (804)
.|+++...+|.+..||||||+++ +|+|++... ....++|+++|||||+|.++.++|+|- |
T Consensus 16 ~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~-----t---------- 76 (109)
T 3r0e_A 16 GHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSG-----A---------- 76 (109)
T ss_dssp CEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECC-----C----------
T ss_pred CEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCC-----C----------
Confidence 34444567899999999999985 799997643 357899999999999999889999851 1
Q ss_pred CeEEecCCCCCCcccccEEEecCCCcceee
Q 038103 164 TTLVSMRSPGTYLSGFYNLKFDDNNILDLI 193 (804)
Q Consensus 164 ~~L~S~~s~~dps~G~y~~~~~~~~~~~~~ 193 (804)
....+.|.+.++++|.+.++
T Consensus 77 ----------~~~~~~~~~~L~~dGNlvly 96 (109)
T 3r0e_A 77 ----------QSVKGNYAAVVHPDGRLVVF 96 (109)
T ss_dssp ----------CCSSSCCEEEEETTTEEEEE
T ss_pred ----------cCCCcCEEEEEcCCCeEEEE
Confidence 01236789999999976543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.84 E-value=1.2e-08 Score=110.84 Aligned_cols=140 Identities=15% Similarity=0.194 Sum_probs=105.4
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEec--CcC--CChHHHHHHHHHHhcCC--CCcccceeeeEEeC---CeeEEEEee
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLE--GVL--QGDAEFWAEVSIIGRIN--HRNLVKLQGFCAEN---EHKLLVYEY 588 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~--~~~--~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~E~ 588 (804)
+.|+.|.++.||+....+ ..+++|+.. ... .....+.+|+.+++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 468999999999998765 467788765 222 22356788999999986 45678889888776 458999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhC-------------------------------------
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC------------------------------------- 631 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------------------------------------- 631 (804)
+++..+.+... ..++...+..++.++++.|+.||...
T Consensus 123 v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 123 VSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred cCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99987754221 23677888899999999999999831
Q ss_pred ------------------CCcEEecccccCeEEEcCCCC--eEEeecCCcccc
Q 038103 632 ------------------LEWVLHCDVKPQNILLDDHFE--PKVTDFGLSKLF 664 (804)
Q Consensus 632 ------------------~~~ivH~Dlkp~NILl~~~~~--~kl~Dfgla~~~ 664 (804)
...++|+|+++.|||++.++. +.|.||+.+..-
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 245999999999999987753 689999998753
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.82 E-value=1.2e-08 Score=88.90 Aligned_cols=75 Identities=31% Similarity=0.492 Sum_probs=59.4
Q ss_pred ceEEEeeCccEEEeCCCCCeEEEeccc--CCcceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccCCCCeEEec
Q 038103 92 SKLTLQRNGNLALTDKDSSVVWSTNTF--TDEGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSM 169 (804)
Q Consensus 92 ~~l~~~~~G~L~l~~~~~~~vWst~~~--~~~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~~~~~L~S~ 169 (804)
-+|.+..||||||++. +++||++|+. ...+..+.|.++|||||+|.++.++|+|=
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~---------------------- 77 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASH---------------------- 77 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECC----------------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEec----------------------
Confidence 4688899999999974 6789999974 33456899999999999999999999961
Q ss_pred CCCCCCcccccEEEecCCCccee
Q 038103 170 RSPGTYLSGFYNLKFDDNNILDL 192 (804)
Q Consensus 170 ~s~~dps~G~y~~~~~~~~~~~~ 192 (804)
+....+.|.+.++++|.+.+
T Consensus 78 ---t~~~~~~~~l~L~ddGNlVl 97 (105)
T 4h3o_A 78 ---STRGSGNYILILQDDGNVII 97 (105)
T ss_dssp ---CCCCSSCEEEEECTTSCEEE
T ss_pred ---CCCCCCCEEEEEeCCCeEEE
Confidence 11234678899988887654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.81 E-value=1.7e-08 Score=102.33 Aligned_cols=57 Identities=35% Similarity=0.508 Sum_probs=48.8
Q ss_pred ceEEEeeCccEEEeCCCCCeEEEecccCCcceEEEEecCCCeEEEecCCCceeeccCC
Q 038103 92 SKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNEANTTIWKSFDS 149 (804)
Q Consensus 92 ~~l~~~~~G~L~l~~~~~~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~lWqSFd~ 149 (804)
-+|.+..+|||+|++. +++||++|+.......++|.++|||||+|.++.++|+|+.+
T Consensus 28 f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~ 84 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTK 84 (236)
T ss_dssp EEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCC
T ss_pred EEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCcc
Confidence 4677777899999886 78999999754456789999999999999999999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.59 E-value=2.4e-08 Score=105.64 Aligned_cols=182 Identities=19% Similarity=0.183 Sum_probs=118.6
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCC-CCc--ccceeeeEEeCC---eeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-HRN--LVKLQGFCAENE---HKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~E~~~~ 591 (804)
+.++.|....||+.. +.+++|+.... .....+.+|+++++.+. +.. +.+++....... ..++|||++++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 358899999999854 45888876532 23457889999998873 332 334444433332 34889999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhC----------------------------------------
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC---------------------------------------- 631 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~---------------------------------------- 631 (804)
.+|..... ..++...+..++.++++.++.||+..
T Consensus 101 ~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 101 VPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp EECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred eECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 88865432 12566677788888888888888611
Q ss_pred ---------------CCcEEecccccCeEEEcC--CCCeEEeecCCcccccccCCccccccccCCCc---cchhhhc---
Q 038103 632 ---------------LEWVLHCDVKPQNILLDD--HFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY---LAPEWMM--- 688 (804)
Q Consensus 632 ---------------~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y---~aPE~~~--- 688 (804)
...++|+|++|.||++++ ...+.|.||+.+..-....+-. ..... ..|+...
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-----~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-----SLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-----TTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-----HHHhhccccCHHHHHHHH
Confidence 134899999999999998 5567899999987543211100 00011 2232211
Q ss_pred --cCCC---------CcccchHHHHHHHHHHHhCCCCC
Q 038103 689 --NLKI---------DAKADVYSYGIVLLELLTGKSAS 715 (804)
Q Consensus 689 --~~~~---------s~k~DV~S~Gvll~el~tg~~p~ 715 (804)
.+.. ....+.|+++.+++++.+|..++
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0111 12368999999999999998664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=2.6e-05 Score=80.46 Aligned_cols=134 Identities=18% Similarity=0.129 Sum_probs=95.6
Q ss_pred ccccCcc-eEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEeeccCCChhh
Q 038103 520 VGKGGFG-SVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYEYVENGSLDK 596 (804)
Q Consensus 520 LG~G~fg-~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 596 (804)
+..|..+ .||+.... +++.+++|+-... ...++.+|...|+.+. +-.+.++++++...+..++|||++++.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 4445555 68988754 4667888976532 2456788999988874 4457788899999999999999999988776
Q ss_pred hhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhC---------------------------------------------
Q 038103 597 LLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC--------------------------------------------- 631 (804)
Q Consensus 597 ~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--------------------------------------------- 631 (804)
..... ......+..++++.|+-||...
T Consensus 110 ~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 110 VLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 54321 1233445566666666666421
Q ss_pred ----------CCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 632 ----------LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 632 ----------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
...++|+|+.+.|||+++++.+-|.||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11279999999999999887778999998874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=2.6e-05 Score=82.26 Aligned_cols=136 Identities=16% Similarity=0.171 Sum_probs=91.7
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCC---cccceeeeEE-eCCeeEEEEeeccCCC
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR---NLVKLQGFCA-ENEHKLLVYEYVENGS 593 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~E~~~~gs 593 (804)
+.++.|....||+. ++.+++|+-.. ......+.+|.++++.+.+. .+.+.+.++. ..+..++|||++++.+
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 34778888899987 45578887432 12245688999999999653 3556666664 3456789999999988
Q ss_pred hhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-------------------------------------------
Q 038103 594 LDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE------------------------------------------- 630 (804)
Q Consensus 594 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------------------------------------------- 630 (804)
|...... .++...+..++.++++.|+.||+.
T Consensus 100 l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 100 LGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred Cchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8663221 133444455555555555555542
Q ss_pred --------------CCCcEEecccccCeEEEcC---CCC-eEEeecCCcccc
Q 038103 631 --------------CLEWVLHCDVKPQNILLDD---HFE-PKVTDFGLSKLF 664 (804)
Q Consensus 631 --------------~~~~ivH~Dlkp~NILl~~---~~~-~kl~Dfgla~~~ 664 (804)
....++|+|+++.|||++. ++. ..|.||+.+..-
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2234799999999999987 455 489999988753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=4.6e-05 Score=82.15 Aligned_cols=79 Identities=8% Similarity=0.019 Sum_probs=55.7
Q ss_pred ccc-cccCcceEEEEEec-------CCcEEEEEEecCcC----CChHHHHHHHHHHhcCC-C--CcccceeeeEEeC---
Q 038103 518 QEV-GKGGFGSVFRGVLD-------DERVVAVKRLEGVL----QGDAEFWAEVSIIGRIN-H--RNLVKLQGFCAEN--- 579 (804)
Q Consensus 518 ~~L-G~G~fg~Vykg~~~-------~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~--- 579 (804)
+.| +.|....+|+.... +++.+++|+..... .....+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78889999998765 25678888765322 12345778998888884 2 3567788877655
Q ss_pred CeeEEEEeeccCCChhh
Q 038103 580 EHKLLVYEYVENGSLDK 596 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~ 596 (804)
...++|||++++..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00027 Score=75.43 Aligned_cols=141 Identities=14% Similarity=0.221 Sum_probs=81.2
Q ss_pred cccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCC-----CCccccee-e--eEEeCCeeEEEEeecc
Q 038103 519 EVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-----HRNLVKLQ-G--FCAENEHKLLVYEYVE 590 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-g--~~~~~~~~~lV~E~~~ 590 (804)
.|+.|..+.||+....+++ +++|+... ...++..|+.++..|. .|.++... | +....+..++++||++
T Consensus 39 ~l~gG~~n~~~~v~~~~~~-~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGA-VCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTEE-EEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCCC-EEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 4666778999999876665 88998864 2344455666666553 23333311 1 1234567899999999
Q ss_pred CCChhh--------------hhcc----C--CCC----CCCCCHHhHH-------------------------------H
Q 038103 591 NGSLDK--------------LLFN----D--PGT----ASILQWDQRY-------------------------------N 615 (804)
Q Consensus 591 ~gsL~~--------------~l~~----~--~~~----~~~l~~~~~~-------------------------------~ 615 (804)
+..+.. .++. . +.. .....|...+ .
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 865430 0111 0 100 0112332211 1
Q ss_pred HHHHHHHHHHHHHh--------h--CCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 616 IAVGTAKGLSYLHE--------E--CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 616 i~~~ia~~l~yLH~--------~--~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+...+.+++++|+. . ....++|+|+++.|||++.++.+.|.||+.+..
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11123345667763 1 234599999999999998888999999998763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00027 Score=77.34 Aligned_cols=73 Identities=22% Similarity=0.194 Sum_probs=48.3
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcC--------CChHHHHHHHHHHhcCCC--Cccc-ceeeeEEeCCeeEEE
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--------QGDAEFWAEVSIIGRINH--RNLV-KLQGFCAENEHKLLV 585 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--------~~~~~~~~E~~~l~~l~H--~niv-~l~g~~~~~~~~~lV 585 (804)
+.||.|..+.||++... +++.++||...... ...+.+..|.++++.+.+ +..+ +++.+ +....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46999999999999864 46789999765211 123456789888887742 3333 44433 34556899
Q ss_pred EeeccCC
Q 038103 586 YEYVENG 592 (804)
Q Consensus 586 ~E~~~~g 592 (804)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0016 Score=68.43 Aligned_cols=138 Identities=17% Similarity=0.134 Sum_probs=90.0
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCC---CCcccceeeeEEeCCeeEEEEeeccCCCh
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN---HRNLVKLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
+.|+.|....+|+.... ++.+++|+.... ....+..|...|+.|. ...+.+++.++...+..++|||++++..+
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 45899999999998864 566888886532 3456888999888883 36688888888888889999999998765
Q ss_pred hh-----------hhccCCC-C-----------------CCCCCHHhHH---HHHH----------------HHHHH-HH
Q 038103 595 DK-----------LLFNDPG-T-----------------ASILQWDQRY---NIAV----------------GTAKG-LS 625 (804)
Q Consensus 595 ~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~~----------------~ia~~-l~ 625 (804)
.. .|+.... . ...-+|...+ ++.. .+++. ..
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 21 1222111 0 0012454322 1111 11111 12
Q ss_pred HHHh-hCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 626 YLHE-ECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 626 yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
.|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3322 2235599999999999999887 8888873
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0011 Score=68.97 Aligned_cols=73 Identities=22% Similarity=0.237 Sum_probs=52.8
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCC---cccceeeeEEeCCeeEEEEeeccCCC
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHR---NLVKLQGFCAENEHKLLVYEYVENGS 593 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lV~E~~~~gs 593 (804)
+.+|.|..+.||+.++.+|+.+.||+-.... .....|..|+..|+.|... .+.+++++. ..++|||+++.+.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 5689999999999999999999999876332 2345678899998888422 234444432 3478999988765
Q ss_pred h
Q 038103 594 L 594 (804)
Q Consensus 594 L 594 (804)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0064 Score=66.85 Aligned_cols=80 Identities=11% Similarity=0.018 Sum_probs=48.6
Q ss_pred CCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCccccccccCCCccchhhhccCC---CCcccchHHHHHHHHHH
Q 038103 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK---IDAKADVYSYGIVLLEL 708 (804)
Q Consensus 632 ~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DV~S~Gvll~el 708 (804)
...++|+|+++.|||++.++ ++|.||+.+..-....+-......-...|++|+...... -....++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 34599999999999998876 999999998864322111000000013356665543211 11235566788888887
Q ss_pred HhCC
Q 038103 709 LTGK 712 (804)
Q Consensus 709 ~tg~ 712 (804)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.018 Score=60.72 Aligned_cols=141 Identities=13% Similarity=0.105 Sum_probs=82.7
Q ss_pred ccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCC--cccceeee-----EEeCCeeEEEEeeccCC
Q 038103 520 VGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR--NLVKLQGF-----CAENEHKLLVYEYVENG 592 (804)
Q Consensus 520 LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lV~E~~~~g 592 (804)
++ |....||+....+|+.+++|.........+++..|..++..+... .+.+++.. ....+..++++|++++.
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~ 112 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 112 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCC
Confidence 55 777899998877777799999864334556777888888877422 23444433 22345668899999875
Q ss_pred Chhh-----h---------hcc----CCC-CCCCCCHHhH----HH---------------HHHHHHHHHHHHHhh----
Q 038103 593 SLDK-----L---------LFN----DPG-TASILQWDQR----YN---------------IAVGTAKGLSYLHEE---- 630 (804)
Q Consensus 593 sL~~-----~---------l~~----~~~-~~~~l~~~~~----~~---------------i~~~ia~~l~yLH~~---- 630 (804)
.+.. . ++. .+. .....++... .. +...+.+.++.+...
T Consensus 113 ~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 192 (328)
T 1zyl_A 113 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 192 (328)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhc
Confidence 4321 0 111 000 1111222111 00 011111223333332
Q ss_pred CCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 631 ~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 193 ~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 193 FTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 233489999999999999 4 899999988764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0046 Score=64.61 Aligned_cols=70 Identities=11% Similarity=0.055 Sum_probs=42.9
Q ss_pred ccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcc-cceeeeEEeCCeeEEEEeec-cCCCh
Q 038103 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNL-VKLQGFCAENEHKLLVYEYV-ENGSL 594 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~-~~gsL 594 (804)
+.|+.|....+|+. +.+++|+............+|+.+++.+....+ .+++++ ....-++++||+ ++.+|
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 56888889999998 448888776322222223568887777743333 345543 334457899999 55444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.63 E-value=0.005 Score=67.83 Aligned_cols=72 Identities=21% Similarity=0.250 Sum_probs=49.1
Q ss_pred ccccccCcceEEEEEecC--------CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcc-cceeeeEEeCCeeEEEEee
Q 038103 518 QEVGKGGFGSVFRGVLDD--------ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNL-VKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~--------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~ 588 (804)
+.|+.|....+|+...++ ++.+++|+.... ...+.+..|..++..+...++ .++++.+.+ .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 457788889999998753 467888887432 122566789999888854344 456665542 289999
Q ss_pred ccCCCh
Q 038103 589 VENGSL 594 (804)
Q Consensus 589 ~~~gsL 594 (804)
+++.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.44 E-value=0.014 Score=61.39 Aligned_cols=143 Identities=12% Similarity=0.082 Sum_probs=81.0
Q ss_pred cccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCc--ccceeee------EEeCCeeEEEEeecc
Q 038103 519 EVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN--LVKLQGF------CAENEHKLLVYEYVE 590 (804)
Q Consensus 519 ~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E~~~ 590 (804)
.|+.|....+|+....++ .+++|..... ...+++..|+.++..+.... +.+++.. ....+..++++++++
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~ 106 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 106 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence 467788889999987766 4778887642 22345667888777764222 2333321 123456789999998
Q ss_pred CCChhhh--------------hccC----CCCC----CCCCHHhHHH------------HHHHHHHHHHHHHhhC----C
Q 038103 591 NGSLDKL--------------LFND----PGTA----SILQWDQRYN------------IAVGTAKGLSYLHEEC----L 632 (804)
Q Consensus 591 ~gsL~~~--------------l~~~----~~~~----~~l~~~~~~~------------i~~~ia~~l~yLH~~~----~ 632 (804)
+..+... ++.. .... ....|...+. +...+.+.++.++... +
T Consensus 107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~ 186 (322)
T 2ppq_A 107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 186 (322)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence 8654210 1110 0000 1112332111 1112445566666431 2
Q ss_pred CcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 633 ~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
..++|+|+.+.|||++++..+.|.||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3489999999999999876568999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.012 Score=63.42 Aligned_cols=142 Identities=20% Similarity=0.187 Sum_probs=82.6
Q ss_pred ccccccCcceEEEEEecC--------CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCc-ccceeeeEEeCCeeEEEEee
Q 038103 518 QEVGKGGFGSVFRGVLDD--------ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN-LVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~--------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~ 588 (804)
+.|..|-...+|+....+ ++.+++|+............+|..+++.+...+ ..++++.+.+ -+|+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 356678888999988752 467888886433334566778999998884322 3456666543 289999
Q ss_pred ccCCChhhh-----------------hccCC-CCCCCCC--HHhHHHHHHHHH-------------------HHHHHHHh
Q 038103 589 VENGSLDKL-----------------LFNDP-GTASILQ--WDQRYNIAVGTA-------------------KGLSYLHE 629 (804)
Q Consensus 589 ~~~gsL~~~-----------------l~~~~-~~~~~l~--~~~~~~i~~~ia-------------------~~l~yLH~ 629 (804)
+++.+|..- |+... .-..... |.++.++..++. +.+..|..
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 988655321 11111 0111222 344444443332 12333332
Q ss_pred ----h-CCCcEEecccccCeEEEcCC----CCeEEeecCCccc
Q 038103 630 ----E-CLEWVLHCDVKPQNILLDDH----FEPKVTDFGLSKL 663 (804)
Q Consensus 630 ----~-~~~~ivH~Dlkp~NILl~~~----~~~kl~Dfgla~~ 663 (804)
. ....++|+|+.+.|||++.+ +.+.|.||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 22348999999999999876 7899999998874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.33 E-value=0.019 Score=63.51 Aligned_cols=73 Identities=12% Similarity=0.028 Sum_probs=47.0
Q ss_pred ccccccCcceEEEEEecC-CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcc-cceeeeEEeCCeeEEEEeeccCCCh
Q 038103 518 QEVGKGGFGSVFRGVLDD-ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNL-VKLQGFCAENEHKLLVYEYVENGSL 594 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL 594 (804)
+.|+.|-...+|+....+ ++.+++|+.........+...|..++..|...++ .++++.+. + .+|+||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 457888889999999876 4678888764322221223578888888865555 45666653 2 259999987554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.32 E-value=0.02 Score=60.55 Aligned_cols=142 Identities=13% Similarity=0.020 Sum_probs=71.6
Q ss_pred cccccCcce-EEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCC--CcccceeeeEEeCCeeEEEEeeccCCChh
Q 038103 519 EVGKGGFGS-VFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINH--RNLVKLQGFCAENEHKLLVYEYVENGSLD 595 (804)
Q Consensus 519 ~LG~G~fg~-Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 595 (804)
.|+.|+... +|+....+++.+++|...... .+++..|+.++..+.. -.+.+++.+..+. -+++||++.+..+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchH
Confidence 465554444 667765446667777654321 1334556777766632 2345566653333 37899998776654
Q ss_pred hhhccC---------------------CCC-CCCCCHHhHH-------H-------------HHHHHHHHHHHHHh---h
Q 038103 596 KLLFND---------------------PGT-ASILQWDQRY-------N-------------IAVGTAKGLSYLHE---E 630 (804)
Q Consensus 596 ~~l~~~---------------------~~~-~~~l~~~~~~-------~-------------i~~~ia~~l~yLH~---~ 630 (804)
+++... ... ....+..... . ....+.+.++.+.. .
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 433211 000 0001110000 0 00111222333321 1
Q ss_pred CCCcEEecccccCeEEEcCC----CCeEEeecCCcccc
Q 038103 631 CLEWVLHCDVKPQNILLDDH----FEPKVTDFGLSKLF 664 (804)
Q Consensus 631 ~~~~ivH~Dlkp~NILl~~~----~~~kl~Dfgla~~~ 664 (804)
....++|+|+.+.|||++.+ ..+.|.||+.+..-
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 23459999999999999874 67899999988753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.24 E-value=0.0092 Score=64.29 Aligned_cols=73 Identities=12% Similarity=0.100 Sum_probs=42.9
Q ss_pred ccccccCcceEEEEEecC---------CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcc-cceeeeEEeCCeeEEEEe
Q 038103 518 QEVGKGGFGSVFRGVLDD---------ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNL-VKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~---------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 587 (804)
+.|+.|....+|+....+ ++.+++|+.........+...|..+++.+...++ .++++.. . -.+|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 357778888999998754 2578888765322111124578888887753343 3555443 2 368999
Q ss_pred eccCCCh
Q 038103 588 YVENGSL 594 (804)
Q Consensus 588 ~~~~gsL 594 (804)
|+++.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.86 E-value=0.055 Score=57.41 Aligned_cols=32 Identities=19% Similarity=0.258 Sum_probs=28.0
Q ss_pred CcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 633 ~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
..++|+|+.+.||++++++.+.|.||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 35999999999999998888999999887753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.59 E-value=0.037 Score=53.82 Aligned_cols=103 Identities=13% Similarity=0.020 Sum_probs=67.0
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
-+|.+.|.. .+.++++.++|.++.|.+++|.-+-.+..+ ..+=+.|..|++..+|.+...+ ..+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 378888875 567899999999999999988766321111 1233457999999999988764 1111
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSA 714 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p 714 (804)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888653 3456788999999999998874444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.41 E-value=0.4 Score=52.20 Aligned_cols=141 Identities=12% Similarity=0.133 Sum_probs=82.2
Q ss_pred ccccccCcceEEEEEecC--------CcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcc-cceeeeEEeCCeeEEEEee
Q 038103 518 QEVGKGGFGSVFRGVLDD--------ERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNL-VKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~--------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~ 588 (804)
+.+..|-...+|+....+ ++.+++++.........+..+|..+++.+...++ .++++.+ . -.+|+||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 346678888999998763 5678888864322222234578888887743333 3455433 2 3789999
Q ss_pred ccCCChhhh-h----------------ccC-------CC--CCCCCCHHhHHHHHHHH-------------------HHH
Q 038103 589 VENGSLDKL-L----------------FND-------PG--TASILQWDQRYNIAVGT-------------------AKG 623 (804)
Q Consensus 589 ~~~gsL~~~-l----------------~~~-------~~--~~~~l~~~~~~~i~~~i-------------------a~~ 623 (804)
+++.+|..- + +.. +. .....-|.++.++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 998654211 0 100 11 11111243333333221 223
Q ss_pred HHHHHhh---------------------CCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 624 LSYLHEE---------------------CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 624 l~yLH~~---------------------~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+..|++. ....++|+|+.+.||+ +.++.+.|.||..+..
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 3333321 1234899999999999 8888999999998875
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=91.18 E-value=0.19 Score=40.49 Aligned_cols=34 Identities=38% Similarity=0.921 Sum_probs=30.0
Q ss_pred CCCHHHHHHHhccCCceeeEEeecCCCCeeeeccc
Q 038103 359 GISLQECRNRCLSDCKCKGFGYSTDGQGECFPKGN 393 (804)
Q Consensus 359 ~~s~~~C~~~Cl~nCsC~Ay~y~~~g~g~C~~~~~ 393 (804)
..++++|+..|+.+=.|.||.|.. ...-|+++..
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~-~s~~CflKs~ 62 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNV-KSGLCYPKRG 62 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEET-TTTEEEEEES
T ss_pred CCCHHHHHHHhhccCCCCeEEecc-CCCceEcccC
Confidence 568999999999999999999975 6678999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.80 E-value=0.57 Score=50.72 Aligned_cols=29 Identities=31% Similarity=0.419 Sum_probs=25.1
Q ss_pred EEecccccCeEEE------cCCCCeEEeecCCccc
Q 038103 635 VLHCDVKPQNILL------DDHFEPKVTDFGLSKL 663 (804)
Q Consensus 635 ivH~Dlkp~NILl------~~~~~~kl~Dfgla~~ 663 (804)
++|+|+.+.|||+ +++..+++.||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999998875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.35 E-value=1.8 Score=41.92 Aligned_cols=116 Identities=9% Similarity=0.157 Sum_probs=79.0
Q ss_pred CCCcccceeeeEEeCCeeEEEEeeccCC-ChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccC
Q 038103 565 NHRNLVKLQGFCAENEHKLLVYEYVENG-SLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQ 643 (804)
Q Consensus 565 ~H~niv~l~g~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 643 (804)
.||+++.. .+-.+.+...+.|+.-+.+ ++.. + ..++...+++++.+|+....+++. -+|--+.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 57877766 4555666666666654422 2222 3 237788899999999987765554 378899999
Q ss_pred eEEEcCCCCeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 644 NILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 644 NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
||+++.++.+++.=.|+-.. ++|. ..++..=.-.+=+++..+++++..|+.
T Consensus 109 NL~f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp GEEECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred eEEEcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999976554332 2222 223333355677889999999988863
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.94 E-value=2.8 Score=40.73 Aligned_cols=116 Identities=15% Similarity=0.120 Sum_probs=76.6
Q ss_pred CCCcccceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHH-HHHhhCCCcEEecccccC
Q 038103 565 NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS-YLHEECLEWVLHCDVKPQ 643 (804)
Q Consensus 565 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~-yLH~~~~~~ivH~Dlkp~ 643 (804)
.||.+ -..+-.+++...+.|+.-+++.=...+. .++...+++++.+|+.... +++. -+|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57776 4444466677777777654432222332 3677888999998887666 5544 478899999
Q ss_pred eEEEcCCCCeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 644 NILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 644 NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
||+++.++.++|.=.|+-. -++|. ..++.-=.-++=+++..++.++..|+.
T Consensus 114 NL~f~~~~~p~i~hRGi~~------------------~lpP~-----e~~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE------------------SLPPD-----EWDDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp GEEECTTCCEEESCCEETT------------------TBSSC-----SCCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred eEEEeCCCcEEEEEcCCcc------------------cCCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999997655433 23332 122222344677888888888887754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 804 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-19 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-18 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 6e-06 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-18 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 8e-05 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 9e-16 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-13 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 0.002 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 2e-08 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 9e-07 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 3e-08 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 0.002 | |
| d1i0ua2 | 41 | g.3.11.1 (A:42-82) Low density lipoprotein (LDL) r | 0.003 | |
| d1lmja2 | 42 | g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapien | 0.003 | |
| d1lmja1 | 44 | g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 8e-63
Identities = 70/289 (24%), Positives = 124/289 (42%), Gaps = 32/289 (11%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRL---EGVLQGDAEFWAEVSIIGRI 564
E+ Q +G G FG+V++G + VAVK L Q F EV ++ +
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 565 NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGL 624
H N++ G+ +V ++ E SL L + + +IA TA+G+
Sbjct: 62 RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGM 117
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF-KERHDTKFSRVRGTRGYLA 683
YLH + ++H D+K NI L + K+ DFGL+ + + +F ++ G+ ++A
Sbjct: 118 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 684 PEWMMNLK---IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740
PE + ++DVY++GIVL EL+TG+ Y N + M
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP------------YSNINNRDQIIFMV 222
Query: 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
G ++ + M ++ C+ + RD RP +++ +
Sbjct: 223 GRGYLSPDLSKVRSNCPKA----MKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 4e-62
Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 26/282 (9%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
E+ R T + +G G FG V+ G + VAVK L+ F AE +++ ++ H+
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LV+L E ++ EY+ENGSL L G L ++ ++A A+G++++
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFI 125
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
E +H D++ NIL+ D K+ DFGL++L ++ T + + APE +
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 688 MNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747
K+DV+S+GI+L E++T M + +
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPY--------------------PGMTNPEVIQN 222
Query: 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
++ V + + ++ LC E + RP + +L
Sbjct: 223 LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-61
Identities = 63/275 (22%), Positives = 129/275 (46%), Gaps = 26/275 (9%)
Query: 515 NFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
F QE+G G FG V G ++ VA+K + + +F E ++ +++H LV+L G
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 575 FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
C E LV+E++E+G L L G + + + + +G++YL E C
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLEEAC--- 121
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDA 694
V+H D+ +N L+ ++ KV+DFG+++ + T + + + +PE + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 695 KADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLND 754
K+DV+S+G+++ E+ + ++ + +V+ ++ ++ PRL
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPY-------ENRSNSEVVEDISTG------FRLYKPRLAS 228
Query: 755 VYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
+ ++ C E + RP S++++ L
Sbjct: 229 -------THVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 7e-61
Identities = 74/306 (24%), Positives = 124/306 (40%), Gaps = 30/306 (9%)
Query: 516 FKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGF 575
++ +GKG FG V+RG VAVK + AE+ + H N++
Sbjct: 7 LQESIGKGRFGEVWRGKWRG-EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 576 CAENEHKL----LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
++ LV +Y E+GSL L + + +A+ TA GL++LH E
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEI 120
Query: 632 LEW-----VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT---KFSRVRGTRGYLA 683
+ + H D+K +NIL+ + + D GL+ DT + GT+ Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 684 PEW------MMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAK 737
PE M + + +AD+Y+ G+V E+ S Y +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI-HEDYQLPYYDLVPSDPSVE 239
Query: 738 QMEQEGLEKIIDPRLNDVYD-REKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796
+M + E+ + P + + + E L M K+ C N R ++ K L+ +
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS----QL 295
Query: 797 SQDESI 802
SQ E I
Sbjct: 296 SQQEGI 301
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 9e-61
Identities = 59/275 (21%), Positives = 111/275 (40%), Gaps = 26/275 (9%)
Query: 515 NFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
F +E+G G FG V G + VA+K ++ + EF E ++ ++H LV+L G
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 575 FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
C + ++ EY+ NG L L Q Q + + + YL +
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESKQ--- 120
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDA 694
LH D+ +N L++D KV+DFGLS+ + T + + PE +M K +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 695 KADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLND 754
K+D++++G+++ E+ + + ++ + I L
Sbjct: 181 KSDIWAFGVLMWEIYSLG--------------------KMPYERFTNSETAEHIAQGLRL 220
Query: 755 VYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
+++ + C E D RP ++ +
Sbjct: 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 4e-59
Identities = 67/294 (22%), Positives = 121/294 (41%), Gaps = 28/294 (9%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
E+ R + + ++G+G FG V+ G + VA+K L+ F E ++ ++ H
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 72
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
LV+L E +V EY+ GSL L + G L+ Q ++A A G++Y+
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYV 129
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
+H D++ NIL+ ++ KV DFGL++L ++ T + + APE
Sbjct: 130 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 688 MNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747
+ + K+DV+S+GI+L EL T M +
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYP--------------------GMVNREVLDQ 226
Query: 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQDES 801
++ E + + + C + + RP + L D+ +S +
Sbjct: 227 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL--EDYFTSTEPQ 278
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (510), Expect = 6e-59
Identities = 76/307 (24%), Positives = 136/307 (44%), Gaps = 47/307 (15%)
Query: 504 FTYAELKRATRNFKQEV-----------GKGGFGSVFRGVL----DDERVVAVKRLEGVL 548
FT+ + A R F +E+ G G FG V G L E VA+K L+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 549 --QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTAS 606
+ +F +E SI+G+ +H N++ L+G ++ +++ E++ENGSLD L + G +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 607 ILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666
Q + G A G+ YL + +H D+ +NIL++ + KV+DFGLS+ ++
Sbjct: 127 ---VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 667 RHD----TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASA 722
T + + APE + K + +DV+SYGIV+ E+++ +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW----- 235
Query: 723 SDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPM 782
M + + I+ + + ++ L C ++R+ RP
Sbjct: 236 ---------------DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 783 SKVVKLL 789
++V L
Sbjct: 281 GQIVNTL 287
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (494), Expect = 6e-57
Identities = 65/298 (21%), Positives = 123/298 (41%), Gaps = 30/298 (10%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRINH 566
E++R K ++G G +G V+ GV VAVK L+ EF E +++ I H
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 72
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
NLV+L G C ++ E++ G+L L + +A + + Y
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEY 130
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
L ++ +H D+ +N L+ ++ KV DFGLS+L T + + + APE
Sbjct: 131 LEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746
+ K K+DV+++G++L E+ T + ++ + +
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY--------------------PGIDLSQVYE 227
Query: 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQDESISD 804
+++ +++ ++ C N RP +++ + Q+ SISD
Sbjct: 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF----ETMFQESSISD 281
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-56
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGD--AEFWAEVSIIGRI 564
ELK E+G G G VF+ V+A K + ++ + E+ ++
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 565 NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGL 624
N +V G + + E+++ GSLD++L A + +++ KGL
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGL 117
Query: 625 SYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
+YL E+ ++H DVKP NIL++ E K+ DFG+S D+ + GTR Y++P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGK 712
E + ++D++S G+ L+E+ G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-55
Identities = 73/283 (25%), Positives = 117/283 (41%), Gaps = 32/283 (11%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHR 567
L Q +GKG FG V G VAVK ++ F AE S++ ++ H
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKND-ATAQAFLAEASVMTQLRHS 60
Query: 568 NLVKLQGFCAENEHKL-LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
NLV+L G E + L +V EY+ GSL L + S+L D ++ + + Y
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEY 118
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
L +H D+ +N+L+ + KV+DFGL+K DT + + APE
Sbjct: 119 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEA 171
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746
+ K K+DV+S+GI+L E+ + Y ++ V ++E+
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRV-----------PYPRIPLKDVVPRVEKGYKMD 220
Query: 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
D VY+ V C + RP ++ + L
Sbjct: 221 APDGCPPAVYE---------VMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (470), Expect = 2e-53
Identities = 64/304 (21%), Positives = 122/304 (40%), Gaps = 52/304 (17%)
Query: 515 NFKQEVGKGGFGSVFRGVL------DDERVVAVKRL--EGVLQGDAEFWAEVSIIGRINH 566
+ +++G+G FG VF+ + +VAVK L E A+F E +++ ++
Sbjct: 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 75
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFN--------------------DPGTAS 606
N+VKL G CA + L++EY+ G L++ L +
Sbjct: 76 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135
Query: 607 ILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666
L ++ IA A G++YL E +H D+ +N L+ ++ K+ DFGLS+
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 667 RHDTKFS-RVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDS 725
K ++ PE + + ++DV++YG+VL E+ +
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG------------- 239
Query: 726 SYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKV 785
+Q +E + + D + + + + LC ++ RP +
Sbjct: 240 ------LQPYYGMAHEEVIYYVRDGNILACPENC-PLELYNLMRLCWSKLPADRPSFCSI 292
Query: 786 VKLL 789
++L
Sbjct: 293 HRIL 296
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-53
Identities = 71/314 (22%), Positives = 114/314 (36%), Gaps = 46/314 (14%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL--EGVLQGDAEFWAEVS 559
E R +F + +G G FG V D VAVK L L +E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 560 IIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASI----------- 607
++ + NH N+V L G C L++ EY G L L +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 608 ---LQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664
L + + + AKG+++L + +H D+ +NILL K+ DFGL++
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 665 KERHDTKFS-RVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASAS 723
K + R ++APE + N ++DV+SYGI L EL + S+
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------- 246
Query: 724 DSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMS 783
K+I + M + C + RP
Sbjct: 247 ----------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 784 KVVKLLTAHDHESS 797
++V+L+ ES+
Sbjct: 297 QIVQLIEKQISEST 310
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-53
Identities = 68/278 (24%), Positives = 115/278 (41%), Gaps = 34/278 (12%)
Query: 519 EVGKGGFGSVFRGVL---DDERVVAVKRL-EGVLQGDAE-FWAEVSIIGRINHRNLVKLQ 573
E+G G FGSV +GV + VA+K L +G + D E E I+ ++++ +V+L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
G C + E +LV E G L K L + + + G+ YL E+
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKN-- 129
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER--HDTKFSRVRGTRGYLAPEWMMNLK 691
+H D+ +N+LL + K++DFGLSK + T S + + APE + K
Sbjct: 130 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 692 IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751
+++DV+SYG+ + E L+ Q K+M+ + I+
Sbjct: 189 FSSRSDVWSYGVTMWEALSYG--------------------QKPYKKMKGPEVMAFIEQG 228
Query: 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
E + + C + RP V + +
Sbjct: 229 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 6e-53
Identities = 70/291 (24%), Positives = 133/291 (45%), Gaps = 35/291 (12%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDD-----ERVVAVKRL--EGVLQGDAEFWAEVSI 560
E+ + ++ +G G FG V++G+L E VA+K L + +F E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGT 620
+G+ +H N+++L+G ++ + +++ EY+ENG+LDK L G Q + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGI 119
Query: 621 AKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE--RHDTKFSRVRGT 678
A G+ YL +H D+ +NIL++ + KV+DFGLS++ ++ S +
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 679 RGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQ 738
+ APE + K + +DV+S+GIV+ E++T + +
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG--------------------ERPYWE 216
Query: 739 MEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
+ + K I+ + + ++ + C + R RP + +V +L
Sbjct: 217 LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 6e-53
Identities = 65/298 (21%), Positives = 124/298 (41%), Gaps = 36/298 (12%)
Query: 515 NFKQEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVLQGD--AEFWAEVSIIGRINHRN 568
+F + +G+G FG V+ G L D + AVK L + ++F E I+ +H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 569 LVKLQGFCAENEHK-LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
++ L G C +E L+V Y+++G L + N+ + AKG+
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGM--- 143
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER---HDTKFSRVRGTRGYLAP 684
+ +H D+ +N +LD+ F KV DFGL++ ++ + + ++A
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744
E + K K+DV+S+G++L EL+T + + ++
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY----------PDVNTFDITVYLLQG--- 250
Query: 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQDESI 802
+++ P D + +V L C + RP S++V ++A + +
Sbjct: 251 RRLLQPEYCP-------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 301
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-52
Identities = 58/281 (20%), Positives = 112/281 (39%), Gaps = 37/281 (13%)
Query: 516 FKQEVGKGGFGSVFRGVL-DDERVVAVKRL---EGVLQGDAEFWAEVSIIGRINHRNLVK 571
F E+G+G F +V++G+ + VA L + F E ++ + H N+V+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 572 LQGFCAE----NEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
+ +LV E + +G+L L +++ + KGL +L
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFL 128
Query: 628 HEECLEWVLHCDVKPQNILLDD-HFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
H ++H D+K NI + K+ D GL+ L + V GT ++APE
Sbjct: 129 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPE- 183
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746
M K D DVY++G+ +LE+ T + + Q + +
Sbjct: 184 MYEEKYDESVDVYAFGMCMLEMATSEYP-------------------YSECQNAAQIYRR 224
Query: 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787
+ +D+ + + ++ C+ +N+D R + ++
Sbjct: 225 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-51
Identities = 58/281 (20%), Positives = 109/281 (38%), Gaps = 30/281 (10%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE---FWAEVSIIGRINHRNLV 570
+G G +G + D +++ K L+ +AE +EV+++ + H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 571 KLQGFCAENEHKLL--VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
+ + + L V EY E G L ++ L + + L H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 629 E--ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEW 686
+ VLH D+KP N+ LD K+ DFGL+++ + GT Y++PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMSPEQ 185
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746
M + + K+D++S G +L EL S ++E K
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------------------QKELAGK 225
Query: 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787
I + + + R D + ++ + RP + ++++
Sbjct: 226 IREGKFRRIPYRYS-DELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-51
Identities = 64/279 (22%), Positives = 118/279 (42%), Gaps = 36/279 (12%)
Query: 519 EVGKGGFGSVFRGVLDDE---RVVAVKRLEGVLQGDA---EFWAEVSIIGRINHRNLVKL 572
E+G G FG+V +G + + VAVK L+ A E AE +++ ++++ +V++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
G C E E +LV E E G L+K L + ++ + + G+ YL E
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEESN- 127
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD--TKFSRVRGTRGYLAPEWMMNL 690
+H D+ +N+LL K++DFGLSK + + + + + APE +
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 691 KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750
K +K+DV+S+G+++ E + Q + M+ + +++
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYG--------------------QKPYRGMKGSEVTAMLEK 225
Query: 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
M + LC + + RP + V L
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (452), Expect = 9e-51
Identities = 63/278 (22%), Positives = 108/278 (38%), Gaps = 40/278 (14%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE----FWAEVSIIGRINHRNLVKL 572
+E+G G FG+V+ + + VVA+K++ + E EV + ++ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
+G LV EY + D L + LQ + + G +GL+YLH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLHS--- 133
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL-- 690
++H DVK NILL + K+ DFG + + + GT ++APE ++ +
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----SFVGTPYWMAPEVILAMDE 188
Query: 691 -KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749
+ D K DV+S GI +EL K N + Q +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP------------LFNMNAMSALYHIAQNESPALQS 236
Query: 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787
++ C+ + RP ++K
Sbjct: 237 GHWSEY--------FRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-50
Identities = 64/313 (20%), Positives = 108/313 (34%), Gaps = 51/313 (16%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVLDDER------VVAVKRL-EGVLQGDAE-FWAEVS 559
E R F + +G G FG V VAVK L E + E +E+
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 92
Query: 560 IIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTAS------------ 606
++ ++ +H N+V L G C + L++EY G L L + S
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 607 -------ILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659
+L ++ A AKG+ +L + +H D+ +N+L+ K+ DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFG 209
Query: 660 LSKLFKER-HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYL 718
L++ + R ++APE + K+DV+SYGI+L E+ +
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV----- 264
Query: 719 SASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDT 778
K+I + + + C A +
Sbjct: 265 --------------NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRK 310
Query: 779 RPPMSKVVKLLTA 791
RP + L
Sbjct: 311 RPSFPNLTSFLGC 323
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-50
Identities = 73/277 (26%), Positives = 114/277 (41%), Gaps = 31/277 (11%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRL--EGVLQGDAEFWAEVSIIGRINHRNLVKL 572
Q +G+G +G V V E VAVK + + + E+ I +NH N+VK
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
G E + L EY G L + D G + G+ YLH
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHG--- 121
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK-FSRVRGTRGYLAPEWMMNLK 691
+ H D+KP+N+LLD+ K++DFGL+ +F+ + + +++ GT Y+APE + +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 692 IDA-KADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750
A DV+S GIVL +L G+ D S C W K+ +K ID
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQ------PSDSCQEYSDWKEKKTYLNPWKK-IDS 234
Query: 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787
+ + + EN R + + K
Sbjct: 235 APLALLHK------------ILVENPSARITIPDIKK 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 3e-50
Identities = 64/280 (22%), Positives = 113/280 (40%), Gaps = 35/280 (12%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-FWAEVSIIGRINHRNLVKLQ 573
E+G G FG V++ + + A K ++ + + E + E+ I+ +H N+VKL
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
+ ++ E+ G++D ++ L Q + T L+YLH+
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLHD---N 129
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM----- 688
++H D+K NIL + K+ DFG+S R + GT ++APE +M
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKN-TRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 689 NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748
+ D KADV+S GI L+E+ + L+ L KI
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELN--------------------PMRVLLKIA 228
Query: 749 DPRLNDVYDREKLDRMVK-VALLCVAENRDTRPPMSKVVK 787
+ + K C+ +N D R S++++
Sbjct: 229 KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-50
Identities = 65/279 (23%), Positives = 113/279 (40%), Gaps = 41/279 (14%)
Query: 516 FKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDA----EFWAEVSIIGRINHRNLV 570
+ +GKG FG+V+ + ++A+K L A + EV I + H N++
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+L G+ + L+ EY G++ + L + A LSY H +
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK 125
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
V+H D+KP+N+LL E K+ DFG S ++ + + GT YL PE +
Sbjct: 126 ---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 179
Query: 691 KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI--I 748
D K D++S G++ E L GK + + QE ++I +
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANT--------------------YQETYKRISRV 219
Query: 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787
+ D D + + + N RP + +V++
Sbjct: 220 EFTFPDFVTEGARDLISR----LLKHNPSQRPMLREVLE 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 5e-50
Identities = 64/285 (22%), Positives = 104/285 (36%), Gaps = 36/285 (12%)
Query: 516 FKQEVGKGGFGSVFRGVLD----DERVVAVKRLEGVLQGDAE----FWAEVSIIGRINHR 567
+++G G FG V RG D VAVK L+ + E F EV+ + ++HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
NL++L G K+ V E GSL L G AV A+G+ YL
Sbjct: 72 NLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYL 127
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD--TKFSRVRGTRGYLAPE 685
+ +H D+ +N+LL K+ DFGL + + D + + APE
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 686 WMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745
+ +D + +G+ L E+ T + + ++++EG
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQ-----------EPWIGLNGSQILHKIDKEGER 233
Query: 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT 790
+ V + C A + RP + L
Sbjct: 234 LPRPEDCP--------QDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-49
Identities = 65/310 (20%), Positives = 129/310 (41%), Gaps = 45/310 (14%)
Query: 515 NFKQEVGKGGFGSVFRGVLDD---ERVVAVKRLEGVL--QGDAEFWAEVSIIGRI-NHRN 568
F+ +G+G FG V + + A+KR++ +F E+ ++ ++ +H N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSLDKLLFN------------DPGTASILQWDQRYNI 616
++ L G C + L EY +G+L L TAS L Q +
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 617 AVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVR 676
A A+G+ YL ++ +H D+ +NIL+ +++ K+ DFGLS+ + K + R
Sbjct: 133 AADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQE--VYVKKTMGR 187
Query: 677 GTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVA 736
++A E + +DV+SYG++L E+++ + YC +
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----------TPYCGMTCAELY 236
Query: 737 KQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLT--AHDH 794
+++ Q RL D + + C E RP ++++ L +
Sbjct: 237 EKLPQ-------GYRLE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
Query: 795 ESSQDESISD 804
++ + ++ +
Sbjct: 288 KTYVNTTLYE 297
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-49
Identities = 55/272 (20%), Positives = 110/272 (40%), Gaps = 30/272 (11%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-FWAEVSIIGRINHRNLVKLQGF 575
+++G+G G+V+ + + + VA++++ Q E E+ ++ + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWV 635
+ +V EY+ GSL ++ Q + + L +LH V
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHSNQ---V 137
Query: 636 LHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAK 695
+H D+K NILL K+TDFG +K S + GT ++APE + K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 696 ADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDV 755
D++S GI+ +E++ G+ Y N + G ++ +P +
Sbjct: 197 VDIWSLGIMAIEMIEGEPP------------YLNENPLRALYLIATNGTPELQNP---EK 241
Query: 756 YDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787
D + + C+ + + R ++++
Sbjct: 242 LSAIFRDFLNR----CLDMDVEKRGSAKELLQ 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-48
Identities = 61/298 (20%), Positives = 118/298 (39%), Gaps = 34/298 (11%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL----DDERVVAVKRLEGVLQGD--AEFWAEVSII 561
E++R + +G+G FG V +G+ + VA+K + +F E +
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 562 GRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTA 621
+ +H ++VKL G EN ++ E G L L + L A +
Sbjct: 63 RQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLS 118
Query: 622 KGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGY 681
L+YL + +H D+ +N+L+ + K+ DFGLS+ ++ K S+ + +
Sbjct: 119 TALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 682 LAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741
+APE + + + +DV+ +G+ + E+L N+ V + E+
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ--------GVKNNDVIGRIENGER 227
Query: 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA-HDHESSQ 798
+ P L + C A + RP +++ L+ + E +Q
Sbjct: 228 LPMPPNCPPTLYS------------LMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 9e-48
Identities = 63/309 (20%), Positives = 128/309 (41%), Gaps = 38/309 (12%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRL--EGVLQGDAEFWAEVS 559
E+ R +E+G+G FG V+ GV + E VA+K + ++ EF E S
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 75
Query: 560 IIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFN------DPGTASILQWDQR 613
++ N ++V+L G ++ + L++ E + G L L + + + +
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 614 YNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT-KF 672
+A A G++YL+ +H D+ +N ++ + F K+ DFG+++ E K
Sbjct: 136 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 673 SRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLV 732
+ +++PE + + +DV+S+G+VL E+ T
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE------------------- 233
Query: 733 QWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792
Q ++ L +++ L D D D + ++ +C N RP +++ +
Sbjct: 234 QPYQGLSNEQVLRFVMEGGLLDKPDNC-PDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
Query: 793 DHESSQDES 801
++ S
Sbjct: 293 MEPGFREVS 301
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 167 bits (423), Expect = 2e-46
Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 12/201 (5%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-FWAEVSIIGRINHRNLVKLQ 573
+E+G G FG V R A K + + D E E+ + + H LV L
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
++ +++YE++ G L + + ++ + D+ KGL ++HE
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 634 WVLHCDVKPQNILLDDHF--EPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK 691
+H D+KP+NI+ E K+ DFGL+ + K GT + APE
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKP 201
Query: 692 IDAKADVYSYGIVLLELLTGK 712
+ D++S G++ LL+G
Sbjct: 202 VGYYTDMWSVGVLSYILLSGL 222
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-45
Identities = 54/283 (19%), Positives = 113/283 (39%), Gaps = 35/283 (12%)
Query: 515 NFKQEVGKGGFGSVFRGVL--DDERV---VAVKRLEGVL--QGDAEFWAEVSIIGRINHR 567
+ +G G FG+V++G+ + E+V VA+K L + + E E ++ +++
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
++ +L G C + L+ + + G L + N V AKG++YL
Sbjct: 72 HVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGMNYL 127
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT-KFSRVRGTRGYLAPEW 686
+ ++H D+ +N+L+ K+TDFGL+KL + ++A E
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 687 MMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746
+++ ++DV+SYG+ + EL+T + +
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFG--------------------SKPYDGIPASEISS 224
Query: 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
I++ + + + C + D+RP +++
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 6e-45
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 15/211 (7%)
Query: 510 KRATRNFK--QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVL----QGDAEFWAEVSIIG 562
K+ +FK + +G+G F +V L R A+K LE E ++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 563 RINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK 622
R++H VKL ++E Y +NG L K +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVS 119
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK-ERHDTKFSRVRGTRGY 681
L YLH + ++H D+KP+NILL++ ++TDFG +K+ E + + GT Y
Sbjct: 120 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 682 LAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
++PE + +D+++ G ++ +L+ G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 2e-44
Identities = 65/305 (21%), Positives = 120/305 (39%), Gaps = 45/305 (14%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGV------LDDERVVAVKRL-EGVLQGDA-EFWAEVS 559
E R + +G+G FG V R VAVK L EG + +E+
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68
Query: 560 IIGRINHR-NLVKLQGFCAENEHKL-LVYEYVENGSLDKLLFNDPG------------TA 605
I+ I H N+V L G C + L ++ E+ + G+L L +
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 606 SILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665
L + + AKG+ +L +H D+ +NILL + K+ DFGL++
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 185
Query: 666 ERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASD 724
+ D + R ++APE + + ++DV+S+G++L E+ + ++
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-------- 237
Query: 725 SSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSK 784
+ + +++++ + D ++Y L C RP S+
Sbjct: 238 --PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSE 286
Query: 785 VVKLL 789
+V+ L
Sbjct: 287 LVEHL 291
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 157 bits (399), Expect = 4e-43
Identities = 48/201 (23%), Positives = 86/201 (42%), Gaps = 12/201 (5%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-FWAEVSIIGRINHRNLVKLQ 573
+E+G G FG V R V RV K + D E+SI+ +++H L+ L
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
+ +L+ E++ G L + + + + N +GL ++HE
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMHEH--- 146
Query: 634 WVLHCDVKPQNILLDDHFEP--KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK 691
++H D+KP+NI+ + K+ DFGL+ D T + APE +
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREP 204
Query: 692 IDAKADVYSYGIVLLELLTGK 712
+ D+++ G++ LL+G
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGL 225
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-43
Identities = 41/200 (20%), Positives = 83/200 (41%), Gaps = 11/200 (5%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
+++G+G FG V R V ++ K ++ E+SI+ HRN++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 575 FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
E ++++E++ + + + L + + + L +LH
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHSH---N 122
Query: 635 VLHCDVKPQNILLDDHFEP--KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI 692
+ H D++P+NI+ K+ +FG ++ K F + Y APE + +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 693 DAKADVYSYGIVLLELLTGK 712
D++S G ++ LL+G
Sbjct: 181 STATDMWSLGTLVYVLLSGI 200
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-42
Identities = 63/306 (20%), Positives = 120/306 (39%), Gaps = 47/306 (15%)
Query: 508 ELKRATRNFKQEVGKGGFGSVFRGVL--------DDERVVAVKRL--EGVLQGDAEFWAE 557
EL R + +G+G FG V + VAVK L + + ++ +E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 558 VSIIGRI-NHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFN------------DPGT 604
+ ++ I H+N++ L G C ++ ++ EY G+L + L
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 605 ASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664
L + A A+G+ YL + +H D+ +N+L+ + K+ DFGL++
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 665 KERHDTKFSRV-RGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASAS 723
K + R ++APE + + ++DV+S+G++L E+ T
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG---------- 235
Query: 724 DSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMS 783
S Y V+ + K +++ N++Y + C RP
Sbjct: 236 -SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFK 285
Query: 784 KVVKLL 789
++V+ L
Sbjct: 286 QLVEDL 291
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 4e-42
Identities = 44/201 (21%), Positives = 79/201 (39%), Gaps = 9/201 (4%)
Query: 515 NFKQEVGKGGFGSVFRGV-LDDERVVAVKRL--EGVLQGDAEFWAEVSIIGRINHRNLVK 571
+F+ +G G F V +++VA+K + + + + E++++ +I H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 572 LQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
L H L+ + V G L + + + YLH+
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDLG 127
Query: 632 LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK 691
+ LD+ + ++DFGLSK+ + S GT GY+APE +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLAQKP 185
Query: 692 IDAKADVYSYGIVLLELLTGK 712
D +S G++ LL G
Sbjct: 186 YSKAVDCWSIGVIAYILLCGY 206
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (379), Expect = 3e-41
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE----FWAEVSIIGRINHRNLV 570
+ +G GG V L R VAVK L L D F E +NH +V
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 571 KLQGFCAENEHKL----LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
+ +V EYV+ +L ++ + + + + + L++
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNF 126
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD--TKFSRVRGTRGYLAP 684
H+ ++H DVKP NI++ KV DFG+++ + + T+ + V GT YL+P
Sbjct: 127 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGK 712
E +DA++DVYS G VL E+LTG+
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 149 bits (378), Expect = 5e-41
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRL----------EGVLQGDAEFWAEVSIIGRI 564
K+ +G+G V R + + AVK + E V + EV I+ ++
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 565 N-HRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKG 623
+ H N+++L+ N LV++ ++ G L L L + I +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEV 122
Query: 624 LSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLA 683
+ LH+ ++H D+KP+NILLDD K+TDFG S K V GT YLA
Sbjct: 123 ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLA 177
Query: 684 PEWMM------NLKIDAKADVYSYGIVLLELLTGK 712
PE + + + D++S G+++ LL G
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 150 bits (379), Expect = 3e-40
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLE----GVLQGDAEFWAEV---SIIGRINHR 567
+ +G+GGFG V+ D ++ A+K L+ + QG+ E S++ +
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
+V + + + + + G L L A GL ++
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILGLEHM 123
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
H +V++ D+KP NILLD+H +++D GL+ F K GT GY+APE +
Sbjct: 124 HNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPEVL 177
Query: 688 M-NLKIDAKADVYSYGIVLLELLTGK 712
+ D+ AD +S G +L +LL G
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 8e-40
Identities = 53/201 (26%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 520 VGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE------FWAEVSIIGRINHRNLVKL 572
+G+G F +V++ + ++VA+K+++ + +A+ E+ ++ ++H N++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
+ LV++++E + N +L + T +GL YLH+
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLK- 691
W+LH D+KP N+LLD++ K+ DFGL+K F + +V TR Y APE + +
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARM 177
Query: 692 IDAKADVYSYGIVLLELLTGK 712
D+++ G +L ELL
Sbjct: 178 YGVGVDMWAVGCILAELLLRV 198
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-39
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 21/210 (10%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRL-------EGVLQGDAEFWAEVSIIGRIN-- 565
+G GGFGSV+ G+ + D VA+K + G L EV ++ +++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 566 HRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
+++L + + +L+ E E + G LQ + + + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVR 124
Query: 626 YLHEECLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAP 684
+ H VLH D+K +NIL+D + E K+ DFG L K+ T F GTR Y P
Sbjct: 125 HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPP 178
Query: 685 EWMMNLK-IDAKADVYSYGIVLLELLTGKS 713
EW+ + A V+S GI+L +++ G
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-39
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE----FWAEVSIIGR-INHRNL 569
+ +GKG FG VF + A+K L+ + + E ++ H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 570 VKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE 629
+ E+ V EY+ G L + + + A GL +LH
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHS 121
Query: 630 ECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMN 689
+ +++ D+K NILLD K+ DFG+ K D K + GT Y+APE ++
Sbjct: 122 KG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML-GDAKTNTFCGTPDYIAPEILLG 177
Query: 690 LKIDAKADVYSYGIVLLELLTGKS 713
K + D +S+G++L E+L G+S
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 141 bits (356), Expect = 6e-38
Identities = 48/287 (16%), Positives = 89/287 (31%), Gaps = 35/287 (12%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRN-LVKLQ 573
+ +G+G FG +F G L + + VA+K + E + + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
F E H +LV + + D L A + +HE+
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEK--- 120
Query: 634 WVLHCDVKPQNILLDDHFEP-----KVTDFGLSKLFKE------RHDTKFSRVRGTRGYL 682
+++ D+KP N L+ V DFG+ K +++ + + GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 683 APEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742
+ + + + D+ + G V + L G L A+ + E
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT----------NKQKYERIGE 230
Query: 743 GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
+ L + E K D P + L
Sbjct: 231 KKQSTPLRELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (358), Expect = 6e-38
Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE----FWAEVSIIGRINHRNLV 570
+ +G G FG V + R A+K L+ + + E ++ + H ++
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
++ G + + ++ +Y+E G L LL A L YLH +
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF----PNPVAKFYAAEVCLALEYLHSK 123
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
+++ D+KP+NILLD + K+TDFG +K + T + GT Y+APE +
Sbjct: 124 D---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVVSTK 176
Query: 691 KIDAKADVYSYGIVLLELLTGKS 713
+ D +S+GI++ E+L G +
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (355), Expect = 9e-38
Identities = 53/285 (18%), Positives = 95/285 (33%), Gaps = 33/285 (11%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
+++G G FG ++ G + VA+K V + E I + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 575 FC-AENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
+C AE ++ ++V E + D F +A + Y+H +
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSKN-- 123
Query: 634 WVLHCDVKPQNIL---LDDHFEPKVTDFGLSKLFKE------RHDTKFSRVRGTRGYLAP 684
+H DVKP N L + DFGL+K +++ + + GT Y +
Sbjct: 124 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 685 EWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744
+ ++ + D+ S G VL+ G L Q + E++
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL--------KAATKRQKYERISEKK-- 232
Query: 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLL 789
L Y E C + D +P S + +L
Sbjct: 233 MSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 50/205 (24%), Positives = 84/205 (40%), Gaps = 20/205 (9%)
Query: 517 KQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKL-- 572
Q +G G G V + + A+K +LQ + EV + R ++V++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALK----MLQDCPKARREVELHWRASQCPHIVRIVD 72
Query: 573 --QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+ A + L+V E ++ G L + + A + I + + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHSI 130
Query: 631 CLEWVLHCDVKPQNILLDDHFEP---KVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
+ H DVKP+N+L K+TDFG +K + T Y+APE +
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTPYYVAPEVL 185
Query: 688 MNLKIDAKADVYSYGIVLLELLTGK 712
K D D++S G+++ LL G
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 511 RATRNFK--QEVGKGGFGSVFRG--VLDDERVVAVKRL------EGVLQGDAEFWAEVSI 560
RA + ++ E+G+G +G VF+ + + R VA+KR+ EG+ A +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 561 IGRINHRNLVKLQGFCAENEHKLLVYEYV--ENGSLDKLLFNDPGTASILQWDQRYNIAV 618
+ H N+V+L C + + E+ D + D + + ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 619 GTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGT 678
+GL +LH V+H D+KPQNIL+ + K+ DFGL++++ + + V T
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVT 178
Query: 679 RGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
Y APE ++ D++S G + E+ K
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (349), Expect = 3e-37
Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 10/198 (5%)
Query: 518 QEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGD---AEFWAEVSIIGRINHRNLVKLQG 574
+++G+G +G V++ + A+K++ + + + E+SI+ + H N+VKL
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 575 FCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEW 634
+ +LV+E+++ L + G L+ + + G++Y H+
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHDRR--- 120
Query: 635 VLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDA 694
VLH D+KPQN+L++ E K+ DFGL++ F + M + K
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 695 KADVYSYGIVLLELLTGK 712
D++S G + E++ G
Sbjct: 181 TIDIWSVGCIFAEMVNGT 198
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 5e-37
Identities = 46/204 (22%), Positives = 89/204 (43%), Gaps = 12/204 (5%)
Query: 515 NFK--QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGD---AEFWAEVSIIGRINHRN 568
NF+ +++G+G +G V++ VVA+K++ + + + E+S++ +NH N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 569 LVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
+VKL LV+E++ + + + + +GL++ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFCH 119
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM 688
VLH D+KPQN+L++ K+ DFGL++ F T V +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 689 NLKIDAKADVYSYGIVLLELLTGK 712
D++S G + E++T +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-36
Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 24/219 (10%)
Query: 502 KRFTYAELKRATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSI 560
+ +Y + K +G G FG V++ L D +VA+K++ LQ E+ I
Sbjct: 18 QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNRELQI 66
Query: 561 IGRINHRNLVKLQGFCAENEHK------LLVYEYVENGSLDKLLFNDPGTASILQWDQRY 614
+ +++H N+V+L+ F + K LV +YV + L
Sbjct: 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVIYVK 125
Query: 615 NIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFKERHDTKFS 673
+ L+Y+H + H D+KPQN+LLD D K+ DFG +K R + S
Sbjct: 126 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS 181
Query: 674 RVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
+ + DV+S G VL ELL G+
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-36
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGV-LQGDAE-FWAEVSIIGRINHRNLVKLQG 574
+G+G +G V ++ VA+K++ Q + E+ I+ R H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 575 FCAENEHK----LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
+ + + ++ L KLL L D +GL Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRGLKYIHSA 128
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK--ERHDTKFSRVRGTRGYLAPEWMM 688
VLH D+KP N+LL+ + K+ DFGL+++ H + TR Y APE M+
Sbjct: 129 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 689 N-LKIDAKADVYSYGIVLLELLTGK 712
N D++S G +L E+L+ +
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 21/209 (10%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE-------FWAEVSIIGRINHR 567
+E+G G F V + A K ++ + EVSI+ I H
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 568 NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
N++ L +L+ E V G L L L ++ G+ YL
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYL 129
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEP----KVTDFGLSKLFKERHDTKFSRVRGTRGYLA 683
H + H D+KP+NI+L D P K+ DFGL+ +F + GT ++A
Sbjct: 130 HSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFVA 184
Query: 684 PEWMMNLKIDAKADVYSYGIVLLELLTGK 712
PE + + +AD++S G++ LL+G
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 51/202 (25%), Positives = 80/202 (39%), Gaps = 13/202 (6%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGD----AEFWAEVSIIGRINHRNLV 570
+ + +GKG FG V R A+K L + A E ++ H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 571 KLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE 630
L+ ++ V EY G L L + ++ L YLH
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR 124
Query: 631 CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
V++ D+K +N++LD K+TDFGL K T + GT YLAPE + +
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN 180
Query: 691 KIDAKADVYSYGIVLLELLTGK 712
D + G+V+ E++ G+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-33
Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 18/220 (8%)
Query: 504 FTYAELKRATRNFK------QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDA---E 553
F E+ + + Q VG G +G+V V VA+K+L Q +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 554 FWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQR 613
+ E+ ++ + H N++ L +E ++ L D+
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 614 YNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFS 673
+ KGL Y+H ++H D+KP N+ +++ E K+ DFGL++ D++ +
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMT 176
Query: 674 RVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGK 712
TR Y APE ++N ++ D++S G ++ E++TGK
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-32
Identities = 45/211 (21%), Positives = 84/211 (39%), Gaps = 23/211 (10%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDA---EFWAEVSIIGRINHRNLVKLQ 573
++G+G FG VF+ + VA+K++ + + E+ I+ + H N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 574 GFCAENEHK--------LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
C LV+++ E+ L + + GL
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGLY 131
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF---KERHDTKFSRVRGTRGYL 682
Y+H +LH D+K N+L+ K+ DFGL++ F K +++ T Y
Sbjct: 132 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 683 APEWMMNLK-IDAKADVYSYGIVLLELLTGK 712
PE ++ + D++ G ++ E+ T
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (314), Expect = 6e-32
Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 16/200 (8%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE----FWAEVSIIGRINHRNLVKL 572
+ +G G FG V + A+K L+ + E I+ +N LVKL
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 573 QGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL 632
+ +N + +V EYV G + L A YLH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL-- 160
Query: 633 EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI 692
+++ D+KP+N+L+D +VTDFG +K K R T + GT LAPE +++
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGY 215
Query: 693 DAKADVYSYGIVLLELLTGK 712
+ D ++ G+++ E+ G
Sbjct: 216 NKAVDWWALGVLIYEMAAGY 235
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-31
Identities = 40/200 (20%), Positives = 80/200 (40%), Gaps = 11/200 (5%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDA---EFWAEVSIIGRINHRNLVKLQ 573
+++G+G +G+VF+ + +VA+KR+ + E+ ++ + H+N+V+L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 574 GFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLE 633
++ LV+E+ + + + + L L
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKID 693
VLH D+KPQN+L++ + E K+ +FGL++ F + V
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 694 AKADVYSYGIVLLELLTGKS 713
D++S G + EL
Sbjct: 181 TSIDMWSAGCIFAELANAGR 200
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-30
Identities = 44/205 (21%), Positives = 84/205 (40%), Gaps = 22/205 (10%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE---FWAEVSIIGRINHRNLVKLQ 573
+ +G G G V +R VA+K+L Q + E+ ++ +NH+N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 574 GFCA------ENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYL 627
E + LV E ++ + ++ + G+ +L
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHL 135
Query: 628 HEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWM 687
H ++H D+KP NI++ K+ DFGL++ + TR Y APE +
Sbjct: 136 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVI 190
Query: 688 MNLKIDAKADVYSYGIVLLELLTGK 712
+ + D++S G ++ E++ K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (297), Expect = 7e-30
Identities = 52/261 (19%), Positives = 111/261 (42%), Gaps = 26/261 (9%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-HRNLVKLQ 573
+++G+G + VF + + + V VK L+ V + + E+ I+ + N++ L
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLA 96
Query: 574 GFCAENEHKL--LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC 631
+ + LV+E+V N +L L K L Y H
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 632 LEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNL 690
++H DVKP N+++D +H + ++ D+GL++ + +++ +R + PE +++
Sbjct: 150 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPELLVDY 204
Query: 691 K-IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI-- 747
+ D D++S G +L ++ K + + + + + + ++K
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 748 -IDPRLNDVYDREKLDRMVKV 767
+DPR ND+ R R +
Sbjct: 262 ELDPRFNDILGRHSRKRWERF 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 19/209 (9%)
Query: 516 FKQEVGKGGFGSVFRGVL----DDERVVAVKRL-----EGVLQGDAEFWAEVSIIGRINH 566
+ +G G +G VF D ++ A+K L + E ++ I
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 567 R-NLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLS 625
LV L L+ +Y+ G L L + L
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALE 143
Query: 626 YLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPE 685
+LH+ +++ D+K +NILLD + +TDFGLSK F + GT Y+AP+
Sbjct: 144 HLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 686 WMM--NLKIDAKADVYSYGIVLLELLTGK 712
+ + D D +S G+++ ELLTG
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-28
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 518 QEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAE---FWAEVSIIGRINHRNLVKLQ 573
VG G +GSV VAVK+L Q + E+ ++ + H N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 574 GFCAENE-----HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLH 628
+ + + ++ L+ ++ L D + +GL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-----LTDDHVQFLIYQILRGLKYIH 138
Query: 629 EECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMM 688
++H D+KP N+ +++ E K+ DFGL++ + + TR Y APE M+
Sbjct: 139 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIML 191
Query: 689 NLK-IDAKADVYSYGIVLLELLTGK 712
N + D++S G ++ ELLTG+
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (279), Expect = 2e-27
Identities = 44/212 (20%), Positives = 84/212 (39%), Gaps = 17/212 (8%)
Query: 516 FKQEVGKGGFGSVFRGV-LDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQG 574
+++G G F +V+ + + VA+K + G E+ ++ R+N + K
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 575 FCAENEHKLLVYEYV------------ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAK 622
A + KLL + E + L + I+
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 623 GLSYLHEECLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFKERH-DTKFSRVRGTRG 680
GL Y+H C ++H D+KP+N+L++ + ++ L D ++ TR
Sbjct: 137 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 681 YLAPEWMMNLKIDAKADVYSYGIVLLELLTGK 712
Y +PE ++ AD++S ++ EL+TG
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.6 bits (211), Expect = 1e-19
Identities = 34/203 (16%), Positives = 64/203 (31%), Gaps = 30/203 (14%)
Query: 518 QEVGKGGFGSVFRGVLDDERVVAVKRLE-----------GVLQGDAEFWAEVSIIGRINH 566
+ +G+G +VF + VK + GD F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 567 RNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSY 626
R L KLQG Y + N L +L+ ++ + + ++
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 627 LHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFSR--VRGTRGYLAP 684
+ ++H D+ N+L+ + + DF S E + VR Y +
Sbjct: 119 FYH---RGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR 174
Query: 685 EWMMNLKIDAKADVYSYGIVLLE 707
+ + D+ S +L+
Sbjct: 175 TY------RTEKDINSAIDRILQ 191
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 80.4 bits (198), Expect = 1e-18
Identities = 19/95 (20%), Positives = 38/95 (40%), Gaps = 2/95 (2%)
Query: 66 SIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQA 125
SI ++ N + + + +L+++ + NL L D+D V + G +A
Sbjct: 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRA 70
Query: 126 QLLETGNLVLVNEANTTIWKSFD--SPTDTLLPSQ 158
L G + ++ N +W S + S + Q
Sbjct: 71 VLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQ 105
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 44.1 bits (104), Expect = 6e-06
Identities = 18/138 (13%), Positives = 38/138 (27%), Gaps = 26/138 (18%)
Query: 131 GNLVLVNEANTTIWK--SFDSPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNN 188
G++V+ N N+ ++ D+ TL +Q L Y L + +
Sbjct: 1 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQ---------------LSPYRLSMETDC 45
Query: 189 ILDLIFNGPLISSIYWPNSAFTVFLNGRTPYNSSRRAYVNASGLFRSSDTFKFNASDYGV 248
L L + S + + + + + + +
Sbjct: 46 NLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMD---------VLTNQNIAVWTSGNSRS 96
Query: 249 GPKRRLTLDYDGILRLYS 266
+ L D L +Y
Sbjct: 97 AGRYVFVLQPDRNLAIYG 114
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 78.8 bits (194), Expect = 3e-18
Identities = 23/104 (22%), Positives = 41/104 (39%), Gaps = 8/104 (7%)
Query: 45 VSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLAL 104
+ + Y C + + +S T VW +N K K LQ +GN +
Sbjct: 10 LYAGQSLDVEPYHFIMQEDCNLVLYDHS---TSVWASNTGILGK-KGCKAVLQSDGNFVV 65
Query: 105 TDKDSSVVWSTNTFTDEG-VQAQLLETGNLVLVNEANTTIWKSF 147
D + +W++++ G L E GN+V+ + IW +
Sbjct: 66 YDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY---GSDIWSTG 106
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 40.3 bits (94), Expect = 8e-05
Identities = 14/61 (22%), Positives = 25/61 (40%), Gaps = 3/61 (4%)
Query: 91 RSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLL--ETGNLVLVNEANTTIWKSFD 148
+Q + NL L D + VW++NT + + GN V+ + ++W S
Sbjct: 20 PYHFIMQEDCNLVLYDHST-SVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHS 78
Query: 149 S 149
Sbjct: 79 V 79
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 71.9 bits (176), Expect = 9e-16
Identities = 24/82 (29%), Positives = 37/82 (45%), Gaps = 1/82 (1%)
Query: 66 SIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQA 125
+I F S + + + + + T+Q + NL L D D VW++NT G +A
Sbjct: 2 NILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVR-VWASNTAGATGCRA 60
Query: 126 QLLETGNLVLVNEANTTIWKSF 147
L G LV++ NT W S
Sbjct: 61 VLQSDGLLVILTAQNTIRWSSG 82
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 65.2 bits (158), Expect = 2e-13
Identities = 20/107 (18%), Positives = 41/107 (38%), Gaps = 5/107 (4%)
Query: 46 SPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALT 105
G+ + G Y C + + N+ VW + + +G L +Q +GNL +
Sbjct: 11 DTGGSLAEGGYLFIIQNDCNLVLYDNN---RAVWASGTNGKASG--CVLKMQNDGNLVIY 65
Query: 106 DKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNEANTTIWKSFDSPTD 152
++ S + L N+V+ + +N IW + + +
Sbjct: 66 SGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 36.3 bits (83), Expect = 0.002
Identities = 18/126 (14%), Positives = 30/126 (23%), Gaps = 24/126 (19%)
Query: 151 TDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNSAFT 210
+D L L +L G Y ++ L L N W
Sbjct: 1 SDRLNSGHQLDTGGSLA---------EGGYLFIIQNDCNLVLYDNNR----AVWA----- 42
Query: 211 VFLNGRTPYNSSRRAYVNASGLFRSSDTFKFNASDYGV--GPKRRLTLDYDGILRLYSFD 268
+G S + G + + L L D + +Y
Sbjct: 43 ---SGTNGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS 99
Query: 269 ESTRLW 274
+ +W
Sbjct: 100 NNA-IW 104
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 51.2 bits (122), Expect = 2e-08
Identities = 16/74 (21%), Positives = 28/74 (37%), Gaps = 6/74 (8%)
Query: 74 NRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNT-FTDEGVQAQLLETGN 132
N +W N NG + LQ +G L + ++ VW + L N
Sbjct: 47 NNNPIWATNTGGLGNG--CRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRN 104
Query: 133 LVLVNEANTTIWKS 146
+V+ +A +W +
Sbjct: 105 VVIYGDA---LWAT 115
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 46.2 bits (109), Expect = 9e-07
Identities = 15/59 (25%), Positives = 28/59 (47%)
Query: 91 RSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNEANTTIWKSFDS 149
+ +Q + NL L D ++ + + G +A L G LV++ N T+W+S +
Sbjct: 31 VYRFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVA 89
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 50.0 bits (119), Expect = 3e-08
Identities = 17/104 (16%), Positives = 35/104 (33%), Gaps = 9/104 (8%)
Query: 46 SPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALT 105
S + G + C +W N + L++Q +GNL +
Sbjct: 11 STGEFLNYGSFVFIMQEDCN---LVLYDVDKPIWATNTGGL--SRSCFLSMQTDGNLVVY 65
Query: 106 DKDSSVVWSTNT-FTDEGVQAQLLETGNLVLVNEANTTIWKSFD 148
+ + +W++NT + L + N+V+ W +
Sbjct: 66 NPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD---RWATGT 106
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 36.5 bits (84), Expect = 0.002
Identities = 16/73 (21%), Positives = 26/73 (35%), Gaps = 1/73 (1%)
Query: 79 WMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNE 138
++ + G +Q + NL L D D + + + GNLV+ N
Sbjct: 9 TLSTGEFLNYG-SFVFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNP 67
Query: 139 ANTTIWKSFDSPT 151
+N IW S
Sbjct: 68 SNKPIWASNTGGQ 80
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Length = 41 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Score = 33.9 bits (78), Expect = 0.003
Identities = 10/35 (28%), Positives = 15/35 (42%), Gaps = 2/35 (5%)
Query: 283 LDYCTVHGLCGPNGICVNRPRQKTCICPNGFRRND 317
+D C C + +CVN C C GF+ +
Sbjct: 1 IDECQDPDTC--SQLCVNLEGGYKCQCEEGFQLDP 33
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 42 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 33.6 bits (77), Expect = 0.003
Identities = 10/34 (29%), Positives = 13/34 (38%)
Query: 284 DYCTVHGLCGPNGICVNRPRQKTCICPNGFRRND 317
D C L G+C N C CP G + +
Sbjct: 3 DECQRDPLLCRGGVCHNTEGSYRCECPPGHQLSP 36
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 44 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 33.6 bits (77), Expect = 0.004
Identities = 10/36 (27%), Positives = 13/36 (36%)
Query: 283 LDYCTVHGLCGPNGICVNRPRQKTCICPNGFRRNDP 318
+D C + G CVN P C C G+
Sbjct: 3 IDECRISPDLCGRGQCVNTPGDFECKCDEGYESGFM 38
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 804 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.79 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.76 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.75 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.67 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.58 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.51 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.14 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.86 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.84 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.79 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.77 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.39 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.02 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.65 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.16 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.87 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.54 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 88.78 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 84.29 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 83.99 | |
| d2qj2a1 | 91 | Hepatocyte growth factor {Human (Homo sapiens) [Ta | 83.77 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 81.02 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.49 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.07 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 80.05 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=414.83 Aligned_cols=254 Identities=24% Similarity=0.461 Sum_probs=201.5
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCC
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGS 593 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 593 (804)
+.+.++||+|+||.||+|++.+++.||||+++......++|.+|++++++++|||||+++|+|.+++..++||||+++|+
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 45678899999999999999888999999998777778899999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcccc
Q 038103 594 LDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFS 673 (804)
Q Consensus 594 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 673 (804)
|.+++.. ....+++..+..++.|||+||+|||+++ |+||||||+|||+++++.+||+|||+++...........
T Consensus 87 L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 87 LSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp HHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred HHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 9999875 3456899999999999999999999998 999999999999999999999999999987665444445
Q ss_pred ccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCC-CcccccccCCccchhhHHHHHHHHhhhcCcccccCCcC
Q 038103 674 RVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSA-SDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRL 752 (804)
Q Consensus 674 ~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 752 (804)
...||+.|+|||.+.+..++.++|||||||++|||+|+..| +.... ...+. +.+..+.. ...+
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--------~~~~~----~~i~~~~~--~~~p-- 224 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVV----EDISTGFR--LYKP-- 224 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--------HHHHH----HHHHHTCC--CCCC--
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--------HHHHH----HHHHhcCC--CCCc--
Confidence 56789999999999999999999999999999999996444 43211 11111 22222211 1111
Q ss_pred CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 753 NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
......+.+|+.+||+.||++||||++|+++|+.+.+
T Consensus 225 -----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 -----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1223468899999999999999999999999987643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=413.24 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=210.8
Q ss_pred HHHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
...+.+.++||+|+||.||+|++++++.||||+++......++|.+|++++++++|||||+++|++.+ +..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 34567788999999999999999989999999998777777889999999999999999999998865 56799999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+|+|.+++... ....+++..+++++.||++||+|||+++ |+||||||+||||++++.+||+|||+++........
T Consensus 91 ~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 91 NGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 99999988542 2345899999999999999999999998 999999999999999999999999999987655444
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
......||+.|+|||.+....++.++|||||||++|||+||..|+.... .... +...+..+. .+
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-------~~~~----~~~~i~~~~-----~~ 229 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-------TNPE----VIQNLERGY-----RM 229 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHH----HHHHHHTTC-----CC
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-------CHHH----HHHHHHhcC-----CC
Confidence 4555678999999999999999999999999999999999766653211 0111 122222221 11
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
..... ..+.+.+|+.+||+.||++||||++|+++|+..
T Consensus 230 ~~p~~----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 230 VRPDN----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccc----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 11122 234688999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-49 Score=415.13 Aligned_cols=264 Identities=24% Similarity=0.350 Sum_probs=219.7
Q ss_pred HHHHHHhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 508 ELKRATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 508 ~l~~~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
||....+.+.++||+|+||+||+|+.. +++.||||+++......++|.+|++++++++|||||+++|+|.+++..++||
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 344556777889999999999999975 5889999999876677788999999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++|+|.+++... ....+++..+..++.|||+||+|||+++ |+||||||+||||++++.+||+|||+++....
T Consensus 93 E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 93 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred ecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC
Confidence 999999999999753 3457899999999999999999999998 99999999999999999999999999998766
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
..........|++.|+|||.+.+..++.++|||||||++|||++|..|+.... .... +.+.+..+.
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-------~~~~----~~~~i~~~~--- 233 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQ----VYELLEKDY--- 233 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-------CHHH----HHHHHHTTC---
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-------hHHH----HHHHHhcCC---
Confidence 55555555678999999999999999999999999999999999877764211 0111 122222221
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCC
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHES 796 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~ 796 (804)
....+......+.+|+.+||+.||++||||++|++.|+.+.+..
T Consensus 234 ------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 234 ------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred ------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 11112223347899999999999999999999999999876543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=399.32 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=214.8
Q ss_pred hcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccCCC
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVENGS 593 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 593 (804)
+.|.++||+|+||+||+|+.++++.||||+++......++|.+|++++++++|||||+++|+|.+.+..++||||+++|+
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 45778999999999999999999999999999777778899999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcccc
Q 038103 594 LDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTKFS 673 (804)
Q Consensus 594 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 673 (804)
|..++.. ....+++..+.+++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...........
T Consensus 86 l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 86 LLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp HHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred HHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 9999865 3456899999999999999999999998 999999999999999999999999999877665444455
Q ss_pred ccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCcC
Q 038103 674 RVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRL 752 (804)
Q Consensus 674 ~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 752 (804)
...+|+.|+|||.+....++.++||||||+++|||+| |+.||+... ... +...+.++.. ...+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------~~~----~~~~i~~~~~--~~~p-- 223 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSE----TAEHIAQGLR--LYRP-- 223 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHH----HHHHHHTTCC--CCCC--
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--------HHH----HHHHHHhCCC--CCCc--
Confidence 5678999999999999999999999999999999998 899986532 111 2222332211 1111
Q ss_pred CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 753 NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
......+.+|+.+||+.||++|||+++|++.|..+
T Consensus 224 -----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 -----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12234788999999999999999999999998653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-48 Score=412.43 Aligned_cols=265 Identities=28% Similarity=0.455 Sum_probs=203.4
Q ss_pred ccchHHHHHHHhccc-----------ccccccCcceEEEEEecC-C---cEEEEEEecCcCC--ChHHHHHHHHHHhcCC
Q 038103 503 RFTYAELKRATRNFK-----------QEVGKGGFGSVFRGVLDD-E---RVVAVKRLEGVLQ--GDAEFWAEVSIIGRIN 565 (804)
Q Consensus 503 ~~~~~~l~~~t~~~~-----------~~LG~G~fg~Vykg~~~~-~---~~vavK~l~~~~~--~~~~~~~E~~~l~~l~ 565 (804)
.++|+++.+++.+|. +.||+|+||+||+|+... + ..||||++..... ..++|.+|++++++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 456677777666553 569999999999999753 2 3689998874322 3457999999999999
Q ss_pred CCcccceeeeEEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeE
Q 038103 566 HRNLVKLQGFCAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNI 645 (804)
Q Consensus 566 H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 645 (804)
|||||+++|+|.+++..++|||||++|+|.+++.. ....++|..+..++.|||+||+|||+++ |+||||||+||
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NI 159 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNI 159 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceE
Confidence 99999999999999999999999999999999875 3456999999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeecCCcccccccCCc----cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCccccc
Q 038103 646 LLDDHFEPKVTDFGLSKLFKERHDT----KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSA 720 (804)
Q Consensus 646 Ll~~~~~~kl~Dfgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~ 720 (804)
||+.++++||+|||+++.+...... ......+|+.|+|||.+.+..++.++|||||||+||||+| |+.||....
T Consensus 160 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~- 238 (299)
T d1jpaa_ 160 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT- 238 (299)
T ss_dssp EECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-
T ss_pred EECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC-
Confidence 9999999999999999977553321 1223457899999999999999999999999999999998 899986432
Q ss_pred ccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 721 SASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
...+ ...+..+.. ...+.+....+.+|+.+||+.||++||||.+|++.|+.+.+
T Consensus 239 -------~~~~----~~~i~~~~~---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 239 -------NQDV----INAIEQDYR---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -------HHHH----HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------HHHH----HHHHHcCCC---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1111 122222211 11122334578899999999999999999999999988755
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=403.09 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=200.8
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
..+.+.+.||+|+||+||+|+.++ .||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 345677899999999999998654 59999997432 234678999999999999999999999865 568999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|.+++.. ....+++..+..++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 85 CEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999999975 3346999999999999999999999998 9999999999999999999999999998765432
Q ss_pred C-ccccccccCCCccchhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 669 D-TKFSRVRGTRGYLAPEWMMN---LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 669 ~-~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
. .......||+.|+|||.+.+ .+++.++|||||||+||||+||+.||..... ...+......+..
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-----------~~~~~~~~~~~~~ 227 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----------RDQIIFMVGRGYL 227 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----------HHHHHHHHHHTSC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-----------HHHHHHHHhcCCC
Confidence 2 34455679999999999864 4589999999999999999999999964320 1111222222211
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
. +.+ ...+......+.+|+.+||+.||++||||++|++.|+.+.+
T Consensus 228 ~----p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 228 S----PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp C----CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 111 01112223478899999999999999999999999987654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=405.81 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=206.8
Q ss_pred HHhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
..+.+.++||+|+||.||+|+.++++.||||+++......++|.+|+.++++++|+|||+++|+|.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 4577889999999999999999988899999998777778899999999999999999999999854 567899999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|..++... ....++|..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.........
T Consensus 96 g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 96 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 9999998642 2345999999999999999999999998 9999999999999999999999999999776554444
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCCc
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDPR 751 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 751 (804)
.....||+.|+|||.+..+.++.++||||||+++|||++|..|+.... ....+. ..+..+.. .
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-------~~~~~~----~~i~~~~~-----~- 233 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVL----DQVERGYR-----M- 233 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHH----HHHHTTCC-----C-
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-------CHHHHH----HHHHhcCC-----C-
Confidence 555678999999999999999999999999999999999777654311 111111 22222211 1
Q ss_pred CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 752 LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
..+....+.+.+|+.+||+.||++||+|++|+++|+.......
T Consensus 234 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 234 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred ---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 1122233478899999999999999999999999987665443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=406.72 Aligned_cols=265 Identities=26% Similarity=0.432 Sum_probs=204.0
Q ss_pred hcccccccccCcceEEEEEecCC-----cEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDE-----RVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~-----~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
+.+.+.||+|+||.||+|++++. ..||||++..... ...+|.+|++++++++|||||+++|+|.+....++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 44567899999999999997542 4799999974332 2357899999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+.+++|.+++.. ....++|..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 89 e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 89 EYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp ECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999998865 3456999999999999999999999998 99999999999999999999999999997655
Q ss_pred cCC--ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 667 RHD--TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 667 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
... .......||+.|+|||.+.+..++.++|||||||++|||++|..|+.... .... +...+.++.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-------~~~~----~~~~i~~~~- 230 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-------SNHE----VMKAINDGF- 230 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHH----HHHHHHTTC-
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-------CHHH----HHHHHhccC-
Confidence 332 22334568999999999999999999999999999999999766653211 0111 122222221
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCC
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESSQDESISD 804 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~~~~~~~~ 804 (804)
+...+.+....+.+|+.+||+.||++||||.+|+++|+.+.+....-++++|
T Consensus 231 --------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l~~l~d 282 (283)
T d1mqba_ 231 --------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282 (283)
T ss_dssp --------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGSBCC
T ss_pred --------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccccccccC
Confidence 1112222345789999999999999999999999999987765444444443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=398.11 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=202.5
Q ss_pred ccc-cccccCcceEEEEEec---CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 516 FKQ-EVGKGGFGSVFRGVLD---DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 516 ~~~-~LG~G~fg~Vykg~~~---~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+.+ +||+|+||.||+|.++ ++..||||+++... ...++|.+|++++++++|||||+++|+|.. +..++||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 445 5999999999999864 35579999997433 234679999999999999999999999865 5689999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
++|+|.+++.. .+..+++..+..++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 91 ~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 91 GGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp TTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 99999999854 3456999999999999999999999998 99999999999999999999999999997755332
Q ss_pred --ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 670 --TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 670 --~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.......||+.|+|||.+....++.++|||||||++|||+| |+.||..... ..+ ...+..+...+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~----~~~i~~~~~~~ 232 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEV----MAFIEQGKRME 232 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHH----HHHHHTTCCCC
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HHH----HHHHHcCCCCC
Confidence 22234568899999999999999999999999999999998 8999964321 111 22233332211
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
.+...+..+.+|+.+||+.||++||||.+|++.|+..
T Consensus 233 ---------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 233 ---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122334688999999999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=390.28 Aligned_cols=248 Identities=27% Similarity=0.365 Sum_probs=199.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
|.+.+.||+|+||+||+|+.. +++.||||++.... ...+++.+|++++++++|||||++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 567789999999999999964 68999999987432 234568999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC-
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD- 669 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 669 (804)
+|+|.++|.. ...+++..+..++.||++||+|||+++ |+||||||+|||+++++++||+|||+|+.......
T Consensus 87 gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 87 GGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp TEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999964 346999999999999999999999999 99999999999999999999999999998755332
Q ss_pred ccccccccCCCccchhhhccCCC-CcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... .... .. .........
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~----~~-~~~~~~~~~- 227 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEY----SD-WKEKKTYLN- 227 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT------SHHH----HH-HHTTCTTST-
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH------HHHH----HH-HhcCCCCCC-
Confidence 33445779999999999988876 57899999999999999999999643210 0011 11 111111100
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
........+.+|+.+||+.||++|||++|+++
T Consensus 228 -------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 -------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01111246778999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=393.34 Aligned_cols=245 Identities=26% Similarity=0.422 Sum_probs=197.0
Q ss_pred ccccccCcceEEEEEecC---CcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 518 QEVGKGGFGSVFRGVLDD---ERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~---~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
++||+|+||.||+|.+++ ++.||||+++..... .++|.+|++++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998653 468999999743222 3579999999999999999999999864 567899999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC--
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD-- 669 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-- 669 (804)
|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999964 345899999999999999999999998 99999999999999999999999999997654333
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ... +...+..+....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--------~~~----~~~~i~~~~~~~-- 230 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSE----VTAMLEKGERMG-- 230 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHH----HHHHHHTTCCCC--
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--------HHH----HHHHHHcCCCCC--
Confidence 22334568999999999999999999999999999999998 899996432 111 122233322111
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
.+......+.+|+.+||+.||++||||++|+++|+.
T Consensus 231 -------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 231 -------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 112223468899999999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=386.08 Aligned_cols=247 Identities=19% Similarity=0.289 Sum_probs=204.2
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCc-CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV-LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.|.+.++||+|+||.||+|+. .+|+.||||+++.. ....+.+.+|++++++++|||||++++++.+.+..++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 467778999999999999995 46899999999743 3455779999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+.... .
T Consensus 101 gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 171 (293)
T d1yhwa1 101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (293)
T ss_dssp TCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred CCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-c
Confidence 9999998854 35899999999999999999999999 9999999999999999999999999999765432 2
Q ss_pred cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 671 KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...........+.. .+
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----------~~~~~~~~~~~~~~-~~--- 236 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-----------PLRALYLIATNGTP-EL--- 236 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----------HHHHHHHHHHHCSC-CC---
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC-----------HHHHHHHHHhCCCC-CC---
Confidence 3345679999999999999999999999999999999999999996422 11111222222111 11
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.. +......+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QN----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SS----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CC----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1112346889999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=403.48 Aligned_cols=260 Identities=23% Similarity=0.361 Sum_probs=206.7
Q ss_pred HHHHHhcccccccccCcceEEEEEecC------CcEEEEEEecCc--CCChHHHHHHHHHHhcC-CCCcccceeeeEEeC
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVLDD------ERVVAVKRLEGV--LQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAEN 579 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~~~------~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 579 (804)
+....+.+.+.||+|+||+||+|+..+ ...||||++... ......+.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 334556778899999999999999643 236999998632 33456789999999998 899999999999999
Q ss_pred CeeEEEEeeccCCChhhhhccCCC-------------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEeccc
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPG-------------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDV 640 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dl 640 (804)
+..++||||+++|+|.++|..... ....+++..++.++.||++||+|||+++ |+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 999999999999999999975421 1245899999999999999999999998 999999
Q ss_pred ccCeEEEcCCCCeEEeecCCcccccccCCc-cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCccc
Q 038103 641 KPQNILLDDHFEPKVTDFGLSKLFKERHDT-KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYL 718 (804)
Q Consensus 641 kp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~ 718 (804)
||+|||++.++.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999976654332 3345668999999999999999999999999999999998 89998643
Q ss_pred ccccCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcc
Q 038103 719 SASASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTA 791 (804)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~ 791 (804)
.. ...+ ...+..+. +...+....+.+.+|+.+||+.||++||||+||+++|..
T Consensus 271 ~~-------~~~~----~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 271 PV-------DANF----YKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CC-------SHHH----HHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CH-------HHHH----HHHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 21 1111 12222211 111122233578999999999999999999999999963
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=388.83 Aligned_cols=253 Identities=22% Similarity=0.336 Sum_probs=193.7
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeEEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAE--NEHKLLVY 586 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 586 (804)
.|.+.+.||+|+||.||+|+. .+|+.||||.+...... .+.+.+|++++++++|||||++++++.+ +...++||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 366778999999999999996 46899999999754333 3458899999999999999999999865 45689999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCC--CcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECL--EWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~--~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||+++|+|.+++.........+++..++.++.||+.||+|||+++. .+|+||||||+|||++.++.+||+|||+++.+
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 9999999999986533344579999999999999999999999762 34999999999999999999999999999976
Q ss_pred cccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.... . ..+...+..+..
T Consensus 165 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--------~----~~~~~~i~~~~~ 231 (269)
T d2java1 165 NHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------Q----KELAGKIREGKF 231 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------H----HHHHHHHHHTCC
T ss_pred ccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--------H----HHHHHHHHcCCC
Confidence 54322 2345678999999999999999999999999999999999999996422 1 112223333333
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..+ ...++ +.+.+|+.+||+.||.+|||+.|+++
T Consensus 232 ~~~-----~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 RRI-----PYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCC-----CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC-----CcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 221 12223 36889999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=381.78 Aligned_cols=243 Identities=26% Similarity=0.389 Sum_probs=203.2
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecC----cCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEG----VLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.+.||+|+||.||+|+.. +++.||||++.. .....+++.+|++++++++|||||++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 3667889999999999999975 588999999863 22345678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 87 y~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 87 YAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred ecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999964 345899999999999999999999998 999999999999999999999999999865442
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
......||+.|+|||++.+..++.++|||||||+||||++|+.||.... ..+ ....+.....
T Consensus 160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----------~~~-~~~~i~~~~~--- 221 (263)
T d2j4za1 160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----------YQE-TYKRISRVEF--- 221 (263)
T ss_dssp ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----------HHH-HHHHHHTTCC---
T ss_pred ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-----------HHH-HHHHHHcCCC---
Confidence 2334679999999999999999999999999999999999999996422 111 1122222211
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+.... .+.+.+|+.+||+.||++|||++||++
T Consensus 222 ---~~p~~~----s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ---TFPDFV----TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCccC----CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111222 246889999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=377.39 Aligned_cols=245 Identities=23% Similarity=0.370 Sum_probs=195.4
Q ss_pred cccccccccCcceEEEEEec-CCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEe----CCeeEEEE
Q 038103 515 NFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAE----NEHKLLVY 586 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 586 (804)
.|.++||+|+||+||+|+.. +++.||+|++..... ..+.+.+|++++++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999965 578999999874332 23568899999999999999999999865 34679999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc-CCCCeEEeecCCccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD-DHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfgla~~~~ 665 (804)
||+++|+|.+++.. ...+++..+..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999964 346899999999999999999999976 4499999999999996 57899999999998643
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
.. ......||+.|+|||++.+ +++.++|||||||++|||++|+.||.... . ...+...+..+...
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-------~----~~~~~~~i~~~~~~ 231 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------N----AAQIYRRVTSGVKP 231 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------S----HHHHHHHHTTTCCC
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-------c----HHHHHHHHHcCCCC
Confidence 32 2335679999999998865 69999999999999999999999996321 0 11112222222111
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..+ .... ...+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~----~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ASF----DKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGG----GGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccc----CccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111 1112 235789999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=384.24 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=201.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCc-CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV-LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
|.+.++||+|+||.||+|+.. +++.||||+++.. ....+++.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 566788999999999999964 6889999999743 34457789999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++++||+|||+++...... ..
T Consensus 94 g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 94 GAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999999864 2346999999999999999999999999 9999999999999999999999999998654321 22
Q ss_pred ccccccCCCccchhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 672 FSRVRGTRGYLAPEWMM-----NLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.....||+.|+|||++. ...++.++|||||||++|||+||+.||..... ... ...+..+....
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--------~~~----~~~i~~~~~~~ 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRV----LLKIAKSEPPT 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--------GGH----HHHHHHSCCCC
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--------HHH----HHHHHcCCCCC
Confidence 33467999999999984 45689999999999999999999999964321 111 11112221111
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
+. .+......+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~-------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 LA-------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CS-------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC-------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 11122346889999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=387.21 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=205.6
Q ss_pred hcccccccccCcceEEEEEecCC----cEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeC-CeeEEEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLDDE----RVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAEN-EHKLLVY 586 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~~~----~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~ 586 (804)
.+|.++||+|+||+||+|++.+. ..||||+++.... ..++|.+|++++++++|||||+++|+|.+. ...++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 35677899999999999997542 3689999974322 346799999999999999999999998764 5889999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
|||++|+|.+++.. ....+++..+.+++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 109 E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp ECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 99999999999875 4456788899999999999999999998 99999999999999999999999999997654
Q ss_pred cCC---ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 667 RHD---TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 667 ~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
... .......||..|+|||.+....++.++||||||+++|||+||+.|+...... ..+ ...+..+.
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-------~~~----~~~i~~g~ 251 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-------FDI----TVYLLQGR 251 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------C----HHHHHTTC
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-------HHH----HHHHHcCC
Confidence 322 2233456899999999999999999999999999999999988887532100 011 11222221
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHESS 797 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~~~ 797 (804)
. ...+ . .....+.+|+.+||+.||++||+|.||+++|+.+.....
T Consensus 252 ~--~~~p---~----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 252 R--LLQP---E----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp C--CCCC---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred C--CCCc---c----cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 1 1111 1 123468899999999999999999999999988765433
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=389.93 Aligned_cols=197 Identities=26% Similarity=0.392 Sum_probs=173.7
Q ss_pred HHHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
...|.+.++||+|+||+||+|+. .+++.||+|+++.... ..+++.+|+.++++++|||||+++++|.+..+.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34566778999999999999996 4689999999974332 24678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhh-CCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEE-CLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
|+++|+|.+++.. ...+++..+..++.|+++||.|||++ + |+||||||+|||++.++++||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999964 34589999999999999999999985 7 99999999999999999999999999997654
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDY 717 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~ 717 (804)
.. .....||+.|+|||++.+.+++.++||||+||++|||++|+.||..
T Consensus 158 ~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 158 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp HT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred Cc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22 2346799999999999999999999999999999999999999964
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-44 Score=384.23 Aligned_cols=259 Identities=23% Similarity=0.379 Sum_probs=207.7
Q ss_pred HHhcccccccccCcceEEEEEec------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
..+.+.++||+|+||.||+|+.. +++.||||+++.... ..++|.+|++++++++||||++++++|......+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 34567789999999999999964 357899999974332 2467999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCCC--------------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccC
Q 038103 584 LVYEYVENGSLDKLLFNDPG--------------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQ 643 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 643 (804)
+++||+++|+|.++++.... ....+++..++.++.|++.||+|||+++ |+||||||+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~ 169 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATR 169 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEccc
Confidence 99999999999999964211 2235889999999999999999999998 999999999
Q ss_pred eEEEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCC-CCCcccccc
Q 038103 644 NILLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK-SASDYLSAS 721 (804)
Q Consensus 644 NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~-~p~~~~~~~ 721 (804)
|||++.++.+||+|||+++.+..... .......+++.|+|||.+.+..++.++|||||||++|||++|. .||....
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~-- 247 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-- 247 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC--
Confidence 99999999999999999987654332 3334566889999999999999999999999999999999986 4565322
Q ss_pred cCCccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 722 ASDSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
... +...+.++..... .... +..+.+|+.+||+.+|++||||.||+++|+.+.+
T Consensus 248 ------~~e----~~~~v~~~~~~~~-----p~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 248 ------HEE----VIYYVRDGNILAC-----PENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp ------HHH----HHHHHHTTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ------HHH----HHHHHHcCCCCCC-----Cccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 1223333332211 1122 3468899999999999999999999999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=385.01 Aligned_cols=256 Identities=21% Similarity=0.327 Sum_probs=196.0
Q ss_pred HHHhcccccccccCcceEEEEEecC----CcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDD----ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
+..+.+.+.||+|+||.||+|++.. +..||||.++.... ..++|.+|++++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3457778899999999999998643 35799999874332 2457999999999999999999999996 467899
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++.+
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998865 3456899999999999999999999998 999999999999999999999999999987
Q ss_pred cccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
............||+.|+|||.+....++.++|||||||++|||+| |+.||..... ..+. ..+..+.
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--------~~~~----~~i~~~~ 226 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVI----GRIENGE 226 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHH----HHHHTTC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--------HHHH----HHHHcCC
Confidence 6555555556678999999999999999999999999999999998 8888865321 1121 2222222
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
... + +......+.+|+.+||+.||++|||+.+|++.|+.+.+
T Consensus 227 ~~~-----~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 227 RLP-----M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp CCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-----C----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111 1 12223478899999999999999999999999987643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-44 Score=379.79 Aligned_cols=244 Identities=25% Similarity=0.355 Sum_probs=199.0
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC----hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG----DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
..|...++||+|+||.||+|+. .+++.||||++...... .+++.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3466778999999999999995 46889999999754322 246889999999999999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
|||.+|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999877653 346899999999999999999999999 99999999999999999999999999986543
Q ss_pred cCCccccccccCCCccchhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMN---LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
. ....||+.|+|||++.+ .+|+.++|||||||++|||++|+.||.... ..+.. .....+.
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-----------~~~~~-~~i~~~~ 230 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----------AMSAL-YHIAQNE 230 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----------HHHHH-HHHHHSC
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-----------HHHHH-HHHHhCC
Confidence 2 34569999999999864 468999999999999999999999986422 11111 1122222
Q ss_pred cccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 744 LEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...+... .+ .+.+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~----~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 SPALQSG----HW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCCSCT----TS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCC----CC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 2211111 12 246889999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=380.93 Aligned_cols=249 Identities=27% Similarity=0.381 Sum_probs=195.7
Q ss_pred HhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeC-CeeEEEEeeccC
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAEN-EHKLLVYEYVEN 591 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~~~ 591 (804)
.+.+.+.||+|+||.||+|+++ ++.||||+++.. ...++|.+|++++++++|||||+++|+|.+. +..++||||+++
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 3456788999999999999985 678999999753 3457799999999999999999999999654 568999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCcc
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDTK 671 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 671 (804)
|+|.++|... ....++|..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 86 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp EEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 9999999642 2345899999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccCC
Q 038103 672 FSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIIDP 750 (804)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 750 (804)
....++..|+|||.+.+..+++++||||||+++|||+| |+.|+.... ...+.. .+..+...
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--------~~~~~~----~i~~~~~~----- 219 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVP----RVEKGYKM----- 219 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--------GGGHHH----HHTTTCCC-----
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--------HHHHHH----HHHcCCCC-----
Confidence 23457889999999999999999999999999999999 677765422 112222 22222111
Q ss_pred cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 751 RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
..+......+.+|+.+||+.||.+||||.+|+++|+.++
T Consensus 220 ----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 220 ----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 112222347889999999999999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=378.08 Aligned_cols=245 Identities=20% Similarity=0.295 Sum_probs=200.3
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 367788999999999999996 46899999998632 2345679999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 89 y~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 89 YAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999864 346899999999999999999999999 999999999999999999999999999977543
Q ss_pred CC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 668 HD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 668 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+ +...+..+..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~~~-~~~~i~~~~~-- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----------EYL-IFQKIIKLEY-- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHH-HHHHHHTTCC--
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-----------HHH-HHHHHHcCCC--
Confidence 32 33345679999999999999999999999999999999999999996422 011 1122222221
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVV 786 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv 786 (804)
.+....+ ..+.+|+.+||+.||++|||++|++
T Consensus 228 ----~~p~~~s----~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 228 ----DFPEKFF----PKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp ----CCCTTCC----HHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ----CCCccCC----HHHHHHHHHHccCCHhHCcCHHHHc
Confidence 1112222 3678999999999999999999863
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-44 Score=379.73 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=188.7
Q ss_pred HHhcccccccccCcceEEEEEec-CCcEEEEEEecCcC--CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVL--QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
..|.+.+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 34778889999999999999965 68899999997432 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc---CCCCeEEeecCCccccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD---DHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~ 665 (804)
+++|+|.++|.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++...
T Consensus 89 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 89 VSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred cCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999964 346999999999999999999999998 99999999999994 57899999999998654
Q ss_pred ccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLE 745 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (804)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ... ....+..+...
T Consensus 162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~----~~~~i~~~~~~ 227 (307)
T d1a06a_ 162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAK----LFEQILKAEYE 227 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHH----HHHHHHTTCCC
T ss_pred CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------HHH----HHHHHhccCCC
Confidence 432 2334679999999999999999999999999999999999999996422 011 11222222111
Q ss_pred cccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 746 KIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
......... ...+.+|+.+||+.||++|||++|+++.
T Consensus 228 --~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 --FDSPYWDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --CCTTTTTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --CCCccccCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111111122 3468899999999999999999999883
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=382.74 Aligned_cols=272 Identities=25% Similarity=0.297 Sum_probs=203.0
Q ss_pred HhcccccccccCcceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCC----eeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENE----HKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~ 588 (804)
++.+.++||+|+||.||+|++ +|+.||||+++........+..|+..+.+++|||||+++++|.+.. ..++||||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 455678899999999999997 5788999999744332223344555667789999999999998654 67999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhC-----CCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC-----LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
|++|+|.++|+. ..++|..+++++.|+|.||+|||+.. ...|+||||||+||||+.++.+||+|||+++.
T Consensus 83 ~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 83 HEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999965 34899999999999999999999742 23499999999999999999999999999998
Q ss_pred ccccCC---ccccccccCCCccchhhhccCC------CCcccchHHHHHHHHHHHhCCCCCcccccccCCcc---chhhH
Q 038103 664 FKERHD---TKFSRVRGTRGYLAPEWMMNLK------IDAKADVYSYGIVLLELLTGKSASDYLSASASDSS---YCNHL 731 (804)
Q Consensus 664 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~---~~~~~ 731 (804)
...... .......||+.|+|||++.+.. ++.++|||||||+||||+||..|+........... .....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 755333 2334567999999999987643 57799999999999999999988754322111000 00111
Q ss_pred HHHHHHHhhhcCcccccCCcCCCcc-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 732 VQWVAKQMEQEGLEKIIDPRLNDVY-DREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 732 ~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
.......... ..+++.+.... +.+....+.+|+.+||+.||++||||.||+++|+.+.+
T Consensus 238 ~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 238 VEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1112222222 22233332222 34456779999999999999999999999999987654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-45 Score=378.82 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=193.9
Q ss_pred HhcccccccccCcceEEEEEecC--C--cEEEEEEecCcC----CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDD--E--RVVAVKRLEGVL----QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~--~--~~vavK~l~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
.+.+.++||+|+||.||+|++.. + ..||||+++... ...++|.+|++++++++|||||+++|+|.+ ...++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence 35677899999999999998642 2 478999987432 223579999999999999999999999965 56789
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccc
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLF 664 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~ 664 (804)
||||+++|+|.+++.. ....+++..+..++.|||.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999998865 3456999999999999999999999998 999999999999999999999999999987
Q ss_pred cccCCc--cccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 665 KERHDT--KFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 665 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
...... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.... ..+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-----------~~~~~~~i~~~ 230 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----------GSQILHKIDKE 230 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------HHHHHHHHHTS
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-----------HHHHHHHHHhC
Confidence 554332 2334567889999999999999999999999999999998 899986432 11111222222
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
+ ... ..+......+.+|+.+||+.||++||||.+|++.|++.
T Consensus 231 ~-~~~--------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 G-ERL--------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C-CCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-CCC--------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 111 11112234688999999999999999999999999753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=384.52 Aligned_cols=251 Identities=22% Similarity=0.362 Sum_probs=199.3
Q ss_pred hcccccccccCcceEEEEEec-CCc----EEEEEEecCc--CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DER----VVAVKRLEGV--LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
|.+.+.||+|+||+||+|+.. +++ .||||+++.. .+..++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 567789999999999999964 343 6899998733 34567899999999999999999999999865 567888
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
|++.+|+|.+++.. ....+++..+++++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 90 QLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp ECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 99999999998875 4567999999999999999999999998 99999999999999999999999999997755
Q ss_pred cCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 667 RHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 667 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
... .......||+.|+|||.+.++.++.++|||||||++|||+| |+.||+.... ..+. ..+..+..
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--------~~~~----~~i~~~~~ 231 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEIS----SILEKGER 231 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--------GGHH----HHHHHTCC
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--------HHHH----HHHHcCCC
Confidence 333 23334568999999999999999999999999999999999 7888864321 1122 22222211
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
. ..+......+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 232 ~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 L---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp C---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1 11122234688999999999999999999999988654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-43 Score=381.89 Aligned_cols=250 Identities=20% Similarity=0.296 Sum_probs=204.3
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.|.+.+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+.++++++|||||++++++.+.+..++|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 577889999999999999996 468999999997543 234668899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc--CCCCeEEeecCCcccccccC
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD--DHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~Dfgla~~~~~~~ 668 (804)
+|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 107 gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 107 GGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp SCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999964 3446999999999999999999999999 99999999999995 45789999999999765432
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+. ...+...... .
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----------~~~~-~~~i~~~~~~--~ 244 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----------DDET-LRNVKSCDWN--M 244 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHH-HHHHHHTCCC--S
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC-----------HHHH-HHHHHhCCCC--C
Confidence 2344678999999999999999999999999999999999999996422 1111 1122222111 0
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
+..... ...+.+.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFS----GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGG----GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred Cccccc----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111 122467899999999999999999999884
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.6e-43 Score=378.09 Aligned_cols=250 Identities=20% Similarity=0.287 Sum_probs=204.7
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcC-CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL-QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.|.+.+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|++++++++|||||++++++.++...++||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 477788999999999999996 468999999997543 234568899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc--CCCCeEEeecCCcccccccC
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD--DHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~Dfgla~~~~~~~ 668 (804)
+|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 110 gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 110 GGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp CCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred CChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 9999988754 3456999999999999999999999999 99999999999997 6789999999999977553
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+ ....+..+... .
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----------~~~-~~~~i~~~~~~--~ 247 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----------DLE-TLQNVKRCDWE--F 247 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----------HHH-HHHHHHHCCCC--C
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----------HHH-HHHHHHhCCCC--C
Confidence 23345678999999999999999999999999999999999999996422 111 11222222211 1
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
........ ...+.+|+.+||+.||.+|||+.|+++.
T Consensus 248 ~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111122 2467899999999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=380.26 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=203.3
Q ss_pred HhcccccccccCcceEEEEEecC-Cc--EEEEEEecCc--CCChHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDD-ER--VVAVKRLEGV--LQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~-~~--~vavK~l~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 586 (804)
.+.+.+.||+|+||.||+|++.+ +. .||||+++.. ....++|.+|++++.++ +|||||+++|+|.+++..++||
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ 90 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 90 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence 34567889999999999999754 43 5888988632 23456799999999999 7999999999999999999999
Q ss_pred eeccCCChhhhhccCC------------CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeE
Q 038103 587 EYVENGSLDKLLFNDP------------GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPK 654 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 654 (804)
||+++|+|.++|+... .....+++..+..++.|||+||.|||+.+ |+||||||+|||++.++.+|
T Consensus 91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceE
Confidence 9999999999997531 23467999999999999999999999998 99999999999999999999
Q ss_pred EeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCC-CCcccccccCCccchhhHHH
Q 038103 655 VTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKS-ASDYLSASASDSSYCNHLVQ 733 (804)
Q Consensus 655 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~-p~~~~~~~~~~~~~~~~~~~ 733 (804)
|+|||+++....... .....||..|+|||.+....++.++|||||||++|||++|.. ||.... ..
T Consensus 168 l~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------------~~ 233 (309)
T d1fvra_ 168 IADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------------CA 233 (309)
T ss_dssp ECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------------HH
T ss_pred Ecccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------------HH
Confidence 999999986544222 234568999999999999999999999999999999999765 554321 11
Q ss_pred HHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 734 WVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
.+...+.++.. +.. +....+.+.+|+.+||+.||++||||++|++.|+.+.+.
T Consensus 234 ~~~~~i~~~~~-----~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 234 ELYEKLPQGYR-----LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHHHGGGTCC-----CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHhcCC-----CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 12222332211 111 122234788999999999999999999999999887654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=370.53 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=202.0
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcC-------CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL-------QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLL 584 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 584 (804)
.|.+.+.||+|+||.||+|+. .+|+.||||+++... ...+++.+|++++++++|||||++++++.+....++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 467788999999999999997 468999999986322 124679999999999999999999999999999999
Q ss_pred EEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC----CeEEeecCC
Q 038103 585 VYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF----EPKVTDFGL 660 (804)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfgl 660 (804)
|||||++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 v~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999964 346999999999999999999999999 99999999999998776 599999999
Q ss_pred cccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 661 SKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 661 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
+....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+ ....+.
T Consensus 164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~~~-~~~~i~ 229 (293)
T d1jksa_ 164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----------KQE-TLANVS 229 (293)
T ss_dssp CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHH-HHHHHH
T ss_pred hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC-----------HHH-HHHHHH
Confidence 98765432 2334568999999999999999999999999999999999999996422 011 111122
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..... ............+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 230 AVNYE------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TTCCC------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hcCCC------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 21111 111111112346789999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-45 Score=385.40 Aligned_cols=260 Identities=24% Similarity=0.366 Sum_probs=196.8
Q ss_pred HHHhcccccccccCcceEEEEEec------CCcEEEEEEecCcC--CChHHHHHHHHHHhcC-CCCcccceeeeEEeCC-
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVL--QGDAEFWAEVSIIGRI-NHRNLVKLQGFCAENE- 580 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~- 580 (804)
+..+.+.++||+|+||.||+|+.. +++.||||+++... ...+++.+|..++.++ +|+||+++++++.+.+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 445777889999999999999853 34689999997432 2345678888888777 6899999999987654
Q ss_pred eeEEEEeeccCCChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD 648 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~ 648 (804)
..++|||||++|+|.++|+.... ....+++..+..++.||++||+|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999965321 2345899999999999999999999998 99999999999999
Q ss_pred CCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCC-CCCcccccccCCcc
Q 038103 649 DHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK-SASDYLSASASDSS 726 (804)
Q Consensus 649 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~-~p~~~~~~~~~~~~ 726 (804)
+++++||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||. .||.....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~------ 242 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------ 242 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC------
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999987654333 3344567999999999999999999999999999999999975 46653221
Q ss_pred chhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 727 YCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
... +...+.++.... ..... ...+.+|+.+||+.||++||||.||+++|+.+.
T Consensus 243 -~~~----~~~~~~~~~~~~-----~~~~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 243 -DEE----FCRRLKEGTRMR-----APDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp -SHH----HHHHHHHTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHH----HHHHHhcCCCCC-----CCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 011 122223322211 11122 346889999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=385.66 Aligned_cols=263 Identities=25% Similarity=0.397 Sum_probs=209.5
Q ss_pred HHHHHhcccccccccCcceEEEEEe------cCCcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEEeC
Q 038103 509 LKRATRNFKQEVGKGGFGSVFRGVL------DDERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCAEN 579 (804)
Q Consensus 509 l~~~t~~~~~~LG~G~fg~Vykg~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 579 (804)
+....+.+.+.||+|+||.||+|++ ..++.||||+++.... ...+|.+|+.++.++ +|||||+++|+|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 4445677888999999999999985 2457899999975432 335689999999999 699999999999999
Q ss_pred CeeEEEEeeccCCChhhhhccCCC--------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeE
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPG--------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNI 645 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 645 (804)
...++||||+++|+|.++++.... ....+++..+..++.||++||+|||+++ ++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 999999999999999999975321 2336899999999999999999999999 99999999999
Q ss_pred EEcCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCC-CcccccccC
Q 038103 646 LLDDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSA-SDYLSASAS 723 (804)
Q Consensus 646 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p-~~~~~~~~~ 723 (804)
|++.++.+||+|||+++....... .......||+.|+|||.+....++.++||||||+++|||+|+..| +.....
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~--- 253 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--- 253 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999997765433 333456789999999999999999999999999999999995544 433210
Q ss_pred CccchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCC
Q 038103 724 DSSYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDH 794 (804)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~ 794 (804)
...+ ...+..+ ... ..+......+.+|+.+||+.||++||||++|+++|+.+..
T Consensus 254 ----~~~~----~~~i~~~-~~~--------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 254 ----DSKF----YKMIKEG-FRM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp ----SHHH----HHHHHHT-CCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHH----HHHHhcC-CCC--------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 0111 1222222 111 1111223468999999999999999999999999987543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=376.51 Aligned_cols=260 Identities=23% Similarity=0.368 Sum_probs=209.0
Q ss_pred HHhcccccccccCcceEEEEEec------CCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVLD------DERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKL 583 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 583 (804)
..+.+.++||+|+||.||+|.+. +++.||||+++.... ....|.+|++++++++|||||+++|+|......+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 45567789999999999999864 357899999974332 2346899999999999999999999999999999
Q ss_pred EEEeeccCCChhhhhccCC------CCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEee
Q 038103 584 LVYEYVENGSLDKLLFNDP------GTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTD 657 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 657 (804)
+||||+++|+|.+++.... .....+++..+..++.|+|+||.|||+++ |+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 9999999999999986421 12245789999999999999999999988 99999999999999999999999
Q ss_pred cCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCC-CCCcccccccCCccchhhHHHHH
Q 038103 658 FGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGK-SASDYLSASASDSSYCNHLVQWV 735 (804)
Q Consensus 658 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~ 735 (804)
||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||+||+ .|+.... ..+ +
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-----------~~~-~ 244 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----------NEQ-V 244 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----------HHH-H
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-----------HHH-H
Confidence 999997655433 2334456899999999999999999999999999999999985 5554321 111 1
Q ss_pred HHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCCCC
Q 038103 736 AKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHDHE 795 (804)
Q Consensus 736 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~~~ 795 (804)
...+.++..... +......+.+|+.+||+.+|++||||++|+++|+...+.
T Consensus 245 ~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 245 LRFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHHhCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 222222222111 112234799999999999999999999999999887653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=378.27 Aligned_cols=259 Identities=23% Similarity=0.340 Sum_probs=205.0
Q ss_pred HHHhcccccccccCcceEEEEEecC--------CcEEEEEEecCcCC--ChHHHHHHHHHHhcC-CCCcccceeeeEEeC
Q 038103 511 RATRNFKQEVGKGGFGSVFRGVLDD--------ERVVAVKRLEGVLQ--GDAEFWAEVSIIGRI-NHRNLVKLQGFCAEN 579 (804)
Q Consensus 511 ~~t~~~~~~LG~G~fg~Vykg~~~~--------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 579 (804)
...+.+.+.||+|+||.||+|+..+ +..||||+++.... ...++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3456778899999999999998532 35799999974432 346788899999888 899999999999999
Q ss_pred CeeEEEEeeccCCChhhhhccCCC------------CCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEE
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPG------------TASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILL 647 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl 647 (804)
...++||||+++|+|.++|..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999975421 2356899999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeecCCcccccccCC-ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHh-CCCCCcccccccCCc
Q 038103 648 DDHFEPKVTDFGLSKLFKERHD-TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLT-GKSASDYLSASASDS 725 (804)
Q Consensus 648 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~t-g~~p~~~~~~~~~~~ 725 (804)
+.++.+||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |+.||....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~------ 242 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 242 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC------
Confidence 9999999999999997765433 33445678999999999999999999999999999999998 677775422
Q ss_pred cchhhHHHHHHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 726 SYCNHLVQWVAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
...+...+..+.... .... ....+.+|+.+||+.||++|||+.||+++|+.+.
T Consensus 243 ------~~~~~~~i~~~~~~~-----~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 243 ------VEELFKLLKEGHRMD-----KPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ------HHHHHHHHHTTCCCC-----CCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHHHHHHHcCCCCC-----CCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 111223333322111 1112 2346899999999999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-42 Score=365.60 Aligned_cols=241 Identities=23% Similarity=0.347 Sum_probs=201.0
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
|++.+.||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 66778999999999999996 46899999999632 23457789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+++|+|..++.. ...+++.....++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 86 ~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 86 IEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred cCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999999864 345788888999999999999999999 999999999999999999999999999876542
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+ +...+..+..
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----------~~~-~~~~i~~~~~---- 218 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----------TMK-TYEKILNAEL---- 218 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----------HHH-HHHHHHHCCC----
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-----------HHH-HHHHHHcCCC----
Confidence 234679999999999999999999999999999999999999996422 111 1122222221
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
.+....+ ..+.+++.+|++.||.+|| +++++++
T Consensus 219 --~~p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 --RFPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CCCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1112222 3588999999999999996 8999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-42 Score=361.26 Aligned_cols=255 Identities=25% Similarity=0.343 Sum_probs=197.9
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC----hHHHHHHHHHHhcCCCCcccceeeeEEeCC----eeE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG----DAEFWAEVSIIGRINHRNLVKLQGFCAENE----HKL 583 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 583 (804)
+|.+.+.||+|+||.||+|+. .+++.||||.++..... .+.+.+|++++++++|||||++++++.... ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 467788999999999999996 56899999999754322 246889999999999999999999987654 478
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++..+|+|||.+..
T Consensus 88 lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 99999999999998864 346899999999999999999999998 99999999999999999999999999986
Q ss_pred ccccCC--ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 664 FKERHD--TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 664 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+........
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----------~~~~~~~~~~~ 229 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----------PVSVAYQHVRE 229 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----------HHHHHHHHHHC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-----------HHHHHHHHHhc
Confidence 544322 23445679999999999999999999999999999999999999996422 11122222222
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhccC
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-PMSKVVKLLTAH 792 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-tm~~Vv~~L~~~ 792 (804)
..... ....... ...+.+|+.+|++.||.+|| +++++.+.|..+
T Consensus 230 ~~~~~---~~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 230 DPIPP---SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCCCG---GGTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCC---chhccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 21110 0111122 24688999999999999999 899999888654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=368.29 Aligned_cols=244 Identities=22% Similarity=0.263 Sum_probs=202.8
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCc----CCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV----LQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
|.+.+.||+|+||.||+++. .+++.||||++++. ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 66778999999999999996 56899999999732 23457789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
|++|+|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+......
T Consensus 87 ~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 87 ANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999964 345888999999999999999999999 9999999999999999999999999998654322
Q ss_pred CccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ... +.+....+.+.
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------~~~----~~~~i~~~~~~--- 223 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HER----LFELILMEEIR--- 223 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHH----HHHHHHHCCCC---
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--------HHH----HHHHHhcCCCC---
Confidence 23345679999999999999999999999999999999999999996432 111 12222222211
Q ss_pred CCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038103 749 DPRLNDVYDREKLDRMVKVALLCVAENRDTRPP-----MSKVVK 787 (804)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~~Vv~ 787 (804)
+....+ ..+.+|+.+||+.||.+||+ +.++++
T Consensus 224 ---~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 ---FPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112233 35789999999999999995 777765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.1e-42 Score=356.64 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=201.4
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC----------hHHHHHHHHHHhcCC-CCcccceeeeEEeCC
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG----------DAEFWAEVSIIGRIN-HRNLVKLQGFCAENE 580 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~----------~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 580 (804)
.|.+.+.||+|+||+||+++. .+++.||||++...... .+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 456778999999999999996 57899999999743221 135788999999997 999999999999999
Q ss_pred eeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCC
Q 038103 581 HKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGL 660 (804)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgl 660 (804)
..+|||||+++|+|.++|.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999964 346899999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCccccccccCCCccchhhhcc------CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHH
Q 038103 661 SKLFKERHDTKFSRVRGTRGYLAPEWMMN------LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQW 734 (804)
Q Consensus 661 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 734 (804)
++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ...
T Consensus 157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~------------~~~ 222 (277)
T d1phka_ 157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK------------QML 222 (277)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------------HHH
T ss_pred eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC------------HHH
Confidence 99765532 2344679999999999863 457889999999999999999999996432 111
Q ss_pred HHHHhhhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 735 VAKQMEQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
....+..+... ...+ ..... .+.+.+|+.+||+.||++|||+.||++.
T Consensus 223 ~~~~i~~~~~~-~~~~-~~~~~----s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 223 MLRMIMSGNYQ-FGSP-EWDDY----SDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHHTCCC-CCTT-TGGGS----CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHhCCCC-CCCc-ccccC----CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 12222222221 1111 11122 2468899999999999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=366.00 Aligned_cols=249 Identities=18% Similarity=0.274 Sum_probs=202.9
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeeccC
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVEN 591 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 591 (804)
+|.+.++||+|+||+||+|+.. +++.||||.++........+.+|++++++++|||||++++++.+.+..++|||||++
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 4667889999999999999964 688999999986555556788999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC--CCCeEEeecCCcccccccCC
Q 038103 592 GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD--HFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~ 669 (804)
|+|.+++.. .+..+++..+..++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+++.....
T Consensus 86 g~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 86 LDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 999999965 3346899999999999999999999999 999999999999985 458999999999876442
Q ss_pred ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
.......+|+.|+|||.+.+..++.++||||+||++|||++|+.||.... ... +...+..+... ++
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------~~~----~~~~i~~~~~~--~~ 223 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQ----IIENIMNAEYT--FD 223 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHH----HHHHHHHTCCC--CC
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--------HHH----HHHHHHhCCCC--CC
Confidence 22334568999999999999999999999999999999999999996432 011 11222222111 00
Q ss_pred CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 750 PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...... ....+.+|+.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 EEAFKE----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011 1235789999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-41 Score=364.49 Aligned_cols=242 Identities=22% Similarity=0.264 Sum_probs=201.8
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecC----cCCChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEG----VLQGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYE 587 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 587 (804)
.|.+.++||+|+||.||+|+.. +|+.||||++.. .....+.+.+|++++++++|||||++++++......++|+|
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 4677789999999999999964 689999999863 22345678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccccc
Q 038103 588 YVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 667 (804)
|+.+|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 122 ~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp CCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999964 245899999999999999999999999 999999999999999999999999999976532
Q ss_pred CCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccc
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKI 747 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (804)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ... ....+..+...
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----------~~~-~~~~i~~~~~~-- 256 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----------PIQ-IYEKIVSGKVR-- 256 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHH-HHHHHHHCCCC--
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----------HHH-HHHHHhcCCCC--
Confidence 234679999999999999999999999999999999999999996422 111 12222222211
Q ss_pred cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038103 748 IDPRLNDVYDREKLDRMVKVALLCVAENRDTRP-----PMSKVVK 787 (804)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----tm~~Vv~ 787 (804)
.....+ ..+.+|+.+||+.||.+|+ |++++++
T Consensus 257 ----~p~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 ----FPSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111222 3688999999999999994 8999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=360.15 Aligned_cols=244 Identities=22% Similarity=0.301 Sum_probs=199.6
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHHHHHHHh-cCCCCcccceeeeEEeCCeeEEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWAEVSIIG-RINHRNLVKLQGFCAENEHKLLVY 586 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV~ 586 (804)
.|.+.+.||+|+||+||+|+.. +++.||||+++.. ....+.+..|..++. .++|||||++++++.+++..++||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 3667889999999999999965 6899999999632 234456777777765 689999999999999999999999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKE 666 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~ 666 (804)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 83 Ey~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 83 EYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred eecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999964 345888999999999999999999998 99999999999999999999999999986554
Q ss_pred cCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccc
Q 038103 667 RHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEK 746 (804)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (804)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+..+..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~------------~~~~~~~i~~~~~-- 220 (320)
T d1xjda_ 156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD------------EEELFHSIRMDNP-- 220 (320)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------------HHHHHHHHHHCCC--
T ss_pred cc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC------------HHHHHHHHHcCCC--
Confidence 32 23344679999999999999999999999999999999999999996422 1112222222221
Q ss_pred ccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 038103 747 IIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMS-KVV 786 (804)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~-~Vv 786 (804)
.+....+ ..+.+|+.+||+.||++||++. +++
T Consensus 221 ----~~p~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 221 ----FYPRWLE----KEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp ----CCCTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----CCCccCC----HHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 1112222 3588999999999999999995 675
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=363.20 Aligned_cols=247 Identities=20% Similarity=0.237 Sum_probs=194.8
Q ss_pred hcccc-cccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcC-CCCcccceeeeEEe----CCeeEEEE
Q 038103 514 RNFKQ-EVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRI-NHRNLVKLQGFCAE----NEHKLLVY 586 (804)
Q Consensus 514 ~~~~~-~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lV~ 586 (804)
|.+.. .||+|+||.||+|+. .+++.||||+++. ...+.+|++++.++ +|||||++++++.+ ....++||
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence 45544 599999999999996 5689999999863 35678899987654 89999999999865 45789999
Q ss_pred eeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC---CCCeEEeecCCccc
Q 038103 587 EYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD---HFEPKVTDFGLSKL 663 (804)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Dfgla~~ 663 (804)
|||++|+|.++|... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. .+.+||+|||+++.
T Consensus 89 Ey~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 89 ECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp ECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceeee
Confidence 999999999999753 2346999999999999999999999999 999999999999975 56799999999987
Q ss_pred ccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG 743 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (804)
..... ......||+.|+|||++.+..++.++|||||||+||||+||+.||....... ....+..
T Consensus 164 ~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--------~~~~~~~------ 227 (335)
T d2ozaa1 164 TTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--------ISPGMKT------ 227 (335)
T ss_dssp CCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------------
T ss_pred ccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--------HHHHHHH------
Confidence 65432 2345679999999999999999999999999999999999999996532111 0000001
Q ss_pred cccccCCcC--CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 744 LEKIIDPRL--NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 744 ~~~~~d~~l--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.+..... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 228 --~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 --RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111111 11111233457899999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-41 Score=365.96 Aligned_cols=245 Identities=23% Similarity=0.328 Sum_probs=194.6
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCc----CCChHHHHH---HHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGV----LQGDAEFWA---EVSIIGRINHRNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~----~~~~~~~~~---E~~~l~~l~H~niv~l~g~~~~~~~~~lV 585 (804)
|.+.+.||+|+||.||+|+.. +|+.||||++... ......+.+ |+++++.++|||||++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 566789999999999999965 6899999998632 223334444 46777888999999999999999999999
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
|||+++|+|.++|.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 86 mE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp ECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999964 345789999999999999999999999 9999999999999999999999999999765
Q ss_pred ccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc
Q 038103 666 ERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL 744 (804)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (804)
.. ......||+.|+|||++.. ..++.++|||||||+||||+||+.||...... .... +.......
T Consensus 159 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~-~~~~~~~~-- 224 (364)
T d1omwa3 159 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--------DKHE-IDRMTLTM-- 224 (364)
T ss_dssp SS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--------CHHH-HHHHSSSC--
T ss_pred CC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--------HHHH-HHHhcccC--
Confidence 43 2334579999999999975 56899999999999999999999999653211 0111 11111111
Q ss_pred ccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038103 745 EKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPP-----MSKVVK 787 (804)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~~Vv~ 787 (804)
...+...++ ..+.+|+.+||+.||++||| ++++++
T Consensus 225 ----~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 ----AVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----CCCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111112223 36889999999999999999 578764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=357.25 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=195.9
Q ss_pred ccccccCcceEEEEEec-CCcEEEEEEecCcCCC------hHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeecc
Q 038103 518 QEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG------DAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
+.||+|+||+||+|+.. +++.||||+++..... .+.+.+|++++++++|||||++++++..+++.++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 57999999999999964 6899999998643221 2468899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCCc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHDT 670 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 670 (804)
++++..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 84 TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred chHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 887766653 3456889999999999999999999999 99999999999999999999999999987654332
Q ss_pred cccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCcccccC
Q 038103 671 KFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKIID 749 (804)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 749 (804)
......||+.|+|||.+... .++.++|||||||++|||++|+.||.... .......+.+...........+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--------~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--------DLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHHHCCCCTTTSSS
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC--------HHHHHHHHHHhcCCCChhhccc
Confidence 22345689999999998754 57999999999999999999999986422 1111111112111110000000
Q ss_pred C---------cCCCccC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HhccC
Q 038103 750 P---------RLNDVYD-----REKLDRMVKVALLCVAENRDTRPPMSKVVK--LLTAH 792 (804)
Q Consensus 750 ~---------~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~--~L~~~ 792 (804)
. ......+ ....+.+.+|+.+||+.||++|||++|+++ .|...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 0000011 112356889999999999999999999987 36543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=351.09 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=198.4
Q ss_pred hcccccccccCcceEEEEEe-cCCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 514 RNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
|.+.++||+|+||+||+|+. .+++.||||+++... ...+++.+|++++++++|||||++++++.++.+.++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 55668899999999999996 568999999997432 23577999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
.++ +..++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 84 HQD-LKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp SEE-HHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred CCc-hhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 764 44444332 3456999999999999999999999999 9999999999999999999999999998765432
Q ss_pred ccccccccCCCccchhhhccCC-CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCccccc
Q 038103 670 TKFSRVRGTRGYLAPEWMMNLK-IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGLEKII 748 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......||+.|+|||.+.... ++.++||||+||++|||++|+.||..... ...+.. +.... +...+..
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~-------~~~~~~-i~~~~--~~~~~~~ 226 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-------IDQLFR-IFRTL--GTPDEVV 226 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHH-HHHHH--CCCCTTT
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH-------HHHHHH-HHHhc--CCCchhh
Confidence 2334457899999999887665 57899999999999999999999964220 011111 11110 0000000
Q ss_pred CCc--------------CCCc---cCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hccC
Q 038103 749 DPR--------------LNDV---YDREKLDRMVKVALLCVAENRDTRPPMSKVVKL--LTAH 792 (804)
Q Consensus 749 d~~--------------l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~--L~~~ 792 (804)
.+. .... ........+.+|+.+||+.||++|||+.|+++. ++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000 0000 011123567899999999999999999999974 6544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-41 Score=350.21 Aligned_cols=237 Identities=24% Similarity=0.383 Sum_probs=193.6
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC-------ChHHHHHHHHHHhcCC--CCcccceeeeEEeCCee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ-------GDAEFWAEVSIIGRIN--HRNLVKLQGFCAENEHK 582 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~ 582 (804)
+|.+.+.||+|+||.||+|+. .+++.||||+++.... ...++.+|+.++++++ |||||++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 467788999999999999996 4689999999864221 1234678999999996 89999999999999999
Q ss_pred EEEEeeccC-CChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-CCCeEEeecCC
Q 038103 583 LLVYEYVEN-GSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-HFEPKVTDFGL 660 (804)
Q Consensus 583 ~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfgl 660 (804)
++||||+.+ +++.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 999999976 577777753 346899999999999999999999999 999999999999985 47999999999
Q ss_pred cccccccCCccccccccCCCccchhhhccCCC-CcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 661 SKLFKERHDTKFSRVRGTRGYLAPEWMMNLKI-DAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 661 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
++..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ..
T Consensus 158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------------~i 216 (273)
T d1xwsa_ 158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------------EI 216 (273)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------------HH
T ss_pred ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------------HH
Confidence 9865432 2345679999999999988776 567899999999999999999996421 01
Q ss_pred hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
..+.. .+...++ ..+.+|+.+||+.||++|||++|+++
T Consensus 217 ~~~~~------~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 217 IRGQV------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHCCC------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhccc------CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11111 1112223 36889999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-40 Score=350.69 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=196.0
Q ss_pred HhcccccccccCcceEEEEEe-cC-CcEEEEEEecCcC---CChHHHHHHHHHHhcC---CCCcccceeeeEEe-----C
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DD-ERVVAVKRLEGVL---QGDAEFWAEVSIIGRI---NHRNLVKLQGFCAE-----N 579 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~ 579 (804)
.|.+.++||+|+||+||+|+. .+ ++.||||+++... .....+.+|+.+++.+ +||||++++++|.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 466778999999999999996 33 6779999986322 2234566788777665 79999999999853 3
Q ss_pred CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
...++++|++.++.+...... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 478999999998776555443 3456889999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 660 LSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 660 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
+++..... .......||+.|+|||++.+.+++.++||||+||++|||++|+.||..... ......+....
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~ 231 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--------VDQLGKILDVI 231 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHH
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH--------HHHHHHHHHhh
Confidence 99865432 233456799999999999999999999999999999999999999964321 11111111111
Q ss_pred hhcCcccc----------cC---CcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hccC
Q 038103 740 EQEGLEKI----------ID---PRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL--LTAH 792 (804)
Q Consensus 740 ~~~~~~~~----------~d---~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~--L~~~ 792 (804)
........ .. ............+.+.+|+.+||+.||++|||+.|+++. |+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 11000000 00 000001111223467889999999999999999999864 5444
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.9e-40 Score=346.66 Aligned_cols=259 Identities=21% Similarity=0.313 Sum_probs=196.5
Q ss_pred HhcccccccccCcceEEEEEecCCcEEEEEEecCcC---CChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEeec
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVL---QGDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEYV 589 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 589 (804)
+|.+.++||+|+||+||+|+.++++.||||+++... ...+.+.+|+.++++++|||||++++++...+..++++|++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 355678899999999999999999999999997432 23578999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccCC
Q 038103 590 ENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERHD 669 (804)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 669 (804)
.++.+..+.. ....++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 83 DQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp SEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred hhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 8876666654 3456999999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcCc----
Q 038103 670 TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEGL---- 744 (804)
Q Consensus 670 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 744 (804)
......+++.|+|||.+... .++.++|||||||++|||++|+.||..... ...+ ..+.........
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-------~~~~-~~i~~~~~~~~~~~~~ 226 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-------ADQL-MRIFRILGTPNSKNWP 226 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHH-HHHHHHHCCCCTTTST
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-------HHHH-HHHHHhhCCCChhhcc
Confidence 22344688999999998754 568999999999999999999999964321 0111 111111111000
Q ss_pred --ccc---------cCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 745 --EKI---------IDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 745 --~~~---------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
... ..+.............+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000001111112346889999999999999999999974
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.2e-39 Score=337.55 Aligned_cols=259 Identities=18% Similarity=0.251 Sum_probs=203.2
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCC-CcccceeeeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINH-RNLVKLQGFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~ 590 (804)
.|.+.++||+|+||.||+|+.. +++.||||.+... ....++.+|++++..++| +|++.+++++.++...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 5677889999999999999954 6899999988643 234457889999999975 89999999999999999999998
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcC-----CCCeEEeecCCccccc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDD-----HFEPKVTDFGLSKLFK 665 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~Dfgla~~~~ 665 (804)
+++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.+.
T Consensus 84 ~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 6799999865 3456899999999999999999999999 999999999999964 5689999999999865
Q ss_pred ccCC------ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHh
Q 038103 666 ERHD------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQM 739 (804)
Q Consensus 666 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (804)
.... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||....... .......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~-----~~~~~~~i~~~~ 232 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQKYERIGEKK 232 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-----HHHHHHHHHHHH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh-----HHHHHHHHHhcc
Confidence 4322 12334679999999999999999999999999999999999999997432110 111111111111
Q ss_pred hhcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccCC
Q 038103 740 EQEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAHD 793 (804)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~~ 793 (804)
......++ ...++ +.+.+++..|++.+|++||+++.+.+.|+.+.
T Consensus 233 ~~~~~~~l-----~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 233 QSTPLREL-----CAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHSCHHHH-----TTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCCChHHh-----cCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111111 11122 46888999999999999999999988887654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.2e-39 Score=338.37 Aligned_cols=258 Identities=20% Similarity=0.268 Sum_probs=195.3
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCccccee-eeEEeCCeeEEEEeecc
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQ-GFCAENEHKLLVYEYVE 590 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~-g~~~~~~~~~lV~E~~~ 590 (804)
+|.+.+.||+|+||.||+|+. .+++.||||.+... ...+++..|++++++++|+|++..+ .+..+....++||||+.
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC-TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh-ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 467788999999999999996 56899999988743 2335678999999999887766555 44567778899999995
Q ss_pred CCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEc---CCCCeEEeecCCccccccc
Q 038103 591 NGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLD---DHFEPKVTDFGLSKLFKER 667 (804)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Dfgla~~~~~~ 667 (804)
++|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++.+...
T Consensus 87 -~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 87 -PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp -CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred -Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 466666654 3456899999999999999999999999 99999999999985 4557999999999987543
Q ss_pred CC------ccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhh
Q 038103 668 HD------TKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQ 741 (804)
Q Consensus 668 ~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (804)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ...... ......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~----~~~~~~-~~~~~~ 234 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----QKYERI-SEKKMS 234 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------HHHH-HHHHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH----HHHHHh-hcccCC
Confidence 22 2234567999999999999999999999999999999999999999653321111 001111 111000
Q ss_pred cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhccC
Q 038103 742 EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKLLTAH 792 (804)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~L~~~ 792 (804)
..... +...+ +..+.+++..|++.+|++||+++++.+.|+.+
T Consensus 235 ~~~~~-----~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 235 TPIEV-----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp SCHHH-----HTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred CChhH-----hccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00110 11112 24688999999999999999999999888764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=339.09 Aligned_cols=262 Identities=18% Similarity=0.237 Sum_probs=193.4
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCc---CCChHHHHHHHHHHhcCCCCcccceeeeEEe--------C
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGV---LQGDAEFWAEVSIIGRINHRNLVKLQGFCAE--------N 579 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 579 (804)
.+|.+.++||+|+||+||+|+. .+++.||||++... ....+++.+|+++|++++|+|++++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 3566788999999999999996 57899999998633 2234678999999999999999999999865 3
Q ss_pred CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecC
Q 038103 580 EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFG 659 (804)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg 659 (804)
.+.++||||+.++.+..+.. ....++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 46799999998876665543 3456888899999999999999999998 9999999999999999999999999
Q ss_pred CcccccccCC---ccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHH
Q 038103 660 LSKLFKERHD---TKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWV 735 (804)
Q Consensus 660 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 735 (804)
+++....... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.... .......+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~--------~~~~~~~i 234 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--------EQHQLALI 234 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--------HHHHHHHH
Confidence 9987654322 222335689999999998765 68999999999999999999999996422 11111111
Q ss_pred HHHhhhcC---cccccCC--------cCCCccCH-------HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 736 AKQMEQEG---LEKIIDP--------RLNDVYDR-------EKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 736 ~~~~~~~~---~~~~~d~--------~l~~~~~~-------~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
.+...... ....... ........ .....+++|+.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11111100 0000000 00000011 112356789999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-39 Score=347.17 Aligned_cols=259 Identities=23% Similarity=0.279 Sum_probs=189.4
Q ss_pred HhcccccccccCcceEEEEEec-CCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcccceeeeEEeC------CeeEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLVKLQGFCAEN------EHKLLV 585 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV 585 (804)
+|+..+.||+|+||+||+|+.. +++.||||++..... .+.+|++++++++|+||+++++++... .+.+||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 3555678999999999999975 689999999975432 234799999999999999999998643 357899
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC-CeEEeecCCcccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF-EPKVTDFGLSKLF 664 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~ 664 (804)
|||++++.+..+.. .......+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 98 ~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99998754333332 1113456899999999999999999999998 99999999999999775 8999999999876
Q ss_pred cccCCccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHH-------
Q 038103 665 KERHDTKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVA------- 736 (804)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------- 736 (804)
.... ......||..|+|||.+.. ..++.++||||+||++|||++|+.||..... ...+.....
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-------~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-------VDQLVEIIKVLGTPTR 244 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-------HHHHHHHHHHHCCCCH
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH-------HHHHHHHHHHhCCChH
Confidence 5432 2234578999999998875 4689999999999999999999999964321 011111100
Q ss_pred ---HHhhhc----CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 737 ---KQMEQE----GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 737 ---~~~~~~----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
...... .+...................+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 001100000000111122346889999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-38 Score=343.35 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=190.9
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeCC------ee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAENE------HK 582 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~ 582 (804)
+|.+.++||+|+||+||+|+. .+++.||||+++..... .+.+.+|+++|++++|||||+++++|...+ +.
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 466678899999999999996 46899999999754333 346889999999999999999999997654 56
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++||||+ +.+|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 99 ~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp EEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 9999999 4577777743 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh-
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME- 740 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 740 (804)
..... .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||...... ..+... .....
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-------~~~~~~-~~~~~~ 237 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-------DQLKEI-MKVTGT 237 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHH-HHHHCC
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-------HHHHHH-HhccCC
Confidence 75442 2345789999999998764 5789999999999999999999999643210 000000 00000
Q ss_pred -------h----------cCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hccCCC
Q 038103 741 -------Q----------EGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL--LTAHDH 794 (804)
Q Consensus 741 -------~----------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~--L~~~~~ 794 (804)
. ..+.+.....+. .........+.+|+.+||+.||.+|||+.|+++. |+.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred CcHHHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 0 000000001010 0111122357889999999999999999999974 666543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=343.06 Aligned_cols=264 Identities=22% Similarity=0.282 Sum_probs=193.6
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC--ChHHHHHHHHHHhcCCCCcccceeeeEEeCC----eeEEE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ--GDAEFWAEVSIIGRINHRNLVKLQGFCAENE----HKLLV 585 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 585 (804)
+|.+.++||+|+||+||+|+. .+++.||||+++.... ..+++++|+.+|++++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 366778999999999999985 5789999999974332 2357889999999999999999999997653 33455
Q ss_pred EeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccccc
Q 038103 586 YEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFK 665 (804)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~ 665 (804)
++++.+|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 667778999999964 25899999999999999999999998 9999999999999999999999999998765
Q ss_pred ccCC--ccccccccCCCccchhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 666 ERHD--TKFSRVRGTRGYLAPEWMMN-LKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 666 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
.... .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||...... .............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~--------~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--------DQLNHILGILGSP 232 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCSC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH--------HHHHHHhhhccCC
Confidence 4322 23445678999999999854 56789999999999999999999999643210 0000000000000
Q ss_pred Ccc-------------cccCCcCC-C---ccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hccC
Q 038103 743 GLE-------------KIIDPRLN-D---VYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL--LTAH 792 (804)
Q Consensus 743 ~~~-------------~~~d~~l~-~---~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~--L~~~ 792 (804)
... ....+... . .........+.+|+.+||+.||++|||+.|+++. |+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000 00000000 0 0001112367899999999999999999999974 5433
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-38 Score=330.52 Aligned_cols=260 Identities=20% Similarity=0.247 Sum_probs=199.1
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCC---ChHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQ---GDAEFWAEVSIIGRINHRNLVKLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 588 (804)
+|++.++||+|+||+||+|+. .+++.||||+++.... ...++.+|+.++++++||||+++++++......++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 356678999999999999996 5688999999974332 246789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcccccccC
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKLFKERH 668 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 668 (804)
+.+++|..++.. ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 83 ~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 83 CDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred cccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999988887753 356789999999999999999999998 9999999999999999999999999999765433
Q ss_pred CccccccccCCCccchhhhccCC-CCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhcC----
Q 038103 669 DTKFSRVRGTRGYLAPEWMMNLK-IDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQEG---- 743 (804)
Q Consensus 669 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 743 (804)
. ......++..|+|||.+.... ++.++||||+||++|||++|+.||.... ........+........
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-------DVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-------SHHHHHHHHHHHHCCCCTTTC
T ss_pred c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC-------CHHHHHHHHHhhcCCCChhhh
Confidence 2 223345678899999987665 6899999999999999999999974311 01111111111111100
Q ss_pred --cccccCC---------cCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 744 --LEKIIDP---------RLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 744 --~~~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
.....+. .-...........+.+|+.+|++.||.+|||++||++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 0001111222346788999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-37 Score=331.75 Aligned_cols=258 Identities=17% Similarity=0.288 Sum_probs=193.5
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcCC-CCcccceeeeEEeC--CeeEEEEee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-HRNLVKLQGFCAEN--EHKLLVYEY 588 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E~ 588 (804)
.|.+.++||+|+||+||+|+. .+++.||||+++. ...+++.+|+++|.+++ ||||+++++++... ...++||||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~--~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH--HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 577788999999999999996 5689999999974 34577899999999995 99999999998743 568999999
Q ss_pred ccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCC-CeEEeecCCccccccc
Q 038103 589 VENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHF-EPKVTDFGLSKLFKER 667 (804)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfgla~~~~~~ 667 (804)
+.+++|..+.. .++...+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 114 ~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 114 VNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp CCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred cCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999977652 4889999999999999999999999 99999999999998655 6899999999876543
Q ss_pred CCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHH-----HHHHHhhh
Q 038103 668 HDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQ-----WVAKQMEQ 741 (804)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 741 (804)
. ......+|+.|+|||.+.+. .++.++||||+|++++||++|+.||....... .....+.. ........
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~---~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY---DQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH---HHHHHHHHHHCHHHHHHHHHH
T ss_pred C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH---HHHHHHHHHHCCchhhhhhhh
Confidence 2 23445689999999998765 47999999999999999999999986422100 00000000 00011111
Q ss_pred cCc------ccccCCc--------CCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038103 742 EGL------EKIIDPR--------LNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK 787 (804)
Q Consensus 742 ~~~------~~~~d~~--------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~ 787 (804)
... ....... ............+.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 100 0000000 000011112345789999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=337.72 Aligned_cols=250 Identities=22% Similarity=0.265 Sum_probs=199.1
Q ss_pred HhcccccccccCcceEEEEEe----cCCcEEEEEEecCc-----CCChHHHHHHHHHHhcCCC-CcccceeeeEEeCCee
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL----DDERVVAVKRLEGV-----LQGDAEFWAEVSIIGRINH-RNLVKLQGFCAENEHK 582 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~----~~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~ 582 (804)
.|.+.++||+|+||+||+|+. .+|+.||||.++.. ....+.+.+|++++++++| |||+++++++.+....
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 377889999999999999984 24789999998632 1234668899999999976 8999999999999999
Q ss_pred EEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCcc
Q 038103 583 LLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSK 662 (804)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~ 662 (804)
++++||+.+|+|.+++.. ...+.......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999964 234677888999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCccccccccCCCccchhhhccC--CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhh
Q 038103 663 LFKERHDTKFSRVRGTRGYLAPEWMMNL--KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQME 740 (804)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (804)
.+............|++.|+|||.+... .++.++|||||||+||||++|+.||....... ....+.....
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--------~~~~i~~~~~ 249 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--------SQAEISRRIL 249 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--------CHHHHHHHHH
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHhcc
Confidence 7765555555567799999999999754 47889999999999999999999996533111 1111111111
Q ss_pred hcCcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038103 741 QEGLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPP-----MSKVVK 787 (804)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----m~~Vv~ 787 (804)
... +.+ +......+.+|+.+||+.||++||+ ++|+++
T Consensus 250 ~~~------~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 KSE------PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HCC------CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCC------CCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111 111 1122347889999999999999994 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-37 Score=332.14 Aligned_cols=263 Identities=19% Similarity=0.264 Sum_probs=185.5
Q ss_pred hcccccccccCcceEEEEEec-CCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEe------CCeeE
Q 038103 514 RNFKQEVGKGGFGSVFRGVLD-DERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAE------NEHKL 583 (804)
Q Consensus 514 ~~~~~~LG~G~fg~Vykg~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~~ 583 (804)
|.+.++||+|+||+||+|+.. +|+.||||++...... ..++.+|+.++++++|||||++++++.. ..+.+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 566789999999999999965 6899999999754333 2458899999999999999999999964 36889
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
+||||+.++.+ ..+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++.
T Consensus 99 iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 99 LVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence 99999977544 4442 23789999999999999999999999 99999999999999999999999999986
Q ss_pred ccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCC-----------ccchhhHH
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASD-----------SSYCNHLV 732 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~-----------~~~~~~~~ 732 (804)
.... .......+|+.|+|||.+.+..+++++||||+||+++||++|+.||......... ........
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 5542 2334456899999999999999999999999999999999999998532100000 00000000
Q ss_pred HHHHHHhhhcC-c-----ccccCCcC---CCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038103 733 QWVAKQMEQEG-L-----EKIIDPRL---NDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVKL 788 (804)
Q Consensus 733 ~~~~~~~~~~~-~-----~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~~ 788 (804)
........... . ........ ...........+.+|+.+||+.||++|||++||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000011100 0 00000001 111223456678999999999999999999999843
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=328.67 Aligned_cols=260 Identities=21% Similarity=0.313 Sum_probs=192.5
Q ss_pred HhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCC---hHHHHHHHHHHhcCCCCcccceeeeEEeC-----CeeE
Q 038103 513 TRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQG---DAEFWAEVSIIGRINHRNLVKLQGFCAEN-----EHKL 583 (804)
Q Consensus 513 t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 583 (804)
+|.+.++||+|+||+||+|+. .+++.||||+++..... .+++.+|++++++++|||+|++++++... ...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 466678999999999999995 57999999999754433 34678999999999999999999998643 3456
Q ss_pred EEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 584 LVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
++++++.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++..
T Consensus 99 ~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp EEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred EEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 77888889999999943 35999999999999999999999999 99999999999999999999999999986
Q ss_pred ccccCCccccccccCCCccchhhhccC-CCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhhHHHHHHHHhhhc
Q 038103 664 FKERHDTKFSRVRGTRGYLAPEWMMNL-KIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNHLVQWVAKQMEQE 742 (804)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (804)
.... .....|++.|+|||.+.+. .++.++||||+||++|||++|+.||..... ......+.......
T Consensus 171 ~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~--------~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 171 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--------IDQLKLILRLVGTP 238 (348)
T ss_dssp CTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHHCCC
T ss_pred cCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhcCCC
Confidence 5432 3345688999999987665 468899999999999999999999964220 01111111110000
Q ss_pred ------------------CcccccCCcCCCccCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HhccCC
Q 038103 743 ------------------GLEKIIDPRLNDVYDREKLDRMVKVALLCVAENRDTRPPMSKVVK--LLTAHD 793 (804)
Q Consensus 743 ------------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~~Vv~--~L~~~~ 793 (804)
.+.......+.. ........+.+|+.+||+.||.+|||++|+++ .+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000000000000 00112346789999999999999999999997 455443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-33 Score=302.88 Aligned_cols=268 Identities=18% Similarity=0.249 Sum_probs=189.8
Q ss_pred HHhcccccccccCcceEEEEEe-cCCcEEEEEEecCcCCChHHHHHHHHHHhcCC-----------CCcccceeeeEEeC
Q 038103 512 ATRNFKQEVGKGGFGSVFRGVL-DDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN-----------HRNLVKLQGFCAEN 579 (804)
Q Consensus 512 ~t~~~~~~LG~G~fg~Vykg~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~~ 579 (804)
.+|.+.++||+|+||+||+|+. .+|+.||||+++......+.+.+|++++++++ |+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 3477889999999999999996 57899999999865444567788999888775 57899999988643
Q ss_pred --CeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHh-hCCCcEEecccccCeEEEcCCC-----
Q 038103 580 --EHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHE-ECLEWVLHCDVKPQNILLDDHF----- 651 (804)
Q Consensus 580 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~----- 651 (804)
...+++++++..+......... .....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred cccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4566667666554332222111 134567889999999999999999998 66 99999999999997665
Q ss_pred -CeEEeecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHHHHHHhCCCCCcccccccCCccchhh
Q 038103 652 -EPKVTDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVLLELLTGKSASDYLSASASDSSYCNH 730 (804)
Q Consensus 652 -~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~ 730 (804)
.+|++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||.......... ....
T Consensus 169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~-~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK-DDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C-HHHH
T ss_pred ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc-hhHH
Confidence 3999999999865432 234568999999999999999999999999999999999999986432111110 0011
Q ss_pred HHHHHHH-------HhhhcCc-ccccC---------C-cC---------CCccCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 038103 731 LVQWVAK-------QMEQEGL-EKIID---------P-RL---------NDVYDREKLDRMVKVALLCVAENRDTRPPMS 783 (804)
Q Consensus 731 ~~~~~~~-------~~~~~~~-~~~~d---------~-~l---------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPtm~ 783 (804)
+...+.. ....... ....+ . .. ...........+.+|+.+|++.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1111100 0000000 00000 0 00 1123456677899999999999999999999
Q ss_pred HHHHH
Q 038103 784 KVVKL 788 (804)
Q Consensus 784 ~Vv~~ 788 (804)
|+++.
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=6.4e-21 Score=186.22 Aligned_cols=168 Identities=12% Similarity=0.082 Sum_probs=119.6
Q ss_pred cccccccccCcceEEEEEecCCcEEEEEEecCcCCC-------------------hHHHHHHHHHHhcCCCCcccceeee
Q 038103 515 NFKQEVGKGGFGSVFRGVLDDERVVAVKRLEGVLQG-------------------DAEFWAEVSIIGRINHRNLVKLQGF 575 (804)
Q Consensus 515 ~~~~~LG~G~fg~Vykg~~~~~~~vavK~l~~~~~~-------------------~~~~~~E~~~l~~l~H~niv~l~g~ 575 (804)
.+.++||+|+||.||+|+..+|+.||||.++..... .....+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356789999999999999989999999987521110 0224568888999999999888765
Q ss_pred EEeCCeeEEEEeeccCCChhhhhccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhCCCcEEecccccCeEEEcCCCCeEE
Q 038103 576 CAENEHKLLVYEYVENGSLDKLLFNDPGTASILQWDQRYNIAVGTAKGLSYLHEECLEWVLHCDVKPQNILLDDHFEPKV 655 (804)
Q Consensus 576 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 655 (804)
. ..+++|||+++..+.. ++......++.|++++++|||+.+ |+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 3 2379999998765433 334455689999999999999999 9999999999999965 5899
Q ss_pred eecCCcccccccCCccccccccCCCccchhhhccCCCCcccchHHHHHHH
Q 038103 656 TDFGLSKLFKERHDTKFSRVRGTRGYLAPEWMMNLKIDAKADVYSYGIVL 705 (804)
Q Consensus 656 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvll 705 (804)
+|||+|...........-. .... .-.|.+ ...|+.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~~~l~--rd~~-~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILE--RDVR-NIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHHHH--HHHH-HHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHH--HHHH-HHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999998654321111000 0000 001222 34678899999986444
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.79 E-value=2.2e-19 Score=157.85 Aligned_cols=110 Identities=22% Similarity=0.396 Sum_probs=91.6
Q ss_pred CCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeC
Q 038103 27 PRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTD 106 (804)
Q Consensus 27 ~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~ 106 (804)
++|.+||.|.. |++|+ +|.|+|+|+..|+ |.+++ ..++||.||++.|. ..+.+.++.||+|+|+|
T Consensus 2 DtL~~gq~L~~---g~~l~--~g~~~l~~q~DGN----Lvly~----~~~~vW~s~~~~~~--~~~~l~l~~dGnLvl~~ 66 (112)
T d1xd5a_ 2 DRLNSGHQLDT---GGSLA--EGGYLFIIQNDCN----LVLYD----NNRAVWASGTNGKA--SGCVLKMQNDGNLVIYS 66 (112)
T ss_dssp CEEETTEEECT---TCEEE--ETTEEEEECTTSC----EEEEE----TTEEEEECCCTTSC--SSEEEEECTTSCEEEEE
T ss_pred CEecCCCEecC---CCEEE--ECCEEEEEcCCCC----EEEEc----CCcEEEEccCccCC--CCcEEEEeccccEEEEe
Confidence 78899999984 78997 4999999987764 55554 35799999999885 44689999999999999
Q ss_pred CCCCeEEEecccC-CcceEEEEecCCCeEEEecCCCceeeccCCCCC
Q 038103 107 KDSSVVWSTNTFT-DEGVQAQLLETGNLVLVNEANTTIWKSFDSPTD 152 (804)
Q Consensus 107 ~~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTD 152 (804)
. +..+|++++.. .....|+|+|+|||||++.++.++|||+.+|+|
T Consensus 67 ~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 67 G-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp T-TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred c-CCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 6 45677777543 355689999999999999999999999999975
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.76 E-value=2e-18 Score=150.04 Aligned_cols=106 Identities=23% Similarity=0.341 Sum_probs=87.2
Q ss_pred CCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeC
Q 038103 27 PRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTD 106 (804)
Q Consensus 27 ~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~ 106 (804)
+.|.+|+.|.+ |++|. +|.|.|+|...++ +.++. ..++||+||++.|.. ..++|.|+.||+|+|+|
T Consensus 2 ~~L~~g~~L~~---g~~l~--~g~~~l~~q~dgn----Lvl~~----~~~~vW~ant~~~~~-~~~~l~l~~dGnLvl~~ 67 (109)
T d1kj1a_ 2 NLLTNGEGLYA---GQSLD--VEPYHFIMQEDCN----LVLYD----HSTSVWASNTGILGK-KGCKAVLQSDGNFVVYD 67 (109)
T ss_dssp CEEETTCEEET---TCEEE--ETTEEEEECTTSC----EEEEE----TTEEEEECCCCCTTC-CCCEEEECTTSCEEEEC
T ss_pred CCccCCCEEeC---CCEEE--eCCEEEEecCCCe----EEEEe----CCEEEEEeCCCCCCc-eeEEEEEcCCceEEEEe
Confidence 56789999974 78886 5889999986654 44443 357999999999984 45789999999999999
Q ss_pred CCCCeEEEeccc-CCcceEEEEecCCCeEEEecCCCceeeccCC
Q 038103 107 KDSSVVWSTNTF-TDEGVQAQLLETGNLVLVNEANTTIWKSFDS 149 (804)
Q Consensus 107 ~~~~~vWst~~~-~~~~~~a~LldsGNlVl~~~~~~~lWqSFd~ 149 (804)
++|++||+|+++ +.....|.|+|+|||||++. .+|||+-|
T Consensus 68 ~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 68 AEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp SSSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred CCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 999999999975 34566899999999999964 69999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.75 E-value=2.3e-18 Score=149.66 Aligned_cols=105 Identities=20% Similarity=0.349 Sum_probs=87.6
Q ss_pred CCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeC
Q 038103 27 PRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTD 106 (804)
Q Consensus 27 ~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~ 106 (804)
++|.+||.|. .|++|. +|.|.|.|+..|+ |.|+.. .++||.||++.| +..+.+.+..+|+|+|.|
T Consensus 2 ~~L~~g~~L~---~G~~l~--ng~~~l~~q~DGN----Lvly~~----~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~ 66 (108)
T d1jpca_ 2 NILYSGETLS---TGEFLN--YGSFVFIMQEDCN----LVLYDV----DKPIWATNTGGL--SRSCFLSMQTDGNLVVYN 66 (108)
T ss_dssp CEEETTEEEC---TTCEEE--ETTEEEEECTTSC----EEEEET----TEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CCccCCCEec---CCCEEE--cCCEEEEECCCCe----EEEEeC----CceeeEeCCCCC--CCccEEEEeccceEEEEC
Confidence 5677899996 478885 6999999998875 667642 479999999988 345689999999999999
Q ss_pred CCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeeccCC
Q 038103 107 KDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKSFDS 149 (804)
Q Consensus 107 ~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqSFd~ 149 (804)
++|.+||+|++... ...+|+|+|+|||||++. .+||||+|
T Consensus 67 ~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 67 PSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp TTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred CCccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 99999999987543 345789999999999964 59999988
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.67 E-value=3.4e-17 Score=144.59 Aligned_cols=101 Identities=23% Similarity=0.379 Sum_probs=86.4
Q ss_pred EEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeCCCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceee
Q 038103 67 IWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWK 145 (804)
Q Consensus 67 iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWq 145 (804)
|||.++++++.+|++|++.|+....-+|.+..||||+|++. +.++|++++... ....|+|+++|||||++.++.+|||
T Consensus 12 il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~ 90 (120)
T d1dlpa2 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWT 90 (120)
T ss_dssp ECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEE
T ss_pred EEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEEE
Confidence 89999999999999999999987777999999999999986 678999997654 3578999999999999999999999
Q ss_pred ccCCCCCccCCCcccCCCCeEEecCCCCCCcccccEEEecCCCcceee
Q 038103 146 SFDSPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNILDLI 193 (804)
Q Consensus 146 SFd~PTDtllpg~~l~~~~~L~S~~s~~dps~G~y~~~~~~~~~~~~~ 193 (804)
||. +.++|.|.+.++++|.+.++
T Consensus 91 S~t-------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 91 SGN-------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp CCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred eCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence 974 34578899999999987553
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.58 E-value=4.8e-16 Score=135.57 Aligned_cols=109 Identities=25% Similarity=0.337 Sum_probs=92.7
Q ss_pred EEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeCCCCCeEEEecccCCcceEEEEecCCCeEEEecCCCceeec
Q 038103 67 IWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFTDEGVQAQLLETGNLVLVNEANTTIWKS 146 (804)
Q Consensus 67 iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~lWqS 146 (804)
|||.-.++.+..|..+.+.++.+...+|.+..||||||++ ++.++|++++.+..+..+.|+|+|||||++.++.+||||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEc
Confidence 7787777888899999999998777899999999999998 478899999877778899999999999999999999998
Q ss_pred cCCCCCccCCCcccCCCCeEEecCCCCCCcccccEEEecCCCcceeecCCCCcccccccCC
Q 038103 147 FDSPTDTLLPSQLLTKNTTLVSMRSPGTYLSGFYNLKFDDNNILDLIFNGPLISSIYWPNS 207 (804)
Q Consensus 147 Fd~PTDtllpg~~l~~~~~L~S~~s~~dps~G~y~~~~~~~~~~~~~~~~~~~~~~yw~~~ 207 (804)
+. +.++|.|.+.++++|.+.++ . ..+|.++
T Consensus 82 ~t-------------------------~~~~g~y~l~Lq~DGNlvlY-~-----~~~Wssg 111 (115)
T d1dlpa1 82 GT-------------------------KGSIGNYVLVLQPDRTVTIY-G-----PGLWDSG 111 (115)
T ss_dssp CC-------------------------CCCSSCCEEEECSSSCEEEE-C-----SEEEECS
T ss_pred CC-------------------------CCCCCCEEEEECCCCcEEEe-C-----CCeecCC
Confidence 63 34679999999999986543 2 2477654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.51 E-value=4.1e-14 Score=124.09 Aligned_cols=102 Identities=16% Similarity=0.268 Sum_probs=81.2
Q ss_pred CCcCCCcceeeecCCCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeC
Q 038103 27 PRLTRGNSLAVEKENDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTD 106 (804)
Q Consensus 27 ~~~~~~~~l~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~ 106 (804)
.+|.++|+|. +.+.+|.|.|.|...|+ |.+ |. ..++||.||+..|. ....|.+..+|+|+|.|
T Consensus 15 ~~l~~~q~l~-------~~~~~~~y~l~mQ~DGN----LVL-y~---~~~~vWssnt~~~~--~~~~l~l~~dGnLvL~d 77 (119)
T d1b2pa_ 15 QILHATESLE-------ILFGTHVYRFIMQTDCN----LVL-YD---NNNPIWATNTGGLG--NGCRAVLQPDGVLVVIT 77 (119)
T ss_dssp CEEETTCEEE-------EEETTEEEEEEECTTSC----EEE-EE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEEC
T ss_pred CEEeCCCeEE-------EecCCceEEEEECCCCc----EEE-EE---CCeEEEEecCCCCC--cceEEEEEeCCCEEEEC
Confidence 5666677663 46779999999988775 444 33 35799999998874 34689999999999999
Q ss_pred CCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeeccC
Q 038103 107 KDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKSFD 148 (804)
Q Consensus 107 ~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqSFd 148 (804)
++|.+||++++... ....|+|+|+|||||++ ..+|||-.
T Consensus 78 ~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 78 NENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp TTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred CCCcEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 99999999987644 44578999999999996 47999853
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.14 E-value=3.2e-11 Score=104.52 Aligned_cols=91 Identities=16% Similarity=0.248 Sum_probs=71.4
Q ss_pred CCEEEcCCCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeCCCCCeEEEecccC-
Q 038103 41 NDFLVSPNGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFT- 119 (804)
Q Consensus 41 ~~~l~S~~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~~~vWst~~~~- 119 (804)
++.| .+|.|.|.|...|+ |.++. ..++||.+|...+ ..+.+.+..+|||||.|.++.+||++++..
T Consensus 20 ~~~l--~~g~~~l~~q~DGN----LvL~~----~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~ 86 (115)
T d1dlpa1 20 AQSL--ELSSFRFTMQSDCN----LVLFD----SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGS 86 (115)
T ss_dssp TCEE--CSTTEEEEECTTSC----EEEEE----SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCCCCCCC
T ss_pred CCcE--EcCCEEEEECCCCe----EEEEc----CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEEEcCCCCC
Confidence 4455 46789999987775 55643 2468999997643 357899999999999999999999998753
Q ss_pred CcceEEEEecCCCeEEEecCCCceeecc
Q 038103 120 DEGVQAQLLETGNLVLVNEANTTIWKSF 147 (804)
Q Consensus 120 ~~~~~a~LldsGNlVl~~~~~~~lWqSF 147 (804)
....+++|+++|||||++ ..+|+|-
T Consensus 87 ~g~y~l~Lq~DGNlvlY~---~~~Wssg 111 (115)
T d1dlpa1 87 IGNYVLVLQPDRTVTIYG---PGLWDSG 111 (115)
T ss_dssp SSCCEEEECSSSCEEEEC---SEEEECS
T ss_pred CCCEEEEECCCCcEEEeC---CCeecCC
Confidence 345579999999999995 4799974
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.86 E-value=3.4e-09 Score=92.16 Aligned_cols=74 Identities=30% Similarity=0.477 Sum_probs=60.2
Q ss_pred eEEEeeCccEEEeCCCCCeEEEecccCC-cceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccCCCCeEEecCC
Q 038103 93 KLTLQRNGNLALTDKDSSVVWSTNTFTD-EGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSMRS 171 (804)
Q Consensus 93 ~l~~~~~G~L~l~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~~~~~L~S~~s 171 (804)
+|.+..||||||+++ +.++|++++.+. ..+.+.|.++|||||++.++.++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~------------------------ 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP------------------------ 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS------------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECC------------------------
Confidence 577889999999975 568999997654 357899999999999999999999862
Q ss_pred CCCCcccccEEEecCCCccee
Q 038103 172 PGTYLSGFYNLKFDDNNILDL 192 (804)
Q Consensus 172 ~~dps~G~y~~~~~~~~~~~~ 192 (804)
+.-+.|.|.+.++++|.+.+
T Consensus 88 -t~~~~~~~~l~Lq~DGNlvl 107 (119)
T d1b2pa_ 88 -VAGKAGHYVLVLQPDRNVVI 107 (119)
T ss_dssp -CCCCSSCEEEEECTTSCEEE
T ss_pred -CcCCCCceEEEEcCCCCEEE
Confidence 12235788999999998754
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.84 E-value=3.3e-09 Score=92.55 Aligned_cols=86 Identities=16% Similarity=0.306 Sum_probs=63.4
Q ss_pred CCeeEeeEeecCCCceEEEEEEecCCCCeEEEeeCCCCCCCCCCceEEEeeCccEEEeCCCCCeEEEecccC-CcceEEE
Q 038103 48 NGTFSSGFYKVGTNAYCYSIWFTNSVNRTVVWMANRDRPVNGKRSKLTLQRNGNLALTDKDSSVVWSTNTFT-DEGVQAQ 126 (804)
Q Consensus 48 ~g~F~lGFf~~~~~~~~~~iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~L~l~~~~~~~vWst~~~~-~~~~~a~ 126 (804)
.|.|.|.|-..| .|.|+. ...+||.+|-.. .+....+.+..+|||+|+|.++.++|+|++.. .....+.
T Consensus 34 ~g~y~L~~q~DG----NLvL~~----~~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~~l~ 103 (120)
T d1dlpa2 34 LSPYRLSMETDC----NLVLFD----RDDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFV 103 (120)
T ss_dssp CSSCEEEEETTT----EEEEEB----TTBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEEE
T ss_pred cCCEEEEEcCCC----cEEEec----CCcEEEEEcccc--CCCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCCCcEEEE
Confidence 355666665444 244432 246789998543 34556899999999999999999999999754 3455789
Q ss_pred EecCCCeEEEecCCCceeec
Q 038103 127 LLETGNLVLVNEANTTIWKS 146 (804)
Q Consensus 127 LldsGNlVl~~~~~~~lWqS 146 (804)
|.++|||||++ ..+|.|
T Consensus 104 Lq~DGnlvlY~---~~~W~t 120 (120)
T d1dlpa2 104 LQPDRNLAIYG---GALWTT 120 (120)
T ss_dssp ECSSSCEEEEC---CCCCBC
T ss_pred ECCCCcEEEeC---CCcccC
Confidence 99999999995 468875
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.79 E-value=9.9e-09 Score=87.89 Aligned_cols=76 Identities=26% Similarity=0.340 Sum_probs=60.8
Q ss_pred ceEEEeeCccEEEeCCCCCeEEEecccCCc-ceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccCCCCeEEecC
Q 038103 92 SKLTLQRNGNLALTDKDSSVVWSTNTFTDE-GVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSMR 170 (804)
Q Consensus 92 ~~l~~~~~G~L~l~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~~~~~L~S~~ 170 (804)
-+|.+..||||||++ .+.+||++++.... ...+.|.++|||||++.++.++|+|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS------------------------ 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS------------------------ 75 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC------------------------
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc------------------------
Confidence 478889999999997 46789999976543 4689999999999999999999996
Q ss_pred CCCCCcccccEEEecCCCcceee
Q 038103 171 SPGTYLSGFYNLKFDDNNILDLI 193 (804)
Q Consensus 171 s~~dps~G~y~~~~~~~~~~~~~ 193 (804)
.+....+.|.+.++++|.+.++
T Consensus 76 -~t~~~~~~~~l~L~ddGNlVly 97 (108)
T d1jpca_ 76 -NTGGQNGNYVCILQKDRNVVIY 97 (108)
T ss_dssp -CCCCSCSCEEEEECTTSCEEEE
T ss_pred -cccCCCCcEEEEEcCCCCEEEe
Confidence 1222457788999999876544
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.77 E-value=1.2e-08 Score=87.31 Aligned_cols=76 Identities=28% Similarity=0.479 Sum_probs=60.2
Q ss_pred ceEEEeeCccEEEeCCCCCeEEEecccC--CcceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccCCCCeEEec
Q 038103 92 SKLTLQRNGNLALTDKDSSVVWSTNTFT--DEGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSM 169 (804)
Q Consensus 92 ~~l~~~~~G~L~l~~~~~~~vWst~~~~--~~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~~~~~L~S~ 169 (804)
-.|.+..||||+|++ ++.+||++|+.. ..+..+.|.++|||||++.++.++|+|
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s----------------------- 76 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS----------------------- 76 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEEC-----------------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEE-----------------------
Confidence 467788999999986 567899999753 345679999999999999999999996
Q ss_pred CCCCCCcccccEEEecCCCcceee
Q 038103 170 RSPGTYLSGFYNLKFDDNNILDLI 193 (804)
Q Consensus 170 ~s~~dps~G~y~~~~~~~~~~~~~ 193 (804)
.+....|.|.+.++++|.+.++
T Consensus 77 --~t~~~~~~~~l~L~ddGNlvly 98 (109)
T d1kj1a_ 77 --HSVRGNGNYVLVLQEDGNVVIY 98 (109)
T ss_dssp --CCCCCSSCCEEEECTTSCEEEE
T ss_pred --eeECCCCCEEEEEeCCCcEEEE
Confidence 1122357789999999876543
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.39 E-value=4.1e-07 Score=78.21 Aligned_cols=75 Identities=25% Similarity=0.443 Sum_probs=57.3
Q ss_pred ceEEEeeCccEEEeCCCCCeEEEecccC-CcceEEEEecCCCeEEEecCCCceeeccCCCCCccCCCcccCCCCeEEecC
Q 038103 92 SKLTLQRNGNLALTDKDSSVVWSTNTFT-DEGVQAQLLETGNLVLVNEANTTIWKSFDSPTDTLLPSQLLTKNTTLVSMR 170 (804)
Q Consensus 92 ~~l~~~~~G~L~l~~~~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWqSFd~PTDtllpg~~l~~~~~L~S~~ 170 (804)
-.|.+..||||+|++ .+.+||++++.. ..++.+.|..+|||||++. +..+|.|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-~~~~w~s------------------------ 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-SRAIWAS------------------------ 74 (112)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET-TEEEEEC------------------------
T ss_pred EEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec-CCeEEEE------------------------
Confidence 478889999999986 567899999654 3457899999999999996 4556654
Q ss_pred CCCCCcccccEEEecCCCcceee
Q 038103 171 SPGTYLSGFYNLKFDDNNILDLI 193 (804)
Q Consensus 171 s~~dps~G~y~~~~~~~~~~~~~ 193 (804)
.+.-..|.|.+.++.+|.+.++
T Consensus 75 -~t~~~~~~~~l~L~ddGNlvly 96 (112)
T d1xd5a_ 75 -NTNRQNGNYYLILQRDRNVVIY 96 (112)
T ss_dssp -CCCCSCCCCEEEECTTSCEEEE
T ss_pred -eeccCCCceEEEEcCCCCEEEE
Confidence 2222347789999999976554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.02 E-value=1.5e-05 Score=79.38 Aligned_cols=133 Identities=14% Similarity=0.030 Sum_probs=90.4
Q ss_pred cccCcceEEEEEecCCcEEEEEEecCc-CCChHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEeeccCCChhhhh
Q 038103 521 GKGGFGSVFRGVLDDERVVAVKRLEGV-LQGDAEFWAEVSIIGRIN-HRNLVKLQGFCAENEHKLLVYEYVENGSLDKLL 598 (804)
Q Consensus 521 G~G~fg~Vykg~~~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l 598 (804)
+.++...||+....+ +.+.||+.... ......+.+|...+..+. +-.+.+++.+...++..++||+++++.++.+..
T Consensus 23 ~G~s~~~v~rv~~~~-~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 23 EGMSPAKVYKLVGEN-ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CCCSSSEEEEEECSS-CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCCCcEEEEEeCC-CeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 334446899887544 45678887633 233445778888887774 444677888888888999999999998776544
Q ss_pred ccCCCCCCCCCHHhHHHHHHHHHHHHHHHHhhC-----------------------------------------------
Q 038103 599 FNDPGTASILQWDQRYNIAVGTAKGLSYLHEEC----------------------------------------------- 631 (804)
Q Consensus 599 ~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~----------------------------------------------- 631 (804)
.. ......++.++++.++.||+..
T Consensus 102 ~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (263)
T d1j7la_ 102 ED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD 172 (263)
T ss_dssp TT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHH
T ss_pred cc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHH
Confidence 21 1112334555555555555321
Q ss_pred ---------CCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 632 ---------LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 632 ---------~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
...++|+|+.|.|||++++...-|.||+.+..
T Consensus 173 ~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11279999999999999876677999988874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.65 E-value=9.3e-05 Score=72.97 Aligned_cols=130 Identities=17% Similarity=0.056 Sum_probs=84.6
Q ss_pred ccccCc-ceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCC--CCcccceeeeEEeCCeeEEEEeeccCCChhh
Q 038103 520 VGKGGF-GSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRIN--HRNLVKLQGFCAENEHKLLVYEYVENGSLDK 596 (804)
Q Consensus 520 LG~G~f-g~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 596 (804)
+..|.. ..||+...+++..+++|.-.... ..++..|...++.+. ...+.+++.++.+++..++||+++++.++.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 444443 67899998888888899765332 234667888777663 3346677888888888999999998866543
Q ss_pred hhccCCCCCCCCCHHhHHHHHHHHHHH---------------------------------------------------HH
Q 038103 597 LLFNDPGTASILQWDQRYNIAVGTAKG---------------------------------------------------LS 625 (804)
Q Consensus 597 ~l~~~~~~~~~l~~~~~~~i~~~ia~~---------------------------------------------------l~ 625 (804)
.... ..+++.++++. +.
T Consensus 96 ~~~~------------~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 96 SHLA------------PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp SCCC------------HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccc------------HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 2100 01111222222 22
Q ss_pred HHHhhC----CCcEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 626 YLHEEC----LEWVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 626 yLH~~~----~~~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
.+.... ...++|+|+.|.|||++++..+-|.||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 332221 12279999999999999876678999988763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.95 E-value=0.0018 Score=67.92 Aligned_cols=74 Identities=22% Similarity=0.197 Sum_probs=46.8
Q ss_pred ccccccCcceEEEEEecC-CcEEEEEEecC----c----CCChHHHHHHHHHHhcCC-C--CcccceeeeEEeCCeeEEE
Q 038103 518 QEVGKGGFGSVFRGVLDD-ERVVAVKRLEG----V----LQGDAEFWAEVSIIGRIN-H--RNLVKLQGFCAENEHKLLV 585 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~-~~~vavK~l~~----~----~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lV 585 (804)
++||.|....||+....+ ++.++||.-.. . .....+...|.+.|+.+. + ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 67899997531 1 112234566888777662 2 234445443 45566899
Q ss_pred EeeccCCC
Q 038103 586 YEYVENGS 593 (804)
Q Consensus 586 ~E~~~~gs 593 (804)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.90 E-value=0.0014 Score=66.86 Aligned_cols=136 Identities=14% Similarity=0.094 Sum_probs=81.5
Q ss_pred ceEEEEEecCCcEEEEEEecCcCCChHHHHHHHHHHhcCCCCcc--ccee-----eeEEeCCeeEEEEeeccCCChhhh-
Q 038103 526 GSVFRGVLDDERVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNL--VKLQ-----GFCAENEHKLLVYEYVENGSLDKL- 597 (804)
Q Consensus 526 g~Vykg~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~-----g~~~~~~~~~lV~E~~~~gsL~~~- 597 (804)
-.||+...++|+.+++|..+......+++..|...+..|....+ +..+ .........+.+++++++..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 48999999999999999987666677888899998887742221 1111 123455677889999876432210
Q ss_pred ----------h-------ccC-CCCCCCCCHH-------------------hHHHHHHHHHHHHHHHHhhC----CCcEE
Q 038103 598 ----------L-------FND-PGTASILQWD-------------------QRYNIAVGTAKGLSYLHEEC----LEWVL 636 (804)
Q Consensus 598 ----------l-------~~~-~~~~~~l~~~-------------------~~~~i~~~ia~~l~yLH~~~----~~~iv 636 (804)
+ ... ...+..+++. .+..+...+.+.++.+.... +..++
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 0 000 0111122211 11112222333344443322 23489
Q ss_pred ecccccCeEEEcCCCCeEEeecCCccc
Q 038103 637 HCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 637 H~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
|+|+.+.|||++++ ..+.||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999754 45899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.16 E-value=0.029 Score=58.33 Aligned_cols=72 Identities=21% Similarity=0.222 Sum_probs=47.8
Q ss_pred ccccccCcceEEEEEecCC--------cEEEEEEecCcCCChHHHHHHHHHHhcCCCCccc-ceeeeEEeCCeeEEEEee
Q 038103 518 QEVGKGGFGSVFRGVLDDE--------RVVAVKRLEGVLQGDAEFWAEVSIIGRINHRNLV-KLQGFCAENEHKLLVYEY 588 (804)
Q Consensus 518 ~~LG~G~fg~Vykg~~~~~--------~~vavK~l~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~ 588 (804)
+.|+.|-.-.+|+...+++ +.|.+++.. .........+|..+++.+.-.++. ++++++.. .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4577888889999986543 345555544 333445567899988888533444 67776643 678999
Q ss_pred ccCCCh
Q 038103 589 VENGSL 594 (804)
Q Consensus 589 ~~~gsL 594 (804)
+++.+|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.87 E-value=0.0065 Score=37.66 Aligned_cols=32 Identities=41% Similarity=0.863 Sum_probs=26.9
Q ss_pred CcccCCcCCCCCcccccCCCCcccCCCCCCCcC
Q 038103 284 DYCTVHGLCGPNGICVNRPRQKTCICPNGFRRN 316 (804)
Q Consensus 284 ~~Cd~~~~CG~~g~C~~~~~~~~C~C~~GF~~~ 316 (804)
|.|.+-..|| +|-|++-...-.|.|-.||+|.
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCC
Confidence 6799999999 8999765555579999999984
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.54 E-value=0.29 Score=48.43 Aligned_cols=30 Identities=20% Similarity=0.211 Sum_probs=26.8
Q ss_pred cEEecccccCeEEEcCCCCeEEeecCCccc
Q 038103 634 WVLHCDVKPQNILLDDHFEPKVTDFGLSKL 663 (804)
Q Consensus 634 ~ivH~Dlkp~NILl~~~~~~kl~Dfgla~~ 663 (804)
.++|+|+.+.||+++++...-|.||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 389999999999999987778999998873
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.78 E-value=0.072 Score=35.40 Aligned_cols=31 Identities=29% Similarity=0.759 Sum_probs=25.4
Q ss_pred CcccC-CcCCCCCcccccCCCCcccCCCCCCC
Q 038103 284 DYCTV-HGLCGPNGICVNRPRQKTCICPNGFR 314 (804)
Q Consensus 284 ~~Cd~-~~~CG~~g~C~~~~~~~~C~C~~GF~ 314 (804)
|+|.. ...|..+|.|.+....-.|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 56775 46799999997766667899999996
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.29 E-value=0.29 Score=32.46 Aligned_cols=32 Identities=28% Similarity=0.615 Sum_probs=25.0
Q ss_pred CCcccCCcCCCCCcccccCCCCcccCCCCCCCc
Q 038103 283 LDYCTVHGLCGPNGICVNRPRQKTCICPNGFRR 315 (804)
Q Consensus 283 ~~~Cd~~~~CG~~g~C~~~~~~~~C~C~~GF~~ 315 (804)
-|+|... .|+.++.|.+...+-.|.|++||+.
T Consensus 5 idEC~~~-~~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEP-DVCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSST-TSCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCc-CCCCCCEeECCCCCeEeECCCCccc
Confidence 3678755 4557899987777778999999975
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.99 E-value=0.23 Score=32.19 Aligned_cols=30 Identities=33% Similarity=0.798 Sum_probs=22.8
Q ss_pred CcccCCcCCCCCcccccCCCCcccCCCCCCC
Q 038103 284 DYCTVHGLCGPNGICVNRPRQKTCICPNGFR 314 (804)
Q Consensus 284 ~~Cd~~~~CG~~g~C~~~~~~~~C~C~~GF~ 314 (804)
|+|. ...|...|.|......-.|.|++||+
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCC
Confidence 3464 46788889997655566899999996
|
| >d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Hairpin loop containing domain-like superfamily: Hairpin loop containing domain-like family: Hairpin loop containing domain domain: Hepatocyte growth factor species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.77 E-value=0.49 Score=37.08 Aligned_cols=52 Identities=21% Similarity=0.403 Sum_probs=34.3
Q ss_pred ceEEcCCCCccCcceee---eccCCCHHHHHHHhccCC----ceeeEEeecCCCCeeeec
Q 038103 339 DFMELPNTDYYGYDLVT---YGIGISLQECRNRCLSDC----KCKGFGYSTDGQGECFPK 391 (804)
Q Consensus 339 ~f~~l~~~~~~~~~~~~---~~~~~s~~~C~~~Cl~nC----sC~Ay~y~~~g~g~C~~~ 391 (804)
+|.+..++.+....... .....+.++|...|+++= .|.+|.|.. ..+.|++.
T Consensus 6 dy~kt~~~~L~~~~~~~~~~~~~~~s~eeCA~rC~~~~~~~f~CrSF~y~~-~~~~C~Ls 64 (91)
T d2qj2a1 6 EFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDK-ARKQCLWF 64 (91)
T ss_dssp GEEEETTEEEEECSTTCCCEEEECSCHHHHHHHHHTTTTCSSCCCEEEEET-TTTEEEEE
T ss_pred hhhhcCCceEeccCccccccccccCCHHHHHHHHHccCCCCceEEeEEEEC-CCCeEEEc
Confidence 46666666553322211 112348999999999854 599999975 66789875
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.02 E-value=0.32 Score=31.84 Aligned_cols=31 Identities=32% Similarity=0.764 Sum_probs=24.2
Q ss_pred CcccCCcCCCCCcccccCCCCcccCCCCCCCcC
Q 038103 284 DYCTVHGLCGPNGICVNRPRQKTCICPNGFRRN 316 (804)
Q Consensus 284 ~~Cd~~~~CG~~g~C~~~~~~~~C~C~~GF~~~ 316 (804)
|+|...+.| ..+|.+...+-.|.|++||+..
T Consensus 2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTTTTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred ccCCCCCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 568777777 4689776667789999999863
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.49 E-value=0.22 Score=33.22 Aligned_cols=32 Identities=38% Similarity=0.949 Sum_probs=24.3
Q ss_pred CcccCC-cCCCCCcccccCCCCcccCCCCCCCcC
Q 038103 284 DYCTVH-GLCGPNGICVNRPRQKTCICPNGFRRN 316 (804)
Q Consensus 284 ~~Cd~~-~~CG~~g~C~~~~~~~~C~C~~GF~~~ 316 (804)
|+|... ..| .++.|.+...+-.|.|++||+..
T Consensus 4 dEC~~~~~~C-~~~~C~Nt~Gsy~C~C~~Gy~~~ 36 (44)
T d1lmja1 4 DECRISPDLC-GRGQCVNTPGDFECKCDEGYESG 36 (44)
T ss_dssp CTTTTCSSTT-TTSCEEEETTEEEECCCSSEEEC
T ss_pred cccCCCCCCC-CCCEeEcCCCCeEEeCCCCCccC
Confidence 678764 456 47899877777789999999753
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.07 E-value=0.19 Score=33.45 Aligned_cols=32 Identities=38% Similarity=0.776 Sum_probs=25.3
Q ss_pred CcccCCcCCCCCcccccCCCCcccCCCCCCCcC
Q 038103 284 DYCTVHGLCGPNGICVNRPRQKTCICPNGFRRN 316 (804)
Q Consensus 284 ~~Cd~~~~CG~~g~C~~~~~~~~C~C~~GF~~~ 316 (804)
|+|.....| -.+.|.+...+-.|.|++||+..
T Consensus 4 dEC~~~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~ 35 (43)
T d1uzka1 4 NECLDPTTC-ISGNCVNTPGSYICDCPPDFELN 35 (43)
T ss_dssp CGGGSTTSS-BTSEEEEETTEEEEECCTTCEEC
T ss_pred cccCCCCcC-cCCEeECCCCCEEEecCCCCEEC
Confidence 678876665 47999877666789999999864
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.05 E-value=0.26 Score=31.91 Aligned_cols=30 Identities=33% Similarity=0.787 Sum_probs=24.1
Q ss_pred CcccCCcCCCCCcccccCCCCcccCCCCCCC
Q 038103 284 DYCTVHGLCGPNGICVNRPRQKTCICPNGFR 314 (804)
Q Consensus 284 ~~Cd~~~~CG~~g~C~~~~~~~~C~C~~GF~ 314 (804)
|+|. ...|-..|.|......-+|.|++||+
T Consensus 4 d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~ 33 (39)
T d1edmb_ 4 DQCE-SNPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CTTT-TCCCCTTCEEEEETTEEEEECCTTCC
T ss_pred ccCC-CCCCCCCcEEEcCCCCEEEECCCCCC
Confidence 5676 57799999997665667899999996
|